data_2myg_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2myg _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.4 t . . . . . 0 CA--C 1.547 0.865 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.6 pt -49.21 -24.82 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 126.741 2.016 . . . . 0.0 116.222 -165.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.26 -21.84 26.16 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.929 1.691 . . . . 0.0 114.264 -178.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.9 m -77.32 -32.74 55.49 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.81 1.244 . . . . 0.0 113.437 170.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 78.8 mtp -63.26 -33.76 76.19 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 121.306 -0.871 . . . . 0.0 111.371 -176.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.0 mm -62.35 -22.47 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 125.726 1.611 . . . . 0.0 112.767 -176.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -85.86 -17.74 34.77 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.24 1.416 . . . . 0.0 113.876 179.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -88.77 -7.5 71.15 Favored Glycine 0 CA--C 1.536 1.395 0 N-CA-C 115.933 1.133 . . . . 0.0 115.933 -173.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -145.04 161.16 40.09 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.292 1.437 . . . . 0.0 110.738 169.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -67.77 -48.33 66.65 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.091 0.956 . . . . 0.0 111.176 177.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.4 t -114.53 131.12 67.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.937 1.295 . . . . 0.0 110.961 171.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 85.3 t -131.06 130.74 63.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 125.014 1.326 . . . . 0.0 110.206 179.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 49.3 t -128.81 146.03 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 124.13 0.972 . . . . 0.0 112.421 -175.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -121.84 111.53 17.23 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.789 1.235 . . . . 0.0 109.099 173.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 18.7 m -121.14 172.68 7.8 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 126.728 2.011 . . . . 0.0 111.319 -173.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.46 ' CD1' ' HB3' ' A' ' 46' ' ' ASP . 23.6 m0 -120.31 135.88 54.86 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.57 1.148 . . . . 0.0 108.86 162.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 60.7 t -57.72 -35.54 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 CA-C-N 118.849 0.75 . . . . 0.0 111.13 -177.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.3 p -74.34 -10.82 59.96 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 127.308 2.243 . . . . 0.0 116.408 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 38.0 t -90.61 143.73 29.52 Favored Pre-proline 0 CA--C 1.537 0.48 0 O-C-N 121.264 -0.898 . . . . 0.0 110.513 -170.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.33 -39.05 0.61 Allowed 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 121.114 1.209 . . . . 0.0 112.655 173.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -59.01 -36.31 74.73 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.307 1.043 . . . . 0.0 113.744 178.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -48.44 -54.73 13.06 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.713 1.205 . . . . 0.0 109.584 168.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 57.5 t -65.2 -39.64 86.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.242 1.017 . . . . 0.0 112.139 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 79.6 mmt-85 -54.78 -41.67 70.8 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 118.687 0.676 . . . . 0.0 111.572 174.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.17 -54.27 8.88 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.608 0.763 . . . . 0.0 113.007 173.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -54.24 -31.94 54.67 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 119.498 1.044 . . . . 0.0 113.349 -177.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -69.32 -49.23 57.68 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.0 0.92 . . . . 0.0 112.669 176.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 8.0 tt -72.59 -36.74 68.22 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 124.651 1.181 . . . . 0.0 111.861 -177.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 93.2 mt -62.25 -44.78 95.77 Favored 'General case' 0 CA--C 1.53 0.175 0 O-C-N 121.607 -0.683 . . . . 0.0 111.395 177.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 14.8 m-70 -69.61 -20.88 63.61 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 172.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.61 -31.91 53.19 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 119.698 1.135 . . . . 0.0 113.203 173.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 39.6 mmt-85 -97.36 -23.79 15.94 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 114.827 1.418 . . . . 0.0 114.827 -176.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 14.6 t -153.78 170.25 21.39 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -177.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 77.6 mttt -112.68 3.82 16.81 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 126.411 1.884 . . . . 0.0 112.224 167.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -105.83 42.94 1.18 Allowed 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 126.081 1.752 . . . . 0.0 113.114 -171.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -119.54 134.97 61.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.858 1.663 . . . . 0.0 111.959 -177.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.0 m -119.19 141.85 48.51 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.803 2.041 . . . . 0.0 110.242 167.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.5 p -135.37 141.04 43.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 125.072 1.349 . . . . 0.0 113.308 176.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -112.77 134.68 54.17 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 127.414 2.286 . . . . 0.0 110.394 175.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -101.62 89.44 3.71 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 124.15 0.98 . . . . 0.0 110.509 -179.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.9 m -76.1 4.65 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -170.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.46 ' HB3' ' CD1' ' A' ' 20' ' ' TRP . 2.5 p-10 -85.23 -22.92 28.47 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.759 1.224 . . . . 0.0 112.038 167.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 30.0 mtmt -90.0 5.09 48.08 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.904 2.082 . . . . 0.0 113.41 176.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 12.2 tpt -120.63 124.25 44.79 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.975 1.71 . . . . 0.0 111.413 -165.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 10.5 m -65.21 -22.91 66.95 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.735 0.814 . . . . 0.0 112.847 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.4 5.58 51.36 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 126.16 1.784 . . . . 0.0 113.549 174.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -55.88 -30.57 57.14 Favored Glycine 0 CA--C 1.532 1.106 0 O-C-N 120.402 -1.436 . . . . 0.0 114.651 -174.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -70.23 -26.23 63.76 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 118.541 1.17 . . . . 0.0 113.043 175.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -72.21 -44.11 63.45 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.97 0.908 . . . . 0.0 110.53 170.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.23 -36.65 83.57 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.044 0.538 . . . . 0.0 110.459 178.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 43.0 mtp180 -63.93 -42.01 97.47 Favored 'General case' 0 N--CA 1.477 0.897 0 O-C-N 121.077 -1.014 . . . . 0.0 112.176 167.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -58.91 -38.38 92.49 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 124.225 0.917 . . . . 0.0 113.627 176.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -61.18 -32.29 72.03 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 118.597 1.199 . . . . 0.0 113.637 173.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 52.0 mt -81.28 -42.55 19.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 123.939 0.896 . . . . 0.0 109.214 177.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -71.93 -39.59 69.36 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 121.115 -0.991 . . . . 0.0 112.941 -176.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 42.2 mm-40 -68.63 -23.91 64.49 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 119.939 1.245 . . . . 0.0 113.069 177.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -98.75 -31.75 11.73 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.533 1.133 . . . . 0.0 113.827 -178.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -134.87 5.0 3.33 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -170.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 66.7 mmtt 47.37 38.94 8.14 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 126.565 1.946 . . . . 0.0 114.429 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -139.88 147.69 40.99 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.704 1.202 . . . . 0.0 111.446 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -140.29 2.47 1.88 Allowed 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.998 1.319 . . . . 0.0 113.861 -172.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 90.2 m -82.22 141.04 33.32 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.284 1.034 . . . . 0.0 111.851 175.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.9 m -101.97 156.06 35.68 Favored Pre-proline 0 N--CA 1.475 0.785 0 C-N-CA 124.826 1.251 . . . . 0.0 112.73 -176.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -73.69 150.96 96.42 Favored 'Cis proline' 0 C--N 1.348 0.546 0 CA-C-N 118.759 0.592 . . . . 0.0 113.013 -5.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -98.02 130.84 44.83 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 161.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 47.8 mt -126.28 141.39 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 C-N-CA 124.084 0.954 . . . . 0.0 109.294 -167.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -139.34 141.11 37.66 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.516 0.727 . . . . 0.0 111.736 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 43.4 mt -136.5 117.07 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.659 1.184 . . . . 0.0 109.508 -179.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 46.37 38.58 5.4 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 125.135 1.374 . . . . 0.0 114.165 -171.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 78.83 0.29 80.64 Favored Glycine 0 CA--C 1.54 1.654 0 N-CA-C 115.723 1.049 . . . . 0.0 115.723 -177.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 -88.61 145.84 25.46 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 119.088 1.444 . . . . 0.0 110.261 174.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -94.06 137.62 33.05 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -172.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 18.3 mm -130.75 115.46 30.95 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 C-N-CA 127.825 2.45 . . . . 0.0 107.663 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -70.97 -16.97 75.11 Favored Glycine 0 CA--C 1.537 1.461 0 N-CA-C 116.41 1.324 . . . . 0.0 116.41 -165.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 172.99 -173.87 45.72 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 124.558 1.075 . . . . 0.0 113.52 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 34.1 t -62.92 -35.63 80.73 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 122.262 -0.552 . . . . 0.0 111.469 174.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 43.5 t -60.96 -44.29 97.5 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.795 -0.565 . . . . 0.0 112.319 173.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -70.94 -31.11 67.61 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.51 1.124 . . . . 0.0 112.015 -179.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 42.5 tp -69.38 -50.82 42.55 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.815 1.646 . . . . 0.0 111.289 172.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -64.36 -31.45 72.66 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 121.422 -0.799 . . . . 0.0 112.521 178.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.43 -22.63 65.2 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 119.131 0.878 . . . . 0.0 112.771 175.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 68.7 mt -90.13 -29.81 18.06 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.987 1.315 . . . . 0.0 112.088 171.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -65.16 -45.4 85.09 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.041 0.936 . . . . 0.0 112.264 172.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -60.33 -22.52 63.32 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.747 1.619 . . . . 0.0 114.059 177.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -105.07 -7.81 18.9 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.061 1.344 . . . . 0.0 114.584 -176.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 84.08 6.11 86.88 Favored Glycine 0 CA--C 1.54 1.627 0 CA-C-N 118.881 0.764 . . . . 0.0 114.673 -176.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 34.0 mtmt -90.51 -25.68 20.15 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 125.662 1.585 . . . . 0.0 113.252 -171.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 52.4 tp -65.19 -38.55 90.85 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.283 1.033 . . . . 0.0 111.258 173.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -62.06 -23.6 66.59 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 173.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -85.2 -23.41 48.51 Favored Glycine 0 CA--C 1.532 1.123 0 O-C-N 121.545 -0.722 . . . . 0.0 114.141 172.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 41.9 mt -79.18 -35.03 42.53 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.893 1.277 . . . . 0.0 112.336 175.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 51.5 mt -81.01 -0.73 40.89 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 115.421 1.638 . . . . 0.0 115.421 -166.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 16.4 m . . . . . 0 C--O 1.254 1.34 0 C-N-CA 127.073 2.149 . . . . 0.0 113.027 -179.57 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 53.8 p . . . . . 0 C--O 1.238 0.498 0 CA-C-O 121.422 0.63 . . . . 0.0 109.557 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 21.3 pt -53.44 -27.55 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 123.344 0.658 . . . . 0.0 112.621 172.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.88 -25.12 64.46 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -172.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.1 m -81.07 -31.95 34.18 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 121.096 -1.003 . . . . 0.0 111.904 167.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 56.5 mtm -68.37 -17.97 64.36 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 178.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.5 mm -60.84 -31.16 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 CA-C-N 119.223 0.919 . . . . 0.0 111.99 171.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.2 mptt -75.53 -1.52 24.71 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -174.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -81.86 -38.03 14.78 Favored Glycine 0 CA--C 1.537 1.436 0 N-CA-C 115.659 1.024 . . . . 0.0 115.659 -172.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -140.84 171.92 13.41 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.304 1.442 . . . . 0.0 112.641 -174.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 29.0 ttpt -68.7 -39.29 80.56 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.849 1.26 . . . . 0.0 112.813 -178.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.1 t -122.47 134.44 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.031 0.932 . . . . 0.0 110.357 172.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 25.2 t -135.27 130.51 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 124.368 1.067 . . . . 0.0 109.985 177.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 54.8 t -127.4 149.12 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.472 1.109 . . . . 0.0 111.977 -173.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -127.31 114.33 17.45 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.408 1.483 . . . . 0.0 109.409 175.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.7 m -130.14 172.13 12.1 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 126.571 1.948 . . . . 0.0 111.444 -168.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 23.0 m0 -114.55 138.99 49.95 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 158.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 96.6 t -65.56 -22.82 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 CA-C-N 118.465 0.575 . . . . 0.0 111.208 175.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 76.6 p -68.54 -18.73 64.42 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.639 1.576 . . . . 0.0 115.001 172.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 49.9 t -93.14 143.3 26.53 Favored Pre-proline 0 CA--C 1.539 0.522 0 CA-C-N 119.698 1.135 . . . . 0.0 111.498 -165.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -82.92 -33.53 0.42 Allowed 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 121.217 1.278 . . . . 0.0 112.932 174.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -61.23 -36.64 80.5 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.67 1.188 . . . . 0.0 112.705 176.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -49.85 -55.13 15.43 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.382 1.473 . . . . 0.0 109.517 168.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 86.0 t -63.97 -39.02 83.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.221 1.008 . . . . 0.0 112.558 -176.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 25.4 mmm180 -53.89 -48.11 70.41 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 118.745 0.702 . . . . 0.0 111.029 173.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.81 -55.77 13.39 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.617 0.767 . . . . 0.0 112.342 175.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.79 -38.27 47.41 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.722 1.209 . . . . 0.0 113.698 -178.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -71.28 -51.08 26.47 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.394 0.678 . . . . 0.0 111.172 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.2 tt -66.19 -38.63 88.46 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 125.151 1.381 . . . . 0.0 111.754 -177.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 71.5 mt -61.86 -52.94 62.07 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.897 0.879 . . . . 0.0 111.172 176.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -63.43 -25.23 68.18 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 172.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.04 -13.27 60.22 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 120.514 -1.366 . . . . 0.0 113.514 175.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 12.3 mmp_? -99.87 -56.88 2.26 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.842 1.257 . . . . 0.0 112.433 171.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 25.4 p -150.02 143.15 24.98 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.556 1.142 . . . . 0.0 113.915 -164.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -83.73 -0.98 53.11 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 126.572 1.949 . . . . 0.0 113.528 175.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -83.29 29.35 0.5 Allowed 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.075 1.35 . . . . 0.0 113.383 -177.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -110.15 132.49 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 126.818 2.047 . . . . 0.0 111.089 -174.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 46.8 m -110.2 138.88 45.97 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 126.956 2.103 . . . . 0.0 108.89 166.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.1 p -134.6 139.61 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-O 122.537 1.161 . . . . 0.0 113.37 170.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 34.6 m-70 -116.23 145.95 42.72 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 127.939 2.496 . . . . 0.0 110.918 -178.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -123.58 90.77 3.34 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.967 0.889 . . . . 0.0 111.335 -168.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 34.9 m -68.24 -11.66 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -174.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.41 -23.58 54.03 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.865 0.866 . . . . 0.0 112.963 170.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -86.43 -32.26 20.97 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.703 1.201 . . . . 0.0 111.977 175.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 67.1 mtt -61.75 143.83 55.62 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.122 0.969 . . . . 0.0 112.157 174.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 9.4 t -70.42 -37.58 74.46 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.835 0.854 . . . . 0.0 111.103 168.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -100.16 7.92 44.22 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.776 1.63 . . . . 0.0 114.026 -176.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -57.02 -27.41 57.12 Favored Glycine 0 CA--C 1.534 1.244 0 O-C-N 120.598 -1.314 . . . . 0.0 115.795 -172.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -67.6 -20.01 65.31 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.052 1.426 . . . . 0.0 112.82 174.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -80.34 -33.82 37.08 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.984 1.314 . . . . 0.0 112.0 170.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -77.9 -27.98 49.71 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 121.52 -0.737 . . . . 0.0 111.495 177.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 66.5 mtp180 -54.72 -39.74 68.53 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-N 119.633 1.106 . . . . 0.0 111.337 159.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.23 -28.02 73.06 Favored Glycine 0 CA--C 1.534 1.271 0 CA-C-O 119.095 -0.836 . . . . 0.0 115.033 175.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -65.0 -35.0 79.79 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 119.557 1.678 . . . . 0.0 112.398 174.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 27.9 mt -72.93 -41.3 60.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 124.44 1.096 . . . . 0.0 109.278 173.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -64.53 -46.29 83.5 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 121.49 -0.757 . . . . 0.0 112.947 -177.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 93.5 mm-40 -70.58 -18.02 62.9 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -92.74 -33.03 14.47 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 175.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -136.35 -0.73 2.41 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 115.678 1.733 . . . . 0.0 115.678 -168.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 53.06 41.35 32.16 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 126.803 2.041 . . . . 0.0 113.835 -169.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -128.72 140.61 51.65 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.592 1.157 . . . . 0.0 113.056 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -142.18 -18.03 0.73 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.684 1.194 . . . . 0.0 113.949 -169.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.7 p -72.68 164.55 26.34 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.49 1.116 . . . . 0.0 113.524 169.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 20.1 m -123.65 155.03 66.82 Favored Pre-proline 0 N--CA 1.478 0.955 0 C-N-CA 124.715 1.206 . . . . 0.0 113.597 -175.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -75.47 151.73 96.59 Favored 'Cis proline' 0 C--N 1.35 0.619 0 CA-C-N 118.793 0.605 . . . . 0.0 112.913 -4.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -100.12 132.5 45.45 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 162.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 69.3 mt -126.23 142.4 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 123.977 0.911 . . . . 0.0 108.725 -167.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -138.68 146.04 41.1 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.669 0.788 . . . . 0.0 112.08 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 51.8 mt -132.73 119.99 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.907 1.283 . . . . 0.0 109.994 176.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 48.05 29.75 1.86 Allowed 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 126.224 1.81 . . . . 0.0 114.57 -176.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 91.21 0.51 73.74 Favored Glycine 0 CA--C 1.541 1.703 0 C-N-CA 125.428 1.489 . . . . 0.0 116.759 -175.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -93.0 144.96 24.74 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 126.022 1.729 . . . . 0.0 110.744 175.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -91.96 141.56 28.5 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.704 1.202 . . . . 0.0 114.065 -176.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 26.4 mm -127.79 123.2 60.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 C-N-CA 128.076 2.55 . . . . 0.0 108.364 -178.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -72.02 16.63 1.51 Allowed Glycine 0 N--CA 1.475 1.274 0 N-CA-C 118.863 2.305 . . . . 0.0 118.863 -167.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 114.59 -159.8 13.53 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 126.831 2.158 . . . . 0.0 114.196 178.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 53.6 t -65.25 -42.22 93.5 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.796 0.838 . . . . 0.0 113.229 -172.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 21.5 m -61.27 -40.9 95.8 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 118.924 0.784 . . . . 0.0 112.025 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -66.03 -40.45 91.05 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.774 1.23 . . . . 0.0 112.107 176.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 56.1 tp -64.14 -50.83 66.68 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.326 1.45 . . . . 0.0 111.35 177.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -63.3 -39.51 94.77 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 118.108 0.413 . . . . 0.0 111.106 175.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.29 -38.67 90.26 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 121.541 -0.724 . . . . 0.0 111.869 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 29.4 mt -66.53 -27.38 67.71 Favored 'General case' 0 N--CA 1.468 0.425 0 O-C-N 121.302 -0.874 . . . . 0.0 112.151 176.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -75.04 -43.42 53.68 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 118.748 0.704 . . . . 0.0 111.634 174.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -65.87 -32.41 73.9 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.582 0.753 . . . . 0.0 112.083 175.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -78.84 -0.48 30.79 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 126.119 1.768 . . . . 0.0 113.601 172.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 73.22 23.0 78.38 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 124.461 1.029 . . . . 0.0 114.925 173.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 43.2 mtmt -113.59 -24.06 9.43 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 127.31 2.244 . . . . 0.0 113.877 -168.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 38.7 tp -63.24 -37.33 86.81 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 123.43 0.692 . . . . 0.0 111.825 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -54.92 -44.14 73.96 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.545 0.738 . . . . 0.0 112.375 175.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -73.53 -33.67 58.09 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 123.991 0.805 . . . . 0.0 113.894 177.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 82.3 mt -68.24 -36.39 79.39 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 118.764 1.282 . . . . 0.0 111.801 173.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 83.0 mt -83.9 6.2 22.55 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.932 1.293 . . . . 0.0 113.184 176.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 61.4 m . . . . . 0 C--O 1.253 1.286 0 C-N-CA 124.054 0.942 . . . . 0.0 111.1 171.891 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 7.8 p . . . . . 0 CA--C 1.534 0.354 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 21.8 pt -54.53 -23.15 10.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 125.072 1.349 . . . . 0.0 113.044 168.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.58 -22.19 66.9 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -174.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 70.5 m -79.12 -28.95 42.97 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 121.08 -1.013 . . . . 0.0 113.148 170.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 54.8 mtt -64.3 -30.97 72.0 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 121.382 -0.824 . . . . 0.0 111.723 -178.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.7 mm -60.74 -27.67 41.35 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 125.012 1.325 . . . . 0.0 112.279 -178.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.4 mptt -81.0 -11.39 59.57 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.996 1.318 . . . . 0.0 113.577 178.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -80.87 -32.71 32.04 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 124.12 0.866 . . . . 0.0 114.985 -176.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 55.0 m-80 -141.56 162.47 35.4 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 115.445 1.646 . . . . 0.0 115.445 -172.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -61.62 -42.36 98.77 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.958 1.303 . . . . 0.0 112.705 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.4 t -127.55 132.12 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.129 0.972 . . . . 0.0 110.317 175.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 48.0 t -132.08 131.17 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.015 0.926 . . . . 0.0 110.92 178.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.0 t -129.84 150.45 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.275 1.03 . . . . 0.0 113.029 -174.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -126.28 106.87 9.83 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.692 1.197 . . . . 0.0 109.992 175.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 60.9 m -125.02 167.33 14.89 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 126.058 1.743 . . . . 0.0 112.134 -169.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 41.7 m0 -113.66 121.55 44.49 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.046 1.338 . . . . 0.0 109.289 166.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 96.4 t -55.99 -27.61 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 C-N-CA 124.777 1.231 . . . . 0.0 112.772 -174.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.6 p -74.45 -17.04 60.84 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 126.998 2.119 . . . . 0.0 115.054 178.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 76.1 m -107.74 158.19 34.01 Favored Pre-proline 0 CA--C 1.54 0.591 0 CA-C-N 120.135 1.334 . . . . 0.0 114.02 -160.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -79.86 -48.11 0.08 OUTLIER 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.175 1.917 . . . . 0.0 112.879 -168.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -60.99 -36.31 79.13 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.067 0.947 . . . . 0.0 113.281 -179.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -43.61 -55.42 4.32 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.701 1.2 . . . . 0.0 110.128 165.18 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 54.5 t -68.3 -40.31 82.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 123.89 0.876 . . . . 0.0 111.967 -178.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 43.6 mmt-85 -56.14 -41.38 75.3 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 118.865 0.757 . . . . 0.0 111.828 175.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.94 -56.72 5.61 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.732 1.213 . . . . 0.0 112.909 173.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -51.44 -35.78 41.1 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 119.857 1.208 . . . . 0.0 113.243 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 25.3 ttpt -69.44 -50.35 46.52 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 124.203 1.001 . . . . 0.0 111.647 178.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.5 tt -65.72 -41.65 92.0 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 124.63 1.172 . . . . 0.0 111.006 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 53.0 mt -62.22 -50.05 73.31 Favored 'General case' 0 C--O 1.227 -0.095 0 CA-C-O 118.359 -0.829 . . . . 0.0 111.112 177.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 14.7 m170 -61.6 -21.81 64.67 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 118.74 0.7 . . . . 0.0 112.617 173.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -83.54 -14.16 52.87 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 119.79 1.177 . . . . 0.0 114.033 174.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.91 -36.99 4.96 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.109 1.364 . . . . 0.0 114.1 -178.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.0 m -147.97 138.98 23.3 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 126.312 1.845 . . . . 0.0 111.107 -171.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -97.37 -22.95 16.33 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.195 0.998 . . . . 0.0 112.665 174.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -78.3 52.5 1.13 Allowed 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 125.263 1.425 . . . . 0.0 112.921 172.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -112.3 136.36 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 127.665 2.386 . . . . 0.0 109.934 178.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.6 m -123.13 119.79 31.32 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.723 1.609 . . . . 0.0 110.185 172.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.3 p -110.26 133.66 54.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 123.772 0.829 . . . . 0.0 111.743 170.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -103.84 125.94 50.62 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.881 1.272 . . . . 0.0 109.802 170.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -95.74 101.83 13.57 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 121.866 0.841 . . . . 0.0 111.169 -176.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . 0.278 29.8 m -81.97 5.57 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 O-C-N 120.552 -1.342 . . . . 0.0 114.481 -173.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -92.04 -20.61 21.14 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 125.26 1.424 . . . . 0.0 112.163 161.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.4 mmmt -89.66 -37.04 14.9 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 126.784 2.034 . . . . 0.0 111.878 176.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 46.1 tpp -85.2 121.12 27.5 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.683 0.793 . . . . 0.0 110.236 177.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 73.2 m -64.46 -24.45 67.62 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 -168.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -86.78 1.46 52.16 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 126.911 2.085 . . . . 0.0 114.551 171.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -50.97 -27.35 13.45 Favored Glycine 0 CA--C 1.533 1.2 0 N-CA-C 116.92 1.528 . . . . 0.0 116.92 -169.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -73.98 -20.86 60.21 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 119.808 1.804 . . . . 0.0 113.157 177.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 63.2 mm-40 -83.3 -29.89 28.0 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 121.03 -1.043 . . . . 0.0 111.803 172.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -73.92 -34.34 64.32 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.777 0.831 . . . . 0.0 111.509 170.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 63.7 mtp85 -53.87 -39.16 65.45 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 119.606 1.094 . . . . 0.0 111.196 161.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -55.54 -42.01 82.95 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.054 0.835 . . . . 0.0 114.13 171.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -65.81 -25.64 67.32 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 119.697 1.748 . . . . 0.0 113.272 177.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.1 mt -79.66 -47.59 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 123.997 0.919 . . . . 0.0 109.477 172.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -66.64 -42.62 86.41 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.441 -0.787 . . . . 0.0 112.434 -175.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -60.76 -26.65 67.39 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 121.409 -0.807 . . . . 0.0 113.057 177.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -94.52 -36.65 11.75 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 -178.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -129.15 -4.03 5.01 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 115.045 1.498 . . . . 0.0 115.045 -168.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.5 mttt 43.9 61.68 2.22 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 127.939 2.496 . . . . 0.0 113.484 -174.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -135.16 109.0 8.07 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 112.428 -2.169 . . . . 0.0 110.896 -171.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -99.92 -5.9 27.56 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.68 1.592 . . . . 0.0 112.555 177.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.0 t -51.35 148.71 4.64 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 127.17 2.188 . . . . 0.0 113.452 162.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.2 m -136.8 141.12 33.92 Favored Pre-proline 0 N--CA 1.477 0.882 0 C-N-CA 125.962 1.705 . . . . 0.0 109.926 164.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -78.6 152.21 89.83 Favored 'Cis proline' 0 N--CA 1.46 -0.492 0 CA-C-N 119.862 0.986 . . . . 0.0 114.086 5.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -97.06 142.14 29.36 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.639 0.776 . . . . 0.0 109.535 161.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 53.6 mt -133.68 139.58 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 123.816 0.846 . . . . 0.0 110.016 -164.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -138.46 144.1 39.94 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.626 1.17 . . . . 0.0 111.468 179.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 66.5 mt -133.72 120.5 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 124.926 1.29 . . . . 0.0 109.029 177.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 45.91 38.96 4.98 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 125.85 1.66 . . . . 0.0 114.134 -176.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 82.36 -3.0 83.58 Favored Glycine 0 CA--C 1.539 1.535 0 N-CA-C 116.514 1.366 . . . . 0.0 116.514 -176.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -88.25 147.14 24.97 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.371 1.468 . . . . 0.0 109.675 174.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -89.65 143.74 26.56 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.809 0.844 . . . . 0.0 112.104 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 20.1 mm -126.92 115.44 41.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 127.039 2.135 . . . . 0.0 107.273 175.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.85 -16.1 61.09 Favored Glycine 0 CA--C 1.534 1.242 0 N-CA-C 116.908 1.523 . . . . 0.0 116.908 -167.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 173.46 177.74 42.91 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-N 118.796 1.298 . . . . 0.0 115.935 174.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 29.8 t -59.41 -35.19 73.52 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 122.904 0.482 . . . . 0.0 112.068 175.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 50.4 m -72.96 -16.91 61.52 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.647 1.179 . . . . 0.0 113.584 178.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -86.72 -39.13 16.3 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.446 1.098 . . . . 0.0 111.386 169.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 51.0 tp -61.06 -51.01 70.98 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.222 1.409 . . . . 0.0 111.514 174.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -55.57 -38.06 68.86 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.554 1.141 . . . . 0.0 111.028 173.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.04 -31.17 65.91 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.09 -1.006 . . . . 0.0 113.235 -177.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 32.1 mt -72.32 -30.94 65.24 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 119.227 0.921 . . . . 0.0 112.339 173.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -65.27 -33.83 76.92 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.791 1.236 . . . . 0.0 111.083 169.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 15.1 mmtt -80.23 -9.32 59.72 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 176.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -98.51 -11.7 21.99 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.92 1.288 . . . . 0.0 114.329 172.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 67.65 29.09 73.59 Favored Glycine 0 CA--C 1.539 1.569 0 C-N-CA 121.163 -0.541 . . . . 0.0 112.357 -171.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 31.8 mtmt -111.98 -16.32 13.12 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 126.547 1.939 . . . . 0.0 113.272 -176.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 42.9 tp -68.35 -36.9 79.91 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.748 0.819 . . . . 0.0 111.776 178.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -54.37 -48.41 71.51 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.269 1.028 . . . . 0.0 111.789 175.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -76.06 -15.6 81.28 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 125.274 1.416 . . . . 0.0 114.852 178.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 53.9 mt -78.18 -32.04 49.92 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 119.393 1.597 . . . . 0.0 111.495 167.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 81.2 mt -92.85 8.63 38.77 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.977 1.711 . . . . 0.0 114.089 -178.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 35.2 t . . . . . 0 C--O 1.252 1.211 0 C-N-CA 127.097 2.159 . . . . 0.0 113.655 178.921 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.6 m . . . . . 0 N--CA 1.477 0.883 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.7 pt -62.23 -20.86 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 -156.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -54.9 -26.44 35.84 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.553 1.541 . . . . 0.0 113.821 -178.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.4 m -72.08 -34.58 68.78 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.939 1.696 . . . . 0.0 113.205 174.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 58.7 mtt -64.39 -36.15 83.2 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.968 0.907 . . . . 0.0 111.247 -178.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.2 mm -62.89 -27.32 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.273 1.029 . . . . 0.0 111.919 -172.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -77.9 -20.53 52.76 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -173.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -78.29 -29.17 54.18 Favored Glycine 0 CA--C 1.533 1.187 0 CA-C-N 119.576 1.08 . . . . 0.0 114.819 -168.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -129.26 170.57 13.43 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.555 -0.967 . . . . 0.0 112.562 -167.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 29.9 ttpt -75.22 -38.38 60.71 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.273 0.629 . . . . 0.0 112.113 177.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.1 t -125.18 139.13 52.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.733 1.213 . . . . 0.0 110.158 168.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 60.9 t -130.82 125.43 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 124.634 1.174 . . . . 0.0 108.919 171.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 50.4 t -127.6 147.65 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 123.867 0.867 . . . . 0.0 111.909 -170.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -121.05 111.43 17.45 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.673 1.189 . . . . 0.0 109.012 174.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.435 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 71.9 m -127.77 168.6 14.9 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 126.447 1.899 . . . . 0.0 110.911 -172.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.496 ' CD1' ' HB3' ' A' ' 46' ' ' ASP . 18.3 m0 -116.06 132.23 56.71 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.521 1.129 . . . . 0.0 108.424 163.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 60.7 t -56.48 -29.14 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 CA-C-N 119.098 0.863 . . . . 0.0 112.288 -176.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.8 p -85.64 -11.09 54.73 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 127.464 2.306 . . . . 0.0 115.65 -175.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 8.5 t -90.04 141.43 27.94 Favored Pre-proline 0 CA--C 1.54 0.592 0 CA-C-N 119.77 1.168 . . . . 0.0 111.146 -170.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -69.62 -39.02 7.29 Favored 'Trans proline' 0 C--N 1.348 0.523 0 CA-C-N 120.584 1.244 . . . . 0.0 112.825 179.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -61.43 -31.83 71.78 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 126.485 1.914 . . . . 0.0 114.4 178.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.435 ' SG ' ' HB3' ' A' ' 19' ' ' SER . 0.1 OUTLIER -60.16 -63.48 1.28 Allowed 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 126.253 1.821 . . . . 0.0 108.856 174.037 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 63.4 t -59.09 -38.99 77.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 124.032 0.933 . . . . 0.0 110.998 -178.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 18.6 ttt180 -56.37 -31.66 64.02 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.259 1.824 . . . . 0.0 114.801 171.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -87.12 -50.97 6.26 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 119.511 1.051 . . . . 0.0 112.65 169.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -49.15 -36.78 20.17 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.232 1.413 . . . . 0.0 112.981 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -67.22 -45.86 75.53 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 123.632 0.773 . . . . 0.0 112.914 178.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.9 tt -76.73 -35.31 57.87 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.17 1.388 . . . . 0.0 111.364 -176.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 96.2 mt -62.6 -48.06 81.08 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.389 0.676 . . . . 0.0 111.37 174.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 16.7 m-70 -65.15 -23.29 67.08 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 173.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.42 -28.75 56.75 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 119.683 1.129 . . . . 0.0 112.758 172.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.83 -18.81 19.31 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 -177.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.8 t -162.25 173.72 13.83 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 -178.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -114.6 -30.03 6.63 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.889 1.276 . . . . 0.0 113.565 175.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -84.05 43.59 0.94 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.541 1.137 . . . . 0.0 113.337 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -101.85 118.29 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 126.361 1.864 . . . . 0.0 110.909 173.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 22.0 m -106.23 141.39 37.65 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.582 1.553 . . . . 0.0 110.005 172.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.4 p -131.19 146.46 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 124.574 1.15 . . . . 0.0 112.525 173.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -114.29 119.13 35.95 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.477 1.911 . . . . 0.0 108.98 173.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -87.44 90.96 8.56 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 122.157 0.98 . . . . 0.0 109.96 179.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.9 m -73.33 0.68 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -171.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.496 ' HB3' ' CD1' ' A' ' 20' ' ' TRP . 2.8 p-10 -88.74 -12.76 41.28 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.443 1.097 . . . . 0.0 113.138 167.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 38.0 mtmt -99.11 -26.22 14.28 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 126.118 1.767 . . . . 0.0 113.794 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 10.1 ttt -98.38 137.87 36.45 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.488 1.115 . . . . 0.0 112.202 178.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 66.1 m -64.42 -26.87 68.64 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 177.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -79.41 -0.29 32.3 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 121.029 -1.045 . . . . 0.0 113.376 175.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -52.2 -31.4 34.05 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 125.268 1.413 . . . . 0.0 115.329 -174.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -83.92 -16.29 44.83 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 118.263 1.031 . . . . 0.0 112.996 -178.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 7.8 mp0 -81.16 -39.28 25.78 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 121.04 -1.037 . . . . 0.0 110.238 167.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.78 -46.12 90.91 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.042 0.537 . . . . 0.0 110.526 171.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 67.2 mtp180 -59.76 -33.14 71.3 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.283 1.033 . . . . 0.0 112.96 170.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.78 -46.66 91.3 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.121 0.867 . . . . 0.0 112.407 174.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -59.46 -42.95 93.19 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 117.997 0.898 . . . . 0.0 112.591 175.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 73.2 mt -66.41 -42.37 90.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 123.483 0.713 . . . . 0.0 110.505 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -71.58 -41.43 69.02 Favored 'General case' 0 CA--C 1.535 0.404 0 O-C-N 121.463 -0.773 . . . . 0.0 112.862 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -63.37 -36.99 85.54 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.733 1.151 . . . . 0.0 112.448 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -82.99 -47.22 11.97 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 178.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -120.16 -4.15 10.03 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -164.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.7 mptt 49.89 53.53 12.63 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.886 1.674 . . . . 0.0 112.185 -177.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 23.2 t-80 -131.44 136.53 48.05 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.951 1.7 . . . . 0.0 109.863 173.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -141.81 -34.46 0.47 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.989 0.915 . . . . 0.0 112.667 -166.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.3 p -63.57 165.53 7.94 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.085 1.354 . . . . 0.0 111.588 156.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 23.1 m -122.33 159.44 52.34 Favored Pre-proline 0 N--CA 1.48 1.043 0 C-N-CA 124.803 1.241 . . . . 0.0 112.402 -174.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -81.85 152.58 77.53 Favored 'Cis proline' 0 C--N 1.349 0.592 0 CA-C-N 119.389 0.817 . . . . 0.0 113.803 -4.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -106.32 136.44 46.05 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.393 1.477 . . . . 0.0 108.979 163.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 73.2 mt -131.16 142.83 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 123.866 0.866 . . . . 0.0 110.164 -163.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -136.98 140.85 42.47 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.349 1.06 . . . . 0.0 110.912 176.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 83.9 mt -128.11 122.11 57.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 125.829 1.652 . . . . 0.0 109.42 179.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 44.7 42.32 5.75 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 125.432 1.493 . . . . 0.0 114.203 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 86.27 -4.63 85.84 Favored Glycine 0 CA--C 1.541 1.713 0 C-N-CA 125.077 1.323 . . . . 0.0 116.219 -177.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -102.49 135.19 44.56 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.654 1.727 . . . . 0.0 111.479 -176.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -73.9 144.26 45.43 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.8 0.84 . . . . 0.0 112.378 178.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 32.2 mm -122.22 127.42 75.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 127.384 2.274 . . . . 0.0 107.995 177.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.81 -5.89 27.46 Favored Glycine 0 CA--C 1.536 1.37 0 N-CA-C 118.212 2.045 . . . . 0.0 118.212 -163.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 144.79 -171.85 25.88 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 126.478 1.99 . . . . 0.0 112.752 176.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 11.4 t -61.41 -32.73 72.69 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 122.067 -0.666 . . . . 0.0 112.441 173.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 35.6 t -67.17 -41.11 86.52 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.317 -0.865 . . . . 0.0 111.735 178.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -66.55 -37.15 84.37 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.273 1.029 . . . . 0.0 113.167 171.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 13.8 tp -63.7 -50.73 68.04 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.278 1.431 . . . . 0.0 110.908 177.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -64.46 -37.76 88.66 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 122.963 0.505 . . . . 0.0 110.836 176.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.55 -34.37 76.79 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 121.066 -1.021 . . . . 0.0 112.77 175.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 64.0 mt -70.99 -24.33 62.37 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.028 0.931 . . . . 0.0 113.186 172.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -77.09 -35.02 56.79 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 119.012 0.824 . . . . 0.0 111.946 172.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -69.35 -29.28 67.04 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.942 0.897 . . . . 0.0 112.906 169.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -81.76 -3.13 53.03 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 169.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.8 14.85 63.66 Favored Glycine 0 CA--C 1.541 1.675 0 CA-C-N 120.11 1.323 . . . . 0.0 114.72 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 34.3 mtpt -100.51 -29.31 12.43 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 126.472 1.909 . . . . 0.0 112.189 -171.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 46.3 tp -58.68 -39.6 81.18 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 118.718 0.69 . . . . 0.0 111.937 177.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -55.97 -48.46 75.77 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.499 0.72 . . . . 0.0 112.579 174.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -76.86 -37.97 32.28 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 123.884 0.754 . . . . 0.0 113.957 -177.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 69.3 mt -58.52 -26.41 63.47 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.767 1.227 . . . . 0.0 112.056 169.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 81.8 mt -103.95 16.77 25.54 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.324 1.45 . . . . 0.0 114.135 176.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 62.4 m . . . . . 0 C--O 1.252 1.229 0 C-N-CA 124.63 1.172 . . . . 0.0 111.989 172.899 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 75.3 m . . . . . 0 N--CA 1.474 0.765 0 CA-C-O 120.694 0.283 . . . . 0.0 110.6 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.8 pt -55.76 -26.2 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 125.585 1.554 . . . . 0.0 115.13 -162.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -54.03 -32.15 53.52 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.591 1.557 . . . . 0.0 113.241 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 47.6 t -71.7 -34.15 69.38 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.096 1.358 . . . . 0.0 112.452 174.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 52.0 mtt -68.68 -34.32 75.48 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.346 1.058 . . . . 0.0 112.255 178.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.6 mm -59.48 -27.67 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 124.267 1.027 . . . . 0.0 111.679 -176.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 26.9 mttm -82.58 -8.08 59.62 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.034 1.734 . . . . 0.0 114.58 178.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -80.89 -17.78 71.68 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 124.005 0.812 . . . . 0.0 114.862 -175.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.646 ' ND2' ' HG1' ' A' ' 41' ' ' THR . 60.7 m-80 -149.53 164.92 33.74 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 127.087 2.155 . . . . 0.0 110.392 -177.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 30.7 ttpt -65.95 -47.42 74.71 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.235 0.614 . . . . 0.0 112.338 173.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.5 t -115.63 129.8 71.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.366 1.067 . . . . 0.0 110.621 176.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 60.3 t -133.51 131.6 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 124.806 1.243 . . . . 0.0 109.568 178.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 60.5 t -134.17 154.32 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 123.82 0.848 . . . . 0.0 111.736 -170.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -129.45 121.54 27.5 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.975 1.31 . . . . 0.0 110.488 175.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 67.2 m -140.93 172.27 12.92 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.354 1.062 . . . . 0.0 113.764 -162.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.415 ' CD1' ' HB3' ' A' ' 46' ' ' ASP . 45.7 m0 -120.73 128.91 53.36 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.944 1.298 . . . . 0.0 110.534 168.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 71.2 t -62.66 -23.32 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 CA-C-N 119.245 0.93 . . . . 0.0 111.854 175.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 51.3 p -72.62 -13.03 61.28 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 116.067 1.877 . . . . 0.0 116.067 -175.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 57.6 m -124.39 149.81 62.43 Favored Pre-proline 0 CA--C 1.551 1.015 0 N-CA-C 116.164 1.913 . . . . 0.0 116.164 -162.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -74.52 -36.72 2.79 Favored 'Trans proline' 0 C--N 1.356 0.947 0 C-N-CA 122.3 2.0 . . . . 0.0 114.317 -166.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -52.06 -41.09 62.07 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.274 1.43 . . . . 0.0 112.141 173.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.475 ' HG ' ' HD3' ' A' ' 68' ' ' PRO . 5.2 m -86.34 -13.4 46.62 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 113.056 -1.884 . . . . 0.0 111.587 -166.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 95.9 t -77.36 -54.41 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 124.487 1.115 . . . . 0.0 110.839 155.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -72.91 -26.89 61.57 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 115.643 1.72 . . . . 0.0 115.643 -166.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -77.6 -50.22 12.98 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 119.175 0.898 . . . . 0.0 109.656 173.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.19 -36.17 79.16 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.177 0.991 . . . . 0.0 111.987 -176.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -60.97 -47.06 88.2 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.484 0.714 . . . . 0.0 112.521 172.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.2 tt -69.0 -38.24 79.17 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.672 1.589 . . . . 0.0 111.695 -179.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 81.7 mt -62.48 -48.14 80.88 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.496 0.719 . . . . 0.0 110.772 173.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 11.6 m-70 -63.61 -30.91 71.96 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 172.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -67.32 -26.98 66.77 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 120.783 -1.198 . . . . 0.0 112.022 174.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -94.09 -35.87 12.35 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.009 1.724 . . . . 0.0 114.701 -173.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 14.0 t -153.16 158.08 41.27 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.19 0.996 . . . . 0.0 113.648 -172.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 36.4 mtmt -91.67 -10.78 39.03 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.206 1.402 . . . . 0.0 112.55 163.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -84.76 40.07 0.78 Allowed 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 124.335 1.054 . . . . 0.0 113.591 -173.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.63 131.88 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 125.437 1.495 . . . . 0.0 113.768 -170.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.646 ' HG1' ' ND2' ' A' ' 13' ' ' ASN . 21.7 m -123.82 139.77 53.64 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 126.996 2.118 . . . . 0.0 110.048 175.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.3 p -139.72 125.35 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 124.724 1.21 . . . . 0.0 112.749 178.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 8.3 t60 -94.25 126.25 39.39 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.587 0.755 . . . . 0.0 110.895 174.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -89.75 97.25 11.08 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 123.387 0.675 . . . . 0.0 109.307 178.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 19.9 m -75.45 -12.32 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-O 119.021 -0.514 . . . . 0.0 112.386 -174.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.415 ' HB3' ' CD1' ' A' ' 20' ' ' TRP . 0.4 OUTLIER -69.33 -15.26 63.29 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.785 1.234 . . . . 0.0 113.248 174.765 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -82.99 -19.1 37.67 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 127.289 2.236 . . . . 0.0 112.448 176.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 58.8 mmm 59.3 18.53 6.75 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 127.592 2.357 . . . . 0.0 116.932 160.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.1 t -61.74 -40.21 94.27 Favored 'General case' 0 N--CA 1.48 1.034 0 O-C-N 119.915 -1.74 . . . . 0.0 111.251 170.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -138.86 0.34 1.97 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.489 1.516 . . . . 0.0 112.414 167.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -48.45 -33.3 11.49 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.786 1.66 . . . . 0.0 116.526 -174.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -69.69 -37.5 76.63 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 119.996 1.898 . . . . 0.0 110.647 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -76.74 -30.02 56.41 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 121.777 -0.577 . . . . 0.0 111.576 179.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -70.78 -45.57 64.48 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.272 0.629 . . . . 0.0 110.787 172.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -57.65 -38.73 75.56 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.203 1.801 . . . . 0.0 111.503 171.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.37 -41.5 94.46 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 124.303 0.954 . . . . 0.0 113.438 175.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -58.04 -43.64 86.95 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 119.214 1.507 . . . . 0.0 112.408 173.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 77.1 mt -64.35 -45.93 94.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.15 0.98 . . . . 0.0 110.328 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -66.75 -41.08 88.38 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.636 -0.665 . . . . 0.0 112.004 176.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -66.75 -25.23 66.39 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 120.774 -1.204 . . . . 0.0 113.337 177.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -92.61 -39.42 11.33 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 119.534 1.061 . . . . 0.0 113.516 178.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -128.39 0.81 5.67 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.669 1.188 . . . . 0.0 114.161 -167.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 48.79 43.3 21.07 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 126.782 2.033 . . . . 0.0 113.258 -176.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 63.7 t-80 -131.82 141.6 49.49 Favored 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 125.701 1.6 . . . . 0.0 111.446 -176.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -142.5 -13.92 0.77 Allowed 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 -164.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 51.3 m -70.99 150.07 46.02 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.097 1.359 . . . . 0.0 111.069 167.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 10.5 m -122.46 152.99 62.2 Favored Pre-proline 0 N--CA 1.477 0.894 0 C-N-CA 126.0 1.72 . . . . 0.0 112.599 -175.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.475 ' HD3' ' HG ' ' A' ' 26' ' ' CYS . 95.4 Cg_endo -73.03 154.45 99.56 Favored 'Cis proline' 0 C--N 1.35 0.652 0 CA-C-N 119.126 0.724 . . . . 0.0 113.815 -2.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -107.27 129.42 54.89 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.019 1.328 . . . . 0.0 108.613 167.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 98.5 mt -124.27 142.86 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 123.646 0.779 . . . . 0.0 109.981 -162.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -136.27 139.16 42.47 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.803 0.841 . . . . 0.0 111.795 179.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 62.4 mt -131.71 116.25 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 124.85 1.26 . . . . 0.0 109.75 179.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 45.43 39.04 4.18 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 126.015 1.726 . . . . 0.0 113.847 -173.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 79.95 12.31 83.55 Favored Glycine 0 CA--C 1.539 1.559 0 N-CA-C 116.403 1.321 . . . . 0.0 116.403 -176.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -103.36 137.92 40.82 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 119.549 1.674 . . . . 0.0 110.691 172.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -85.93 131.0 34.38 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 -176.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 15.3 mm -116.27 125.29 73.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 128.506 2.722 . . . . 0.0 108.561 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -69.23 -15.74 70.32 Favored Glycine 0 CA--C 1.537 1.421 0 N-CA-C 117.407 1.723 . . . . 0.0 117.407 -165.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 149.54 -165.29 29.54 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-N 118.847 1.323 . . . . 0.0 115.36 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 32.2 t -65.17 -37.56 87.77 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.355 1.062 . . . . 0.0 112.563 -175.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 72.6 p -74.39 -15.62 60.92 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 178.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -87.34 -43.17 12.34 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.667 1.187 . . . . 0.0 110.598 166.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 51.7 tp -59.41 -47.9 83.68 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.571 1.149 . . . . 0.0 111.872 177.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -74.75 -11.78 60.24 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.804 0.842 . . . . 0.0 112.968 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -78.79 -46.84 17.91 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.117 0.967 . . . . 0.0 111.516 163.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 88.5 mt -61.17 -28.98 69.52 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.286 1.035 . . . . 0.0 112.85 175.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -64.48 -52.89 55.61 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.405 1.082 . . . . 0.0 112.093 169.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 6.9 mptt -71.14 -30.77 66.89 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.725 1.21 . . . . 0.0 112.546 -173.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -82.56 -1.94 52.18 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.29 1.036 . . . . 0.0 113.452 169.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 73.84 8.11 76.84 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 124.727 1.156 . . . . 0.0 115.759 174.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 47.5 mtmt -82.18 -29.6 31.4 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 127.639 2.376 . . . . 0.0 112.453 -172.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 36.8 tp -52.39 -36.23 53.58 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.603 1.161 . . . . 0.0 112.169 175.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -73.88 -36.17 64.77 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -67.94 -29.5 73.62 Favored Glycine 0 CA--C 1.536 1.379 0 O-C-N 120.818 -1.176 . . . . 0.0 113.325 170.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 89.3 mt -74.96 -23.63 58.32 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.621 1.168 . . . . 0.0 112.582 173.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 81.0 mt -95.58 -2.2 48.84 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.853 1.661 . . . . 0.0 114.869 174.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 39.7 m . . . . . 0 C--O 1.252 1.206 0 C-N-CA 126.028 1.731 . . . . 0.0 114.289 -175.603 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 61.4 m . . . . . 0 CA--C 1.548 0.897 0 CA-C-O 119.61 -0.233 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.6 pt -56.17 -19.71 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 N-CA-C 116.083 1.883 . . . . 0.0 116.083 -161.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -49.7 -30.19 8.81 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.584 1.554 . . . . 0.0 113.005 175.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 45.4 p -70.04 -38.05 75.74 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.087 0.955 . . . . 0.0 112.998 173.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 54.5 mtt -66.56 -32.41 73.74 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.599 1.56 . . . . 0.0 111.493 -174.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.6 mm -57.62 -33.81 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 123.919 0.888 . . . . 0.0 111.249 176.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 46.9 mttm -81.3 -9.22 59.8 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.054 1.342 . . . . 0.0 113.215 -173.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -75.69 -27.04 63.76 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 124.264 0.935 . . . . 0.0 115.201 -173.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -145.7 165.83 27.61 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.714 1.605 . . . . 0.0 112.606 179.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -63.09 -38.18 90.16 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.946 0.898 . . . . 0.0 113.128 178.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.5 t -125.26 129.58 73.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.864 1.266 . . . . 0.0 111.007 175.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 58.5 t -133.26 129.79 57.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.552 1.141 . . . . 0.0 110.559 -179.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 42.4 t -128.69 147.65 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.202 1.001 . . . . 0.0 112.337 -177.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -118.15 123.86 46.57 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.572 1.149 . . . . 0.0 109.802 170.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.8 m -140.63 177.71 7.84 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 126.328 1.851 . . . . 0.0 112.458 -165.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 37.7 m0 -123.54 136.87 54.78 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.645 1.978 . . . . 0.0 107.016 159.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 82.3 t -54.22 -31.69 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 C-N-CA 125.763 1.625 . . . . 0.0 113.64 -165.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.7 t -105.62 -5.12 20.35 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 114.865 1.432 . . . . 0.0 114.865 -165.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 71.8 m -90.24 141.93 28.07 Favored Pre-proline 0 C--O 1.234 0.249 0 O-C-N 121.651 -0.655 . . . . 0.0 111.268 -165.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -70.82 -36.82 7.4 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 CA-C-N 119.114 0.719 . . . . 0.0 112.769 -160.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -59.91 -38.26 81.8 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 127.783 2.433 . . . . 0.0 114.207 174.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 1.6 t -59.12 -49.55 77.46 Favored 'General case' 0 C--O 1.222 -0.352 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 173.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 52.8 t -63.47 -40.42 88.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 123.948 0.899 . . . . 0.0 111.451 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -56.12 -46.11 79.27 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 118.789 0.722 . . . . 0.0 111.916 175.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.98 -55.47 9.53 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.658 0.783 . . . . 0.0 111.692 177.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -42.28 -48.56 4.99 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 126.739 2.016 . . . . 0.0 111.755 178.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.485 ' HA ' ' CD2' ' A' ' 34' ' ' HIS . 16.9 ttpp -76.07 -27.31 57.17 Favored 'General case' 0 C--O 1.225 -0.23 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 -171.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.1 tt -79.24 -38.18 36.23 Favored 'General case' 0 C--N 1.317 -0.825 0 O-C-N 121.257 -0.902 . . . . 0.0 111.133 173.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 17.8 mt -67.45 -59.71 3.16 Favored 'General case' 0 CA--C 1.514 -0.415 0 C-N-CA 125.867 1.667 . . . . 0.0 112.956 -176.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.485 ' CD2' ' HA ' ' A' ' 31' ' ' LYS . 0.1 OUTLIER -52.61 -28.93 23.36 Favored 'General case' 0 C--O 1.233 0.188 0 O-C-N 124.173 0.921 . . . . 0.0 110.217 176.244 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.0 -14.27 47.96 Favored 'General case' 0 N--CA 1.441 -0.876 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.814 -172.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -105.19 -40.47 5.85 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 126.533 1.933 . . . . 0.0 112.612 179.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 23.0 m -142.63 128.13 19.02 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.743 1.617 . . . . 0.0 110.807 -175.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 45.2 mtmt -76.5 -23.95 53.74 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.47 1.508 . . . . 0.0 112.768 177.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -79.2 54.26 1.62 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.417 1.087 . . . . 0.0 113.908 175.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.67 139.03 24.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 125.821 1.649 . . . . 0.0 110.872 173.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.4 m -127.24 132.72 50.33 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 126.783 2.033 . . . . 0.0 109.306 167.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.7 p -128.02 139.96 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-O 122.238 1.018 . . . . 0.0 113.029 171.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -109.12 119.64 40.12 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.385 1.874 . . . . 0.0 109.405 176.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -91.44 92.05 8.38 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.427 0.691 . . . . 0.0 110.079 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.6 m -77.02 14.65 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 N-CA-C 115.874 1.805 . . . . 0.0 115.874 -162.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -100.69 -20.74 15.48 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 120.693 -1.254 . . . . 0.0 112.252 160.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 23.4 mmmt -71.46 -36.77 71.31 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.146 0.978 . . . . 0.0 111.34 175.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -96.13 142.23 28.56 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.098 0.959 . . . . 0.0 112.885 -167.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 16.4 m -69.3 -7.96 41.85 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 115.598 1.703 . . . . 0.0 115.598 -172.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -113.46 8.86 17.98 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.978 1.711 . . . . 0.0 113.062 175.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -54.59 -32.51 53.62 Favored Glycine 0 CA--C 1.531 1.063 0 N-CA-C 116.211 1.244 . . . . 0.0 116.211 -173.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -72.92 -29.4 63.1 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 119.169 1.485 . . . . 0.0 112.581 176.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -79.62 -31.26 41.61 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 121.586 -0.696 . . . . 0.0 111.852 174.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.04 -41.91 81.35 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 121.657 -0.652 . . . . 0.0 110.491 170.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 59.6 mtp85 -53.89 -45.75 71.16 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 119.344 0.974 . . . . 0.0 111.56 166.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.17 -38.47 93.18 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 124.15 0.881 . . . . 0.0 114.472 178.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -68.49 -25.14 64.81 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 119.088 1.444 . . . . 0.0 113.709 176.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 57.7 mt -76.88 -45.19 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 123.505 0.722 . . . . 0.0 109.263 173.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -67.42 -36.93 82.22 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 121.525 -0.734 . . . . 0.0 112.66 -178.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -57.57 -51.61 68.8 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 121.403 -0.811 . . . . 0.0 112.12 176.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -81.1 -33.08 33.56 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 114.452 1.278 . . . . 0.0 114.452 -175.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -123.52 -7.53 8.05 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 -166.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.5 mmtm 50.13 47.28 23.77 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 126.824 2.05 . . . . 0.0 112.745 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 17.7 t60 -138.18 136.18 36.37 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 127.082 2.153 . . . . 0.0 109.028 -177.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -123.54 -22.66 4.95 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 -177.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.2 p -68.19 135.17 51.64 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.644 0.778 . . . . 0.0 112.507 -178.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.8 m -88.91 149.06 42.73 Favored Pre-proline 0 N--CA 1.478 0.952 0 N-CA-C 112.519 0.562 . . . . 0.0 112.519 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -83.82 160.73 71.09 Favored 'Cis proline' 0 CA--C 1.537 0.645 0 CA-C-N 119.654 0.912 . . . . 0.0 114.181 -2.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -104.2 142.23 34.88 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.49 1.116 . . . . 0.0 109.479 159.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 56.6 mt -131.76 139.92 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.084 0.954 . . . . 0.0 110.301 -166.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -140.44 145.65 37.26 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.141 0.976 . . . . 0.0 111.964 178.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 70.1 mt -136.73 124.35 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 125.111 1.364 . . . . 0.0 109.307 177.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 47.56 37.93 7.28 Favored 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 124.649 1.18 . . . . 0.0 113.967 -177.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 73.05 11.88 79.14 Favored Glycine 0 CA--C 1.541 1.659 0 O-C-N 120.013 -1.68 . . . . 0.0 115.864 -176.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 24.8 m-80 -97.61 143.82 27.9 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.008 1.723 . . . . 0.0 110.032 169.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -89.2 141.51 28.46 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.94 0.896 . . . . 0.0 112.982 176.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 22.4 mm -126.32 122.97 62.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 127.731 2.412 . . . . 0.0 108.331 -179.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.95 -2.72 6.89 Favored Glycine 0 CA--C 1.538 1.501 0 N-CA-C 118.981 2.352 . . . . 0.0 118.981 -166.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 137.45 -166.9 24.92 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 126.934 2.207 . . . . 0.0 112.988 176.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 16.6 t -66.63 -33.48 75.74 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 121.65 -0.912 . . . . 0.0 113.008 -175.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 68.1 m -76.76 -28.7 55.82 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 121.277 -0.89 . . . . 0.0 111.993 178.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.11 -35.71 71.89 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.089 0.859 . . . . 0.0 112.782 167.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 51.6 tp -61.84 -48.64 79.67 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.797 0.839 . . . . 0.0 111.106 170.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -69.83 -13.62 62.36 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.161 0.984 . . . . 0.0 113.305 175.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -82.65 -43.5 16.86 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 121.04 -1.038 . . . . 0.0 111.331 168.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 76.6 mt -66.5 -28.53 68.64 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 120.93 -1.106 . . . . 0.0 113.0 177.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -61.08 -39.51 90.18 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.678 1.591 . . . . 0.0 112.23 168.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 5.0 mptt -84.3 -34.33 23.76 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.403 1.481 . . . . 0.0 112.364 -178.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -75.07 -0.9 20.56 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.732 1.213 . . . . 0.0 113.606 174.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 75.76 22.23 75.18 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 124.457 1.027 . . . . 0.0 114.51 170.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 35.5 mtmt -113.96 -20.2 11.13 Favored 'General case' 0 C--N 1.341 0.231 0 C-N-CA 126.551 1.94 . . . . 0.0 113.263 -170.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 43.0 tp -60.9 -40.37 92.84 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 118.738 0.699 . . . . 0.0 111.449 178.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -65.2 -42.28 93.71 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 177.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -70.7 -26.75 73.53 Favored Glycine 0 CA--C 1.537 1.439 0 C-N-CA 124.323 0.963 . . . . 0.0 114.511 175.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 30.0 mt -71.03 -31.95 68.57 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 118.276 1.038 . . . . 0.0 112.187 172.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 85.1 mt -97.85 -27.11 14.44 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 114.487 1.291 . . . . 0.0 114.487 -174.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 56.9 m . . . . . 0 C--O 1.254 1.29 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 -170.964 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 60.0 p . . . . . 0 CA--C 1.542 0.648 0 CA-C-O 120.758 0.313 . . . . 0.0 111.448 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.7 pt -56.35 -19.7 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 124.591 1.156 . . . . 0.0 113.264 170.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -58.88 -29.87 67.33 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.686 0.794 . . . . 0.0 112.816 -174.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 67.7 m -68.18 -24.45 64.97 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 173.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 54.4 mtt -72.5 -33.89 67.25 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 121.46 -0.775 . . . . 0.0 111.429 -178.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.8 mm -60.29 -30.78 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 123.681 0.792 . . . . 0.0 111.67 -175.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -80.36 -8.75 59.64 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.162 1.385 . . . . 0.0 114.148 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -80.03 -35.55 27.2 Favored Glycine 0 CA--C 1.535 1.292 0 N-CA-C 115.158 0.823 . . . . 0.0 115.158 -173.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 55.5 m-80 -145.08 164.13 32.17 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 118.626 1.213 . . . . 0.0 112.186 -172.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 21.7 ttpt -63.89 -42.25 97.52 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.285 1.034 . . . . 0.0 113.111 -178.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.9 t -119.84 130.62 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.251 1.021 . . . . 0.0 110.65 172.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 57.0 t -132.88 126.93 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.849 1.26 . . . . 0.0 109.744 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 40.4 t -127.1 149.29 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.129 0.972 . . . . 0.0 112.253 -173.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -123.15 114.4 20.25 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.355 1.462 . . . . 0.0 110.111 175.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.432 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 35.2 m -134.28 173.32 11.74 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.556 1.542 . . . . 0.0 112.754 -167.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 47.6 m0 -121.9 143.1 49.64 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.69 1.196 . . . . 0.0 110.237 166.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 76.7 t -65.18 -25.58 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 CA-C-O 120.771 0.32 . . . . 0.0 111.25 177.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.5 p -75.98 -18.49 59.29 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 126.196 1.798 . . . . 0.0 115.599 177.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.8 t -94.89 140.02 22.36 Favored Pre-proline 0 CA--C 1.538 0.501 0 CA-C-N 120.241 1.382 . . . . 0.0 112.571 -163.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -73.91 -37.17 3.0 Favored 'Trans proline' 0 CA--C 1.534 0.496 0 CA-C-N 120.704 1.287 . . . . 0.0 112.008 174.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -55.84 -37.66 69.02 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.164 1.386 . . . . 0.0 113.528 176.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.432 ' SG ' ' HB3' ' A' ' 19' ' ' SER . 0.5 OUTLIER -55.1 -51.89 64.98 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.192 0.997 . . . . 0.0 109.636 172.759 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.1 t -66.27 -37.53 79.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 123.943 0.897 . . . . 0.0 111.614 -177.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.1 mmt180 -54.06 -42.62 69.46 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 118.787 0.721 . . . . 0.0 112.115 173.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.93 -55.17 7.96 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.007 0.923 . . . . 0.0 112.463 173.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -54.18 -35.05 61.91 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 119.506 1.048 . . . . 0.0 113.398 -177.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.95 -38.25 69.83 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.273 1.029 . . . . 0.0 112.598 -178.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.4 tt -74.49 -46.18 41.11 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 126.499 1.92 . . . . 0.0 110.892 178.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 68.0 mt -64.69 -38.21 90.22 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.556 0.742 . . . . 0.0 112.765 -176.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 45.7 m-70 -74.74 -22.07 59.01 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 170.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -73.39 -36.38 66.04 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 119.894 1.225 . . . . 0.0 112.062 172.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 13.5 mmp_? -73.52 -52.64 12.85 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.378 1.471 . . . . 0.0 113.247 175.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.2 p -140.68 166.24 25.29 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 116.167 1.914 . . . . 0.0 116.167 -157.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 71.5 mttt -109.51 -27.74 9.27 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 127.976 2.511 . . . . 0.0 113.108 173.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -84.5 43.55 0.97 Allowed 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 125.205 1.402 . . . . 0.0 112.274 -178.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -113.43 129.13 69.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 126.558 1.943 . . . . 0.0 111.982 178.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.9 m -122.3 141.83 51.11 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 126.644 1.978 . . . . 0.0 111.169 174.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.4 p -135.72 136.27 50.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 124.441 1.096 . . . . 0.0 113.232 178.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 38.6 t60 -105.48 122.4 45.92 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.957 2.103 . . . . 0.0 109.752 175.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -92.22 89.12 6.74 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 123.689 0.796 . . . . 0.0 108.986 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 35.7 m -65.2 -18.69 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -175.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -55.88 -43.13 76.88 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.409 1.484 . . . . 0.0 111.572 164.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 34.1 mtmt -86.68 7.87 24.79 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 127.188 2.195 . . . . 0.0 113.756 179.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -114.68 129.9 56.74 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.192 1.397 . . . . 0.0 110.229 178.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 11.8 p -64.52 -20.24 66.09 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 115.753 1.76 . . . . 0.0 115.753 -170.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -113.95 8.4 17.17 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.502 1.921 . . . . 0.0 112.389 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -51.95 -25.19 16.04 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 125.807 1.67 . . . . 0.0 116.896 -168.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -69.05 -27.94 66.1 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 118.947 1.373 . . . . 0.0 112.853 174.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -80.48 -25.56 38.74 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 120.573 -1.33 . . . . 0.0 112.083 172.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -79.72 -32.65 41.21 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.722 0.809 . . . . 0.0 111.883 174.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 55.4 mtp180 -52.79 -43.32 65.8 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 119.119 0.872 . . . . 0.0 110.769 158.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.56 -35.78 89.96 Favored Glycine 0 CA--C 1.539 1.557 0 CA-C-O 118.972 -0.904 . . . . 0.0 115.21 173.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -63.47 -31.84 73.11 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 119.828 1.814 . . . . 0.0 112.914 176.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 65.2 mt -79.57 -45.73 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 C-N-CA 125.806 1.642 . . . . 0.0 109.608 175.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -64.77 -41.21 96.05 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.458 -0.776 . . . . 0.0 112.483 -178.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 76.6 mm-40 -72.14 -16.11 61.99 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 120.898 -1.126 . . . . 0.0 113.617 177.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -89.88 -41.49 11.77 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 169.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -135.0 0.43 2.88 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 115.329 1.603 . . . . 0.0 115.329 -163.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp 55.55 26.0 8.57 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 126.402 1.881 . . . . 0.0 115.513 177.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 37.2 t60 -114.96 140.03 49.35 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.391 1.077 . . . . 0.0 111.196 167.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -125.79 -27.42 3.35 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.167 0.987 . . . . 0.0 112.644 -163.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.2 p -85.96 144.09 27.81 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.474 1.11 . . . . 0.0 113.907 -178.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.3 m -89.35 153.76 48.62 Favored Pre-proline 0 N--CA 1.481 1.087 0 C-N-CA 125.017 1.327 . . . . 0.0 113.292 -173.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -79.49 158.08 89.75 Favored 'Cis proline' 0 C--N 1.349 0.577 0 CA-C-N 119.441 0.836 . . . . 0.0 113.4 -3.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -109.55 136.84 48.29 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.089 1.356 . . . . 0.0 108.709 162.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.9 mt -126.21 144.27 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 124.243 1.017 . . . . 0.0 109.444 -169.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -137.53 143.94 41.88 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.23 1.012 . . . . 0.0 110.967 177.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 48.9 mt -135.3 118.47 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.879 1.272 . . . . 0.0 109.059 179.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 47.44 43.78 15.95 Favored 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 125.023 1.329 . . . . 0.0 113.831 -175.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.18 1.17 59.46 Favored Glycine 0 CA--C 1.544 1.893 0 O-C-N 120.709 -1.245 . . . . 0.0 116.015 -176.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -92.26 134.84 34.51 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.223 1.409 . . . . 0.0 109.759 175.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -84.33 137.7 33.29 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.897 0.879 . . . . 0.0 112.831 -178.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 36.0 mm -118.1 122.84 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 127.662 2.385 . . . . 0.0 108.538 177.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.37 -6.19 39.52 Favored Glycine 0 CA--C 1.536 1.371 0 N-CA-C 118.252 2.061 . . . . 0.0 118.252 -162.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 152.91 -174.53 31.68 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 125.851 1.691 . . . . 0.0 112.99 176.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 12.8 t -65.32 -31.53 72.72 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.975 -0.721 . . . . 0.0 112.373 177.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 12.5 m -69.01 -32.63 72.32 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.732 -0.605 . . . . 0.0 111.829 -177.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -76.41 -40.65 50.26 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.122 1.369 . . . . 0.0 112.458 170.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 56.9 tp -59.48 -45.27 92.13 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.334 1.054 . . . . 0.0 111.488 175.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -64.92 -37.66 88.39 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.822 0.849 . . . . 0.0 111.35 173.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.45 -23.58 66.31 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 120.914 -1.116 . . . . 0.0 113.223 177.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 40.3 mt -84.69 -32.33 23.64 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.038 1.735 . . . . 0.0 112.709 170.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -67.46 -46.92 71.61 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.154 0.982 . . . . 0.0 112.38 175.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.2 mptt -62.25 -42.24 99.16 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.796 1.238 . . . . 0.0 111.772 178.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -76.16 -6.75 52.68 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 176.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 72.21 22.88 78.69 Favored Glycine 0 CA--C 1.535 1.293 0 CA-C-N 119.375 0.989 . . . . 0.0 114.88 174.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 40.7 mtmt -102.37 -14.21 17.0 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 127.995 2.518 . . . . 0.0 112.381 -172.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 30.5 tp -64.75 -31.75 73.12 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.047 1.739 . . . . 0.0 112.067 175.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -57.0 -46.28 82.41 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.703 -0.623 . . . . 0.0 112.281 174.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -66.39 -27.61 73.19 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 123.918 0.77 . . . . 0.0 113.677 176.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 83.3 mt -76.74 -26.11 54.24 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.475 1.11 . . . . 0.0 113.416 174.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 84.9 mt -102.93 -9.65 19.67 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 115.602 1.704 . . . . 0.0 115.602 -172.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 16.1 m . . . . . 0 N--CA 1.486 1.365 0 C-N-CA 127.25 2.22 . . . . 0.0 115.642 167.81 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 54.5 p . . . . . 0 N--CA 1.47 0.565 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 14.0 pt -45.33 -28.64 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 124.846 1.259 . . . . 0.0 113.115 168.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -57.13 -33.32 67.26 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 25.9 m -84.34 -20.08 32.62 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 175.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 45.1 mtt -68.39 -28.05 66.76 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 119.639 1.108 . . . . 0.0 112.063 173.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 83.8 mt -67.17 -22.4 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 CA-C-O 122.457 1.122 . . . . 0.0 112.165 -171.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -82.55 3.63 27.8 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.354 1.861 . . . . 0.0 114.482 174.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -87.87 -13.62 64.3 Favored Glycine 0 CA--C 1.541 1.682 0 C-N-CA 125.153 1.358 . . . . 0.0 116.365 -178.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -156.87 175.78 13.62 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 119.285 1.543 . . . . 0.0 112.318 177.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -72.61 -33.33 66.6 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 121.805 -0.56 . . . . 0.0 112.234 174.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.4 t -125.72 130.18 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 124.894 1.278 . . . . 0.0 110.151 173.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 62.1 t -131.49 130.49 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 123.842 0.857 . . . . 0.0 110.636 178.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 47.0 t -130.43 148.11 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.321 1.048 . . . . 0.0 112.277 -170.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -126.18 113.67 17.32 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.917 1.287 . . . . 0.0 110.097 177.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 59.8 m -132.25 167.32 20.03 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 126.0 1.72 . . . . 0.0 111.879 -166.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.436 ' CD1' ' HB3' ' A' ' 46' ' ' ASP . 34.6 m0 -117.66 126.12 51.93 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.763 1.225 . . . . 0.0 109.389 166.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 89.3 t -56.42 -39.61 62.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -166.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.7 t -74.87 -12.57 60.4 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 127.66 2.384 . . . . 0.0 115.716 -179.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.9 t -88.6 139.51 29.72 Favored Pre-proline 0 CA--C 1.539 0.523 0 O-C-N 121.395 -0.816 . . . . 0.0 110.87 -165.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -66.75 -38.25 18.45 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 CA-C-N 120.327 1.152 . . . . 0.0 112.943 -178.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 51.9 m-85 -62.24 -36.72 82.87 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.263 1.425 . . . . 0.0 114.225 178.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -56.13 -54.49 44.51 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.3 1.04 . . . . 0.0 108.989 169.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 73.2 t -62.74 -37.5 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 124.291 1.037 . . . . 0.0 112.388 -178.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 71.0 mmt-85 -52.95 -45.94 67.95 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 119.205 0.911 . . . . 0.0 112.001 172.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.75 -53.26 10.72 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.885 0.874 . . . . 0.0 112.113 178.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -59.32 -25.57 64.28 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -177.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -71.44 -46.39 60.17 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.637 0.775 . . . . 0.0 112.615 173.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.7 tt -74.26 -38.32 63.48 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.59 1.556 . . . . 0.0 111.808 -177.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 87.0 mt -63.56 -46.5 85.63 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.073 0.549 . . . . 0.0 111.047 178.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -64.32 -22.6 67.01 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 172.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -80.9 -17.2 51.41 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 176.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 10.6 mmt180 -131.94 -10.27 3.43 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 117.078 2.251 . . . . 0.0 117.078 -168.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 14.9 t -152.54 155.8 38.12 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 170.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 8.8 mptt -105.91 0.82 26.18 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.385 1.474 . . . . 0.0 112.722 166.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -105.07 40.76 1.45 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.536 1.535 . . . . 0.0 112.411 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -113.88 141.63 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 126.199 1.8 . . . . 0.0 111.695 177.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.9 m -129.33 129.39 44.76 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 127.363 2.265 . . . . 0.0 109.29 172.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -121.32 136.49 58.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 125.027 1.331 . . . . 0.0 112.784 172.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -108.99 130.97 55.49 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 125.295 1.438 . . . . 0.0 110.569 173.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -97.81 94.43 6.91 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.708 -0.62 . . . . 0.0 110.821 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.8 m -73.77 -6.59 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -176.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.436 ' HB3' ' CD1' ' A' ' 20' ' ' TRP . 0.0 OUTLIER -80.73 -19.28 45.34 Favored 'General case' 0 CA--C 1.545 0.766 0 O-C-N 121.15 -0.969 . . . . 0.0 112.004 169.161 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 39.9 mtmt -95.96 11.07 35.25 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 127.468 2.307 . . . . 0.0 113.772 175.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 12.8 ttt -125.32 128.78 48.74 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 127.584 2.353 . . . . 0.0 110.502 -167.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 25.8 m -68.49 -36.7 79.31 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.972 0.909 . . . . 0.0 113.232 -176.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.4 mp0 -84.7 -0.58 54.08 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.845 1.258 . . . . 0.0 113.289 173.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -56.35 -24.44 45.4 Favored Glycine 0 CA--C 1.535 1.321 0 O-C-N 120.471 -1.393 . . . . 0.0 115.879 -169.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 60.7 mt-10 -73.58 -28.71 61.98 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 118.714 1.257 . . . . 0.0 112.649 174.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -74.42 -37.24 63.38 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 120.908 -1.12 . . . . 0.0 111.403 172.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -69.56 -32.1 70.68 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.77 0.828 . . . . 0.0 112.765 173.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 60.6 mtp180 -56.16 -38.17 70.53 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 120.004 1.274 . . . . 0.0 111.511 164.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -64.1 -38.4 95.93 Favored Glycine 0 CA--C 1.539 1.546 0 CA-C-O 118.744 -1.031 . . . . 0.0 114.176 169.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -61.5 -29.55 70.05 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 119.988 1.894 . . . . 0.0 113.06 173.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 38.6 mt -77.38 -46.78 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 118.549 0.613 . . . . 0.0 109.973 171.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -65.83 -42.18 90.86 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 120.868 -1.145 . . . . 0.0 113.183 -175.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -73.92 -9.83 59.04 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -178.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -108.04 -32.98 7.32 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.705 1.202 . . . . 0.0 114.197 173.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -133.4 -0.11 3.29 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 114.879 1.437 . . . . 0.0 114.879 -171.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.5 mptt 48.02 51.94 13.81 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 126.033 1.733 . . . . 0.0 113.256 -177.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 33.9 t-80 -134.79 131.75 37.89 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.251 1.42 . . . . 0.0 110.587 175.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -135.82 11.94 3.4 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 126.193 1.797 . . . . 0.0 112.595 -166.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.443 HG21 ' H ' ' A' ' 67' ' ' VAL . 0.3 OUTLIER -106.59 -172.04 2.01 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 126.438 1.895 . . . . 0.0 110.266 173.414 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.443 ' H ' HG21 ' A' ' 66' ' ' THR . 21.4 m -137.93 158.47 71.3 Favored Pre-proline 0 N--CA 1.48 1.026 0 O-C-N 120.53 -1.356 . . . . 0.0 113.025 175.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -71.77 155.08 97.95 Favored 'Cis proline' 0 C--N 1.348 0.548 0 CA-C-N 118.486 0.495 . . . . 0.0 112.673 -11.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -102.57 134.01 46.62 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.437 1.095 . . . . 0.0 108.391 161.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 46.9 mt -128.59 141.39 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 123.542 0.737 . . . . 0.0 109.916 -165.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -137.95 145.56 42.17 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.983 0.913 . . . . 0.0 112.102 179.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 64.7 mt -130.28 114.06 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.214 1.405 . . . . 0.0 108.675 174.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 49.91 41.53 22.92 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.0 1.32 . . . . 0.0 113.951 -172.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 75.31 4.11 72.76 Favored Glycine 0 CA--C 1.54 1.651 0 O-C-N 120.606 -1.309 . . . . 0.0 115.128 -178.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -97.07 133.98 41.02 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.157 1.383 . . . . 0.0 109.896 173.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -83.31 146.61 28.42 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.694 1.198 . . . . 0.0 113.691 -170.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 28.6 mm -130.56 120.3 47.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 128.365 2.666 . . . . 0.0 108.131 -178.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.11 -9.87 43.87 Favored Glycine 0 CA--C 1.534 1.28 0 N-CA-C 119.084 2.393 . . . . 0.0 119.084 -163.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 158.13 -175.35 35.34 Favored Glycine 0 CA--C 1.532 1.127 0 CA-C-N 118.936 1.368 . . . . 0.0 113.766 176.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 30.1 t -65.65 -37.66 87.16 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.97 -0.724 . . . . 0.0 112.474 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 66.5 m -70.47 -32.14 69.55 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.436 -0.79 . . . . 0.0 112.097 177.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -68.62 -41.37 79.61 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.363 0.983 . . . . 0.0 112.108 172.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 15.1 tp -58.45 -50.92 71.99 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.731 1.612 . . . . 0.0 110.843 173.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -64.37 -36.32 83.75 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.934 -0.479 . . . . 0.0 112.056 175.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.04 -34.56 77.98 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 121.147 -0.971 . . . . 0.0 111.824 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 92.4 mt -70.78 -31.19 67.88 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.815 0.846 . . . . 0.0 112.052 169.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -69.45 -39.1 77.96 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 176.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -63.79 -32.96 74.63 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.986 0.914 . . . . 0.0 112.59 174.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -75.51 -13.03 60.35 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 114.29 1.218 . . . . 0.0 114.29 169.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 78.74 6.32 88.43 Favored Glycine 0 CA--C 1.538 1.494 0 CA-C-N 118.84 0.746 . . . . 0.0 114.078 -173.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 35.4 mtpt -81.66 -27.65 33.96 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 126.823 2.049 . . . . 0.0 112.15 -171.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 59.2 tp -64.78 -43.73 92.27 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.081 0.952 . . . . 0.0 111.559 172.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 -59.07 -34.89 72.48 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.788 -0.57 . . . . 0.0 111.622 177.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -77.11 -18.71 78.21 Favored Glycine 0 CA--C 1.536 1.354 0 N-CA-C 115.605 1.002 . . . . 0.0 115.605 175.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 39.0 mt -81.61 -35.57 29.92 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.965 1.306 . . . . 0.0 111.533 168.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 84.2 mt -72.76 -3.28 24.33 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.386 1.474 . . . . 0.0 113.893 177.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.1 t . . . . . 0 C--O 1.252 1.217 0 C-N-CA 127.454 2.301 . . . . 0.0 112.333 177.492 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 53.8 p . . . . . 0 CA--C 1.54 0.583 0 CA-C-O 121.175 0.512 . . . . 0.0 111.579 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 23.5 pt -59.47 -23.94 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 123.846 0.859 . . . . 0.0 113.295 174.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.52 -32.62 72.67 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 118.244 0.474 . . . . 0.0 111.944 -175.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 83.4 p -69.26 -33.59 73.48 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.729 1.212 . . . . 0.0 113.319 170.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 43.3 mtt -67.19 -31.39 71.76 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.023 0.929 . . . . 0.0 111.516 -178.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.3 mm -56.47 -35.87 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 123.592 0.757 . . . . 0.0 111.834 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -73.61 -19.01 60.98 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.08 0.952 . . . . 0.0 113.263 -175.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -77.79 -26.92 59.7 Favored Glycine 0 CA--C 1.533 1.202 0 N-CA-C 115.998 1.159 . . . . 0.0 115.998 -166.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 26.7 m-80 -134.69 172.32 13.12 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.896 1.278 . . . . 0.0 111.993 -177.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -70.03 -40.72 75.01 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.233 1.013 . . . . 0.0 112.208 178.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.0 t -128.37 136.36 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 124.774 1.23 . . . . 0.0 110.172 174.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 43.5 t -132.7 130.34 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.4 1.08 . . . . 0.0 109.997 176.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 37.6 t -127.93 145.92 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 124.279 1.032 . . . . 0.0 111.94 -176.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -120.35 116.51 25.65 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.894 1.278 . . . . 0.0 108.54 172.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.4 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 14.7 m -130.64 169.14 16.02 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.911 1.684 . . . . 0.0 111.492 -169.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 25.6 m0 -115.59 135.88 53.63 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.197 0.999 . . . . 0.0 108.975 162.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 54.9 t -58.28 -28.54 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 CA-C-O 121.295 0.569 . . . . 0.0 111.071 176.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.7 p -82.72 -6.87 59.61 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 116.284 1.957 . . . . 0.0 116.284 178.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.9 t -92.47 140.15 24.03 Favored Pre-proline 0 CA--C 1.544 0.717 0 CA-C-N 120.55 1.523 . . . . 0.0 111.339 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -75.13 -34.75 3.48 Favored 'Trans proline' 0 CA--C 1.534 0.489 0 C-N-CA 121.855 1.704 . . . . 0.0 112.871 173.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -59.29 -38.12 79.4 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.611 1.164 . . . . 0.0 113.408 176.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.4 ' SG ' ' HB3' ' A' ' 19' ' ' SER . 0.1 OUTLIER -49.98 -52.65 32.09 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.288 1.035 . . . . 0.0 109.746 171.027 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 57.5 t -63.29 -40.46 89.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 124.005 0.922 . . . . 0.0 111.63 -176.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 37.0 mmt-85 -53.98 -48.74 70.05 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 118.997 0.817 . . . . 0.0 111.098 175.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.34 -54.14 23.28 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.896 0.878 . . . . 0.0 112.455 177.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -48.94 -40.48 30.39 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.544 1.138 . . . . 0.0 113.142 178.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.05 -45.22 58.76 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 124.676 1.19 . . . . 0.0 112.154 -175.055 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.9 tt -68.72 -41.1 79.51 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.538 1.535 . . . . 0.0 111.558 176.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 63.0 mt -63.02 -46.46 87.5 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 123.282 0.633 . . . . 0.0 111.197 175.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -64.81 -20.11 66.21 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 174.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.33 -12.87 57.71 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 173.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -116.47 -30.51 5.85 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.762 1.225 . . . . 0.0 114.302 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.7 m -146.9 134.77 21.3 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 119.678 1.126 . . . . 0.0 112.577 -168.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 10.6 mmpt? -86.87 -32.38 20.26 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.242 1.417 . . . . 0.0 112.717 169.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -77.33 47.56 0.58 Allowed 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 125.579 1.552 . . . . 0.0 113.296 177.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -110.46 128.44 66.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 127.265 2.226 . . . . 0.0 109.833 175.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.5 m -112.17 129.0 56.39 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.494 1.918 . . . . 0.0 108.728 174.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.5 p -125.55 142.54 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-O 122.117 0.96 . . . . 0.0 113.042 172.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 33.0 m-70 -120.09 121.68 39.39 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 127.302 2.241 . . . . 0.0 110.51 -174.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -94.63 90.99 6.34 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 122.558 1.17 . . . . 0.0 110.513 -177.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 34.4 m -70.18 -16.13 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-N 115.154 -0.93 . . . . 0.0 112.735 -176.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.13 -32.97 72.72 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.396 -0.815 . . . . 0.0 112.123 174.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -77.58 -27.57 51.42 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.52 1.928 . . . . 0.0 112.244 174.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 21.2 ttt -71.43 142.18 50.26 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.612 1.565 . . . . 0.0 112.48 -177.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 4.9 m -76.34 -12.28 60.04 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 177.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -125.21 9.9 8.02 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 126.116 1.766 . . . . 0.0 113.825 178.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -53.5 -29.01 38.27 Favored Glycine 0 CA--C 1.539 1.566 0 N-CA-C 116.457 1.343 . . . . 0.0 116.457 -171.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -69.19 -28.91 66.81 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 118.829 1.315 . . . . 0.0 112.869 174.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -67.39 -28.97 68.37 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.937 0.895 . . . . 0.0 111.424 169.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -83.57 -31.89 26.1 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.012 0.925 . . . . 0.0 111.961 178.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 49.5 mtp85 -53.36 -41.71 66.11 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 119.628 1.104 . . . . 0.0 111.058 154.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -57.93 -38.17 87.85 Favored Glycine 0 CA--C 1.536 1.405 0 CA-C-O 118.631 -1.094 . . . . 0.0 114.445 172.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -62.19 -41.8 98.68 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 120.299 2.049 . . . . 0.0 111.864 176.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 52.1 mt -70.13 -42.43 79.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.243 1.417 . . . . 0.0 110.069 179.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -67.84 -43.22 80.02 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 121.8 -0.563 . . . . 0.0 111.895 179.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -64.09 -33.94 76.91 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.459 -0.776 . . . . 0.0 111.812 177.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -79.35 -48.88 13.3 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 176.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -125.58 -1.45 7.42 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 114.552 1.316 . . . . 0.0 114.552 -164.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.2 mmtp 55.25 36.11 26.33 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 126.83 2.052 . . . . 0.0 114.148 -178.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 25.1 m80 -119.84 140.81 50.22 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 128.128 2.571 . . . . 0.0 109.367 176.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -125.88 -32.0 2.85 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.508 1.523 . . . . 0.0 114.395 -176.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 77.7 p -67.76 147.93 51.94 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 -169.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.3 m -99.46 152.68 37.88 Favored Pre-proline 0 N--CA 1.474 0.75 0 C-N-CA 123.726 0.811 . . . . 0.0 112.34 177.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -70.32 149.37 89.8 Favored 'Cis proline' 0 N--CA 1.458 -0.597 0 CA-C-N 119.029 0.689 . . . . 0.0 111.28 -9.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -102.85 130.78 49.98 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.219 1.007 . . . . 0.0 108.346 166.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 13.2 mt -124.62 142.28 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 124.163 0.985 . . . . 0.0 109.338 -164.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -138.36 141.21 39.68 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 123.764 0.826 . . . . 0.0 111.052 177.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 55.8 mt -133.7 117.44 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 124.467 1.107 . . . . 0.0 109.428 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 74.9 m-80 48.83 35.98 7.39 Favored 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 125.633 1.573 . . . . 0.0 114.092 -174.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 80.35 5.65 89.66 Favored Glycine 0 CA--C 1.537 1.423 0 N-CA-C 116.737 1.455 . . . . 0.0 116.737 -176.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 -95.76 139.33 32.15 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 118.834 1.317 . . . . 0.0 110.77 168.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -81.32 137.93 35.72 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.074 0.949 . . . . 0.0 112.181 178.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 28.6 mm -116.97 121.93 68.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 127.349 2.259 . . . . 0.0 107.416 174.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.9 -22.81 68.84 Favored Glycine 0 CA--C 1.534 1.223 0 N-CA-C 116.211 1.244 . . . . 0.0 116.211 -162.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 168.93 -171.47 42.92 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-N 118.193 0.997 . . . . 0.0 113.785 179.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 49.1 t -61.87 -37.85 86.08 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.784 1.234 . . . . 0.0 112.174 175.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 71.1 m -56.46 -44.66 80.74 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 118.908 0.777 . . . . 0.0 112.486 176.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -72.45 -39.14 68.02 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.998 0.919 . . . . 0.0 111.589 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 67.2 tp -62.42 -50.21 72.42 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.035 0.934 . . . . 0.0 112.168 174.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -68.67 -15.15 63.43 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 121.754 -0.591 . . . . 0.0 112.508 176.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -81.68 -47.12 13.38 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.417 -0.802 . . . . 0.0 111.49 169.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 66.5 mt -62.42 -32.58 73.44 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 120.831 -1.168 . . . . 0.0 112.783 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -64.72 -29.68 70.67 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.707 1.603 . . . . 0.0 113.467 173.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.1 mptt -93.36 -37.08 12.19 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 126.58 1.952 . . . . 0.0 112.089 -178.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -71.33 -6.2 38.22 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.996 1.318 . . . . 0.0 113.582 171.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 76.2 17.63 79.86 Favored Glycine 0 CA--C 1.534 1.256 0 O-C-N 120.942 -1.099 . . . . 0.0 113.945 177.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 44.6 mtmt -99.5 -21.45 15.93 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 126.27 1.828 . . . . 0.0 113.061 -172.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 31.1 tp -66.34 -34.82 78.84 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.861 0.865 . . . . 0.0 111.615 176.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -53.27 -41.77 65.87 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.694 1.198 . . . . 0.0 112.068 173.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -85.45 -6.9 83.15 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 125.966 1.746 . . . . 0.0 114.794 179.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 69.7 mt -95.73 -26.16 15.8 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.144 1.378 . . . . 0.0 112.471 172.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 76.6 mt -105.69 -16.13 14.77 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 114.838 1.422 . . . . 0.0 114.838 -177.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 63.3 p . . . . . 0 N--CA 1.479 1.009 0 C-N-CA 126.229 1.812 . . . . 0.0 114.836 178.479 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 74.1 p . . . . . 0 CA--C 1.54 0.578 0 N-CA-C 110.462 -0.199 . . . . 0.0 110.462 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 27.5 pt -51.53 -23.0 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 124.181 0.993 . . . . 0.0 113.493 173.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.28 -18.59 61.69 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.477 1.111 . . . . 0.0 113.407 -175.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.5 m -84.16 -19.39 34.2 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 171.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 64.7 mtt -64.2 -37.28 86.91 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 119.557 1.072 . . . . 0.0 110.851 175.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.4 mm -59.64 -20.63 19.28 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 124.004 0.921 . . . . 0.0 113.069 -173.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.3 mptt -91.74 -7.67 49.06 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.452 1.501 . . . . 0.0 114.143 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -96.82 -18.65 29.16 Favored Glycine 0 CA--C 1.539 1.579 0 N-CA-C 116.754 1.462 . . . . 0.0 116.754 -174.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 27.7 m120 -141.33 151.0 43.21 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 118.894 1.347 . . . . 0.0 112.164 -176.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt -54.85 -40.9 70.12 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.008 1.323 . . . . 0.0 112.992 176.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.6 t -129.83 134.43 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.131 0.972 . . . . 0.0 110.175 174.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 58.9 t -131.8 129.85 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.065 1.346 . . . . 0.0 109.751 177.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 47.0 t -127.33 146.9 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 124.294 1.038 . . . . 0.0 111.855 -175.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -121.72 113.48 19.77 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.696 1.198 . . . . 0.0 109.971 173.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.4 m -131.17 170.83 14.02 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.529 1.532 . . . . 0.0 112.092 -167.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.408 ' CD1' ' HB3' ' A' ' 46' ' ' ASP . 33.2 m0 -117.36 133.85 55.5 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.571 1.149 . . . . 0.0 108.867 162.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 71.4 t -58.55 -30.43 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 C-N-CA 123.567 0.747 . . . . 0.0 111.887 -175.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.8 p -82.56 -8.49 59.61 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 126.496 1.919 . . . . 0.0 116.08 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.7 t -91.62 141.4 25.74 Favored Pre-proline 0 CA--C 1.54 0.567 0 CA-C-N 120.372 1.442 . . . . 0.0 112.394 -168.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -69.26 -39.58 7.27 Favored 'Trans proline' 0 C--N 1.349 0.576 0 CA-C-N 120.343 1.158 . . . . 0.0 112.058 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -62.45 -36.47 82.52 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 126.166 1.786 . . . . 0.0 113.083 -178.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -55.1 -53.15 59.61 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.265 1.026 . . . . 0.0 109.125 169.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 94.8 t -64.32 -39.8 86.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 123.716 0.806 . . . . 0.0 111.871 -178.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.5 mmt85 -53.37 -43.4 67.75 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 118.87 0.759 . . . . 0.0 111.566 172.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.75 -54.27 9.37 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.487 0.715 . . . . 0.0 112.839 175.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.38 -33.32 58.96 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.671 1.188 . . . . 0.0 113.395 -179.005 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -68.68 -49.94 54.99 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.512 0.725 . . . . 0.0 111.58 177.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.6 tt -65.66 -43.32 89.74 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.796 1.639 . . . . 0.0 111.378 -178.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 95.0 mt -64.0 -40.07 95.54 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.633 0.773 . . . . 0.0 111.921 -178.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 54.3 m-70 -78.48 -13.38 59.86 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 171.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -80.37 -39.35 28.65 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 119.208 0.913 . . . . 0.0 111.952 172.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -87.46 -28.56 22.01 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 125.053 1.341 . . . . 0.0 114.267 -178.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.2 p -151.15 170.38 19.58 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 125.118 1.367 . . . . 0.0 112.628 -168.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -116.85 -19.33 9.91 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 126.562 1.945 . . . . 0.0 114.047 164.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -78.35 27.82 0.2 Allowed 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -171.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.21 132.47 44.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.365 0 C-N-CA 126.887 2.075 . . . . 0.0 111.563 -178.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 16.5 m -112.81 141.53 46.51 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 126.107 1.763 . . . . 0.0 109.65 168.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.4 p -132.85 140.24 47.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 125.259 1.424 . . . . 0.0 111.883 173.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -116.06 127.85 55.22 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.975 1.31 . . . . 0.0 110.46 176.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -95.99 87.95 4.74 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 122.06 0.933 . . . . 0.0 111.714 -172.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.0 m -71.79 3.61 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 -174.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.408 ' HB3' ' CD1' ' A' ' 20' ' ' TRP . 0.0 OUTLIER -87.33 -31.03 20.39 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 121.294 -0.879 . . . . 0.0 111.732 165.873 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 25.1 mtmt -81.42 -23.81 37.3 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.822 1.249 . . . . 0.0 113.367 176.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 21.0 ttt -85.2 121.97 28.71 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.212 1.805 . . . . 0.0 110.955 173.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 72.5 m -63.55 -31.6 72.81 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -176.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -83.32 1.48 40.93 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 175.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -56.12 -21.71 33.03 Favored Glycine 0 CA--C 1.535 1.311 0 N-CA-C 116.663 1.425 . . . . 0.0 116.663 -169.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -67.11 -29.07 68.72 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 119.365 1.582 . . . . 0.0 112.576 173.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -76.9 -25.37 52.93 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 121.103 -0.998 . . . . 0.0 111.724 174.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -84.48 -30.07 25.51 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.438 1.095 . . . . 0.0 111.57 175.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 41.1 mtp180 -54.18 -41.96 69.14 Favored 'General case' 0 N--CA 1.484 1.241 0 O-C-N 120.977 -1.077 . . . . 0.0 110.666 154.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.13 -38.86 93.68 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 124.329 0.966 . . . . 0.0 114.203 171.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -65.37 -31.66 72.88 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 120.038 1.919 . . . . 0.0 113.501 176.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 28.2 mt -71.68 -46.89 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 172.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -62.9 -39.58 94.92 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 121.109 -0.995 . . . . 0.0 113.039 -178.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 38.6 mm-40 -71.81 -10.74 60.21 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.865 1.266 . . . . 0.0 114.135 -179.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -113.99 -26.12 8.26 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 114.217 1.192 . . . . 0.0 114.217 173.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -135.31 0.87 2.85 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 115.255 1.576 . . . . 0.0 115.255 -170.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp 49.49 35.23 7.87 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 127.089 2.155 . . . . 0.0 115.226 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -141.06 153.79 45.65 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 125.148 1.379 . . . . 0.0 110.311 175.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -141.35 -24.33 0.73 Allowed 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -160.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 22.0 m -77.36 131.99 38.34 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.988 1.315 . . . . 0.0 112.353 -173.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 14.1 m -81.22 158.43 69.53 Favored Pre-proline 0 CA--C 1.547 0.857 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 -171.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -68.63 153.18 89.74 Favored 'Cis proline' 0 CA--C 1.534 0.503 0 CA-C-N 118.528 0.51 . . . . 0.0 112.219 -15.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -98.6 135.63 39.84 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 159.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 69.4 mt -129.61 142.52 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 123.599 0.759 . . . . 0.0 109.28 -166.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -138.22 140.67 39.82 Favored 'General case' 0 C--N 1.332 -0.152 0 C-N-CA 123.934 0.894 . . . . 0.0 111.145 177.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 73.8 mt -128.5 115.03 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.994 1.318 . . . . 0.0 108.202 176.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 45.69 47.83 11.59 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.547 1.539 . . . . 0.0 113.54 -174.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 79.54 -10.48 37.11 Favored Glycine 0 CA--C 1.535 1.302 0 N-CA-C 115.793 1.077 . . . . 0.0 115.793 -178.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 26.8 m-80 -86.65 132.77 33.79 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 118.887 1.343 . . . . 0.0 109.541 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -82.65 143.01 31.26 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.531 1.132 . . . . 0.0 113.056 -174.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 20.2 mm -132.5 119.58 39.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 127.93 2.492 . . . . 0.0 107.246 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.97 -22.75 65.05 Favored Glycine 0 CA--C 1.537 1.426 0 N-CA-C 116.785 1.474 . . . . 0.0 116.785 -164.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 156.64 -152.51 23.89 Favored Glycine 0 CA--C 1.527 0.79 0 CA-C-N 118.058 0.929 . . . . 0.0 114.154 173.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 8.2 t -54.91 -56.23 21.88 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.196 0.998 . . . . 0.0 112.593 -175.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 65.6 m -75.27 3.16 9.4 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -95.73 -43.09 8.05 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.357 1.063 . . . . 0.0 111.646 165.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 28.6 tp -63.39 -51.21 66.8 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.188 1.395 . . . . 0.0 111.003 175.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -57.39 -43.81 83.99 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.5 0.72 . . . . 0.0 110.24 174.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.16 -35.36 78.54 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.351 -0.843 . . . . 0.0 112.861 -177.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 42.8 mt -73.65 -26.74 60.9 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.681 0.792 . . . . 0.0 112.91 173.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -72.75 -38.92 67.23 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 119.24 0.927 . . . . 0.0 111.601 169.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -64.21 -38.64 91.77 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.565 0.746 . . . . 0.0 111.549 173.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -73.32 -7.68 52.64 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 171.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.95 28.94 74.08 Favored Glycine 0 CA--C 1.539 1.534 0 CA-C-N 120.617 1.553 . . . . 0.0 112.993 -176.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 21.2 mtpp -110.09 -30.19 7.88 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.882 2.073 . . . . 0.0 112.392 -176.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 50.2 tp -56.36 -37.51 70.14 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.444 0.697 . . . . 0.0 111.837 172.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -51.13 -46.44 61.95 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.695 1.598 . . . . 0.0 112.577 174.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -78.23 -25.42 61.62 Favored Glycine 0 CA--C 1.531 1.061 0 O-C-N 121.616 -0.677 . . . . 0.0 114.279 177.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 79.6 mt -71.19 -37.6 72.13 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 118.642 1.221 . . . . 0.0 111.734 175.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 87.3 mt -86.89 -8.26 57.43 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.166 0.987 . . . . 0.0 112.973 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.9 t . . . . . 0 C--O 1.253 1.246 0 C-N-CA 126.695 1.998 . . . . 0.0 111.224 173.456 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 51.0 m . . . . . 0 CA--C 1.543 0.702 0 CA-C-O 121.022 0.439 . . . . 0.0 111.549 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 13.2 pt -54.81 -22.25 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 N-CA-C 115.198 1.555 . . . . 0.0 115.198 -168.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.36 -22.03 60.72 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 93.4 p -80.48 -25.89 38.54 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.668 1.587 . . . . 0.0 113.923 172.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 62.1 mtt -65.12 -33.62 76.47 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 120.624 -1.297 . . . . 0.0 111.704 176.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.5 mm -61.89 -24.49 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 124.017 0.927 . . . . 0.0 112.222 -174.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -75.75 -11.02 59.91 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.356 1.462 . . . . 0.0 114.265 177.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -95.73 -26.38 11.86 Favored Glycine 0 CA--C 1.536 1.346 0 N-CA-C 117.8 1.88 . . . . 0.0 117.8 -164.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -143.35 158.72 43.4 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 119.335 1.568 . . . . 0.0 111.918 -173.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -59.69 -38.73 82.35 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.837 1.255 . . . . 0.0 112.931 -176.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.4 t -131.54 134.66 60.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.322 1.449 . . . . 0.0 109.446 173.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 56.1 t -132.26 128.48 58.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.702 1.201 . . . . 0.0 110.075 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 44.9 t -131.33 153.03 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.49 1.116 . . . . 0.0 111.981 -173.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -128.37 105.95 8.68 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.582 1.153 . . . . 0.0 109.393 176.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 68.9 m -126.46 171.23 11.21 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 125.744 1.618 . . . . 0.0 111.816 -170.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 47.3 m0 -118.94 129.4 55.15 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.847 1.259 . . . . 0.0 109.399 168.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 31.6 t -61.61 -20.33 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 C-N-CA 124.864 1.266 . . . . 0.0 112.661 -168.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.7 p -83.08 -22.26 33.5 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 128.671 2.788 . . . . 0.0 115.485 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 66.3 m -105.24 153.97 39.23 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 120.154 1.343 . . . . 0.0 114.06 -154.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -71.8 -49.48 0.32 Allowed 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 121.382 1.388 . . . . 0.0 114.023 -168.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -62.16 -37.37 84.99 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 -177.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -42.73 -58.29 2.4 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.973 1.709 . . . . 0.0 110.341 164.049 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 61.4 t -66.34 -38.45 81.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 O-C-N 121.5 -0.75 . . . . 0.0 112.125 -177.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 37.6 mmt-85 -54.37 -39.74 67.48 Favored 'General case' 0 N--CA 1.484 1.258 0 CA-C-N 119.12 0.873 . . . . 0.0 111.915 174.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.64 -54.74 6.5 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.55 1.14 . . . . 0.0 112.988 174.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -54.3 -30.4 50.83 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 119.392 0.997 . . . . 0.0 113.27 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.6 ttpt -69.53 -50.58 43.61 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.675 0.79 . . . . 0.0 112.21 175.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.1 tt -64.13 -43.04 96.46 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.521 1.528 . . . . 0.0 111.132 -177.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 90.5 mt -66.45 -24.27 66.41 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.263 1.025 . . . . 0.0 113.335 -177.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 44.1 m-70 -92.46 -16.3 26.02 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 168.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.0 -27.44 22.05 Favored 'General case' 0 CA--C 1.545 0.76 0 O-C-N 120.793 -1.192 . . . . 0.0 113.967 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 7.5 mmm-85 -103.2 -18.93 14.69 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 125.23 1.412 . . . . 0.0 113.973 177.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -153.02 174.49 14.1 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 127.037 2.135 . . . . 0.0 111.739 -171.13 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -129.78 -7.81 4.52 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 125.309 1.444 . . . . 0.0 114.532 170.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -97.76 87.69 4.1 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 119.506 1.048 . . . . 0.0 111.454 179.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.42 129.55 22.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 125.073 1.349 . . . . 0.0 110.641 -179.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 22.7 m -104.49 127.53 52.22 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.319 1.448 . . . . 0.0 108.632 168.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.5 p -125.18 134.29 67.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 118.957 0.798 . . . . 0.0 112.264 170.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -104.06 122.93 46.29 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.941 1.296 . . . . 0.0 110.3 175.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -93.7 82.91 4.36 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.568 0.699 . . . . 0.0 111.964 -172.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 29.6 m -76.08 33.32 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 -169.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -129.04 -16.67 4.03 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 126.449 1.9 . . . . 0.0 111.708 161.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 20.4 mtmt -80.2 -24.7 40.1 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.445 1.098 . . . . 0.0 112.229 162.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -92.21 127.62 37.76 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.677 1.591 . . . . 0.0 110.781 177.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 58.1 m -71.55 -20.95 61.96 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 -165.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -97.85 7.49 46.29 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 126.028 1.731 . . . . 0.0 112.686 174.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -49.51 -30.83 13.46 Favored Glycine 0 CA--C 1.537 1.416 0 CA-C-N 119.743 1.156 . . . . 0.0 115.028 -175.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -58.4 -35.34 71.89 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.368 1.867 . . . . 0.0 114.907 171.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -80.36 -36.14 34.48 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.809 1.244 . . . . 0.0 112.08 175.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -69.67 -36.11 75.73 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.715 -0.615 . . . . 0.0 111.075 176.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 42.2 mtp180 -53.14 -38.83 63.05 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.834 1.254 . . . . 0.0 112.258 165.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -57.94 -40.08 92.71 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 123.974 0.797 . . . . 0.0 113.797 173.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 56.7 mm-40 -66.55 -24.87 66.43 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 118.841 1.321 . . . . 0.0 112.984 175.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 26.1 mt -74.72 -45.45 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 O-C-N 121.498 -0.751 . . . . 0.0 109.722 172.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -68.88 -39.11 79.97 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 121.618 -0.677 . . . . 0.0 112.671 -177.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -59.58 -35.31 74.03 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 121.456 -0.777 . . . . 0.0 112.834 176.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -94.61 -32.13 13.56 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 114.293 1.219 . . . . 0.0 114.293 -175.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -134.69 4.02 3.3 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 114.741 1.386 . . . . 0.0 114.741 -169.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt 52.96 31.48 11.0 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 126.513 1.925 . . . . 0.0 114.903 176.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 -116.71 111.31 19.62 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 127.745 2.418 . . . . 0.0 110.466 -166.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -100.13 -5.37 27.93 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 115.942 1.83 . . . . 0.0 115.942 -177.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 44.7 p -81.29 171.13 15.2 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 124.895 1.278 . . . . 0.0 113.51 178.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.3 m -125.7 143.58 45.49 Favored Pre-proline 0 N--CA 1.481 1.119 0 C-N-CA 124.189 0.996 . . . . 0.0 111.748 169.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -88.64 162.62 41.42 Favored 'Cis proline' 0 N--CA 1.457 -0.621 0 CA-C-N 119.525 0.866 . . . . 0.0 113.976 5.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -100.14 143.25 30.56 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.81 0.844 . . . . 0.0 109.476 159.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 15.8 mt -133.03 141.71 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 124.21 1.004 . . . . 0.0 110.137 -167.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -142.77 147.63 35.85 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.119 0.968 . . . . 0.0 112.253 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 79.8 mt -130.65 122.79 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 125.731 1.613 . . . . 0.0 109.765 177.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 31.2 m120 44.78 39.5 3.53 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 125.645 1.578 . . . . 0.0 114.305 -178.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 92.72 -6.25 77.05 Favored Glycine 0 CA--C 1.539 1.574 0 O-C-N 120.208 -1.558 . . . . 0.0 116.231 -176.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -104.77 134.79 47.32 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.292 1.437 . . . . 0.0 111.755 -173.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -75.42 143.83 42.51 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 27.0 mm -125.61 133.19 69.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 128.266 2.627 . . . . 0.0 108.522 178.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -72.95 53.63 1.73 Allowed Glycine 0 N--CA 1.474 1.226 0 C-N-CA 126.324 1.916 . . . . 0.0 117.353 -177.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 78.21 -164.63 51.36 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 128.075 2.75 . . . . 0.0 113.459 175.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 18.6 t -62.15 -29.39 70.32 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 122.087 -0.655 . . . . 0.0 111.672 175.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 36.6 m -64.1 -45.01 90.54 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.338 1.055 . . . . 0.0 112.664 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -72.79 -37.83 67.45 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 118.823 0.738 . . . . 0.0 112.205 172.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 50.6 tp -58.67 -50.07 75.23 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.74 0.816 . . . . 0.0 111.38 176.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -61.55 -43.55 98.66 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.845 0.858 . . . . 0.0 110.697 173.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.98 -33.68 75.91 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 120.848 -1.158 . . . . 0.0 112.806 -176.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 98.7 mt -78.34 -23.82 46.81 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.511 1.124 . . . . 0.0 113.345 173.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -70.51 -41.24 72.89 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 119.566 1.076 . . . . 0.0 110.85 166.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -65.02 -28.85 69.78 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.564 1.146 . . . . 0.0 113.148 175.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -91.28 2.1 56.62 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 114.641 1.349 . . . . 0.0 114.641 169.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 67.77 4.7 34.62 Favored Glycine 0 CA--C 1.537 1.41 0 O-C-N 120.948 -1.095 . . . . 0.0 115.261 179.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 44.2 mtmt -78.57 -28.13 45.85 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 126.178 1.791 . . . . 0.0 111.949 -174.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 35.4 tp -56.07 -36.15 67.78 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.528 1.131 . . . . 0.0 112.361 172.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -65.75 -28.38 69.0 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 178.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -76.19 -36.88 38.77 Favored Glycine 0 CA--C 1.53 0.974 0 O-C-N 121.584 -0.698 . . . . 0.0 111.992 171.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 90.4 mt -70.52 -25.87 63.32 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.986 0.914 . . . . 0.0 113.367 -178.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 85.2 mt -105.42 2.14 28.4 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 -173.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 41.6 m . . . . . 0 C--O 1.255 1.351 0 C-N-CA 125.645 1.578 . . . . 0.0 114.487 -174.619 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 60.6 p . . . . . 0 CA--C 1.543 0.674 0 CA-C-O 120.888 0.375 . . . . 0.0 111.244 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.4 pt -53.22 -22.88 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 125.136 1.374 . . . . 0.0 113.89 174.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.62 -32.39 72.53 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 118.868 0.758 . . . . 0.0 112.574 -174.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 62.9 m -76.84 -19.3 57.67 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 173.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 38.4 mtt -73.68 -25.72 60.39 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.036 -1.04 . . . . 0.0 112.01 176.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.8 mm -63.54 -33.13 59.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.862 0.865 . . . . 0.0 111.615 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -76.45 1.41 16.56 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.884 1.274 . . . . 0.0 113.416 175.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -86.03 -18.82 58.78 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 125.115 1.341 . . . . 0.0 115.385 -177.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.692 ' ND2' ' HG1' ' A' ' 41' ' ' THR . 22.2 m-80 -151.37 170.56 19.25 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 126.133 1.773 . . . . 0.0 111.943 -179.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -70.19 -36.8 74.87 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.257 0.623 . . . . 0.0 112.651 174.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.3 t -128.09 135.09 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.842 1.257 . . . . 0.0 110.574 172.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 47.2 t -131.48 129.18 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 124.411 1.084 . . . . 0.0 110.069 174.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.0 t -124.9 144.73 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 124.565 1.146 . . . . 0.0 111.883 -176.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -120.2 113.01 19.8 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.17 1.388 . . . . 0.0 108.692 173.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.412 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 14.2 m -130.63 -179.06 5.07 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 127.279 2.232 . . . . 0.0 110.58 -169.158 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 19.7 m0 -126.82 138.08 53.29 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.491 1.116 . . . . 0.0 108.425 159.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 40.6 t -59.36 -31.07 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 CA-C-O 122.06 0.933 . . . . 0.0 111.619 -170.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.6 p -81.96 -11.08 59.05 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 127.349 2.26 . . . . 0.0 115.526 -177.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 8.2 t -89.01 141.9 29.83 Favored Pre-proline 0 CA--C 1.542 0.653 0 CA-C-N 120.373 1.442 . . . . 0.0 110.384 -168.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -75.75 -31.39 5.34 Favored 'Trans proline' 0 C--N 1.347 0.467 0 CA-C-N 120.605 1.252 . . . . 0.0 113.361 179.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -62.65 -41.45 99.06 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.532 1.133 . . . . 0.0 113.264 174.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.412 ' SG ' ' HB3' ' A' ' 19' ' ' SER . 0.2 OUTLIER -50.72 -56.51 11.65 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.597 1.159 . . . . 0.0 109.55 171.924 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 81.3 t -63.23 -40.92 90.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 118.761 -0.637 . . . . 0.0 112.579 -173.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -66.94 -20.19 65.85 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 176.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.2 -54.42 5.53 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 118.448 -0.787 . . . . 0.0 111.042 165.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -46.36 -46.76 18.55 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.438 1.095 . . . . 0.0 112.756 178.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -67.37 -36.31 81.1 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.005 1.322 . . . . 0.0 113.01 -176.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.27 -35.72 54.99 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.225 1.01 . . . . 0.0 111.402 175.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 96.7 mt -64.94 -34.54 78.66 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 121.126 -0.984 . . . . 0.0 111.409 171.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -70.25 -27.08 64.16 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.912 1.078 . . . . 0.0 113.912 167.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -74.11 -36.74 64.23 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 119.69 1.132 . . . . 0.0 112.711 174.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 73.7 mmt-85 -99.31 -28.02 13.5 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 -172.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.3 p -136.76 163.89 29.55 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.313 1.045 . . . . 0.0 113.442 -162.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -122.88 -26.04 4.5 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.949 1.3 . . . . 0.0 113.189 165.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -85.44 48.16 1.54 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 125.427 1.491 . . . . 0.0 113.569 -178.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.04 134.17 58.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 126.128 1.771 . . . . 0.0 112.083 -176.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.692 ' HG1' ' ND2' ' A' ' 13' ' ' ASN . 4.1 m -121.09 136.87 54.89 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.817 1.647 . . . . 0.0 110.66 171.254 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.1 p -127.17 141.29 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 125.013 1.325 . . . . 0.0 113.002 173.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 56.9 m-70 -119.43 135.82 54.58 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 128.641 2.776 . . . . 0.0 109.804 -176.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -109.25 93.18 4.38 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.251 0.62 . . . . 0.0 111.668 -173.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . 0.266 34.5 m -79.76 44.81 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 CA-C-O 123.117 1.437 . . . . 0.0 114.578 -173.323 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -145.84 -27.3 0.44 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 129.057 2.943 . . . . 0.0 110.217 172.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 28.2 mmmt -70.45 -39.06 74.56 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.444 1.098 . . . . 0.0 110.478 155.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 14.3 ttt -69.71 127.94 34.71 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.703 0.801 . . . . 0.0 111.579 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 9.1 m -78.92 -18.78 53.26 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.725 1.21 . . . . 0.0 113.927 179.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -95.54 -5.29 43.09 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.944 1.297 . . . . 0.0 112.807 167.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -51.34 -25.54 12.43 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 126.067 1.794 . . . . 0.0 116.841 -169.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -73.22 -28.13 61.99 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 118.871 1.336 . . . . 0.0 112.673 177.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 14.4 tm0? -70.04 -37.36 75.54 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.409 1.084 . . . . 0.0 110.714 172.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -74.43 -36.19 63.39 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.825 1.25 . . . . 0.0 112.52 177.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 72.0 mtp180 -54.13 -40.17 67.14 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 119.097 0.862 . . . . 0.0 111.158 162.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.45 -33.36 86.24 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 125.256 1.408 . . . . 0.0 114.631 172.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -63.51 -42.56 98.47 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 120.414 2.107 . . . . 0.0 111.088 175.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 26.4 mt -69.64 -39.47 78.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 123.828 0.851 . . . . 0.0 110.308 177.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -70.28 -44.23 68.8 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 121.148 -0.97 . . . . 0.0 112.808 -179.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -62.6 -30.66 71.51 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 118.93 0.786 . . . . 0.0 112.477 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -83.47 -55.09 4.5 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 174.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -117.84 -1.74 11.48 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.446 1.098 . . . . 0.0 113.918 -161.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.5 mmtp 54.21 29.74 11.08 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 126.364 1.866 . . . . 0.0 114.102 -178.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -99.74 119.88 38.84 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.087 1.755 . . . . 0.0 109.939 -179.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -115.37 -17.75 11.2 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.01 1.324 . . . . 0.0 114.502 -172.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.3 p -75.2 166.48 23.57 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.564 1.146 . . . . 0.0 112.419 172.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 21.6 m -120.52 151.27 53.73 Favored Pre-proline 0 N--CA 1.475 0.783 0 C-N-CA 124.912 1.285 . . . . 0.0 110.609 166.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -78.32 154.56 93.03 Favored 'Cis proline' 0 C--N 1.349 0.56 0 CA-C-N 118.986 0.673 . . . . 0.0 113.561 -0.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -104.84 135.25 46.56 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.144 1.378 . . . . 0.0 108.776 161.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.9 mt -126.69 142.78 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.391 1.076 . . . . 0.0 109.514 -167.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -139.9 136.41 33.87 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.274 1.03 . . . . 0.0 110.272 178.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 52.5 mt -133.84 122.03 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.02 0.928 . . . . 0.0 110.403 -176.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 48.5 m-20 49.75 30.91 4.02 Favored 'General case' 0 CA--C 1.554 1.114 0 O-C-N 121.238 -0.914 . . . . 0.0 113.257 -175.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 95.21 -8.99 69.91 Favored Glycine 0 CA--C 1.54 1.602 0 N-CA-C 117.606 1.802 . . . . 0.0 117.606 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 25.4 p30 -76.33 169.28 18.53 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 121.248 2.524 . . . . 0.0 113.482 175.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -108.16 129.45 55.18 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.447 0.699 . . . . 0.0 111.808 169.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 45.5 mm -113.99 121.88 67.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 126.611 1.964 . . . . 0.0 108.64 -178.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -74.14 21.77 1.34 Allowed Glycine 0 N--CA 1.472 1.073 0 N-CA-C 118.569 2.188 . . . . 0.0 118.569 -164.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 121.39 -172.03 15.18 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 126.639 2.066 . . . . 0.0 115.058 174.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 29.9 t -66.49 -38.51 87.43 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 121.853 -0.792 . . . . 0.0 113.033 -174.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 63.4 m -63.1 -20.27 65.21 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 176.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -90.13 -43.6 10.35 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.763 1.225 . . . . 0.0 111.008 175.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 48.4 tp -57.43 -49.48 76.1 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.442 1.097 . . . . 0.0 111.435 174.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -67.28 -29.43 69.03 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.26 0.624 . . . . 0.0 111.825 177.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -73.3 -40.2 64.72 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 121.025 -1.047 . . . . 0.0 112.672 176.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 75.8 mt -65.29 -28.2 69.16 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.083 0.953 . . . . 0.0 112.616 177.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -59.78 -47.44 85.69 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.535 1.134 . . . . 0.0 111.515 171.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -68.71 -40.74 79.83 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.199 1.0 . . . . 0.0 112.944 178.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -73.3 2.87 6.62 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 70.0 16.5 72.78 Favored Glycine 0 CA--C 1.538 1.508 0 O-C-N 120.332 -1.48 . . . . 0.0 114.145 178.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 44.4 mtmt -100.29 -34.23 10.08 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.874 1.669 . . . . 0.0 112.592 -175.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 54.4 tp -59.39 -41.36 89.23 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.244 0.929 . . . . 0.0 111.411 175.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -57.21 -41.0 78.59 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.805 0.842 . . . . 0.0 113.134 176.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -76.58 -34.05 45.59 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 124.542 1.068 . . . . 0.0 113.376 178.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 62.9 mt -65.07 -23.21 67.1 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.909 0.884 . . . . 0.0 112.483 172.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 46.5 mt -100.65 -3.29 30.63 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 126.069 1.748 . . . . 0.0 113.751 177.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 69.3 m . . . . . 0 C--O 1.253 1.277 0 C-N-CA 125.311 1.445 . . . . 0.0 112.091 -179.284 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 25.5 p . . . . . 0 N--CA 1.472 0.631 0 CA-C-O 121.607 0.718 . . . . 0.0 112.224 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 26.8 pt -57.21 -22.46 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 124.068 0.947 . . . . 0.0 113.127 169.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.47 -21.28 64.63 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -173.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 74.0 m -83.28 -33.02 26.08 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.291 1.037 . . . . 0.0 112.48 166.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 73.4 mtp -61.78 -25.93 67.77 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.081 0.952 . . . . 0.0 112.736 178.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.9 mm -57.66 -34.59 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.283 1.033 . . . . 0.0 112.039 175.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.3 mptt -76.95 -3.41 38.73 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.29 1.036 . . . . 0.0 113.427 -178.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -76.11 -26.51 64.03 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.791 1.186 . . . . 0.0 114.96 -176.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -146.52 171.89 14.38 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 118.662 1.231 . . . . 0.0 114.026 -173.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -66.57 -35.9 81.34 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.286 1.034 . . . . 0.0 111.886 172.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.9 t -134.57 131.49 54.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 124.857 1.263 . . . . 0.0 110.23 177.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 39.5 t -134.85 130.0 52.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.467 1.107 . . . . 0.0 110.005 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 48.8 t -131.67 148.75 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 124.224 1.01 . . . . 0.0 112.513 -171.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -125.59 110.58 14.0 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.252 1.421 . . . . 0.0 109.423 175.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 58.3 m -130.61 173.66 10.67 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.604 1.562 . . . . 0.0 111.698 -169.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 47.8 m0 -122.73 129.63 51.99 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.809 1.244 . . . . 0.0 108.63 166.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 49.0 t -63.45 -23.88 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 123.361 0.664 . . . . 0.0 112.689 -164.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.4 p -78.07 -16.49 57.98 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 177.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 84.0 m -99.51 148.37 34.62 Favored Pre-proline 0 CA--C 1.537 0.45 0 CA-C-N 120.346 1.43 . . . . 0.0 114.212 -154.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -67.76 -48.68 1.37 Allowed 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 121.282 1.321 . . . . 0.0 113.964 -165.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -69.47 -31.44 69.73 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.463 1.105 . . . . 0.0 113.364 -178.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -50.71 -54.3 24.31 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.829 0.852 . . . . 0.0 109.641 168.463 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.7 t -66.93 -39.07 82.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 123.284 0.634 . . . . 0.0 111.658 -177.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 17.3 mmt85 -54.26 -49.2 70.1 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 118.612 0.642 . . . . 0.0 111.565 172.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.71 -57.94 7.64 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.93 0.892 . . . . 0.0 112.429 176.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -48.19 -44.51 32.79 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.538 1.135 . . . . 0.0 112.963 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -65.85 -43.34 88.75 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 123.727 0.811 . . . . 0.0 111.943 -177.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.6 tt -72.76 -34.36 66.94 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.995 1.318 . . . . 0.0 111.969 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 76.5 mt -67.47 -42.95 82.17 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.529 0.732 . . . . 0.0 111.282 172.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -60.92 -28.2 68.76 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 118.472 0.578 . . . . 0.0 112.301 167.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.73 4.07 38.37 Favored 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 114.877 1.436 . . . . 0.0 114.877 175.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -126.68 -39.72 1.97 Allowed 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 174.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 17.9 p -143.15 131.96 22.7 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 119.236 0.925 . . . . 0.0 113.343 -166.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 39.4 mtmt -70.05 -27.0 64.29 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 163.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -88.05 60.4 5.8 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.224 1.01 . . . . 0.0 113.059 -175.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.83 137.86 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 125.759 1.624 . . . . 0.0 111.622 178.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 75.6 m -120.82 135.13 55.24 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 127.288 2.235 . . . . 0.0 109.434 172.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.7 p -133.8 141.76 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 169.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 33.3 t60 -121.13 119.22 31.77 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.837 2.055 . . . . 0.0 109.632 -178.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -94.93 91.32 6.35 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.223 -0.923 . . . . 0.0 112.387 -168.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . 0.252 32.0 m -78.26 36.73 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 115.735 1.754 . . . . 0.0 115.735 -168.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -134.68 -28.68 1.22 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 127.91 2.484 . . . . 0.0 110.473 163.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 20.0 mmmt -64.09 -25.93 68.32 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.592 1.157 . . . . 0.0 112.086 160.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 91.6 mmm -91.02 144.22 25.89 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.039 1.336 . . . . 0.0 110.922 176.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.9 m -82.55 -27.09 31.85 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -174.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -99.12 8.02 45.29 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.255 1.822 . . . . 0.0 112.877 178.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -52.35 -26.56 22.4 Favored Glycine 0 CA--C 1.537 1.467 0 N-CA-C 116.751 1.46 . . . . 0.0 116.751 -173.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 70.2 mt-10 -70.39 -26.67 63.81 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 120.76 2.28 . . . . 0.0 112.895 174.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -78.08 -28.26 48.71 Favored 'General case' 0 N--CA 1.469 0.488 0 O-C-N 120.98 -1.075 . . . . 0.0 111.611 173.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -80.88 -33.21 34.5 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.539 -0.726 . . . . 0.0 111.343 175.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 56.5 mtp180 -58.82 -33.53 70.48 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 120.852 -1.155 . . . . 0.0 111.521 161.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -56.31 -40.18 84.36 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 124.013 0.816 . . . . 0.0 113.919 168.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -66.55 -24.8 66.42 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 119.442 1.621 . . . . 0.0 113.172 175.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 52.3 mt -81.43 -46.07 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 124.565 1.146 . . . . 0.0 109.725 175.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -69.38 -44.2 71.96 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 121.42 -0.8 . . . . 0.0 112.192 -178.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -58.11 -41.2 83.06 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.415 -0.803 . . . . 0.0 112.216 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -89.11 -37.83 14.79 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 114.247 1.202 . . . . 0.0 114.247 -175.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -124.25 -2.01 8.12 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 -170.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 53.71 47.99 22.51 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 126.703 2.001 . . . . 0.0 113.369 -176.171 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -132.2 142.39 49.42 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.679 1.192 . . . . 0.0 111.781 175.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -135.71 -28.83 1.08 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.076 1.35 . . . . 0.0 112.996 -157.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 20.8 p -79.12 167.05 21.57 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 128.023 2.529 . . . . 0.0 113.265 177.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 26.8 m -114.99 152.92 47.02 Favored Pre-proline 0 N--CA 1.48 1.063 0 C-N-CA 124.173 0.989 . . . . 0.0 112.694 173.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -77.28 143.28 74.54 Favored 'Cis proline' 0 C--N 1.349 0.592 0 CA-C-N 119.18 0.743 . . . . 0.0 112.498 -6.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -97.63 127.9 43.93 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 165.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 35.4 mt -123.73 142.37 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 124.128 0.971 . . . . 0.0 109.527 -165.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -137.63 143.03 41.22 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.813 0.845 . . . . 0.0 111.666 177.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 89.1 mt -130.01 119.65 47.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 125.165 1.386 . . . . 0.0 108.753 176.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 44.2 46.1 7.28 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 125.112 1.365 . . . . 0.0 113.178 -177.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 77.65 -2.35 63.72 Favored Glycine 0 CA--C 1.541 1.716 0 N-CA-C 117.066 1.586 . . . . 0.0 117.066 -178.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 25.7 m-80 -88.5 138.09 31.74 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 120.291 2.046 . . . . 0.0 110.326 175.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -82.61 136.11 34.89 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 118.994 0.816 . . . . 0.0 112.37 176.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 40.6 mm -115.98 124.97 72.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 127.016 2.126 . . . . 0.0 108.928 -178.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -68.72 2.63 7.63 Favored Glycine 0 CA--C 1.535 1.313 0 N-CA-C 119.25 2.46 . . . . 0.0 119.25 -163.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 142.6 -171.25 24.83 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 126.137 1.827 . . . . 0.0 113.216 175.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 42.4 t -64.07 -40.87 97.2 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 121.757 -0.849 . . . . 0.0 112.4 -177.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 68.1 m -72.89 -21.06 60.98 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.131 -0.981 . . . . 0.0 113.374 178.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -73.26 -42.65 62.24 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.262 0.937 . . . . 0.0 111.882 167.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 53.5 tp -61.06 -45.17 95.83 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.956 0.902 . . . . 0.0 110.988 175.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -64.71 -38.98 92.85 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 122.065 -0.397 . . . . 0.0 111.823 173.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.08 -36.95 83.23 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.081 -1.012 . . . . 0.0 112.106 178.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 92.4 mt -67.79 -28.69 67.81 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.69 -0.631 . . . . 0.0 112.173 175.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -69.7 -43.82 71.67 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.313 0.645 . . . . 0.0 111.098 173.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -69.93 -36.19 75.12 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.299 1.039 . . . . 0.0 113.065 175.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -73.15 -7.68 52.45 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.157 1.383 . . . . 0.0 113.299 175.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 79.37 10.13 86.27 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 123.846 0.736 . . . . 0.0 114.523 177.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 40.7 mtmt -91.11 -30.62 16.62 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 126.424 1.89 . . . . 0.0 112.527 -174.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 19.5 tp -61.97 -35.91 79.88 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 119.147 0.885 . . . . 0.0 111.392 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -65.55 -35.62 81.38 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.19 0.996 . . . . 0.0 112.318 171.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -77.36 -23.77 67.33 Favored Glycine 0 CA--C 1.532 1.121 0 O-C-N 120.879 -1.138 . . . . 0.0 114.566 177.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 86.8 mt -86.95 -27.38 23.34 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.412 1.485 . . . . 0.0 113.021 176.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 74.8 mt -117.93 -16.84 9.86 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 -170.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.7 m . . . . . 0 C--O 1.254 1.322 0 C-N-CA 126.625 1.97 . . . . 0.0 114.152 177.278 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 44.1 p . . . . . 0 CA--C 1.537 0.448 0 CA-C-O 121.703 0.763 . . . . 0.0 111.786 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 11.5 pt -50.98 -23.32 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.841 1.256 . . . . 0.0 113.553 168.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.69 -27.27 69.13 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -175.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.6 m -85.4 -11.44 54.46 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 172.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 55.7 mtt -68.79 -32.7 72.63 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 120.795 -1.19 . . . . 0.0 111.176 170.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.3 mm -60.51 -30.41 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 123.788 0.835 . . . . 0.0 111.905 -176.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.0 mttm -74.28 -8.9 57.82 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.825 1.25 . . . . 0.0 113.725 -177.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -89.8 -28.37 18.86 Favored Glycine 0 CA--C 1.537 1.41 0 N-CA-C 116.961 1.544 . . . . 0.0 116.961 -166.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.532 ' ND2' ' HG1' ' A' ' 41' ' ' THR . 35.2 m-80 -145.07 159.27 43.22 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.504 1.522 . . . . 0.0 111.05 -178.311 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -52.91 -42.29 65.23 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.711 1.605 . . . . 0.0 113.63 178.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.2 t -125.09 135.68 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.809 1.244 . . . . 0.0 110.464 174.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 48.4 t -133.85 131.73 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.394 1.078 . . . . 0.0 110.46 178.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.4 t -129.36 147.43 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 125.265 1.426 . . . . 0.0 111.545 -172.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -124.3 115.39 20.94 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.18 0.992 . . . . 0.0 109.212 172.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.403 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 21.0 m -130.19 168.22 17.17 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 126.18 1.792 . . . . 0.0 111.022 -168.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.422 ' CD1' ' HB3' ' A' ' 46' ' ' ASP . 19.5 m0 -111.81 135.79 51.96 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 157.232 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 72.2 t -59.22 -28.23 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 O-C-N 123.189 0.305 . . . . 0.0 111.109 175.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 48.7 p -67.65 -20.33 65.31 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 175.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 46.0 t -89.76 143.81 30.8 Favored Pre-proline 0 CA--C 1.538 0.491 0 O-C-N 121.281 -0.887 . . . . 0.0 111.193 -163.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -77.05 -39.48 0.6 Allowed 'Trans proline' 0 N--CA 1.459 -0.544 0 CA-C-N 119.656 0.913 . . . . 0.0 114.122 177.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -58.82 -36.33 74.32 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.049 1.739 . . . . 0.0 113.4 175.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.403 ' SG ' ' HB3' ' A' ' 19' ' ' SER . 0.3 OUTLIER -52.63 -55.67 20.82 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.949 1.3 . . . . 0.0 109.14 171.847 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.8 t -65.9 -39.99 86.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 123.53 0.732 . . . . 0.0 111.124 -178.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . 0.288 2.4 ttp180 -54.22 -28.84 43.67 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.012 1.725 . . . . 0.0 115.369 167.036 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -85.38 -55.53 3.97 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 119.911 1.232 . . . . 0.0 111.883 167.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -48.37 -38.33 19.06 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.96 1.704 . . . . 0.0 113.776 -178.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -75.0 -43.69 52.45 Favored 'General case' 0 C--O 1.231 0.081 0 C-N-CA 124.385 1.074 . . . . 0.0 111.889 -177.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 8.4 tt -71.53 -39.56 70.67 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 124.714 1.206 . . . . 0.0 110.888 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 88.8 mt -61.75 -51.77 66.97 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.56 0.744 . . . . 0.0 110.746 176.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 24.2 m-70 -65.87 -15.92 63.37 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 172.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.72 -43.84 24.87 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 119.844 1.202 . . . . 0.0 111.43 169.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 68.7 mmt-85 -82.0 -50.41 9.15 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.219 1.008 . . . . 0.0 113.43 -171.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 21.9 m -160.54 129.09 4.7 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 125.106 1.362 . . . . 0.0 111.95 177.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 42.9 mttm -85.98 2.25 46.99 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 126.007 1.723 . . . . 0.0 115.228 -166.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -82.31 53.83 2.39 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.534 1.133 . . . . 0.0 112.04 172.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -118.87 127.43 75.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 126.567 1.947 . . . . 0.0 111.14 -177.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.532 ' HG1' ' ND2' ' A' ' 13' ' ' ASN . 3.6 m -110.78 141.31 44.28 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 126.067 1.747 . . . . 0.0 110.44 171.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.6 p -137.47 135.92 46.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 C-N-CA 124.535 1.134 . . . . 0.0 112.766 175.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -110.79 125.9 54.04 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.379 1.472 . . . . 0.0 109.45 175.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -97.21 88.27 4.41 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 122.526 1.155 . . . . 0.0 110.966 -174.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 22.1 m -64.6 -12.86 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 -174.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.422 ' HB3' ' CD1' ' A' ' 20' ' ' TRP . 0.1 OUTLIER -73.69 -21.37 60.27 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.619 1.168 . . . . 0.0 113.323 172.612 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -86.78 -27.1 23.8 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.257 1.423 . . . . 0.0 113.14 177.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 90.7 mtp -69.55 154.28 42.24 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.724 1.61 . . . . 0.0 112.117 175.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 8.6 t -84.02 -24.85 30.34 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.902 0.881 . . . . 0.0 111.691 163.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -93.47 -5.38 49.33 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.49 1.516 . . . . 0.0 114.779 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -57.41 -24.16 51.09 Favored Glycine 0 CA--C 1.536 1.386 0 N-CA-C 116.147 1.219 . . . . 0.0 116.147 -172.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -69.65 -22.49 63.46 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 118.687 1.243 . . . . 0.0 112.898 174.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -82.0 -35.63 28.68 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.937 0.895 . . . . 0.0 111.345 170.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -74.45 -32.94 62.78 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.132 -0.98 . . . . 0.0 111.996 177.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 62.0 mtp180 -53.71 -39.97 65.67 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 121.123 -0.985 . . . . 0.0 111.632 162.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -67.83 -37.06 88.05 Favored Glycine 0 CA--C 1.535 1.321 0 CA-C-O 118.3 -1.278 . . . . 0.0 114.155 172.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -60.72 -32.32 71.59 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 120.746 2.273 . . . . 0.0 113.296 174.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 57.2 mt -75.53 -43.99 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 123.904 0.882 . . . . 0.0 109.95 174.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 19.0 t80 -67.7 -43.19 80.68 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.026 -1.046 . . . . 0.0 112.728 -177.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -67.38 -15.2 63.55 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 113.944 1.091 . . . . 0.0 113.944 178.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -106.71 -26.54 11.27 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 177.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -143.44 4.84 1.4 Allowed 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 115.858 1.799 . . . . 0.0 115.858 -170.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm 54.42 24.49 5.26 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 127.608 2.363 . . . . 0.0 116.952 178.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 -101.52 111.13 23.27 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.057 1.343 . . . . 0.0 111.615 -174.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -96.36 -17.16 20.85 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 178.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 98.3 m -72.52 153.71 41.19 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.682 1.593 . . . . 0.0 111.862 176.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.7 m -115.99 151.74 46.85 Favored Pre-proline 0 N--CA 1.477 0.904 0 C-N-CA 123.713 0.805 . . . . 0.0 111.546 165.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -74.19 155.62 99.84 Favored 'Cis proline' 0 N--CA 1.459 -0.539 0 CA-C-N 119.207 0.753 . . . . 0.0 112.944 -3.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -98.13 139.33 34.1 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.542 1.137 . . . . 0.0 108.447 159.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 53.0 mt -129.91 140.81 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 123.972 0.909 . . . . 0.0 109.487 -165.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -138.13 143.13 40.2 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.126 0.97 . . . . 0.0 111.18 178.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 72.4 mt -135.22 123.13 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 125.346 1.458 . . . . 0.0 109.17 -178.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 45.27 48.33 10.26 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 124.902 1.281 . . . . 0.0 113.371 -179.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 75.04 10.92 84.19 Favored Glycine 0 CA--C 1.539 1.545 0 N-CA-C 116.066 1.186 . . . . 0.0 116.066 179.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 21.1 m-80 -116.04 140.39 49.32 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.472 1.509 . . . . 0.0 111.683 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -82.47 131.9 35.21 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.596 1.158 . . . . 0.0 112.944 179.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 41.1 mm -107.25 123.43 62.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 127.047 2.139 . . . . 0.0 108.288 177.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.18 12.02 0.66 Allowed Glycine 0 CA--C 1.531 1.055 0 N-CA-C 119.089 2.395 . . . . 0.0 119.089 -166.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 142.36 -177.1 21.83 Favored Glycine 0 CA--C 1.535 1.316 0 C-N-CA 127.582 2.515 . . . . 0.0 113.643 170.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 39.1 t -57.09 -42.86 81.52 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.721 -0.87 . . . . 0.0 111.458 173.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 68.5 m -65.53 -26.06 67.72 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 178.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.44 -40.56 64.13 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 119.703 1.138 . . . . 0.0 111.768 172.08 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 40.1 tp -60.55 -48.96 79.45 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.865 0.866 . . . . 0.0 110.738 173.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -66.19 -34.36 77.86 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.522 0.729 . . . . 0.0 111.438 177.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.85 -35.66 74.9 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 120.227 -1.546 . . . . 0.0 112.79 175.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 84.0 mt -72.55 -31.05 64.97 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.216 1.007 . . . . 0.0 112.777 173.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -59.4 -48.55 81.2 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.788 0.835 . . . . 0.0 110.109 166.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.92 -34.4 75.33 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 -178.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -75.74 0.72 16.86 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 172.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 71.05 21.47 78.36 Favored Glycine 0 CA--C 1.534 1.219 0 O-C-N 121.322 -0.861 . . . . 0.0 113.445 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt -101.38 -25.96 13.76 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 125.688 1.595 . . . . 0.0 113.107 -174.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 39.4 tp -64.2 -37.4 87.33 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.267 1.027 . . . . 0.0 112.189 176.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -52.8 -44.09 66.39 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.002 0.921 . . . . 0.0 111.973 173.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -75.01 -29.78 60.2 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.044 0.831 . . . . 0.0 114.525 178.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 85.1 mt -66.09 -40.84 91.13 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 118.382 1.091 . . . . 0.0 111.356 170.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 86.4 mt -90.53 -18.87 24.51 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 -170.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 72.7 m . . . . . 0 C--O 1.252 1.205 0 C-N-CA 124.506 1.122 . . . . 0.0 113.385 -179.286 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 17.5 p . . . . . 0 N--CA 1.476 0.854 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 16.2 pt -51.03 -24.04 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 124.496 1.118 . . . . 0.0 113.589 173.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.86 -27.99 67.14 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.87 0.868 . . . . 0.0 113.094 -175.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.1 p -80.65 -28.82 36.78 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 121.242 -0.911 . . . . 0.0 113.426 174.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 43.3 mtt -63.97 -35.47 80.79 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.29 1.036 . . . . 0.0 110.478 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -62.88 -27.39 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 125.89 1.676 . . . . 0.0 111.826 -176.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 45.2 mmtm -79.21 -17.04 55.61 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.018 1.327 . . . . 0.0 113.779 -175.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -87.34 -26.77 29.64 Favored Glycine 0 CA--C 1.533 1.198 0 N-CA-C 116.331 1.292 . . . . 0.0 116.331 -167.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.528 ' ND2' ' HG1' ' A' ' 41' ' ' THR . 69.4 m-80 -134.05 153.77 51.59 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.694 1.197 . . . . 0.0 111.628 -178.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -62.77 -34.62 77.62 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.002 0.741 . . . . 0.0 113.002 -174.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.4 t -122.27 131.53 72.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.373 1.069 . . . . 0.0 109.896 167.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 65.1 t -132.01 127.77 58.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.158 0.983 . . . . 0.0 109.571 176.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 37.5 t -126.28 147.3 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 123.929 0.892 . . . . 0.0 111.773 -175.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -122.55 108.81 13.56 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.568 1.147 . . . . 0.0 109.44 176.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 37.1 m -128.93 173.88 10.01 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 126.638 1.975 . . . . 0.0 111.458 -167.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 28.9 m0 -120.11 144.58 47.54 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.367 1.067 . . . . 0.0 109.699 163.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.5 t -68.73 -17.2 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 CA-C-O 120.934 0.397 . . . . 0.0 111.079 178.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.3 p -86.31 -10.81 53.75 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 128.066 2.547 . . . . 0.0 116.579 178.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.9 t -96.45 143.42 26.08 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-N 120.017 1.28 . . . . 0.0 112.731 -170.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -72.21 -40.19 2.55 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 121.28 1.32 . . . . 0.0 113.634 173.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -58.0 -36.81 73.18 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.334 1.453 . . . . 0.0 113.802 179.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -54.02 -61.22 2.45 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.477 1.911 . . . . 0.0 109.573 174.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 92.0 t -60.9 -39.37 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.346 1.058 . . . . 0.0 111.104 -179.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.2 ttt180 -52.54 -38.57 60.02 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.684 1.594 . . . . 0.0 114.901 169.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -79.53 -54.59 5.75 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 119.079 0.854 . . . . 0.0 111.79 171.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -48.19 -43.35 31.72 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.386 1.474 . . . . 0.0 113.137 -178.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -62.3 -40.22 95.57 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 123.722 0.809 . . . . 0.0 112.35 -175.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.4 tt -79.08 -42.34 26.59 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 126.538 1.935 . . . . 0.0 110.867 -178.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 91.5 mt -62.07 -40.66 96.56 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 121.868 -0.52 . . . . 0.0 111.665 177.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -71.27 -24.48 62.17 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 172.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.56 -25.04 53.62 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 120.144 1.338 . . . . 0.0 112.921 174.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 7.5 tpt180 -106.88 -31.98 8.12 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.868 1.667 . . . . 0.0 114.823 -170.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 13.6 p -134.05 154.44 51.15 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 -166.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -103.81 -31.91 9.58 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 127.406 2.282 . . . . 0.0 112.455 174.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -93.06 38.52 1.03 Allowed 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 125.451 1.5 . . . . 0.0 113.186 -171.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.14 122.4 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 124.974 1.309 . . . . 0.0 112.96 -175.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.528 ' HG1' ' ND2' ' A' ' 13' ' ' ASN . 3.9 m -113.3 135.28 54.02 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.811 1.645 . . . . 0.0 109.847 170.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.3 p -124.21 138.05 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.457 1.103 . . . . 0.0 112.304 171.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -109.37 125.95 52.91 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.015 1.726 . . . . 0.0 110.637 177.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -98.17 79.82 2.62 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.351 1.061 . . . . 0.0 110.233 -177.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 31.0 m -56.89 -28.55 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -167.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -70.66 -14.25 62.4 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 124.329 1.052 . . . . 0.0 113.693 176.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.2 mmmt -83.0 -13.02 56.76 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 126.3 1.84 . . . . 0.0 112.559 173.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 22.3 mmt -101.5 172.26 7.07 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.178 1.791 . . . . 0.0 111.787 -178.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.0 m -81.19 -18.75 45.12 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 121.063 -1.023 . . . . 0.0 113.331 -177.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -122.05 8.29 9.82 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.702 1.601 . . . . 0.0 114.42 -163.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -55.45 -27.98 49.51 Favored Glycine 0 CA--C 1.538 1.523 0 CA-C-N 120.035 1.289 . . . . 0.0 115.18 -172.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -67.82 -31.65 71.65 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 119.973 1.886 . . . . 0.0 113.088 171.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 63.8 mt-30 -73.69 -38.55 64.85 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.686 1.194 . . . . 0.0 111.344 173.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -75.18 -33.9 61.49 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.484 1.038 . . . . 0.0 111.962 177.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 15.7 mtp85 -55.32 -41.06 71.93 Favored 'General case' 0 N--CA 1.478 0.965 0 O-C-N 120.953 -1.092 . . . . 0.0 111.303 161.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.38 -24.16 67.27 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 124.444 1.021 . . . . 0.0 115.127 171.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 -71.45 -37.29 71.41 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 120.471 2.136 . . . . 0.0 111.72 172.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 44.1 mt -72.35 -43.55 64.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 123.948 0.899 . . . . 0.0 109.539 179.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -67.76 -42.75 81.27 Favored 'General case' 0 CA--C 1.532 0.262 0 O-C-N 121.298 -0.876 . . . . 0.0 112.914 -178.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -65.7 -26.06 67.6 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -177.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -100.19 -29.55 12.42 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -131.58 -2.41 3.81 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 114.752 1.39 . . . . 0.0 114.752 -172.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt 51.33 39.0 23.11 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 126.152 1.781 . . . . 0.0 113.629 -175.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -123.52 138.66 54.52 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 126.828 2.051 . . . . 0.0 110.701 -178.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -142.39 -33.17 0.48 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.603 1.561 . . . . 0.0 111.966 -155.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.7 p -84.03 113.18 20.83 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.43 1.492 . . . . 0.0 113.102 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.2 m -66.77 153.54 93.64 Favored Pre-proline 0 N--CA 1.484 1.245 0 C-N-CA 124.811 1.245 . . . . 0.0 113.1 -179.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -75.89 151.94 96.21 Favored 'Cis proline' 0 C--N 1.352 0.715 0 CA-C-N 119.327 0.795 . . . . 0.0 113.918 -6.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -93.79 137.05 33.44 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 159.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 46.3 mt -125.1 141.64 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 124.209 1.004 . . . . 0.0 109.243 -168.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -142.41 147.09 35.62 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.391 0.676 . . . . 0.0 111.587 179.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 74.9 mt -127.91 123.37 60.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 125.277 1.431 . . . . 0.0 108.099 175.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 50.62 27.57 3.02 Favored 'General case' 0 CA--C 1.555 1.149 0 N-CA-C 115.257 1.577 . . . . 0.0 115.257 -177.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 89.89 -7.39 81.81 Favored Glycine 0 CA--C 1.543 1.827 0 O-C-N 120.697 -1.252 . . . . 0.0 115.257 -173.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -90.86 143.3 26.87 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.103 1.761 . . . . 0.0 110.336 179.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -90.19 142.6 27.56 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 -167.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 15.9 mm -130.84 125.49 58.36 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 C-N-CA 128.245 2.618 . . . . 0.0 108.981 176.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.7 -13.94 64.3 Favored Glycine 0 CA--C 1.538 1.488 0 N-CA-C 117.166 1.627 . . . . 0.0 117.166 -168.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 158.25 -175.24 35.44 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-N 118.271 1.035 . . . . 0.0 113.528 175.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 14.7 t -63.43 -35.36 80.18 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.507 -0.996 . . . . 0.0 112.943 -178.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 52.2 m -64.65 -23.1 67.15 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 121.113 -0.992 . . . . 0.0 113.271 176.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -88.17 -39.74 14.28 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.504 1.522 . . . . 0.0 112.702 174.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 37.7 tp -58.21 -51.93 67.68 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.38 1.472 . . . . 0.0 111.502 171.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -63.17 -24.52 67.93 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.041 0.536 . . . . 0.0 111.714 178.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -78.84 -31.96 45.9 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 121.304 -0.872 . . . . 0.0 113.334 176.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 14.2 mt -65.34 -34.91 79.43 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 119.278 0.944 . . . . 0.0 112.059 169.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -61.6 -44.87 96.2 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.861 0.864 . . . . 0.0 110.932 171.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.1 mmtt -71.54 -30.4 65.85 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -177.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -72.86 -10.88 60.3 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 172.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 74.89 30.24 59.73 Favored Glycine 0 CA--C 1.533 1.19 0 O-C-N 121.292 -0.88 . . . . 0.0 113.649 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 45.8 mtmt -118.97 -16.0 9.25 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 126.668 1.987 . . . . 0.0 113.021 -169.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 35.1 tp -71.35 -38.94 71.58 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.857 1.263 . . . . 0.0 111.915 -175.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -65.46 -28.42 69.2 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 178.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -85.31 -12.7 72.62 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 125.622 1.582 . . . . 0.0 115.22 172.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 24.9 mt -81.2 -39.31 25.62 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 119.377 1.589 . . . . 0.0 111.055 165.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 79.3 mt -89.29 26.25 1.7 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 126.328 1.851 . . . . 0.0 113.035 -175.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 10.7 p . . . . . 0 C--O 1.251 1.143 0 C-N-CA 127.099 2.159 . . . . 0.0 114.673 -177.502 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 59.8 p . . . . . 0 N--CA 1.471 0.623 0 CA-C-O 120.978 0.418 . . . . 0.0 110.616 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 29.9 pt -56.08 -25.68 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 O-C-N 120.762 -1.211 . . . . 0.0 112.49 168.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.96 -19.77 65.98 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -173.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.3 m -89.08 -19.84 25.07 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.425 1.09 . . . . 0.0 113.256 173.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 66.4 mtp -62.53 -33.35 74.72 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 119.39 0.995 . . . . 0.0 111.804 172.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.2 mm -60.47 -18.09 15.99 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 124.672 1.189 . . . . 0.0 112.267 -177.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.2 mptt -91.37 -9.02 46.34 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.245 1.418 . . . . 0.0 113.859 177.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -88.19 -39.04 7.02 Favored Glycine 0 CA--C 1.538 1.528 0 C-N-CA 124.715 1.15 . . . . 0.0 115.814 -175.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 29.1 m120 -120.96 167.33 12.69 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.369 1.467 . . . . 0.0 112.072 -178.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -68.83 -42.02 77.74 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.57 0.748 . . . . 0.0 112.67 176.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.9 t -125.5 134.17 67.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.95 1.3 . . . . 0.0 110.2 176.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 27.1 t -134.74 135.1 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.249 1.02 . . . . 0.0 110.361 177.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 53.0 t -134.42 149.24 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 124.55 1.14 . . . . 0.0 112.085 -171.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -129.69 123.1 30.32 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.993 1.317 . . . . 0.0 110.873 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 54.1 m -143.9 169.92 16.88 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 114.452 1.278 . . . . 0.0 114.452 -159.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.447 ' CD1' ' HB3' ' A' ' 46' ' ' ASP . 40.5 m0 -115.17 139.5 49.87 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.547 1.539 . . . . 0.0 109.616 161.224 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.418 ' HB ' ' HE2' ' A' ' 47' ' ' LYS . 24.8 t -60.21 -53.72 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 -161.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.7 t -94.23 3.43 55.26 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 -164.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 96.4 m -88.76 142.31 30.6 Favored Pre-proline 0 CA--C 1.542 0.667 0 C-N-CA 124.328 1.051 . . . . 0.0 112.599 -165.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -68.0 -36.97 16.09 Favored 'Trans proline' 0 C--N 1.351 0.68 0 N-CA-C 115.677 1.376 . . . . 0.0 115.677 -162.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -52.93 -41.83 64.83 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 122.24 1.019 . . . . 0.0 113.075 171.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 3.8 m -81.73 -32.52 31.53 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.359 -162.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 99.6 t -62.46 -53.07 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 124.954 1.301 . . . . 0.0 111.51 161.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . 0.263 7.2 ptp180 -67.45 -29.27 68.69 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -173.032 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.28 -53.24 13.05 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.438 1.095 . . . . 0.0 111.685 171.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -46.65 -44.88 18.8 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-N 119.91 1.232 . . . . 0.0 112.879 175.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -64.07 -45.58 88.13 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.501 0.72 . . . . 0.0 112.595 -179.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.2 tt -72.4 -36.55 68.68 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.446 1.098 . . . . 0.0 111.206 -178.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 95.9 mt -61.1 -46.54 90.19 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.443 -0.785 . . . . 0.0 110.735 171.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 8.7 m-70 -66.83 -21.71 66.02 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 173.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -73.0 -18.44 61.35 Favored 'General case' 0 CA--C 1.545 0.782 0 O-C-N 120.716 -1.24 . . . . 0.0 113.069 173.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 21.7 mmt85 -115.73 -19.83 10.34 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 -179.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 48.8 p -147.32 166.89 25.74 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 115.394 1.627 . . . . 0.0 115.394 -166.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 28.9 mtmm -116.69 -32.05 5.29 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 127.165 2.186 . . . . 0.0 113.623 162.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -82.73 50.59 1.71 Allowed 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -175.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.2 113.07 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 126.16 1.784 . . . . 0.0 111.964 177.116 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.4 m -100.49 142.91 31.32 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 127.014 2.125 . . . . 0.0 110.097 175.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.7 p -145.24 140.58 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -178.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 38.8 t60 -116.67 131.8 56.85 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 126.595 1.958 . . . . 0.0 110.98 -176.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -101.93 96.62 7.16 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 122.761 1.267 . . . . 0.0 111.973 -177.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 22.4 m -80.43 -1.63 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -174.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.447 ' HB3' ' CD1' ' A' ' 20' ' ' TRP . 0.0 OUTLIER -83.64 -12.11 56.4 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.146 0.978 . . . . 0.0 112.085 162.855 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.418 ' HE2' ' HB ' ' A' ' 21' ' ' VAL . 70.0 mmtt -107.29 -44.07 4.43 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.588 1.555 . . . . 0.0 112.013 179.064 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 29.2 tpp -67.97 127.23 32.07 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 118.833 0.742 . . . . 0.0 110.224 176.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 62.8 m -68.42 -29.49 68.17 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 119.373 0.988 . . . . 0.0 113.354 -174.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 20.5 tp10 -79.74 -3.09 46.01 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.021 0.928 . . . . 0.0 112.648 170.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -56.53 -26.27 51.93 Favored Glycine 0 CA--C 1.529 0.914 0 O-C-N 120.489 -1.382 . . . . 0.0 114.511 -171.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -70.18 -24.11 63.08 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 118.537 1.169 . . . . 0.0 112.67 176.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 16.8 tm0? -86.72 -34.58 19.64 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.126 1.37 . . . . 0.0 111.811 170.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -67.16 -33.76 76.11 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 119.572 1.078 . . . . 0.0 112.293 171.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 30.1 ttt180 -62.01 -29.93 70.6 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.405 1.482 . . . . 0.0 110.937 165.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.29 -24.7 75.94 Favored Glycine 0 CA--C 1.542 1.72 0 C-N-CA 125.632 1.587 . . . . 0.0 115.784 165.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -71.96 -25.78 62.01 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 121.19 2.495 . . . . 0.0 112.017 169.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 23.8 mt -74.66 -46.46 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 123.253 0.621 . . . . 0.0 109.461 166.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -63.69 -42.21 98.02 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.14 -0.975 . . . . 0.0 113.398 -176.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 95.0 mm-40 -71.87 -10.0 59.14 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 178.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -107.54 -35.64 6.68 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.536 1.135 . . . . 0.0 113.547 176.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -137.49 4.7 2.64 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.349 1.459 . . . . 0.0 114.703 -169.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 50.71 42.3 27.18 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 127.006 2.122 . . . . 0.0 114.516 176.589 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 61.8 t60 -127.44 129.92 48.36 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.847 1.259 . . . . 0.0 111.119 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -119.91 -1.33 10.47 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.621 1.568 . . . . 0.0 113.759 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.3 m -86.06 173.45 9.87 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.998 1.719 . . . . 0.0 110.468 175.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.7 m -132.73 156.95 79.51 Favored Pre-proline 0 N--CA 1.48 1.025 0 O-C-N 120.631 -1.293 . . . . 0.0 113.917 -175.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -73.16 159.8 96.73 Favored 'Cis proline' 0 C--N 1.349 0.591 0 CA-C-N 118.588 0.531 . . . . 0.0 112.471 -13.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -101.9 141.02 35.39 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.972 0.909 . . . . 0.0 108.986 159.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 82.0 mt -130.68 144.15 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 123.726 0.811 . . . . 0.0 109.65 -168.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -140.5 146.37 38.07 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.243 1.017 . . . . 0.0 111.998 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 71.5 mt -129.26 118.98 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 125.367 1.467 . . . . 0.0 108.241 172.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 47.49 38.23 7.5 Favored 'General case' 0 CA--C 1.552 1.056 0 N-CA-C 115.821 1.785 . . . . 0.0 115.821 176.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 93.48 -7.51 74.9 Favored Glycine 0 CA--C 1.538 1.477 0 C-N-CA 124.593 1.092 . . . . 0.0 115.312 -178.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -102.47 138.03 39.93 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.939 1.696 . . . . 0.0 110.406 -174.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -85.23 147.73 26.43 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.073 0.949 . . . . 0.0 113.076 -170.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 20.6 mm -133.34 120.64 39.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 128.473 2.709 . . . . 0.0 106.279 177.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.88 -15.66 55.68 Favored Glycine 0 CA--C 1.533 1.182 0 N-CA-C 116.851 1.5 . . . . 0.0 116.851 -160.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 138.8 -152.14 22.01 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 125.609 1.576 . . . . 0.0 112.739 179.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 8.6 t -72.25 -20.48 61.53 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -173.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.8 m -83.38 -38.52 21.87 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 121.254 -0.904 . . . . 0.0 112.012 171.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -70.7 -36.38 73.23 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.148 0.979 . . . . 0.0 111.641 177.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 47.5 tp -59.82 -57.49 12.68 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.405 1.482 . . . . 0.0 111.645 -179.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -69.59 -30.58 68.38 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.892 -0.505 . . . . 0.0 111.305 178.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.02 -38.25 87.98 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 119.474 1.034 . . . . 0.0 112.49 176.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 85.4 mt -73.81 -25.24 60.0 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.917 0.887 . . . . 0.0 112.702 176.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -73.08 -40.12 65.29 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 118.779 0.718 . . . . 0.0 111.609 169.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.1 mptt -65.19 -30.4 71.3 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.371 1.068 . . . . 0.0 112.889 173.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -80.34 1.97 26.69 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.083 1.353 . . . . 0.0 113.851 169.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 71.21 24.13 77.34 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 124.732 1.158 . . . . 0.0 114.761 175.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -113.2 -31.74 6.52 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 126.051 1.74 . . . . 0.0 113.365 -170.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 36.7 tp -57.23 -42.7 81.92 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 122.618 0.367 . . . . 0.0 111.467 -175.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -63.56 -42.73 98.33 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -178.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -73.05 -29.45 64.72 Favored Glycine 0 CA--C 1.528 0.876 0 CA-C-O 119.123 -0.821 . . . . 0.0 114.439 177.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 81.8 mt -72.8 -34.21 66.74 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 118.332 1.066 . . . . 0.0 112.188 172.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 66.5 mt -86.7 -16.32 36.83 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.294 1.038 . . . . 0.0 113.607 179.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 58.7 m . . . . . 0 C--O 1.254 1.314 0 C-N-CA 124.976 1.31 . . . . 0.0 111.714 175.031 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.0 m . . . . . 0 CA--C 1.547 0.844 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.5 pt -60.99 -23.09 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 124.529 1.131 . . . . 0.0 113.941 -168.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -54.58 -27.25 37.65 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.729 1.212 . . . . 0.0 112.177 178.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 92.9 p -68.56 -36.37 78.68 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.765 1.226 . . . . 0.0 113.444 172.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 45.3 mtt -72.45 -38.56 68.25 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.385 1.474 . . . . 0.0 111.59 -177.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -66.52 -25.59 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 124.074 0.95 . . . . 0.0 111.551 -171.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -70.75 -11.13 60.76 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.826 1.65 . . . . 0.0 114.123 179.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -84.48 -31.27 25.2 Favored Glycine 0 CA--C 1.534 1.258 0 N-CA-C 115.944 1.137 . . . . 0.0 115.944 -167.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -136.71 156.72 48.15 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 119.499 1.649 . . . . 0.0 112.568 -174.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 28.4 ttpt -62.54 -39.41 93.52 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.986 0.914 . . . . 0.0 112.657 -176.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.9 t -124.96 129.08 73.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.524 1.13 . . . . 0.0 109.821 167.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 83.1 t -126.11 127.09 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.389 1.476 . . . . 0.0 109.04 178.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 40.3 t -123.53 144.55 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 123.611 0.765 . . . . 0.0 111.169 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -118.3 113.18 21.07 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.672 1.189 . . . . 0.0 109.018 171.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 28.4 m -131.35 168.17 18.01 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.384 1.474 . . . . 0.0 112.281 -170.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 51.7 m0 -107.92 126.12 52.31 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.644 1.178 . . . . 0.0 107.872 159.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 25.9 t -49.95 -36.48 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 126.49 1.916 . . . . 0.0 113.237 -164.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.5 t -93.3 -8.91 40.76 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 127.175 2.19 . . . . 0.0 115.137 -167.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 95.6 m -94.28 149.31 36.53 Favored Pre-proline 0 CA--C 1.535 0.374 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -159.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -67.39 -47.34 2.23 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 CA-C-N 119.127 0.724 . . . . 0.0 113.603 -163.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -68.22 -33.43 74.39 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.438 1.095 . . . . 0.0 113.243 -179.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -51.25 -53.37 36.07 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.776 0.83 . . . . 0.0 109.246 167.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 62.6 t -68.75 -36.36 73.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 O-C-N 121.714 -0.617 . . . . 0.0 112.244 -177.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 27.7 mmt85 -52.79 -42.07 64.71 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 119.227 0.922 . . . . 0.0 112.046 170.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.64 -56.56 5.14 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.396 0.678 . . . . 0.0 111.878 173.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -50.82 -39.52 53.35 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 119.435 1.016 . . . . 0.0 113.028 -177.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -69.6 -43.64 72.38 Favored 'General case' 0 C--O 1.233 0.184 0 C-N-CA 123.892 0.877 . . . . 0.0 112.312 -178.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.4 tt -73.77 -37.62 64.95 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 124.309 1.044 . . . . 0.0 111.464 -178.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 98.0 mt -62.61 -42.84 99.81 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.239 0.616 . . . . 0.0 110.9 174.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -67.93 -13.15 61.93 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 171.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -95.6 -13.03 24.7 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.301 1.041 . . . . 0.0 113.751 170.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 20.1 mmt180 -111.67 -30.34 7.37 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 114.981 1.474 . . . . 0.0 114.981 -173.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.0 t -149.03 156.6 42.48 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -173.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 48.1 mtmt -91.6 -9.13 45.24 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 126.785 2.034 . . . . 0.0 112.499 166.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -105.51 20.49 18.81 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -162.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.26 136.81 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 125.481 1.513 . . . . 0.0 112.692 -178.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.9 m -125.44 133.7 52.36 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 126.696 1.999 . . . . 0.0 110.014 168.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.4 p -121.29 136.11 59.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 125.013 1.325 . . . . 0.0 112.998 173.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -104.1 116.65 32.6 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.917 2.087 . . . . 0.0 108.989 174.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -88.56 96.37 10.6 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 121.0 -1.063 . . . . 0.0 111.2 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 22.0 m -73.74 1.65 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 -172.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -85.29 -22.44 28.56 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.437 1.095 . . . . 0.0 112.756 163.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.5 mmmt -90.34 -35.08 15.43 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.035 1.734 . . . . 0.0 111.667 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -89.35 130.44 35.73 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.692 0.797 . . . . 0.0 110.962 -177.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 74.4 m -70.69 -16.09 62.77 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 115.235 1.569 . . . . 0.0 115.235 -169.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -93.02 6.67 47.11 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.843 1.657 . . . . 0.0 112.908 173.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -51.7 -29.03 24.56 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 125.368 1.461 . . . . 0.0 116.385 -174.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -79.73 -25.13 41.2 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.052 1.426 . . . . 0.0 113.358 178.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -74.81 -33.95 62.29 Favored 'General case' 0 N--CA 1.469 0.489 0 O-C-N 121.462 -0.774 . . . . 0.0 111.052 168.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.54 -42.79 86.63 Favored 'General case' 0 CA--C 1.548 0.882 0 O-C-N 121.716 -0.615 . . . . 0.0 110.342 171.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 56.3 mtp85 -54.76 -43.96 73.21 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 119.397 0.999 . . . . 0.0 111.936 167.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.41 -42.94 99.14 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 124.24 0.924 . . . . 0.0 113.732 178.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 51.2 mm-40 -63.44 -38.18 90.16 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 118.413 1.107 . . . . 0.0 113.449 173.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 65.9 mt -66.46 -44.58 90.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 118.573 0.624 . . . . 0.0 109.621 175.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -64.26 -40.35 95.81 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 121.432 -0.793 . . . . 0.0 112.059 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -69.46 -24.88 63.86 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 121.092 -1.005 . . . . 0.0 113.363 -179.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -99.53 -25.17 14.52 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 115.008 1.485 . . . . 0.0 115.008 176.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -135.92 0.52 2.66 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 114.741 1.386 . . . . 0.0 114.741 -171.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp 48.6 46.05 21.19 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 126.525 1.93 . . . . 0.0 113.729 175.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 8.5 t60 -140.39 134.2 30.5 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.283 1.833 . . . . 0.0 109.46 -175.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -117.3 -25.38 7.08 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.696 1.599 . . . . 0.0 113.418 -178.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.3 p -77.8 129.02 34.93 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.047 0.939 . . . . 0.0 112.621 -171.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.6 m -83.77 151.11 60.66 Favored Pre-proline 0 N--CA 1.478 0.93 0 C-N-CA 123.652 0.781 . . . . 0.0 112.109 -173.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -80.2 156.55 87.12 Favored 'Cis proline' 0 C--N 1.352 0.717 0 N-CA-C 114.118 0.776 . . . . 0.0 114.118 -0.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -101.34 135.35 42.96 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.907 0.883 . . . . 0.0 108.856 159.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 50.9 mt -128.28 139.53 51.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 123.984 0.914 . . . . 0.0 109.149 -166.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -140.0 148.23 41.57 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.62 0.768 . . . . 0.0 112.467 -179.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 62.1 mt -130.28 120.19 48.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.445 1.498 . . . . 0.0 108.633 174.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 45.3 40.62 5.4 Favored 'General case' 0 CA--C 1.558 1.269 0 C-N-CA 125.599 1.559 . . . . 0.0 114.625 -176.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 82.16 0.85 90.1 Favored Glycine 0 CA--C 1.542 1.762 0 O-C-N 120.822 -1.174 . . . . 0.0 115.629 -178.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -95.62 140.12 30.89 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.885 1.674 . . . . 0.0 110.416 176.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -85.07 144.85 27.98 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 119.253 0.933 . . . . 0.0 113.444 -177.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 31.5 mm -123.44 127.44 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 128.764 2.826 . . . . 0.0 107.023 177.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -69.82 18.28 0.64 Allowed Glycine 0 CA--C 1.532 1.118 0 N-CA-C 119.135 2.414 . . . . 0.0 119.135 -163.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 114.82 -173.15 14.61 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 128.85 3.119 . . . . 0.0 112.666 -178.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 12.9 t -63.5 -33.71 76.18 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 121.485 -1.009 . . . . 0.0 111.688 179.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 67.4 m -61.78 -21.99 65.05 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 172.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -88.88 -43.8 10.93 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.652 1.181 . . . . 0.0 110.903 174.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 48.8 tp -57.24 -48.24 79.33 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.027 1.331 . . . . 0.0 111.683 176.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -72.47 -25.96 61.63 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 121.734 -0.604 . . . . 0.0 112.054 179.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.48 -28.98 63.24 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.196 -0.94 . . . . 0.0 112.54 175.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 52.2 mt -73.78 -26.73 60.79 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.124 1.37 . . . . 0.0 112.808 171.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -64.58 -44.43 90.7 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 118.616 0.644 . . . . 0.0 110.343 162.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 20.3 mmtt -68.74 -34.18 75.17 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 121.828 -0.545 . . . . 0.0 112.28 -177.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -79.83 -3.23 46.93 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 168.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.18 44.64 93.64 Favored Glycine 0 CA--C 1.532 1.105 0 CA-C-N 120.262 1.392 . . . . 0.0 112.983 172.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 36.6 mtmt -131.18 -8.68 3.81 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 126.996 2.118 . . . . 0.0 113.487 -170.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 29.8 tp -66.08 -34.66 78.58 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 122.205 1.002 . . . . 0.0 110.663 -176.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -60.87 -48.05 83.57 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 127.577 2.351 . . . . 0.0 114.053 171.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -69.42 -22.68 76.5 Favored Glycine 0 CA--C 1.53 1.012 0 O-C-N 121.131 -0.98 . . . . 0.0 113.697 175.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 36.7 mt -74.03 -37.33 64.37 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 117.663 0.731 . . . . 0.0 111.3 172.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 69.4 mt -75.47 -7.01 53.0 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.603 1.561 . . . . 0.0 114.29 176.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 19.6 m . . . . . 0 C--O 1.249 1.03 0 C-N-CA 127.15 2.18 . . . . 0.0 113.739 177.691 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 89.4 p . . . . . 0 N--CA 1.476 0.828 0 N-CA-C 110.79 -0.078 . . . . 0.0 110.79 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.5 pt -55.02 -21.32 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 179.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.14 -18.93 51.07 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 123.817 0.847 . . . . 0.0 113.203 -178.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 40.9 m -83.78 -25.76 30.19 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.807 1.243 . . . . 0.0 113.486 172.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 76.9 mtp -69.49 -28.69 66.29 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.281 1.032 . . . . 0.0 112.09 178.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.1 mm -64.11 -21.17 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 124.248 1.019 . . . . 0.0 112.342 179.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -81.77 -28.24 33.37 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 121.113 -0.992 . . . . 0.0 113.058 173.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -87.41 -8.03 75.08 Favored Glycine 0 CA--C 1.53 1.02 0 N-CA-C 116.742 1.457 . . . . 0.0 116.742 -166.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -143.61 151.83 40.64 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 119.354 1.577 . . . . 0.0 111.431 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -67.41 -42.56 83.03 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.941 1.296 . . . . 0.0 112.413 -178.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.6 t -121.4 130.94 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 124.878 1.271 . . . . 0.0 110.065 170.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.6 t -129.7 128.1 65.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.528 1.131 . . . . 0.0 110.167 178.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 42.2 t -127.43 148.11 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 123.785 0.834 . . . . 0.0 111.715 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -123.64 116.56 23.29 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.798 1.239 . . . . 0.0 109.208 173.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 25.2 m -134.09 172.73 12.43 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.28 1.432 . . . . 0.0 112.203 -167.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.411 ' CD1' ' HB3' ' A' ' 46' ' ' ASP . 28.0 m0 -120.42 142.28 49.36 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.266 1.026 . . . . 0.0 109.784 161.285 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 75.4 t -59.91 -31.6 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 123.042 0.537 . . . . 0.0 111.332 172.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -69.09 -15.31 63.41 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 175.177 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 44.1 t -92.99 143.16 26.37 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-N 120.385 1.448 . . . . 0.0 111.278 -167.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -83.57 -31.32 0.62 Allowed 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 121.498 1.465 . . . . 0.0 113.157 174.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -69.05 -33.56 73.78 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.29 1.436 . . . . 0.0 113.54 178.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -45.74 -55.55 6.38 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.363 1.065 . . . . 0.0 109.356 164.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 85.9 t -63.91 -38.84 83.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 123.983 0.913 . . . . 0.0 112.068 -179.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.4 mmt85 -54.9 -37.82 66.81 Favored 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 119.536 1.062 . . . . 0.0 112.777 174.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -76.37 -59.18 2.88 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 123.735 0.647 . . . . 0.0 111.859 172.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -44.75 -47.56 10.78 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.854 1.262 . . . . 0.0 112.583 -179.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -65.53 -44.22 87.58 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 123.689 0.796 . . . . 0.0 111.627 -173.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.9 tt -69.6 -41.24 76.0 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.632 1.573 . . . . 0.0 110.775 179.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 92.2 mt -60.99 -50.43 73.42 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.095 0.558 . . . . 0.0 110.816 176.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 69.2 m-70 -66.64 -18.0 65.14 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 173.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.73 -13.73 59.66 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 119.908 1.231 . . . . 0.0 113.702 174.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 26.5 mmt85 -119.63 -25.89 5.85 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.73 1.612 . . . . 0.0 114.558 -178.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 19.3 m -145.98 150.39 35.95 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.605 1.162 . . . . 0.0 112.909 -157.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? -108.53 -23.52 11.8 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 126.766 2.027 . . . . 0.0 112.654 165.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -79.76 50.58 1.18 Allowed 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 125.317 1.447 . . . . 0.0 112.762 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -121.99 130.78 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 126.19 1.796 . . . . 0.0 111.013 -178.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.1 m -123.07 123.85 41.77 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.861 1.664 . . . . 0.0 109.57 176.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.5 p -119.49 143.43 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 123.938 0.895 . . . . 0.0 112.375 175.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 30.0 t60 -111.55 117.28 32.54 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.515 1.526 . . . . 0.0 110.236 173.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -86.67 91.89 8.75 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 175.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 27.6 m -67.09 -17.41 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -176.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.411 ' HB3' ' CD1' ' A' ' 20' ' ' TRP . 0.3 OUTLIER -68.47 -26.48 65.5 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 121.174 -0.953 . . . . 0.0 111.995 172.646 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 20.1 mtmt -98.67 -5.71 31.12 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 126.275 1.83 . . . . 0.0 114.227 -179.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 13.1 tpt -93.28 133.04 36.92 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.246 1.418 . . . . 0.0 111.467 -178.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 17.0 p -63.76 2.14 0.52 Allowed 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 126.657 1.983 . . . . 0.0 116.184 -179.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -143.98 13.69 1.67 Allowed 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.522 1.529 . . . . 0.0 112.804 170.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -57.77 -24.58 53.9 Favored Glycine 0 CA--C 1.53 1.012 0 O-C-N 120.52 -1.363 . . . . 0.0 116.121 -167.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -63.66 -30.98 72.01 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 119.518 1.659 . . . . 0.0 112.096 174.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -74.89 -29.11 60.9 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.7 0.8 . . . . 0.0 111.941 176.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -81.02 -32.68 34.05 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.687 1.195 . . . . 0.0 111.602 176.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.8 ttt85 -56.87 -36.43 70.07 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.904 1.281 . . . . 0.0 110.667 159.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.53 -35.15 90.88 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 124.495 1.045 . . . . 0.0 115.465 167.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -64.98 -32.23 73.86 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 120.394 2.097 . . . . 0.0 112.267 176.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.2 mt -70.5 -42.13 78.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 123.682 0.793 . . . . 0.0 109.643 171.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -62.92 -41.44 99.47 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 178.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 33.0 mm-40 -62.09 -30.08 70.76 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 120.923 -1.111 . . . . 0.0 112.844 176.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -88.83 -38.41 14.62 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 179.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -133.76 0.82 3.28 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 -168.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.5 mptt 44.66 50.27 8.5 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 127.016 2.126 . . . . 0.0 113.126 -177.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 48.9 t60 -129.25 127.09 40.52 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 127.53 2.332 . . . . 0.0 108.102 178.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -108.13 -14.03 14.81 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.208 1.003 . . . . 0.0 113.53 178.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.9 m -74.82 141.86 44.25 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.3 1.04 . . . . 0.0 111.685 -176.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.0 m -97.88 150.81 37.15 Favored Pre-proline 0 N--CA 1.477 0.904 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 172.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -81.08 161.71 81.73 Favored 'Cis proline' 0 C--N 1.351 0.703 0 CA-C-N 118.686 0.566 . . . . 0.0 113.556 -3.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -107.61 139.45 42.14 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.093 0.957 . . . . 0.0 109.13 158.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 75.7 mt -131.88 139.08 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 124.22 1.008 . . . . 0.0 109.374 -165.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -140.98 145.39 35.91 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.937 0.895 . . . . 0.0 112.432 -178.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 58.2 mt -132.19 122.28 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 124.702 1.201 . . . . 0.0 109.405 172.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 32.0 m120 44.31 45.13 7.16 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 125.017 1.327 . . . . 0.0 113.327 -177.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 86.02 -12.96 58.64 Favored Glycine 0 CA--C 1.539 1.553 0 O-C-N 120.463 -1.398 . . . . 0.0 116.284 -178.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 59.8 m-80 -86.6 141.13 29.23 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.353 1.576 . . . . 0.0 110.634 -177.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -86.47 136.95 32.9 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.32 0.648 . . . . 0.0 112.177 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 38.5 mm -115.1 117.97 57.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 126.937 2.095 . . . . 0.0 107.099 178.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -70.55 3.58 11.47 Favored Glycine 0 N--CA 1.475 1.281 0 N-CA-C 117.919 1.928 . . . . 0.0 117.919 -159.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 155.64 173.91 24.86 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 128.072 2.749 . . . . 0.0 111.048 178.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 39.4 t -58.56 -32.79 69.24 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 121.317 -1.108 . . . . 0.0 112.494 171.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 69.7 m -66.61 -28.54 68.58 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 120.654 -1.279 . . . . 0.0 112.957 173.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -74.47 -36.21 63.3 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 119.516 1.053 . . . . 0.0 111.632 173.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 43.5 tp -62.91 -50.84 69.25 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.877 1.271 . . . . 0.0 110.794 172.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -59.5 -37.93 79.58 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.689 0.796 . . . . 0.0 111.481 176.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.98 -29.7 68.8 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.019 0.928 . . . . 0.0 113.483 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 35.7 mt -70.96 -25.48 62.74 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.066 0.848 . . . . 0.0 112.303 172.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -73.52 -37.54 65.6 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 118.56 0.618 . . . . 0.0 111.036 170.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 43.3 mmtt -66.57 -34.7 78.49 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 176.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -73.43 -9.36 58.61 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 169.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 79.46 22.36 64.96 Favored Glycine 0 CA--C 1.535 1.282 0 CA-C-N 119.686 1.13 . . . . 0.0 114.579 178.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -107.29 -32.01 7.96 Favored 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 125.678 1.591 . . . . 0.0 112.305 -172.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 46.0 tp -57.71 -41.76 82.38 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 118.454 0.57 . . . . 0.0 112.432 -176.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -60.44 -43.64 96.61 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 118.928 -0.558 . . . . 0.0 112.437 -178.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -74.77 -38.09 43.3 Favored Glycine 0 CA--C 1.535 1.306 0 O-C-N 123.556 0.535 . . . . 0.0 113.324 177.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 37.6 mt -57.66 -36.42 71.87 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.404 1.082 . . . . 0.0 112.309 177.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 86.5 mt -73.92 -4.03 32.56 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 114.895 1.442 . . . . 0.0 114.895 -179.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 6.8 t . . . . . 0 C--O 1.257 1.495 0 C-N-CA 125.146 1.378 . . . . 0.0 112.733 -178.993 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 15.8 p . . . . . 0 CA--C 1.537 0.478 0 CA-C-O 122.108 0.956 . . . . 0.0 112.844 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 25.4 pt -55.71 -25.21 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.471 1.108 . . . . 0.0 112.717 170.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.38 -23.85 66.4 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -171.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.1 t -87.96 -20.04 26.43 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 121.238 -0.914 . . . . 0.0 113.424 170.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 41.3 mtt -68.39 -26.09 65.38 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 121.27 -0.894 . . . . 0.0 112.334 175.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.6 mm -58.06 -31.4 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.953 0.901 . . . . 0.0 111.667 177.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.1 mptt -80.56 -4.23 53.24 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.899 1.28 . . . . 0.0 114.039 -173.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -82.99 -28.4 37.68 Favored Glycine 0 CA--C 1.538 1.496 0 N-CA-C 115.953 1.141 . . . . 0.0 115.953 -173.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -145.35 163.71 33.73 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.597 1.199 . . . . 0.0 112.526 -173.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -63.16 -43.58 97.9 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.298 1.439 . . . . 0.0 112.723 -179.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.3 t -121.88 131.89 72.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 123.798 0.839 . . . . 0.0 110.26 171.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 54.4 t -132.56 127.39 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 125.006 1.322 . . . . 0.0 109.263 179.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 42.4 t -124.56 148.24 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 124.337 1.055 . . . . 0.0 111.624 -177.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -121.92 112.3 18.14 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.202 1.401 . . . . 0.0 108.869 172.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 10.7 m -126.5 174.14 8.87 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 126.646 1.978 . . . . 0.0 111.356 -171.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 20.8 m0 -118.78 137.75 53.16 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.317 1.047 . . . . 0.0 109.078 161.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 82.6 t -62.67 -15.86 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.013 0.925 . . . . 0.0 112.378 177.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.4 p -89.7 -9.68 48.57 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.484 1.914 . . . . 0.0 116.046 175.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 8.0 t -94.2 142.03 24.38 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-N 119.424 1.011 . . . . 0.0 111.565 -170.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -79.67 -32.58 1.53 Allowed 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 121.812 1.675 . . . . 0.0 112.226 173.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -62.85 -35.28 79.45 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.122 1.369 . . . . 0.0 113.543 177.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -49.04 -54.24 16.73 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.518 1.127 . . . . 0.0 109.451 165.285 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.2 t -64.88 -39.47 85.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.117 0.967 . . . . 0.0 112.766 -179.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 78.4 mmt-85 -53.35 -41.78 66.15 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-N 119.118 0.872 . . . . 0.0 111.811 173.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.86 -53.7 8.61 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.123 0.969 . . . . 0.0 112.592 174.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -52.41 -32.99 41.69 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.608 1.163 . . . . 0.0 112.992 -179.398 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -72.36 -47.37 50.05 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.838 0.855 . . . . 0.0 112.581 177.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.8 tt -72.81 -36.75 67.62 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.582 1.153 . . . . 0.0 111.465 -176.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 70.3 mt -63.47 -47.65 80.91 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.401 0.68 . . . . 0.0 111.283 173.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -64.76 -14.82 60.31 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 172.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.21 -17.74 58.26 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 120.158 1.344 . . . . 0.0 113.828 175.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 87.2 mmt-85 -131.97 -13.09 3.23 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 -177.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 29.0 m -138.62 136.99 36.51 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.315 1.046 . . . . 0.0 112.601 -172.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.24 -30.48 12.59 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 126.868 2.067 . . . . 0.0 111.207 166.321 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -79.26 48.09 0.85 Allowed 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.507 1.523 . . . . 0.0 113.409 177.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.28 118.89 60.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 125.758 1.623 . . . . 0.0 110.688 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 54.9 m -101.48 135.47 42.92 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 126.205 1.802 . . . . 0.0 109.672 172.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.6 p -128.1 141.6 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-O 122.277 1.037 . . . . 0.0 112.961 169.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -113.6 133.27 55.38 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 129.12 2.968 . . . . 0.0 109.523 -177.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -111.06 90.59 3.38 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 122.04 0.924 . . . . 0.0 111.52 -176.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 16.7 m -67.8 -8.94 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 O-C-N 121.341 -0.849 . . . . 0.0 113.17 -178.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.45 -18.35 61.14 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 119.042 0.837 . . . . 0.0 112.657 170.155 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 57.3 mmtt -102.44 -32.24 10.07 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 127.156 2.182 . . . . 0.0 113.009 179.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 58.9 mtt -65.03 126.64 28.67 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.193 0.997 . . . . 0.0 110.783 177.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 18.2 m -74.87 20.31 0.13 Allowed 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 114.614 1.338 . . . . 0.0 114.614 -172.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -150.24 10.26 0.68 Allowed 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 127.395 2.278 . . . . 0.0 111.528 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -53.96 -25.87 32.32 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 125.81 1.672 . . . . 0.0 116.954 -172.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -66.22 -28.04 68.44 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 120.079 1.939 . . . . 0.0 111.698 173.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -82.27 -28.75 31.6 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 121.03 -1.044 . . . . 0.0 112.005 177.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -78.16 -32.21 50.12 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.624 0.77 . . . . 0.0 111.559 172.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 67.0 mtp180 -55.25 -40.34 70.82 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 119.524 1.056 . . . . 0.0 111.257 162.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -58.78 -36.25 85.85 Favored Glycine 0 CA--C 1.536 1.37 0 CA-C-O 119.255 -0.747 . . . . 0.0 114.044 171.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -65.42 -35.55 81.26 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 119.41 1.605 . . . . 0.0 112.446 176.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 53.3 mt -73.05 -48.87 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 124.306 1.042 . . . . 0.0 109.724 176.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -67.07 -41.28 86.65 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 121.449 -0.782 . . . . 0.0 112.477 -174.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 77.4 mm-40 -69.07 -21.57 64.07 Favored 'General case' 0 CA--C 1.546 0.812 0 O-C-N 121.138 -0.976 . . . . 0.0 112.471 176.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -88.79 -29.78 19.49 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 177.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -140.4 -1.41 1.51 Allowed 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 116.075 1.88 . . . . 0.0 116.075 -170.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.5 mptt 45.75 48.32 11.72 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 125.922 1.689 . . . . 0.0 112.716 -165.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 60.2 t-80 -129.26 133.51 47.54 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 125.333 1.453 . . . . 0.0 110.471 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -142.27 -25.1 0.66 Allowed 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -160.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 60.6 p -77.78 151.97 33.78 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 121.727 -0.608 . . . . 0.0 111.603 168.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 13.6 m -104.55 155.95 36.62 Favored Pre-proline 0 N--CA 1.478 0.949 0 C-N-CA 124.673 1.189 . . . . 0.0 111.67 -176.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -75.04 154.31 99.58 Favored 'Cis proline' 0 CA--C 1.535 0.542 0 CA-C-N 119.071 0.704 . . . . 0.0 113.782 -6.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -99.23 138.08 36.83 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 159.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 60.9 mt -131.03 140.62 48.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 124.199 1.0 . . . . 0.0 109.35 -165.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -138.56 144.96 40.1 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.808 0.843 . . . . 0.0 111.982 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 65.8 mt -130.01 117.05 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.973 1.309 . . . . 0.0 109.186 175.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 46.13 44.64 12.12 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 125.565 1.546 . . . . 0.0 113.503 -176.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 82.46 -7.47 64.66 Favored Glycine 0 CA--C 1.534 1.229 0 N-CA-C 116.293 1.277 . . . . 0.0 116.293 -177.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -91.03 138.34 31.68 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 119.168 1.484 . . . . 0.0 110.578 -178.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 39.6 t80 -82.14 133.89 35.29 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.858 0.837 . . . . 0.0 112.915 -176.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 37.9 mm -113.98 119.73 61.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 126.656 1.983 . . . . 0.0 107.726 175.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -71.07 27.08 0.54 Allowed Glycine 0 N--CA 1.472 1.086 0 N-CA-C 119.137 2.415 . . . . 0.0 119.137 -167.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 116.21 -175.63 15.93 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 128.076 2.75 . . . . 0.0 114.552 175.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 25.1 t -64.54 -33.38 75.77 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.364 -1.08 . . . . 0.0 112.866 -179.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 37.0 m -70.01 -34.88 73.87 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 121.088 -1.007 . . . . 0.0 111.924 175.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.87 -39.04 90.33 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.452 1.101 . . . . 0.0 111.974 171.009 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 51.9 tp -62.93 -45.84 90.61 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.246 1.019 . . . . 0.0 111.196 175.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -64.77 -33.26 75.55 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.582 -0.699 . . . . 0.0 112.324 173.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.83 -29.84 71.0 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 121.008 -1.057 . . . . 0.0 111.954 177.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 83.6 mt -71.75 -30.03 65.15 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.441 1.096 . . . . 0.0 112.985 170.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -67.82 -41.13 83.52 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.698 0.799 . . . . 0.0 110.25 172.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -71.81 -39.75 69.62 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.113 0.965 . . . . 0.0 113.575 175.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -69.69 -18.27 63.54 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 119.547 1.067 . . . . 0.0 112.82 171.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 78.01 35.48 34.71 Favored Glycine 0 CA--C 1.531 1.083 0 CA-C-N 118.801 0.728 . . . . 0.0 113.65 175.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -116.19 -19.51 10.21 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 127.787 2.435 . . . . 0.0 113.351 -174.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 27.2 tp -63.21 -31.82 73.06 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.919 0.888 . . . . 0.0 111.684 -174.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -54.55 -53.6 52.34 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.526 1.131 . . . . 0.0 112.933 175.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -76.89 -23.4 69.45 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-O 119.446 -0.641 . . . . 0.0 113.862 -178.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 75.5 mt -69.91 -37.75 76.06 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 118.869 1.334 . . . . 0.0 112.012 172.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 92.8 mt -86.47 5.89 33.05 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -178.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 81.7 p . . . . . 0 C--O 1.255 1.387 0 C-N-CA 126.566 1.947 . . . . 0.0 115.973 -174.755 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 39.5 p . . . . . 0 C--O 1.239 0.502 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.6 pt -49.37 -25.3 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 125.981 1.712 . . . . 0.0 114.07 171.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.29 -28.48 69.22 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 118.935 0.789 . . . . 0.0 112.063 -176.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 96.4 p -72.32 -32.7 66.78 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 171.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 59.9 mtp -70.61 -30.65 67.38 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.15 0.98 . . . . 0.0 111.914 -176.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -64.88 -24.06 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 124.315 1.046 . . . . 0.0 111.573 -174.077 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -82.04 -9.54 59.52 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.063 1.745 . . . . 0.0 114.716 176.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -91.28 -22.06 33.32 Favored Glycine 0 CA--C 1.54 1.638 0 N-CA-C 117.451 1.741 . . . . 0.0 117.451 -166.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -135.86 170.04 16.61 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 118.941 1.37 . . . . 0.0 110.941 169.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 20.9 ttpt -66.59 -30.71 71.06 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 119.146 -0.454 . . . . 0.0 111.945 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 28.4 t -133.4 130.22 56.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.563 1.545 . . . . 0.0 109.394 177.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 42.9 t -134.21 127.67 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 124.245 1.018 . . . . 0.0 109.809 -177.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.1 t -128.35 146.92 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.295 1.038 . . . . 0.0 112.053 -170.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -125.97 106.88 9.95 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.797 1.239 . . . . 0.0 109.526 178.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 37.2 m -128.41 176.94 7.33 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 127.044 2.137 . . . . 0.0 112.371 -164.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 43.8 m0 -125.71 129.23 49.12 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.609 1.563 . . . . 0.0 108.335 163.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 46.6 t -53.63 -38.9 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 124.842 1.257 . . . . 0.0 114.325 -158.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.7 t -89.79 -6.99 55.4 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 -170.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 94.9 m -92.63 146.25 31.95 Favored Pre-proline 0 CA--C 1.537 0.456 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -160.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -69.59 -34.47 15.07 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 120.662 0.908 . . . . 0.0 114.057 -162.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -71.22 -42.12 69.31 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 124.073 0.949 . . . . 0.0 112.675 176.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -51.96 -54.65 27.23 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 169.667 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 53.3 t -60.23 -51.78 69.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 124.149 0.98 . . . . 0.0 111.63 -175.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . 0.272 7.7 ptp180 -61.67 -35.99 79.58 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 119.05 0.841 . . . . 0.0 112.164 -178.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.73 -55.91 8.63 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 118.226 -0.892 . . . . 0.0 112.716 173.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -48.02 -41.98 26.96 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 120.283 1.401 . . . . 0.0 112.584 176.149 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.28 -45.37 66.5 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 124.558 1.143 . . . . 0.0 111.577 -175.036 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.2 tt -70.4 -37.7 74.53 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.414 1.086 . . . . 0.0 112.021 176.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 80.7 mt -63.64 -41.71 98.21 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 120.923 -1.11 . . . . 0.0 111.461 176.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -64.41 -24.07 67.5 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 169.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.2 -16.07 53.85 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 119.974 1.261 . . . . 0.0 113.37 171.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 3.0 mmt180 -107.41 -36.69 6.43 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 115.972 1.842 . . . . 0.0 115.972 -173.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 13.9 t -155.04 150.56 27.41 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-N 120.312 1.415 . . . . 0.0 114.611 -176.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -84.03 -19.29 34.7 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.826 1.25 . . . . 0.0 113.02 170.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -85.97 37.1 0.7 Allowed 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -176.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -106.12 136.05 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 124.617 1.167 . . . . 0.0 111.984 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.3 m -128.6 142.25 51.1 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 126.489 1.915 . . . . 0.0 109.819 169.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.4 p -135.4 143.62 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 125.041 1.336 . . . . 0.0 113.315 177.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -118.99 135.98 54.34 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 127.187 2.195 . . . . 0.0 110.55 176.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -103.52 88.17 3.02 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.873 0.869 . . . . 0.0 111.604 -172.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 31.6 m -80.31 40.34 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 -168.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -141.92 -30.82 0.57 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 128.56 2.744 . . . . 0.0 109.879 171.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 26.4 mmmt -65.48 -31.29 72.29 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.088 1.355 . . . . 0.0 111.554 158.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -94.02 117.63 30.38 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.724 1.21 . . . . 0.0 109.387 178.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 73.8 m -70.89 -19.09 62.65 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 -163.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -92.39 5.96 48.75 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.453 1.501 . . . . 0.0 113.095 173.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -52.1 -25.23 17.16 Favored Glycine 0 CA--C 1.539 1.545 0 C-N-CA 125.524 1.535 . . . . 0.0 116.8 -173.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -64.24 -28.75 69.95 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 120.378 2.089 . . . . 0.0 112.802 172.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -80.11 -31.16 39.18 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.88 1.272 . . . . 0.0 112.441 176.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -78.15 -36.2 47.99 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.615 0.766 . . . . 0.0 110.768 174.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 57.3 mtp180 -54.93 -36.22 65.03 Favored 'General case' 0 N--CA 1.477 0.9 0 O-C-N 121.43 -0.794 . . . . 0.0 111.165 159.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.04 -44.08 97.61 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 124.498 1.047 . . . . 0.0 113.995 170.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -61.61 -32.3 72.42 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 119.745 1.772 . . . . 0.0 112.296 176.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 57.6 mt -74.48 -43.5 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.095 0.958 . . . . 0.0 110.08 174.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -64.83 -44.35 90.12 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 121.286 -0.884 . . . . 0.0 112.253 -179.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -57.05 -41.34 78.5 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.431 0.692 . . . . 0.0 111.674 -179.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -91.34 -28.26 17.84 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 -176.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -133.42 2.78 3.56 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 114.973 1.471 . . . . 0.0 114.973 -171.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 44.2 mmtm 54.12 33.65 18.3 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 127.039 2.136 . . . . 0.0 114.172 178.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 65.6 t-80 -130.92 141.82 50.32 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 126.088 1.755 . . . . 0.0 110.759 -175.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -142.0 -20.22 0.72 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.742 1.217 . . . . 0.0 113.593 -164.124 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.8 p -68.54 153.31 44.01 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.716 1.607 . . . . 0.0 111.876 167.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 25.6 m -115.92 151.25 46.24 Favored Pre-proline 0 N--CA 1.476 0.856 0 C-N-CA 124.421 1.088 . . . . 0.0 112.736 177.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -74.58 147.33 89.12 Favored 'Cis proline' 0 N--CA 1.457 -0.62 0 CA-C-N 119.079 0.707 . . . . 0.0 113.884 0.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -99.02 138.35 36.25 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.414 158.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 44.4 mt -130.45 141.07 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 123.714 0.805 . . . . 0.0 109.089 -164.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -140.16 146.07 38.31 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.007 0.923 . . . . 0.0 111.555 -179.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 65.2 mt -128.85 127.19 66.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 125.384 1.474 . . . . 0.0 107.916 174.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 35.8 m120 50.54 28.17 3.28 Favored 'General case' 0 CA--C 1.56 1.355 0 N-CA-C 115.651 1.723 . . . . 0.0 115.651 -178.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 82.4 0.97 90.34 Favored Glycine 0 CA--C 1.544 1.891 0 O-C-N 120.397 -1.44 . . . . 0.0 115.047 -173.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -91.72 151.65 20.55 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 126.964 2.106 . . . . 0.0 110.387 172.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -93.97 142.37 27.46 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -174.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 31.7 mm -121.22 130.07 75.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 128.56 2.744 . . . . 0.0 107.512 176.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -71.38 23.37 0.62 Allowed Glycine 0 N--CA 1.472 1.034 0 C-N-CA 126.744 2.116 . . . . 0.0 118.101 -165.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 107.79 -171.9 16.79 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 127.941 2.686 . . . . 0.0 113.498 178.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 42.7 t -54.12 -41.94 68.89 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.821 1.248 . . . . 0.0 112.362 -178.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 10.4 m -82.58 -10.28 59.04 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -178.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -76.6 -42.68 41.57 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 120.002 1.273 . . . . 0.0 109.838 162.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 48.7 tp -64.13 -50.03 69.84 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.115 1.366 . . . . 0.0 112.395 177.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -70.01 -12.95 61.98 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 113.24 0.829 . . . . 0.0 113.24 178.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -85.89 -39.41 17.03 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 121.206 -0.934 . . . . 0.0 112.121 164.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 33.6 mt -64.42 -33.66 76.38 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 120.375 1.443 . . . . 0.0 113.29 175.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -62.98 -47.39 83.35 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.975 1.31 . . . . 0.0 111.352 171.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 6.8 mptt -73.44 -34.91 65.65 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.598 1.559 . . . . 0.0 112.319 -177.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -70.41 -11.58 61.01 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.231 1.813 . . . . 0.0 113.142 169.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 70.17 10.65 65.97 Favored Glycine 0 CA--C 1.534 1.258 0 CA-C-N 119.053 0.842 . . . . 0.0 114.301 -177.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 17.4 mtpt -81.5 -26.6 35.04 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 125.949 1.7 . . . . 0.0 112.103 -178.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 34.7 tp -59.51 -40.23 86.41 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.645 1.178 . . . . 0.0 112.126 170.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -60.66 -42.04 96.22 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.812 -0.555 . . . . 0.0 111.932 174.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -70.33 -14.08 71.28 Favored Glycine 0 CA--C 1.535 1.301 0 CA-C-O 119.16 -0.8 . . . . 0.0 114.959 176.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 88.7 mt -97.64 -21.99 16.73 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.065 1.746 . . . . 0.0 113.341 175.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 93.2 mt -103.8 -5.67 22.2 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.236 1.415 . . . . 0.0 114.447 -179.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 61.2 p . . . . . 0 C--O 1.25 1.1 0 C-N-CA 126.07 1.748 . . . . 0.0 114.159 173.465 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.07 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.81 -14.13 62.61 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 115.43 1.641 . . . . 0.0 115.43 -177.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 50.2 mtp -115.18 92.39 31.39 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 125.878 1.671 . . . . 0.0 113.02 -171.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -50.51 138.25 39.59 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 124.122 3.215 . . . . 0.0 116.191 -175.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.4 t -151.18 -147.89 0.25 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 127.939 2.495 . . . . 0.0 109.766 -175.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.6 pt -49.21 -24.82 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 126.741 2.016 . . . . 0.0 116.222 -165.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.26 -21.84 26.16 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.929 1.691 . . . . 0.0 114.264 -178.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.9 m -77.32 -32.74 55.49 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.81 1.244 . . . . 0.0 113.437 170.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 78.8 mtp -63.26 -33.76 76.19 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 121.306 -0.871 . . . . 0.0 111.371 -176.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.0 mm -62.35 -22.47 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 125.726 1.611 . . . . 0.0 112.767 -176.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -85.86 -17.74 34.77 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.24 1.416 . . . . 0.0 113.876 179.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -88.77 -7.5 71.15 Favored Glycine 0 CA--C 1.536 1.395 0 N-CA-C 115.933 1.133 . . . . 0.0 115.933 -173.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -145.04 161.16 40.09 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.292 1.437 . . . . 0.0 110.738 169.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -67.77 -48.33 66.65 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.091 0.956 . . . . 0.0 111.176 177.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.4 t -114.53 131.12 67.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.937 1.295 . . . . 0.0 110.961 171.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 85.3 t -131.06 130.74 63.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 125.014 1.326 . . . . 0.0 110.206 179.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 49.3 t -128.81 146.03 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 124.13 0.972 . . . . 0.0 112.421 -175.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -121.84 111.53 17.23 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.789 1.235 . . . . 0.0 109.099 173.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 18.7 m -121.14 172.68 7.8 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 126.728 2.011 . . . . 0.0 111.319 -173.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.46 ' CD1' ' HB3' ' A' ' 46' ' ' ASP . 23.6 m0 -120.31 135.88 54.86 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.57 1.148 . . . . 0.0 108.86 162.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 60.7 t -57.72 -35.54 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 CA-C-N 118.849 0.75 . . . . 0.0 111.13 -177.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.3 p -74.34 -10.82 59.96 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 127.308 2.243 . . . . 0.0 116.408 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 38.0 t -90.61 143.73 29.52 Favored Pre-proline 0 CA--C 1.537 0.48 0 O-C-N 121.264 -0.898 . . . . 0.0 110.513 -170.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.33 -39.05 0.61 Allowed 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 121.114 1.209 . . . . 0.0 112.655 173.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -59.01 -36.31 74.73 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.307 1.043 . . . . 0.0 113.744 178.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -48.44 -54.73 13.06 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.713 1.205 . . . . 0.0 109.584 168.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 57.5 t -65.2 -39.64 86.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.242 1.017 . . . . 0.0 112.139 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 79.6 mmt-85 -54.78 -41.67 70.8 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 118.687 0.676 . . . . 0.0 111.572 174.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.17 -54.27 8.88 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.608 0.763 . . . . 0.0 113.007 173.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -54.24 -31.94 54.67 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 119.498 1.044 . . . . 0.0 113.349 -177.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -69.32 -49.23 57.68 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.0 0.92 . . . . 0.0 112.669 176.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 8.0 tt -72.59 -36.74 68.22 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 124.651 1.181 . . . . 0.0 111.861 -177.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 93.2 mt -62.25 -44.78 95.77 Favored 'General case' 0 CA--C 1.53 0.175 0 O-C-N 121.607 -0.683 . . . . 0.0 111.395 177.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 14.8 m-70 -69.61 -20.88 63.61 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 172.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.61 -31.91 53.19 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 119.698 1.135 . . . . 0.0 113.203 173.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 39.6 mmt-85 -97.36 -23.79 15.94 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 114.827 1.418 . . . . 0.0 114.827 -176.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 14.6 t -153.78 170.25 21.39 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -177.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 77.6 mttt -112.68 3.82 16.81 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 126.411 1.884 . . . . 0.0 112.224 167.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -105.83 42.94 1.18 Allowed 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 126.081 1.752 . . . . 0.0 113.114 -171.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -119.54 134.97 61.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.858 1.663 . . . . 0.0 111.959 -177.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.0 m -119.19 141.85 48.51 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.803 2.041 . . . . 0.0 110.242 167.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.5 p -135.37 141.04 43.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 125.072 1.349 . . . . 0.0 113.308 176.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -112.77 134.68 54.17 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 127.414 2.286 . . . . 0.0 110.394 175.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -101.62 89.44 3.71 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 124.15 0.98 . . . . 0.0 110.509 -179.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.9 m -76.1 4.65 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -170.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.46 ' HB3' ' CD1' ' A' ' 20' ' ' TRP . 2.5 p-10 -85.23 -22.92 28.47 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.759 1.224 . . . . 0.0 112.038 167.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 30.0 mtmt -90.0 5.09 48.08 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.904 2.082 . . . . 0.0 113.41 176.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 12.2 tpt -120.63 124.25 44.79 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.975 1.71 . . . . 0.0 111.413 -165.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 10.5 m -65.21 -22.91 66.95 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.735 0.814 . . . . 0.0 112.847 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.4 5.58 51.36 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 126.16 1.784 . . . . 0.0 113.549 174.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -55.88 -30.57 57.14 Favored Glycine 0 CA--C 1.532 1.106 0 O-C-N 120.402 -1.436 . . . . 0.0 114.651 -174.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -70.23 -26.23 63.76 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 118.541 1.17 . . . . 0.0 113.043 175.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -72.21 -44.11 63.45 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.97 0.908 . . . . 0.0 110.53 170.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.23 -36.65 83.57 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.044 0.538 . . . . 0.0 110.459 178.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 43.0 mtp180 -63.93 -42.01 97.47 Favored 'General case' 0 N--CA 1.477 0.897 0 O-C-N 121.077 -1.014 . . . . 0.0 112.176 167.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -58.91 -38.38 92.49 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 124.225 0.917 . . . . 0.0 113.627 176.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -61.18 -32.29 72.03 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 118.597 1.199 . . . . 0.0 113.637 173.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 52.0 mt -81.28 -42.55 19.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 123.939 0.896 . . . . 0.0 109.214 177.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -71.93 -39.59 69.36 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 121.115 -0.991 . . . . 0.0 112.941 -176.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 42.2 mm-40 -68.63 -23.91 64.49 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 119.939 1.245 . . . . 0.0 113.069 177.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -98.75 -31.75 11.73 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.533 1.133 . . . . 0.0 113.827 -178.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -134.87 5.0 3.33 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -170.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 66.7 mmtt 47.37 38.94 8.14 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 126.565 1.946 . . . . 0.0 114.429 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -139.88 147.69 40.99 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.704 1.202 . . . . 0.0 111.446 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -140.29 2.47 1.88 Allowed 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.998 1.319 . . . . 0.0 113.861 -172.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 90.2 m -82.22 141.04 33.32 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.284 1.034 . . . . 0.0 111.851 175.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.9 m -101.97 156.06 35.68 Favored Pre-proline 0 N--CA 1.475 0.785 0 C-N-CA 124.826 1.251 . . . . 0.0 112.73 -176.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -73.69 150.96 96.42 Favored 'Cis proline' 0 C--N 1.348 0.546 0 CA-C-N 118.759 0.592 . . . . 0.0 113.013 -5.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -98.02 130.84 44.83 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 161.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 47.8 mt -126.28 141.39 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 C-N-CA 124.084 0.954 . . . . 0.0 109.294 -167.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -139.34 141.11 37.66 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.516 0.727 . . . . 0.0 111.736 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 43.4 mt -136.5 117.07 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.659 1.184 . . . . 0.0 109.508 -179.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 46.37 38.58 5.4 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 125.135 1.374 . . . . 0.0 114.165 -171.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 78.83 0.29 80.64 Favored Glycine 0 CA--C 1.54 1.654 0 N-CA-C 115.723 1.049 . . . . 0.0 115.723 -177.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 -88.61 145.84 25.46 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 119.088 1.444 . . . . 0.0 110.261 174.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -94.06 137.62 33.05 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -172.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 18.3 mm -130.75 115.46 30.95 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 C-N-CA 127.825 2.45 . . . . 0.0 107.663 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -70.97 -16.97 75.11 Favored Glycine 0 CA--C 1.537 1.461 0 N-CA-C 116.41 1.324 . . . . 0.0 116.41 -165.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 172.99 -173.87 45.72 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 124.558 1.075 . . . . 0.0 113.52 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 34.1 t -62.92 -35.63 80.73 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 122.262 -0.552 . . . . 0.0 111.469 174.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 43.5 t -60.96 -44.29 97.5 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.795 -0.565 . . . . 0.0 112.319 173.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -70.94 -31.11 67.61 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.51 1.124 . . . . 0.0 112.015 -179.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 42.5 tp -69.38 -50.82 42.55 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.815 1.646 . . . . 0.0 111.289 172.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -64.36 -31.45 72.66 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 121.422 -0.799 . . . . 0.0 112.521 178.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.43 -22.63 65.2 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 119.131 0.878 . . . . 0.0 112.771 175.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 68.7 mt -90.13 -29.81 18.06 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.987 1.315 . . . . 0.0 112.088 171.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -65.16 -45.4 85.09 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.041 0.936 . . . . 0.0 112.264 172.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -60.33 -22.52 63.32 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.747 1.619 . . . . 0.0 114.059 177.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -105.07 -7.81 18.9 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.061 1.344 . . . . 0.0 114.584 -176.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 84.08 6.11 86.88 Favored Glycine 0 CA--C 1.54 1.627 0 CA-C-N 118.881 0.764 . . . . 0.0 114.673 -176.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 34.0 mtmt -90.51 -25.68 20.15 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 125.662 1.585 . . . . 0.0 113.252 -171.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 52.4 tp -65.19 -38.55 90.85 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.283 1.033 . . . . 0.0 111.258 173.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -62.06 -23.6 66.59 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 173.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -85.2 -23.41 48.51 Favored Glycine 0 CA--C 1.532 1.123 0 O-C-N 121.545 -0.722 . . . . 0.0 114.141 172.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 41.9 mt -79.18 -35.03 42.53 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.893 1.277 . . . . 0.0 112.336 175.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 51.5 mt -81.01 -0.73 40.89 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 115.421 1.638 . . . . 0.0 115.421 -166.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 16.4 m . . . . . 0 C--O 1.254 1.34 0 C-N-CA 127.073 2.149 . . . . 0.0 113.027 -179.57 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.219 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -147.6 144.46 28.46 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.895 0.878 . . . . 0.0 112.234 177.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.76 90.03 42.73 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 126.03 1.732 . . . . 0.0 110.576 -178.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -60.77 108.62 0.56 Allowed 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 123.245 2.63 . . . . 0.0 112.938 176.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 53.8 p -149.66 -179.34 7.03 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 125.514 1.526 . . . . 0.0 109.557 165.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 21.3 pt -53.44 -27.55 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 123.344 0.658 . . . . 0.0 112.621 172.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.88 -25.12 64.46 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -172.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.1 m -81.07 -31.95 34.18 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 121.096 -1.003 . . . . 0.0 111.904 167.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 56.5 mtm -68.37 -17.97 64.36 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 178.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.5 mm -60.84 -31.16 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 CA-C-N 119.223 0.919 . . . . 0.0 111.99 171.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.2 mptt -75.53 -1.52 24.71 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -174.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -81.86 -38.03 14.78 Favored Glycine 0 CA--C 1.537 1.436 0 N-CA-C 115.659 1.024 . . . . 0.0 115.659 -172.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -140.84 171.92 13.41 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.304 1.442 . . . . 0.0 112.641 -174.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 29.0 ttpt -68.7 -39.29 80.56 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.849 1.26 . . . . 0.0 112.813 -178.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.1 t -122.47 134.44 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.031 0.932 . . . . 0.0 110.357 172.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 25.2 t -135.27 130.51 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 124.368 1.067 . . . . 0.0 109.985 177.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 54.8 t -127.4 149.12 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.472 1.109 . . . . 0.0 111.977 -173.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -127.31 114.33 17.45 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.408 1.483 . . . . 0.0 109.409 175.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.7 m -130.14 172.13 12.1 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 126.571 1.948 . . . . 0.0 111.444 -168.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 23.0 m0 -114.55 138.99 49.95 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 158.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 96.6 t -65.56 -22.82 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 CA-C-N 118.465 0.575 . . . . 0.0 111.208 175.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 76.6 p -68.54 -18.73 64.42 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.639 1.576 . . . . 0.0 115.001 172.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 49.9 t -93.14 143.3 26.53 Favored Pre-proline 0 CA--C 1.539 0.522 0 CA-C-N 119.698 1.135 . . . . 0.0 111.498 -165.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -82.92 -33.53 0.42 Allowed 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 121.217 1.278 . . . . 0.0 112.932 174.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -61.23 -36.64 80.5 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.67 1.188 . . . . 0.0 112.705 176.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -49.85 -55.13 15.43 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.382 1.473 . . . . 0.0 109.517 168.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 86.0 t -63.97 -39.02 83.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.221 1.008 . . . . 0.0 112.558 -176.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 25.4 mmm180 -53.89 -48.11 70.41 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 118.745 0.702 . . . . 0.0 111.029 173.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.81 -55.77 13.39 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.617 0.767 . . . . 0.0 112.342 175.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.79 -38.27 47.41 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.722 1.209 . . . . 0.0 113.698 -178.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -71.28 -51.08 26.47 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.394 0.678 . . . . 0.0 111.172 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.2 tt -66.19 -38.63 88.46 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 125.151 1.381 . . . . 0.0 111.754 -177.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 71.5 mt -61.86 -52.94 62.07 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.897 0.879 . . . . 0.0 111.172 176.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -63.43 -25.23 68.18 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 172.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.04 -13.27 60.22 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 120.514 -1.366 . . . . 0.0 113.514 175.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 12.3 mmp_? -99.87 -56.88 2.26 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.842 1.257 . . . . 0.0 112.433 171.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 25.4 p -150.02 143.15 24.98 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.556 1.142 . . . . 0.0 113.915 -164.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -83.73 -0.98 53.11 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 126.572 1.949 . . . . 0.0 113.528 175.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -83.29 29.35 0.5 Allowed 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.075 1.35 . . . . 0.0 113.383 -177.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -110.15 132.49 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 126.818 2.047 . . . . 0.0 111.089 -174.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 46.8 m -110.2 138.88 45.97 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 126.956 2.103 . . . . 0.0 108.89 166.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.1 p -134.6 139.61 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-O 122.537 1.161 . . . . 0.0 113.37 170.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 34.6 m-70 -116.23 145.95 42.72 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 127.939 2.496 . . . . 0.0 110.918 -178.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -123.58 90.77 3.34 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.967 0.889 . . . . 0.0 111.335 -168.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 34.9 m -68.24 -11.66 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -174.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.41 -23.58 54.03 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.865 0.866 . . . . 0.0 112.963 170.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -86.43 -32.26 20.97 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.703 1.201 . . . . 0.0 111.977 175.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 67.1 mtt -61.75 143.83 55.62 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.122 0.969 . . . . 0.0 112.157 174.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 9.4 t -70.42 -37.58 74.46 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.835 0.854 . . . . 0.0 111.103 168.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -100.16 7.92 44.22 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.776 1.63 . . . . 0.0 114.026 -176.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -57.02 -27.41 57.12 Favored Glycine 0 CA--C 1.534 1.244 0 O-C-N 120.598 -1.314 . . . . 0.0 115.795 -172.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -67.6 -20.01 65.31 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.052 1.426 . . . . 0.0 112.82 174.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -80.34 -33.82 37.08 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.984 1.314 . . . . 0.0 112.0 170.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -77.9 -27.98 49.71 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 121.52 -0.737 . . . . 0.0 111.495 177.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 66.5 mtp180 -54.72 -39.74 68.53 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-N 119.633 1.106 . . . . 0.0 111.337 159.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.23 -28.02 73.06 Favored Glycine 0 CA--C 1.534 1.271 0 CA-C-O 119.095 -0.836 . . . . 0.0 115.033 175.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -65.0 -35.0 79.79 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 119.557 1.678 . . . . 0.0 112.398 174.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 27.9 mt -72.93 -41.3 60.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 124.44 1.096 . . . . 0.0 109.278 173.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -64.53 -46.29 83.5 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 121.49 -0.757 . . . . 0.0 112.947 -177.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 93.5 mm-40 -70.58 -18.02 62.9 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -92.74 -33.03 14.47 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 175.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -136.35 -0.73 2.41 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 115.678 1.733 . . . . 0.0 115.678 -168.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 53.06 41.35 32.16 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 126.803 2.041 . . . . 0.0 113.835 -169.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -128.72 140.61 51.65 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.592 1.157 . . . . 0.0 113.056 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -142.18 -18.03 0.73 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.684 1.194 . . . . 0.0 113.949 -169.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.7 p -72.68 164.55 26.34 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.49 1.116 . . . . 0.0 113.524 169.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 20.1 m -123.65 155.03 66.82 Favored Pre-proline 0 N--CA 1.478 0.955 0 C-N-CA 124.715 1.206 . . . . 0.0 113.597 -175.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -75.47 151.73 96.59 Favored 'Cis proline' 0 C--N 1.35 0.619 0 CA-C-N 118.793 0.605 . . . . 0.0 112.913 -4.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -100.12 132.5 45.45 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 162.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 69.3 mt -126.23 142.4 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 123.977 0.911 . . . . 0.0 108.725 -167.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -138.68 146.04 41.1 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.669 0.788 . . . . 0.0 112.08 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 51.8 mt -132.73 119.99 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.907 1.283 . . . . 0.0 109.994 176.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 48.05 29.75 1.86 Allowed 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 126.224 1.81 . . . . 0.0 114.57 -176.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 91.21 0.51 73.74 Favored Glycine 0 CA--C 1.541 1.703 0 C-N-CA 125.428 1.489 . . . . 0.0 116.759 -175.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -93.0 144.96 24.74 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 126.022 1.729 . . . . 0.0 110.744 175.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -91.96 141.56 28.5 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.704 1.202 . . . . 0.0 114.065 -176.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 26.4 mm -127.79 123.2 60.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 C-N-CA 128.076 2.55 . . . . 0.0 108.364 -178.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -72.02 16.63 1.51 Allowed Glycine 0 N--CA 1.475 1.274 0 N-CA-C 118.863 2.305 . . . . 0.0 118.863 -167.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 114.59 -159.8 13.53 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 126.831 2.158 . . . . 0.0 114.196 178.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 53.6 t -65.25 -42.22 93.5 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.796 0.838 . . . . 0.0 113.229 -172.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 21.5 m -61.27 -40.9 95.8 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 118.924 0.784 . . . . 0.0 112.025 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -66.03 -40.45 91.05 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.774 1.23 . . . . 0.0 112.107 176.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 56.1 tp -64.14 -50.83 66.68 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.326 1.45 . . . . 0.0 111.35 177.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -63.3 -39.51 94.77 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 118.108 0.413 . . . . 0.0 111.106 175.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.29 -38.67 90.26 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 121.541 -0.724 . . . . 0.0 111.869 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 29.4 mt -66.53 -27.38 67.71 Favored 'General case' 0 N--CA 1.468 0.425 0 O-C-N 121.302 -0.874 . . . . 0.0 112.151 176.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -75.04 -43.42 53.68 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 118.748 0.704 . . . . 0.0 111.634 174.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -65.87 -32.41 73.9 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.582 0.753 . . . . 0.0 112.083 175.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -78.84 -0.48 30.79 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 126.119 1.768 . . . . 0.0 113.601 172.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 73.22 23.0 78.38 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 124.461 1.029 . . . . 0.0 114.925 173.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 43.2 mtmt -113.59 -24.06 9.43 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 127.31 2.244 . . . . 0.0 113.877 -168.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 38.7 tp -63.24 -37.33 86.81 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 123.43 0.692 . . . . 0.0 111.825 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -54.92 -44.14 73.96 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.545 0.738 . . . . 0.0 112.375 175.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -73.53 -33.67 58.09 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 123.991 0.805 . . . . 0.0 113.894 177.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 82.3 mt -68.24 -36.39 79.39 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 118.764 1.282 . . . . 0.0 111.801 173.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 83.0 mt -83.9 6.2 22.55 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.932 1.293 . . . . 0.0 113.184 176.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 61.4 m . . . . . 0 C--O 1.253 1.286 0 C-N-CA 124.054 0.942 . . . . 0.0 111.1 171.891 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.929 0 N-CA-C 112.347 -0.301 . . . . 0.0 112.347 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.75 163.53 38.96 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.368 1.467 . . . . 0.0 112.752 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 28.3 ttt -149.18 95.11 3.88 Favored Pre-proline 0 CA--C 1.55 0.967 0 C-N-CA 125.34 1.456 . . . . 0.0 112.31 -174.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -78.09 179.76 29.78 Favored 'Cis proline' 0 C--N 1.351 0.661 0 CA-C-N 120.454 1.198 . . . . 0.0 111.421 0.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 7.8 p -143.64 -168.42 2.83 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 -174.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 21.8 pt -54.53 -23.15 10.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 125.072 1.349 . . . . 0.0 113.044 168.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.58 -22.19 66.9 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -174.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 70.5 m -79.12 -28.95 42.97 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 121.08 -1.013 . . . . 0.0 113.148 170.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 54.8 mtt -64.3 -30.97 72.0 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 121.382 -0.824 . . . . 0.0 111.723 -178.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.7 mm -60.74 -27.67 41.35 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 125.012 1.325 . . . . 0.0 112.279 -178.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.4 mptt -81.0 -11.39 59.57 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.996 1.318 . . . . 0.0 113.577 178.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -80.87 -32.71 32.04 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 124.12 0.866 . . . . 0.0 114.985 -176.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 55.0 m-80 -141.56 162.47 35.4 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 115.445 1.646 . . . . 0.0 115.445 -172.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -61.62 -42.36 98.77 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.958 1.303 . . . . 0.0 112.705 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.4 t -127.55 132.12 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.129 0.972 . . . . 0.0 110.317 175.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 48.0 t -132.08 131.17 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.015 0.926 . . . . 0.0 110.92 178.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.0 t -129.84 150.45 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.275 1.03 . . . . 0.0 113.029 -174.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -126.28 106.87 9.83 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.692 1.197 . . . . 0.0 109.992 175.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 60.9 m -125.02 167.33 14.89 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 126.058 1.743 . . . . 0.0 112.134 -169.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 41.7 m0 -113.66 121.55 44.49 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.046 1.338 . . . . 0.0 109.289 166.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 96.4 t -55.99 -27.61 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 C-N-CA 124.777 1.231 . . . . 0.0 112.772 -174.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.6 p -74.45 -17.04 60.84 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 126.998 2.119 . . . . 0.0 115.054 178.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 76.1 m -107.74 158.19 34.01 Favored Pre-proline 0 CA--C 1.54 0.591 0 CA-C-N 120.135 1.334 . . . . 0.0 114.02 -160.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -79.86 -48.11 0.08 OUTLIER 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.175 1.917 . . . . 0.0 112.879 -168.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -60.99 -36.31 79.13 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.067 0.947 . . . . 0.0 113.281 -179.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -43.61 -55.42 4.32 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.701 1.2 . . . . 0.0 110.128 165.18 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 54.5 t -68.3 -40.31 82.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 123.89 0.876 . . . . 0.0 111.967 -178.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 43.6 mmt-85 -56.14 -41.38 75.3 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 118.865 0.757 . . . . 0.0 111.828 175.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.94 -56.72 5.61 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.732 1.213 . . . . 0.0 112.909 173.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -51.44 -35.78 41.1 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 119.857 1.208 . . . . 0.0 113.243 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 25.3 ttpt -69.44 -50.35 46.52 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 124.203 1.001 . . . . 0.0 111.647 178.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.5 tt -65.72 -41.65 92.0 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 124.63 1.172 . . . . 0.0 111.006 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 53.0 mt -62.22 -50.05 73.31 Favored 'General case' 0 C--O 1.227 -0.095 0 CA-C-O 118.359 -0.829 . . . . 0.0 111.112 177.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 14.7 m170 -61.6 -21.81 64.67 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 118.74 0.7 . . . . 0.0 112.617 173.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -83.54 -14.16 52.87 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 119.79 1.177 . . . . 0.0 114.033 174.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.91 -36.99 4.96 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.109 1.364 . . . . 0.0 114.1 -178.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.0 m -147.97 138.98 23.3 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 126.312 1.845 . . . . 0.0 111.107 -171.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -97.37 -22.95 16.33 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.195 0.998 . . . . 0.0 112.665 174.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -78.3 52.5 1.13 Allowed 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 125.263 1.425 . . . . 0.0 112.921 172.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -112.3 136.36 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 127.665 2.386 . . . . 0.0 109.934 178.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.6 m -123.13 119.79 31.32 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.723 1.609 . . . . 0.0 110.185 172.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.3 p -110.26 133.66 54.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 123.772 0.829 . . . . 0.0 111.743 170.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -103.84 125.94 50.62 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.881 1.272 . . . . 0.0 109.802 170.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -95.74 101.83 13.57 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 121.866 0.841 . . . . 0.0 111.169 -176.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . 0.278 29.8 m -81.97 5.57 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 O-C-N 120.552 -1.342 . . . . 0.0 114.481 -173.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -92.04 -20.61 21.14 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 125.26 1.424 . . . . 0.0 112.163 161.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.4 mmmt -89.66 -37.04 14.9 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 126.784 2.034 . . . . 0.0 111.878 176.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 46.1 tpp -85.2 121.12 27.5 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.683 0.793 . . . . 0.0 110.236 177.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 73.2 m -64.46 -24.45 67.62 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 -168.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -86.78 1.46 52.16 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 126.911 2.085 . . . . 0.0 114.551 171.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -50.97 -27.35 13.45 Favored Glycine 0 CA--C 1.533 1.2 0 N-CA-C 116.92 1.528 . . . . 0.0 116.92 -169.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -73.98 -20.86 60.21 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 119.808 1.804 . . . . 0.0 113.157 177.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 63.2 mm-40 -83.3 -29.89 28.0 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 121.03 -1.043 . . . . 0.0 111.803 172.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -73.92 -34.34 64.32 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.777 0.831 . . . . 0.0 111.509 170.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 63.7 mtp85 -53.87 -39.16 65.45 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 119.606 1.094 . . . . 0.0 111.196 161.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -55.54 -42.01 82.95 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.054 0.835 . . . . 0.0 114.13 171.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -65.81 -25.64 67.32 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 119.697 1.748 . . . . 0.0 113.272 177.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.1 mt -79.66 -47.59 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 123.997 0.919 . . . . 0.0 109.477 172.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -66.64 -42.62 86.41 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.441 -0.787 . . . . 0.0 112.434 -175.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -60.76 -26.65 67.39 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 121.409 -0.807 . . . . 0.0 113.057 177.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -94.52 -36.65 11.75 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 -178.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -129.15 -4.03 5.01 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 115.045 1.498 . . . . 0.0 115.045 -168.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.5 mttt 43.9 61.68 2.22 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 127.939 2.496 . . . . 0.0 113.484 -174.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -135.16 109.0 8.07 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 112.428 -2.169 . . . . 0.0 110.896 -171.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -99.92 -5.9 27.56 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.68 1.592 . . . . 0.0 112.555 177.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.0 t -51.35 148.71 4.64 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 127.17 2.188 . . . . 0.0 113.452 162.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.2 m -136.8 141.12 33.92 Favored Pre-proline 0 N--CA 1.477 0.882 0 C-N-CA 125.962 1.705 . . . . 0.0 109.926 164.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -78.6 152.21 89.83 Favored 'Cis proline' 0 N--CA 1.46 -0.492 0 CA-C-N 119.862 0.986 . . . . 0.0 114.086 5.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -97.06 142.14 29.36 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.639 0.776 . . . . 0.0 109.535 161.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 53.6 mt -133.68 139.58 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 123.816 0.846 . . . . 0.0 110.016 -164.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -138.46 144.1 39.94 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.626 1.17 . . . . 0.0 111.468 179.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 66.5 mt -133.72 120.5 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 124.926 1.29 . . . . 0.0 109.029 177.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 45.91 38.96 4.98 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 125.85 1.66 . . . . 0.0 114.134 -176.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 82.36 -3.0 83.58 Favored Glycine 0 CA--C 1.539 1.535 0 N-CA-C 116.514 1.366 . . . . 0.0 116.514 -176.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -88.25 147.14 24.97 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.371 1.468 . . . . 0.0 109.675 174.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -89.65 143.74 26.56 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.809 0.844 . . . . 0.0 112.104 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 20.1 mm -126.92 115.44 41.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 127.039 2.135 . . . . 0.0 107.273 175.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.85 -16.1 61.09 Favored Glycine 0 CA--C 1.534 1.242 0 N-CA-C 116.908 1.523 . . . . 0.0 116.908 -167.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 173.46 177.74 42.91 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-N 118.796 1.298 . . . . 0.0 115.935 174.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 29.8 t -59.41 -35.19 73.52 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 122.904 0.482 . . . . 0.0 112.068 175.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 50.4 m -72.96 -16.91 61.52 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.647 1.179 . . . . 0.0 113.584 178.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -86.72 -39.13 16.3 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.446 1.098 . . . . 0.0 111.386 169.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 51.0 tp -61.06 -51.01 70.98 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.222 1.409 . . . . 0.0 111.514 174.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -55.57 -38.06 68.86 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.554 1.141 . . . . 0.0 111.028 173.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.04 -31.17 65.91 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.09 -1.006 . . . . 0.0 113.235 -177.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 32.1 mt -72.32 -30.94 65.24 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 119.227 0.921 . . . . 0.0 112.339 173.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -65.27 -33.83 76.92 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.791 1.236 . . . . 0.0 111.083 169.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 15.1 mmtt -80.23 -9.32 59.72 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 176.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -98.51 -11.7 21.99 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.92 1.288 . . . . 0.0 114.329 172.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 67.65 29.09 73.59 Favored Glycine 0 CA--C 1.539 1.569 0 C-N-CA 121.163 -0.541 . . . . 0.0 112.357 -171.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 31.8 mtmt -111.98 -16.32 13.12 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 126.547 1.939 . . . . 0.0 113.272 -176.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 42.9 tp -68.35 -36.9 79.91 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.748 0.819 . . . . 0.0 111.776 178.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -54.37 -48.41 71.51 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.269 1.028 . . . . 0.0 111.789 175.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -76.06 -15.6 81.28 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 125.274 1.416 . . . . 0.0 114.852 178.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 53.9 mt -78.18 -32.04 49.92 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 119.393 1.597 . . . . 0.0 111.495 167.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 81.2 mt -92.85 8.63 38.77 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.977 1.711 . . . . 0.0 114.089 -178.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 35.2 t . . . . . 0 C--O 1.252 1.211 0 C-N-CA 127.097 2.159 . . . . 0.0 113.655 178.921 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.156 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -89.89 10.54 23.42 Favored 'General case' 0 CA--C 1.551 1.004 0 N-CA-C 115.751 1.76 . . . . 0.0 115.751 -172.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 22.7 mmt -119.98 77.87 23.74 Favored Pre-proline 0 CA--C 1.55 0.957 0 CA-C-N 119.551 1.069 . . . . 0.0 113.212 -170.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -79.07 90.51 1.27 Allowed 'Trans proline' 0 CA--C 1.545 1.059 0 C-N-CA 123.638 2.892 . . . . 0.0 110.917 174.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.6 m -108.79 -151.18 0.47 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.704 1.202 . . . . 0.0 113.906 -166.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.7 pt -62.23 -20.86 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 -156.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -54.9 -26.44 35.84 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.553 1.541 . . . . 0.0 113.821 -178.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.4 m -72.08 -34.58 68.78 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.939 1.696 . . . . 0.0 113.205 174.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 58.7 mtt -64.39 -36.15 83.2 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.968 0.907 . . . . 0.0 111.247 -178.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.2 mm -62.89 -27.32 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.273 1.029 . . . . 0.0 111.919 -172.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -77.9 -20.53 52.76 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -173.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -78.29 -29.17 54.18 Favored Glycine 0 CA--C 1.533 1.187 0 CA-C-N 119.576 1.08 . . . . 0.0 114.819 -168.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -129.26 170.57 13.43 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.555 -0.967 . . . . 0.0 112.562 -167.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 29.9 ttpt -75.22 -38.38 60.71 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.273 0.629 . . . . 0.0 112.113 177.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.1 t -125.18 139.13 52.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.733 1.213 . . . . 0.0 110.158 168.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 60.9 t -130.82 125.43 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 124.634 1.174 . . . . 0.0 108.919 171.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 50.4 t -127.6 147.65 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 123.867 0.867 . . . . 0.0 111.909 -170.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -121.05 111.43 17.45 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.673 1.189 . . . . 0.0 109.012 174.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.435 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 71.9 m -127.77 168.6 14.9 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 126.447 1.899 . . . . 0.0 110.911 -172.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.496 ' CD1' ' HB3' ' A' ' 46' ' ' ASP . 18.3 m0 -116.06 132.23 56.71 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.521 1.129 . . . . 0.0 108.424 163.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 60.7 t -56.48 -29.14 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 CA-C-N 119.098 0.863 . . . . 0.0 112.288 -176.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.8 p -85.64 -11.09 54.73 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 127.464 2.306 . . . . 0.0 115.65 -175.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 8.5 t -90.04 141.43 27.94 Favored Pre-proline 0 CA--C 1.54 0.592 0 CA-C-N 119.77 1.168 . . . . 0.0 111.146 -170.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -69.62 -39.02 7.29 Favored 'Trans proline' 0 C--N 1.348 0.523 0 CA-C-N 120.584 1.244 . . . . 0.0 112.825 179.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -61.43 -31.83 71.78 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 126.485 1.914 . . . . 0.0 114.4 178.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.435 ' SG ' ' HB3' ' A' ' 19' ' ' SER . 0.1 OUTLIER -60.16 -63.48 1.28 Allowed 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 126.253 1.821 . . . . 0.0 108.856 174.037 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 63.4 t -59.09 -38.99 77.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 124.032 0.933 . . . . 0.0 110.998 -178.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 18.6 ttt180 -56.37 -31.66 64.02 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.259 1.824 . . . . 0.0 114.801 171.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -87.12 -50.97 6.26 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 119.511 1.051 . . . . 0.0 112.65 169.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -49.15 -36.78 20.17 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.232 1.413 . . . . 0.0 112.981 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -67.22 -45.86 75.53 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 123.632 0.773 . . . . 0.0 112.914 178.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.9 tt -76.73 -35.31 57.87 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.17 1.388 . . . . 0.0 111.364 -176.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 96.2 mt -62.6 -48.06 81.08 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.389 0.676 . . . . 0.0 111.37 174.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 16.7 m-70 -65.15 -23.29 67.08 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 173.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.42 -28.75 56.75 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 119.683 1.129 . . . . 0.0 112.758 172.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.83 -18.81 19.31 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 -177.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.8 t -162.25 173.72 13.83 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 -178.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -114.6 -30.03 6.63 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.889 1.276 . . . . 0.0 113.565 175.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -84.05 43.59 0.94 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.541 1.137 . . . . 0.0 113.337 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -101.85 118.29 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 126.361 1.864 . . . . 0.0 110.909 173.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 22.0 m -106.23 141.39 37.65 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.582 1.553 . . . . 0.0 110.005 172.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.4 p -131.19 146.46 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 124.574 1.15 . . . . 0.0 112.525 173.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -114.29 119.13 35.95 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.477 1.911 . . . . 0.0 108.98 173.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -87.44 90.96 8.56 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 122.157 0.98 . . . . 0.0 109.96 179.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.9 m -73.33 0.68 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -171.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.496 ' HB3' ' CD1' ' A' ' 20' ' ' TRP . 2.8 p-10 -88.74 -12.76 41.28 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.443 1.097 . . . . 0.0 113.138 167.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 38.0 mtmt -99.11 -26.22 14.28 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 126.118 1.767 . . . . 0.0 113.794 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 10.1 ttt -98.38 137.87 36.45 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.488 1.115 . . . . 0.0 112.202 178.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 66.1 m -64.42 -26.87 68.64 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 177.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -79.41 -0.29 32.3 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 121.029 -1.045 . . . . 0.0 113.376 175.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -52.2 -31.4 34.05 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 125.268 1.413 . . . . 0.0 115.329 -174.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -83.92 -16.29 44.83 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 118.263 1.031 . . . . 0.0 112.996 -178.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 7.8 mp0 -81.16 -39.28 25.78 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 121.04 -1.037 . . . . 0.0 110.238 167.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.78 -46.12 90.91 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.042 0.537 . . . . 0.0 110.526 171.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 67.2 mtp180 -59.76 -33.14 71.3 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.283 1.033 . . . . 0.0 112.96 170.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.78 -46.66 91.3 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.121 0.867 . . . . 0.0 112.407 174.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -59.46 -42.95 93.19 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 117.997 0.898 . . . . 0.0 112.591 175.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 73.2 mt -66.41 -42.37 90.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 123.483 0.713 . . . . 0.0 110.505 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -71.58 -41.43 69.02 Favored 'General case' 0 CA--C 1.535 0.404 0 O-C-N 121.463 -0.773 . . . . 0.0 112.862 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -63.37 -36.99 85.54 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.733 1.151 . . . . 0.0 112.448 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -82.99 -47.22 11.97 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 178.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -120.16 -4.15 10.03 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -164.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.7 mptt 49.89 53.53 12.63 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.886 1.674 . . . . 0.0 112.185 -177.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 23.2 t-80 -131.44 136.53 48.05 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.951 1.7 . . . . 0.0 109.863 173.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -141.81 -34.46 0.47 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.989 0.915 . . . . 0.0 112.667 -166.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.3 p -63.57 165.53 7.94 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.085 1.354 . . . . 0.0 111.588 156.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 23.1 m -122.33 159.44 52.34 Favored Pre-proline 0 N--CA 1.48 1.043 0 C-N-CA 124.803 1.241 . . . . 0.0 112.402 -174.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -81.85 152.58 77.53 Favored 'Cis proline' 0 C--N 1.349 0.592 0 CA-C-N 119.389 0.817 . . . . 0.0 113.803 -4.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -106.32 136.44 46.05 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.393 1.477 . . . . 0.0 108.979 163.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 73.2 mt -131.16 142.83 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 123.866 0.866 . . . . 0.0 110.164 -163.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -136.98 140.85 42.47 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.349 1.06 . . . . 0.0 110.912 176.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 83.9 mt -128.11 122.11 57.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 125.829 1.652 . . . . 0.0 109.42 179.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 44.7 42.32 5.75 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 125.432 1.493 . . . . 0.0 114.203 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 86.27 -4.63 85.84 Favored Glycine 0 CA--C 1.541 1.713 0 C-N-CA 125.077 1.323 . . . . 0.0 116.219 -177.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -102.49 135.19 44.56 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.654 1.727 . . . . 0.0 111.479 -176.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -73.9 144.26 45.43 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.8 0.84 . . . . 0.0 112.378 178.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 32.2 mm -122.22 127.42 75.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 127.384 2.274 . . . . 0.0 107.995 177.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.81 -5.89 27.46 Favored Glycine 0 CA--C 1.536 1.37 0 N-CA-C 118.212 2.045 . . . . 0.0 118.212 -163.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 144.79 -171.85 25.88 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 126.478 1.99 . . . . 0.0 112.752 176.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 11.4 t -61.41 -32.73 72.69 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 122.067 -0.666 . . . . 0.0 112.441 173.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 35.6 t -67.17 -41.11 86.52 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.317 -0.865 . . . . 0.0 111.735 178.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -66.55 -37.15 84.37 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.273 1.029 . . . . 0.0 113.167 171.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 13.8 tp -63.7 -50.73 68.04 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.278 1.431 . . . . 0.0 110.908 177.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -64.46 -37.76 88.66 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 122.963 0.505 . . . . 0.0 110.836 176.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.55 -34.37 76.79 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 121.066 -1.021 . . . . 0.0 112.77 175.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 64.0 mt -70.99 -24.33 62.37 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.028 0.931 . . . . 0.0 113.186 172.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -77.09 -35.02 56.79 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 119.012 0.824 . . . . 0.0 111.946 172.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -69.35 -29.28 67.04 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.942 0.897 . . . . 0.0 112.906 169.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -81.76 -3.13 53.03 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 169.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.8 14.85 63.66 Favored Glycine 0 CA--C 1.541 1.675 0 CA-C-N 120.11 1.323 . . . . 0.0 114.72 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 34.3 mtpt -100.51 -29.31 12.43 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 126.472 1.909 . . . . 0.0 112.189 -171.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 46.3 tp -58.68 -39.6 81.18 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 118.718 0.69 . . . . 0.0 111.937 177.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -55.97 -48.46 75.77 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.499 0.72 . . . . 0.0 112.579 174.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -76.86 -37.97 32.28 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 123.884 0.754 . . . . 0.0 113.957 -177.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 69.3 mt -58.52 -26.41 63.47 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.767 1.227 . . . . 0.0 112.056 169.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 81.8 mt -103.95 16.77 25.54 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.324 1.45 . . . . 0.0 114.135 176.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 62.4 m . . . . . 0 C--O 1.252 1.229 0 C-N-CA 124.63 1.172 . . . . 0.0 111.989 172.899 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.14 0 N-CA-C 111.355 -0.698 . . . . 0.0 111.355 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 49.55 40.73 20.0 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 125.821 1.648 . . . . 0.0 114.836 -177.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 48.0 mtt -130.41 85.34 56.78 Favored Pre-proline 0 N--CA 1.474 0.74 0 C-N-CA 125.236 1.414 . . . . 0.0 111.529 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -81.7 59.1 7.07 Favored 'Trans proline' 0 CA--C 1.545 1.04 0 C-N-CA 123.066 2.511 . . . . 0.0 111.904 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 75.3 m -150.75 -159.65 1.06 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 126.765 2.026 . . . . 0.0 110.6 171.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.8 pt -55.76 -26.2 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 125.585 1.554 . . . . 0.0 115.13 -162.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -54.03 -32.15 53.52 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.591 1.557 . . . . 0.0 113.241 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 47.6 t -71.7 -34.15 69.38 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.096 1.358 . . . . 0.0 112.452 174.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 52.0 mtt -68.68 -34.32 75.48 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.346 1.058 . . . . 0.0 112.255 178.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.6 mm -59.48 -27.67 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 124.267 1.027 . . . . 0.0 111.679 -176.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 26.9 mttm -82.58 -8.08 59.62 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.034 1.734 . . . . 0.0 114.58 178.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -80.89 -17.78 71.68 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 124.005 0.812 . . . . 0.0 114.862 -175.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.646 ' ND2' ' HG1' ' A' ' 41' ' ' THR . 60.7 m-80 -149.53 164.92 33.74 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 127.087 2.155 . . . . 0.0 110.392 -177.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 30.7 ttpt -65.95 -47.42 74.71 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.235 0.614 . . . . 0.0 112.338 173.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.5 t -115.63 129.8 71.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.366 1.067 . . . . 0.0 110.621 176.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 60.3 t -133.51 131.6 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 124.806 1.243 . . . . 0.0 109.568 178.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 60.5 t -134.17 154.32 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 123.82 0.848 . . . . 0.0 111.736 -170.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -129.45 121.54 27.5 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.975 1.31 . . . . 0.0 110.488 175.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 67.2 m -140.93 172.27 12.92 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.354 1.062 . . . . 0.0 113.764 -162.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.415 ' CD1' ' HB3' ' A' ' 46' ' ' ASP . 45.7 m0 -120.73 128.91 53.36 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.944 1.298 . . . . 0.0 110.534 168.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 71.2 t -62.66 -23.32 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 CA-C-N 119.245 0.93 . . . . 0.0 111.854 175.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 51.3 p -72.62 -13.03 61.28 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 116.067 1.877 . . . . 0.0 116.067 -175.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 57.6 m -124.39 149.81 62.43 Favored Pre-proline 0 CA--C 1.551 1.015 0 N-CA-C 116.164 1.913 . . . . 0.0 116.164 -162.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -74.52 -36.72 2.79 Favored 'Trans proline' 0 C--N 1.356 0.947 0 C-N-CA 122.3 2.0 . . . . 0.0 114.317 -166.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -52.06 -41.09 62.07 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.274 1.43 . . . . 0.0 112.141 173.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.475 ' HG ' ' HD3' ' A' ' 68' ' ' PRO . 5.2 m -86.34 -13.4 46.62 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 113.056 -1.884 . . . . 0.0 111.587 -166.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 95.9 t -77.36 -54.41 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 124.487 1.115 . . . . 0.0 110.839 155.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -72.91 -26.89 61.57 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 115.643 1.72 . . . . 0.0 115.643 -166.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -77.6 -50.22 12.98 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 119.175 0.898 . . . . 0.0 109.656 173.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.19 -36.17 79.16 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.177 0.991 . . . . 0.0 111.987 -176.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -60.97 -47.06 88.2 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.484 0.714 . . . . 0.0 112.521 172.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.2 tt -69.0 -38.24 79.17 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.672 1.589 . . . . 0.0 111.695 -179.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 81.7 mt -62.48 -48.14 80.88 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.496 0.719 . . . . 0.0 110.772 173.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 11.6 m-70 -63.61 -30.91 71.96 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 172.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -67.32 -26.98 66.77 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 120.783 -1.198 . . . . 0.0 112.022 174.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -94.09 -35.87 12.35 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.009 1.724 . . . . 0.0 114.701 -173.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 14.0 t -153.16 158.08 41.27 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.19 0.996 . . . . 0.0 113.648 -172.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 36.4 mtmt -91.67 -10.78 39.03 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.206 1.402 . . . . 0.0 112.55 163.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -84.76 40.07 0.78 Allowed 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 124.335 1.054 . . . . 0.0 113.591 -173.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.63 131.88 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 125.437 1.495 . . . . 0.0 113.768 -170.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.646 ' HG1' ' ND2' ' A' ' 13' ' ' ASN . 21.7 m -123.82 139.77 53.64 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 126.996 2.118 . . . . 0.0 110.048 175.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.3 p -139.72 125.35 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 124.724 1.21 . . . . 0.0 112.749 178.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 8.3 t60 -94.25 126.25 39.39 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.587 0.755 . . . . 0.0 110.895 174.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -89.75 97.25 11.08 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 123.387 0.675 . . . . 0.0 109.307 178.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 19.9 m -75.45 -12.32 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-O 119.021 -0.514 . . . . 0.0 112.386 -174.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.415 ' HB3' ' CD1' ' A' ' 20' ' ' TRP . 0.4 OUTLIER -69.33 -15.26 63.29 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.785 1.234 . . . . 0.0 113.248 174.765 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -82.99 -19.1 37.67 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 127.289 2.236 . . . . 0.0 112.448 176.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 58.8 mmm 59.3 18.53 6.75 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 127.592 2.357 . . . . 0.0 116.932 160.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.1 t -61.74 -40.21 94.27 Favored 'General case' 0 N--CA 1.48 1.034 0 O-C-N 119.915 -1.74 . . . . 0.0 111.251 170.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -138.86 0.34 1.97 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.489 1.516 . . . . 0.0 112.414 167.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -48.45 -33.3 11.49 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.786 1.66 . . . . 0.0 116.526 -174.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -69.69 -37.5 76.63 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 119.996 1.898 . . . . 0.0 110.647 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -76.74 -30.02 56.41 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 121.777 -0.577 . . . . 0.0 111.576 179.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -70.78 -45.57 64.48 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.272 0.629 . . . . 0.0 110.787 172.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -57.65 -38.73 75.56 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.203 1.801 . . . . 0.0 111.503 171.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.37 -41.5 94.46 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 124.303 0.954 . . . . 0.0 113.438 175.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -58.04 -43.64 86.95 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 119.214 1.507 . . . . 0.0 112.408 173.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 77.1 mt -64.35 -45.93 94.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.15 0.98 . . . . 0.0 110.328 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -66.75 -41.08 88.38 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.636 -0.665 . . . . 0.0 112.004 176.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -66.75 -25.23 66.39 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 120.774 -1.204 . . . . 0.0 113.337 177.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -92.61 -39.42 11.33 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 119.534 1.061 . . . . 0.0 113.516 178.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -128.39 0.81 5.67 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.669 1.188 . . . . 0.0 114.161 -167.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 48.79 43.3 21.07 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 126.782 2.033 . . . . 0.0 113.258 -176.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 63.7 t-80 -131.82 141.6 49.49 Favored 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 125.701 1.6 . . . . 0.0 111.446 -176.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -142.5 -13.92 0.77 Allowed 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 -164.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 51.3 m -70.99 150.07 46.02 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.097 1.359 . . . . 0.0 111.069 167.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 10.5 m -122.46 152.99 62.2 Favored Pre-proline 0 N--CA 1.477 0.894 0 C-N-CA 126.0 1.72 . . . . 0.0 112.599 -175.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.475 ' HD3' ' HG ' ' A' ' 26' ' ' CYS . 95.4 Cg_endo -73.03 154.45 99.56 Favored 'Cis proline' 0 C--N 1.35 0.652 0 CA-C-N 119.126 0.724 . . . . 0.0 113.815 -2.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -107.27 129.42 54.89 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.019 1.328 . . . . 0.0 108.613 167.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 98.5 mt -124.27 142.86 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 123.646 0.779 . . . . 0.0 109.981 -162.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -136.27 139.16 42.47 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.803 0.841 . . . . 0.0 111.795 179.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 62.4 mt -131.71 116.25 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 124.85 1.26 . . . . 0.0 109.75 179.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 45.43 39.04 4.18 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 126.015 1.726 . . . . 0.0 113.847 -173.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 79.95 12.31 83.55 Favored Glycine 0 CA--C 1.539 1.559 0 N-CA-C 116.403 1.321 . . . . 0.0 116.403 -176.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -103.36 137.92 40.82 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 119.549 1.674 . . . . 0.0 110.691 172.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -85.93 131.0 34.38 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 -176.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 15.3 mm -116.27 125.29 73.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 128.506 2.722 . . . . 0.0 108.561 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -69.23 -15.74 70.32 Favored Glycine 0 CA--C 1.537 1.421 0 N-CA-C 117.407 1.723 . . . . 0.0 117.407 -165.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 149.54 -165.29 29.54 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-N 118.847 1.323 . . . . 0.0 115.36 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 32.2 t -65.17 -37.56 87.77 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.355 1.062 . . . . 0.0 112.563 -175.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 72.6 p -74.39 -15.62 60.92 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 178.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -87.34 -43.17 12.34 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.667 1.187 . . . . 0.0 110.598 166.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 51.7 tp -59.41 -47.9 83.68 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.571 1.149 . . . . 0.0 111.872 177.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -74.75 -11.78 60.24 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.804 0.842 . . . . 0.0 112.968 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -78.79 -46.84 17.91 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.117 0.967 . . . . 0.0 111.516 163.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 88.5 mt -61.17 -28.98 69.52 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.286 1.035 . . . . 0.0 112.85 175.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -64.48 -52.89 55.61 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.405 1.082 . . . . 0.0 112.093 169.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 6.9 mptt -71.14 -30.77 66.89 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.725 1.21 . . . . 0.0 112.546 -173.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -82.56 -1.94 52.18 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.29 1.036 . . . . 0.0 113.452 169.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 73.84 8.11 76.84 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 124.727 1.156 . . . . 0.0 115.759 174.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 47.5 mtmt -82.18 -29.6 31.4 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 127.639 2.376 . . . . 0.0 112.453 -172.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 36.8 tp -52.39 -36.23 53.58 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.603 1.161 . . . . 0.0 112.169 175.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -73.88 -36.17 64.77 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -67.94 -29.5 73.62 Favored Glycine 0 CA--C 1.536 1.379 0 O-C-N 120.818 -1.176 . . . . 0.0 113.325 170.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 89.3 mt -74.96 -23.63 58.32 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.621 1.168 . . . . 0.0 112.582 173.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 81.0 mt -95.58 -2.2 48.84 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.853 1.661 . . . . 0.0 114.869 174.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 39.7 m . . . . . 0 C--O 1.252 1.206 0 C-N-CA 126.028 1.731 . . . . 0.0 114.289 -175.603 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.103 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.76 27.73 0.62 Allowed 'General case' 0 CA--C 1.552 1.029 0 N-CA-C 114.84 1.422 . . . . 0.0 114.84 -176.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 43.9 ttp -121.49 86.06 43.84 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 125.538 1.535 . . . . 0.0 108.821 174.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -81.18 -171.58 1.27 Allowed 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 123.91 3.074 . . . . 0.0 114.516 -161.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 61.4 m -80.61 -151.81 0.08 Allowed 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 126.541 1.937 . . . . 0.0 111.178 167.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.6 pt -56.17 -19.71 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 N-CA-C 116.083 1.883 . . . . 0.0 116.083 -161.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -49.7 -30.19 8.81 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.584 1.554 . . . . 0.0 113.005 175.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 45.4 p -70.04 -38.05 75.74 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.087 0.955 . . . . 0.0 112.998 173.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 54.5 mtt -66.56 -32.41 73.74 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.599 1.56 . . . . 0.0 111.493 -174.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.6 mm -57.62 -33.81 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 123.919 0.888 . . . . 0.0 111.249 176.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 46.9 mttm -81.3 -9.22 59.8 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.054 1.342 . . . . 0.0 113.215 -173.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -75.69 -27.04 63.76 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 124.264 0.935 . . . . 0.0 115.201 -173.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -145.7 165.83 27.61 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.714 1.605 . . . . 0.0 112.606 179.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -63.09 -38.18 90.16 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.946 0.898 . . . . 0.0 113.128 178.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.5 t -125.26 129.58 73.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.864 1.266 . . . . 0.0 111.007 175.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 58.5 t -133.26 129.79 57.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.552 1.141 . . . . 0.0 110.559 -179.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 42.4 t -128.69 147.65 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.202 1.001 . . . . 0.0 112.337 -177.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -118.15 123.86 46.57 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.572 1.149 . . . . 0.0 109.802 170.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.8 m -140.63 177.71 7.84 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 126.328 1.851 . . . . 0.0 112.458 -165.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 37.7 m0 -123.54 136.87 54.78 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.645 1.978 . . . . 0.0 107.016 159.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 82.3 t -54.22 -31.69 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 C-N-CA 125.763 1.625 . . . . 0.0 113.64 -165.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.7 t -105.62 -5.12 20.35 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 114.865 1.432 . . . . 0.0 114.865 -165.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 71.8 m -90.24 141.93 28.07 Favored Pre-proline 0 C--O 1.234 0.249 0 O-C-N 121.651 -0.655 . . . . 0.0 111.268 -165.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -70.82 -36.82 7.4 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 CA-C-N 119.114 0.719 . . . . 0.0 112.769 -160.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -59.91 -38.26 81.8 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 127.783 2.433 . . . . 0.0 114.207 174.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 1.6 t -59.12 -49.55 77.46 Favored 'General case' 0 C--O 1.222 -0.352 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 173.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 52.8 t -63.47 -40.42 88.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 123.948 0.899 . . . . 0.0 111.451 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -56.12 -46.11 79.27 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 118.789 0.722 . . . . 0.0 111.916 175.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.98 -55.47 9.53 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.658 0.783 . . . . 0.0 111.692 177.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -42.28 -48.56 4.99 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 126.739 2.016 . . . . 0.0 111.755 178.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.485 ' HA ' ' CD2' ' A' ' 34' ' ' HIS . 16.9 ttpp -76.07 -27.31 57.17 Favored 'General case' 0 C--O 1.225 -0.23 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 -171.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.1 tt -79.24 -38.18 36.23 Favored 'General case' 0 C--N 1.317 -0.825 0 O-C-N 121.257 -0.902 . . . . 0.0 111.133 173.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 17.8 mt -67.45 -59.71 3.16 Favored 'General case' 0 CA--C 1.514 -0.415 0 C-N-CA 125.867 1.667 . . . . 0.0 112.956 -176.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.485 ' CD2' ' HA ' ' A' ' 31' ' ' LYS . 0.1 OUTLIER -52.61 -28.93 23.36 Favored 'General case' 0 C--O 1.233 0.188 0 O-C-N 124.173 0.921 . . . . 0.0 110.217 176.244 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.0 -14.27 47.96 Favored 'General case' 0 N--CA 1.441 -0.876 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.814 -172.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -105.19 -40.47 5.85 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 126.533 1.933 . . . . 0.0 112.612 179.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 23.0 m -142.63 128.13 19.02 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.743 1.617 . . . . 0.0 110.807 -175.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 45.2 mtmt -76.5 -23.95 53.74 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.47 1.508 . . . . 0.0 112.768 177.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -79.2 54.26 1.62 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.417 1.087 . . . . 0.0 113.908 175.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.67 139.03 24.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 125.821 1.649 . . . . 0.0 110.872 173.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.4 m -127.24 132.72 50.33 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 126.783 2.033 . . . . 0.0 109.306 167.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.7 p -128.02 139.96 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-O 122.238 1.018 . . . . 0.0 113.029 171.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -109.12 119.64 40.12 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.385 1.874 . . . . 0.0 109.405 176.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -91.44 92.05 8.38 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.427 0.691 . . . . 0.0 110.079 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.6 m -77.02 14.65 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 N-CA-C 115.874 1.805 . . . . 0.0 115.874 -162.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -100.69 -20.74 15.48 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 120.693 -1.254 . . . . 0.0 112.252 160.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 23.4 mmmt -71.46 -36.77 71.31 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.146 0.978 . . . . 0.0 111.34 175.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -96.13 142.23 28.56 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.098 0.959 . . . . 0.0 112.885 -167.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 16.4 m -69.3 -7.96 41.85 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 115.598 1.703 . . . . 0.0 115.598 -172.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -113.46 8.86 17.98 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.978 1.711 . . . . 0.0 113.062 175.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -54.59 -32.51 53.62 Favored Glycine 0 CA--C 1.531 1.063 0 N-CA-C 116.211 1.244 . . . . 0.0 116.211 -173.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -72.92 -29.4 63.1 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 119.169 1.485 . . . . 0.0 112.581 176.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -79.62 -31.26 41.61 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 121.586 -0.696 . . . . 0.0 111.852 174.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.04 -41.91 81.35 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 121.657 -0.652 . . . . 0.0 110.491 170.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 59.6 mtp85 -53.89 -45.75 71.16 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 119.344 0.974 . . . . 0.0 111.56 166.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.17 -38.47 93.18 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 124.15 0.881 . . . . 0.0 114.472 178.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -68.49 -25.14 64.81 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 119.088 1.444 . . . . 0.0 113.709 176.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 57.7 mt -76.88 -45.19 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 123.505 0.722 . . . . 0.0 109.263 173.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -67.42 -36.93 82.22 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 121.525 -0.734 . . . . 0.0 112.66 -178.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -57.57 -51.61 68.8 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 121.403 -0.811 . . . . 0.0 112.12 176.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -81.1 -33.08 33.56 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 114.452 1.278 . . . . 0.0 114.452 -175.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -123.52 -7.53 8.05 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 -166.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.5 mmtm 50.13 47.28 23.77 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 126.824 2.05 . . . . 0.0 112.745 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 17.7 t60 -138.18 136.18 36.37 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 127.082 2.153 . . . . 0.0 109.028 -177.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -123.54 -22.66 4.95 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 -177.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.2 p -68.19 135.17 51.64 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.644 0.778 . . . . 0.0 112.507 -178.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.8 m -88.91 149.06 42.73 Favored Pre-proline 0 N--CA 1.478 0.952 0 N-CA-C 112.519 0.562 . . . . 0.0 112.519 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -83.82 160.73 71.09 Favored 'Cis proline' 0 CA--C 1.537 0.645 0 CA-C-N 119.654 0.912 . . . . 0.0 114.181 -2.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -104.2 142.23 34.88 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.49 1.116 . . . . 0.0 109.479 159.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 56.6 mt -131.76 139.92 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.084 0.954 . . . . 0.0 110.301 -166.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -140.44 145.65 37.26 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.141 0.976 . . . . 0.0 111.964 178.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 70.1 mt -136.73 124.35 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 125.111 1.364 . . . . 0.0 109.307 177.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 47.56 37.93 7.28 Favored 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 124.649 1.18 . . . . 0.0 113.967 -177.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 73.05 11.88 79.14 Favored Glycine 0 CA--C 1.541 1.659 0 O-C-N 120.013 -1.68 . . . . 0.0 115.864 -176.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 24.8 m-80 -97.61 143.82 27.9 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.008 1.723 . . . . 0.0 110.032 169.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -89.2 141.51 28.46 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.94 0.896 . . . . 0.0 112.982 176.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 22.4 mm -126.32 122.97 62.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 127.731 2.412 . . . . 0.0 108.331 -179.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.95 -2.72 6.89 Favored Glycine 0 CA--C 1.538 1.501 0 N-CA-C 118.981 2.352 . . . . 0.0 118.981 -166.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 137.45 -166.9 24.92 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 126.934 2.207 . . . . 0.0 112.988 176.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 16.6 t -66.63 -33.48 75.74 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 121.65 -0.912 . . . . 0.0 113.008 -175.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 68.1 m -76.76 -28.7 55.82 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 121.277 -0.89 . . . . 0.0 111.993 178.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.11 -35.71 71.89 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.089 0.859 . . . . 0.0 112.782 167.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 51.6 tp -61.84 -48.64 79.67 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.797 0.839 . . . . 0.0 111.106 170.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -69.83 -13.62 62.36 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.161 0.984 . . . . 0.0 113.305 175.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -82.65 -43.5 16.86 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 121.04 -1.038 . . . . 0.0 111.331 168.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 76.6 mt -66.5 -28.53 68.64 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 120.93 -1.106 . . . . 0.0 113.0 177.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -61.08 -39.51 90.18 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.678 1.591 . . . . 0.0 112.23 168.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 5.0 mptt -84.3 -34.33 23.76 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.403 1.481 . . . . 0.0 112.364 -178.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -75.07 -0.9 20.56 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.732 1.213 . . . . 0.0 113.606 174.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 75.76 22.23 75.18 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 124.457 1.027 . . . . 0.0 114.51 170.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 35.5 mtmt -113.96 -20.2 11.13 Favored 'General case' 0 C--N 1.341 0.231 0 C-N-CA 126.551 1.94 . . . . 0.0 113.263 -170.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 43.0 tp -60.9 -40.37 92.84 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 118.738 0.699 . . . . 0.0 111.449 178.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -65.2 -42.28 93.71 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 177.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -70.7 -26.75 73.53 Favored Glycine 0 CA--C 1.537 1.439 0 C-N-CA 124.323 0.963 . . . . 0.0 114.511 175.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 30.0 mt -71.03 -31.95 68.57 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 118.276 1.038 . . . . 0.0 112.187 172.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 85.1 mt -97.85 -27.11 14.44 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 114.487 1.291 . . . . 0.0 114.487 -174.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 56.9 m . . . . . 0 C--O 1.254 1.29 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 -170.964 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.226 0 N-CA-C 113.35 0.1 . . . . 0.0 113.35 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -67.92 151.84 46.49 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.092 1.757 . . . . 0.0 113.633 -178.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 4.6 mpp? 52.16 57.77 15.58 Favored Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 125.652 1.581 . . . . 0.0 112.56 -176.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -72.69 168.19 25.16 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 124.669 3.579 . . . . 0.0 115.435 -165.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 60.0 p -145.84 -154.66 0.56 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.608 1.963 . . . . 0.0 111.448 174.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.7 pt -56.35 -19.7 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 124.591 1.156 . . . . 0.0 113.264 170.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -58.88 -29.87 67.33 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.686 0.794 . . . . 0.0 112.816 -174.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 67.7 m -68.18 -24.45 64.97 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 173.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 54.4 mtt -72.5 -33.89 67.25 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 121.46 -0.775 . . . . 0.0 111.429 -178.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.8 mm -60.29 -30.78 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 123.681 0.792 . . . . 0.0 111.67 -175.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -80.36 -8.75 59.64 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.162 1.385 . . . . 0.0 114.148 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -80.03 -35.55 27.2 Favored Glycine 0 CA--C 1.535 1.292 0 N-CA-C 115.158 0.823 . . . . 0.0 115.158 -173.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 55.5 m-80 -145.08 164.13 32.17 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 118.626 1.213 . . . . 0.0 112.186 -172.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 21.7 ttpt -63.89 -42.25 97.52 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.285 1.034 . . . . 0.0 113.111 -178.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.9 t -119.84 130.62 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.251 1.021 . . . . 0.0 110.65 172.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 57.0 t -132.88 126.93 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.849 1.26 . . . . 0.0 109.744 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 40.4 t -127.1 149.29 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.129 0.972 . . . . 0.0 112.253 -173.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -123.15 114.4 20.25 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.355 1.462 . . . . 0.0 110.111 175.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.432 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 35.2 m -134.28 173.32 11.74 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.556 1.542 . . . . 0.0 112.754 -167.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 47.6 m0 -121.9 143.1 49.64 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.69 1.196 . . . . 0.0 110.237 166.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 76.7 t -65.18 -25.58 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 CA-C-O 120.771 0.32 . . . . 0.0 111.25 177.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.5 p -75.98 -18.49 59.29 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 126.196 1.798 . . . . 0.0 115.599 177.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.8 t -94.89 140.02 22.36 Favored Pre-proline 0 CA--C 1.538 0.501 0 CA-C-N 120.241 1.382 . . . . 0.0 112.571 -163.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -73.91 -37.17 3.0 Favored 'Trans proline' 0 CA--C 1.534 0.496 0 CA-C-N 120.704 1.287 . . . . 0.0 112.008 174.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -55.84 -37.66 69.02 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.164 1.386 . . . . 0.0 113.528 176.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.432 ' SG ' ' HB3' ' A' ' 19' ' ' SER . 0.5 OUTLIER -55.1 -51.89 64.98 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.192 0.997 . . . . 0.0 109.636 172.759 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.1 t -66.27 -37.53 79.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 123.943 0.897 . . . . 0.0 111.614 -177.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.1 mmt180 -54.06 -42.62 69.46 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 118.787 0.721 . . . . 0.0 112.115 173.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.93 -55.17 7.96 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.007 0.923 . . . . 0.0 112.463 173.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -54.18 -35.05 61.91 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 119.506 1.048 . . . . 0.0 113.398 -177.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.95 -38.25 69.83 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.273 1.029 . . . . 0.0 112.598 -178.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.4 tt -74.49 -46.18 41.11 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 126.499 1.92 . . . . 0.0 110.892 178.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 68.0 mt -64.69 -38.21 90.22 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.556 0.742 . . . . 0.0 112.765 -176.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 45.7 m-70 -74.74 -22.07 59.01 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 170.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -73.39 -36.38 66.04 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 119.894 1.225 . . . . 0.0 112.062 172.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 13.5 mmp_? -73.52 -52.64 12.85 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.378 1.471 . . . . 0.0 113.247 175.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.2 p -140.68 166.24 25.29 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 116.167 1.914 . . . . 0.0 116.167 -157.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 71.5 mttt -109.51 -27.74 9.27 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 127.976 2.511 . . . . 0.0 113.108 173.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -84.5 43.55 0.97 Allowed 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 125.205 1.402 . . . . 0.0 112.274 -178.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -113.43 129.13 69.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 126.558 1.943 . . . . 0.0 111.982 178.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.9 m -122.3 141.83 51.11 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 126.644 1.978 . . . . 0.0 111.169 174.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.4 p -135.72 136.27 50.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 124.441 1.096 . . . . 0.0 113.232 178.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 38.6 t60 -105.48 122.4 45.92 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.957 2.103 . . . . 0.0 109.752 175.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -92.22 89.12 6.74 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 123.689 0.796 . . . . 0.0 108.986 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 35.7 m -65.2 -18.69 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -175.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -55.88 -43.13 76.88 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.409 1.484 . . . . 0.0 111.572 164.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 34.1 mtmt -86.68 7.87 24.79 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 127.188 2.195 . . . . 0.0 113.756 179.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -114.68 129.9 56.74 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.192 1.397 . . . . 0.0 110.229 178.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 11.8 p -64.52 -20.24 66.09 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 115.753 1.76 . . . . 0.0 115.753 -170.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -113.95 8.4 17.17 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.502 1.921 . . . . 0.0 112.389 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -51.95 -25.19 16.04 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 125.807 1.67 . . . . 0.0 116.896 -168.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -69.05 -27.94 66.1 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 118.947 1.373 . . . . 0.0 112.853 174.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -80.48 -25.56 38.74 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 120.573 -1.33 . . . . 0.0 112.083 172.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -79.72 -32.65 41.21 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.722 0.809 . . . . 0.0 111.883 174.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 55.4 mtp180 -52.79 -43.32 65.8 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 119.119 0.872 . . . . 0.0 110.769 158.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.56 -35.78 89.96 Favored Glycine 0 CA--C 1.539 1.557 0 CA-C-O 118.972 -0.904 . . . . 0.0 115.21 173.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -63.47 -31.84 73.11 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 119.828 1.814 . . . . 0.0 112.914 176.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 65.2 mt -79.57 -45.73 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 C-N-CA 125.806 1.642 . . . . 0.0 109.608 175.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -64.77 -41.21 96.05 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.458 -0.776 . . . . 0.0 112.483 -178.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 76.6 mm-40 -72.14 -16.11 61.99 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 120.898 -1.126 . . . . 0.0 113.617 177.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -89.88 -41.49 11.77 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 169.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -135.0 0.43 2.88 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 115.329 1.603 . . . . 0.0 115.329 -163.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp 55.55 26.0 8.57 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 126.402 1.881 . . . . 0.0 115.513 177.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 37.2 t60 -114.96 140.03 49.35 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.391 1.077 . . . . 0.0 111.196 167.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -125.79 -27.42 3.35 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.167 0.987 . . . . 0.0 112.644 -163.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.2 p -85.96 144.09 27.81 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.474 1.11 . . . . 0.0 113.907 -178.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.3 m -89.35 153.76 48.62 Favored Pre-proline 0 N--CA 1.481 1.087 0 C-N-CA 125.017 1.327 . . . . 0.0 113.292 -173.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -79.49 158.08 89.75 Favored 'Cis proline' 0 C--N 1.349 0.577 0 CA-C-N 119.441 0.836 . . . . 0.0 113.4 -3.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -109.55 136.84 48.29 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.089 1.356 . . . . 0.0 108.709 162.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.9 mt -126.21 144.27 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 124.243 1.017 . . . . 0.0 109.444 -169.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -137.53 143.94 41.88 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.23 1.012 . . . . 0.0 110.967 177.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 48.9 mt -135.3 118.47 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.879 1.272 . . . . 0.0 109.059 179.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 47.44 43.78 15.95 Favored 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 125.023 1.329 . . . . 0.0 113.831 -175.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.18 1.17 59.46 Favored Glycine 0 CA--C 1.544 1.893 0 O-C-N 120.709 -1.245 . . . . 0.0 116.015 -176.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -92.26 134.84 34.51 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.223 1.409 . . . . 0.0 109.759 175.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -84.33 137.7 33.29 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.897 0.879 . . . . 0.0 112.831 -178.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 36.0 mm -118.1 122.84 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 127.662 2.385 . . . . 0.0 108.538 177.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.37 -6.19 39.52 Favored Glycine 0 CA--C 1.536 1.371 0 N-CA-C 118.252 2.061 . . . . 0.0 118.252 -162.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 152.91 -174.53 31.68 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 125.851 1.691 . . . . 0.0 112.99 176.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 12.8 t -65.32 -31.53 72.72 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.975 -0.721 . . . . 0.0 112.373 177.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 12.5 m -69.01 -32.63 72.32 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.732 -0.605 . . . . 0.0 111.829 -177.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -76.41 -40.65 50.26 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.122 1.369 . . . . 0.0 112.458 170.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 56.9 tp -59.48 -45.27 92.13 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.334 1.054 . . . . 0.0 111.488 175.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -64.92 -37.66 88.39 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.822 0.849 . . . . 0.0 111.35 173.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.45 -23.58 66.31 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 120.914 -1.116 . . . . 0.0 113.223 177.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 40.3 mt -84.69 -32.33 23.64 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.038 1.735 . . . . 0.0 112.709 170.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -67.46 -46.92 71.61 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.154 0.982 . . . . 0.0 112.38 175.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.2 mptt -62.25 -42.24 99.16 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.796 1.238 . . . . 0.0 111.772 178.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -76.16 -6.75 52.68 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 176.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 72.21 22.88 78.69 Favored Glycine 0 CA--C 1.535 1.293 0 CA-C-N 119.375 0.989 . . . . 0.0 114.88 174.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 40.7 mtmt -102.37 -14.21 17.0 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 127.995 2.518 . . . . 0.0 112.381 -172.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 30.5 tp -64.75 -31.75 73.12 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.047 1.739 . . . . 0.0 112.067 175.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -57.0 -46.28 82.41 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.703 -0.623 . . . . 0.0 112.281 174.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -66.39 -27.61 73.19 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 123.918 0.77 . . . . 0.0 113.677 176.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 83.3 mt -76.74 -26.11 54.24 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.475 1.11 . . . . 0.0 113.416 174.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 84.9 mt -102.93 -9.65 19.67 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 115.602 1.704 . . . . 0.0 115.602 -172.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 16.1 m . . . . . 0 N--CA 1.486 1.365 0 C-N-CA 127.25 2.22 . . . . 0.0 115.642 167.81 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.119 0 N-CA-C 111.526 -0.629 . . . . 0.0 111.526 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 51.3 -153.78 0.17 Allowed 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 126.752 2.021 . . . . 0.0 114.739 176.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -122.9 145.87 46.83 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 125.037 1.335 . . . . 0.0 110.485 173.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -80.17 71.99 6.76 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 124.032 3.154 . . . . 0.0 110.33 175.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 54.5 p -158.22 -167.15 2.11 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.035 1.734 . . . . 0.0 110.222 179.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 14.0 pt -45.33 -28.64 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 124.846 1.259 . . . . 0.0 113.115 168.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -57.13 -33.32 67.26 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 25.9 m -84.34 -20.08 32.62 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 175.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 45.1 mtt -68.39 -28.05 66.76 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 119.639 1.108 . . . . 0.0 112.063 173.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 83.8 mt -67.17 -22.4 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 CA-C-O 122.457 1.122 . . . . 0.0 112.165 -171.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -82.55 3.63 27.8 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.354 1.861 . . . . 0.0 114.482 174.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -87.87 -13.62 64.3 Favored Glycine 0 CA--C 1.541 1.682 0 C-N-CA 125.153 1.358 . . . . 0.0 116.365 -178.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -156.87 175.78 13.62 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 119.285 1.543 . . . . 0.0 112.318 177.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -72.61 -33.33 66.6 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 121.805 -0.56 . . . . 0.0 112.234 174.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.4 t -125.72 130.18 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 124.894 1.278 . . . . 0.0 110.151 173.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 62.1 t -131.49 130.49 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 123.842 0.857 . . . . 0.0 110.636 178.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 47.0 t -130.43 148.11 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.321 1.048 . . . . 0.0 112.277 -170.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -126.18 113.67 17.32 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.917 1.287 . . . . 0.0 110.097 177.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 59.8 m -132.25 167.32 20.03 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 126.0 1.72 . . . . 0.0 111.879 -166.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.436 ' CD1' ' HB3' ' A' ' 46' ' ' ASP . 34.6 m0 -117.66 126.12 51.93 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.763 1.225 . . . . 0.0 109.389 166.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 89.3 t -56.42 -39.61 62.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -166.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.7 t -74.87 -12.57 60.4 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 127.66 2.384 . . . . 0.0 115.716 -179.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.9 t -88.6 139.51 29.72 Favored Pre-proline 0 CA--C 1.539 0.523 0 O-C-N 121.395 -0.816 . . . . 0.0 110.87 -165.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -66.75 -38.25 18.45 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 CA-C-N 120.327 1.152 . . . . 0.0 112.943 -178.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 51.9 m-85 -62.24 -36.72 82.87 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.263 1.425 . . . . 0.0 114.225 178.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -56.13 -54.49 44.51 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.3 1.04 . . . . 0.0 108.989 169.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 73.2 t -62.74 -37.5 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 124.291 1.037 . . . . 0.0 112.388 -178.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 71.0 mmt-85 -52.95 -45.94 67.95 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 119.205 0.911 . . . . 0.0 112.001 172.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.75 -53.26 10.72 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.885 0.874 . . . . 0.0 112.113 178.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -59.32 -25.57 64.28 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -177.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -71.44 -46.39 60.17 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.637 0.775 . . . . 0.0 112.615 173.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.7 tt -74.26 -38.32 63.48 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.59 1.556 . . . . 0.0 111.808 -177.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 87.0 mt -63.56 -46.5 85.63 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.073 0.549 . . . . 0.0 111.047 178.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -64.32 -22.6 67.01 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 172.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -80.9 -17.2 51.41 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 176.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 10.6 mmt180 -131.94 -10.27 3.43 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 117.078 2.251 . . . . 0.0 117.078 -168.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 14.9 t -152.54 155.8 38.12 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 170.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 8.8 mptt -105.91 0.82 26.18 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.385 1.474 . . . . 0.0 112.722 166.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -105.07 40.76 1.45 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.536 1.535 . . . . 0.0 112.411 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -113.88 141.63 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 126.199 1.8 . . . . 0.0 111.695 177.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.9 m -129.33 129.39 44.76 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 127.363 2.265 . . . . 0.0 109.29 172.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -121.32 136.49 58.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 125.027 1.331 . . . . 0.0 112.784 172.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -108.99 130.97 55.49 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 125.295 1.438 . . . . 0.0 110.569 173.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -97.81 94.43 6.91 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.708 -0.62 . . . . 0.0 110.821 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.8 m -73.77 -6.59 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -176.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.436 ' HB3' ' CD1' ' A' ' 20' ' ' TRP . 0.0 OUTLIER -80.73 -19.28 45.34 Favored 'General case' 0 CA--C 1.545 0.766 0 O-C-N 121.15 -0.969 . . . . 0.0 112.004 169.161 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 39.9 mtmt -95.96 11.07 35.25 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 127.468 2.307 . . . . 0.0 113.772 175.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 12.8 ttt -125.32 128.78 48.74 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 127.584 2.353 . . . . 0.0 110.502 -167.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 25.8 m -68.49 -36.7 79.31 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.972 0.909 . . . . 0.0 113.232 -176.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.4 mp0 -84.7 -0.58 54.08 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.845 1.258 . . . . 0.0 113.289 173.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -56.35 -24.44 45.4 Favored Glycine 0 CA--C 1.535 1.321 0 O-C-N 120.471 -1.393 . . . . 0.0 115.879 -169.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 60.7 mt-10 -73.58 -28.71 61.98 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 118.714 1.257 . . . . 0.0 112.649 174.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -74.42 -37.24 63.38 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 120.908 -1.12 . . . . 0.0 111.403 172.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -69.56 -32.1 70.68 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.77 0.828 . . . . 0.0 112.765 173.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 60.6 mtp180 -56.16 -38.17 70.53 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 120.004 1.274 . . . . 0.0 111.511 164.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -64.1 -38.4 95.93 Favored Glycine 0 CA--C 1.539 1.546 0 CA-C-O 118.744 -1.031 . . . . 0.0 114.176 169.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -61.5 -29.55 70.05 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 119.988 1.894 . . . . 0.0 113.06 173.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 38.6 mt -77.38 -46.78 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 118.549 0.613 . . . . 0.0 109.973 171.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -65.83 -42.18 90.86 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 120.868 -1.145 . . . . 0.0 113.183 -175.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -73.92 -9.83 59.04 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -178.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -108.04 -32.98 7.32 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.705 1.202 . . . . 0.0 114.197 173.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -133.4 -0.11 3.29 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 114.879 1.437 . . . . 0.0 114.879 -171.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.5 mptt 48.02 51.94 13.81 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 126.033 1.733 . . . . 0.0 113.256 -177.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 33.9 t-80 -134.79 131.75 37.89 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.251 1.42 . . . . 0.0 110.587 175.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -135.82 11.94 3.4 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 126.193 1.797 . . . . 0.0 112.595 -166.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.443 HG21 ' H ' ' A' ' 67' ' ' VAL . 0.3 OUTLIER -106.59 -172.04 2.01 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 126.438 1.895 . . . . 0.0 110.266 173.414 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.443 ' H ' HG21 ' A' ' 66' ' ' THR . 21.4 m -137.93 158.47 71.3 Favored Pre-proline 0 N--CA 1.48 1.026 0 O-C-N 120.53 -1.356 . . . . 0.0 113.025 175.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -71.77 155.08 97.95 Favored 'Cis proline' 0 C--N 1.348 0.548 0 CA-C-N 118.486 0.495 . . . . 0.0 112.673 -11.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -102.57 134.01 46.62 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.437 1.095 . . . . 0.0 108.391 161.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 46.9 mt -128.59 141.39 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 123.542 0.737 . . . . 0.0 109.916 -165.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -137.95 145.56 42.17 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.983 0.913 . . . . 0.0 112.102 179.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 64.7 mt -130.28 114.06 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.214 1.405 . . . . 0.0 108.675 174.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 49.91 41.53 22.92 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.0 1.32 . . . . 0.0 113.951 -172.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 75.31 4.11 72.76 Favored Glycine 0 CA--C 1.54 1.651 0 O-C-N 120.606 -1.309 . . . . 0.0 115.128 -178.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -97.07 133.98 41.02 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.157 1.383 . . . . 0.0 109.896 173.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -83.31 146.61 28.42 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.694 1.198 . . . . 0.0 113.691 -170.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 28.6 mm -130.56 120.3 47.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 128.365 2.666 . . . . 0.0 108.131 -178.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.11 -9.87 43.87 Favored Glycine 0 CA--C 1.534 1.28 0 N-CA-C 119.084 2.393 . . . . 0.0 119.084 -163.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 158.13 -175.35 35.34 Favored Glycine 0 CA--C 1.532 1.127 0 CA-C-N 118.936 1.368 . . . . 0.0 113.766 176.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 30.1 t -65.65 -37.66 87.16 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.97 -0.724 . . . . 0.0 112.474 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 66.5 m -70.47 -32.14 69.55 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.436 -0.79 . . . . 0.0 112.097 177.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -68.62 -41.37 79.61 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.363 0.983 . . . . 0.0 112.108 172.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 15.1 tp -58.45 -50.92 71.99 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.731 1.612 . . . . 0.0 110.843 173.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -64.37 -36.32 83.75 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.934 -0.479 . . . . 0.0 112.056 175.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.04 -34.56 77.98 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 121.147 -0.971 . . . . 0.0 111.824 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 92.4 mt -70.78 -31.19 67.88 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.815 0.846 . . . . 0.0 112.052 169.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -69.45 -39.1 77.96 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 176.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -63.79 -32.96 74.63 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.986 0.914 . . . . 0.0 112.59 174.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -75.51 -13.03 60.35 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 114.29 1.218 . . . . 0.0 114.29 169.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 78.74 6.32 88.43 Favored Glycine 0 CA--C 1.538 1.494 0 CA-C-N 118.84 0.746 . . . . 0.0 114.078 -173.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 35.4 mtpt -81.66 -27.65 33.96 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 126.823 2.049 . . . . 0.0 112.15 -171.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 59.2 tp -64.78 -43.73 92.27 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.081 0.952 . . . . 0.0 111.559 172.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 -59.07 -34.89 72.48 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.788 -0.57 . . . . 0.0 111.622 177.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -77.11 -18.71 78.21 Favored Glycine 0 CA--C 1.536 1.354 0 N-CA-C 115.605 1.002 . . . . 0.0 115.605 175.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 39.0 mt -81.61 -35.57 29.92 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.965 1.306 . . . . 0.0 111.533 168.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 84.2 mt -72.76 -3.28 24.33 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.386 1.474 . . . . 0.0 113.893 177.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.1 t . . . . . 0 C--O 1.252 1.217 0 C-N-CA 127.454 2.301 . . . . 0.0 112.333 177.492 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.012 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.63 159.43 21.96 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 -171.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 34.7 ttp 54.9 64.77 5.56 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 127.384 2.273 . . . . 0.0 113.059 -168.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -71.09 -26.19 21.71 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 123.075 2.517 . . . . 0.0 114.299 -173.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 53.8 p -164.08 -170.27 2.07 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 127.314 2.246 . . . . 0.0 111.579 166.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 23.5 pt -59.47 -23.94 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 123.846 0.859 . . . . 0.0 113.295 174.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.52 -32.62 72.67 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 118.244 0.474 . . . . 0.0 111.944 -175.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 83.4 p -69.26 -33.59 73.48 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.729 1.212 . . . . 0.0 113.319 170.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 43.3 mtt -67.19 -31.39 71.76 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.023 0.929 . . . . 0.0 111.516 -178.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.3 mm -56.47 -35.87 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 123.592 0.757 . . . . 0.0 111.834 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -73.61 -19.01 60.98 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.08 0.952 . . . . 0.0 113.263 -175.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -77.79 -26.92 59.7 Favored Glycine 0 CA--C 1.533 1.202 0 N-CA-C 115.998 1.159 . . . . 0.0 115.998 -166.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 26.7 m-80 -134.69 172.32 13.12 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.896 1.278 . . . . 0.0 111.993 -177.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -70.03 -40.72 75.01 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.233 1.013 . . . . 0.0 112.208 178.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.0 t -128.37 136.36 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 124.774 1.23 . . . . 0.0 110.172 174.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 43.5 t -132.7 130.34 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.4 1.08 . . . . 0.0 109.997 176.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 37.6 t -127.93 145.92 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 124.279 1.032 . . . . 0.0 111.94 -176.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -120.35 116.51 25.65 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.894 1.278 . . . . 0.0 108.54 172.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.4 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 14.7 m -130.64 169.14 16.02 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.911 1.684 . . . . 0.0 111.492 -169.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 25.6 m0 -115.59 135.88 53.63 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.197 0.999 . . . . 0.0 108.975 162.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 54.9 t -58.28 -28.54 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 CA-C-O 121.295 0.569 . . . . 0.0 111.071 176.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.7 p -82.72 -6.87 59.61 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 116.284 1.957 . . . . 0.0 116.284 178.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.9 t -92.47 140.15 24.03 Favored Pre-proline 0 CA--C 1.544 0.717 0 CA-C-N 120.55 1.523 . . . . 0.0 111.339 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -75.13 -34.75 3.48 Favored 'Trans proline' 0 CA--C 1.534 0.489 0 C-N-CA 121.855 1.704 . . . . 0.0 112.871 173.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -59.29 -38.12 79.4 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.611 1.164 . . . . 0.0 113.408 176.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.4 ' SG ' ' HB3' ' A' ' 19' ' ' SER . 0.1 OUTLIER -49.98 -52.65 32.09 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.288 1.035 . . . . 0.0 109.746 171.027 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 57.5 t -63.29 -40.46 89.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 124.005 0.922 . . . . 0.0 111.63 -176.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 37.0 mmt-85 -53.98 -48.74 70.05 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 118.997 0.817 . . . . 0.0 111.098 175.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.34 -54.14 23.28 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.896 0.878 . . . . 0.0 112.455 177.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -48.94 -40.48 30.39 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.544 1.138 . . . . 0.0 113.142 178.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.05 -45.22 58.76 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 124.676 1.19 . . . . 0.0 112.154 -175.055 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.9 tt -68.72 -41.1 79.51 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.538 1.535 . . . . 0.0 111.558 176.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 63.0 mt -63.02 -46.46 87.5 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 123.282 0.633 . . . . 0.0 111.197 175.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -64.81 -20.11 66.21 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 174.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.33 -12.87 57.71 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 173.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -116.47 -30.51 5.85 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.762 1.225 . . . . 0.0 114.302 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.7 m -146.9 134.77 21.3 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 119.678 1.126 . . . . 0.0 112.577 -168.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 10.6 mmpt? -86.87 -32.38 20.26 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.242 1.417 . . . . 0.0 112.717 169.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -77.33 47.56 0.58 Allowed 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 125.579 1.552 . . . . 0.0 113.296 177.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -110.46 128.44 66.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 127.265 2.226 . . . . 0.0 109.833 175.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.5 m -112.17 129.0 56.39 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.494 1.918 . . . . 0.0 108.728 174.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.5 p -125.55 142.54 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-O 122.117 0.96 . . . . 0.0 113.042 172.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 33.0 m-70 -120.09 121.68 39.39 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 127.302 2.241 . . . . 0.0 110.51 -174.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -94.63 90.99 6.34 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 122.558 1.17 . . . . 0.0 110.513 -177.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 34.4 m -70.18 -16.13 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-N 115.154 -0.93 . . . . 0.0 112.735 -176.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.13 -32.97 72.72 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.396 -0.815 . . . . 0.0 112.123 174.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -77.58 -27.57 51.42 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.52 1.928 . . . . 0.0 112.244 174.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 21.2 ttt -71.43 142.18 50.26 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.612 1.565 . . . . 0.0 112.48 -177.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 4.9 m -76.34 -12.28 60.04 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 177.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -125.21 9.9 8.02 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 126.116 1.766 . . . . 0.0 113.825 178.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -53.5 -29.01 38.27 Favored Glycine 0 CA--C 1.539 1.566 0 N-CA-C 116.457 1.343 . . . . 0.0 116.457 -171.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -69.19 -28.91 66.81 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 118.829 1.315 . . . . 0.0 112.869 174.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -67.39 -28.97 68.37 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.937 0.895 . . . . 0.0 111.424 169.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -83.57 -31.89 26.1 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.012 0.925 . . . . 0.0 111.961 178.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 49.5 mtp85 -53.36 -41.71 66.11 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 119.628 1.104 . . . . 0.0 111.058 154.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -57.93 -38.17 87.85 Favored Glycine 0 CA--C 1.536 1.405 0 CA-C-O 118.631 -1.094 . . . . 0.0 114.445 172.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -62.19 -41.8 98.68 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 120.299 2.049 . . . . 0.0 111.864 176.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 52.1 mt -70.13 -42.43 79.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.243 1.417 . . . . 0.0 110.069 179.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -67.84 -43.22 80.02 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 121.8 -0.563 . . . . 0.0 111.895 179.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -64.09 -33.94 76.91 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.459 -0.776 . . . . 0.0 111.812 177.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -79.35 -48.88 13.3 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 176.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -125.58 -1.45 7.42 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 114.552 1.316 . . . . 0.0 114.552 -164.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.2 mmtp 55.25 36.11 26.33 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 126.83 2.052 . . . . 0.0 114.148 -178.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 25.1 m80 -119.84 140.81 50.22 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 128.128 2.571 . . . . 0.0 109.367 176.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -125.88 -32.0 2.85 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.508 1.523 . . . . 0.0 114.395 -176.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 77.7 p -67.76 147.93 51.94 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 -169.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.3 m -99.46 152.68 37.88 Favored Pre-proline 0 N--CA 1.474 0.75 0 C-N-CA 123.726 0.811 . . . . 0.0 112.34 177.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -70.32 149.37 89.8 Favored 'Cis proline' 0 N--CA 1.458 -0.597 0 CA-C-N 119.029 0.689 . . . . 0.0 111.28 -9.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -102.85 130.78 49.98 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.219 1.007 . . . . 0.0 108.346 166.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 13.2 mt -124.62 142.28 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 124.163 0.985 . . . . 0.0 109.338 -164.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -138.36 141.21 39.68 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 123.764 0.826 . . . . 0.0 111.052 177.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 55.8 mt -133.7 117.44 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 124.467 1.107 . . . . 0.0 109.428 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 74.9 m-80 48.83 35.98 7.39 Favored 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 125.633 1.573 . . . . 0.0 114.092 -174.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 80.35 5.65 89.66 Favored Glycine 0 CA--C 1.537 1.423 0 N-CA-C 116.737 1.455 . . . . 0.0 116.737 -176.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 -95.76 139.33 32.15 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 118.834 1.317 . . . . 0.0 110.77 168.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -81.32 137.93 35.72 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.074 0.949 . . . . 0.0 112.181 178.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 28.6 mm -116.97 121.93 68.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 127.349 2.259 . . . . 0.0 107.416 174.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.9 -22.81 68.84 Favored Glycine 0 CA--C 1.534 1.223 0 N-CA-C 116.211 1.244 . . . . 0.0 116.211 -162.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 168.93 -171.47 42.92 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-N 118.193 0.997 . . . . 0.0 113.785 179.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 49.1 t -61.87 -37.85 86.08 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.784 1.234 . . . . 0.0 112.174 175.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 71.1 m -56.46 -44.66 80.74 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 118.908 0.777 . . . . 0.0 112.486 176.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -72.45 -39.14 68.02 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.998 0.919 . . . . 0.0 111.589 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 67.2 tp -62.42 -50.21 72.42 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.035 0.934 . . . . 0.0 112.168 174.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -68.67 -15.15 63.43 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 121.754 -0.591 . . . . 0.0 112.508 176.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -81.68 -47.12 13.38 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.417 -0.802 . . . . 0.0 111.49 169.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 66.5 mt -62.42 -32.58 73.44 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 120.831 -1.168 . . . . 0.0 112.783 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -64.72 -29.68 70.67 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.707 1.603 . . . . 0.0 113.467 173.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.1 mptt -93.36 -37.08 12.19 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 126.58 1.952 . . . . 0.0 112.089 -178.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -71.33 -6.2 38.22 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.996 1.318 . . . . 0.0 113.582 171.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 76.2 17.63 79.86 Favored Glycine 0 CA--C 1.534 1.256 0 O-C-N 120.942 -1.099 . . . . 0.0 113.945 177.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 44.6 mtmt -99.5 -21.45 15.93 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 126.27 1.828 . . . . 0.0 113.061 -172.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 31.1 tp -66.34 -34.82 78.84 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.861 0.865 . . . . 0.0 111.615 176.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -53.27 -41.77 65.87 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.694 1.198 . . . . 0.0 112.068 173.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -85.45 -6.9 83.15 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 125.966 1.746 . . . . 0.0 114.794 179.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 69.7 mt -95.73 -26.16 15.8 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.144 1.378 . . . . 0.0 112.471 172.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 76.6 mt -105.69 -16.13 14.77 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 114.838 1.422 . . . . 0.0 114.838 -177.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 63.3 p . . . . . 0 N--CA 1.479 1.009 0 C-N-CA 126.229 1.812 . . . . 0.0 114.836 178.479 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.97 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -58.5 -31.49 67.93 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.246 1.018 . . . . 0.0 112.595 170.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 5.3 mpp? -74.34 98.34 0.22 Allowed Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 126.934 2.094 . . . . 0.0 108.875 158.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -31.71 124.26 0.09 OUTLIER 'Trans proline' 0 C--N 1.354 0.821 1 C-N-CA 127.223 5.282 . . . . 0.0 117.96 -160.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 74.1 p -152.63 -164.07 1.86 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.359 1.864 . . . . 0.0 110.462 174.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 27.5 pt -51.53 -23.0 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 124.181 0.993 . . . . 0.0 113.493 173.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.28 -18.59 61.69 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.477 1.111 . . . . 0.0 113.407 -175.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.5 m -84.16 -19.39 34.2 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 171.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 64.7 mtt -64.2 -37.28 86.91 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 119.557 1.072 . . . . 0.0 110.851 175.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.4 mm -59.64 -20.63 19.28 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 124.004 0.921 . . . . 0.0 113.069 -173.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.3 mptt -91.74 -7.67 49.06 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.452 1.501 . . . . 0.0 114.143 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -96.82 -18.65 29.16 Favored Glycine 0 CA--C 1.539 1.579 0 N-CA-C 116.754 1.462 . . . . 0.0 116.754 -174.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 27.7 m120 -141.33 151.0 43.21 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 118.894 1.347 . . . . 0.0 112.164 -176.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt -54.85 -40.9 70.12 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.008 1.323 . . . . 0.0 112.992 176.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.6 t -129.83 134.43 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.131 0.972 . . . . 0.0 110.175 174.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 58.9 t -131.8 129.85 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.065 1.346 . . . . 0.0 109.751 177.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 47.0 t -127.33 146.9 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 124.294 1.038 . . . . 0.0 111.855 -175.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -121.72 113.48 19.77 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.696 1.198 . . . . 0.0 109.971 173.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.4 m -131.17 170.83 14.02 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.529 1.532 . . . . 0.0 112.092 -167.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.408 ' CD1' ' HB3' ' A' ' 46' ' ' ASP . 33.2 m0 -117.36 133.85 55.5 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.571 1.149 . . . . 0.0 108.867 162.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 71.4 t -58.55 -30.43 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 C-N-CA 123.567 0.747 . . . . 0.0 111.887 -175.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.8 p -82.56 -8.49 59.61 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 126.496 1.919 . . . . 0.0 116.08 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.7 t -91.62 141.4 25.74 Favored Pre-proline 0 CA--C 1.54 0.567 0 CA-C-N 120.372 1.442 . . . . 0.0 112.394 -168.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -69.26 -39.58 7.27 Favored 'Trans proline' 0 C--N 1.349 0.576 0 CA-C-N 120.343 1.158 . . . . 0.0 112.058 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -62.45 -36.47 82.52 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 126.166 1.786 . . . . 0.0 113.083 -178.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -55.1 -53.15 59.61 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.265 1.026 . . . . 0.0 109.125 169.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 94.8 t -64.32 -39.8 86.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 123.716 0.806 . . . . 0.0 111.871 -178.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.5 mmt85 -53.37 -43.4 67.75 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 118.87 0.759 . . . . 0.0 111.566 172.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.75 -54.27 9.37 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.487 0.715 . . . . 0.0 112.839 175.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.38 -33.32 58.96 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.671 1.188 . . . . 0.0 113.395 -179.005 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -68.68 -49.94 54.99 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.512 0.725 . . . . 0.0 111.58 177.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.6 tt -65.66 -43.32 89.74 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.796 1.639 . . . . 0.0 111.378 -178.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 95.0 mt -64.0 -40.07 95.54 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.633 0.773 . . . . 0.0 111.921 -178.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 54.3 m-70 -78.48 -13.38 59.86 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 171.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -80.37 -39.35 28.65 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 119.208 0.913 . . . . 0.0 111.952 172.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -87.46 -28.56 22.01 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 125.053 1.341 . . . . 0.0 114.267 -178.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.2 p -151.15 170.38 19.58 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 125.118 1.367 . . . . 0.0 112.628 -168.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -116.85 -19.33 9.91 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 126.562 1.945 . . . . 0.0 114.047 164.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -78.35 27.82 0.2 Allowed 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -171.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.21 132.47 44.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.365 0 C-N-CA 126.887 2.075 . . . . 0.0 111.563 -178.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 16.5 m -112.81 141.53 46.51 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 126.107 1.763 . . . . 0.0 109.65 168.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.4 p -132.85 140.24 47.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 125.259 1.424 . . . . 0.0 111.883 173.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -116.06 127.85 55.22 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.975 1.31 . . . . 0.0 110.46 176.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -95.99 87.95 4.74 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 122.06 0.933 . . . . 0.0 111.714 -172.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.0 m -71.79 3.61 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 -174.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.408 ' HB3' ' CD1' ' A' ' 20' ' ' TRP . 0.0 OUTLIER -87.33 -31.03 20.39 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 121.294 -0.879 . . . . 0.0 111.732 165.873 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 25.1 mtmt -81.42 -23.81 37.3 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.822 1.249 . . . . 0.0 113.367 176.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 21.0 ttt -85.2 121.97 28.71 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.212 1.805 . . . . 0.0 110.955 173.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 72.5 m -63.55 -31.6 72.81 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -176.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -83.32 1.48 40.93 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 175.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -56.12 -21.71 33.03 Favored Glycine 0 CA--C 1.535 1.311 0 N-CA-C 116.663 1.425 . . . . 0.0 116.663 -169.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -67.11 -29.07 68.72 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 119.365 1.582 . . . . 0.0 112.576 173.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -76.9 -25.37 52.93 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 121.103 -0.998 . . . . 0.0 111.724 174.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -84.48 -30.07 25.51 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.438 1.095 . . . . 0.0 111.57 175.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 41.1 mtp180 -54.18 -41.96 69.14 Favored 'General case' 0 N--CA 1.484 1.241 0 O-C-N 120.977 -1.077 . . . . 0.0 110.666 154.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.13 -38.86 93.68 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 124.329 0.966 . . . . 0.0 114.203 171.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -65.37 -31.66 72.88 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 120.038 1.919 . . . . 0.0 113.501 176.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 28.2 mt -71.68 -46.89 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 172.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -62.9 -39.58 94.92 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 121.109 -0.995 . . . . 0.0 113.039 -178.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 38.6 mm-40 -71.81 -10.74 60.21 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.865 1.266 . . . . 0.0 114.135 -179.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -113.99 -26.12 8.26 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 114.217 1.192 . . . . 0.0 114.217 173.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -135.31 0.87 2.85 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 115.255 1.576 . . . . 0.0 115.255 -170.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp 49.49 35.23 7.87 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 127.089 2.155 . . . . 0.0 115.226 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -141.06 153.79 45.65 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 125.148 1.379 . . . . 0.0 110.311 175.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -141.35 -24.33 0.73 Allowed 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -160.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 22.0 m -77.36 131.99 38.34 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.988 1.315 . . . . 0.0 112.353 -173.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 14.1 m -81.22 158.43 69.53 Favored Pre-proline 0 CA--C 1.547 0.857 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 -171.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -68.63 153.18 89.74 Favored 'Cis proline' 0 CA--C 1.534 0.503 0 CA-C-N 118.528 0.51 . . . . 0.0 112.219 -15.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -98.6 135.63 39.84 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 159.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 69.4 mt -129.61 142.52 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 123.599 0.759 . . . . 0.0 109.28 -166.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -138.22 140.67 39.82 Favored 'General case' 0 C--N 1.332 -0.152 0 C-N-CA 123.934 0.894 . . . . 0.0 111.145 177.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 73.8 mt -128.5 115.03 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.994 1.318 . . . . 0.0 108.202 176.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 45.69 47.83 11.59 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.547 1.539 . . . . 0.0 113.54 -174.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 79.54 -10.48 37.11 Favored Glycine 0 CA--C 1.535 1.302 0 N-CA-C 115.793 1.077 . . . . 0.0 115.793 -178.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 26.8 m-80 -86.65 132.77 33.79 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 118.887 1.343 . . . . 0.0 109.541 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -82.65 143.01 31.26 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.531 1.132 . . . . 0.0 113.056 -174.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 20.2 mm -132.5 119.58 39.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 127.93 2.492 . . . . 0.0 107.246 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.97 -22.75 65.05 Favored Glycine 0 CA--C 1.537 1.426 0 N-CA-C 116.785 1.474 . . . . 0.0 116.785 -164.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 156.64 -152.51 23.89 Favored Glycine 0 CA--C 1.527 0.79 0 CA-C-N 118.058 0.929 . . . . 0.0 114.154 173.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 8.2 t -54.91 -56.23 21.88 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.196 0.998 . . . . 0.0 112.593 -175.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 65.6 m -75.27 3.16 9.4 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -95.73 -43.09 8.05 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.357 1.063 . . . . 0.0 111.646 165.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 28.6 tp -63.39 -51.21 66.8 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.188 1.395 . . . . 0.0 111.003 175.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -57.39 -43.81 83.99 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.5 0.72 . . . . 0.0 110.24 174.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.16 -35.36 78.54 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.351 -0.843 . . . . 0.0 112.861 -177.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 42.8 mt -73.65 -26.74 60.9 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.681 0.792 . . . . 0.0 112.91 173.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -72.75 -38.92 67.23 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 119.24 0.927 . . . . 0.0 111.601 169.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -64.21 -38.64 91.77 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.565 0.746 . . . . 0.0 111.549 173.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -73.32 -7.68 52.64 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 171.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.95 28.94 74.08 Favored Glycine 0 CA--C 1.539 1.534 0 CA-C-N 120.617 1.553 . . . . 0.0 112.993 -176.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 21.2 mtpp -110.09 -30.19 7.88 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.882 2.073 . . . . 0.0 112.392 -176.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 50.2 tp -56.36 -37.51 70.14 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.444 0.697 . . . . 0.0 111.837 172.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -51.13 -46.44 61.95 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.695 1.598 . . . . 0.0 112.577 174.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -78.23 -25.42 61.62 Favored Glycine 0 CA--C 1.531 1.061 0 O-C-N 121.616 -0.677 . . . . 0.0 114.279 177.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 79.6 mt -71.19 -37.6 72.13 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 118.642 1.221 . . . . 0.0 111.734 175.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 87.3 mt -86.89 -8.26 57.43 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.166 0.987 . . . . 0.0 112.973 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.9 t . . . . . 0 C--O 1.253 1.246 0 C-N-CA 126.695 1.998 . . . . 0.0 111.224 173.456 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.902 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -70.19 159.72 33.44 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.402 1.481 . . . . 0.0 114.345 -171.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 79.0 mmm -113.43 78.23 3.45 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 125.949 1.699 . . . . 0.0 110.673 178.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -68.82 158.14 59.04 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 122.868 2.379 . . . . 0.0 112.806 -176.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 51.0 m -97.09 -170.71 2.08 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.495 1.518 . . . . 0.0 111.549 172.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 13.2 pt -54.81 -22.25 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 N-CA-C 115.198 1.555 . . . . 0.0 115.198 -168.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.36 -22.03 60.72 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 93.4 p -80.48 -25.89 38.54 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.668 1.587 . . . . 0.0 113.923 172.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 62.1 mtt -65.12 -33.62 76.47 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 120.624 -1.297 . . . . 0.0 111.704 176.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.5 mm -61.89 -24.49 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 124.017 0.927 . . . . 0.0 112.222 -174.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -75.75 -11.02 59.91 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.356 1.462 . . . . 0.0 114.265 177.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -95.73 -26.38 11.86 Favored Glycine 0 CA--C 1.536 1.346 0 N-CA-C 117.8 1.88 . . . . 0.0 117.8 -164.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -143.35 158.72 43.4 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 119.335 1.568 . . . . 0.0 111.918 -173.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -59.69 -38.73 82.35 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.837 1.255 . . . . 0.0 112.931 -176.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.4 t -131.54 134.66 60.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.322 1.449 . . . . 0.0 109.446 173.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 56.1 t -132.26 128.48 58.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.702 1.201 . . . . 0.0 110.075 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 44.9 t -131.33 153.03 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.49 1.116 . . . . 0.0 111.981 -173.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -128.37 105.95 8.68 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.582 1.153 . . . . 0.0 109.393 176.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 68.9 m -126.46 171.23 11.21 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 125.744 1.618 . . . . 0.0 111.816 -170.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 47.3 m0 -118.94 129.4 55.15 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.847 1.259 . . . . 0.0 109.399 168.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 31.6 t -61.61 -20.33 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 C-N-CA 124.864 1.266 . . . . 0.0 112.661 -168.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.7 p -83.08 -22.26 33.5 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 128.671 2.788 . . . . 0.0 115.485 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 66.3 m -105.24 153.97 39.23 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 120.154 1.343 . . . . 0.0 114.06 -154.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -71.8 -49.48 0.32 Allowed 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 121.382 1.388 . . . . 0.0 114.023 -168.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -62.16 -37.37 84.99 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 -177.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -42.73 -58.29 2.4 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.973 1.709 . . . . 0.0 110.341 164.049 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 61.4 t -66.34 -38.45 81.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 O-C-N 121.5 -0.75 . . . . 0.0 112.125 -177.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 37.6 mmt-85 -54.37 -39.74 67.48 Favored 'General case' 0 N--CA 1.484 1.258 0 CA-C-N 119.12 0.873 . . . . 0.0 111.915 174.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.64 -54.74 6.5 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.55 1.14 . . . . 0.0 112.988 174.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -54.3 -30.4 50.83 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 119.392 0.997 . . . . 0.0 113.27 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.6 ttpt -69.53 -50.58 43.61 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.675 0.79 . . . . 0.0 112.21 175.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.1 tt -64.13 -43.04 96.46 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.521 1.528 . . . . 0.0 111.132 -177.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 90.5 mt -66.45 -24.27 66.41 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.263 1.025 . . . . 0.0 113.335 -177.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 44.1 m-70 -92.46 -16.3 26.02 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 168.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.0 -27.44 22.05 Favored 'General case' 0 CA--C 1.545 0.76 0 O-C-N 120.793 -1.192 . . . . 0.0 113.967 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 7.5 mmm-85 -103.2 -18.93 14.69 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 125.23 1.412 . . . . 0.0 113.973 177.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -153.02 174.49 14.1 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 127.037 2.135 . . . . 0.0 111.739 -171.13 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -129.78 -7.81 4.52 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 125.309 1.444 . . . . 0.0 114.532 170.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -97.76 87.69 4.1 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 119.506 1.048 . . . . 0.0 111.454 179.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.42 129.55 22.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 125.073 1.349 . . . . 0.0 110.641 -179.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 22.7 m -104.49 127.53 52.22 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.319 1.448 . . . . 0.0 108.632 168.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.5 p -125.18 134.29 67.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 118.957 0.798 . . . . 0.0 112.264 170.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -104.06 122.93 46.29 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.941 1.296 . . . . 0.0 110.3 175.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -93.7 82.91 4.36 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.568 0.699 . . . . 0.0 111.964 -172.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 29.6 m -76.08 33.32 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 -169.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -129.04 -16.67 4.03 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 126.449 1.9 . . . . 0.0 111.708 161.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 20.4 mtmt -80.2 -24.7 40.1 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.445 1.098 . . . . 0.0 112.229 162.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -92.21 127.62 37.76 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.677 1.591 . . . . 0.0 110.781 177.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 58.1 m -71.55 -20.95 61.96 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 -165.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -97.85 7.49 46.29 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 126.028 1.731 . . . . 0.0 112.686 174.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -49.51 -30.83 13.46 Favored Glycine 0 CA--C 1.537 1.416 0 CA-C-N 119.743 1.156 . . . . 0.0 115.028 -175.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -58.4 -35.34 71.89 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.368 1.867 . . . . 0.0 114.907 171.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -80.36 -36.14 34.48 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.809 1.244 . . . . 0.0 112.08 175.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -69.67 -36.11 75.73 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.715 -0.615 . . . . 0.0 111.075 176.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 42.2 mtp180 -53.14 -38.83 63.05 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.834 1.254 . . . . 0.0 112.258 165.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -57.94 -40.08 92.71 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 123.974 0.797 . . . . 0.0 113.797 173.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 56.7 mm-40 -66.55 -24.87 66.43 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 118.841 1.321 . . . . 0.0 112.984 175.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 26.1 mt -74.72 -45.45 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 O-C-N 121.498 -0.751 . . . . 0.0 109.722 172.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -68.88 -39.11 79.97 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 121.618 -0.677 . . . . 0.0 112.671 -177.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -59.58 -35.31 74.03 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 121.456 -0.777 . . . . 0.0 112.834 176.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -94.61 -32.13 13.56 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 114.293 1.219 . . . . 0.0 114.293 -175.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -134.69 4.02 3.3 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 114.741 1.386 . . . . 0.0 114.741 -169.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt 52.96 31.48 11.0 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 126.513 1.925 . . . . 0.0 114.903 176.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 -116.71 111.31 19.62 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 127.745 2.418 . . . . 0.0 110.466 -166.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -100.13 -5.37 27.93 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 115.942 1.83 . . . . 0.0 115.942 -177.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 44.7 p -81.29 171.13 15.2 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 124.895 1.278 . . . . 0.0 113.51 178.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.3 m -125.7 143.58 45.49 Favored Pre-proline 0 N--CA 1.481 1.119 0 C-N-CA 124.189 0.996 . . . . 0.0 111.748 169.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -88.64 162.62 41.42 Favored 'Cis proline' 0 N--CA 1.457 -0.621 0 CA-C-N 119.525 0.866 . . . . 0.0 113.976 5.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -100.14 143.25 30.56 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.81 0.844 . . . . 0.0 109.476 159.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 15.8 mt -133.03 141.71 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 124.21 1.004 . . . . 0.0 110.137 -167.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -142.77 147.63 35.85 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.119 0.968 . . . . 0.0 112.253 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 79.8 mt -130.65 122.79 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 125.731 1.613 . . . . 0.0 109.765 177.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 31.2 m120 44.78 39.5 3.53 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 125.645 1.578 . . . . 0.0 114.305 -178.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 92.72 -6.25 77.05 Favored Glycine 0 CA--C 1.539 1.574 0 O-C-N 120.208 -1.558 . . . . 0.0 116.231 -176.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -104.77 134.79 47.32 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.292 1.437 . . . . 0.0 111.755 -173.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -75.42 143.83 42.51 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 27.0 mm -125.61 133.19 69.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 128.266 2.627 . . . . 0.0 108.522 178.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -72.95 53.63 1.73 Allowed Glycine 0 N--CA 1.474 1.226 0 C-N-CA 126.324 1.916 . . . . 0.0 117.353 -177.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 78.21 -164.63 51.36 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 128.075 2.75 . . . . 0.0 113.459 175.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 18.6 t -62.15 -29.39 70.32 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 122.087 -0.655 . . . . 0.0 111.672 175.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 36.6 m -64.1 -45.01 90.54 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.338 1.055 . . . . 0.0 112.664 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -72.79 -37.83 67.45 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 118.823 0.738 . . . . 0.0 112.205 172.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 50.6 tp -58.67 -50.07 75.23 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.74 0.816 . . . . 0.0 111.38 176.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -61.55 -43.55 98.66 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.845 0.858 . . . . 0.0 110.697 173.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.98 -33.68 75.91 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 120.848 -1.158 . . . . 0.0 112.806 -176.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 98.7 mt -78.34 -23.82 46.81 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.511 1.124 . . . . 0.0 113.345 173.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -70.51 -41.24 72.89 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 119.566 1.076 . . . . 0.0 110.85 166.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -65.02 -28.85 69.78 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.564 1.146 . . . . 0.0 113.148 175.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -91.28 2.1 56.62 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 114.641 1.349 . . . . 0.0 114.641 169.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 67.77 4.7 34.62 Favored Glycine 0 CA--C 1.537 1.41 0 O-C-N 120.948 -1.095 . . . . 0.0 115.261 179.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 44.2 mtmt -78.57 -28.13 45.85 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 126.178 1.791 . . . . 0.0 111.949 -174.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 35.4 tp -56.07 -36.15 67.78 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.528 1.131 . . . . 0.0 112.361 172.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -65.75 -28.38 69.0 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 178.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -76.19 -36.88 38.77 Favored Glycine 0 CA--C 1.53 0.974 0 O-C-N 121.584 -0.698 . . . . 0.0 111.992 171.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 90.4 mt -70.52 -25.87 63.32 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.986 0.914 . . . . 0.0 113.367 -178.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 85.2 mt -105.42 2.14 28.4 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 -173.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 41.6 m . . . . . 0 C--O 1.255 1.351 0 C-N-CA 125.645 1.578 . . . . 0.0 114.487 -174.619 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.144 0 N-CA-C 112.182 -0.367 . . . . 0.0 112.182 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 50.12 39.98 20.64 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 125.215 1.406 . . . . 0.0 114.503 -177.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 52.5 mtt -136.29 86.96 23.52 Favored Pre-proline 0 CA--C 1.542 0.648 0 C-N-CA 126.13 1.772 . . . . 0.0 109.684 -175.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -67.87 148.08 75.98 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 122.575 2.183 . . . . 0.0 112.841 -178.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 60.6 p -110.75 -152.21 0.49 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 127.253 2.221 . . . . 0.0 111.244 -178.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.4 pt -53.22 -22.88 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 125.136 1.374 . . . . 0.0 113.89 174.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.62 -32.39 72.53 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 118.868 0.758 . . . . 0.0 112.574 -174.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 62.9 m -76.84 -19.3 57.67 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 173.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 38.4 mtt -73.68 -25.72 60.39 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.036 -1.04 . . . . 0.0 112.01 176.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.8 mm -63.54 -33.13 59.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.862 0.865 . . . . 0.0 111.615 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -76.45 1.41 16.56 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.884 1.274 . . . . 0.0 113.416 175.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -86.03 -18.82 58.78 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 125.115 1.341 . . . . 0.0 115.385 -177.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.692 ' ND2' ' HG1' ' A' ' 41' ' ' THR . 22.2 m-80 -151.37 170.56 19.25 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 126.133 1.773 . . . . 0.0 111.943 -179.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -70.19 -36.8 74.87 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.257 0.623 . . . . 0.0 112.651 174.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.3 t -128.09 135.09 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.842 1.257 . . . . 0.0 110.574 172.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 47.2 t -131.48 129.18 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 124.411 1.084 . . . . 0.0 110.069 174.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.0 t -124.9 144.73 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 124.565 1.146 . . . . 0.0 111.883 -176.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -120.2 113.01 19.8 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.17 1.388 . . . . 0.0 108.692 173.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.412 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 14.2 m -130.63 -179.06 5.07 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 127.279 2.232 . . . . 0.0 110.58 -169.158 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 19.7 m0 -126.82 138.08 53.29 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.491 1.116 . . . . 0.0 108.425 159.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 40.6 t -59.36 -31.07 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 CA-C-O 122.06 0.933 . . . . 0.0 111.619 -170.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.6 p -81.96 -11.08 59.05 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 127.349 2.26 . . . . 0.0 115.526 -177.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 8.2 t -89.01 141.9 29.83 Favored Pre-proline 0 CA--C 1.542 0.653 0 CA-C-N 120.373 1.442 . . . . 0.0 110.384 -168.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -75.75 -31.39 5.34 Favored 'Trans proline' 0 C--N 1.347 0.467 0 CA-C-N 120.605 1.252 . . . . 0.0 113.361 179.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -62.65 -41.45 99.06 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.532 1.133 . . . . 0.0 113.264 174.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.412 ' SG ' ' HB3' ' A' ' 19' ' ' SER . 0.2 OUTLIER -50.72 -56.51 11.65 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.597 1.159 . . . . 0.0 109.55 171.924 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 81.3 t -63.23 -40.92 90.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 118.761 -0.637 . . . . 0.0 112.579 -173.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -66.94 -20.19 65.85 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 176.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.2 -54.42 5.53 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 118.448 -0.787 . . . . 0.0 111.042 165.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -46.36 -46.76 18.55 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.438 1.095 . . . . 0.0 112.756 178.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -67.37 -36.31 81.1 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.005 1.322 . . . . 0.0 113.01 -176.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.27 -35.72 54.99 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.225 1.01 . . . . 0.0 111.402 175.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 96.7 mt -64.94 -34.54 78.66 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 121.126 -0.984 . . . . 0.0 111.409 171.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -70.25 -27.08 64.16 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.912 1.078 . . . . 0.0 113.912 167.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -74.11 -36.74 64.23 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 119.69 1.132 . . . . 0.0 112.711 174.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 73.7 mmt-85 -99.31 -28.02 13.5 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 -172.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.3 p -136.76 163.89 29.55 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.313 1.045 . . . . 0.0 113.442 -162.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -122.88 -26.04 4.5 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.949 1.3 . . . . 0.0 113.189 165.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -85.44 48.16 1.54 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 125.427 1.491 . . . . 0.0 113.569 -178.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.04 134.17 58.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 126.128 1.771 . . . . 0.0 112.083 -176.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.692 ' HG1' ' ND2' ' A' ' 13' ' ' ASN . 4.1 m -121.09 136.87 54.89 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.817 1.647 . . . . 0.0 110.66 171.254 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.1 p -127.17 141.29 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 125.013 1.325 . . . . 0.0 113.002 173.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 56.9 m-70 -119.43 135.82 54.58 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 128.641 2.776 . . . . 0.0 109.804 -176.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -109.25 93.18 4.38 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.251 0.62 . . . . 0.0 111.668 -173.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . 0.266 34.5 m -79.76 44.81 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 CA-C-O 123.117 1.437 . . . . 0.0 114.578 -173.323 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -145.84 -27.3 0.44 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 129.057 2.943 . . . . 0.0 110.217 172.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 28.2 mmmt -70.45 -39.06 74.56 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.444 1.098 . . . . 0.0 110.478 155.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 14.3 ttt -69.71 127.94 34.71 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.703 0.801 . . . . 0.0 111.579 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 9.1 m -78.92 -18.78 53.26 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.725 1.21 . . . . 0.0 113.927 179.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -95.54 -5.29 43.09 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.944 1.297 . . . . 0.0 112.807 167.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -51.34 -25.54 12.43 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 126.067 1.794 . . . . 0.0 116.841 -169.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -73.22 -28.13 61.99 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 118.871 1.336 . . . . 0.0 112.673 177.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 14.4 tm0? -70.04 -37.36 75.54 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.409 1.084 . . . . 0.0 110.714 172.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -74.43 -36.19 63.39 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.825 1.25 . . . . 0.0 112.52 177.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 72.0 mtp180 -54.13 -40.17 67.14 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 119.097 0.862 . . . . 0.0 111.158 162.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.45 -33.36 86.24 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 125.256 1.408 . . . . 0.0 114.631 172.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -63.51 -42.56 98.47 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 120.414 2.107 . . . . 0.0 111.088 175.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 26.4 mt -69.64 -39.47 78.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 123.828 0.851 . . . . 0.0 110.308 177.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -70.28 -44.23 68.8 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 121.148 -0.97 . . . . 0.0 112.808 -179.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -62.6 -30.66 71.51 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 118.93 0.786 . . . . 0.0 112.477 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -83.47 -55.09 4.5 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 174.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -117.84 -1.74 11.48 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.446 1.098 . . . . 0.0 113.918 -161.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.5 mmtp 54.21 29.74 11.08 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 126.364 1.866 . . . . 0.0 114.102 -178.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -99.74 119.88 38.84 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.087 1.755 . . . . 0.0 109.939 -179.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -115.37 -17.75 11.2 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.01 1.324 . . . . 0.0 114.502 -172.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.3 p -75.2 166.48 23.57 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.564 1.146 . . . . 0.0 112.419 172.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 21.6 m -120.52 151.27 53.73 Favored Pre-proline 0 N--CA 1.475 0.783 0 C-N-CA 124.912 1.285 . . . . 0.0 110.609 166.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -78.32 154.56 93.03 Favored 'Cis proline' 0 C--N 1.349 0.56 0 CA-C-N 118.986 0.673 . . . . 0.0 113.561 -0.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -104.84 135.25 46.56 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.144 1.378 . . . . 0.0 108.776 161.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.9 mt -126.69 142.78 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.391 1.076 . . . . 0.0 109.514 -167.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -139.9 136.41 33.87 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.274 1.03 . . . . 0.0 110.272 178.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 52.5 mt -133.84 122.03 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.02 0.928 . . . . 0.0 110.403 -176.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 48.5 m-20 49.75 30.91 4.02 Favored 'General case' 0 CA--C 1.554 1.114 0 O-C-N 121.238 -0.914 . . . . 0.0 113.257 -175.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 95.21 -8.99 69.91 Favored Glycine 0 CA--C 1.54 1.602 0 N-CA-C 117.606 1.802 . . . . 0.0 117.606 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 25.4 p30 -76.33 169.28 18.53 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 121.248 2.524 . . . . 0.0 113.482 175.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -108.16 129.45 55.18 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.447 0.699 . . . . 0.0 111.808 169.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 45.5 mm -113.99 121.88 67.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 126.611 1.964 . . . . 0.0 108.64 -178.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -74.14 21.77 1.34 Allowed Glycine 0 N--CA 1.472 1.073 0 N-CA-C 118.569 2.188 . . . . 0.0 118.569 -164.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 121.39 -172.03 15.18 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 126.639 2.066 . . . . 0.0 115.058 174.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 29.9 t -66.49 -38.51 87.43 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 121.853 -0.792 . . . . 0.0 113.033 -174.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 63.4 m -63.1 -20.27 65.21 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 176.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -90.13 -43.6 10.35 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.763 1.225 . . . . 0.0 111.008 175.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 48.4 tp -57.43 -49.48 76.1 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.442 1.097 . . . . 0.0 111.435 174.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -67.28 -29.43 69.03 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.26 0.624 . . . . 0.0 111.825 177.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -73.3 -40.2 64.72 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 121.025 -1.047 . . . . 0.0 112.672 176.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 75.8 mt -65.29 -28.2 69.16 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.083 0.953 . . . . 0.0 112.616 177.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -59.78 -47.44 85.69 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.535 1.134 . . . . 0.0 111.515 171.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -68.71 -40.74 79.83 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.199 1.0 . . . . 0.0 112.944 178.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -73.3 2.87 6.62 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 70.0 16.5 72.78 Favored Glycine 0 CA--C 1.538 1.508 0 O-C-N 120.332 -1.48 . . . . 0.0 114.145 178.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 44.4 mtmt -100.29 -34.23 10.08 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.874 1.669 . . . . 0.0 112.592 -175.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 54.4 tp -59.39 -41.36 89.23 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.244 0.929 . . . . 0.0 111.411 175.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -57.21 -41.0 78.59 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.805 0.842 . . . . 0.0 113.134 176.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -76.58 -34.05 45.59 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 124.542 1.068 . . . . 0.0 113.376 178.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 62.9 mt -65.07 -23.21 67.1 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.909 0.884 . . . . 0.0 112.483 172.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 46.5 mt -100.65 -3.29 30.63 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 126.069 1.748 . . . . 0.0 113.751 177.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 69.3 m . . . . . 0 C--O 1.253 1.277 0 C-N-CA 125.311 1.445 . . . . 0.0 112.091 -179.284 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.257 0 N-CA-C 110.731 -0.948 . . . . 0.0 110.731 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.69 138.58 37.39 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 117.767 0.784 . . . . 0.0 110.679 172.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 3.0 tpt 49.88 57.23 17.96 Favored Pre-proline 0 CA--C 1.554 1.107 0 C-N-CA 124.711 1.204 . . . . 0.0 112.286 -172.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.5 139.7 41.78 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 123.699 2.933 . . . . 0.0 113.061 -167.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 25.5 p -151.51 -167.63 2.85 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.175 0.99 . . . . 0.0 112.224 177.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 26.8 pt -57.21 -22.46 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 124.068 0.947 . . . . 0.0 113.127 169.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.47 -21.28 64.63 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -173.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 74.0 m -83.28 -33.02 26.08 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.291 1.037 . . . . 0.0 112.48 166.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 73.4 mtp -61.78 -25.93 67.77 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.081 0.952 . . . . 0.0 112.736 178.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.9 mm -57.66 -34.59 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.283 1.033 . . . . 0.0 112.039 175.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.3 mptt -76.95 -3.41 38.73 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.29 1.036 . . . . 0.0 113.427 -178.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -76.11 -26.51 64.03 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.791 1.186 . . . . 0.0 114.96 -176.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -146.52 171.89 14.38 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 118.662 1.231 . . . . 0.0 114.026 -173.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -66.57 -35.9 81.34 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.286 1.034 . . . . 0.0 111.886 172.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.9 t -134.57 131.49 54.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 124.857 1.263 . . . . 0.0 110.23 177.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 39.5 t -134.85 130.0 52.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.467 1.107 . . . . 0.0 110.005 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 48.8 t -131.67 148.75 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 124.224 1.01 . . . . 0.0 112.513 -171.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -125.59 110.58 14.0 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.252 1.421 . . . . 0.0 109.423 175.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 58.3 m -130.61 173.66 10.67 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.604 1.562 . . . . 0.0 111.698 -169.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 47.8 m0 -122.73 129.63 51.99 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.809 1.244 . . . . 0.0 108.63 166.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 49.0 t -63.45 -23.88 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 123.361 0.664 . . . . 0.0 112.689 -164.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.4 p -78.07 -16.49 57.98 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 177.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 84.0 m -99.51 148.37 34.62 Favored Pre-proline 0 CA--C 1.537 0.45 0 CA-C-N 120.346 1.43 . . . . 0.0 114.212 -154.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -67.76 -48.68 1.37 Allowed 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 121.282 1.321 . . . . 0.0 113.964 -165.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -69.47 -31.44 69.73 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.463 1.105 . . . . 0.0 113.364 -178.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -50.71 -54.3 24.31 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.829 0.852 . . . . 0.0 109.641 168.463 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.7 t -66.93 -39.07 82.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 123.284 0.634 . . . . 0.0 111.658 -177.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 17.3 mmt85 -54.26 -49.2 70.1 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 118.612 0.642 . . . . 0.0 111.565 172.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.71 -57.94 7.64 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.93 0.892 . . . . 0.0 112.429 176.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -48.19 -44.51 32.79 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.538 1.135 . . . . 0.0 112.963 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -65.85 -43.34 88.75 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 123.727 0.811 . . . . 0.0 111.943 -177.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.6 tt -72.76 -34.36 66.94 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.995 1.318 . . . . 0.0 111.969 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 76.5 mt -67.47 -42.95 82.17 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.529 0.732 . . . . 0.0 111.282 172.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -60.92 -28.2 68.76 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 118.472 0.578 . . . . 0.0 112.301 167.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.73 4.07 38.37 Favored 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 114.877 1.436 . . . . 0.0 114.877 175.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -126.68 -39.72 1.97 Allowed 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 174.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 17.9 p -143.15 131.96 22.7 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 119.236 0.925 . . . . 0.0 113.343 -166.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 39.4 mtmt -70.05 -27.0 64.29 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 163.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -88.05 60.4 5.8 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.224 1.01 . . . . 0.0 113.059 -175.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.83 137.86 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 125.759 1.624 . . . . 0.0 111.622 178.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 75.6 m -120.82 135.13 55.24 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 127.288 2.235 . . . . 0.0 109.434 172.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.7 p -133.8 141.76 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 169.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 33.3 t60 -121.13 119.22 31.77 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.837 2.055 . . . . 0.0 109.632 -178.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -94.93 91.32 6.35 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.223 -0.923 . . . . 0.0 112.387 -168.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . 0.252 32.0 m -78.26 36.73 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 115.735 1.754 . . . . 0.0 115.735 -168.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -134.68 -28.68 1.22 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 127.91 2.484 . . . . 0.0 110.473 163.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 20.0 mmmt -64.09 -25.93 68.32 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.592 1.157 . . . . 0.0 112.086 160.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 91.6 mmm -91.02 144.22 25.89 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.039 1.336 . . . . 0.0 110.922 176.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.9 m -82.55 -27.09 31.85 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -174.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -99.12 8.02 45.29 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.255 1.822 . . . . 0.0 112.877 178.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -52.35 -26.56 22.4 Favored Glycine 0 CA--C 1.537 1.467 0 N-CA-C 116.751 1.46 . . . . 0.0 116.751 -173.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 70.2 mt-10 -70.39 -26.67 63.81 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 120.76 2.28 . . . . 0.0 112.895 174.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -78.08 -28.26 48.71 Favored 'General case' 0 N--CA 1.469 0.488 0 O-C-N 120.98 -1.075 . . . . 0.0 111.611 173.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -80.88 -33.21 34.5 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.539 -0.726 . . . . 0.0 111.343 175.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 56.5 mtp180 -58.82 -33.53 70.48 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 120.852 -1.155 . . . . 0.0 111.521 161.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -56.31 -40.18 84.36 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 124.013 0.816 . . . . 0.0 113.919 168.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -66.55 -24.8 66.42 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 119.442 1.621 . . . . 0.0 113.172 175.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 52.3 mt -81.43 -46.07 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 124.565 1.146 . . . . 0.0 109.725 175.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -69.38 -44.2 71.96 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 121.42 -0.8 . . . . 0.0 112.192 -178.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -58.11 -41.2 83.06 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.415 -0.803 . . . . 0.0 112.216 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -89.11 -37.83 14.79 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 114.247 1.202 . . . . 0.0 114.247 -175.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -124.25 -2.01 8.12 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 -170.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 53.71 47.99 22.51 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 126.703 2.001 . . . . 0.0 113.369 -176.171 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -132.2 142.39 49.42 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.679 1.192 . . . . 0.0 111.781 175.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -135.71 -28.83 1.08 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.076 1.35 . . . . 0.0 112.996 -157.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 20.8 p -79.12 167.05 21.57 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 128.023 2.529 . . . . 0.0 113.265 177.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 26.8 m -114.99 152.92 47.02 Favored Pre-proline 0 N--CA 1.48 1.063 0 C-N-CA 124.173 0.989 . . . . 0.0 112.694 173.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -77.28 143.28 74.54 Favored 'Cis proline' 0 C--N 1.349 0.592 0 CA-C-N 119.18 0.743 . . . . 0.0 112.498 -6.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -97.63 127.9 43.93 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 165.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 35.4 mt -123.73 142.37 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 124.128 0.971 . . . . 0.0 109.527 -165.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -137.63 143.03 41.22 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.813 0.845 . . . . 0.0 111.666 177.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 89.1 mt -130.01 119.65 47.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 125.165 1.386 . . . . 0.0 108.753 176.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 44.2 46.1 7.28 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 125.112 1.365 . . . . 0.0 113.178 -177.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 77.65 -2.35 63.72 Favored Glycine 0 CA--C 1.541 1.716 0 N-CA-C 117.066 1.586 . . . . 0.0 117.066 -178.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 25.7 m-80 -88.5 138.09 31.74 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 120.291 2.046 . . . . 0.0 110.326 175.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -82.61 136.11 34.89 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 118.994 0.816 . . . . 0.0 112.37 176.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 40.6 mm -115.98 124.97 72.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 127.016 2.126 . . . . 0.0 108.928 -178.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -68.72 2.63 7.63 Favored Glycine 0 CA--C 1.535 1.313 0 N-CA-C 119.25 2.46 . . . . 0.0 119.25 -163.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 142.6 -171.25 24.83 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 126.137 1.827 . . . . 0.0 113.216 175.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 42.4 t -64.07 -40.87 97.2 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 121.757 -0.849 . . . . 0.0 112.4 -177.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 68.1 m -72.89 -21.06 60.98 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.131 -0.981 . . . . 0.0 113.374 178.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -73.26 -42.65 62.24 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.262 0.937 . . . . 0.0 111.882 167.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 53.5 tp -61.06 -45.17 95.83 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.956 0.902 . . . . 0.0 110.988 175.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -64.71 -38.98 92.85 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 122.065 -0.397 . . . . 0.0 111.823 173.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.08 -36.95 83.23 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.081 -1.012 . . . . 0.0 112.106 178.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 92.4 mt -67.79 -28.69 67.81 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.69 -0.631 . . . . 0.0 112.173 175.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -69.7 -43.82 71.67 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.313 0.645 . . . . 0.0 111.098 173.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -69.93 -36.19 75.12 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.299 1.039 . . . . 0.0 113.065 175.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -73.15 -7.68 52.45 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.157 1.383 . . . . 0.0 113.299 175.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 79.37 10.13 86.27 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 123.846 0.736 . . . . 0.0 114.523 177.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 40.7 mtmt -91.11 -30.62 16.62 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 126.424 1.89 . . . . 0.0 112.527 -174.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 19.5 tp -61.97 -35.91 79.88 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 119.147 0.885 . . . . 0.0 111.392 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -65.55 -35.62 81.38 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.19 0.996 . . . . 0.0 112.318 171.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -77.36 -23.77 67.33 Favored Glycine 0 CA--C 1.532 1.121 0 O-C-N 120.879 -1.138 . . . . 0.0 114.566 177.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 86.8 mt -86.95 -27.38 23.34 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.412 1.485 . . . . 0.0 113.021 176.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 74.8 mt -117.93 -16.84 9.86 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 -170.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.7 m . . . . . 0 C--O 1.254 1.322 0 C-N-CA 126.625 1.97 . . . . 0.0 114.152 177.278 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.062 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.37 156.32 31.3 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -175.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.4 ttt -116.52 85.57 16.74 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 124.857 1.263 . . . . 0.0 111.789 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -76.76 146.53 26.68 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.785 2.323 . . . . 0.0 112.833 177.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 44.1 p -86.6 -169.88 2.83 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.453 1.501 . . . . 0.0 111.786 169.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 11.5 pt -50.98 -23.32 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.841 1.256 . . . . 0.0 113.553 168.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.69 -27.27 69.13 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -175.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.6 m -85.4 -11.44 54.46 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 172.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 55.7 mtt -68.79 -32.7 72.63 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 120.795 -1.19 . . . . 0.0 111.176 170.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.3 mm -60.51 -30.41 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 123.788 0.835 . . . . 0.0 111.905 -176.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.0 mttm -74.28 -8.9 57.82 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.825 1.25 . . . . 0.0 113.725 -177.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -89.8 -28.37 18.86 Favored Glycine 0 CA--C 1.537 1.41 0 N-CA-C 116.961 1.544 . . . . 0.0 116.961 -166.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.532 ' ND2' ' HG1' ' A' ' 41' ' ' THR . 35.2 m-80 -145.07 159.27 43.22 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.504 1.522 . . . . 0.0 111.05 -178.311 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -52.91 -42.29 65.23 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.711 1.605 . . . . 0.0 113.63 178.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.2 t -125.09 135.68 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.809 1.244 . . . . 0.0 110.464 174.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 48.4 t -133.85 131.73 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.394 1.078 . . . . 0.0 110.46 178.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.4 t -129.36 147.43 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 125.265 1.426 . . . . 0.0 111.545 -172.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -124.3 115.39 20.94 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.18 0.992 . . . . 0.0 109.212 172.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.403 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 21.0 m -130.19 168.22 17.17 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 126.18 1.792 . . . . 0.0 111.022 -168.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.422 ' CD1' ' HB3' ' A' ' 46' ' ' ASP . 19.5 m0 -111.81 135.79 51.96 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 157.232 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 72.2 t -59.22 -28.23 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 O-C-N 123.189 0.305 . . . . 0.0 111.109 175.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 48.7 p -67.65 -20.33 65.31 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 175.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 46.0 t -89.76 143.81 30.8 Favored Pre-proline 0 CA--C 1.538 0.491 0 O-C-N 121.281 -0.887 . . . . 0.0 111.193 -163.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -77.05 -39.48 0.6 Allowed 'Trans proline' 0 N--CA 1.459 -0.544 0 CA-C-N 119.656 0.913 . . . . 0.0 114.122 177.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -58.82 -36.33 74.32 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.049 1.739 . . . . 0.0 113.4 175.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.403 ' SG ' ' HB3' ' A' ' 19' ' ' SER . 0.3 OUTLIER -52.63 -55.67 20.82 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.949 1.3 . . . . 0.0 109.14 171.847 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.8 t -65.9 -39.99 86.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 123.53 0.732 . . . . 0.0 111.124 -178.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . 0.288 2.4 ttp180 -54.22 -28.84 43.67 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.012 1.725 . . . . 0.0 115.369 167.036 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -85.38 -55.53 3.97 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 119.911 1.232 . . . . 0.0 111.883 167.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -48.37 -38.33 19.06 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.96 1.704 . . . . 0.0 113.776 -178.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -75.0 -43.69 52.45 Favored 'General case' 0 C--O 1.231 0.081 0 C-N-CA 124.385 1.074 . . . . 0.0 111.889 -177.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 8.4 tt -71.53 -39.56 70.67 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 124.714 1.206 . . . . 0.0 110.888 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 88.8 mt -61.75 -51.77 66.97 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.56 0.744 . . . . 0.0 110.746 176.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 24.2 m-70 -65.87 -15.92 63.37 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 172.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.72 -43.84 24.87 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 119.844 1.202 . . . . 0.0 111.43 169.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 68.7 mmt-85 -82.0 -50.41 9.15 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.219 1.008 . . . . 0.0 113.43 -171.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 21.9 m -160.54 129.09 4.7 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 125.106 1.362 . . . . 0.0 111.95 177.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 42.9 mttm -85.98 2.25 46.99 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 126.007 1.723 . . . . 0.0 115.228 -166.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -82.31 53.83 2.39 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.534 1.133 . . . . 0.0 112.04 172.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -118.87 127.43 75.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 126.567 1.947 . . . . 0.0 111.14 -177.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.532 ' HG1' ' ND2' ' A' ' 13' ' ' ASN . 3.6 m -110.78 141.31 44.28 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 126.067 1.747 . . . . 0.0 110.44 171.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.6 p -137.47 135.92 46.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 C-N-CA 124.535 1.134 . . . . 0.0 112.766 175.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -110.79 125.9 54.04 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.379 1.472 . . . . 0.0 109.45 175.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -97.21 88.27 4.41 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 122.526 1.155 . . . . 0.0 110.966 -174.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 22.1 m -64.6 -12.86 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 -174.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.422 ' HB3' ' CD1' ' A' ' 20' ' ' TRP . 0.1 OUTLIER -73.69 -21.37 60.27 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.619 1.168 . . . . 0.0 113.323 172.612 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -86.78 -27.1 23.8 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.257 1.423 . . . . 0.0 113.14 177.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 90.7 mtp -69.55 154.28 42.24 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.724 1.61 . . . . 0.0 112.117 175.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 8.6 t -84.02 -24.85 30.34 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.902 0.881 . . . . 0.0 111.691 163.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -93.47 -5.38 49.33 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.49 1.516 . . . . 0.0 114.779 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -57.41 -24.16 51.09 Favored Glycine 0 CA--C 1.536 1.386 0 N-CA-C 116.147 1.219 . . . . 0.0 116.147 -172.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -69.65 -22.49 63.46 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 118.687 1.243 . . . . 0.0 112.898 174.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -82.0 -35.63 28.68 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.937 0.895 . . . . 0.0 111.345 170.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -74.45 -32.94 62.78 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.132 -0.98 . . . . 0.0 111.996 177.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 62.0 mtp180 -53.71 -39.97 65.67 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 121.123 -0.985 . . . . 0.0 111.632 162.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -67.83 -37.06 88.05 Favored Glycine 0 CA--C 1.535 1.321 0 CA-C-O 118.3 -1.278 . . . . 0.0 114.155 172.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -60.72 -32.32 71.59 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 120.746 2.273 . . . . 0.0 113.296 174.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 57.2 mt -75.53 -43.99 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 123.904 0.882 . . . . 0.0 109.95 174.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 19.0 t80 -67.7 -43.19 80.68 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.026 -1.046 . . . . 0.0 112.728 -177.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -67.38 -15.2 63.55 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 113.944 1.091 . . . . 0.0 113.944 178.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -106.71 -26.54 11.27 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 177.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -143.44 4.84 1.4 Allowed 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 115.858 1.799 . . . . 0.0 115.858 -170.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm 54.42 24.49 5.26 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 127.608 2.363 . . . . 0.0 116.952 178.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 -101.52 111.13 23.27 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.057 1.343 . . . . 0.0 111.615 -174.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -96.36 -17.16 20.85 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 178.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 98.3 m -72.52 153.71 41.19 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.682 1.593 . . . . 0.0 111.862 176.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.7 m -115.99 151.74 46.85 Favored Pre-proline 0 N--CA 1.477 0.904 0 C-N-CA 123.713 0.805 . . . . 0.0 111.546 165.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -74.19 155.62 99.84 Favored 'Cis proline' 0 N--CA 1.459 -0.539 0 CA-C-N 119.207 0.753 . . . . 0.0 112.944 -3.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -98.13 139.33 34.1 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.542 1.137 . . . . 0.0 108.447 159.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 53.0 mt -129.91 140.81 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 123.972 0.909 . . . . 0.0 109.487 -165.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -138.13 143.13 40.2 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.126 0.97 . . . . 0.0 111.18 178.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 72.4 mt -135.22 123.13 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 125.346 1.458 . . . . 0.0 109.17 -178.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 45.27 48.33 10.26 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 124.902 1.281 . . . . 0.0 113.371 -179.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 75.04 10.92 84.19 Favored Glycine 0 CA--C 1.539 1.545 0 N-CA-C 116.066 1.186 . . . . 0.0 116.066 179.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 21.1 m-80 -116.04 140.39 49.32 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.472 1.509 . . . . 0.0 111.683 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -82.47 131.9 35.21 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.596 1.158 . . . . 0.0 112.944 179.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 41.1 mm -107.25 123.43 62.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 127.047 2.139 . . . . 0.0 108.288 177.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.18 12.02 0.66 Allowed Glycine 0 CA--C 1.531 1.055 0 N-CA-C 119.089 2.395 . . . . 0.0 119.089 -166.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 142.36 -177.1 21.83 Favored Glycine 0 CA--C 1.535 1.316 0 C-N-CA 127.582 2.515 . . . . 0.0 113.643 170.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 39.1 t -57.09 -42.86 81.52 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.721 -0.87 . . . . 0.0 111.458 173.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 68.5 m -65.53 -26.06 67.72 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 178.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.44 -40.56 64.13 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 119.703 1.138 . . . . 0.0 111.768 172.08 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 40.1 tp -60.55 -48.96 79.45 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.865 0.866 . . . . 0.0 110.738 173.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -66.19 -34.36 77.86 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.522 0.729 . . . . 0.0 111.438 177.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.85 -35.66 74.9 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 120.227 -1.546 . . . . 0.0 112.79 175.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 84.0 mt -72.55 -31.05 64.97 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.216 1.007 . . . . 0.0 112.777 173.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -59.4 -48.55 81.2 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.788 0.835 . . . . 0.0 110.109 166.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.92 -34.4 75.33 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 -178.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -75.74 0.72 16.86 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 172.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 71.05 21.47 78.36 Favored Glycine 0 CA--C 1.534 1.219 0 O-C-N 121.322 -0.861 . . . . 0.0 113.445 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt -101.38 -25.96 13.76 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 125.688 1.595 . . . . 0.0 113.107 -174.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 39.4 tp -64.2 -37.4 87.33 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.267 1.027 . . . . 0.0 112.189 176.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -52.8 -44.09 66.39 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.002 0.921 . . . . 0.0 111.973 173.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -75.01 -29.78 60.2 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.044 0.831 . . . . 0.0 114.525 178.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 85.1 mt -66.09 -40.84 91.13 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 118.382 1.091 . . . . 0.0 111.356 170.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 86.4 mt -90.53 -18.87 24.51 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 -170.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 72.7 m . . . . . 0 C--O 1.252 1.205 0 C-N-CA 124.506 1.122 . . . . 0.0 113.385 -179.286 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.105 0 N-CA-C 111.261 -0.736 . . . . 0.0 111.261 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -81.66 161.47 23.4 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.651 1.18 . . . . 0.0 113.068 -176.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 16.6 tpt -70.06 140.48 88.4 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 124.062 0.945 . . . . 0.0 110.796 176.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -75.5 130.24 12.6 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.502 2.135 . . . . 0.0 111.129 171.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 17.5 p -132.05 -162.48 1.23 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.323 1.049 . . . . 0.0 111.865 176.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 16.2 pt -51.03 -24.04 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 124.496 1.118 . . . . 0.0 113.589 173.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.86 -27.99 67.14 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.87 0.868 . . . . 0.0 113.094 -175.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.1 p -80.65 -28.82 36.78 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 121.242 -0.911 . . . . 0.0 113.426 174.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 43.3 mtt -63.97 -35.47 80.79 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.29 1.036 . . . . 0.0 110.478 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -62.88 -27.39 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 125.89 1.676 . . . . 0.0 111.826 -176.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 45.2 mmtm -79.21 -17.04 55.61 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.018 1.327 . . . . 0.0 113.779 -175.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -87.34 -26.77 29.64 Favored Glycine 0 CA--C 1.533 1.198 0 N-CA-C 116.331 1.292 . . . . 0.0 116.331 -167.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.528 ' ND2' ' HG1' ' A' ' 41' ' ' THR . 69.4 m-80 -134.05 153.77 51.59 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.694 1.197 . . . . 0.0 111.628 -178.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -62.77 -34.62 77.62 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.002 0.741 . . . . 0.0 113.002 -174.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.4 t -122.27 131.53 72.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.373 1.069 . . . . 0.0 109.896 167.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 65.1 t -132.01 127.77 58.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.158 0.983 . . . . 0.0 109.571 176.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 37.5 t -126.28 147.3 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 123.929 0.892 . . . . 0.0 111.773 -175.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -122.55 108.81 13.56 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.568 1.147 . . . . 0.0 109.44 176.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 37.1 m -128.93 173.88 10.01 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 126.638 1.975 . . . . 0.0 111.458 -167.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 28.9 m0 -120.11 144.58 47.54 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.367 1.067 . . . . 0.0 109.699 163.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.5 t -68.73 -17.2 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 CA-C-O 120.934 0.397 . . . . 0.0 111.079 178.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.3 p -86.31 -10.81 53.75 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 128.066 2.547 . . . . 0.0 116.579 178.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.9 t -96.45 143.42 26.08 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-N 120.017 1.28 . . . . 0.0 112.731 -170.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -72.21 -40.19 2.55 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 121.28 1.32 . . . . 0.0 113.634 173.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -58.0 -36.81 73.18 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.334 1.453 . . . . 0.0 113.802 179.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -54.02 -61.22 2.45 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.477 1.911 . . . . 0.0 109.573 174.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 92.0 t -60.9 -39.37 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.346 1.058 . . . . 0.0 111.104 -179.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.2 ttt180 -52.54 -38.57 60.02 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.684 1.594 . . . . 0.0 114.901 169.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -79.53 -54.59 5.75 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 119.079 0.854 . . . . 0.0 111.79 171.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -48.19 -43.35 31.72 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.386 1.474 . . . . 0.0 113.137 -178.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -62.3 -40.22 95.57 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 123.722 0.809 . . . . 0.0 112.35 -175.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.4 tt -79.08 -42.34 26.59 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 126.538 1.935 . . . . 0.0 110.867 -178.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 91.5 mt -62.07 -40.66 96.56 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 121.868 -0.52 . . . . 0.0 111.665 177.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -71.27 -24.48 62.17 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 172.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.56 -25.04 53.62 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 120.144 1.338 . . . . 0.0 112.921 174.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 7.5 tpt180 -106.88 -31.98 8.12 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.868 1.667 . . . . 0.0 114.823 -170.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 13.6 p -134.05 154.44 51.15 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 -166.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -103.81 -31.91 9.58 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 127.406 2.282 . . . . 0.0 112.455 174.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -93.06 38.52 1.03 Allowed 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 125.451 1.5 . . . . 0.0 113.186 -171.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.14 122.4 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 124.974 1.309 . . . . 0.0 112.96 -175.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.528 ' HG1' ' ND2' ' A' ' 13' ' ' ASN . 3.9 m -113.3 135.28 54.02 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.811 1.645 . . . . 0.0 109.847 170.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.3 p -124.21 138.05 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.457 1.103 . . . . 0.0 112.304 171.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -109.37 125.95 52.91 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.015 1.726 . . . . 0.0 110.637 177.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -98.17 79.82 2.62 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.351 1.061 . . . . 0.0 110.233 -177.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 31.0 m -56.89 -28.55 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -167.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -70.66 -14.25 62.4 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 124.329 1.052 . . . . 0.0 113.693 176.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.2 mmmt -83.0 -13.02 56.76 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 126.3 1.84 . . . . 0.0 112.559 173.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 22.3 mmt -101.5 172.26 7.07 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.178 1.791 . . . . 0.0 111.787 -178.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.0 m -81.19 -18.75 45.12 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 121.063 -1.023 . . . . 0.0 113.331 -177.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -122.05 8.29 9.82 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.702 1.601 . . . . 0.0 114.42 -163.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -55.45 -27.98 49.51 Favored Glycine 0 CA--C 1.538 1.523 0 CA-C-N 120.035 1.289 . . . . 0.0 115.18 -172.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -67.82 -31.65 71.65 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 119.973 1.886 . . . . 0.0 113.088 171.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 63.8 mt-30 -73.69 -38.55 64.85 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.686 1.194 . . . . 0.0 111.344 173.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -75.18 -33.9 61.49 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.484 1.038 . . . . 0.0 111.962 177.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 15.7 mtp85 -55.32 -41.06 71.93 Favored 'General case' 0 N--CA 1.478 0.965 0 O-C-N 120.953 -1.092 . . . . 0.0 111.303 161.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.38 -24.16 67.27 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 124.444 1.021 . . . . 0.0 115.127 171.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 -71.45 -37.29 71.41 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 120.471 2.136 . . . . 0.0 111.72 172.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 44.1 mt -72.35 -43.55 64.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 123.948 0.899 . . . . 0.0 109.539 179.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -67.76 -42.75 81.27 Favored 'General case' 0 CA--C 1.532 0.262 0 O-C-N 121.298 -0.876 . . . . 0.0 112.914 -178.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -65.7 -26.06 67.6 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -177.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -100.19 -29.55 12.42 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -131.58 -2.41 3.81 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 114.752 1.39 . . . . 0.0 114.752 -172.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt 51.33 39.0 23.11 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 126.152 1.781 . . . . 0.0 113.629 -175.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -123.52 138.66 54.52 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 126.828 2.051 . . . . 0.0 110.701 -178.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -142.39 -33.17 0.48 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.603 1.561 . . . . 0.0 111.966 -155.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.7 p -84.03 113.18 20.83 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.43 1.492 . . . . 0.0 113.102 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.2 m -66.77 153.54 93.64 Favored Pre-proline 0 N--CA 1.484 1.245 0 C-N-CA 124.811 1.245 . . . . 0.0 113.1 -179.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -75.89 151.94 96.21 Favored 'Cis proline' 0 C--N 1.352 0.715 0 CA-C-N 119.327 0.795 . . . . 0.0 113.918 -6.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -93.79 137.05 33.44 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 159.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 46.3 mt -125.1 141.64 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 124.209 1.004 . . . . 0.0 109.243 -168.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -142.41 147.09 35.62 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.391 0.676 . . . . 0.0 111.587 179.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 74.9 mt -127.91 123.37 60.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 125.277 1.431 . . . . 0.0 108.099 175.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 50.62 27.57 3.02 Favored 'General case' 0 CA--C 1.555 1.149 0 N-CA-C 115.257 1.577 . . . . 0.0 115.257 -177.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 89.89 -7.39 81.81 Favored Glycine 0 CA--C 1.543 1.827 0 O-C-N 120.697 -1.252 . . . . 0.0 115.257 -173.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -90.86 143.3 26.87 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.103 1.761 . . . . 0.0 110.336 179.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -90.19 142.6 27.56 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 -167.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 15.9 mm -130.84 125.49 58.36 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 C-N-CA 128.245 2.618 . . . . 0.0 108.981 176.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.7 -13.94 64.3 Favored Glycine 0 CA--C 1.538 1.488 0 N-CA-C 117.166 1.627 . . . . 0.0 117.166 -168.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 158.25 -175.24 35.44 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-N 118.271 1.035 . . . . 0.0 113.528 175.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 14.7 t -63.43 -35.36 80.18 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.507 -0.996 . . . . 0.0 112.943 -178.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 52.2 m -64.65 -23.1 67.15 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 121.113 -0.992 . . . . 0.0 113.271 176.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -88.17 -39.74 14.28 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.504 1.522 . . . . 0.0 112.702 174.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 37.7 tp -58.21 -51.93 67.68 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.38 1.472 . . . . 0.0 111.502 171.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -63.17 -24.52 67.93 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.041 0.536 . . . . 0.0 111.714 178.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -78.84 -31.96 45.9 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 121.304 -0.872 . . . . 0.0 113.334 176.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 14.2 mt -65.34 -34.91 79.43 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 119.278 0.944 . . . . 0.0 112.059 169.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -61.6 -44.87 96.2 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.861 0.864 . . . . 0.0 110.932 171.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.1 mmtt -71.54 -30.4 65.85 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -177.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -72.86 -10.88 60.3 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 172.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 74.89 30.24 59.73 Favored Glycine 0 CA--C 1.533 1.19 0 O-C-N 121.292 -0.88 . . . . 0.0 113.649 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 45.8 mtmt -118.97 -16.0 9.25 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 126.668 1.987 . . . . 0.0 113.021 -169.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 35.1 tp -71.35 -38.94 71.58 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.857 1.263 . . . . 0.0 111.915 -175.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -65.46 -28.42 69.2 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 178.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -85.31 -12.7 72.62 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 125.622 1.582 . . . . 0.0 115.22 172.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 24.9 mt -81.2 -39.31 25.62 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 119.377 1.589 . . . . 0.0 111.055 165.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 79.3 mt -89.29 26.25 1.7 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 126.328 1.851 . . . . 0.0 113.035 -175.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 10.7 p . . . . . 0 C--O 1.251 1.143 0 C-N-CA 127.099 2.159 . . . . 0.0 114.673 -177.502 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.861 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -58.72 -23.44 59.71 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.86 1.264 . . . . 0.0 114.378 179.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 63.7 mtt -121.65 156.9 58.15 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 125.798 1.639 . . . . 0.0 109.021 158.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -64.5 112.04 1.83 Allowed 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.02 1.813 . . . . 0.0 112.192 -175.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 59.8 p -107.52 -161.57 0.79 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 126.082 1.753 . . . . 0.0 110.616 179.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 29.9 pt -56.08 -25.68 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 O-C-N 120.762 -1.211 . . . . 0.0 112.49 168.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.96 -19.77 65.98 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -173.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.3 m -89.08 -19.84 25.07 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.425 1.09 . . . . 0.0 113.256 173.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 66.4 mtp -62.53 -33.35 74.72 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 119.39 0.995 . . . . 0.0 111.804 172.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.2 mm -60.47 -18.09 15.99 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 124.672 1.189 . . . . 0.0 112.267 -177.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.2 mptt -91.37 -9.02 46.34 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.245 1.418 . . . . 0.0 113.859 177.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -88.19 -39.04 7.02 Favored Glycine 0 CA--C 1.538 1.528 0 C-N-CA 124.715 1.15 . . . . 0.0 115.814 -175.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 29.1 m120 -120.96 167.33 12.69 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.369 1.467 . . . . 0.0 112.072 -178.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -68.83 -42.02 77.74 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.57 0.748 . . . . 0.0 112.67 176.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.9 t -125.5 134.17 67.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.95 1.3 . . . . 0.0 110.2 176.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 27.1 t -134.74 135.1 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.249 1.02 . . . . 0.0 110.361 177.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 53.0 t -134.42 149.24 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 124.55 1.14 . . . . 0.0 112.085 -171.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -129.69 123.1 30.32 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.993 1.317 . . . . 0.0 110.873 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 54.1 m -143.9 169.92 16.88 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 114.452 1.278 . . . . 0.0 114.452 -159.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.447 ' CD1' ' HB3' ' A' ' 46' ' ' ASP . 40.5 m0 -115.17 139.5 49.87 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.547 1.539 . . . . 0.0 109.616 161.224 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.418 ' HB ' ' HE2' ' A' ' 47' ' ' LYS . 24.8 t -60.21 -53.72 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 -161.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.7 t -94.23 3.43 55.26 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 -164.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 96.4 m -88.76 142.31 30.6 Favored Pre-proline 0 CA--C 1.542 0.667 0 C-N-CA 124.328 1.051 . . . . 0.0 112.599 -165.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -68.0 -36.97 16.09 Favored 'Trans proline' 0 C--N 1.351 0.68 0 N-CA-C 115.677 1.376 . . . . 0.0 115.677 -162.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -52.93 -41.83 64.83 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 122.24 1.019 . . . . 0.0 113.075 171.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 3.8 m -81.73 -32.52 31.53 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.359 -162.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 99.6 t -62.46 -53.07 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 124.954 1.301 . . . . 0.0 111.51 161.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . 0.263 7.2 ptp180 -67.45 -29.27 68.69 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -173.032 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.28 -53.24 13.05 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.438 1.095 . . . . 0.0 111.685 171.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -46.65 -44.88 18.8 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-N 119.91 1.232 . . . . 0.0 112.879 175.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -64.07 -45.58 88.13 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.501 0.72 . . . . 0.0 112.595 -179.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.2 tt -72.4 -36.55 68.68 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.446 1.098 . . . . 0.0 111.206 -178.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 95.9 mt -61.1 -46.54 90.19 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.443 -0.785 . . . . 0.0 110.735 171.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 8.7 m-70 -66.83 -21.71 66.02 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 173.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -73.0 -18.44 61.35 Favored 'General case' 0 CA--C 1.545 0.782 0 O-C-N 120.716 -1.24 . . . . 0.0 113.069 173.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 21.7 mmt85 -115.73 -19.83 10.34 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 -179.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 48.8 p -147.32 166.89 25.74 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 115.394 1.627 . . . . 0.0 115.394 -166.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 28.9 mtmm -116.69 -32.05 5.29 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 127.165 2.186 . . . . 0.0 113.623 162.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -82.73 50.59 1.71 Allowed 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -175.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.2 113.07 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 126.16 1.784 . . . . 0.0 111.964 177.116 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.4 m -100.49 142.91 31.32 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 127.014 2.125 . . . . 0.0 110.097 175.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.7 p -145.24 140.58 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -178.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 38.8 t60 -116.67 131.8 56.85 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 126.595 1.958 . . . . 0.0 110.98 -176.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -101.93 96.62 7.16 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 122.761 1.267 . . . . 0.0 111.973 -177.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 22.4 m -80.43 -1.63 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -174.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.447 ' HB3' ' CD1' ' A' ' 20' ' ' TRP . 0.0 OUTLIER -83.64 -12.11 56.4 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.146 0.978 . . . . 0.0 112.085 162.855 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.418 ' HE2' ' HB ' ' A' ' 21' ' ' VAL . 70.0 mmtt -107.29 -44.07 4.43 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.588 1.555 . . . . 0.0 112.013 179.064 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 29.2 tpp -67.97 127.23 32.07 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 118.833 0.742 . . . . 0.0 110.224 176.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 62.8 m -68.42 -29.49 68.17 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 119.373 0.988 . . . . 0.0 113.354 -174.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 20.5 tp10 -79.74 -3.09 46.01 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.021 0.928 . . . . 0.0 112.648 170.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -56.53 -26.27 51.93 Favored Glycine 0 CA--C 1.529 0.914 0 O-C-N 120.489 -1.382 . . . . 0.0 114.511 -171.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -70.18 -24.11 63.08 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 118.537 1.169 . . . . 0.0 112.67 176.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 16.8 tm0? -86.72 -34.58 19.64 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.126 1.37 . . . . 0.0 111.811 170.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -67.16 -33.76 76.11 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 119.572 1.078 . . . . 0.0 112.293 171.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 30.1 ttt180 -62.01 -29.93 70.6 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.405 1.482 . . . . 0.0 110.937 165.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.29 -24.7 75.94 Favored Glycine 0 CA--C 1.542 1.72 0 C-N-CA 125.632 1.587 . . . . 0.0 115.784 165.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -71.96 -25.78 62.01 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 121.19 2.495 . . . . 0.0 112.017 169.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 23.8 mt -74.66 -46.46 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 123.253 0.621 . . . . 0.0 109.461 166.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -63.69 -42.21 98.02 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.14 -0.975 . . . . 0.0 113.398 -176.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 95.0 mm-40 -71.87 -10.0 59.14 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 178.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -107.54 -35.64 6.68 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.536 1.135 . . . . 0.0 113.547 176.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -137.49 4.7 2.64 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.349 1.459 . . . . 0.0 114.703 -169.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 50.71 42.3 27.18 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 127.006 2.122 . . . . 0.0 114.516 176.589 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 61.8 t60 -127.44 129.92 48.36 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.847 1.259 . . . . 0.0 111.119 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -119.91 -1.33 10.47 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.621 1.568 . . . . 0.0 113.759 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.3 m -86.06 173.45 9.87 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.998 1.719 . . . . 0.0 110.468 175.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.7 m -132.73 156.95 79.51 Favored Pre-proline 0 N--CA 1.48 1.025 0 O-C-N 120.631 -1.293 . . . . 0.0 113.917 -175.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -73.16 159.8 96.73 Favored 'Cis proline' 0 C--N 1.349 0.591 0 CA-C-N 118.588 0.531 . . . . 0.0 112.471 -13.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -101.9 141.02 35.39 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.972 0.909 . . . . 0.0 108.986 159.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 82.0 mt -130.68 144.15 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 123.726 0.811 . . . . 0.0 109.65 -168.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -140.5 146.37 38.07 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.243 1.017 . . . . 0.0 111.998 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 71.5 mt -129.26 118.98 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 125.367 1.467 . . . . 0.0 108.241 172.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 47.49 38.23 7.5 Favored 'General case' 0 CA--C 1.552 1.056 0 N-CA-C 115.821 1.785 . . . . 0.0 115.821 176.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 93.48 -7.51 74.9 Favored Glycine 0 CA--C 1.538 1.477 0 C-N-CA 124.593 1.092 . . . . 0.0 115.312 -178.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -102.47 138.03 39.93 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.939 1.696 . . . . 0.0 110.406 -174.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -85.23 147.73 26.43 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.073 0.949 . . . . 0.0 113.076 -170.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 20.6 mm -133.34 120.64 39.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 128.473 2.709 . . . . 0.0 106.279 177.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.88 -15.66 55.68 Favored Glycine 0 CA--C 1.533 1.182 0 N-CA-C 116.851 1.5 . . . . 0.0 116.851 -160.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 138.8 -152.14 22.01 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 125.609 1.576 . . . . 0.0 112.739 179.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 8.6 t -72.25 -20.48 61.53 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -173.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.8 m -83.38 -38.52 21.87 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 121.254 -0.904 . . . . 0.0 112.012 171.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -70.7 -36.38 73.23 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.148 0.979 . . . . 0.0 111.641 177.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 47.5 tp -59.82 -57.49 12.68 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.405 1.482 . . . . 0.0 111.645 -179.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -69.59 -30.58 68.38 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.892 -0.505 . . . . 0.0 111.305 178.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.02 -38.25 87.98 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 119.474 1.034 . . . . 0.0 112.49 176.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 85.4 mt -73.81 -25.24 60.0 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.917 0.887 . . . . 0.0 112.702 176.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -73.08 -40.12 65.29 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 118.779 0.718 . . . . 0.0 111.609 169.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.1 mptt -65.19 -30.4 71.3 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.371 1.068 . . . . 0.0 112.889 173.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -80.34 1.97 26.69 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.083 1.353 . . . . 0.0 113.851 169.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 71.21 24.13 77.34 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 124.732 1.158 . . . . 0.0 114.761 175.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -113.2 -31.74 6.52 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 126.051 1.74 . . . . 0.0 113.365 -170.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 36.7 tp -57.23 -42.7 81.92 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 122.618 0.367 . . . . 0.0 111.467 -175.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -63.56 -42.73 98.33 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -178.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -73.05 -29.45 64.72 Favored Glycine 0 CA--C 1.528 0.876 0 CA-C-O 119.123 -0.821 . . . . 0.0 114.439 177.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 81.8 mt -72.8 -34.21 66.74 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 118.332 1.066 . . . . 0.0 112.188 172.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 66.5 mt -86.7 -16.32 36.83 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.294 1.038 . . . . 0.0 113.607 179.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 58.7 m . . . . . 0 C--O 1.254 1.314 0 C-N-CA 124.976 1.31 . . . . 0.0 111.714 175.031 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.893 0 N-CA-C 111.62 -0.592 . . . . 0.0 111.62 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 55.73 21.24 4.52 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 126.838 2.055 . . . . 0.0 115.834 178.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 7.4 tpt -142.08 86.62 10.2 Favored Pre-proline 0 CA--C 1.547 0.857 0 C-N-CA 124.538 1.135 . . . . 0.0 110.868 -167.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_exo -53.99 -31.91 65.99 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 123.954 3.103 . . . . 0.0 116.091 -171.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.0 m 57.44 -152.0 0.41 Allowed 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.071 1.348 . . . . 0.0 114.594 168.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.5 pt -60.99 -23.09 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 124.529 1.131 . . . . 0.0 113.941 -168.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -54.58 -27.25 37.65 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.729 1.212 . . . . 0.0 112.177 178.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 92.9 p -68.56 -36.37 78.68 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.765 1.226 . . . . 0.0 113.444 172.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 45.3 mtt -72.45 -38.56 68.25 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.385 1.474 . . . . 0.0 111.59 -177.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -66.52 -25.59 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 124.074 0.95 . . . . 0.0 111.551 -171.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -70.75 -11.13 60.76 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.826 1.65 . . . . 0.0 114.123 179.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -84.48 -31.27 25.2 Favored Glycine 0 CA--C 1.534 1.258 0 N-CA-C 115.944 1.137 . . . . 0.0 115.944 -167.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -136.71 156.72 48.15 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 119.499 1.649 . . . . 0.0 112.568 -174.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 28.4 ttpt -62.54 -39.41 93.52 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.986 0.914 . . . . 0.0 112.657 -176.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.9 t -124.96 129.08 73.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.524 1.13 . . . . 0.0 109.821 167.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 83.1 t -126.11 127.09 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.389 1.476 . . . . 0.0 109.04 178.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 40.3 t -123.53 144.55 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 123.611 0.765 . . . . 0.0 111.169 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -118.3 113.18 21.07 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.672 1.189 . . . . 0.0 109.018 171.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 28.4 m -131.35 168.17 18.01 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.384 1.474 . . . . 0.0 112.281 -170.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 51.7 m0 -107.92 126.12 52.31 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.644 1.178 . . . . 0.0 107.872 159.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 25.9 t -49.95 -36.48 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 126.49 1.916 . . . . 0.0 113.237 -164.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.5 t -93.3 -8.91 40.76 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 127.175 2.19 . . . . 0.0 115.137 -167.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 95.6 m -94.28 149.31 36.53 Favored Pre-proline 0 CA--C 1.535 0.374 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -159.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -67.39 -47.34 2.23 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 CA-C-N 119.127 0.724 . . . . 0.0 113.603 -163.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -68.22 -33.43 74.39 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.438 1.095 . . . . 0.0 113.243 -179.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -51.25 -53.37 36.07 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.776 0.83 . . . . 0.0 109.246 167.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 62.6 t -68.75 -36.36 73.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 O-C-N 121.714 -0.617 . . . . 0.0 112.244 -177.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 27.7 mmt85 -52.79 -42.07 64.71 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 119.227 0.922 . . . . 0.0 112.046 170.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.64 -56.56 5.14 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.396 0.678 . . . . 0.0 111.878 173.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -50.82 -39.52 53.35 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 119.435 1.016 . . . . 0.0 113.028 -177.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -69.6 -43.64 72.38 Favored 'General case' 0 C--O 1.233 0.184 0 C-N-CA 123.892 0.877 . . . . 0.0 112.312 -178.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.4 tt -73.77 -37.62 64.95 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 124.309 1.044 . . . . 0.0 111.464 -178.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 98.0 mt -62.61 -42.84 99.81 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.239 0.616 . . . . 0.0 110.9 174.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -67.93 -13.15 61.93 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 171.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -95.6 -13.03 24.7 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.301 1.041 . . . . 0.0 113.751 170.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 20.1 mmt180 -111.67 -30.34 7.37 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 114.981 1.474 . . . . 0.0 114.981 -173.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.0 t -149.03 156.6 42.48 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -173.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 48.1 mtmt -91.6 -9.13 45.24 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 126.785 2.034 . . . . 0.0 112.499 166.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -105.51 20.49 18.81 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -162.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.26 136.81 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 125.481 1.513 . . . . 0.0 112.692 -178.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.9 m -125.44 133.7 52.36 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 126.696 1.999 . . . . 0.0 110.014 168.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.4 p -121.29 136.11 59.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 125.013 1.325 . . . . 0.0 112.998 173.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -104.1 116.65 32.6 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.917 2.087 . . . . 0.0 108.989 174.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -88.56 96.37 10.6 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 121.0 -1.063 . . . . 0.0 111.2 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 22.0 m -73.74 1.65 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 -172.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -85.29 -22.44 28.56 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.437 1.095 . . . . 0.0 112.756 163.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.5 mmmt -90.34 -35.08 15.43 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.035 1.734 . . . . 0.0 111.667 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -89.35 130.44 35.73 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.692 0.797 . . . . 0.0 110.962 -177.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 74.4 m -70.69 -16.09 62.77 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 115.235 1.569 . . . . 0.0 115.235 -169.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -93.02 6.67 47.11 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.843 1.657 . . . . 0.0 112.908 173.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -51.7 -29.03 24.56 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 125.368 1.461 . . . . 0.0 116.385 -174.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -79.73 -25.13 41.2 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.052 1.426 . . . . 0.0 113.358 178.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -74.81 -33.95 62.29 Favored 'General case' 0 N--CA 1.469 0.489 0 O-C-N 121.462 -0.774 . . . . 0.0 111.052 168.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.54 -42.79 86.63 Favored 'General case' 0 CA--C 1.548 0.882 0 O-C-N 121.716 -0.615 . . . . 0.0 110.342 171.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 56.3 mtp85 -54.76 -43.96 73.21 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 119.397 0.999 . . . . 0.0 111.936 167.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.41 -42.94 99.14 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 124.24 0.924 . . . . 0.0 113.732 178.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 51.2 mm-40 -63.44 -38.18 90.16 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 118.413 1.107 . . . . 0.0 113.449 173.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 65.9 mt -66.46 -44.58 90.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 118.573 0.624 . . . . 0.0 109.621 175.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -64.26 -40.35 95.81 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 121.432 -0.793 . . . . 0.0 112.059 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -69.46 -24.88 63.86 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 121.092 -1.005 . . . . 0.0 113.363 -179.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -99.53 -25.17 14.52 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 115.008 1.485 . . . . 0.0 115.008 176.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -135.92 0.52 2.66 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 114.741 1.386 . . . . 0.0 114.741 -171.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp 48.6 46.05 21.19 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 126.525 1.93 . . . . 0.0 113.729 175.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 8.5 t60 -140.39 134.2 30.5 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.283 1.833 . . . . 0.0 109.46 -175.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -117.3 -25.38 7.08 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.696 1.599 . . . . 0.0 113.418 -178.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.3 p -77.8 129.02 34.93 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.047 0.939 . . . . 0.0 112.621 -171.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.6 m -83.77 151.11 60.66 Favored Pre-proline 0 N--CA 1.478 0.93 0 C-N-CA 123.652 0.781 . . . . 0.0 112.109 -173.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -80.2 156.55 87.12 Favored 'Cis proline' 0 C--N 1.352 0.717 0 N-CA-C 114.118 0.776 . . . . 0.0 114.118 -0.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -101.34 135.35 42.96 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.907 0.883 . . . . 0.0 108.856 159.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 50.9 mt -128.28 139.53 51.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 123.984 0.914 . . . . 0.0 109.149 -166.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -140.0 148.23 41.57 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.62 0.768 . . . . 0.0 112.467 -179.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 62.1 mt -130.28 120.19 48.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.445 1.498 . . . . 0.0 108.633 174.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 45.3 40.62 5.4 Favored 'General case' 0 CA--C 1.558 1.269 0 C-N-CA 125.599 1.559 . . . . 0.0 114.625 -176.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 82.16 0.85 90.1 Favored Glycine 0 CA--C 1.542 1.762 0 O-C-N 120.822 -1.174 . . . . 0.0 115.629 -178.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -95.62 140.12 30.89 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.885 1.674 . . . . 0.0 110.416 176.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -85.07 144.85 27.98 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 119.253 0.933 . . . . 0.0 113.444 -177.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 31.5 mm -123.44 127.44 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 128.764 2.826 . . . . 0.0 107.023 177.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -69.82 18.28 0.64 Allowed Glycine 0 CA--C 1.532 1.118 0 N-CA-C 119.135 2.414 . . . . 0.0 119.135 -163.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 114.82 -173.15 14.61 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 128.85 3.119 . . . . 0.0 112.666 -178.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 12.9 t -63.5 -33.71 76.18 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 121.485 -1.009 . . . . 0.0 111.688 179.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 67.4 m -61.78 -21.99 65.05 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 172.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -88.88 -43.8 10.93 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.652 1.181 . . . . 0.0 110.903 174.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 48.8 tp -57.24 -48.24 79.33 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.027 1.331 . . . . 0.0 111.683 176.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -72.47 -25.96 61.63 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 121.734 -0.604 . . . . 0.0 112.054 179.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.48 -28.98 63.24 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.196 -0.94 . . . . 0.0 112.54 175.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 52.2 mt -73.78 -26.73 60.79 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.124 1.37 . . . . 0.0 112.808 171.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -64.58 -44.43 90.7 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 118.616 0.644 . . . . 0.0 110.343 162.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 20.3 mmtt -68.74 -34.18 75.17 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 121.828 -0.545 . . . . 0.0 112.28 -177.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -79.83 -3.23 46.93 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 168.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.18 44.64 93.64 Favored Glycine 0 CA--C 1.532 1.105 0 CA-C-N 120.262 1.392 . . . . 0.0 112.983 172.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 36.6 mtmt -131.18 -8.68 3.81 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 126.996 2.118 . . . . 0.0 113.487 -170.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 29.8 tp -66.08 -34.66 78.58 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 122.205 1.002 . . . . 0.0 110.663 -176.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -60.87 -48.05 83.57 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 127.577 2.351 . . . . 0.0 114.053 171.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -69.42 -22.68 76.5 Favored Glycine 0 CA--C 1.53 1.012 0 O-C-N 121.131 -0.98 . . . . 0.0 113.697 175.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 36.7 mt -74.03 -37.33 64.37 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 117.663 0.731 . . . . 0.0 111.3 172.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 69.4 mt -75.47 -7.01 53.0 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.603 1.561 . . . . 0.0 114.29 176.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 19.6 m . . . . . 0 C--O 1.249 1.03 0 C-N-CA 127.15 2.18 . . . . 0.0 113.739 177.691 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.533 0 N-CA-C 111.718 -0.553 . . . . 0.0 111.718 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -128.45 -26.4 2.78 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 115.073 1.508 . . . . 0.0 115.073 -177.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.5 mpt? 47.61 59.36 16.7 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 127.867 2.467 . . . . 0.0 114.346 175.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -62.08 146.26 96.22 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 123.097 2.531 . . . . 0.0 112.274 179.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 89.4 p -159.8 -167.14 1.9 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.344 1.458 . . . . 0.0 110.79 178.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.5 pt -55.02 -21.32 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 179.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.14 -18.93 51.07 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 123.817 0.847 . . . . 0.0 113.203 -178.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 40.9 m -83.78 -25.76 30.19 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.807 1.243 . . . . 0.0 113.486 172.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 76.9 mtp -69.49 -28.69 66.29 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.281 1.032 . . . . 0.0 112.09 178.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.1 mm -64.11 -21.17 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 124.248 1.019 . . . . 0.0 112.342 179.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -81.77 -28.24 33.37 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 121.113 -0.992 . . . . 0.0 113.058 173.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -87.41 -8.03 75.08 Favored Glycine 0 CA--C 1.53 1.02 0 N-CA-C 116.742 1.457 . . . . 0.0 116.742 -166.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -143.61 151.83 40.64 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 119.354 1.577 . . . . 0.0 111.431 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -67.41 -42.56 83.03 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.941 1.296 . . . . 0.0 112.413 -178.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.6 t -121.4 130.94 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 124.878 1.271 . . . . 0.0 110.065 170.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.6 t -129.7 128.1 65.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.528 1.131 . . . . 0.0 110.167 178.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 42.2 t -127.43 148.11 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 123.785 0.834 . . . . 0.0 111.715 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -123.64 116.56 23.29 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.798 1.239 . . . . 0.0 109.208 173.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 25.2 m -134.09 172.73 12.43 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.28 1.432 . . . . 0.0 112.203 -167.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.411 ' CD1' ' HB3' ' A' ' 46' ' ' ASP . 28.0 m0 -120.42 142.28 49.36 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.266 1.026 . . . . 0.0 109.784 161.285 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 75.4 t -59.91 -31.6 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 123.042 0.537 . . . . 0.0 111.332 172.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -69.09 -15.31 63.41 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 175.177 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 44.1 t -92.99 143.16 26.37 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-N 120.385 1.448 . . . . 0.0 111.278 -167.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -83.57 -31.32 0.62 Allowed 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 121.498 1.465 . . . . 0.0 113.157 174.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -69.05 -33.56 73.78 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.29 1.436 . . . . 0.0 113.54 178.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -45.74 -55.55 6.38 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.363 1.065 . . . . 0.0 109.356 164.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 85.9 t -63.91 -38.84 83.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 123.983 0.913 . . . . 0.0 112.068 -179.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.4 mmt85 -54.9 -37.82 66.81 Favored 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 119.536 1.062 . . . . 0.0 112.777 174.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -76.37 -59.18 2.88 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 123.735 0.647 . . . . 0.0 111.859 172.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -44.75 -47.56 10.78 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.854 1.262 . . . . 0.0 112.583 -179.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -65.53 -44.22 87.58 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 123.689 0.796 . . . . 0.0 111.627 -173.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.9 tt -69.6 -41.24 76.0 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.632 1.573 . . . . 0.0 110.775 179.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 92.2 mt -60.99 -50.43 73.42 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.095 0.558 . . . . 0.0 110.816 176.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 69.2 m-70 -66.64 -18.0 65.14 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 173.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.73 -13.73 59.66 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 119.908 1.231 . . . . 0.0 113.702 174.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 26.5 mmt85 -119.63 -25.89 5.85 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.73 1.612 . . . . 0.0 114.558 -178.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 19.3 m -145.98 150.39 35.95 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.605 1.162 . . . . 0.0 112.909 -157.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? -108.53 -23.52 11.8 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 126.766 2.027 . . . . 0.0 112.654 165.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -79.76 50.58 1.18 Allowed 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 125.317 1.447 . . . . 0.0 112.762 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -121.99 130.78 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 126.19 1.796 . . . . 0.0 111.013 -178.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.1 m -123.07 123.85 41.77 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.861 1.664 . . . . 0.0 109.57 176.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.5 p -119.49 143.43 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 123.938 0.895 . . . . 0.0 112.375 175.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 30.0 t60 -111.55 117.28 32.54 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.515 1.526 . . . . 0.0 110.236 173.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -86.67 91.89 8.75 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 175.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 27.6 m -67.09 -17.41 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -176.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.411 ' HB3' ' CD1' ' A' ' 20' ' ' TRP . 0.3 OUTLIER -68.47 -26.48 65.5 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 121.174 -0.953 . . . . 0.0 111.995 172.646 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 20.1 mtmt -98.67 -5.71 31.12 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 126.275 1.83 . . . . 0.0 114.227 -179.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 13.1 tpt -93.28 133.04 36.92 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.246 1.418 . . . . 0.0 111.467 -178.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 17.0 p -63.76 2.14 0.52 Allowed 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 126.657 1.983 . . . . 0.0 116.184 -179.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -143.98 13.69 1.67 Allowed 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.522 1.529 . . . . 0.0 112.804 170.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -57.77 -24.58 53.9 Favored Glycine 0 CA--C 1.53 1.012 0 O-C-N 120.52 -1.363 . . . . 0.0 116.121 -167.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -63.66 -30.98 72.01 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 119.518 1.659 . . . . 0.0 112.096 174.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -74.89 -29.11 60.9 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.7 0.8 . . . . 0.0 111.941 176.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -81.02 -32.68 34.05 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.687 1.195 . . . . 0.0 111.602 176.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.8 ttt85 -56.87 -36.43 70.07 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.904 1.281 . . . . 0.0 110.667 159.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.53 -35.15 90.88 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 124.495 1.045 . . . . 0.0 115.465 167.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -64.98 -32.23 73.86 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 120.394 2.097 . . . . 0.0 112.267 176.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.2 mt -70.5 -42.13 78.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 123.682 0.793 . . . . 0.0 109.643 171.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -62.92 -41.44 99.47 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 178.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 33.0 mm-40 -62.09 -30.08 70.76 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 120.923 -1.111 . . . . 0.0 112.844 176.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -88.83 -38.41 14.62 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 179.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -133.76 0.82 3.28 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 -168.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.5 mptt 44.66 50.27 8.5 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 127.016 2.126 . . . . 0.0 113.126 -177.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 48.9 t60 -129.25 127.09 40.52 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 127.53 2.332 . . . . 0.0 108.102 178.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -108.13 -14.03 14.81 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.208 1.003 . . . . 0.0 113.53 178.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.9 m -74.82 141.86 44.25 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.3 1.04 . . . . 0.0 111.685 -176.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.0 m -97.88 150.81 37.15 Favored Pre-proline 0 N--CA 1.477 0.904 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 172.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -81.08 161.71 81.73 Favored 'Cis proline' 0 C--N 1.351 0.703 0 CA-C-N 118.686 0.566 . . . . 0.0 113.556 -3.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -107.61 139.45 42.14 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.093 0.957 . . . . 0.0 109.13 158.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 75.7 mt -131.88 139.08 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 124.22 1.008 . . . . 0.0 109.374 -165.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -140.98 145.39 35.91 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.937 0.895 . . . . 0.0 112.432 -178.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 58.2 mt -132.19 122.28 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 124.702 1.201 . . . . 0.0 109.405 172.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 32.0 m120 44.31 45.13 7.16 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 125.017 1.327 . . . . 0.0 113.327 -177.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 86.02 -12.96 58.64 Favored Glycine 0 CA--C 1.539 1.553 0 O-C-N 120.463 -1.398 . . . . 0.0 116.284 -178.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 59.8 m-80 -86.6 141.13 29.23 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.353 1.576 . . . . 0.0 110.634 -177.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -86.47 136.95 32.9 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.32 0.648 . . . . 0.0 112.177 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 38.5 mm -115.1 117.97 57.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 126.937 2.095 . . . . 0.0 107.099 178.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -70.55 3.58 11.47 Favored Glycine 0 N--CA 1.475 1.281 0 N-CA-C 117.919 1.928 . . . . 0.0 117.919 -159.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 155.64 173.91 24.86 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 128.072 2.749 . . . . 0.0 111.048 178.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 39.4 t -58.56 -32.79 69.24 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 121.317 -1.108 . . . . 0.0 112.494 171.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 69.7 m -66.61 -28.54 68.58 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 120.654 -1.279 . . . . 0.0 112.957 173.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -74.47 -36.21 63.3 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 119.516 1.053 . . . . 0.0 111.632 173.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 43.5 tp -62.91 -50.84 69.25 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.877 1.271 . . . . 0.0 110.794 172.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -59.5 -37.93 79.58 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.689 0.796 . . . . 0.0 111.481 176.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.98 -29.7 68.8 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.019 0.928 . . . . 0.0 113.483 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 35.7 mt -70.96 -25.48 62.74 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.066 0.848 . . . . 0.0 112.303 172.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -73.52 -37.54 65.6 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 118.56 0.618 . . . . 0.0 111.036 170.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 43.3 mmtt -66.57 -34.7 78.49 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 176.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -73.43 -9.36 58.61 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 169.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 79.46 22.36 64.96 Favored Glycine 0 CA--C 1.535 1.282 0 CA-C-N 119.686 1.13 . . . . 0.0 114.579 178.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -107.29 -32.01 7.96 Favored 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 125.678 1.591 . . . . 0.0 112.305 -172.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 46.0 tp -57.71 -41.76 82.38 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 118.454 0.57 . . . . 0.0 112.432 -176.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -60.44 -43.64 96.61 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 118.928 -0.558 . . . . 0.0 112.437 -178.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -74.77 -38.09 43.3 Favored Glycine 0 CA--C 1.535 1.306 0 O-C-N 123.556 0.535 . . . . 0.0 113.324 177.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 37.6 mt -57.66 -36.42 71.87 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.404 1.082 . . . . 0.0 112.309 177.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 86.5 mt -73.92 -4.03 32.56 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 114.895 1.442 . . . . 0.0 114.895 -179.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 6.8 t . . . . . 0 C--O 1.257 1.495 0 C-N-CA 125.146 1.378 . . . . 0.0 112.733 -178.993 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.935 0 N-CA-C 110.879 -0.888 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -89.69 -14.22 35.22 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.576 1.15 . . . . 0.0 114.005 -177.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 25.6 ttt -128.75 87.42 54.84 Favored Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 125.446 1.498 . . . . 0.0 111.273 -166.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -57.79 130.86 40.65 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 122.024 1.816 . . . . 0.0 109.899 168.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 15.8 p -153.88 -164.86 1.97 Allowed 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 122.108 0.956 . . . . 0.0 112.844 -164.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 25.4 pt -55.71 -25.21 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.471 1.108 . . . . 0.0 112.717 170.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.38 -23.85 66.4 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -171.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.1 t -87.96 -20.04 26.43 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 121.238 -0.914 . . . . 0.0 113.424 170.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 41.3 mtt -68.39 -26.09 65.38 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 121.27 -0.894 . . . . 0.0 112.334 175.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.6 mm -58.06 -31.4 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.953 0.901 . . . . 0.0 111.667 177.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.1 mptt -80.56 -4.23 53.24 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.899 1.28 . . . . 0.0 114.039 -173.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -82.99 -28.4 37.68 Favored Glycine 0 CA--C 1.538 1.496 0 N-CA-C 115.953 1.141 . . . . 0.0 115.953 -173.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -145.35 163.71 33.73 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.597 1.199 . . . . 0.0 112.526 -173.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -63.16 -43.58 97.9 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.298 1.439 . . . . 0.0 112.723 -179.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.3 t -121.88 131.89 72.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 123.798 0.839 . . . . 0.0 110.26 171.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 54.4 t -132.56 127.39 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 125.006 1.322 . . . . 0.0 109.263 179.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 42.4 t -124.56 148.24 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 124.337 1.055 . . . . 0.0 111.624 -177.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -121.92 112.3 18.14 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.202 1.401 . . . . 0.0 108.869 172.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 10.7 m -126.5 174.14 8.87 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 126.646 1.978 . . . . 0.0 111.356 -171.178 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 20.8 m0 -118.78 137.75 53.16 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.317 1.047 . . . . 0.0 109.078 161.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 82.6 t -62.67 -15.86 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.013 0.925 . . . . 0.0 112.378 177.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.4 p -89.7 -9.68 48.57 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.484 1.914 . . . . 0.0 116.046 175.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 8.0 t -94.2 142.03 24.38 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-N 119.424 1.011 . . . . 0.0 111.565 -170.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -79.67 -32.58 1.53 Allowed 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 121.812 1.675 . . . . 0.0 112.226 173.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -62.85 -35.28 79.45 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.122 1.369 . . . . 0.0 113.543 177.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -49.04 -54.24 16.73 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.518 1.127 . . . . 0.0 109.451 165.285 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.2 t -64.88 -39.47 85.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.117 0.967 . . . . 0.0 112.766 -179.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 78.4 mmt-85 -53.35 -41.78 66.15 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-N 119.118 0.872 . . . . 0.0 111.811 173.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.86 -53.7 8.61 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.123 0.969 . . . . 0.0 112.592 174.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -52.41 -32.99 41.69 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.608 1.163 . . . . 0.0 112.992 -179.398 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -72.36 -47.37 50.05 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.838 0.855 . . . . 0.0 112.581 177.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.8 tt -72.81 -36.75 67.62 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.582 1.153 . . . . 0.0 111.465 -176.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 70.3 mt -63.47 -47.65 80.91 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.401 0.68 . . . . 0.0 111.283 173.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -64.76 -14.82 60.31 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 172.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.21 -17.74 58.26 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 120.158 1.344 . . . . 0.0 113.828 175.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 87.2 mmt-85 -131.97 -13.09 3.23 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 -177.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 29.0 m -138.62 136.99 36.51 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.315 1.046 . . . . 0.0 112.601 -172.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.24 -30.48 12.59 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 126.868 2.067 . . . . 0.0 111.207 166.321 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -79.26 48.09 0.85 Allowed 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.507 1.523 . . . . 0.0 113.409 177.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.28 118.89 60.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 125.758 1.623 . . . . 0.0 110.688 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 54.9 m -101.48 135.47 42.92 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 126.205 1.802 . . . . 0.0 109.672 172.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.6 p -128.1 141.6 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-O 122.277 1.037 . . . . 0.0 112.961 169.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -113.6 133.27 55.38 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 129.12 2.968 . . . . 0.0 109.523 -177.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -111.06 90.59 3.38 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 122.04 0.924 . . . . 0.0 111.52 -176.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 16.7 m -67.8 -8.94 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 O-C-N 121.341 -0.849 . . . . 0.0 113.17 -178.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.45 -18.35 61.14 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 119.042 0.837 . . . . 0.0 112.657 170.155 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 57.3 mmtt -102.44 -32.24 10.07 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 127.156 2.182 . . . . 0.0 113.009 179.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 58.9 mtt -65.03 126.64 28.67 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.193 0.997 . . . . 0.0 110.783 177.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 18.2 m -74.87 20.31 0.13 Allowed 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 114.614 1.338 . . . . 0.0 114.614 -172.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -150.24 10.26 0.68 Allowed 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 127.395 2.278 . . . . 0.0 111.528 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -53.96 -25.87 32.32 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 125.81 1.672 . . . . 0.0 116.954 -172.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -66.22 -28.04 68.44 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 120.079 1.939 . . . . 0.0 111.698 173.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -82.27 -28.75 31.6 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 121.03 -1.044 . . . . 0.0 112.005 177.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -78.16 -32.21 50.12 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.624 0.77 . . . . 0.0 111.559 172.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 67.0 mtp180 -55.25 -40.34 70.82 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 119.524 1.056 . . . . 0.0 111.257 162.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -58.78 -36.25 85.85 Favored Glycine 0 CA--C 1.536 1.37 0 CA-C-O 119.255 -0.747 . . . . 0.0 114.044 171.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -65.42 -35.55 81.26 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 119.41 1.605 . . . . 0.0 112.446 176.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 53.3 mt -73.05 -48.87 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 124.306 1.042 . . . . 0.0 109.724 176.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -67.07 -41.28 86.65 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 121.449 -0.782 . . . . 0.0 112.477 -174.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 77.4 mm-40 -69.07 -21.57 64.07 Favored 'General case' 0 CA--C 1.546 0.812 0 O-C-N 121.138 -0.976 . . . . 0.0 112.471 176.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -88.79 -29.78 19.49 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 177.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -140.4 -1.41 1.51 Allowed 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 116.075 1.88 . . . . 0.0 116.075 -170.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.5 mptt 45.75 48.32 11.72 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 125.922 1.689 . . . . 0.0 112.716 -165.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 60.2 t-80 -129.26 133.51 47.54 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 125.333 1.453 . . . . 0.0 110.471 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -142.27 -25.1 0.66 Allowed 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -160.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 60.6 p -77.78 151.97 33.78 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 121.727 -0.608 . . . . 0.0 111.603 168.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 13.6 m -104.55 155.95 36.62 Favored Pre-proline 0 N--CA 1.478 0.949 0 C-N-CA 124.673 1.189 . . . . 0.0 111.67 -176.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -75.04 154.31 99.58 Favored 'Cis proline' 0 CA--C 1.535 0.542 0 CA-C-N 119.071 0.704 . . . . 0.0 113.782 -6.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -99.23 138.08 36.83 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 159.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 60.9 mt -131.03 140.62 48.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 124.199 1.0 . . . . 0.0 109.35 -165.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -138.56 144.96 40.1 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.808 0.843 . . . . 0.0 111.982 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 65.8 mt -130.01 117.05 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.973 1.309 . . . . 0.0 109.186 175.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 46.13 44.64 12.12 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 125.565 1.546 . . . . 0.0 113.503 -176.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 82.46 -7.47 64.66 Favored Glycine 0 CA--C 1.534 1.229 0 N-CA-C 116.293 1.277 . . . . 0.0 116.293 -177.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -91.03 138.34 31.68 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 119.168 1.484 . . . . 0.0 110.578 -178.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 39.6 t80 -82.14 133.89 35.29 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.858 0.837 . . . . 0.0 112.915 -176.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 37.9 mm -113.98 119.73 61.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 126.656 1.983 . . . . 0.0 107.726 175.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -71.07 27.08 0.54 Allowed Glycine 0 N--CA 1.472 1.086 0 N-CA-C 119.137 2.415 . . . . 0.0 119.137 -167.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 116.21 -175.63 15.93 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 128.076 2.75 . . . . 0.0 114.552 175.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 25.1 t -64.54 -33.38 75.77 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.364 -1.08 . . . . 0.0 112.866 -179.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 37.0 m -70.01 -34.88 73.87 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 121.088 -1.007 . . . . 0.0 111.924 175.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.87 -39.04 90.33 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.452 1.101 . . . . 0.0 111.974 171.009 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 51.9 tp -62.93 -45.84 90.61 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.246 1.019 . . . . 0.0 111.196 175.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -64.77 -33.26 75.55 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.582 -0.699 . . . . 0.0 112.324 173.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.83 -29.84 71.0 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 121.008 -1.057 . . . . 0.0 111.954 177.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 83.6 mt -71.75 -30.03 65.15 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.441 1.096 . . . . 0.0 112.985 170.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -67.82 -41.13 83.52 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.698 0.799 . . . . 0.0 110.25 172.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -71.81 -39.75 69.62 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.113 0.965 . . . . 0.0 113.575 175.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -69.69 -18.27 63.54 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 119.547 1.067 . . . . 0.0 112.82 171.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 78.01 35.48 34.71 Favored Glycine 0 CA--C 1.531 1.083 0 CA-C-N 118.801 0.728 . . . . 0.0 113.65 175.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -116.19 -19.51 10.21 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 127.787 2.435 . . . . 0.0 113.351 -174.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 27.2 tp -63.21 -31.82 73.06 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.919 0.888 . . . . 0.0 111.684 -174.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -54.55 -53.6 52.34 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.526 1.131 . . . . 0.0 112.933 175.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -76.89 -23.4 69.45 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-O 119.446 -0.641 . . . . 0.0 113.862 -178.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 75.5 mt -69.91 -37.75 76.06 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 118.869 1.334 . . . . 0.0 112.012 172.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 92.8 mt -86.47 5.89 33.05 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -178.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 81.7 p . . . . . 0 C--O 1.255 1.387 0 C-N-CA 126.566 1.947 . . . . 0.0 115.973 -174.755 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.998 0 N-CA-C 110.401 -1.08 . . . . 0.0 110.401 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -142.65 -3.45 1.01 Allowed 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 -176.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 21.2 mmt -113.76 77.43 3.5 Favored Pre-proline 0 CA--C 1.548 0.877 0 CA-C-N 119.737 1.153 . . . . 0.0 111.426 -177.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -71.63 156.34 57.73 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 123.85 3.034 . . . . 0.0 113.239 -175.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 39.5 p -157.39 173.22 17.25 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 -174.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.6 pt -49.37 -25.3 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 125.981 1.712 . . . . 0.0 114.07 171.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.29 -28.48 69.22 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 118.935 0.789 . . . . 0.0 112.063 -176.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 96.4 p -72.32 -32.7 66.78 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 171.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 59.9 mtp -70.61 -30.65 67.38 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.15 0.98 . . . . 0.0 111.914 -176.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -64.88 -24.06 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 124.315 1.046 . . . . 0.0 111.573 -174.077 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -82.04 -9.54 59.52 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.063 1.745 . . . . 0.0 114.716 176.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -91.28 -22.06 33.32 Favored Glycine 0 CA--C 1.54 1.638 0 N-CA-C 117.451 1.741 . . . . 0.0 117.451 -166.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -135.86 170.04 16.61 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 118.941 1.37 . . . . 0.0 110.941 169.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 20.9 ttpt -66.59 -30.71 71.06 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 119.146 -0.454 . . . . 0.0 111.945 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 28.4 t -133.4 130.22 56.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.563 1.545 . . . . 0.0 109.394 177.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 42.9 t -134.21 127.67 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 124.245 1.018 . . . . 0.0 109.809 -177.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.1 t -128.35 146.92 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.295 1.038 . . . . 0.0 112.053 -170.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -125.97 106.88 9.95 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.797 1.239 . . . . 0.0 109.526 178.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 37.2 m -128.41 176.94 7.33 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 127.044 2.137 . . . . 0.0 112.371 -164.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 43.8 m0 -125.71 129.23 49.12 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.609 1.563 . . . . 0.0 108.335 163.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 46.6 t -53.63 -38.9 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 124.842 1.257 . . . . 0.0 114.325 -158.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.7 t -89.79 -6.99 55.4 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 -170.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 94.9 m -92.63 146.25 31.95 Favored Pre-proline 0 CA--C 1.537 0.456 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -160.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -69.59 -34.47 15.07 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 120.662 0.908 . . . . 0.0 114.057 -162.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -71.22 -42.12 69.31 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 124.073 0.949 . . . . 0.0 112.675 176.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -51.96 -54.65 27.23 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 169.667 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 53.3 t -60.23 -51.78 69.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 124.149 0.98 . . . . 0.0 111.63 -175.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . 0.272 7.7 ptp180 -61.67 -35.99 79.58 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 119.05 0.841 . . . . 0.0 112.164 -178.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.73 -55.91 8.63 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 118.226 -0.892 . . . . 0.0 112.716 173.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -48.02 -41.98 26.96 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 120.283 1.401 . . . . 0.0 112.584 176.149 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.28 -45.37 66.5 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 124.558 1.143 . . . . 0.0 111.577 -175.036 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.2 tt -70.4 -37.7 74.53 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.414 1.086 . . . . 0.0 112.021 176.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 80.7 mt -63.64 -41.71 98.21 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 120.923 -1.11 . . . . 0.0 111.461 176.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -64.41 -24.07 67.5 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 169.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.2 -16.07 53.85 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 119.974 1.261 . . . . 0.0 113.37 171.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 3.0 mmt180 -107.41 -36.69 6.43 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 115.972 1.842 . . . . 0.0 115.972 -173.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 13.9 t -155.04 150.56 27.41 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-N 120.312 1.415 . . . . 0.0 114.611 -176.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -84.03 -19.29 34.7 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.826 1.25 . . . . 0.0 113.02 170.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -85.97 37.1 0.7 Allowed 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -176.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -106.12 136.05 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 124.617 1.167 . . . . 0.0 111.984 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.3 m -128.6 142.25 51.1 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 126.489 1.915 . . . . 0.0 109.819 169.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.4 p -135.4 143.62 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 125.041 1.336 . . . . 0.0 113.315 177.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -118.99 135.98 54.34 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 127.187 2.195 . . . . 0.0 110.55 176.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -103.52 88.17 3.02 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.873 0.869 . . . . 0.0 111.604 -172.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 31.6 m -80.31 40.34 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 -168.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -141.92 -30.82 0.57 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 128.56 2.744 . . . . 0.0 109.879 171.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 26.4 mmmt -65.48 -31.29 72.29 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.088 1.355 . . . . 0.0 111.554 158.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -94.02 117.63 30.38 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.724 1.21 . . . . 0.0 109.387 178.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 73.8 m -70.89 -19.09 62.65 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 -163.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -92.39 5.96 48.75 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.453 1.501 . . . . 0.0 113.095 173.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -52.1 -25.23 17.16 Favored Glycine 0 CA--C 1.539 1.545 0 C-N-CA 125.524 1.535 . . . . 0.0 116.8 -173.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -64.24 -28.75 69.95 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 120.378 2.089 . . . . 0.0 112.802 172.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -80.11 -31.16 39.18 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.88 1.272 . . . . 0.0 112.441 176.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -78.15 -36.2 47.99 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.615 0.766 . . . . 0.0 110.768 174.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 57.3 mtp180 -54.93 -36.22 65.03 Favored 'General case' 0 N--CA 1.477 0.9 0 O-C-N 121.43 -0.794 . . . . 0.0 111.165 159.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.04 -44.08 97.61 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 124.498 1.047 . . . . 0.0 113.995 170.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -61.61 -32.3 72.42 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 119.745 1.772 . . . . 0.0 112.296 176.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 57.6 mt -74.48 -43.5 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.095 0.958 . . . . 0.0 110.08 174.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -64.83 -44.35 90.12 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 121.286 -0.884 . . . . 0.0 112.253 -179.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -57.05 -41.34 78.5 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.431 0.692 . . . . 0.0 111.674 -179.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -91.34 -28.26 17.84 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 -176.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -133.42 2.78 3.56 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 114.973 1.471 . . . . 0.0 114.973 -171.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 44.2 mmtm 54.12 33.65 18.3 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 127.039 2.136 . . . . 0.0 114.172 178.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 65.6 t-80 -130.92 141.82 50.32 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 126.088 1.755 . . . . 0.0 110.759 -175.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -142.0 -20.22 0.72 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.742 1.217 . . . . 0.0 113.593 -164.124 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.8 p -68.54 153.31 44.01 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.716 1.607 . . . . 0.0 111.876 167.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 25.6 m -115.92 151.25 46.24 Favored Pre-proline 0 N--CA 1.476 0.856 0 C-N-CA 124.421 1.088 . . . . 0.0 112.736 177.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -74.58 147.33 89.12 Favored 'Cis proline' 0 N--CA 1.457 -0.62 0 CA-C-N 119.079 0.707 . . . . 0.0 113.884 0.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -99.02 138.35 36.25 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.414 158.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 44.4 mt -130.45 141.07 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 123.714 0.805 . . . . 0.0 109.089 -164.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -140.16 146.07 38.31 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.007 0.923 . . . . 0.0 111.555 -179.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 65.2 mt -128.85 127.19 66.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 125.384 1.474 . . . . 0.0 107.916 174.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 35.8 m120 50.54 28.17 3.28 Favored 'General case' 0 CA--C 1.56 1.355 0 N-CA-C 115.651 1.723 . . . . 0.0 115.651 -178.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 82.4 0.97 90.34 Favored Glycine 0 CA--C 1.544 1.891 0 O-C-N 120.397 -1.44 . . . . 0.0 115.047 -173.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -91.72 151.65 20.55 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 126.964 2.106 . . . . 0.0 110.387 172.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -93.97 142.37 27.46 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -174.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 31.7 mm -121.22 130.07 75.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 128.56 2.744 . . . . 0.0 107.512 176.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -71.38 23.37 0.62 Allowed Glycine 0 N--CA 1.472 1.034 0 C-N-CA 126.744 2.116 . . . . 0.0 118.101 -165.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 107.79 -171.9 16.79 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 127.941 2.686 . . . . 0.0 113.498 178.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 42.7 t -54.12 -41.94 68.89 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.821 1.248 . . . . 0.0 112.362 -178.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 10.4 m -82.58 -10.28 59.04 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -178.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -76.6 -42.68 41.57 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 120.002 1.273 . . . . 0.0 109.838 162.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 48.7 tp -64.13 -50.03 69.84 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.115 1.366 . . . . 0.0 112.395 177.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -70.01 -12.95 61.98 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 113.24 0.829 . . . . 0.0 113.24 178.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -85.89 -39.41 17.03 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 121.206 -0.934 . . . . 0.0 112.121 164.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 33.6 mt -64.42 -33.66 76.38 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 120.375 1.443 . . . . 0.0 113.29 175.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -62.98 -47.39 83.35 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.975 1.31 . . . . 0.0 111.352 171.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 6.8 mptt -73.44 -34.91 65.65 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.598 1.559 . . . . 0.0 112.319 -177.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -70.41 -11.58 61.01 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.231 1.813 . . . . 0.0 113.142 169.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 70.17 10.65 65.97 Favored Glycine 0 CA--C 1.534 1.258 0 CA-C-N 119.053 0.842 . . . . 0.0 114.301 -177.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 17.4 mtpt -81.5 -26.6 35.04 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 125.949 1.7 . . . . 0.0 112.103 -178.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 34.7 tp -59.51 -40.23 86.41 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.645 1.178 . . . . 0.0 112.126 170.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -60.66 -42.04 96.22 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.812 -0.555 . . . . 0.0 111.932 174.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -70.33 -14.08 71.28 Favored Glycine 0 CA--C 1.535 1.301 0 CA-C-O 119.16 -0.8 . . . . 0.0 114.959 176.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 88.7 mt -97.64 -21.99 16.73 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.065 1.746 . . . . 0.0 113.341 175.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 93.2 mt -103.8 -5.67 22.2 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.236 1.415 . . . . 0.0 114.447 -179.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 61.2 p . . . . . 0 C--O 1.25 1.1 0 C-N-CA 126.07 1.748 . . . . 0.0 114.159 173.465 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.4 t . . . . . 0 CA--C 1.547 0.865 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.6 pt -49.21 -24.82 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 126.741 2.016 . . . . 0.0 116.222 -165.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.26 -21.84 26.16 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.929 1.691 . . . . 0.0 114.264 -178.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.9 m -77.32 -32.74 55.49 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.81 1.244 . . . . 0.0 113.437 170.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 78.8 mtp -63.26 -33.76 76.19 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 121.306 -0.871 . . . . 0.0 111.371 -176.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.0 mm -62.35 -22.47 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 125.726 1.611 . . . . 0.0 112.767 -176.063 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -85.86 -17.74 34.77 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.24 1.416 . . . . 0.0 113.876 179.137 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -88.77 -7.5 71.15 Favored Glycine 0 CA--C 1.536 1.395 0 N-CA-C 115.933 1.133 . . . . 0.0 115.933 -173.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -145.04 161.16 40.09 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.292 1.437 . . . . 0.0 110.738 169.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -67.77 -48.33 66.65 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.091 0.956 . . . . 0.0 111.176 177.503 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.4 t -114.53 131.12 67.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.937 1.295 . . . . 0.0 110.961 171.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 85.3 t -131.06 130.74 63.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 125.014 1.326 . . . . 0.0 110.206 179.03 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 49.3 t -128.81 146.03 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 124.13 0.972 . . . . 0.0 112.421 -175.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -121.84 111.53 17.23 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.789 1.235 . . . . 0.0 109.099 173.008 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 18.7 m -121.14 172.68 7.8 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 126.728 2.011 . . . . 0.0 111.319 -173.246 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.486 ' CD1' ' HB3' ' A' ' 46' ' ' ASP . 23.6 m0 -120.31 135.88 54.86 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.57 1.148 . . . . 0.0 108.86 162.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 60.7 t -57.72 -35.54 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 CA-C-N 118.849 0.75 . . . . 0.0 111.13 -177.436 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.3 p -74.34 -10.82 59.96 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 127.308 2.243 . . . . 0.0 116.408 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 38.0 t -90.61 143.73 29.52 Favored Pre-proline 0 CA--C 1.537 0.48 0 O-C-N 121.264 -0.898 . . . . 0.0 110.513 -170.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.33 -39.05 0.61 Allowed 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 121.114 1.209 . . . . 0.0 112.655 173.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -59.01 -36.31 74.73 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.307 1.043 . . . . 0.0 113.744 178.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -48.44 -54.73 13.06 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.713 1.205 . . . . 0.0 109.584 168.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 57.5 t -65.2 -39.64 86.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.242 1.017 . . . . 0.0 112.139 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 79.6 mmt-85 -54.78 -41.67 70.8 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 118.687 0.676 . . . . 0.0 111.572 174.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.17 -54.27 8.88 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.608 0.763 . . . . 0.0 113.007 173.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -54.24 -31.94 54.67 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 119.498 1.044 . . . . 0.0 113.349 -177.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -69.32 -49.23 57.68 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.0 0.92 . . . . 0.0 112.669 176.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 8.0 tt -72.59 -36.74 68.22 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 124.651 1.181 . . . . 0.0 111.861 -177.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 93.2 mt -62.25 -44.78 95.77 Favored 'General case' 0 CA--C 1.53 0.175 0 O-C-N 121.607 -0.683 . . . . 0.0 111.395 177.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 14.8 m-70 -69.61 -20.88 63.61 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 172.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.61 -31.91 53.19 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 119.698 1.135 . . . . 0.0 113.203 173.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 39.6 mmt-85 -97.36 -23.79 15.94 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 114.827 1.418 . . . . 0.0 114.827 -176.389 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 14.6 t -153.78 170.25 21.39 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -177.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 77.6 mttt -112.68 3.82 16.81 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 126.411 1.884 . . . . 0.0 112.224 167.343 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -105.83 42.94 1.18 Allowed 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 126.081 1.752 . . . . 0.0 113.114 -171.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -119.54 134.97 61.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.858 1.663 . . . . 0.0 111.959 -177.048 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.0 m -119.19 141.85 48.51 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.803 2.041 . . . . 0.0 110.242 167.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.5 p -135.37 141.04 43.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 125.072 1.349 . . . . 0.0 113.308 176.159 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -112.77 134.68 54.17 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 127.414 2.286 . . . . 0.0 110.394 175.247 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -101.62 89.44 3.71 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 124.15 0.98 . . . . 0.0 110.509 -179.144 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.9 m -76.1 4.65 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -170.422 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.486 ' HB3' ' CD1' ' A' ' 20' ' ' TRP . 2.5 p-10 -85.23 -22.92 28.47 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.759 1.224 . . . . 0.0 112.038 167.467 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 30.0 mtmt -90.0 5.09 48.08 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.904 2.082 . . . . 0.0 113.41 176.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 12.2 tpt -120.63 124.25 44.79 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.975 1.71 . . . . 0.0 111.413 -165.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 10.5 m -65.21 -22.91 66.95 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.735 0.814 . . . . 0.0 112.847 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.4 5.58 51.36 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 126.16 1.784 . . . . 0.0 113.549 174.498 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -55.88 -30.57 57.14 Favored Glycine 0 CA--C 1.532 1.106 0 O-C-N 120.402 -1.436 . . . . 0.0 114.651 -174.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -70.23 -26.23 63.76 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 118.541 1.17 . . . . 0.0 113.043 175.068 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -72.21 -44.11 63.45 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.97 0.908 . . . . 0.0 110.53 170.537 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.23 -36.65 83.57 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.044 0.538 . . . . 0.0 110.459 178.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 43.0 mtp180 -63.93 -42.01 97.47 Favored 'General case' 0 N--CA 1.477 0.897 0 O-C-N 121.077 -1.014 . . . . 0.0 112.176 167.148 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -58.91 -38.38 92.49 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 124.225 0.917 . . . . 0.0 113.627 176.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -61.18 -32.29 72.03 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 118.597 1.199 . . . . 0.0 113.637 173.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 52.0 mt -81.28 -42.55 19.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 123.939 0.896 . . . . 0.0 109.214 177.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -71.93 -39.59 69.36 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 121.115 -0.991 . . . . 0.0 112.941 -176.387 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 42.2 mm-40 -68.63 -23.91 64.49 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 119.939 1.245 . . . . 0.0 113.069 177.444 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -98.75 -31.75 11.73 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.533 1.133 . . . . 0.0 113.827 -178.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -134.87 5.0 3.33 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -170.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 66.7 mmtt 47.37 38.94 8.14 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 126.565 1.946 . . . . 0.0 114.429 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -139.88 147.69 40.99 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.704 1.202 . . . . 0.0 111.446 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -140.29 2.47 1.88 Allowed 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.998 1.319 . . . . 0.0 113.861 -172.149 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 90.2 m -82.22 141.04 33.32 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.284 1.034 . . . . 0.0 111.851 175.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.9 m -101.97 156.06 35.68 Favored Pre-proline 0 N--CA 1.475 0.785 0 C-N-CA 124.826 1.251 . . . . 0.0 112.73 -176.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -73.69 150.96 96.42 Favored 'Cis proline' 0 C--N 1.348 0.546 0 CA-C-N 118.759 0.592 . . . . 0.0 113.013 -5.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -98.02 130.84 44.83 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 161.382 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 47.8 mt -126.28 141.39 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 C-N-CA 124.084 0.954 . . . . 0.0 109.294 -167.146 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -139.34 141.11 37.66 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.516 0.727 . . . . 0.0 111.736 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 43.4 mt -136.5 117.07 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.659 1.184 . . . . 0.0 109.508 -179.196 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 46.37 38.58 5.4 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 125.135 1.374 . . . . 0.0 114.165 -171.316 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 78.83 0.29 80.64 Favored Glycine 0 CA--C 1.54 1.654 0 N-CA-C 115.723 1.049 . . . . 0.0 115.723 -177.118 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 -88.61 145.84 25.46 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 119.088 1.444 . . . . 0.0 110.261 174.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -94.06 137.62 33.05 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -172.363 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 18.3 mm -130.75 115.46 30.95 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 C-N-CA 127.825 2.45 . . . . 0.0 107.663 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -70.97 -16.97 75.11 Favored Glycine 0 CA--C 1.537 1.461 0 N-CA-C 116.41 1.324 . . . . 0.0 116.41 -165.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 172.99 -173.87 45.72 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 124.558 1.075 . . . . 0.0 113.52 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 34.1 t -62.92 -35.63 80.73 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 122.262 -0.552 . . . . 0.0 111.469 174.222 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 43.5 t -60.96 -44.29 97.5 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.795 -0.565 . . . . 0.0 112.319 173.126 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -70.94 -31.11 67.61 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.51 1.124 . . . . 0.0 112.015 -179.081 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 42.5 tp -69.38 -50.82 42.55 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.815 1.646 . . . . 0.0 111.289 172.491 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -64.36 -31.45 72.66 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 121.422 -0.799 . . . . 0.0 112.521 178.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.43 -22.63 65.2 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 119.131 0.878 . . . . 0.0 112.771 175.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 68.7 mt -90.13 -29.81 18.06 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.987 1.315 . . . . 0.0 112.088 171.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -65.16 -45.4 85.09 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.041 0.936 . . . . 0.0 112.264 172.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -60.33 -22.52 63.32 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.747 1.619 . . . . 0.0 114.059 177.148 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -105.07 -7.81 18.9 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.061 1.344 . . . . 0.0 114.584 -176.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 84.08 6.11 86.88 Favored Glycine 0 CA--C 1.54 1.627 0 CA-C-N 118.881 0.764 . . . . 0.0 114.673 -176.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 34.0 mtmt -90.51 -25.68 20.15 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 125.662 1.585 . . . . 0.0 113.252 -171.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 52.4 tp -65.19 -38.55 90.85 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.283 1.033 . . . . 0.0 111.258 173.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -62.06 -23.6 66.59 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 173.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -85.2 -23.41 48.51 Favored Glycine 0 CA--C 1.532 1.123 0 O-C-N 121.545 -0.722 . . . . 0.0 114.141 172.337 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 41.9 mt -79.18 -35.03 42.53 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.893 1.277 . . . . 0.0 112.336 175.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 51.5 mt -81.01 -0.73 40.89 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 115.421 1.638 . . . . 0.0 115.421 -166.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 16.4 m . . . . . 0 C--O 1.254 1.34 0 C-N-CA 127.073 2.149 . . . . 0.0 113.027 -179.57 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 53.8 p . . . . . 0 C--O 1.238 0.498 0 CA-C-O 121.422 0.63 . . . . 0.0 109.557 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.464 HG23 HD12 ' A' ' 54' ' ' LEU . 21.3 pt -53.44 -27.55 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 123.344 0.658 . . . . 0.0 112.621 172.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.88 -25.12 64.46 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -172.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.1 m -81.07 -31.95 34.18 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 121.096 -1.003 . . . . 0.0 111.904 167.043 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 56.5 mtm -68.37 -17.97 64.36 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 178.565 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.5 mm -60.84 -31.16 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 CA-C-N 119.223 0.919 . . . . 0.0 111.99 171.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.2 mptt -75.53 -1.52 24.71 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -174.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -81.86 -38.03 14.78 Favored Glycine 0 CA--C 1.537 1.436 0 N-CA-C 115.659 1.024 . . . . 0.0 115.659 -172.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -140.84 171.92 13.41 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.304 1.442 . . . . 0.0 112.641 -174.228 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 29.0 ttpt -68.7 -39.29 80.56 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.849 1.26 . . . . 0.0 112.813 -178.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.1 t -122.47 134.44 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.031 0.932 . . . . 0.0 110.357 172.176 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 25.2 t -135.27 130.51 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 124.368 1.067 . . . . 0.0 109.985 177.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 54.8 t -127.4 149.12 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.472 1.109 . . . . 0.0 111.977 -173.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -127.31 114.33 17.45 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.408 1.483 . . . . 0.0 109.409 175.191 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.7 m -130.14 172.13 12.1 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 126.571 1.948 . . . . 0.0 111.444 -168.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 23.0 m0 -114.55 138.99 49.95 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 158.047 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.41 ' CG2' ' HE2' ' A' ' 47' ' ' LYS . 96.6 t -65.56 -22.82 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 CA-C-N 118.465 0.575 . . . . 0.0 111.208 175.573 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 76.6 p -68.54 -18.73 64.42 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.639 1.576 . . . . 0.0 115.001 172.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 49.9 t -93.14 143.3 26.53 Favored Pre-proline 0 CA--C 1.539 0.522 0 CA-C-N 119.698 1.135 . . . . 0.0 111.498 -165.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -82.92 -33.53 0.42 Allowed 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 121.217 1.278 . . . . 0.0 112.932 174.425 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -61.23 -36.64 80.5 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.67 1.188 . . . . 0.0 112.705 176.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -49.85 -55.13 15.43 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.382 1.473 . . . . 0.0 109.517 168.011 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 86.0 t -63.97 -39.02 83.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.221 1.008 . . . . 0.0 112.558 -176.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 25.4 mmm180 -53.89 -48.11 70.41 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 118.745 0.702 . . . . 0.0 111.029 173.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.81 -55.77 13.39 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.617 0.767 . . . . 0.0 112.342 175.251 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.79 -38.27 47.41 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.722 1.209 . . . . 0.0 113.698 -178.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -71.28 -51.08 26.47 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.394 0.678 . . . . 0.0 111.172 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.2 tt -66.19 -38.63 88.46 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 125.151 1.381 . . . . 0.0 111.754 -177.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 71.5 mt -61.86 -52.94 62.07 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.897 0.879 . . . . 0.0 111.172 176.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -63.43 -25.23 68.18 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 172.165 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.04 -13.27 60.22 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 120.514 -1.366 . . . . 0.0 113.514 175.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 12.3 mmp_? -99.87 -56.88 2.26 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.842 1.257 . . . . 0.0 112.433 171.31 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 25.4 p -150.02 143.15 24.98 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.556 1.142 . . . . 0.0 113.915 -164.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -83.73 -0.98 53.11 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 126.572 1.949 . . . . 0.0 113.528 175.135 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -83.29 29.35 0.5 Allowed 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.075 1.35 . . . . 0.0 113.383 -177.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -110.15 132.49 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 126.818 2.047 . . . . 0.0 111.089 -174.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 46.8 m -110.2 138.88 45.97 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 126.956 2.103 . . . . 0.0 108.89 166.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.1 p -134.6 139.61 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-O 122.537 1.161 . . . . 0.0 113.37 170.002 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 34.6 m-70 -116.23 145.95 42.72 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 127.939 2.496 . . . . 0.0 110.918 -178.071 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -123.58 90.77 3.34 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.967 0.889 . . . . 0.0 111.335 -168.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 34.9 m -68.24 -11.66 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -174.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.41 -23.58 54.03 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.865 0.866 . . . . 0.0 112.963 170.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.41 ' HE2' ' CG2' ' A' ' 21' ' ' VAL . 71.2 mmtt -86.43 -32.26 20.97 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.703 1.201 . . . . 0.0 111.977 175.392 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 67.1 mtt -61.75 143.83 55.62 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.122 0.969 . . . . 0.0 112.157 174.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 9.4 t -70.42 -37.58 74.46 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.835 0.854 . . . . 0.0 111.103 168.132 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -100.16 7.92 44.22 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.776 1.63 . . . . 0.0 114.026 -176.299 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -57.02 -27.41 57.12 Favored Glycine 0 CA--C 1.534 1.244 0 O-C-N 120.598 -1.314 . . . . 0.0 115.795 -172.014 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -67.6 -20.01 65.31 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.052 1.426 . . . . 0.0 112.82 174.407 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -80.34 -33.82 37.08 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.984 1.314 . . . . 0.0 112.0 170.422 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.464 HD12 HG23 ' A' ' 6' ' ' ILE . 3.0 mm? -77.9 -27.98 49.71 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 121.52 -0.737 . . . . 0.0 111.495 177.756 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 66.5 mtp180 -54.72 -39.74 68.53 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-N 119.633 1.106 . . . . 0.0 111.337 159.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.23 -28.02 73.06 Favored Glycine 0 CA--C 1.534 1.271 0 CA-C-O 119.095 -0.836 . . . . 0.0 115.033 175.25 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -65.0 -35.0 79.79 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 119.557 1.678 . . . . 0.0 112.398 174.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 27.9 mt -72.93 -41.3 60.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 124.44 1.096 . . . . 0.0 109.278 173.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -64.53 -46.29 83.5 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 121.49 -0.757 . . . . 0.0 112.947 -177.359 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 93.5 mm-40 -70.58 -18.02 62.9 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -92.74 -33.03 14.47 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 175.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -136.35 -0.73 2.41 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 115.678 1.733 . . . . 0.0 115.678 -168.179 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 53.06 41.35 32.16 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 126.803 2.041 . . . . 0.0 113.835 -169.124 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -128.72 140.61 51.65 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.592 1.157 . . . . 0.0 113.056 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -142.18 -18.03 0.73 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.684 1.194 . . . . 0.0 113.949 -169.137 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.7 p -72.68 164.55 26.34 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.49 1.116 . . . . 0.0 113.524 169.367 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 20.1 m -123.65 155.03 66.82 Favored Pre-proline 0 N--CA 1.478 0.955 0 C-N-CA 124.715 1.206 . . . . 0.0 113.597 -175.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -75.47 151.73 96.59 Favored 'Cis proline' 0 C--N 1.35 0.619 0 CA-C-N 118.793 0.605 . . . . 0.0 112.913 -4.154 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -100.12 132.5 45.45 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 162.026 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 69.3 mt -126.23 142.4 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 123.977 0.911 . . . . 0.0 108.725 -167.035 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -138.68 146.04 41.1 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.669 0.788 . . . . 0.0 112.08 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 51.8 mt -132.73 119.99 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.907 1.283 . . . . 0.0 109.994 176.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 48.05 29.75 1.86 Allowed 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 126.224 1.81 . . . . 0.0 114.57 -176.366 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 91.21 0.51 73.74 Favored Glycine 0 CA--C 1.541 1.703 0 C-N-CA 125.428 1.489 . . . . 0.0 116.759 -175.165 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -93.0 144.96 24.74 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 126.022 1.729 . . . . 0.0 110.744 175.162 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -91.96 141.56 28.5 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.704 1.202 . . . . 0.0 114.065 -176.485 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 26.4 mm -127.79 123.2 60.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 C-N-CA 128.076 2.55 . . . . 0.0 108.364 -178.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -72.02 16.63 1.51 Allowed Glycine 0 N--CA 1.475 1.274 0 N-CA-C 118.863 2.305 . . . . 0.0 118.863 -167.147 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 114.59 -159.8 13.53 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 126.831 2.158 . . . . 0.0 114.196 178.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 53.6 t -65.25 -42.22 93.5 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.796 0.838 . . . . 0.0 113.229 -172.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 21.5 m -61.27 -40.9 95.8 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 118.924 0.784 . . . . 0.0 112.025 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -66.03 -40.45 91.05 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.774 1.23 . . . . 0.0 112.107 176.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 56.1 tp -64.14 -50.83 66.68 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.326 1.45 . . . . 0.0 111.35 177.437 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -63.3 -39.51 94.77 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 118.108 0.413 . . . . 0.0 111.106 175.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.29 -38.67 90.26 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 121.541 -0.724 . . . . 0.0 111.869 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 29.4 mt -66.53 -27.38 67.71 Favored 'General case' 0 N--CA 1.468 0.425 0 O-C-N 121.302 -0.874 . . . . 0.0 112.151 176.089 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -75.04 -43.42 53.68 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 118.748 0.704 . . . . 0.0 111.634 174.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -65.87 -32.41 73.9 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.582 0.753 . . . . 0.0 112.083 175.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -78.84 -0.48 30.79 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 126.119 1.768 . . . . 0.0 113.601 172.073 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 73.22 23.0 78.38 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 124.461 1.029 . . . . 0.0 114.925 173.113 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 43.2 mtmt -113.59 -24.06 9.43 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 127.31 2.244 . . . . 0.0 113.877 -168.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 38.7 tp -63.24 -37.33 86.81 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 123.43 0.692 . . . . 0.0 111.825 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -54.92 -44.14 73.96 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.545 0.738 . . . . 0.0 112.375 175.171 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -73.53 -33.67 58.09 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 123.991 0.805 . . . . 0.0 113.894 177.071 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 82.3 mt -68.24 -36.39 79.39 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 118.764 1.282 . . . . 0.0 111.801 173.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 83.0 mt -83.9 6.2 22.55 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.932 1.293 . . . . 0.0 113.184 176.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 61.4 m . . . . . 0 C--O 1.253 1.286 0 C-N-CA 124.054 0.942 . . . . 0.0 111.1 171.891 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 7.8 p . . . . . 0 CA--C 1.534 0.354 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.429 HG23 HD12 ' A' ' 54' ' ' LEU . 21.8 pt -54.53 -23.15 10.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 125.072 1.349 . . . . 0.0 113.044 168.135 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.58 -22.19 66.9 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -174.133 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 70.5 m -79.12 -28.95 42.97 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 121.08 -1.013 . . . . 0.0 113.148 170.185 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 54.8 mtt -64.3 -30.97 72.0 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 121.382 -0.824 . . . . 0.0 111.723 -178.085 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.7 mm -60.74 -27.67 41.35 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 125.012 1.325 . . . . 0.0 112.279 -178.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.4 mptt -81.0 -11.39 59.57 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.996 1.318 . . . . 0.0 113.577 178.26 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -80.87 -32.71 32.04 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 124.12 0.866 . . . . 0.0 114.985 -176.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 55.0 m-80 -141.56 162.47 35.4 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 115.445 1.646 . . . . 0.0 115.445 -172.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -61.62 -42.36 98.77 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.958 1.303 . . . . 0.0 112.705 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.4 t -127.55 132.12 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.129 0.972 . . . . 0.0 110.317 175.33 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 48.0 t -132.08 131.17 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.015 0.926 . . . . 0.0 110.92 178.477 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.0 t -129.84 150.45 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.275 1.03 . . . . 0.0 113.029 -174.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -126.28 106.87 9.83 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.692 1.197 . . . . 0.0 109.992 175.305 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 60.9 m -125.02 167.33 14.89 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 126.058 1.743 . . . . 0.0 112.134 -169.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 41.7 m0 -113.66 121.55 44.49 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.046 1.338 . . . . 0.0 109.289 166.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 96.4 t -55.99 -27.61 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 C-N-CA 124.777 1.231 . . . . 0.0 112.772 -174.11 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.6 p -74.45 -17.04 60.84 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 126.998 2.119 . . . . 0.0 115.054 178.464 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 76.1 m -107.74 158.19 34.01 Favored Pre-proline 0 CA--C 1.54 0.591 0 CA-C-N 120.135 1.334 . . . . 0.0 114.02 -160.048 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -79.86 -48.11 0.08 OUTLIER 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.175 1.917 . . . . 0.0 112.879 -168.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -60.99 -36.31 79.13 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.067 0.947 . . . . 0.0 113.281 -179.357 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -43.61 -55.42 4.32 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.701 1.2 . . . . 0.0 110.128 165.18 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 54.5 t -68.3 -40.31 82.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 123.89 0.876 . . . . 0.0 111.967 -178.207 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 43.6 mmt-85 -56.14 -41.38 75.3 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 118.865 0.757 . . . . 0.0 111.828 175.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.94 -56.72 5.61 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.732 1.213 . . . . 0.0 112.909 173.056 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -51.44 -35.78 41.1 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 119.857 1.208 . . . . 0.0 113.243 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 25.3 ttpt -69.44 -50.35 46.52 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 124.203 1.001 . . . . 0.0 111.647 178.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.5 tt -65.72 -41.65 92.0 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 124.63 1.172 . . . . 0.0 111.006 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 53.0 mt -62.22 -50.05 73.31 Favored 'General case' 0 C--O 1.227 -0.095 0 CA-C-O 118.359 -0.829 . . . . 0.0 111.112 177.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 14.7 m170 -61.6 -21.81 64.67 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 118.74 0.7 . . . . 0.0 112.617 173.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -83.54 -14.16 52.87 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 119.79 1.177 . . . . 0.0 114.033 174.126 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.91 -36.99 4.96 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.109 1.364 . . . . 0.0 114.1 -178.253 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.0 m -147.97 138.98 23.3 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 126.312 1.845 . . . . 0.0 111.107 -171.126 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -97.37 -22.95 16.33 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.195 0.998 . . . . 0.0 112.665 174.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -78.3 52.5 1.13 Allowed 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 125.263 1.425 . . . . 0.0 112.921 172.183 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -112.3 136.36 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 127.665 2.386 . . . . 0.0 109.934 178.274 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.6 m -123.13 119.79 31.32 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.723 1.609 . . . . 0.0 110.185 172.063 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.3 p -110.26 133.66 54.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 123.772 0.829 . . . . 0.0 111.743 170.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -103.84 125.94 50.62 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.881 1.272 . . . . 0.0 109.802 170.275 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -95.74 101.83 13.57 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 121.866 0.841 . . . . 0.0 111.169 -176.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . 0.278 29.8 m -81.97 5.57 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 O-C-N 120.552 -1.342 . . . . 0.0 114.481 -173.036 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -92.04 -20.61 21.14 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 125.26 1.424 . . . . 0.0 112.163 161.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.4 mmmt -89.66 -37.04 14.9 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 126.784 2.034 . . . . 0.0 111.878 176.347 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 46.1 tpp -85.2 121.12 27.5 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.683 0.793 . . . . 0.0 110.236 177.595 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 73.2 m -64.46 -24.45 67.62 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 -168.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -86.78 1.46 52.16 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 126.911 2.085 . . . . 0.0 114.551 171.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -50.97 -27.35 13.45 Favored Glycine 0 CA--C 1.533 1.2 0 N-CA-C 116.92 1.528 . . . . 0.0 116.92 -169.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -73.98 -20.86 60.21 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 119.808 1.804 . . . . 0.0 113.157 177.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 63.2 mm-40 -83.3 -29.89 28.0 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 121.03 -1.043 . . . . 0.0 111.803 172.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.429 HD12 HG23 ' A' ' 6' ' ' ILE . 2.7 mm? -73.92 -34.34 64.32 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.777 0.831 . . . . 0.0 111.509 170.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 63.7 mtp85 -53.87 -39.16 65.45 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 119.606 1.094 . . . . 0.0 111.196 161.299 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -55.54 -42.01 82.95 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.054 0.835 . . . . 0.0 114.13 171.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -65.81 -25.64 67.32 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 119.697 1.748 . . . . 0.0 113.272 177.162 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.1 mt -79.66 -47.59 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 123.997 0.919 . . . . 0.0 109.477 172.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -66.64 -42.62 86.41 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.441 -0.787 . . . . 0.0 112.434 -175.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -60.76 -26.65 67.39 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 121.409 -0.807 . . . . 0.0 113.057 177.046 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -94.52 -36.65 11.75 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 -178.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -129.15 -4.03 5.01 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 115.045 1.498 . . . . 0.0 115.045 -168.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.5 mttt 43.9 61.68 2.22 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 127.939 2.496 . . . . 0.0 113.484 -174.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -135.16 109.0 8.07 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 112.428 -2.169 . . . . 0.0 110.896 -171.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -99.92 -5.9 27.56 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.68 1.592 . . . . 0.0 112.555 177.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.0 t -51.35 148.71 4.64 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 127.17 2.188 . . . . 0.0 113.452 162.235 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.2 m -136.8 141.12 33.92 Favored Pre-proline 0 N--CA 1.477 0.882 0 C-N-CA 125.962 1.705 . . . . 0.0 109.926 164.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -78.6 152.21 89.83 Favored 'Cis proline' 0 N--CA 1.46 -0.492 0 CA-C-N 119.862 0.986 . . . . 0.0 114.086 5.273 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -97.06 142.14 29.36 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.639 0.776 . . . . 0.0 109.535 161.193 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 53.6 mt -133.68 139.58 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 123.816 0.846 . . . . 0.0 110.016 -164.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -138.46 144.1 39.94 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.626 1.17 . . . . 0.0 111.468 179.279 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 66.5 mt -133.72 120.5 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 124.926 1.29 . . . . 0.0 109.029 177.137 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 45.91 38.96 4.98 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 125.85 1.66 . . . . 0.0 114.134 -176.316 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 82.36 -3.0 83.58 Favored Glycine 0 CA--C 1.539 1.535 0 N-CA-C 116.514 1.366 . . . . 0.0 116.514 -176.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -88.25 147.14 24.97 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.371 1.468 . . . . 0.0 109.675 174.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -89.65 143.74 26.56 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.809 0.844 . . . . 0.0 112.104 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 20.1 mm -126.92 115.44 41.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 127.039 2.135 . . . . 0.0 107.273 175.56 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.85 -16.1 61.09 Favored Glycine 0 CA--C 1.534 1.242 0 N-CA-C 116.908 1.523 . . . . 0.0 116.908 -167.015 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 173.46 177.74 42.91 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-N 118.796 1.298 . . . . 0.0 115.935 174.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 29.8 t -59.41 -35.19 73.52 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 122.904 0.482 . . . . 0.0 112.068 175.014 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 50.4 m -72.96 -16.91 61.52 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.647 1.179 . . . . 0.0 113.584 178.122 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -86.72 -39.13 16.3 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.446 1.098 . . . . 0.0 111.386 169.071 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 51.0 tp -61.06 -51.01 70.98 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.222 1.409 . . . . 0.0 111.514 174.365 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -55.57 -38.06 68.86 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.554 1.141 . . . . 0.0 111.028 173.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.04 -31.17 65.91 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.09 -1.006 . . . . 0.0 113.235 -177.165 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 32.1 mt -72.32 -30.94 65.24 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 119.227 0.921 . . . . 0.0 112.339 173.187 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -65.27 -33.83 76.92 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.791 1.236 . . . . 0.0 111.083 169.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 15.1 mmtt -80.23 -9.32 59.72 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 176.056 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -98.51 -11.7 21.99 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.92 1.288 . . . . 0.0 114.329 172.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 67.65 29.09 73.59 Favored Glycine 0 CA--C 1.539 1.569 0 C-N-CA 121.163 -0.541 . . . . 0.0 112.357 -171.313 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 31.8 mtmt -111.98 -16.32 13.12 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 126.547 1.939 . . . . 0.0 113.272 -176.505 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 42.9 tp -68.35 -36.9 79.91 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.748 0.819 . . . . 0.0 111.776 178.559 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -54.37 -48.41 71.51 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.269 1.028 . . . . 0.0 111.789 175.303 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -76.06 -15.6 81.28 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 125.274 1.416 . . . . 0.0 114.852 178.302 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 53.9 mt -78.18 -32.04 49.92 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 119.393 1.597 . . . . 0.0 111.495 167.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 81.2 mt -92.85 8.63 38.77 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.977 1.711 . . . . 0.0 114.089 -178.007 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 35.2 t . . . . . 0 C--O 1.252 1.211 0 C-N-CA 127.097 2.159 . . . . 0.0 113.655 178.921 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.6 m . . . . . 0 N--CA 1.477 0.883 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.7 pt -62.23 -20.86 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 -156.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -54.9 -26.44 35.84 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.553 1.541 . . . . 0.0 113.821 -178.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.4 m -72.08 -34.58 68.78 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.939 1.696 . . . . 0.0 113.205 174.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 58.7 mtt -64.39 -36.15 83.2 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.968 0.907 . . . . 0.0 111.247 -178.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.2 mm -62.89 -27.32 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.273 1.029 . . . . 0.0 111.919 -172.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -77.9 -20.53 52.76 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -173.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -78.29 -29.17 54.18 Favored Glycine 0 CA--C 1.533 1.187 0 CA-C-N 119.576 1.08 . . . . 0.0 114.819 -168.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -129.26 170.57 13.43 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.555 -0.967 . . . . 0.0 112.562 -167.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 29.9 ttpt -75.22 -38.38 60.71 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.273 0.629 . . . . 0.0 112.113 177.032 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.1 t -125.18 139.13 52.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.733 1.213 . . . . 0.0 110.158 168.193 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 60.9 t -130.82 125.43 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 124.634 1.174 . . . . 0.0 108.919 171.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 50.4 t -127.6 147.65 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 123.867 0.867 . . . . 0.0 111.909 -170.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -121.05 111.43 17.45 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.673 1.189 . . . . 0.0 109.012 174.34 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.454 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 71.9 m -127.77 168.6 14.9 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 126.447 1.899 . . . . 0.0 110.911 -172.219 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.528 ' CD1' ' HB3' ' A' ' 46' ' ' ASP . 18.3 m0 -116.06 132.23 56.71 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.521 1.129 . . . . 0.0 108.424 163.303 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 60.7 t -56.48 -29.14 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 CA-C-N 119.098 0.863 . . . . 0.0 112.288 -176.206 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.8 p -85.64 -11.09 54.73 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 127.464 2.306 . . . . 0.0 115.65 -175.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 8.5 t -90.04 141.43 27.94 Favored Pre-proline 0 CA--C 1.54 0.592 0 CA-C-N 119.77 1.168 . . . . 0.0 111.146 -170.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -69.62 -39.02 7.29 Favored 'Trans proline' 0 C--N 1.348 0.523 0 CA-C-N 120.584 1.244 . . . . 0.0 112.825 179.024 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -61.43 -31.83 71.78 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 126.485 1.914 . . . . 0.0 114.4 178.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.454 ' SG ' ' HB3' ' A' ' 19' ' ' SER . 0.1 OUTLIER -60.16 -63.48 1.28 Allowed 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 126.253 1.821 . . . . 0.0 108.856 174.037 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 63.4 t -59.09 -38.99 77.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 124.032 0.933 . . . . 0.0 110.998 -178.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 18.6 ttt180 -56.37 -31.66 64.02 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.259 1.824 . . . . 0.0 114.801 171.148 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -87.12 -50.97 6.26 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 119.511 1.051 . . . . 0.0 112.65 169.476 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -49.15 -36.78 20.17 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.232 1.413 . . . . 0.0 112.981 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -67.22 -45.86 75.53 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 123.632 0.773 . . . . 0.0 112.914 178.111 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.9 tt -76.73 -35.31 57.87 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.17 1.388 . . . . 0.0 111.364 -176.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 96.2 mt -62.6 -48.06 81.08 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.389 0.676 . . . . 0.0 111.37 174.044 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 16.7 m-70 -65.15 -23.29 67.08 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 173.194 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.42 -28.75 56.75 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 119.683 1.129 . . . . 0.0 112.758 172.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.83 -18.81 19.31 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 -177.518 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.8 t -162.25 173.72 13.83 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 -178.196 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -114.6 -30.03 6.63 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.889 1.276 . . . . 0.0 113.565 175.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -84.05 43.59 0.94 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.541 1.137 . . . . 0.0 113.337 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -101.85 118.29 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 126.361 1.864 . . . . 0.0 110.909 173.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 22.0 m -106.23 141.39 37.65 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.582 1.553 . . . . 0.0 110.005 172.37 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.4 p -131.19 146.46 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 124.574 1.15 . . . . 0.0 112.525 173.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -114.29 119.13 35.95 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.477 1.911 . . . . 0.0 108.98 173.242 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -87.44 90.96 8.56 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 122.157 0.98 . . . . 0.0 109.96 179.542 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.9 m -73.33 0.68 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -171.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.528 ' HB3' ' CD1' ' A' ' 20' ' ' TRP . 2.8 p-10 -88.74 -12.76 41.28 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.443 1.097 . . . . 0.0 113.138 167.336 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 38.0 mtmt -99.11 -26.22 14.28 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 126.118 1.767 . . . . 0.0 113.794 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 10.1 ttt -98.38 137.87 36.45 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.488 1.115 . . . . 0.0 112.202 178.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 66.1 m -64.42 -26.87 68.64 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 177.487 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -79.41 -0.29 32.3 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 121.029 -1.045 . . . . 0.0 113.376 175.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -52.2 -31.4 34.05 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 125.268 1.413 . . . . 0.0 115.329 -174.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -83.92 -16.29 44.83 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 118.263 1.031 . . . . 0.0 112.996 -178.319 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 7.8 mp0 -81.16 -39.28 25.78 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 121.04 -1.037 . . . . 0.0 110.238 167.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.78 -46.12 90.91 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.042 0.537 . . . . 0.0 110.526 171.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 67.2 mtp180 -59.76 -33.14 71.3 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.283 1.033 . . . . 0.0 112.96 170.066 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.78 -46.66 91.3 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.121 0.867 . . . . 0.0 112.407 174.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -59.46 -42.95 93.19 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 117.997 0.898 . . . . 0.0 112.591 175.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 73.2 mt -66.41 -42.37 90.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 123.483 0.713 . . . . 0.0 110.505 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -71.58 -41.43 69.02 Favored 'General case' 0 CA--C 1.535 0.404 0 O-C-N 121.463 -0.773 . . . . 0.0 112.862 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -63.37 -36.99 85.54 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.733 1.151 . . . . 0.0 112.448 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -82.99 -47.22 11.97 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 178.006 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -120.16 -4.15 10.03 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -164.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.7 mptt 49.89 53.53 12.63 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.886 1.674 . . . . 0.0 112.185 -177.013 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 23.2 t-80 -131.44 136.53 48.05 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.951 1.7 . . . . 0.0 109.863 173.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -141.81 -34.46 0.47 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.989 0.915 . . . . 0.0 112.667 -166.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.3 p -63.57 165.53 7.94 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.085 1.354 . . . . 0.0 111.588 156.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.425 ' HB ' ' HA ' ' A' ' 68' ' ' PRO . 23.1 m -122.33 159.44 52.34 Favored Pre-proline 0 N--CA 1.48 1.043 0 C-N-CA 124.803 1.241 . . . . 0.0 112.402 -174.269 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.425 ' HA ' ' HB ' ' A' ' 67' ' ' VAL . 63.2 Cg_endo -81.85 152.58 77.53 Favored 'Cis proline' 0 C--N 1.349 0.592 0 CA-C-N 119.389 0.817 . . . . 0.0 113.803 -4.5 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -106.32 136.44 46.05 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.393 1.477 . . . . 0.0 108.979 163.247 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 73.2 mt -131.16 142.83 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 123.866 0.866 . . . . 0.0 110.164 -163.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -136.98 140.85 42.47 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.349 1.06 . . . . 0.0 110.912 176.364 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 83.9 mt -128.11 122.11 57.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 125.829 1.652 . . . . 0.0 109.42 179.121 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 44.7 42.32 5.75 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 125.432 1.493 . . . . 0.0 114.203 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 86.27 -4.63 85.84 Favored Glycine 0 CA--C 1.541 1.713 0 C-N-CA 125.077 1.323 . . . . 0.0 116.219 -177.296 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -102.49 135.19 44.56 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.654 1.727 . . . . 0.0 111.479 -176.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -73.9 144.26 45.43 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.8 0.84 . . . . 0.0 112.378 178.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 32.2 mm -122.22 127.42 75.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 127.384 2.274 . . . . 0.0 107.995 177.389 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.81 -5.89 27.46 Favored Glycine 0 CA--C 1.536 1.37 0 N-CA-C 118.212 2.045 . . . . 0.0 118.212 -163.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 144.79 -171.85 25.88 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 126.478 1.99 . . . . 0.0 112.752 176.342 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 11.4 t -61.41 -32.73 72.69 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 122.067 -0.666 . . . . 0.0 112.441 173.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 35.6 t -67.17 -41.11 86.52 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.317 -0.865 . . . . 0.0 111.735 178.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -66.55 -37.15 84.37 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.273 1.029 . . . . 0.0 113.167 171.49 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 13.8 tp -63.7 -50.73 68.04 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.278 1.431 . . . . 0.0 110.908 177.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -64.46 -37.76 88.66 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 122.963 0.505 . . . . 0.0 110.836 176.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.55 -34.37 76.79 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 121.066 -1.021 . . . . 0.0 112.77 175.341 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 64.0 mt -70.99 -24.33 62.37 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.028 0.931 . . . . 0.0 113.186 172.48 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -77.09 -35.02 56.79 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 119.012 0.824 . . . . 0.0 111.946 172.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -69.35 -29.28 67.04 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.942 0.897 . . . . 0.0 112.906 169.587 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -81.76 -3.13 53.03 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 169.162 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.8 14.85 63.66 Favored Glycine 0 CA--C 1.541 1.675 0 CA-C-N 120.11 1.323 . . . . 0.0 114.72 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 34.3 mtpt -100.51 -29.31 12.43 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 126.472 1.909 . . . . 0.0 112.189 -171.214 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 46.3 tp -58.68 -39.6 81.18 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 118.718 0.69 . . . . 0.0 111.937 177.172 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -55.97 -48.46 75.77 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.499 0.72 . . . . 0.0 112.579 174.086 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -76.86 -37.97 32.28 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 123.884 0.754 . . . . 0.0 113.957 -177.043 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 69.3 mt -58.52 -26.41 63.47 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.767 1.227 . . . . 0.0 112.056 169.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 81.8 mt -103.95 16.77 25.54 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.324 1.45 . . . . 0.0 114.135 176.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 62.4 m . . . . . 0 C--O 1.252 1.229 0 C-N-CA 124.63 1.172 . . . . 0.0 111.989 172.899 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 75.3 m . . . . . 0 N--CA 1.474 0.765 0 CA-C-O 120.694 0.283 . . . . 0.0 110.6 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.8 pt -55.76 -26.2 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 125.585 1.554 . . . . 0.0 115.13 -162.172 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -54.03 -32.15 53.52 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.591 1.557 . . . . 0.0 113.241 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 47.6 t -71.7 -34.15 69.38 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.096 1.358 . . . . 0.0 112.452 174.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 52.0 mtt -68.68 -34.32 75.48 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.346 1.058 . . . . 0.0 112.255 178.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.6 mm -59.48 -27.67 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 124.267 1.027 . . . . 0.0 111.679 -176.453 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 26.9 mttm -82.58 -8.08 59.62 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.034 1.734 . . . . 0.0 114.58 178.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -80.89 -17.78 71.68 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 124.005 0.812 . . . . 0.0 114.862 -175.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 22.3 m120 -149.53 164.92 33.74 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 127.087 2.155 . . . . 0.0 110.392 -177.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 30.7 ttpt -65.95 -47.42 74.71 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.235 0.614 . . . . 0.0 112.338 173.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.5 t -115.63 129.8 71.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.366 1.067 . . . . 0.0 110.621 176.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 60.3 t -133.51 131.6 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 124.806 1.243 . . . . 0.0 109.568 178.256 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 60.5 t -134.17 154.32 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 123.82 0.848 . . . . 0.0 111.736 -170.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -129.45 121.54 27.5 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.975 1.31 . . . . 0.0 110.488 175.684 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 67.2 m -140.93 172.27 12.92 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.354 1.062 . . . . 0.0 113.764 -162.438 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.447 ' CD1' ' HB3' ' A' ' 46' ' ' ASP . 45.7 m0 -120.73 128.91 53.36 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.944 1.298 . . . . 0.0 110.534 168.419 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 71.2 t -62.66 -23.32 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 CA-C-N 119.245 0.93 . . . . 0.0 111.854 175.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 51.3 p -72.62 -13.03 61.28 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 116.067 1.877 . . . . 0.0 116.067 -175.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 57.6 m -124.39 149.81 62.43 Favored Pre-proline 0 CA--C 1.551 1.015 0 N-CA-C 116.164 1.913 . . . . 0.0 116.164 -162.282 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -74.52 -36.72 2.79 Favored 'Trans proline' 0 C--N 1.356 0.947 0 C-N-CA 122.3 2.0 . . . . 0.0 114.317 -166.24 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -52.06 -41.09 62.07 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.274 1.43 . . . . 0.0 112.141 173.024 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 5.2 m -86.34 -13.4 46.62 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 113.056 -1.884 . . . . 0.0 111.587 -166.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 95.9 t -77.36 -54.41 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 124.487 1.115 . . . . 0.0 110.839 155.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -72.91 -26.89 61.57 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 115.643 1.72 . . . . 0.0 115.643 -166.234 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -77.6 -50.22 12.98 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 119.175 0.898 . . . . 0.0 109.656 173.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.19 -36.17 79.16 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.177 0.991 . . . . 0.0 111.987 -176.422 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -60.97 -47.06 88.2 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.484 0.714 . . . . 0.0 112.521 172.697 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.2 tt -69.0 -38.24 79.17 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.672 1.589 . . . . 0.0 111.695 -179.126 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 81.7 mt -62.48 -48.14 80.88 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.496 0.719 . . . . 0.0 110.772 173.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 11.6 m-70 -63.61 -30.91 71.96 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 172.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -67.32 -26.98 66.77 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 120.783 -1.198 . . . . 0.0 112.022 174.569 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -94.09 -35.87 12.35 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.009 1.724 . . . . 0.0 114.701 -173.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 14.0 t -153.16 158.08 41.27 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.19 0.996 . . . . 0.0 113.648 -172.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 36.4 mtmt -91.67 -10.78 39.03 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.206 1.402 . . . . 0.0 112.55 163.55 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -84.76 40.07 0.78 Allowed 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 124.335 1.054 . . . . 0.0 113.591 -173.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.63 131.88 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 125.437 1.495 . . . . 0.0 113.768 -170.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.7 m -123.82 139.77 53.64 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 126.996 2.118 . . . . 0.0 110.048 175.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.3 p -139.72 125.35 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 124.724 1.21 . . . . 0.0 112.749 178.163 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 8.3 t60 -94.25 126.25 39.39 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.587 0.755 . . . . 0.0 110.895 174.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -89.75 97.25 11.08 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 123.387 0.675 . . . . 0.0 109.307 178.005 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 19.9 m -75.45 -12.32 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-O 119.021 -0.514 . . . . 0.0 112.386 -174.429 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.447 ' HB3' ' CD1' ' A' ' 20' ' ' TRP . 0.4 OUTLIER -69.33 -15.26 63.29 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.785 1.234 . . . . 0.0 113.248 174.765 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -82.99 -19.1 37.67 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 127.289 2.236 . . . . 0.0 112.448 176.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 58.8 mmm 59.3 18.53 6.75 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 127.592 2.357 . . . . 0.0 116.932 160.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.1 t -61.74 -40.21 94.27 Favored 'General case' 0 N--CA 1.48 1.034 0 O-C-N 119.915 -1.74 . . . . 0.0 111.251 170.492 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -138.86 0.34 1.97 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.489 1.516 . . . . 0.0 112.414 167.383 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -48.45 -33.3 11.49 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.786 1.66 . . . . 0.0 116.526 -174.114 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -69.69 -37.5 76.63 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 119.996 1.898 . . . . 0.0 110.647 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -76.74 -30.02 56.41 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 121.777 -0.577 . . . . 0.0 111.576 179.002 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -70.78 -45.57 64.48 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.272 0.629 . . . . 0.0 110.787 172.557 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -57.65 -38.73 75.56 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.203 1.801 . . . . 0.0 111.503 171.426 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.37 -41.5 94.46 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 124.303 0.954 . . . . 0.0 113.438 175.198 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -58.04 -43.64 86.95 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 119.214 1.507 . . . . 0.0 112.408 173.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 77.1 mt -64.35 -45.93 94.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.15 0.98 . . . . 0.0 110.328 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -66.75 -41.08 88.38 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.636 -0.665 . . . . 0.0 112.004 176.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -66.75 -25.23 66.39 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 120.774 -1.204 . . . . 0.0 113.337 177.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -92.61 -39.42 11.33 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 119.534 1.061 . . . . 0.0 113.516 178.347 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -128.39 0.81 5.67 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.669 1.188 . . . . 0.0 114.161 -167.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 48.79 43.3 21.07 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 126.782 2.033 . . . . 0.0 113.258 -176.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 63.7 t-80 -131.82 141.6 49.49 Favored 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 125.701 1.6 . . . . 0.0 111.446 -176.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -142.5 -13.92 0.77 Allowed 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 -164.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 51.3 m -70.99 150.07 46.02 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.097 1.359 . . . . 0.0 111.069 167.08 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 10.5 m -122.46 152.99 62.2 Favored Pre-proline 0 N--CA 1.477 0.894 0 C-N-CA 126.0 1.72 . . . . 0.0 112.599 -175.443 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -73.03 154.45 99.56 Favored 'Cis proline' 0 C--N 1.35 0.652 0 CA-C-N 119.126 0.724 . . . . 0.0 113.815 -2.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -107.27 129.42 54.89 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.019 1.328 . . . . 0.0 108.613 167.248 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 98.5 mt -124.27 142.86 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 123.646 0.779 . . . . 0.0 109.981 -162.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -136.27 139.16 42.47 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.803 0.841 . . . . 0.0 111.795 179.249 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 62.4 mt -131.71 116.25 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 124.85 1.26 . . . . 0.0 109.75 179.243 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 45.43 39.04 4.18 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 126.015 1.726 . . . . 0.0 113.847 -173.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 79.95 12.31 83.55 Favored Glycine 0 CA--C 1.539 1.559 0 N-CA-C 116.403 1.321 . . . . 0.0 116.403 -176.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -103.36 137.92 40.82 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 119.549 1.674 . . . . 0.0 110.691 172.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -85.93 131.0 34.38 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 -176.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 15.3 mm -116.27 125.29 73.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 128.506 2.722 . . . . 0.0 108.561 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -69.23 -15.74 70.32 Favored Glycine 0 CA--C 1.537 1.421 0 N-CA-C 117.407 1.723 . . . . 0.0 117.407 -165.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 149.54 -165.29 29.54 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-N 118.847 1.323 . . . . 0.0 115.36 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 32.2 t -65.17 -37.56 87.77 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.355 1.062 . . . . 0.0 112.563 -175.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 72.6 p -74.39 -15.62 60.92 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 178.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -87.34 -43.17 12.34 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.667 1.187 . . . . 0.0 110.598 166.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 51.7 tp -59.41 -47.9 83.68 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.571 1.149 . . . . 0.0 111.872 177.141 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -74.75 -11.78 60.24 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.804 0.842 . . . . 0.0 112.968 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -78.79 -46.84 17.91 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.117 0.967 . . . . 0.0 111.516 163.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 88.5 mt -61.17 -28.98 69.52 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.286 1.035 . . . . 0.0 112.85 175.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -64.48 -52.89 55.61 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.405 1.082 . . . . 0.0 112.093 169.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 6.9 mptt -71.14 -30.77 66.89 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.725 1.21 . . . . 0.0 112.546 -173.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -82.56 -1.94 52.18 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.29 1.036 . . . . 0.0 113.452 169.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 73.84 8.11 76.84 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 124.727 1.156 . . . . 0.0 115.759 174.55 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 47.5 mtmt -82.18 -29.6 31.4 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 127.639 2.376 . . . . 0.0 112.453 -172.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 36.8 tp -52.39 -36.23 53.58 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.603 1.161 . . . . 0.0 112.169 175.162 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -73.88 -36.17 64.77 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -67.94 -29.5 73.62 Favored Glycine 0 CA--C 1.536 1.379 0 O-C-N 120.818 -1.176 . . . . 0.0 113.325 170.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 89.3 mt -74.96 -23.63 58.32 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.621 1.168 . . . . 0.0 112.582 173.095 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 81.0 mt -95.58 -2.2 48.84 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.853 1.661 . . . . 0.0 114.869 174.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 39.7 m . . . . . 0 C--O 1.252 1.206 0 C-N-CA 126.028 1.731 . . . . 0.0 114.289 -175.603 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 61.4 m . . . . . 0 CA--C 1.548 0.897 0 CA-C-O 119.61 -0.233 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.6 pt -56.17 -19.71 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 N-CA-C 116.083 1.883 . . . . 0.0 116.083 -161.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -49.7 -30.19 8.81 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.584 1.554 . . . . 0.0 113.005 175.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 45.4 p -70.04 -38.05 75.74 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.087 0.955 . . . . 0.0 112.998 173.164 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 54.5 mtt -66.56 -32.41 73.74 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.599 1.56 . . . . 0.0 111.493 -174.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.6 mm -57.62 -33.81 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 123.919 0.888 . . . . 0.0 111.249 176.306 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 46.9 mttm -81.3 -9.22 59.8 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.054 1.342 . . . . 0.0 113.215 -173.126 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -75.69 -27.04 63.76 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 124.264 0.935 . . . . 0.0 115.201 -173.045 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -145.7 165.83 27.61 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.714 1.605 . . . . 0.0 112.606 179.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -63.09 -38.18 90.16 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.946 0.898 . . . . 0.0 113.128 178.271 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.5 t -125.26 129.58 73.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.864 1.266 . . . . 0.0 111.007 175.268 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 58.5 t -133.26 129.79 57.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.552 1.141 . . . . 0.0 110.559 -179.065 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 42.4 t -128.69 147.65 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.202 1.001 . . . . 0.0 112.337 -177.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -118.15 123.86 46.57 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.572 1.149 . . . . 0.0 109.802 170.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.8 m -140.63 177.71 7.84 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 126.328 1.851 . . . . 0.0 112.458 -165.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 37.7 m0 -123.54 136.87 54.78 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.645 1.978 . . . . 0.0 107.016 159.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 82.3 t -54.22 -31.69 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 C-N-CA 125.763 1.625 . . . . 0.0 113.64 -165.253 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.7 t -105.62 -5.12 20.35 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 114.865 1.432 . . . . 0.0 114.865 -165.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 71.8 m -90.24 141.93 28.07 Favored Pre-proline 0 C--O 1.234 0.249 0 O-C-N 121.651 -0.655 . . . . 0.0 111.268 -165.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -70.82 -36.82 7.4 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 CA-C-N 119.114 0.719 . . . . 0.0 112.769 -160.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -59.91 -38.26 81.8 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 127.783 2.433 . . . . 0.0 114.207 174.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 1.6 t -59.12 -49.55 77.46 Favored 'General case' 0 C--O 1.222 -0.352 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 173.306 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 52.8 t -63.47 -40.42 88.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 123.948 0.899 . . . . 0.0 111.451 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -56.12 -46.11 79.27 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 118.789 0.722 . . . . 0.0 111.916 175.292 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.98 -55.47 9.53 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.658 0.783 . . . . 0.0 111.692 177.281 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -42.28 -48.56 4.99 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 126.739 2.016 . . . . 0.0 111.755 178.332 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.408 ' HE3' ' HB3' ' A' ' 31' ' ' LYS . 16.9 ttpp -76.07 -27.31 57.17 Favored 'General case' 0 C--O 1.225 -0.23 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 -171.482 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.1 tt -79.24 -38.18 36.23 Favored 'General case' 0 C--N 1.317 -0.825 0 O-C-N 121.257 -0.902 . . . . 0.0 111.133 173.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 17.8 mt -67.45 -59.71 3.16 Favored 'General case' 0 CA--C 1.514 -0.415 0 C-N-CA 125.867 1.667 . . . . 0.0 112.956 -176.028 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 3.0 p-80 -52.61 -28.93 23.36 Favored 'General case' 0 C--O 1.233 0.188 0 O-C-N 124.173 0.921 . . . . 0.0 110.217 176.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.0 -14.27 47.96 Favored 'General case' 0 N--CA 1.441 -0.876 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.814 -172.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -105.19 -40.47 5.85 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 126.533 1.933 . . . . 0.0 112.612 179.233 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 23.0 m -142.63 128.13 19.02 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.743 1.617 . . . . 0.0 110.807 -175.165 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 45.2 mtmt -76.5 -23.95 53.74 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.47 1.508 . . . . 0.0 112.768 177.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -79.2 54.26 1.62 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.417 1.087 . . . . 0.0 113.908 175.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.67 139.03 24.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 125.821 1.649 . . . . 0.0 110.872 173.086 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.4 m -127.24 132.72 50.33 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 126.783 2.033 . . . . 0.0 109.306 167.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.7 p -128.02 139.96 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-O 122.238 1.018 . . . . 0.0 113.029 171.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -109.12 119.64 40.12 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.385 1.874 . . . . 0.0 109.405 176.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -91.44 92.05 8.38 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.427 0.691 . . . . 0.0 110.079 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.6 m -77.02 14.65 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 N-CA-C 115.874 1.805 . . . . 0.0 115.874 -162.575 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -100.69 -20.74 15.48 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 120.693 -1.254 . . . . 0.0 112.252 160.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 23.4 mmmt -71.46 -36.77 71.31 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.146 0.978 . . . . 0.0 111.34 175.435 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -96.13 142.23 28.56 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.098 0.959 . . . . 0.0 112.885 -167.357 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 16.4 m -69.3 -7.96 41.85 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 115.598 1.703 . . . . 0.0 115.598 -172.508 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -113.46 8.86 17.98 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.978 1.711 . . . . 0.0 113.062 175.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -54.59 -32.51 53.62 Favored Glycine 0 CA--C 1.531 1.063 0 N-CA-C 116.211 1.244 . . . . 0.0 116.211 -173.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -72.92 -29.4 63.1 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 119.169 1.485 . . . . 0.0 112.581 176.391 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -79.62 -31.26 41.61 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 121.586 -0.696 . . . . 0.0 111.852 174.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.04 -41.91 81.35 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 121.657 -0.652 . . . . 0.0 110.491 170.568 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 59.6 mtp85 -53.89 -45.75 71.16 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 119.344 0.974 . . . . 0.0 111.56 166.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.17 -38.47 93.18 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 124.15 0.881 . . . . 0.0 114.472 178.137 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -68.49 -25.14 64.81 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 119.088 1.444 . . . . 0.0 113.709 176.358 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 57.7 mt -76.88 -45.19 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 123.505 0.722 . . . . 0.0 109.263 173.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -67.42 -36.93 82.22 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 121.525 -0.734 . . . . 0.0 112.66 -178.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -57.57 -51.61 68.8 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 121.403 -0.811 . . . . 0.0 112.12 176.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -81.1 -33.08 33.56 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 114.452 1.278 . . . . 0.0 114.452 -175.479 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -123.52 -7.53 8.05 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 -166.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.5 mmtm 50.13 47.28 23.77 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 126.824 2.05 . . . . 0.0 112.745 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 17.7 t60 -138.18 136.18 36.37 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 127.082 2.153 . . . . 0.0 109.028 -177.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -123.54 -22.66 4.95 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 -177.293 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.2 p -68.19 135.17 51.64 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.644 0.778 . . . . 0.0 112.507 -178.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.8 m -88.91 149.06 42.73 Favored Pre-proline 0 N--CA 1.478 0.952 0 N-CA-C 112.519 0.562 . . . . 0.0 112.519 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -83.82 160.73 71.09 Favored 'Cis proline' 0 CA--C 1.537 0.645 0 CA-C-N 119.654 0.912 . . . . 0.0 114.181 -2.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -104.2 142.23 34.88 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.49 1.116 . . . . 0.0 109.479 159.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 56.6 mt -131.76 139.92 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.084 0.954 . . . . 0.0 110.301 -166.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -140.44 145.65 37.26 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.141 0.976 . . . . 0.0 111.964 178.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 70.1 mt -136.73 124.35 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 125.111 1.364 . . . . 0.0 109.307 177.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 47.56 37.93 7.28 Favored 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 124.649 1.18 . . . . 0.0 113.967 -177.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 73.05 11.88 79.14 Favored Glycine 0 CA--C 1.541 1.659 0 O-C-N 120.013 -1.68 . . . . 0.0 115.864 -176.104 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 24.8 m-80 -97.61 143.82 27.9 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.008 1.723 . . . . 0.0 110.032 169.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -89.2 141.51 28.46 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.94 0.896 . . . . 0.0 112.982 176.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 22.4 mm -126.32 122.97 62.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 127.731 2.412 . . . . 0.0 108.331 -179.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.95 -2.72 6.89 Favored Glycine 0 CA--C 1.538 1.501 0 N-CA-C 118.981 2.352 . . . . 0.0 118.981 -166.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 137.45 -166.9 24.92 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 126.934 2.207 . . . . 0.0 112.988 176.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 16.6 t -66.63 -33.48 75.74 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 121.65 -0.912 . . . . 0.0 113.008 -175.239 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 68.1 m -76.76 -28.7 55.82 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 121.277 -0.89 . . . . 0.0 111.993 178.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.11 -35.71 71.89 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.089 0.859 . . . . 0.0 112.782 167.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 51.6 tp -61.84 -48.64 79.67 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.797 0.839 . . . . 0.0 111.106 170.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -69.83 -13.62 62.36 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.161 0.984 . . . . 0.0 113.305 175.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -82.65 -43.5 16.86 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 121.04 -1.038 . . . . 0.0 111.331 168.223 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 76.6 mt -66.5 -28.53 68.64 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 120.93 -1.106 . . . . 0.0 113.0 177.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -61.08 -39.51 90.18 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.678 1.591 . . . . 0.0 112.23 168.154 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 5.0 mptt -84.3 -34.33 23.76 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.403 1.481 . . . . 0.0 112.364 -178.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -75.07 -0.9 20.56 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.732 1.213 . . . . 0.0 113.606 174.063 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 75.76 22.23 75.18 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 124.457 1.027 . . . . 0.0 114.51 170.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 35.5 mtmt -113.96 -20.2 11.13 Favored 'General case' 0 C--N 1.341 0.231 0 C-N-CA 126.551 1.94 . . . . 0.0 113.263 -170.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 43.0 tp -60.9 -40.37 92.84 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 118.738 0.699 . . . . 0.0 111.449 178.303 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -65.2 -42.28 93.71 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 177.189 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -70.7 -26.75 73.53 Favored Glycine 0 CA--C 1.537 1.439 0 C-N-CA 124.323 0.963 . . . . 0.0 114.511 175.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 30.0 mt -71.03 -31.95 68.57 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 118.276 1.038 . . . . 0.0 112.187 172.339 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 85.1 mt -97.85 -27.11 14.44 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 114.487 1.291 . . . . 0.0 114.487 -174.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 56.9 m . . . . . 0 C--O 1.254 1.29 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 -170.964 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 60.0 p . . . . . 0 CA--C 1.542 0.648 0 CA-C-O 120.758 0.313 . . . . 0.0 111.448 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.422 HG23 HD12 ' A' ' 54' ' ' LEU . 19.7 pt -56.35 -19.7 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 124.591 1.156 . . . . 0.0 113.264 170.052 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -58.88 -29.87 67.33 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.686 0.794 . . . . 0.0 112.816 -174.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 67.7 m -68.18 -24.45 64.97 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 173.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 54.4 mtt -72.5 -33.89 67.25 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 121.46 -0.775 . . . . 0.0 111.429 -178.26 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.8 mm -60.29 -30.78 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 123.681 0.792 . . . . 0.0 111.67 -175.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -80.36 -8.75 59.64 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.162 1.385 . . . . 0.0 114.148 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -80.03 -35.55 27.2 Favored Glycine 0 CA--C 1.535 1.292 0 N-CA-C 115.158 0.823 . . . . 0.0 115.158 -173.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 55.5 m-80 -145.08 164.13 32.17 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 118.626 1.213 . . . . 0.0 112.186 -172.057 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 21.7 ttpt -63.89 -42.25 97.52 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.285 1.034 . . . . 0.0 113.111 -178.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.9 t -119.84 130.62 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.251 1.021 . . . . 0.0 110.65 172.059 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 57.0 t -132.88 126.93 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.849 1.26 . . . . 0.0 109.744 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 40.4 t -127.1 149.29 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.129 0.972 . . . . 0.0 112.253 -173.337 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -123.15 114.4 20.25 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.355 1.462 . . . . 0.0 110.111 175.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.439 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 35.2 m -134.28 173.32 11.74 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.556 1.542 . . . . 0.0 112.754 -167.29 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 47.6 m0 -121.9 143.1 49.64 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.69 1.196 . . . . 0.0 110.237 166.015 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 76.7 t -65.18 -25.58 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 CA-C-O 120.771 0.32 . . . . 0.0 111.25 177.232 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.5 p -75.98 -18.49 59.29 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 126.196 1.798 . . . . 0.0 115.599 177.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.8 t -94.89 140.02 22.36 Favored Pre-proline 0 CA--C 1.538 0.501 0 CA-C-N 120.241 1.382 . . . . 0.0 112.571 -163.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -73.91 -37.17 3.0 Favored 'Trans proline' 0 CA--C 1.534 0.496 0 CA-C-N 120.704 1.287 . . . . 0.0 112.008 174.149 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -55.84 -37.66 69.02 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.164 1.386 . . . . 0.0 113.528 176.397 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.439 ' SG ' ' HB3' ' A' ' 19' ' ' SER . 0.5 OUTLIER -55.1 -51.89 64.98 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.192 0.997 . . . . 0.0 109.636 172.759 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.1 t -66.27 -37.53 79.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 123.943 0.897 . . . . 0.0 111.614 -177.22 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.1 mmt180 -54.06 -42.62 69.46 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 118.787 0.721 . . . . 0.0 112.115 173.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.93 -55.17 7.96 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.007 0.923 . . . . 0.0 112.463 173.38 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -54.18 -35.05 61.91 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 119.506 1.048 . . . . 0.0 113.398 -177.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.95 -38.25 69.83 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.273 1.029 . . . . 0.0 112.598 -178.34 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.4 tt -74.49 -46.18 41.11 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 126.499 1.92 . . . . 0.0 110.892 178.524 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 68.0 mt -64.69 -38.21 90.22 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.556 0.742 . . . . 0.0 112.765 -176.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 45.7 m-70 -74.74 -22.07 59.01 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 170.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -73.39 -36.38 66.04 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 119.894 1.225 . . . . 0.0 112.062 172.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 13.5 mmp_? -73.52 -52.64 12.85 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.378 1.471 . . . . 0.0 113.247 175.431 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.2 p -140.68 166.24 25.29 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 116.167 1.914 . . . . 0.0 116.167 -157.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 71.5 mttt -109.51 -27.74 9.27 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 127.976 2.511 . . . . 0.0 113.108 173.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -84.5 43.55 0.97 Allowed 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 125.205 1.402 . . . . 0.0 112.274 -178.121 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -113.43 129.13 69.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 126.558 1.943 . . . . 0.0 111.982 178.309 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.9 m -122.3 141.83 51.11 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 126.644 1.978 . . . . 0.0 111.169 174.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.4 p -135.72 136.27 50.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 124.441 1.096 . . . . 0.0 113.232 178.328 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 38.6 t60 -105.48 122.4 45.92 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.957 2.103 . . . . 0.0 109.752 175.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -92.22 89.12 6.74 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 123.689 0.796 . . . . 0.0 108.986 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 35.7 m -65.2 -18.69 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -175.359 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -55.88 -43.13 76.88 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.409 1.484 . . . . 0.0 111.572 164.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 34.1 mtmt -86.68 7.87 24.79 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 127.188 2.195 . . . . 0.0 113.756 179.335 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -114.68 129.9 56.74 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.192 1.397 . . . . 0.0 110.229 178.658 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 11.8 p -64.52 -20.24 66.09 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 115.753 1.76 . . . . 0.0 115.753 -170.043 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -113.95 8.4 17.17 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.502 1.921 . . . . 0.0 112.389 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -51.95 -25.19 16.04 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 125.807 1.67 . . . . 0.0 116.896 -168.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -69.05 -27.94 66.1 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 118.947 1.373 . . . . 0.0 112.853 174.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -80.48 -25.56 38.74 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 120.573 -1.33 . . . . 0.0 112.083 172.42 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.422 HD12 HG23 ' A' ' 6' ' ' ILE . 2.7 mm? -79.72 -32.65 41.21 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.722 0.809 . . . . 0.0 111.883 174.712 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 55.4 mtp180 -52.79 -43.32 65.8 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 119.119 0.872 . . . . 0.0 110.769 158.418 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.56 -35.78 89.96 Favored Glycine 0 CA--C 1.539 1.557 0 CA-C-O 118.972 -0.904 . . . . 0.0 115.21 173.335 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -63.47 -31.84 73.11 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 119.828 1.814 . . . . 0.0 112.914 176.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 65.2 mt -79.57 -45.73 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 C-N-CA 125.806 1.642 . . . . 0.0 109.608 175.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -64.77 -41.21 96.05 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.458 -0.776 . . . . 0.0 112.483 -178.638 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 76.6 mm-40 -72.14 -16.11 61.99 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 120.898 -1.126 . . . . 0.0 113.617 177.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -89.88 -41.49 11.77 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 169.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -135.0 0.43 2.88 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 115.329 1.603 . . . . 0.0 115.329 -163.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp 55.55 26.0 8.57 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 126.402 1.881 . . . . 0.0 115.513 177.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 37.2 t60 -114.96 140.03 49.35 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.391 1.077 . . . . 0.0 111.196 167.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -125.79 -27.42 3.35 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.167 0.987 . . . . 0.0 112.644 -163.692 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.2 p -85.96 144.09 27.81 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.474 1.11 . . . . 0.0 113.907 -178.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.3 m -89.35 153.76 48.62 Favored Pre-proline 0 N--CA 1.481 1.087 0 C-N-CA 125.017 1.327 . . . . 0.0 113.292 -173.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -79.49 158.08 89.75 Favored 'Cis proline' 0 C--N 1.349 0.577 0 CA-C-N 119.441 0.836 . . . . 0.0 113.4 -3.253 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -109.55 136.84 48.29 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.089 1.356 . . . . 0.0 108.709 162.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.9 mt -126.21 144.27 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 124.243 1.017 . . . . 0.0 109.444 -169.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -137.53 143.94 41.88 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.23 1.012 . . . . 0.0 110.967 177.038 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 48.9 mt -135.3 118.47 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.879 1.272 . . . . 0.0 109.059 179.389 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 47.44 43.78 15.95 Favored 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 125.023 1.329 . . . . 0.0 113.831 -175.221 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.18 1.17 59.46 Favored Glycine 0 CA--C 1.544 1.893 0 O-C-N 120.709 -1.245 . . . . 0.0 116.015 -176.389 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -92.26 134.84 34.51 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.223 1.409 . . . . 0.0 109.759 175.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -84.33 137.7 33.29 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.897 0.879 . . . . 0.0 112.831 -178.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 36.0 mm -118.1 122.84 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 127.662 2.385 . . . . 0.0 108.538 177.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.37 -6.19 39.52 Favored Glycine 0 CA--C 1.536 1.371 0 N-CA-C 118.252 2.061 . . . . 0.0 118.252 -162.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 152.91 -174.53 31.68 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 125.851 1.691 . . . . 0.0 112.99 176.272 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 12.8 t -65.32 -31.53 72.72 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.975 -0.721 . . . . 0.0 112.373 177.144 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 12.5 m -69.01 -32.63 72.32 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.732 -0.605 . . . . 0.0 111.829 -177.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -76.41 -40.65 50.26 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.122 1.369 . . . . 0.0 112.458 170.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 56.9 tp -59.48 -45.27 92.13 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.334 1.054 . . . . 0.0 111.488 175.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -64.92 -37.66 88.39 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.822 0.849 . . . . 0.0 111.35 173.019 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.45 -23.58 66.31 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 120.914 -1.116 . . . . 0.0 113.223 177.168 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 40.3 mt -84.69 -32.33 23.64 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.038 1.735 . . . . 0.0 112.709 170.33 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -67.46 -46.92 71.61 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.154 0.982 . . . . 0.0 112.38 175.079 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.2 mptt -62.25 -42.24 99.16 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.796 1.238 . . . . 0.0 111.772 178.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -76.16 -6.75 52.68 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 176.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 72.21 22.88 78.69 Favored Glycine 0 CA--C 1.535 1.293 0 CA-C-N 119.375 0.989 . . . . 0.0 114.88 174.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 40.7 mtmt -102.37 -14.21 17.0 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 127.995 2.518 . . . . 0.0 112.381 -172.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 30.5 tp -64.75 -31.75 73.12 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.047 1.739 . . . . 0.0 112.067 175.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -57.0 -46.28 82.41 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.703 -0.623 . . . . 0.0 112.281 174.111 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -66.39 -27.61 73.19 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 123.918 0.77 . . . . 0.0 113.677 176.014 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 83.3 mt -76.74 -26.11 54.24 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.475 1.11 . . . . 0.0 113.416 174.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 84.9 mt -102.93 -9.65 19.67 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 115.602 1.704 . . . . 0.0 115.602 -172.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 16.1 m . . . . . 0 N--CA 1.486 1.365 0 C-N-CA 127.25 2.22 . . . . 0.0 115.642 167.81 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 54.5 p . . . . . 0 N--CA 1.47 0.565 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.522 HG23 HD12 ' A' ' 54' ' ' LEU . 14.0 pt -45.33 -28.64 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 124.846 1.259 . . . . 0.0 113.115 168.274 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -57.13 -33.32 67.26 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 25.9 m -84.34 -20.08 32.62 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 175.414 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 45.1 mtt -68.39 -28.05 66.76 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 119.639 1.108 . . . . 0.0 112.063 173.137 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.491 HG21 ' HA2' ' A' ' 74' ' ' GLY . 83.8 mt -67.17 -22.4 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 CA-C-O 122.457 1.122 . . . . 0.0 112.165 -171.25 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -82.55 3.63 27.8 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.354 1.861 . . . . 0.0 114.482 174.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -87.87 -13.62 64.3 Favored Glycine 0 CA--C 1.541 1.682 0 C-N-CA 125.153 1.358 . . . . 0.0 116.365 -178.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -156.87 175.78 13.62 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 119.285 1.543 . . . . 0.0 112.318 177.379 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -72.61 -33.33 66.6 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 121.805 -0.56 . . . . 0.0 112.234 174.533 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.4 t -125.72 130.18 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 124.894 1.278 . . . . 0.0 110.151 173.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 62.1 t -131.49 130.49 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 123.842 0.857 . . . . 0.0 110.636 178.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 47.0 t -130.43 148.11 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.321 1.048 . . . . 0.0 112.277 -170.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -126.18 113.67 17.32 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.917 1.287 . . . . 0.0 110.097 177.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 59.8 m -132.25 167.32 20.03 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 126.0 1.72 . . . . 0.0 111.879 -166.448 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.463 ' CD1' ' HB3' ' A' ' 46' ' ' ASP . 34.6 m0 -117.66 126.12 51.93 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.763 1.225 . . . . 0.0 109.389 166.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 89.3 t -56.42 -39.61 62.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -166.566 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.7 t -74.87 -12.57 60.4 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 127.66 2.384 . . . . 0.0 115.716 -179.069 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.9 t -88.6 139.51 29.72 Favored Pre-proline 0 CA--C 1.539 0.523 0 O-C-N 121.395 -0.816 . . . . 0.0 110.87 -165.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -66.75 -38.25 18.45 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 CA-C-N 120.327 1.152 . . . . 0.0 112.943 -178.551 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 51.9 m-85 -62.24 -36.72 82.87 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.263 1.425 . . . . 0.0 114.225 178.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -56.13 -54.49 44.51 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.3 1.04 . . . . 0.0 108.989 169.415 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 73.2 t -62.74 -37.5 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 124.291 1.037 . . . . 0.0 112.388 -178.288 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 71.0 mmt-85 -52.95 -45.94 67.95 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 119.205 0.911 . . . . 0.0 112.001 172.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.75 -53.26 10.72 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.885 0.874 . . . . 0.0 112.113 178.251 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -59.32 -25.57 64.28 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -177.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -71.44 -46.39 60.17 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.637 0.775 . . . . 0.0 112.615 173.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.7 tt -74.26 -38.32 63.48 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.59 1.556 . . . . 0.0 111.808 -177.017 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 87.0 mt -63.56 -46.5 85.63 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.073 0.549 . . . . 0.0 111.047 178.037 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -64.32 -22.6 67.01 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 172.103 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -80.9 -17.2 51.41 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 176.063 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 10.6 mmt180 -131.94 -10.27 3.43 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 117.078 2.251 . . . . 0.0 117.078 -168.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 14.9 t -152.54 155.8 38.12 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 170.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 8.8 mptt -105.91 0.82 26.18 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.385 1.474 . . . . 0.0 112.722 166.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -105.07 40.76 1.45 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.536 1.535 . . . . 0.0 112.411 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -113.88 141.63 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 126.199 1.8 . . . . 0.0 111.695 177.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.9 m -129.33 129.39 44.76 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 127.363 2.265 . . . . 0.0 109.29 172.278 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -121.32 136.49 58.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 125.027 1.331 . . . . 0.0 112.784 172.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -108.99 130.97 55.49 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 125.295 1.438 . . . . 0.0 110.569 173.383 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -97.81 94.43 6.91 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.708 -0.62 . . . . 0.0 110.821 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.8 m -73.77 -6.59 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -176.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.463 ' HB3' ' CD1' ' A' ' 20' ' ' TRP . 0.0 OUTLIER -80.73 -19.28 45.34 Favored 'General case' 0 CA--C 1.545 0.766 0 O-C-N 121.15 -0.969 . . . . 0.0 112.004 169.161 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 39.9 mtmt -95.96 11.07 35.25 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 127.468 2.307 . . . . 0.0 113.772 175.159 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 12.8 ttt -125.32 128.78 48.74 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 127.584 2.353 . . . . 0.0 110.502 -167.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 25.8 m -68.49 -36.7 79.31 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.972 0.909 . . . . 0.0 113.232 -176.057 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.4 mp0 -84.7 -0.58 54.08 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.845 1.258 . . . . 0.0 113.289 173.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -56.35 -24.44 45.4 Favored Glycine 0 CA--C 1.535 1.321 0 O-C-N 120.471 -1.393 . . . . 0.0 115.879 -169.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 60.7 mt-10 -73.58 -28.71 61.98 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 118.714 1.257 . . . . 0.0 112.649 174.017 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -74.42 -37.24 63.38 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 120.908 -1.12 . . . . 0.0 111.403 172.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.522 HD12 HG23 ' A' ' 6' ' ' ILE . 3.0 mm? -69.56 -32.1 70.68 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.77 0.828 . . . . 0.0 112.765 173.258 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 60.6 mtp180 -56.16 -38.17 70.53 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 120.004 1.274 . . . . 0.0 111.511 164.152 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -64.1 -38.4 95.93 Favored Glycine 0 CA--C 1.539 1.546 0 CA-C-O 118.744 -1.031 . . . . 0.0 114.176 169.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -61.5 -29.55 70.05 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 119.988 1.894 . . . . 0.0 113.06 173.192 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 38.6 mt -77.38 -46.78 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 118.549 0.613 . . . . 0.0 109.973 171.231 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -65.83 -42.18 90.86 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 120.868 -1.145 . . . . 0.0 113.183 -175.141 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -73.92 -9.83 59.04 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -178.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -108.04 -32.98 7.32 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.705 1.202 . . . . 0.0 114.197 173.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -133.4 -0.11 3.29 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 114.879 1.437 . . . . 0.0 114.879 -171.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.5 mptt 48.02 51.94 13.81 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 126.033 1.733 . . . . 0.0 113.256 -177.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 33.9 t-80 -134.79 131.75 37.89 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.251 1.42 . . . . 0.0 110.587 175.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -135.82 11.94 3.4 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 126.193 1.797 . . . . 0.0 112.595 -166.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.447 HG22 ' H ' ' A' ' 67' ' ' VAL . 0.3 OUTLIER -106.59 -172.04 2.01 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 126.438 1.895 . . . . 0.0 110.266 173.414 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.447 ' H ' HG22 ' A' ' 66' ' ' THR . 21.4 m -137.93 158.47 71.3 Favored Pre-proline 0 N--CA 1.48 1.026 0 O-C-N 120.53 -1.356 . . . . 0.0 113.025 175.651 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -71.77 155.08 97.95 Favored 'Cis proline' 0 C--N 1.348 0.548 0 CA-C-N 118.486 0.495 . . . . 0.0 112.673 -11.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -102.57 134.01 46.62 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.437 1.095 . . . . 0.0 108.391 161.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 46.9 mt -128.59 141.39 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 123.542 0.737 . . . . 0.0 109.916 -165.156 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -137.95 145.56 42.17 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.983 0.913 . . . . 0.0 112.102 179.246 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 64.7 mt -130.28 114.06 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.214 1.405 . . . . 0.0 108.675 174.287 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 49.91 41.53 22.92 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.0 1.32 . . . . 0.0 113.951 -172.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.491 ' HA2' HG21 ' A' ' 10' ' ' ILE . . . 75.31 4.11 72.76 Favored Glycine 0 CA--C 1.54 1.651 0 O-C-N 120.606 -1.309 . . . . 0.0 115.128 -178.643 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -97.07 133.98 41.02 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.157 1.383 . . . . 0.0 109.896 173.04 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -83.31 146.61 28.42 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.694 1.198 . . . . 0.0 113.691 -170.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 28.6 mm -130.56 120.3 47.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 128.365 2.666 . . . . 0.0 108.131 -178.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.11 -9.87 43.87 Favored Glycine 0 CA--C 1.534 1.28 0 N-CA-C 119.084 2.393 . . . . 0.0 119.084 -163.212 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 158.13 -175.35 35.34 Favored Glycine 0 CA--C 1.532 1.127 0 CA-C-N 118.936 1.368 . . . . 0.0 113.766 176.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 30.1 t -65.65 -37.66 87.16 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.97 -0.724 . . . . 0.0 112.474 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 66.5 m -70.47 -32.14 69.55 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.436 -0.79 . . . . 0.0 112.097 177.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -68.62 -41.37 79.61 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.363 0.983 . . . . 0.0 112.108 172.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 15.1 tp -58.45 -50.92 71.99 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.731 1.612 . . . . 0.0 110.843 173.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -64.37 -36.32 83.75 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.934 -0.479 . . . . 0.0 112.056 175.351 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.04 -34.56 77.98 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 121.147 -0.971 . . . . 0.0 111.824 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 92.4 mt -70.78 -31.19 67.88 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.815 0.846 . . . . 0.0 112.052 169.121 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -69.45 -39.1 77.96 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 176.264 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -63.79 -32.96 74.63 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.986 0.914 . . . . 0.0 112.59 174.366 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -75.51 -13.03 60.35 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 114.29 1.218 . . . . 0.0 114.29 169.106 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 78.74 6.32 88.43 Favored Glycine 0 CA--C 1.538 1.494 0 CA-C-N 118.84 0.746 . . . . 0.0 114.078 -173.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 35.4 mtpt -81.66 -27.65 33.96 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 126.823 2.049 . . . . 0.0 112.15 -171.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 59.2 tp -64.78 -43.73 92.27 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.081 0.952 . . . . 0.0 111.559 172.033 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 -59.07 -34.89 72.48 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.788 -0.57 . . . . 0.0 111.622 177.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -77.11 -18.71 78.21 Favored Glycine 0 CA--C 1.536 1.354 0 N-CA-C 115.605 1.002 . . . . 0.0 115.605 175.37 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 39.0 mt -81.61 -35.57 29.92 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.965 1.306 . . . . 0.0 111.533 168.115 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 84.2 mt -72.76 -3.28 24.33 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.386 1.474 . . . . 0.0 113.893 177.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.1 t . . . . . 0 C--O 1.252 1.217 0 C-N-CA 127.454 2.301 . . . . 0.0 112.333 177.492 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 53.8 p . . . . . 0 CA--C 1.54 0.583 0 CA-C-O 121.175 0.512 . . . . 0.0 111.579 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.571 HG23 HD12 ' A' ' 54' ' ' LEU . 23.5 pt -59.47 -23.94 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 123.846 0.859 . . . . 0.0 113.295 174.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.52 -32.62 72.67 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 118.244 0.474 . . . . 0.0 111.944 -175.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 83.4 p -69.26 -33.59 73.48 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.729 1.212 . . . . 0.0 113.319 170.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 43.3 mtt -67.19 -31.39 71.76 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.023 0.929 . . . . 0.0 111.516 -178.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.3 mm -56.47 -35.87 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 123.592 0.757 . . . . 0.0 111.834 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -73.61 -19.01 60.98 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.08 0.952 . . . . 0.0 113.263 -175.074 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -77.79 -26.92 59.7 Favored Glycine 0 CA--C 1.533 1.202 0 N-CA-C 115.998 1.159 . . . . 0.0 115.998 -166.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 26.7 m-80 -134.69 172.32 13.12 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.896 1.278 . . . . 0.0 111.993 -177.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -70.03 -40.72 75.01 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.233 1.013 . . . . 0.0 112.208 178.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.0 t -128.37 136.36 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 124.774 1.23 . . . . 0.0 110.172 174.215 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 43.5 t -132.7 130.34 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.4 1.08 . . . . 0.0 109.997 176.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 37.6 t -127.93 145.92 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 124.279 1.032 . . . . 0.0 111.94 -176.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -120.35 116.51 25.65 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.894 1.278 . . . . 0.0 108.54 172.192 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 14.7 m -130.64 169.14 16.02 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.911 1.684 . . . . 0.0 111.492 -169.568 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.412 ' CD1' ' HB3' ' A' ' 46' ' ' ASP . 25.6 m0 -115.59 135.88 53.63 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.197 0.999 . . . . 0.0 108.975 162.295 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.421 HG21 ' HE2' ' A' ' 47' ' ' LYS . 54.9 t -58.28 -28.54 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 CA-C-O 121.295 0.569 . . . . 0.0 111.071 176.143 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.7 p -82.72 -6.87 59.61 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 116.284 1.957 . . . . 0.0 116.284 178.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.9 t -92.47 140.15 24.03 Favored Pre-proline 0 CA--C 1.544 0.717 0 CA-C-N 120.55 1.523 . . . . 0.0 111.339 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -75.13 -34.75 3.48 Favored 'Trans proline' 0 CA--C 1.534 0.489 0 C-N-CA 121.855 1.704 . . . . 0.0 112.871 173.046 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -59.29 -38.12 79.4 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.611 1.164 . . . . 0.0 113.408 176.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -49.98 -52.65 32.09 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.288 1.035 . . . . 0.0 109.746 171.027 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 57.5 t -63.29 -40.46 89.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 124.005 0.922 . . . . 0.0 111.63 -176.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 37.0 mmt-85 -53.98 -48.74 70.05 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 118.997 0.817 . . . . 0.0 111.098 175.196 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.34 -54.14 23.28 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.896 0.878 . . . . 0.0 112.455 177.486 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -48.94 -40.48 30.39 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.544 1.138 . . . . 0.0 113.142 178.151 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.05 -45.22 58.76 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 124.676 1.19 . . . . 0.0 112.154 -175.055 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.9 tt -68.72 -41.1 79.51 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.538 1.535 . . . . 0.0 111.558 176.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 63.0 mt -63.02 -46.46 87.5 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 123.282 0.633 . . . . 0.0 111.197 175.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -64.81 -20.11 66.21 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 174.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.33 -12.87 57.71 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 173.461 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -116.47 -30.51 5.85 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.762 1.225 . . . . 0.0 114.302 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.7 m -146.9 134.77 21.3 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 119.678 1.126 . . . . 0.0 112.577 -168.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 10.6 mmpt? -86.87 -32.38 20.26 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.242 1.417 . . . . 0.0 112.717 169.186 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -77.33 47.56 0.58 Allowed 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 125.579 1.552 . . . . 0.0 113.296 177.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -110.46 128.44 66.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 127.265 2.226 . . . . 0.0 109.833 175.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.5 m -112.17 129.0 56.39 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.494 1.918 . . . . 0.0 108.728 174.459 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.5 p -125.55 142.54 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-O 122.117 0.96 . . . . 0.0 113.042 172.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 33.0 m-70 -120.09 121.68 39.39 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 127.302 2.241 . . . . 0.0 110.51 -174.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -94.63 90.99 6.34 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 122.558 1.17 . . . . 0.0 110.513 -177.055 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 34.4 m -70.18 -16.13 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-N 115.154 -0.93 . . . . 0.0 112.735 -176.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.412 ' HB3' ' CD1' ' A' ' 20' ' ' TRP . 0.2 OUTLIER -69.13 -32.97 72.72 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.396 -0.815 . . . . 0.0 112.123 174.377 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.421 ' HE2' HG21 ' A' ' 21' ' ' VAL . 70.4 mmtt -77.58 -27.57 51.42 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.52 1.928 . . . . 0.0 112.244 174.266 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.411 ' HG2' ' H ' ' A' ' 50' ' ' GLU . 21.2 ttt -71.43 142.18 50.26 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.612 1.565 . . . . 0.0 112.48 -177.543 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 4.9 m -76.34 -12.28 60.04 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 177.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.411 ' H ' ' HG2' ' A' ' 48' ' ' MET . 2.0 mt-10 -125.21 9.9 8.02 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 126.116 1.766 . . . . 0.0 113.825 178.814 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -53.5 -29.01 38.27 Favored Glycine 0 CA--C 1.539 1.566 0 N-CA-C 116.457 1.343 . . . . 0.0 116.457 -171.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -69.19 -28.91 66.81 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 118.829 1.315 . . . . 0.0 112.869 174.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -67.39 -28.97 68.37 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.937 0.895 . . . . 0.0 111.424 169.119 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.571 HD12 HG23 ' A' ' 6' ' ' ILE . 2.9 mm? -83.57 -31.89 26.1 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.012 0.925 . . . . 0.0 111.961 178.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 49.5 mtp85 -53.36 -41.71 66.11 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 119.628 1.104 . . . . 0.0 111.058 154.416 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -57.93 -38.17 87.85 Favored Glycine 0 CA--C 1.536 1.405 0 CA-C-O 118.631 -1.094 . . . . 0.0 114.445 172.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -62.19 -41.8 98.68 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 120.299 2.049 . . . . 0.0 111.864 176.083 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 52.1 mt -70.13 -42.43 79.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.243 1.417 . . . . 0.0 110.069 179.028 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -67.84 -43.22 80.02 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 121.8 -0.563 . . . . 0.0 111.895 179.388 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -64.09 -33.94 76.91 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.459 -0.776 . . . . 0.0 111.812 177.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -79.35 -48.88 13.3 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 176.264 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -125.58 -1.45 7.42 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 114.552 1.316 . . . . 0.0 114.552 -164.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.2 mmtp 55.25 36.11 26.33 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 126.83 2.052 . . . . 0.0 114.148 -178.206 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 25.1 m80 -119.84 140.81 50.22 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 128.128 2.571 . . . . 0.0 109.367 176.397 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -125.88 -32.0 2.85 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.508 1.523 . . . . 0.0 114.395 -176.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 77.7 p -67.76 147.93 51.94 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 -169.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.3 m -99.46 152.68 37.88 Favored Pre-proline 0 N--CA 1.474 0.75 0 C-N-CA 123.726 0.811 . . . . 0.0 112.34 177.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -70.32 149.37 89.8 Favored 'Cis proline' 0 N--CA 1.458 -0.597 0 CA-C-N 119.029 0.689 . . . . 0.0 111.28 -9.126 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -102.85 130.78 49.98 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.219 1.007 . . . . 0.0 108.346 166.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 13.2 mt -124.62 142.28 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 124.163 0.985 . . . . 0.0 109.338 -164.536 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -138.36 141.21 39.68 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 123.764 0.826 . . . . 0.0 111.052 177.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 55.8 mt -133.7 117.44 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 124.467 1.107 . . . . 0.0 109.428 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 74.9 m-80 48.83 35.98 7.39 Favored 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 125.633 1.573 . . . . 0.0 114.092 -174.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 80.35 5.65 89.66 Favored Glycine 0 CA--C 1.537 1.423 0 N-CA-C 116.737 1.455 . . . . 0.0 116.737 -176.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 -95.76 139.33 32.15 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 118.834 1.317 . . . . 0.0 110.77 168.148 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -81.32 137.93 35.72 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.074 0.949 . . . . 0.0 112.181 178.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 28.6 mm -116.97 121.93 68.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 127.349 2.259 . . . . 0.0 107.416 174.424 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.9 -22.81 68.84 Favored Glycine 0 CA--C 1.534 1.223 0 N-CA-C 116.211 1.244 . . . . 0.0 116.211 -162.092 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 168.93 -171.47 42.92 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-N 118.193 0.997 . . . . 0.0 113.785 179.185 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 49.1 t -61.87 -37.85 86.08 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.784 1.234 . . . . 0.0 112.174 175.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 71.1 m -56.46 -44.66 80.74 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 118.908 0.777 . . . . 0.0 112.486 176.175 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -72.45 -39.14 68.02 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.998 0.919 . . . . 0.0 111.589 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 67.2 tp -62.42 -50.21 72.42 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.035 0.934 . . . . 0.0 112.168 174.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -68.67 -15.15 63.43 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 121.754 -0.591 . . . . 0.0 112.508 176.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -81.68 -47.12 13.38 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.417 -0.802 . . . . 0.0 111.49 169.137 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 66.5 mt -62.42 -32.58 73.44 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 120.831 -1.168 . . . . 0.0 112.783 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -64.72 -29.68 70.67 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.707 1.603 . . . . 0.0 113.467 173.536 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.1 mptt -93.36 -37.08 12.19 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 126.58 1.952 . . . . 0.0 112.089 -178.041 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -71.33 -6.2 38.22 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.996 1.318 . . . . 0.0 113.582 171.091 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 76.2 17.63 79.86 Favored Glycine 0 CA--C 1.534 1.256 0 O-C-N 120.942 -1.099 . . . . 0.0 113.945 177.059 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 44.6 mtmt -99.5 -21.45 15.93 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 126.27 1.828 . . . . 0.0 113.061 -172.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 31.1 tp -66.34 -34.82 78.84 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.861 0.865 . . . . 0.0 111.615 176.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -53.27 -41.77 65.87 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.694 1.198 . . . . 0.0 112.068 173.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -85.45 -6.9 83.15 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 125.966 1.746 . . . . 0.0 114.794 179.088 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 69.7 mt -95.73 -26.16 15.8 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.144 1.378 . . . . 0.0 112.471 172.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 76.6 mt -105.69 -16.13 14.77 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 114.838 1.422 . . . . 0.0 114.838 -177.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 63.3 p . . . . . 0 N--CA 1.479 1.009 0 C-N-CA 126.229 1.812 . . . . 0.0 114.836 178.479 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 74.1 p . . . . . 0 CA--C 1.54 0.578 0 N-CA-C 110.462 -0.199 . . . . 0.0 110.462 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.567 HG23 HD12 ' A' ' 54' ' ' LEU . 27.5 pt -51.53 -23.0 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 124.181 0.993 . . . . 0.0 113.493 173.387 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.28 -18.59 61.69 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.477 1.111 . . . . 0.0 113.407 -175.339 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.5 m -84.16 -19.39 34.2 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 171.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 64.7 mtt -64.2 -37.28 86.91 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 119.557 1.072 . . . . 0.0 110.851 175.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.4 mm -59.64 -20.63 19.28 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 124.004 0.921 . . . . 0.0 113.069 -173.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.3 mptt -91.74 -7.67 49.06 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.452 1.501 . . . . 0.0 114.143 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -96.82 -18.65 29.16 Favored Glycine 0 CA--C 1.539 1.579 0 N-CA-C 116.754 1.462 . . . . 0.0 116.754 -174.128 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 27.7 m120 -141.33 151.0 43.21 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 118.894 1.347 . . . . 0.0 112.164 -176.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt -54.85 -40.9 70.12 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.008 1.323 . . . . 0.0 112.992 176.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.6 t -129.83 134.43 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.131 0.972 . . . . 0.0 110.175 174.037 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 58.9 t -131.8 129.85 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.065 1.346 . . . . 0.0 109.751 177.073 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 47.0 t -127.33 146.9 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 124.294 1.038 . . . . 0.0 111.855 -175.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -121.72 113.48 19.77 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.696 1.198 . . . . 0.0 109.971 173.036 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.4 m -131.17 170.83 14.02 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.529 1.532 . . . . 0.0 112.092 -167.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.437 ' CD1' ' HB3' ' A' ' 46' ' ' ASP . 33.2 m0 -117.36 133.85 55.5 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.571 1.149 . . . . 0.0 108.867 162.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 71.4 t -58.55 -30.43 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 C-N-CA 123.567 0.747 . . . . 0.0 111.887 -175.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.8 p -82.56 -8.49 59.61 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 126.496 1.919 . . . . 0.0 116.08 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.7 t -91.62 141.4 25.74 Favored Pre-proline 0 CA--C 1.54 0.567 0 CA-C-N 120.372 1.442 . . . . 0.0 112.394 -168.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -69.26 -39.58 7.27 Favored 'Trans proline' 0 C--N 1.349 0.576 0 CA-C-N 120.343 1.158 . . . . 0.0 112.058 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -62.45 -36.47 82.52 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 126.166 1.786 . . . . 0.0 113.083 -178.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -55.1 -53.15 59.61 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.265 1.026 . . . . 0.0 109.125 169.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 94.8 t -64.32 -39.8 86.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 123.716 0.806 . . . . 0.0 111.871 -178.091 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.5 mmt85 -53.37 -43.4 67.75 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 118.87 0.759 . . . . 0.0 111.566 172.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.75 -54.27 9.37 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.487 0.715 . . . . 0.0 112.839 175.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.38 -33.32 58.96 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.671 1.188 . . . . 0.0 113.395 -179.005 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -68.68 -49.94 54.99 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.512 0.725 . . . . 0.0 111.58 177.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.6 tt -65.66 -43.32 89.74 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.796 1.639 . . . . 0.0 111.378 -178.431 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 95.0 mt -64.0 -40.07 95.54 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.633 0.773 . . . . 0.0 111.921 -178.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 54.3 m-70 -78.48 -13.38 59.86 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 171.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -80.37 -39.35 28.65 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 119.208 0.913 . . . . 0.0 111.952 172.117 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -87.46 -28.56 22.01 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 125.053 1.341 . . . . 0.0 114.267 -178.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.2 p -151.15 170.38 19.58 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 125.118 1.367 . . . . 0.0 112.628 -168.181 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -116.85 -19.33 9.91 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 126.562 1.945 . . . . 0.0 114.047 164.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -78.35 27.82 0.2 Allowed 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -171.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.21 132.47 44.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.365 0 C-N-CA 126.887 2.075 . . . . 0.0 111.563 -178.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 16.5 m -112.81 141.53 46.51 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 126.107 1.763 . . . . 0.0 109.65 168.334 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.4 p -132.85 140.24 47.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 125.259 1.424 . . . . 0.0 111.883 173.091 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -116.06 127.85 55.22 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.975 1.31 . . . . 0.0 110.46 176.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -95.99 87.95 4.74 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 122.06 0.933 . . . . 0.0 111.714 -172.088 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.0 m -71.79 3.61 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 -174.161 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.437 ' HB3' ' CD1' ' A' ' 20' ' ' TRP . 0.0 OUTLIER -87.33 -31.03 20.39 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 121.294 -0.879 . . . . 0.0 111.732 165.873 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 25.1 mtmt -81.42 -23.81 37.3 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.822 1.249 . . . . 0.0 113.367 176.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 21.0 ttt -85.2 121.97 28.71 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.212 1.805 . . . . 0.0 110.955 173.43 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 72.5 m -63.55 -31.6 72.81 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -176.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -83.32 1.48 40.93 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 175.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -56.12 -21.71 33.03 Favored Glycine 0 CA--C 1.535 1.311 0 N-CA-C 116.663 1.425 . . . . 0.0 116.663 -169.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -67.11 -29.07 68.72 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 119.365 1.582 . . . . 0.0 112.576 173.024 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -76.9 -25.37 52.93 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 121.103 -0.998 . . . . 0.0 111.724 174.405 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.567 HD12 HG23 ' A' ' 6' ' ' ILE . 2.8 mm? -84.48 -30.07 25.51 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.438 1.095 . . . . 0.0 111.57 175.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 41.1 mtp180 -54.18 -41.96 69.14 Favored 'General case' 0 N--CA 1.484 1.241 0 O-C-N 120.977 -1.077 . . . . 0.0 110.666 154.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.13 -38.86 93.68 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 124.329 0.966 . . . . 0.0 114.203 171.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -65.37 -31.66 72.88 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 120.038 1.919 . . . . 0.0 113.501 176.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 28.2 mt -71.68 -46.89 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 172.169 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -62.9 -39.58 94.92 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 121.109 -0.995 . . . . 0.0 113.039 -178.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 38.6 mm-40 -71.81 -10.74 60.21 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.865 1.266 . . . . 0.0 114.135 -179.315 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -113.99 -26.12 8.26 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 114.217 1.192 . . . . 0.0 114.217 173.507 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -135.31 0.87 2.85 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 115.255 1.576 . . . . 0.0 115.255 -170.351 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp 49.49 35.23 7.87 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 127.089 2.155 . . . . 0.0 115.226 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -141.06 153.79 45.65 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 125.148 1.379 . . . . 0.0 110.311 175.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -141.35 -24.33 0.73 Allowed 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -160.239 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 22.0 m -77.36 131.99 38.34 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.988 1.315 . . . . 0.0 112.353 -173.214 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 14.1 m -81.22 158.43 69.53 Favored Pre-proline 0 CA--C 1.547 0.857 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 -171.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -68.63 153.18 89.74 Favored 'Cis proline' 0 CA--C 1.534 0.503 0 CA-C-N 118.528 0.51 . . . . 0.0 112.219 -15.339 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -98.6 135.63 39.84 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 159.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 69.4 mt -129.61 142.52 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 123.599 0.759 . . . . 0.0 109.28 -166.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -138.22 140.67 39.82 Favored 'General case' 0 C--N 1.332 -0.152 0 C-N-CA 123.934 0.894 . . . . 0.0 111.145 177.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 73.8 mt -128.5 115.03 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.994 1.318 . . . . 0.0 108.202 176.048 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 45.69 47.83 11.59 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.547 1.539 . . . . 0.0 113.54 -174.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 79.54 -10.48 37.11 Favored Glycine 0 CA--C 1.535 1.302 0 N-CA-C 115.793 1.077 . . . . 0.0 115.793 -178.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 26.8 m-80 -86.65 132.77 33.79 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 118.887 1.343 . . . . 0.0 109.541 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -82.65 143.01 31.26 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.531 1.132 . . . . 0.0 113.056 -174.385 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 20.2 mm -132.5 119.58 39.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 127.93 2.492 . . . . 0.0 107.246 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.97 -22.75 65.05 Favored Glycine 0 CA--C 1.537 1.426 0 N-CA-C 116.785 1.474 . . . . 0.0 116.785 -164.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 156.64 -152.51 23.89 Favored Glycine 0 CA--C 1.527 0.79 0 CA-C-N 118.058 0.929 . . . . 0.0 114.154 173.01 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 8.2 t -54.91 -56.23 21.88 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.196 0.998 . . . . 0.0 112.593 -175.015 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 65.6 m -75.27 3.16 9.4 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -95.73 -43.09 8.05 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.357 1.063 . . . . 0.0 111.646 165.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 28.6 tp -63.39 -51.21 66.8 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.188 1.395 . . . . 0.0 111.003 175.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -57.39 -43.81 83.99 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.5 0.72 . . . . 0.0 110.24 174.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.16 -35.36 78.54 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.351 -0.843 . . . . 0.0 112.861 -177.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 42.8 mt -73.65 -26.74 60.9 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.681 0.792 . . . . 0.0 112.91 173.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -72.75 -38.92 67.23 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 119.24 0.927 . . . . 0.0 111.601 169.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -64.21 -38.64 91.77 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.565 0.746 . . . . 0.0 111.549 173.198 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -73.32 -7.68 52.64 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 171.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.95 28.94 74.08 Favored Glycine 0 CA--C 1.539 1.534 0 CA-C-N 120.617 1.553 . . . . 0.0 112.993 -176.127 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 21.2 mtpp -110.09 -30.19 7.88 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.882 2.073 . . . . 0.0 112.392 -176.295 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 50.2 tp -56.36 -37.51 70.14 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.444 0.697 . . . . 0.0 111.837 172.224 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -51.13 -46.44 61.95 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.695 1.598 . . . . 0.0 112.577 174.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -78.23 -25.42 61.62 Favored Glycine 0 CA--C 1.531 1.061 0 O-C-N 121.616 -0.677 . . . . 0.0 114.279 177.097 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 79.6 mt -71.19 -37.6 72.13 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 118.642 1.221 . . . . 0.0 111.734 175.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 87.3 mt -86.89 -8.26 57.43 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.166 0.987 . . . . 0.0 112.973 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.9 t . . . . . 0 C--O 1.253 1.246 0 C-N-CA 126.695 1.998 . . . . 0.0 111.224 173.456 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 51.0 m . . . . . 0 CA--C 1.543 0.702 0 CA-C-O 121.022 0.439 . . . . 0.0 111.549 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.481 HG23 HD12 ' A' ' 54' ' ' LEU . 13.2 pt -54.81 -22.25 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 N-CA-C 115.198 1.555 . . . . 0.0 115.198 -168.136 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.36 -22.03 60.72 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 93.4 p -80.48 -25.89 38.54 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.668 1.587 . . . . 0.0 113.923 172.316 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 62.1 mtt -65.12 -33.62 76.47 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 120.624 -1.297 . . . . 0.0 111.704 176.344 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.403 HG22 ' HA2' ' A' ' 74' ' ' GLY . 1.5 mm -61.89 -24.49 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 124.017 0.927 . . . . 0.0 112.222 -174.725 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -75.75 -11.02 59.91 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.356 1.462 . . . . 0.0 114.265 177.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -95.73 -26.38 11.86 Favored Glycine 0 CA--C 1.536 1.346 0 N-CA-C 117.8 1.88 . . . . 0.0 117.8 -164.398 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -143.35 158.72 43.4 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 119.335 1.568 . . . . 0.0 111.918 -173.597 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -59.69 -38.73 82.35 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.837 1.255 . . . . 0.0 112.931 -176.148 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.4 t -131.54 134.66 60.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.322 1.449 . . . . 0.0 109.446 173.068 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 56.1 t -132.26 128.48 58.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.702 1.201 . . . . 0.0 110.075 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 44.9 t -131.33 153.03 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.49 1.116 . . . . 0.0 111.981 -173.671 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -128.37 105.95 8.68 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.582 1.153 . . . . 0.0 109.393 176.468 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 68.9 m -126.46 171.23 11.21 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 125.744 1.618 . . . . 0.0 111.816 -170.649 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 47.3 m0 -118.94 129.4 55.15 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.847 1.259 . . . . 0.0 109.399 168.02 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 31.6 t -61.61 -20.33 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 C-N-CA 124.864 1.266 . . . . 0.0 112.661 -168.676 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.7 p -83.08 -22.26 33.5 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 128.671 2.788 . . . . 0.0 115.485 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 66.3 m -105.24 153.97 39.23 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 120.154 1.343 . . . . 0.0 114.06 -154.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -71.8 -49.48 0.32 Allowed 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 121.382 1.388 . . . . 0.0 114.023 -168.087 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -62.16 -37.37 84.99 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 -177.319 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -42.73 -58.29 2.4 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.973 1.709 . . . . 0.0 110.341 164.049 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 61.4 t -66.34 -38.45 81.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 O-C-N 121.5 -0.75 . . . . 0.0 112.125 -177.505 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 37.6 mmt-85 -54.37 -39.74 67.48 Favored 'General case' 0 N--CA 1.484 1.258 0 CA-C-N 119.12 0.873 . . . . 0.0 111.915 174.599 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.64 -54.74 6.5 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.55 1.14 . . . . 0.0 112.988 174.026 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -54.3 -30.4 50.83 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 119.392 0.997 . . . . 0.0 113.27 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.6 ttpt -69.53 -50.58 43.61 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.675 0.79 . . . . 0.0 112.21 175.143 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.1 tt -64.13 -43.04 96.46 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.521 1.528 . . . . 0.0 111.132 -177.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 90.5 mt -66.45 -24.27 66.41 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.263 1.025 . . . . 0.0 113.335 -177.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 44.1 m-70 -92.46 -16.3 26.02 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 168.192 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.0 -27.44 22.05 Favored 'General case' 0 CA--C 1.545 0.76 0 O-C-N 120.793 -1.192 . . . . 0.0 113.967 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 7.5 mmm-85 -103.2 -18.93 14.69 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 125.23 1.412 . . . . 0.0 113.973 177.377 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -153.02 174.49 14.1 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 127.037 2.135 . . . . 0.0 111.739 -171.13 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -129.78 -7.81 4.52 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 125.309 1.444 . . . . 0.0 114.532 170.096 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -97.76 87.69 4.1 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 119.506 1.048 . . . . 0.0 111.454 179.459 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.42 129.55 22.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 125.073 1.349 . . . . 0.0 110.641 -179.37 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 22.7 m -104.49 127.53 52.22 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.319 1.448 . . . . 0.0 108.632 168.158 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.5 p -125.18 134.29 67.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 118.957 0.798 . . . . 0.0 112.264 170.013 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -104.06 122.93 46.29 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.941 1.296 . . . . 0.0 110.3 175.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -93.7 82.91 4.36 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.568 0.699 . . . . 0.0 111.964 -172.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 29.6 m -76.08 33.32 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 -169.023 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -129.04 -16.67 4.03 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 126.449 1.9 . . . . 0.0 111.708 161.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 20.4 mtmt -80.2 -24.7 40.1 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.445 1.098 . . . . 0.0 112.229 162.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -92.21 127.62 37.76 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.677 1.591 . . . . 0.0 110.781 177.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 58.1 m -71.55 -20.95 61.96 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 -165.53 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -97.85 7.49 46.29 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 126.028 1.731 . . . . 0.0 112.686 174.236 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -49.51 -30.83 13.46 Favored Glycine 0 CA--C 1.537 1.416 0 CA-C-N 119.743 1.156 . . . . 0.0 115.028 -175.617 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -58.4 -35.34 71.89 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.368 1.867 . . . . 0.0 114.907 171.444 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -80.36 -36.14 34.48 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.809 1.244 . . . . 0.0 112.08 175.127 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.481 HD12 HG23 ' A' ' 6' ' ' ILE . 2.5 mm? -69.67 -36.11 75.73 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.715 -0.615 . . . . 0.0 111.075 176.229 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 42.2 mtp180 -53.14 -38.83 63.05 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.834 1.254 . . . . 0.0 112.258 165.393 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -57.94 -40.08 92.71 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 123.974 0.797 . . . . 0.0 113.797 173.782 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 56.7 mm-40 -66.55 -24.87 66.43 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 118.841 1.321 . . . . 0.0 112.984 175.742 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 26.1 mt -74.72 -45.45 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 O-C-N 121.498 -0.751 . . . . 0.0 109.722 172.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -68.88 -39.11 79.97 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 121.618 -0.677 . . . . 0.0 112.671 -177.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -59.58 -35.31 74.03 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 121.456 -0.777 . . . . 0.0 112.834 176.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -94.61 -32.13 13.56 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 114.293 1.219 . . . . 0.0 114.293 -175.618 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -134.69 4.02 3.3 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 114.741 1.386 . . . . 0.0 114.741 -169.672 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt 52.96 31.48 11.0 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 126.513 1.925 . . . . 0.0 114.903 176.059 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 -116.71 111.31 19.62 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 127.745 2.418 . . . . 0.0 110.466 -166.425 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -100.13 -5.37 27.93 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 115.942 1.83 . . . . 0.0 115.942 -177.571 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 44.7 p -81.29 171.13 15.2 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 124.895 1.278 . . . . 0.0 113.51 178.01 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.3 m -125.7 143.58 45.49 Favored Pre-proline 0 N--CA 1.481 1.119 0 C-N-CA 124.189 0.996 . . . . 0.0 111.748 169.64 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -88.64 162.62 41.42 Favored 'Cis proline' 0 N--CA 1.457 -0.621 0 CA-C-N 119.525 0.866 . . . . 0.0 113.976 5.042 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -100.14 143.25 30.56 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.81 0.844 . . . . 0.0 109.476 159.259 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 15.8 mt -133.03 141.71 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 124.21 1.004 . . . . 0.0 110.137 -167.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -142.77 147.63 35.85 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.119 0.968 . . . . 0.0 112.253 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 79.8 mt -130.65 122.79 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 125.731 1.613 . . . . 0.0 109.765 177.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 62.9 m-80 44.78 39.5 3.53 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 125.645 1.578 . . . . 0.0 114.305 -178.313 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.403 ' HA2' HG22 ' A' ' 10' ' ' ILE . . . 92.72 -6.25 77.05 Favored Glycine 0 CA--C 1.539 1.574 0 O-C-N 120.208 -1.558 . . . . 0.0 116.231 -176.463 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -104.77 134.79 47.32 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.292 1.437 . . . . 0.0 111.755 -173.092 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -75.42 143.83 42.51 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 27.0 mm -125.61 133.19 69.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 128.266 2.627 . . . . 0.0 108.522 178.08 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -72.95 53.63 1.73 Allowed Glycine 0 N--CA 1.474 1.226 0 C-N-CA 126.324 1.916 . . . . 0.0 117.353 -177.297 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 78.21 -164.63 51.36 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 128.075 2.75 . . . . 0.0 113.459 175.742 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 18.6 t -62.15 -29.39 70.32 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 122.087 -0.655 . . . . 0.0 111.672 175.421 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 36.6 m -64.1 -45.01 90.54 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.338 1.055 . . . . 0.0 112.664 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -72.79 -37.83 67.45 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 118.823 0.738 . . . . 0.0 112.205 172.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 50.6 tp -58.67 -50.07 75.23 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.74 0.816 . . . . 0.0 111.38 176.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -61.55 -43.55 98.66 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.845 0.858 . . . . 0.0 110.697 173.178 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.98 -33.68 75.91 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 120.848 -1.158 . . . . 0.0 112.806 -176.53 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 98.7 mt -78.34 -23.82 46.81 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.511 1.124 . . . . 0.0 113.345 173.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -70.51 -41.24 72.89 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 119.566 1.076 . . . . 0.0 110.85 166.115 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -65.02 -28.85 69.78 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.564 1.146 . . . . 0.0 113.148 175.601 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.447 ' HB3' ' HE2' ' A' ' 91' ' ' LYS . 7.3 mt-10 -91.28 2.1 56.62 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 114.641 1.349 . . . . 0.0 114.641 169.019 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 67.77 4.7 34.62 Favored Glycine 0 CA--C 1.537 1.41 0 O-C-N 120.948 -1.095 . . . . 0.0 115.261 179.084 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.447 ' HE2' ' HB3' ' A' ' 89' ' ' GLU . 44.2 mtmt -78.57 -28.13 45.85 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 126.178 1.791 . . . . 0.0 111.949 -174.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 35.4 tp -56.07 -36.15 67.78 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.528 1.131 . . . . 0.0 112.361 172.709 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -65.75 -28.38 69.0 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 178.007 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -76.19 -36.88 38.77 Favored Glycine 0 CA--C 1.53 0.974 0 O-C-N 121.584 -0.698 . . . . 0.0 111.992 171.67 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 90.4 mt -70.52 -25.87 63.32 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.986 0.914 . . . . 0.0 113.367 -178.283 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 85.2 mt -105.42 2.14 28.4 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 -173.694 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 41.6 m . . . . . 0 C--O 1.255 1.351 0 C-N-CA 125.645 1.578 . . . . 0.0 114.487 -174.619 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 60.6 p . . . . . 0 CA--C 1.543 0.674 0 CA-C-O 120.888 0.375 . . . . 0.0 111.244 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.584 HG23 HD12 ' A' ' 54' ' ' LEU . 12.4 pt -53.22 -22.88 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 125.136 1.374 . . . . 0.0 113.89 174.57 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.62 -32.39 72.53 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 118.868 0.758 . . . . 0.0 112.574 -174.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 62.9 m -76.84 -19.3 57.67 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 173.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 38.4 mtt -73.68 -25.72 60.39 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.036 -1.04 . . . . 0.0 112.01 176.257 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.8 mm -63.54 -33.13 59.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.862 0.865 . . . . 0.0 111.615 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -76.45 1.41 16.56 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.884 1.274 . . . . 0.0 113.416 175.469 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -86.03 -18.82 58.78 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 125.115 1.341 . . . . 0.0 115.385 -177.555 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -151.37 170.56 19.25 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 126.133 1.773 . . . . 0.0 111.943 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -70.19 -36.8 74.87 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.257 0.623 . . . . 0.0 112.651 174.204 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.3 t -128.09 135.09 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.842 1.257 . . . . 0.0 110.574 172.145 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 47.2 t -131.48 129.18 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 124.411 1.084 . . . . 0.0 110.069 174.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.0 t -124.9 144.73 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 124.565 1.146 . . . . 0.0 111.883 -176.364 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -120.2 113.01 19.8 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.17 1.388 . . . . 0.0 108.692 173.238 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.412 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 14.2 m -130.63 -179.06 5.07 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 127.279 2.232 . . . . 0.0 110.58 -169.158 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 19.7 m0 -126.82 138.08 53.29 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.491 1.116 . . . . 0.0 108.425 159.173 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 40.6 t -59.36 -31.07 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 CA-C-O 122.06 0.933 . . . . 0.0 111.619 -170.226 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.6 p -81.96 -11.08 59.05 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 127.349 2.26 . . . . 0.0 115.526 -177.359 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 8.2 t -89.01 141.9 29.83 Favored Pre-proline 0 CA--C 1.542 0.653 0 CA-C-N 120.373 1.442 . . . . 0.0 110.384 -168.667 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -75.75 -31.39 5.34 Favored 'Trans proline' 0 C--N 1.347 0.467 0 CA-C-N 120.605 1.252 . . . . 0.0 113.361 179.357 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -62.65 -41.45 99.06 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.532 1.133 . . . . 0.0 113.264 174.37 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.412 ' SG ' ' HB3' ' A' ' 19' ' ' SER . 0.2 OUTLIER -50.72 -56.51 11.65 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.597 1.159 . . . . 0.0 109.55 171.924 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 81.3 t -63.23 -40.92 90.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 118.761 -0.637 . . . . 0.0 112.579 -173.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -66.94 -20.19 65.85 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 176.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.2 -54.42 5.53 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 118.448 -0.787 . . . . 0.0 111.042 165.438 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -46.36 -46.76 18.55 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.438 1.095 . . . . 0.0 112.756 178.198 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -67.37 -36.31 81.1 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.005 1.322 . . . . 0.0 113.01 -176.179 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.27 -35.72 54.99 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.225 1.01 . . . . 0.0 111.402 175.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 96.7 mt -64.94 -34.54 78.66 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 121.126 -0.984 . . . . 0.0 111.409 171.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -70.25 -27.08 64.16 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.912 1.078 . . . . 0.0 113.912 167.425 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -74.11 -36.74 64.23 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 119.69 1.132 . . . . 0.0 112.711 174.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 73.7 mmt-85 -99.31 -28.02 13.5 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 -172.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.417 HG22 HD13 ' A' ' 96' ' ' LEU . 1.3 p -136.76 163.89 29.55 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.313 1.045 . . . . 0.0 113.442 -162.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -122.88 -26.04 4.5 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.949 1.3 . . . . 0.0 113.189 165.548 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -85.44 48.16 1.54 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 125.427 1.491 . . . . 0.0 113.569 -178.092 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.04 134.17 58.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 126.128 1.771 . . . . 0.0 112.083 -176.784 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.1 m -121.09 136.87 54.89 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.817 1.647 . . . . 0.0 110.66 171.254 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.1 p -127.17 141.29 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 125.013 1.325 . . . . 0.0 113.002 173.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 56.9 m-70 -119.43 135.82 54.58 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 128.641 2.776 . . . . 0.0 109.804 -176.795 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -109.25 93.18 4.38 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.251 0.62 . . . . 0.0 111.668 -173.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . 0.266 34.5 m -79.76 44.81 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 CA-C-O 123.117 1.437 . . . . 0.0 114.578 -173.323 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -145.84 -27.3 0.44 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 129.057 2.943 . . . . 0.0 110.217 172.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 28.2 mmmt -70.45 -39.06 74.56 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.444 1.098 . . . . 0.0 110.478 155.301 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 14.3 ttt -69.71 127.94 34.71 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.703 0.801 . . . . 0.0 111.579 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 9.1 m -78.92 -18.78 53.26 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.725 1.21 . . . . 0.0 113.927 179.014 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -95.54 -5.29 43.09 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.944 1.297 . . . . 0.0 112.807 167.226 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -51.34 -25.54 12.43 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 126.067 1.794 . . . . 0.0 116.841 -169.451 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -73.22 -28.13 61.99 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 118.871 1.336 . . . . 0.0 112.673 177.182 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 14.4 tm0? -70.04 -37.36 75.54 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.409 1.084 . . . . 0.0 110.714 172.004 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.584 HD12 HG23 ' A' ' 6' ' ' ILE . 2.2 mm? -74.43 -36.19 63.39 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.825 1.25 . . . . 0.0 112.52 177.074 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 72.0 mtp180 -54.13 -40.17 67.14 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 119.097 0.862 . . . . 0.0 111.158 162.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.45 -33.36 86.24 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 125.256 1.408 . . . . 0.0 114.631 172.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -63.51 -42.56 98.47 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 120.414 2.107 . . . . 0.0 111.088 175.136 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 26.4 mt -69.64 -39.47 78.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 123.828 0.851 . . . . 0.0 110.308 177.253 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -70.28 -44.23 68.8 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 121.148 -0.97 . . . . 0.0 112.808 -179.593 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -62.6 -30.66 71.51 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 118.93 0.786 . . . . 0.0 112.477 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -83.47 -55.09 4.5 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 174.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -117.84 -1.74 11.48 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.446 1.098 . . . . 0.0 113.918 -161.277 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.5 mmtp 54.21 29.74 11.08 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 126.364 1.866 . . . . 0.0 114.102 -178.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -99.74 119.88 38.84 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.087 1.755 . . . . 0.0 109.939 -179.547 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -115.37 -17.75 11.2 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.01 1.324 . . . . 0.0 114.502 -172.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.3 p -75.2 166.48 23.57 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.564 1.146 . . . . 0.0 112.419 172.478 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 21.6 m -120.52 151.27 53.73 Favored Pre-proline 0 N--CA 1.475 0.783 0 C-N-CA 124.912 1.285 . . . . 0.0 110.609 166.696 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -78.32 154.56 93.03 Favored 'Cis proline' 0 C--N 1.349 0.56 0 CA-C-N 118.986 0.673 . . . . 0.0 113.561 -0.083 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -104.84 135.25 46.56 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.144 1.378 . . . . 0.0 108.776 161.127 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.9 mt -126.69 142.78 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.391 1.076 . . . . 0.0 109.514 -167.228 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -139.9 136.41 33.87 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.274 1.03 . . . . 0.0 110.272 178.648 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 52.5 mt -133.84 122.03 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.02 0.928 . . . . 0.0 110.403 -176.714 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 48.5 m-20 49.75 30.91 4.02 Favored 'General case' 0 CA--C 1.554 1.114 0 O-C-N 121.238 -0.914 . . . . 0.0 113.257 -175.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 95.21 -8.99 69.91 Favored Glycine 0 CA--C 1.54 1.602 0 N-CA-C 117.606 1.802 . . . . 0.0 117.606 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 25.4 p30 -76.33 169.28 18.53 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 121.248 2.524 . . . . 0.0 113.482 175.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -108.16 129.45 55.18 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.447 0.699 . . . . 0.0 111.808 169.629 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 45.5 mm -113.99 121.88 67.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 126.611 1.964 . . . . 0.0 108.64 -178.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -74.14 21.77 1.34 Allowed Glycine 0 N--CA 1.472 1.073 0 N-CA-C 118.569 2.188 . . . . 0.0 118.569 -164.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 121.39 -172.03 15.18 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 126.639 2.066 . . . . 0.0 115.058 174.36 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 29.9 t -66.49 -38.51 87.43 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 121.853 -0.792 . . . . 0.0 113.033 -174.275 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 63.4 m -63.1 -20.27 65.21 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 176.444 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -90.13 -43.6 10.35 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.763 1.225 . . . . 0.0 111.008 175.707 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 48.4 tp -57.43 -49.48 76.1 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.442 1.097 . . . . 0.0 111.435 174.151 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -67.28 -29.43 69.03 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.26 0.624 . . . . 0.0 111.825 177.631 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -73.3 -40.2 64.72 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 121.025 -1.047 . . . . 0.0 112.672 176.533 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 75.8 mt -65.29 -28.2 69.16 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.083 0.953 . . . . 0.0 112.616 177.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -59.78 -47.44 85.69 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.535 1.134 . . . . 0.0 111.515 171.493 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -68.71 -40.74 79.83 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.199 1.0 . . . . 0.0 112.944 178.366 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -73.3 2.87 6.62 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 70.0 16.5 72.78 Favored Glycine 0 CA--C 1.538 1.508 0 O-C-N 120.332 -1.48 . . . . 0.0 114.145 178.189 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 44.4 mtmt -100.29 -34.23 10.08 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.874 1.669 . . . . 0.0 112.592 -175.367 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 54.4 tp -59.39 -41.36 89.23 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.244 0.929 . . . . 0.0 111.411 175.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -57.21 -41.0 78.59 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.805 0.842 . . . . 0.0 113.134 176.142 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -76.58 -34.05 45.59 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 124.542 1.068 . . . . 0.0 113.376 178.198 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 62.9 mt -65.07 -23.21 67.1 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.909 0.884 . . . . 0.0 112.483 172.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.417 HD13 HG22 ' A' ' 37' ' ' THR . 46.5 mt -100.65 -3.29 30.63 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 126.069 1.748 . . . . 0.0 113.751 177.062 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 69.3 m . . . . . 0 C--O 1.253 1.277 0 C-N-CA 125.311 1.445 . . . . 0.0 112.091 -179.284 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 25.5 p . . . . . 0 N--CA 1.472 0.631 0 CA-C-O 121.607 0.718 . . . . 0.0 112.224 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.634 HG23 HD12 ' A' ' 54' ' ' LEU . 26.8 pt -57.21 -22.46 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 124.068 0.947 . . . . 0.0 113.127 169.456 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.47 -21.28 64.63 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -173.097 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 74.0 m -83.28 -33.02 26.08 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.291 1.037 . . . . 0.0 112.48 166.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 73.4 mtp -61.78 -25.93 67.77 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.081 0.952 . . . . 0.0 112.736 178.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.9 mm -57.66 -34.59 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.283 1.033 . . . . 0.0 112.039 175.017 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.3 mptt -76.95 -3.41 38.73 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.29 1.036 . . . . 0.0 113.427 -178.054 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -76.11 -26.51 64.03 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.791 1.186 . . . . 0.0 114.96 -176.388 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -146.52 171.89 14.38 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 118.662 1.231 . . . . 0.0 114.026 -173.282 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -66.57 -35.9 81.34 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.286 1.034 . . . . 0.0 111.886 172.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.9 t -134.57 131.49 54.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 124.857 1.263 . . . . 0.0 110.23 177.278 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 39.5 t -134.85 130.0 52.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.467 1.107 . . . . 0.0 110.005 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 48.8 t -131.67 148.75 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 124.224 1.01 . . . . 0.0 112.513 -171.36 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -125.59 110.58 14.0 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.252 1.421 . . . . 0.0 109.423 175.028 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 58.3 m -130.61 173.66 10.67 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.604 1.562 . . . . 0.0 111.698 -169.1 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 47.8 m0 -122.73 129.63 51.99 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.809 1.244 . . . . 0.0 108.63 166.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 49.0 t -63.45 -23.88 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 123.361 0.664 . . . . 0.0 112.689 -164.718 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.4 p -78.07 -16.49 57.98 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 177.653 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 84.0 m -99.51 148.37 34.62 Favored Pre-proline 0 CA--C 1.537 0.45 0 CA-C-N 120.346 1.43 . . . . 0.0 114.212 -154.44 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -67.76 -48.68 1.37 Allowed 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 121.282 1.321 . . . . 0.0 113.964 -165.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -69.47 -31.44 69.73 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.463 1.105 . . . . 0.0 113.364 -178.644 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -50.71 -54.3 24.31 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.829 0.852 . . . . 0.0 109.641 168.463 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.7 t -66.93 -39.07 82.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 123.284 0.634 . . . . 0.0 111.658 -177.475 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 17.3 mmt85 -54.26 -49.2 70.1 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 118.612 0.642 . . . . 0.0 111.565 172.476 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.71 -57.94 7.64 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.93 0.892 . . . . 0.0 112.429 176.412 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -48.19 -44.51 32.79 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.538 1.135 . . . . 0.0 112.963 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -65.85 -43.34 88.75 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 123.727 0.811 . . . . 0.0 111.943 -177.697 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.6 tt -72.76 -34.36 66.94 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.995 1.318 . . . . 0.0 111.969 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 76.5 mt -67.47 -42.95 82.17 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.529 0.732 . . . . 0.0 111.282 172.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -60.92 -28.2 68.76 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 118.472 0.578 . . . . 0.0 112.301 167.464 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.73 4.07 38.37 Favored 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 114.877 1.436 . . . . 0.0 114.877 175.618 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -126.68 -39.72 1.97 Allowed 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 174.707 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 17.9 p -143.15 131.96 22.7 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 119.236 0.925 . . . . 0.0 113.343 -166.412 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 39.4 mtmt -70.05 -27.0 64.29 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 163.397 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -88.05 60.4 5.8 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.224 1.01 . . . . 0.0 113.059 -175.038 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.83 137.86 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 125.759 1.624 . . . . 0.0 111.622 178.499 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 75.6 m -120.82 135.13 55.24 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 127.288 2.235 . . . . 0.0 109.434 172.605 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.7 p -133.8 141.76 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 169.081 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 33.3 t60 -121.13 119.22 31.77 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.837 2.055 . . . . 0.0 109.632 -178.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -94.93 91.32 6.35 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.223 -0.923 . . . . 0.0 112.387 -168.224 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . 0.252 32.0 m -78.26 36.73 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 115.735 1.754 . . . . 0.0 115.735 -168.803 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -134.68 -28.68 1.22 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 127.91 2.484 . . . . 0.0 110.473 163.395 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 20.0 mmmt -64.09 -25.93 68.32 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.592 1.157 . . . . 0.0 112.086 160.087 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 91.6 mmm -91.02 144.22 25.89 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.039 1.336 . . . . 0.0 110.922 176.753 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.9 m -82.55 -27.09 31.85 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -174.198 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -99.12 8.02 45.29 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.255 1.822 . . . . 0.0 112.877 178.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -52.35 -26.56 22.4 Favored Glycine 0 CA--C 1.537 1.467 0 N-CA-C 116.751 1.46 . . . . 0.0 116.751 -173.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 70.2 mt-10 -70.39 -26.67 63.81 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 120.76 2.28 . . . . 0.0 112.895 174.337 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -78.08 -28.26 48.71 Favored 'General case' 0 N--CA 1.469 0.488 0 O-C-N 120.98 -1.075 . . . . 0.0 111.611 173.056 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.634 HD12 HG23 ' A' ' 6' ' ' ILE . 3.0 mm? -80.88 -33.21 34.5 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.539 -0.726 . . . . 0.0 111.343 175.003 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 56.5 mtp180 -58.82 -33.53 70.48 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 120.852 -1.155 . . . . 0.0 111.521 161.475 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -56.31 -40.18 84.36 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 124.013 0.816 . . . . 0.0 113.919 168.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -66.55 -24.8 66.42 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 119.442 1.621 . . . . 0.0 113.172 175.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 52.3 mt -81.43 -46.07 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 124.565 1.146 . . . . 0.0 109.725 175.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -69.38 -44.2 71.96 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 121.42 -0.8 . . . . 0.0 112.192 -178.473 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -58.11 -41.2 83.06 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.415 -0.803 . . . . 0.0 112.216 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -89.11 -37.83 14.79 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 114.247 1.202 . . . . 0.0 114.247 -175.496 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -124.25 -2.01 8.12 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 -170.084 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 53.71 47.99 22.51 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 126.703 2.001 . . . . 0.0 113.369 -176.171 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -132.2 142.39 49.42 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.679 1.192 . . . . 0.0 111.781 175.489 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -135.71 -28.83 1.08 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.076 1.35 . . . . 0.0 112.996 -157.654 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 20.8 p -79.12 167.05 21.57 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 128.023 2.529 . . . . 0.0 113.265 177.508 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 26.8 m -114.99 152.92 47.02 Favored Pre-proline 0 N--CA 1.48 1.063 0 C-N-CA 124.173 0.989 . . . . 0.0 112.694 173.17 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -77.28 143.28 74.54 Favored 'Cis proline' 0 C--N 1.349 0.592 0 CA-C-N 119.18 0.743 . . . . 0.0 112.498 -6.391 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -97.63 127.9 43.93 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 165.519 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 35.4 mt -123.73 142.37 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 124.128 0.971 . . . . 0.0 109.527 -165.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -137.63 143.03 41.22 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.813 0.845 . . . . 0.0 111.666 177.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 89.1 mt -130.01 119.65 47.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 125.165 1.386 . . . . 0.0 108.753 176.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 44.2 46.1 7.28 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 125.112 1.365 . . . . 0.0 113.178 -177.005 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 77.65 -2.35 63.72 Favored Glycine 0 CA--C 1.541 1.716 0 N-CA-C 117.066 1.586 . . . . 0.0 117.066 -178.006 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 25.7 m-80 -88.5 138.09 31.74 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 120.291 2.046 . . . . 0.0 110.326 175.518 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -82.61 136.11 34.89 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 118.994 0.816 . . . . 0.0 112.37 176.736 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 40.6 mm -115.98 124.97 72.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 127.016 2.126 . . . . 0.0 108.928 -178.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -68.72 2.63 7.63 Favored Glycine 0 CA--C 1.535 1.313 0 N-CA-C 119.25 2.46 . . . . 0.0 119.25 -163.433 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 142.6 -171.25 24.83 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 126.137 1.827 . . . . 0.0 113.216 175.092 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 42.4 t -64.07 -40.87 97.2 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 121.757 -0.849 . . . . 0.0 112.4 -177.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 68.1 m -72.89 -21.06 60.98 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.131 -0.981 . . . . 0.0 113.374 178.628 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -73.26 -42.65 62.24 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.262 0.937 . . . . 0.0 111.882 167.027 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 53.5 tp -61.06 -45.17 95.83 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.956 0.902 . . . . 0.0 110.988 175.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -64.71 -38.98 92.85 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 122.065 -0.397 . . . . 0.0 111.823 173.103 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.08 -36.95 83.23 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.081 -1.012 . . . . 0.0 112.106 178.733 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 92.4 mt -67.79 -28.69 67.81 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.69 -0.631 . . . . 0.0 112.173 175.58 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -69.7 -43.82 71.67 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.313 0.645 . . . . 0.0 111.098 173.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -69.93 -36.19 75.12 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.299 1.039 . . . . 0.0 113.065 175.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -73.15 -7.68 52.45 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.157 1.383 . . . . 0.0 113.299 175.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 79.37 10.13 86.27 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 123.846 0.736 . . . . 0.0 114.523 177.559 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 40.7 mtmt -91.11 -30.62 16.62 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 126.424 1.89 . . . . 0.0 112.527 -174.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 19.5 tp -61.97 -35.91 79.88 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 119.147 0.885 . . . . 0.0 111.392 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -65.55 -35.62 81.38 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.19 0.996 . . . . 0.0 112.318 171.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -77.36 -23.77 67.33 Favored Glycine 0 CA--C 1.532 1.121 0 O-C-N 120.879 -1.138 . . . . 0.0 114.566 177.708 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 86.8 mt -86.95 -27.38 23.34 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.412 1.485 . . . . 0.0 113.021 176.33 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 74.8 mt -117.93 -16.84 9.86 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 -170.24 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.7 m . . . . . 0 C--O 1.254 1.322 0 C-N-CA 126.625 1.97 . . . . 0.0 114.152 177.278 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 44.1 p . . . . . 0 CA--C 1.537 0.448 0 CA-C-O 121.703 0.763 . . . . 0.0 111.786 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.557 HG23 HD12 ' A' ' 54' ' ' LEU . 11.5 pt -50.98 -23.32 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.841 1.256 . . . . 0.0 113.553 168.269 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.69 -27.27 69.13 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -175.211 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.6 m -85.4 -11.44 54.46 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 172.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 55.7 mtt -68.79 -32.7 72.63 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 120.795 -1.19 . . . . 0.0 111.176 170.612 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.3 mm -60.51 -30.41 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 123.788 0.835 . . . . 0.0 111.905 -176.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.0 mttm -74.28 -8.9 57.82 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.825 1.25 . . . . 0.0 113.725 -177.435 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -89.8 -28.37 18.86 Favored Glycine 0 CA--C 1.537 1.41 0 N-CA-C 116.961 1.544 . . . . 0.0 116.961 -166.151 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -145.07 159.27 43.22 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.504 1.522 . . . . 0.0 111.05 -178.311 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -52.91 -42.29 65.23 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.711 1.605 . . . . 0.0 113.63 178.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.2 t -125.09 135.68 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.809 1.244 . . . . 0.0 110.464 174.578 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 48.4 t -133.85 131.73 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.394 1.078 . . . . 0.0 110.46 178.083 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.4 t -129.36 147.43 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 125.265 1.426 . . . . 0.0 111.545 -172.147 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -124.3 115.39 20.94 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.18 0.992 . . . . 0.0 109.212 172.172 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.407 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 21.0 m -130.19 168.22 17.17 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 126.18 1.792 . . . . 0.0 111.022 -168.493 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.45 ' CD1' ' HB3' ' A' ' 46' ' ' ASP . 19.5 m0 -111.81 135.79 51.96 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 157.232 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 72.2 t -59.22 -28.23 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 O-C-N 123.189 0.305 . . . . 0.0 111.109 175.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 48.7 p -67.65 -20.33 65.31 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 175.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 46.0 t -89.76 143.81 30.8 Favored Pre-proline 0 CA--C 1.538 0.491 0 O-C-N 121.281 -0.887 . . . . 0.0 111.193 -163.127 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -77.05 -39.48 0.6 Allowed 'Trans proline' 0 N--CA 1.459 -0.544 0 CA-C-N 119.656 0.913 . . . . 0.0 114.122 177.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -58.82 -36.33 74.32 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.049 1.739 . . . . 0.0 113.4 175.698 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.407 ' SG ' ' HB3' ' A' ' 19' ' ' SER . 0.3 OUTLIER -52.63 -55.67 20.82 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.949 1.3 . . . . 0.0 109.14 171.847 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.8 t -65.9 -39.99 86.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 123.53 0.732 . . . . 0.0 111.124 -178.63 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . 0.288 2.4 ttp180 -54.22 -28.84 43.67 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.012 1.725 . . . . 0.0 115.369 167.036 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -85.38 -55.53 3.97 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 119.911 1.232 . . . . 0.0 111.883 167.304 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -48.37 -38.33 19.06 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.96 1.704 . . . . 0.0 113.776 -178.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -75.0 -43.69 52.45 Favored 'General case' 0 C--O 1.231 0.081 0 C-N-CA 124.385 1.074 . . . . 0.0 111.889 -177.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 8.4 tt -71.53 -39.56 70.67 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 124.714 1.206 . . . . 0.0 110.888 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 88.8 mt -61.75 -51.77 66.97 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.56 0.744 . . . . 0.0 110.746 176.013 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 24.2 m-70 -65.87 -15.92 63.37 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 172.511 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.72 -43.84 24.87 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 119.844 1.202 . . . . 0.0 111.43 169.182 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 68.7 mmt-85 -82.0 -50.41 9.15 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.219 1.008 . . . . 0.0 113.43 -171.372 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 21.9 m -160.54 129.09 4.7 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 125.106 1.362 . . . . 0.0 111.95 177.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 42.9 mttm -85.98 2.25 46.99 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 126.007 1.723 . . . . 0.0 115.228 -166.213 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -82.31 53.83 2.39 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.534 1.133 . . . . 0.0 112.04 172.389 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -118.87 127.43 75.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 126.567 1.947 . . . . 0.0 111.14 -177.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.6 m -110.78 141.31 44.28 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 126.067 1.747 . . . . 0.0 110.44 171.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.6 p -137.47 135.92 46.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 C-N-CA 124.535 1.134 . . . . 0.0 112.766 175.229 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -110.79 125.9 54.04 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.379 1.472 . . . . 0.0 109.45 175.613 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -97.21 88.27 4.41 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 122.526 1.155 . . . . 0.0 110.966 -174.333 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 22.1 m -64.6 -12.86 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 -174.664 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.45 ' HB3' ' CD1' ' A' ' 20' ' ' TRP . 0.1 OUTLIER -73.69 -21.37 60.27 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.619 1.168 . . . . 0.0 113.323 172.612 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -86.78 -27.1 23.8 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.257 1.423 . . . . 0.0 113.14 177.087 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 90.7 mtp -69.55 154.28 42.24 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.724 1.61 . . . . 0.0 112.117 175.6 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 8.6 t -84.02 -24.85 30.34 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.902 0.881 . . . . 0.0 111.691 163.308 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -93.47 -5.38 49.33 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.49 1.516 . . . . 0.0 114.779 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -57.41 -24.16 51.09 Favored Glycine 0 CA--C 1.536 1.386 0 N-CA-C 116.147 1.219 . . . . 0.0 116.147 -172.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -69.65 -22.49 63.46 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 118.687 1.243 . . . . 0.0 112.898 174.492 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -82.0 -35.63 28.68 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.937 0.895 . . . . 0.0 111.345 170.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.557 HD12 HG23 ' A' ' 6' ' ' ILE . 2.9 mm? -74.45 -32.94 62.78 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.132 -0.98 . . . . 0.0 111.996 177.871 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 62.0 mtp180 -53.71 -39.97 65.67 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 121.123 -0.985 . . . . 0.0 111.632 162.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -67.83 -37.06 88.05 Favored Glycine 0 CA--C 1.535 1.321 0 CA-C-O 118.3 -1.278 . . . . 0.0 114.155 172.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -60.72 -32.32 71.59 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 120.746 2.273 . . . . 0.0 113.296 174.024 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 57.2 mt -75.53 -43.99 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 123.904 0.882 . . . . 0.0 109.95 174.032 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 19.0 t80 -67.7 -43.19 80.68 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.026 -1.046 . . . . 0.0 112.728 -177.577 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -67.38 -15.2 63.55 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 113.944 1.091 . . . . 0.0 113.944 178.283 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -106.71 -26.54 11.27 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 177.499 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -143.44 4.84 1.4 Allowed 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 115.858 1.799 . . . . 0.0 115.858 -170.581 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm 54.42 24.49 5.26 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 127.608 2.363 . . . . 0.0 116.952 178.565 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 -101.52 111.13 23.27 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.057 1.343 . . . . 0.0 111.615 -174.154 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -96.36 -17.16 20.85 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 178.331 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 98.3 m -72.52 153.71 41.19 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.682 1.593 . . . . 0.0 111.862 176.193 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.7 m -115.99 151.74 46.85 Favored Pre-proline 0 N--CA 1.477 0.904 0 C-N-CA 123.713 0.805 . . . . 0.0 111.546 165.469 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -74.19 155.62 99.84 Favored 'Cis proline' 0 N--CA 1.459 -0.539 0 CA-C-N 119.207 0.753 . . . . 0.0 112.944 -3.481 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -98.13 139.33 34.1 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.542 1.137 . . . . 0.0 108.447 159.058 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 53.0 mt -129.91 140.81 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 123.972 0.909 . . . . 0.0 109.487 -165.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -138.13 143.13 40.2 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.126 0.97 . . . . 0.0 111.18 178.187 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 72.4 mt -135.22 123.13 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 125.346 1.458 . . . . 0.0 109.17 -178.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 45.27 48.33 10.26 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 124.902 1.281 . . . . 0.0 113.371 -179.306 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 75.04 10.92 84.19 Favored Glycine 0 CA--C 1.539 1.545 0 N-CA-C 116.066 1.186 . . . . 0.0 116.066 179.434 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 21.1 m-80 -116.04 140.39 49.32 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.472 1.509 . . . . 0.0 111.683 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -82.47 131.9 35.21 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.596 1.158 . . . . 0.0 112.944 179.531 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 41.1 mm -107.25 123.43 62.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 127.047 2.139 . . . . 0.0 108.288 177.401 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.18 12.02 0.66 Allowed Glycine 0 CA--C 1.531 1.055 0 N-CA-C 119.089 2.395 . . . . 0.0 119.089 -166.716 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 142.36 -177.1 21.83 Favored Glycine 0 CA--C 1.535 1.316 0 C-N-CA 127.582 2.515 . . . . 0.0 113.643 170.324 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 39.1 t -57.09 -42.86 81.52 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.721 -0.87 . . . . 0.0 111.458 173.247 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 68.5 m -65.53 -26.06 67.72 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 178.151 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.44 -40.56 64.13 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 119.703 1.138 . . . . 0.0 111.768 172.08 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 40.1 tp -60.55 -48.96 79.45 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.865 0.866 . . . . 0.0 110.738 173.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -66.19 -34.36 77.86 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.522 0.729 . . . . 0.0 111.438 177.504 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.85 -35.66 74.9 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 120.227 -1.546 . . . . 0.0 112.79 175.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 84.0 mt -72.55 -31.05 64.97 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.216 1.007 . . . . 0.0 112.777 173.265 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -59.4 -48.55 81.2 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.788 0.835 . . . . 0.0 110.109 166.408 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.92 -34.4 75.33 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 -178.681 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -75.74 0.72 16.86 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 172.492 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 71.05 21.47 78.36 Favored Glycine 0 CA--C 1.534 1.219 0 O-C-N 121.322 -0.861 . . . . 0.0 113.445 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt -101.38 -25.96 13.76 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 125.688 1.595 . . . . 0.0 113.107 -174.114 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 39.4 tp -64.2 -37.4 87.33 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.267 1.027 . . . . 0.0 112.189 176.172 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -52.8 -44.09 66.39 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.002 0.921 . . . . 0.0 111.973 173.201 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -75.01 -29.78 60.2 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.044 0.831 . . . . 0.0 114.525 178.3 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 85.1 mt -66.09 -40.84 91.13 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 118.382 1.091 . . . . 0.0 111.356 170.535 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 86.4 mt -90.53 -18.87 24.51 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 -170.154 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 72.7 m . . . . . 0 C--O 1.252 1.205 0 C-N-CA 124.506 1.122 . . . . 0.0 113.385 -179.286 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 17.5 p . . . . . 0 N--CA 1.476 0.854 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.493 HG23 HD12 ' A' ' 54' ' ' LEU . 16.2 pt -51.03 -24.04 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 124.496 1.118 . . . . 0.0 113.589 173.107 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.86 -27.99 67.14 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.87 0.868 . . . . 0.0 113.094 -175.037 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.1 p -80.65 -28.82 36.78 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 121.242 -0.911 . . . . 0.0 113.426 174.354 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 43.3 mtt -63.97 -35.47 80.79 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.29 1.036 . . . . 0.0 110.478 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -62.88 -27.39 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 125.89 1.676 . . . . 0.0 111.826 -176.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 45.2 mmtm -79.21 -17.04 55.61 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.018 1.327 . . . . 0.0 113.779 -175.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -87.34 -26.77 29.64 Favored Glycine 0 CA--C 1.533 1.198 0 N-CA-C 116.331 1.292 . . . . 0.0 116.331 -167.24 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -134.05 153.77 51.59 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.694 1.197 . . . . 0.0 111.628 -178.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -62.77 -34.62 77.62 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.002 0.741 . . . . 0.0 113.002 -174.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.4 t -122.27 131.53 72.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.373 1.069 . . . . 0.0 109.896 167.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 65.1 t -132.01 127.77 58.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.158 0.983 . . . . 0.0 109.571 176.695 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 37.5 t -126.28 147.3 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 123.929 0.892 . . . . 0.0 111.773 -175.484 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -122.55 108.81 13.56 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.568 1.147 . . . . 0.0 109.44 176.238 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 37.1 m -128.93 173.88 10.01 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 126.638 1.975 . . . . 0.0 111.458 -167.697 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 28.9 m0 -120.11 144.58 47.54 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.367 1.067 . . . . 0.0 109.699 163.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.5 t -68.73 -17.2 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 CA-C-O 120.934 0.397 . . . . 0.0 111.079 178.123 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.3 p -86.31 -10.81 53.75 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 128.066 2.547 . . . . 0.0 116.579 178.063 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.9 t -96.45 143.42 26.08 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-N 120.017 1.28 . . . . 0.0 112.731 -170.291 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -72.21 -40.19 2.55 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 121.28 1.32 . . . . 0.0 113.634 173.409 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -58.0 -36.81 73.18 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.334 1.453 . . . . 0.0 113.802 179.012 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -54.02 -61.22 2.45 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.477 1.911 . . . . 0.0 109.573 174.751 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 92.0 t -60.9 -39.37 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.346 1.058 . . . . 0.0 111.104 -179.296 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.2 ttt180 -52.54 -38.57 60.02 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.684 1.594 . . . . 0.0 114.901 169.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -79.53 -54.59 5.75 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 119.079 0.854 . . . . 0.0 111.79 171.25 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -48.19 -43.35 31.72 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.386 1.474 . . . . 0.0 113.137 -178.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -62.3 -40.22 95.57 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 123.722 0.809 . . . . 0.0 112.35 -175.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.4 tt -79.08 -42.34 26.59 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 126.538 1.935 . . . . 0.0 110.867 -178.503 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 91.5 mt -62.07 -40.66 96.56 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 121.868 -0.52 . . . . 0.0 111.665 177.535 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -71.27 -24.48 62.17 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 172.377 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.56 -25.04 53.62 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 120.144 1.338 . . . . 0.0 112.921 174.028 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 7.5 tpt180 -106.88 -31.98 8.12 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.868 1.667 . . . . 0.0 114.823 -170.265 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 13.6 p -134.05 154.44 51.15 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 -166.247 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -103.81 -31.91 9.58 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 127.406 2.282 . . . . 0.0 112.455 174.65 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -93.06 38.52 1.03 Allowed 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 125.451 1.5 . . . . 0.0 113.186 -171.035 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.14 122.4 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 124.974 1.309 . . . . 0.0 112.96 -175.802 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.9 m -113.3 135.28 54.02 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.811 1.645 . . . . 0.0 109.847 170.463 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.3 p -124.21 138.05 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.457 1.103 . . . . 0.0 112.304 171.202 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -109.37 125.95 52.91 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.015 1.726 . . . . 0.0 110.637 177.15 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -98.17 79.82 2.62 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.351 1.061 . . . . 0.0 110.233 -177.174 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 31.0 m -56.89 -28.55 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -167.502 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -70.66 -14.25 62.4 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 124.329 1.052 . . . . 0.0 113.693 176.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.2 mmmt -83.0 -13.02 56.76 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 126.3 1.84 . . . . 0.0 112.559 173.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 22.3 mmt -101.5 172.26 7.07 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.178 1.791 . . . . 0.0 111.787 -178.381 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.0 m -81.19 -18.75 45.12 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 121.063 -1.023 . . . . 0.0 113.331 -177.135 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -122.05 8.29 9.82 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.702 1.601 . . . . 0.0 114.42 -163.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -55.45 -27.98 49.51 Favored Glycine 0 CA--C 1.538 1.523 0 CA-C-N 120.035 1.289 . . . . 0.0 115.18 -172.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -67.82 -31.65 71.65 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 119.973 1.886 . . . . 0.0 113.088 171.002 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 63.8 mt-30 -73.69 -38.55 64.85 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.686 1.194 . . . . 0.0 111.344 173.472 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.493 HD12 HG23 ' A' ' 6' ' ' ILE . 2.7 mm? -75.18 -33.9 61.49 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.484 1.038 . . . . 0.0 111.962 177.691 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 15.7 mtp85 -55.32 -41.06 71.93 Favored 'General case' 0 N--CA 1.478 0.965 0 O-C-N 120.953 -1.092 . . . . 0.0 111.303 161.358 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.38 -24.16 67.27 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 124.444 1.021 . . . . 0.0 115.127 171.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 -71.45 -37.29 71.41 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 120.471 2.136 . . . . 0.0 111.72 172.131 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 44.1 mt -72.35 -43.55 64.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 123.948 0.899 . . . . 0.0 109.539 179.225 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -67.76 -42.75 81.27 Favored 'General case' 0 CA--C 1.532 0.262 0 O-C-N 121.298 -0.876 . . . . 0.0 112.914 -178.031 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -65.7 -26.06 67.6 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -177.668 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -100.19 -29.55 12.42 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -131.58 -2.41 3.81 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 114.752 1.39 . . . . 0.0 114.752 -172.206 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt 51.33 39.0 23.11 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 126.152 1.781 . . . . 0.0 113.629 -175.355 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -123.52 138.66 54.52 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 126.828 2.051 . . . . 0.0 110.701 -178.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -142.39 -33.17 0.48 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.603 1.561 . . . . 0.0 111.966 -155.302 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.7 p -84.03 113.18 20.83 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.43 1.492 . . . . 0.0 113.102 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.2 m -66.77 153.54 93.64 Favored Pre-proline 0 N--CA 1.484 1.245 0 C-N-CA 124.811 1.245 . . . . 0.0 113.1 -179.684 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -75.89 151.94 96.21 Favored 'Cis proline' 0 C--N 1.352 0.715 0 CA-C-N 119.327 0.795 . . . . 0.0 113.918 -6.372 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -93.79 137.05 33.44 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 159.372 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 46.3 mt -125.1 141.64 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 124.209 1.004 . . . . 0.0 109.243 -168.587 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -142.41 147.09 35.62 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.391 0.676 . . . . 0.0 111.587 179.147 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 74.9 mt -127.91 123.37 60.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 125.277 1.431 . . . . 0.0 108.099 175.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 50.62 27.57 3.02 Favored 'General case' 0 CA--C 1.555 1.149 0 N-CA-C 115.257 1.577 . . . . 0.0 115.257 -177.49 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 89.89 -7.39 81.81 Favored Glycine 0 CA--C 1.543 1.827 0 O-C-N 120.697 -1.252 . . . . 0.0 115.257 -173.468 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -90.86 143.3 26.87 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.103 1.761 . . . . 0.0 110.336 179.13 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -90.19 142.6 27.56 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 -167.188 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 15.9 mm -130.84 125.49 58.36 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 C-N-CA 128.245 2.618 . . . . 0.0 108.981 176.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.7 -13.94 64.3 Favored Glycine 0 CA--C 1.538 1.488 0 N-CA-C 117.166 1.627 . . . . 0.0 117.166 -168.636 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 158.25 -175.24 35.44 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-N 118.271 1.035 . . . . 0.0 113.528 175.628 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 14.7 t -63.43 -35.36 80.18 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.507 -0.996 . . . . 0.0 112.943 -178.382 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 52.2 m -64.65 -23.1 67.15 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 121.113 -0.992 . . . . 0.0 113.271 176.564 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -88.17 -39.74 14.28 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.504 1.522 . . . . 0.0 112.702 174.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 37.7 tp -58.21 -51.93 67.68 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.38 1.472 . . . . 0.0 111.502 171.605 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -63.17 -24.52 67.93 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.041 0.536 . . . . 0.0 111.714 178.483 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -78.84 -31.96 45.9 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 121.304 -0.872 . . . . 0.0 113.334 176.686 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 14.2 mt -65.34 -34.91 79.43 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 119.278 0.944 . . . . 0.0 112.059 169.518 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -61.6 -44.87 96.2 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.861 0.864 . . . . 0.0 110.932 171.176 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.1 mmtt -71.54 -30.4 65.85 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -177.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -72.86 -10.88 60.3 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 172.199 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 74.89 30.24 59.73 Favored Glycine 0 CA--C 1.533 1.19 0 O-C-N 121.292 -0.88 . . . . 0.0 113.649 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 45.8 mtmt -118.97 -16.0 9.25 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 126.668 1.987 . . . . 0.0 113.021 -169.084 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 35.1 tp -71.35 -38.94 71.58 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.857 1.263 . . . . 0.0 111.915 -175.08 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -65.46 -28.42 69.2 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 178.45 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -85.31 -12.7 72.62 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 125.622 1.582 . . . . 0.0 115.22 172.387 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 24.9 mt -81.2 -39.31 25.62 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 119.377 1.589 . . . . 0.0 111.055 165.806 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 79.3 mt -89.29 26.25 1.7 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 126.328 1.851 . . . . 0.0 113.035 -175.548 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 10.7 p . . . . . 0 C--O 1.251 1.143 0 C-N-CA 127.099 2.159 . . . . 0.0 114.673 -177.502 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 59.8 p . . . . . 0 N--CA 1.471 0.623 0 CA-C-O 120.978 0.418 . . . . 0.0 110.616 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.516 HG23 HD12 ' A' ' 54' ' ' LEU . 29.9 pt -56.08 -25.68 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 O-C-N 120.762 -1.211 . . . . 0.0 112.49 168.342 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.96 -19.77 65.98 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -173.54 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.3 m -89.08 -19.84 25.07 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.425 1.09 . . . . 0.0 113.256 173.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 66.4 mtp -62.53 -33.35 74.72 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 119.39 0.995 . . . . 0.0 111.804 172.724 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.2 mm -60.47 -18.09 15.99 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 124.672 1.189 . . . . 0.0 112.267 -177.105 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.2 mptt -91.37 -9.02 46.34 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.245 1.418 . . . . 0.0 113.859 177.09 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -88.19 -39.04 7.02 Favored Glycine 0 CA--C 1.538 1.528 0 C-N-CA 124.715 1.15 . . . . 0.0 115.814 -175.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 29.1 m120 -120.96 167.33 12.69 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.369 1.467 . . . . 0.0 112.072 -178.433 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -68.83 -42.02 77.74 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.57 0.748 . . . . 0.0 112.67 176.512 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.9 t -125.5 134.17 67.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.95 1.3 . . . . 0.0 110.2 176.48 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 27.1 t -134.74 135.1 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.249 1.02 . . . . 0.0 110.361 177.234 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 53.0 t -134.42 149.24 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 124.55 1.14 . . . . 0.0 112.085 -171.116 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -129.69 123.1 30.32 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.993 1.317 . . . . 0.0 110.873 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 54.1 m -143.9 169.92 16.88 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 114.452 1.278 . . . . 0.0 114.452 -159.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.484 ' CD1' ' HB3' ' A' ' 46' ' ' ASP . 40.5 m0 -115.17 139.5 49.87 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.547 1.539 . . . . 0.0 109.616 161.224 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 24.8 t -60.21 -53.72 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 -161.783 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.7 t -94.23 3.43 55.26 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 -164.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.447 ' HA ' ' HD3' ' A' ' 24' ' ' PRO . 96.4 m -88.76 142.31 30.6 Favored Pre-proline 0 CA--C 1.542 0.667 0 C-N-CA 124.328 1.051 . . . . 0.0 112.599 -165.005 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 23' ' ' CYS . 65.8 Cg_exo -68.0 -36.97 16.09 Favored 'Trans proline' 0 C--N 1.351 0.68 0 N-CA-C 115.677 1.376 . . . . 0.0 115.677 -162.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -52.93 -41.83 64.83 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 122.24 1.019 . . . . 0.0 113.075 171.102 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 3.8 m -81.73 -32.52 31.53 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.359 -162.141 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 99.6 t -62.46 -53.07 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 124.954 1.301 . . . . 0.0 111.51 161.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . 0.263 7.2 ptp180 -67.45 -29.27 68.69 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -173.032 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.28 -53.24 13.05 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.438 1.095 . . . . 0.0 111.685 171.556 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -46.65 -44.88 18.8 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-N 119.91 1.232 . . . . 0.0 112.879 175.155 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -64.07 -45.58 88.13 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.501 0.72 . . . . 0.0 112.595 -179.344 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.2 tt -72.4 -36.55 68.68 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.446 1.098 . . . . 0.0 111.206 -178.486 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 95.9 mt -61.1 -46.54 90.19 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.443 -0.785 . . . . 0.0 110.735 171.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 8.7 m-70 -66.83 -21.71 66.02 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 173.254 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -73.0 -18.44 61.35 Favored 'General case' 0 CA--C 1.545 0.782 0 O-C-N 120.716 -1.24 . . . . 0.0 113.069 173.227 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 21.7 mmt85 -115.73 -19.83 10.34 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 -179.193 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 48.8 p -147.32 166.89 25.74 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 115.394 1.627 . . . . 0.0 115.394 -166.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 28.9 mtmm -116.69 -32.05 5.29 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 127.165 2.186 . . . . 0.0 113.623 162.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -82.73 50.59 1.71 Allowed 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -175.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.2 113.07 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 126.16 1.784 . . . . 0.0 111.964 177.116 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.4 m -100.49 142.91 31.32 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 127.014 2.125 . . . . 0.0 110.097 175.355 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.7 p -145.24 140.58 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -178.524 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 38.8 t60 -116.67 131.8 56.85 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 126.595 1.958 . . . . 0.0 110.98 -176.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -101.93 96.62 7.16 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 122.761 1.267 . . . . 0.0 111.973 -177.586 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 22.4 m -80.43 -1.63 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -174.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.484 ' HB3' ' CD1' ' A' ' 20' ' ' TRP . 0.0 OUTLIER -83.64 -12.11 56.4 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.146 0.978 . . . . 0.0 112.085 162.855 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -107.29 -44.07 4.43 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.588 1.555 . . . . 0.0 112.013 179.064 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 29.2 tpp -67.97 127.23 32.07 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 118.833 0.742 . . . . 0.0 110.224 176.47 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 62.8 m -68.42 -29.49 68.17 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 119.373 0.988 . . . . 0.0 113.354 -174.257 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 20.5 tp10 -79.74 -3.09 46.01 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.021 0.928 . . . . 0.0 112.648 170.314 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -56.53 -26.27 51.93 Favored Glycine 0 CA--C 1.529 0.914 0 O-C-N 120.489 -1.382 . . . . 0.0 114.511 -171.573 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -70.18 -24.11 63.08 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 118.537 1.169 . . . . 0.0 112.67 176.03 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 16.8 tm0? -86.72 -34.58 19.64 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.126 1.37 . . . . 0.0 111.811 170.465 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.516 HD12 HG23 ' A' ' 6' ' ' ILE . 3.0 mm? -67.16 -33.76 76.11 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 119.572 1.078 . . . . 0.0 112.293 171.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 30.1 ttt180 -62.01 -29.93 70.6 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.405 1.482 . . . . 0.0 110.937 165.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.29 -24.7 75.94 Favored Glycine 0 CA--C 1.542 1.72 0 C-N-CA 125.632 1.587 . . . . 0.0 115.784 165.725 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -71.96 -25.78 62.01 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 121.19 2.495 . . . . 0.0 112.017 169.457 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 23.8 mt -74.66 -46.46 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 123.253 0.621 . . . . 0.0 109.461 166.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -63.69 -42.21 98.02 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.14 -0.975 . . . . 0.0 113.398 -176.531 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 95.0 mm-40 -71.87 -10.0 59.14 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 178.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -107.54 -35.64 6.68 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.536 1.135 . . . . 0.0 113.547 176.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -137.49 4.7 2.64 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.349 1.459 . . . . 0.0 114.703 -169.572 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 50.71 42.3 27.18 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 127.006 2.122 . . . . 0.0 114.516 176.589 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 61.8 t60 -127.44 129.92 48.36 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.847 1.259 . . . . 0.0 111.119 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -119.91 -1.33 10.47 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.621 1.568 . . . . 0.0 113.759 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.3 m -86.06 173.45 9.87 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.998 1.719 . . . . 0.0 110.468 175.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.7 m -132.73 156.95 79.51 Favored Pre-proline 0 N--CA 1.48 1.025 0 O-C-N 120.631 -1.293 . . . . 0.0 113.917 -175.503 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -73.16 159.8 96.73 Favored 'Cis proline' 0 C--N 1.349 0.591 0 CA-C-N 118.588 0.531 . . . . 0.0 112.471 -13.346 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -101.9 141.02 35.39 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.972 0.909 . . . . 0.0 108.986 159.42 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 82.0 mt -130.68 144.15 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 123.726 0.811 . . . . 0.0 109.65 -168.591 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -140.5 146.37 38.07 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.243 1.017 . . . . 0.0 111.998 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 71.5 mt -129.26 118.98 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 125.367 1.467 . . . . 0.0 108.241 172.46 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 47.49 38.23 7.5 Favored 'General case' 0 CA--C 1.552 1.056 0 N-CA-C 115.821 1.785 . . . . 0.0 115.821 176.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 93.48 -7.51 74.9 Favored Glycine 0 CA--C 1.538 1.477 0 C-N-CA 124.593 1.092 . . . . 0.0 115.312 -178.452 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -102.47 138.03 39.93 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.939 1.696 . . . . 0.0 110.406 -174.154 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -85.23 147.73 26.43 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.073 0.949 . . . . 0.0 113.076 -170.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 20.6 mm -133.34 120.64 39.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 128.473 2.709 . . . . 0.0 106.279 177.041 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.88 -15.66 55.68 Favored Glycine 0 CA--C 1.533 1.182 0 N-CA-C 116.851 1.5 . . . . 0.0 116.851 -160.472 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 138.8 -152.14 22.01 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 125.609 1.576 . . . . 0.0 112.739 179.138 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 8.6 t -72.25 -20.48 61.53 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -173.733 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.8 m -83.38 -38.52 21.87 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 121.254 -0.904 . . . . 0.0 112.012 171.324 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -70.7 -36.38 73.23 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.148 0.979 . . . . 0.0 111.641 177.694 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 47.5 tp -59.82 -57.49 12.68 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.405 1.482 . . . . 0.0 111.645 -179.434 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -69.59 -30.58 68.38 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.892 -0.505 . . . . 0.0 111.305 178.262 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.02 -38.25 87.98 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 119.474 1.034 . . . . 0.0 112.49 176.39 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 85.4 mt -73.81 -25.24 60.0 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.917 0.887 . . . . 0.0 112.702 176.109 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -73.08 -40.12 65.29 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 118.779 0.718 . . . . 0.0 111.609 169.173 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.1 mptt -65.19 -30.4 71.3 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.371 1.068 . . . . 0.0 112.889 173.656 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -80.34 1.97 26.69 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.083 1.353 . . . . 0.0 113.851 169.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 71.21 24.13 77.34 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 124.732 1.158 . . . . 0.0 114.761 175.069 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -113.2 -31.74 6.52 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 126.051 1.74 . . . . 0.0 113.365 -170.422 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 36.7 tp -57.23 -42.7 81.92 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 122.618 0.367 . . . . 0.0 111.467 -175.405 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -63.56 -42.73 98.33 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -178.459 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -73.05 -29.45 64.72 Favored Glycine 0 CA--C 1.528 0.876 0 CA-C-O 119.123 -0.821 . . . . 0.0 114.439 177.533 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 81.8 mt -72.8 -34.21 66.74 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 118.332 1.066 . . . . 0.0 112.188 172.202 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 66.5 mt -86.7 -16.32 36.83 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.294 1.038 . . . . 0.0 113.607 179.144 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 58.7 m . . . . . 0 C--O 1.254 1.314 0 C-N-CA 124.976 1.31 . . . . 0.0 111.714 175.031 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.0 m . . . . . 0 CA--C 1.547 0.844 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.5 pt -60.99 -23.09 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 124.529 1.131 . . . . 0.0 113.941 -168.217 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -54.58 -27.25 37.65 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.729 1.212 . . . . 0.0 112.177 178.034 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 92.9 p -68.56 -36.37 78.68 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.765 1.226 . . . . 0.0 113.444 172.326 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 45.3 mtt -72.45 -38.56 68.25 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.385 1.474 . . . . 0.0 111.59 -177.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -66.52 -25.59 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 124.074 0.95 . . . . 0.0 111.551 -171.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -70.75 -11.13 60.76 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.826 1.65 . . . . 0.0 114.123 179.261 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -84.48 -31.27 25.2 Favored Glycine 0 CA--C 1.534 1.258 0 N-CA-C 115.944 1.137 . . . . 0.0 115.944 -167.676 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -136.71 156.72 48.15 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 119.499 1.649 . . . . 0.0 112.568 -174.243 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 28.4 ttpt -62.54 -39.41 93.52 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.986 0.914 . . . . 0.0 112.657 -176.139 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.9 t -124.96 129.08 73.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.524 1.13 . . . . 0.0 109.821 167.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 83.1 t -126.11 127.09 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.389 1.476 . . . . 0.0 109.04 178.478 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 40.3 t -123.53 144.55 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 123.611 0.765 . . . . 0.0 111.169 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -118.3 113.18 21.07 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.672 1.189 . . . . 0.0 109.018 171.401 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 28.4 m -131.35 168.17 18.01 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.384 1.474 . . . . 0.0 112.281 -170.159 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 51.7 m0 -107.92 126.12 52.31 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.644 1.178 . . . . 0.0 107.872 159.828 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 25.9 t -49.95 -36.48 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 126.49 1.916 . . . . 0.0 113.237 -164.167 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.5 t -93.3 -8.91 40.76 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 127.175 2.19 . . . . 0.0 115.137 -167.476 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 95.6 m -94.28 149.31 36.53 Favored Pre-proline 0 CA--C 1.535 0.374 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -159.348 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -67.39 -47.34 2.23 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 CA-C-N 119.127 0.724 . . . . 0.0 113.603 -163.639 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -68.22 -33.43 74.39 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.438 1.095 . . . . 0.0 113.243 -179.011 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -51.25 -53.37 36.07 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.776 0.83 . . . . 0.0 109.246 167.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 62.6 t -68.75 -36.36 73.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 O-C-N 121.714 -0.617 . . . . 0.0 112.244 -177.409 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 27.7 mmt85 -52.79 -42.07 64.71 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 119.227 0.922 . . . . 0.0 112.046 170.596 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.64 -56.56 5.14 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.396 0.678 . . . . 0.0 111.878 173.625 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -50.82 -39.52 53.35 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 119.435 1.016 . . . . 0.0 113.028 -177.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -69.6 -43.64 72.38 Favored 'General case' 0 C--O 1.233 0.184 0 C-N-CA 123.892 0.877 . . . . 0.0 112.312 -178.01 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.4 tt -73.77 -37.62 64.95 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 124.309 1.044 . . . . 0.0 111.464 -178.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 98.0 mt -62.61 -42.84 99.81 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.239 0.616 . . . . 0.0 110.9 174.666 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -67.93 -13.15 61.93 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 171.778 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -95.6 -13.03 24.7 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.301 1.041 . . . . 0.0 113.751 170.723 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 20.1 mmt180 -111.67 -30.34 7.37 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 114.981 1.474 . . . . 0.0 114.981 -173.572 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.0 t -149.03 156.6 42.48 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -173.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 48.1 mtmt -91.6 -9.13 45.24 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 126.785 2.034 . . . . 0.0 112.499 166.042 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -105.51 20.49 18.81 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -162.02 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.26 136.81 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 125.481 1.513 . . . . 0.0 112.692 -178.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.9 m -125.44 133.7 52.36 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 126.696 1.999 . . . . 0.0 110.014 168.549 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.4 p -121.29 136.11 59.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 125.013 1.325 . . . . 0.0 112.998 173.632 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -104.1 116.65 32.6 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.917 2.087 . . . . 0.0 108.989 174.222 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -88.56 96.37 10.6 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 121.0 -1.063 . . . . 0.0 111.2 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 22.0 m -73.74 1.65 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 -172.463 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -85.29 -22.44 28.56 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.437 1.095 . . . . 0.0 112.756 163.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.5 mmmt -90.34 -35.08 15.43 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.035 1.734 . . . . 0.0 111.667 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -89.35 130.44 35.73 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.692 0.797 . . . . 0.0 110.962 -177.122 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 74.4 m -70.69 -16.09 62.77 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 115.235 1.569 . . . . 0.0 115.235 -169.031 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -93.02 6.67 47.11 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.843 1.657 . . . . 0.0 112.908 173.303 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -51.7 -29.03 24.56 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 125.368 1.461 . . . . 0.0 116.385 -174.247 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -79.73 -25.13 41.2 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.052 1.426 . . . . 0.0 113.358 178.035 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -74.81 -33.95 62.29 Favored 'General case' 0 N--CA 1.469 0.489 0 O-C-N 121.462 -0.774 . . . . 0.0 111.052 168.316 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.54 -42.79 86.63 Favored 'General case' 0 CA--C 1.548 0.882 0 O-C-N 121.716 -0.615 . . . . 0.0 110.342 171.613 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 56.3 mtp85 -54.76 -43.96 73.21 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 119.397 0.999 . . . . 0.0 111.936 167.226 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.41 -42.94 99.14 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 124.24 0.924 . . . . 0.0 113.732 178.547 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 51.2 mm-40 -63.44 -38.18 90.16 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 118.413 1.107 . . . . 0.0 113.449 173.744 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 65.9 mt -66.46 -44.58 90.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 118.573 0.624 . . . . 0.0 109.621 175.464 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -64.26 -40.35 95.81 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 121.432 -0.793 . . . . 0.0 112.059 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -69.46 -24.88 63.86 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 121.092 -1.005 . . . . 0.0 113.363 -179.109 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -99.53 -25.17 14.52 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 115.008 1.485 . . . . 0.0 115.008 176.688 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -135.92 0.52 2.66 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 114.741 1.386 . . . . 0.0 114.741 -171.229 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp 48.6 46.05 21.19 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 126.525 1.93 . . . . 0.0 113.729 175.599 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 8.5 t60 -140.39 134.2 30.5 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.283 1.833 . . . . 0.0 109.46 -175.615 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -117.3 -25.38 7.08 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.696 1.599 . . . . 0.0 113.418 -178.177 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.3 p -77.8 129.02 34.93 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.047 0.939 . . . . 0.0 112.621 -171.759 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.6 m -83.77 151.11 60.66 Favored Pre-proline 0 N--CA 1.478 0.93 0 C-N-CA 123.652 0.781 . . . . 0.0 112.109 -173.861 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -80.2 156.55 87.12 Favored 'Cis proline' 0 C--N 1.352 0.717 0 N-CA-C 114.118 0.776 . . . . 0.0 114.118 -0.833 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -101.34 135.35 42.96 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.907 0.883 . . . . 0.0 108.856 159.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 50.9 mt -128.28 139.53 51.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 123.984 0.914 . . . . 0.0 109.149 -166.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -140.0 148.23 41.57 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.62 0.768 . . . . 0.0 112.467 -179.198 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 62.1 mt -130.28 120.19 48.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.445 1.498 . . . . 0.0 108.633 174.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 45.3 40.62 5.4 Favored 'General case' 0 CA--C 1.558 1.269 0 C-N-CA 125.599 1.559 . . . . 0.0 114.625 -176.588 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 82.16 0.85 90.1 Favored Glycine 0 CA--C 1.542 1.762 0 O-C-N 120.822 -1.174 . . . . 0.0 115.629 -178.056 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -95.62 140.12 30.89 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.885 1.674 . . . . 0.0 110.416 176.796 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -85.07 144.85 27.98 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 119.253 0.933 . . . . 0.0 113.444 -177.519 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 31.5 mm -123.44 127.44 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 128.764 2.826 . . . . 0.0 107.023 177.258 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -69.82 18.28 0.64 Allowed Glycine 0 CA--C 1.532 1.118 0 N-CA-C 119.135 2.414 . . . . 0.0 119.135 -163.101 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 114.82 -173.15 14.61 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 128.85 3.119 . . . . 0.0 112.666 -178.125 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 12.9 t -63.5 -33.71 76.18 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 121.485 -1.009 . . . . 0.0 111.688 179.056 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 67.4 m -61.78 -21.99 65.05 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 172.166 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -88.88 -43.8 10.93 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.652 1.181 . . . . 0.0 110.903 174.271 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 48.8 tp -57.24 -48.24 79.33 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.027 1.331 . . . . 0.0 111.683 176.113 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -72.47 -25.96 61.63 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 121.734 -0.604 . . . . 0.0 112.054 179.514 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.48 -28.98 63.24 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.196 -0.94 . . . . 0.0 112.54 175.341 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 52.2 mt -73.78 -26.73 60.79 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.124 1.37 . . . . 0.0 112.808 171.687 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -64.58 -44.43 90.7 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 118.616 0.644 . . . . 0.0 110.343 162.225 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 20.3 mmtt -68.74 -34.18 75.17 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 121.828 -0.545 . . . . 0.0 112.28 -177.172 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLU . . . . . 0.42 ' HB3' ' HE2' ' A' ' 91' ' ' LYS . 6.4 mt-10 -79.83 -3.23 46.93 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 168.322 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.18 44.64 93.64 Favored Glycine 0 CA--C 1.532 1.105 0 CA-C-N 120.262 1.392 . . . . 0.0 112.983 172.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.42 ' HE2' ' HB3' ' A' ' 89' ' ' GLU . 36.6 mtmt -131.18 -8.68 3.81 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 126.996 2.118 . . . . 0.0 113.487 -170.676 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 29.8 tp -66.08 -34.66 78.58 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 122.205 1.002 . . . . 0.0 110.663 -176.145 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -60.87 -48.05 83.57 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 127.577 2.351 . . . . 0.0 114.053 171.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -69.42 -22.68 76.5 Favored Glycine 0 CA--C 1.53 1.012 0 O-C-N 121.131 -0.98 . . . . 0.0 113.697 175.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 36.7 mt -74.03 -37.33 64.37 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 117.663 0.731 . . . . 0.0 111.3 172.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 69.4 mt -75.47 -7.01 53.0 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.603 1.561 . . . . 0.0 114.29 176.495 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 19.6 m . . . . . 0 C--O 1.249 1.03 0 C-N-CA 127.15 2.18 . . . . 0.0 113.739 177.691 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 89.4 p . . . . . 0 N--CA 1.476 0.828 0 N-CA-C 110.79 -0.078 . . . . 0.0 110.79 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.571 HG23 HD12 ' A' ' 54' ' ' LEU . 20.5 pt -55.02 -21.32 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 179.679 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.14 -18.93 51.07 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 123.817 0.847 . . . . 0.0 113.203 -178.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 40.9 m -83.78 -25.76 30.19 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.807 1.243 . . . . 0.0 113.486 172.146 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 76.9 mtp -69.49 -28.69 66.29 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.281 1.032 . . . . 0.0 112.09 178.185 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.1 mm -64.11 -21.17 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 124.248 1.019 . . . . 0.0 112.342 179.037 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -81.77 -28.24 33.37 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 121.113 -0.992 . . . . 0.0 113.058 173.094 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -87.41 -8.03 75.08 Favored Glycine 0 CA--C 1.53 1.02 0 N-CA-C 116.742 1.457 . . . . 0.0 116.742 -166.295 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -143.61 151.83 40.64 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 119.354 1.577 . . . . 0.0 111.431 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -67.41 -42.56 83.03 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.941 1.296 . . . . 0.0 112.413 -178.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.6 t -121.4 130.94 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 124.878 1.271 . . . . 0.0 110.065 170.262 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.6 t -129.7 128.1 65.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.528 1.131 . . . . 0.0 110.167 178.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 42.2 t -127.43 148.11 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 123.785 0.834 . . . . 0.0 111.715 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -123.64 116.56 23.29 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.798 1.239 . . . . 0.0 109.208 173.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 25.2 m -134.09 172.73 12.43 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.28 1.432 . . . . 0.0 112.203 -167.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.438 ' CD1' ' HB3' ' A' ' 46' ' ' ASP . 28.0 m0 -120.42 142.28 49.36 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.266 1.026 . . . . 0.0 109.784 161.285 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 75.4 t -59.91 -31.6 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 123.042 0.537 . . . . 0.0 111.332 172.722 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -69.09 -15.31 63.41 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 175.177 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 44.1 t -92.99 143.16 26.37 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-N 120.385 1.448 . . . . 0.0 111.278 -167.207 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -83.57 -31.32 0.62 Allowed 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 121.498 1.465 . . . . 0.0 113.157 174.056 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -69.05 -33.56 73.78 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.29 1.436 . . . . 0.0 113.54 178.216 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -45.74 -55.55 6.38 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.363 1.065 . . . . 0.0 109.356 164.703 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 85.9 t -63.91 -38.84 83.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 123.983 0.913 . . . . 0.0 112.068 -179.56 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.4 mmt85 -54.9 -37.82 66.81 Favored 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 119.536 1.062 . . . . 0.0 112.777 174.595 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -76.37 -59.18 2.88 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 123.735 0.647 . . . . 0.0 111.859 172.012 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -44.75 -47.56 10.78 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.854 1.262 . . . . 0.0 112.583 -179.578 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -65.53 -44.22 87.58 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 123.689 0.796 . . . . 0.0 111.627 -173.074 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.9 tt -69.6 -41.24 76.0 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.632 1.573 . . . . 0.0 110.775 179.489 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 92.2 mt -60.99 -50.43 73.42 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.095 0.558 . . . . 0.0 110.816 176.27 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 69.2 m-70 -66.64 -18.0 65.14 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 173.728 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.73 -13.73 59.66 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 119.908 1.231 . . . . 0.0 113.702 174.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 26.5 mmt85 -119.63 -25.89 5.85 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.73 1.612 . . . . 0.0 114.558 -178.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 19.3 m -145.98 150.39 35.95 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.605 1.162 . . . . 0.0 112.909 -157.665 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? -108.53 -23.52 11.8 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 126.766 2.027 . . . . 0.0 112.654 165.583 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -79.76 50.58 1.18 Allowed 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 125.317 1.447 . . . . 0.0 112.762 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -121.99 130.78 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 126.19 1.796 . . . . 0.0 111.013 -178.821 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.1 m -123.07 123.85 41.77 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.861 1.664 . . . . 0.0 109.57 176.391 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.5 p -119.49 143.43 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 123.938 0.895 . . . . 0.0 112.375 175.626 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 30.0 t60 -111.55 117.28 32.54 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.515 1.526 . . . . 0.0 110.236 173.298 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -86.67 91.89 8.75 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 175.49 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 27.6 m -67.09 -17.41 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -176.593 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.438 ' HB3' ' CD1' ' A' ' 20' ' ' TRP . 0.3 OUTLIER -68.47 -26.48 65.5 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 121.174 -0.953 . . . . 0.0 111.995 172.646 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 20.1 mtmt -98.67 -5.71 31.12 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 126.275 1.83 . . . . 0.0 114.227 -179.088 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' MET . . . . . 0.43 ' HG3' ' H ' ' A' ' 50' ' ' GLU . 13.1 tpt -93.28 133.04 36.92 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.246 1.418 . . . . 0.0 111.467 -178.751 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 17.0 p -63.76 2.14 0.52 Allowed 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 126.657 1.983 . . . . 0.0 116.184 -179.168 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.43 ' H ' ' HG3' ' A' ' 48' ' ' MET . 7.0 tp10 -143.98 13.69 1.67 Allowed 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.522 1.529 . . . . 0.0 112.804 170.341 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -57.77 -24.58 53.9 Favored Glycine 0 CA--C 1.53 1.012 0 O-C-N 120.52 -1.363 . . . . 0.0 116.121 -167.674 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -63.66 -30.98 72.01 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 119.518 1.659 . . . . 0.0 112.096 174.738 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -74.89 -29.11 60.9 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.7 0.8 . . . . 0.0 111.941 176.452 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.571 HD12 HG23 ' A' ' 6' ' ' ILE . 2.8 mm? -81.02 -32.68 34.05 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.687 1.195 . . . . 0.0 111.602 176.713 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.8 ttt85 -56.87 -36.43 70.07 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.904 1.281 . . . . 0.0 110.667 159.154 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.53 -35.15 90.88 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 124.495 1.045 . . . . 0.0 115.465 167.358 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -64.98 -32.23 73.86 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 120.394 2.097 . . . . 0.0 112.267 176.565 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.2 mt -70.5 -42.13 78.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 123.682 0.793 . . . . 0.0 109.643 171.326 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -62.92 -41.44 99.47 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 178.469 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 33.0 mm-40 -62.09 -30.08 70.76 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 120.923 -1.111 . . . . 0.0 112.844 176.13 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -88.83 -38.41 14.62 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 179.298 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -133.76 0.82 3.28 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 -168.196 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.5 mptt 44.66 50.27 8.5 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 127.016 2.126 . . . . 0.0 113.126 -177.767 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 48.9 t60 -129.25 127.09 40.52 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 127.53 2.332 . . . . 0.0 108.102 178.707 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -108.13 -14.03 14.81 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.208 1.003 . . . . 0.0 113.53 178.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.9 m -74.82 141.86 44.25 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.3 1.04 . . . . 0.0 111.685 -176.631 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.0 m -97.88 150.81 37.15 Favored Pre-proline 0 N--CA 1.477 0.904 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 172.747 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -81.08 161.71 81.73 Favored 'Cis proline' 0 C--N 1.351 0.703 0 CA-C-N 118.686 0.566 . . . . 0.0 113.556 -3.354 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -107.61 139.45 42.14 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.093 0.957 . . . . 0.0 109.13 158.676 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 75.7 mt -131.88 139.08 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 124.22 1.008 . . . . 0.0 109.374 -165.311 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -140.98 145.39 35.91 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.937 0.895 . . . . 0.0 112.432 -178.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 58.2 mt -132.19 122.28 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 124.702 1.201 . . . . 0.0 109.405 172.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 32.0 m120 44.31 45.13 7.16 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 125.017 1.327 . . . . 0.0 113.327 -177.235 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 86.02 -12.96 58.64 Favored Glycine 0 CA--C 1.539 1.553 0 O-C-N 120.463 -1.398 . . . . 0.0 116.284 -178.659 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 59.8 m-80 -86.6 141.13 29.23 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.353 1.576 . . . . 0.0 110.634 -177.22 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -86.47 136.95 32.9 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.32 0.648 . . . . 0.0 112.177 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 38.5 mm -115.1 117.97 57.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 126.937 2.095 . . . . 0.0 107.099 178.249 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -70.55 3.58 11.47 Favored Glycine 0 N--CA 1.475 1.281 0 N-CA-C 117.919 1.928 . . . . 0.0 117.919 -159.696 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 155.64 173.91 24.86 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 128.072 2.749 . . . . 0.0 111.048 178.135 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 39.4 t -58.56 -32.79 69.24 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 121.317 -1.108 . . . . 0.0 112.494 171.436 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 69.7 m -66.61 -28.54 68.58 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 120.654 -1.279 . . . . 0.0 112.957 173.424 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -74.47 -36.21 63.3 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 119.516 1.053 . . . . 0.0 111.632 173.421 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 43.5 tp -62.91 -50.84 69.25 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.877 1.271 . . . . 0.0 110.794 172.804 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -59.5 -37.93 79.58 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.689 0.796 . . . . 0.0 111.481 176.473 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.98 -29.7 68.8 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.019 0.928 . . . . 0.0 113.483 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 35.7 mt -70.96 -25.48 62.74 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.066 0.848 . . . . 0.0 112.303 172.166 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -73.52 -37.54 65.6 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 118.56 0.618 . . . . 0.0 111.036 170.093 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 43.3 mmtt -66.57 -34.7 78.49 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 176.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -73.43 -9.36 58.61 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 169.169 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 79.46 22.36 64.96 Favored Glycine 0 CA--C 1.535 1.282 0 CA-C-N 119.686 1.13 . . . . 0.0 114.579 178.629 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -107.29 -32.01 7.96 Favored 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 125.678 1.591 . . . . 0.0 112.305 -172.603 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 46.0 tp -57.71 -41.76 82.38 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 118.454 0.57 . . . . 0.0 112.432 -176.2 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -60.44 -43.64 96.61 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 118.928 -0.558 . . . . 0.0 112.437 -178.062 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -74.77 -38.09 43.3 Favored Glycine 0 CA--C 1.535 1.306 0 O-C-N 123.556 0.535 . . . . 0.0 113.324 177.027 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 37.6 mt -57.66 -36.42 71.87 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.404 1.082 . . . . 0.0 112.309 177.106 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 86.5 mt -73.92 -4.03 32.56 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 114.895 1.442 . . . . 0.0 114.895 -179.542 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 6.8 t . . . . . 0 C--O 1.257 1.495 0 C-N-CA 125.146 1.378 . . . . 0.0 112.733 -178.993 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 15.8 p . . . . . 0 CA--C 1.537 0.478 0 CA-C-O 122.108 0.956 . . . . 0.0 112.844 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.458 HG23 HD12 ' A' ' 54' ' ' LEU . 25.4 pt -55.71 -25.21 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.471 1.108 . . . . 0.0 112.717 170.311 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.38 -23.85 66.4 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -171.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.1 t -87.96 -20.04 26.43 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 121.238 -0.914 . . . . 0.0 113.424 170.064 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 41.3 mtt -68.39 -26.09 65.38 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 121.27 -0.894 . . . . 0.0 112.334 175.084 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.6 mm -58.06 -31.4 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.953 0.901 . . . . 0.0 111.667 177.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.1 mptt -80.56 -4.23 53.24 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.899 1.28 . . . . 0.0 114.039 -173.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -82.99 -28.4 37.68 Favored Glycine 0 CA--C 1.538 1.496 0 N-CA-C 115.953 1.141 . . . . 0.0 115.953 -173.53 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -145.35 163.71 33.73 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.597 1.199 . . . . 0.0 112.526 -173.264 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -63.16 -43.58 97.9 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.298 1.439 . . . . 0.0 112.723 -179.46 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.3 t -121.88 131.89 72.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 123.798 0.839 . . . . 0.0 110.26 171.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 54.4 t -132.56 127.39 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 125.006 1.322 . . . . 0.0 109.263 179.141 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 42.4 t -124.56 148.24 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 124.337 1.055 . . . . 0.0 111.624 -177.635 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -121.92 112.3 18.14 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.202 1.401 . . . . 0.0 108.869 172.129 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 10.7 m -126.5 174.14 8.87 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 126.646 1.978 . . . . 0.0 111.356 -171.178 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 20.8 m0 -118.78 137.75 53.16 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.317 1.047 . . . . 0.0 109.078 161.662 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.407 ' CG2' ' HE2' ' A' ' 47' ' ' LYS . 82.6 t -62.67 -15.86 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.013 0.925 . . . . 0.0 112.378 177.823 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.4 p -89.7 -9.68 48.57 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.484 1.914 . . . . 0.0 116.046 175.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 8.0 t -94.2 142.03 24.38 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-N 119.424 1.011 . . . . 0.0 111.565 -170.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -79.67 -32.58 1.53 Allowed 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 121.812 1.675 . . . . 0.0 112.226 173.545 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -62.85 -35.28 79.45 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.122 1.369 . . . . 0.0 113.543 177.426 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -49.04 -54.24 16.73 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.518 1.127 . . . . 0.0 109.451 165.285 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.2 t -64.88 -39.47 85.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.117 0.967 . . . . 0.0 112.766 -179.05 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 78.4 mmt-85 -53.35 -41.78 66.15 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-N 119.118 0.872 . . . . 0.0 111.811 173.378 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.86 -53.7 8.61 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.123 0.969 . . . . 0.0 112.592 174.547 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -52.41 -32.99 41.69 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.608 1.163 . . . . 0.0 112.992 -179.398 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -72.36 -47.37 50.05 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.838 0.855 . . . . 0.0 112.581 177.63 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.8 tt -72.81 -36.75 67.62 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.582 1.153 . . . . 0.0 111.465 -176.389 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 70.3 mt -63.47 -47.65 80.91 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.401 0.68 . . . . 0.0 111.283 173.763 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -64.76 -14.82 60.31 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 172.731 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.21 -17.74 58.26 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 120.158 1.344 . . . . 0.0 113.828 175.405 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 87.2 mmt-85 -131.97 -13.09 3.23 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 -177.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 29.0 m -138.62 136.99 36.51 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.315 1.046 . . . . 0.0 112.601 -172.175 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.24 -30.48 12.59 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 126.868 2.067 . . . . 0.0 111.207 166.321 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -79.26 48.09 0.85 Allowed 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.507 1.523 . . . . 0.0 113.409 177.365 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.28 118.89 60.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 125.758 1.623 . . . . 0.0 110.688 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 54.9 m -101.48 135.47 42.92 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 126.205 1.802 . . . . 0.0 109.672 172.516 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.6 p -128.1 141.6 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-O 122.277 1.037 . . . . 0.0 112.961 169.159 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -113.6 133.27 55.38 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 129.12 2.968 . . . . 0.0 109.523 -177.341 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -111.06 90.59 3.38 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 122.04 0.924 . . . . 0.0 111.52 -176.44 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 16.7 m -67.8 -8.94 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 O-C-N 121.341 -0.849 . . . . 0.0 113.17 -178.073 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.45 -18.35 61.14 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 119.042 0.837 . . . . 0.0 112.657 170.155 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.407 ' HE2' ' CG2' ' A' ' 21' ' ' VAL . 57.3 mmtt -102.44 -32.24 10.07 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 127.156 2.182 . . . . 0.0 113.009 179.1 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 58.9 mtt -65.03 126.64 28.67 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.193 0.997 . . . . 0.0 110.783 177.584 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 18.2 m -74.87 20.31 0.13 Allowed 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 114.614 1.338 . . . . 0.0 114.614 -172.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -150.24 10.26 0.68 Allowed 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 127.395 2.278 . . . . 0.0 111.528 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -53.96 -25.87 32.32 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 125.81 1.672 . . . . 0.0 116.954 -172.414 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -66.22 -28.04 68.44 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 120.079 1.939 . . . . 0.0 111.698 173.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -82.27 -28.75 31.6 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 121.03 -1.044 . . . . 0.0 112.005 177.084 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.458 HD12 HG23 ' A' ' 6' ' ' ILE . 2.7 mm? -78.16 -32.21 50.12 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.624 0.77 . . . . 0.0 111.559 172.826 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 67.0 mtp180 -55.25 -40.34 70.82 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 119.524 1.056 . . . . 0.0 111.257 162.183 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -58.78 -36.25 85.85 Favored Glycine 0 CA--C 1.536 1.37 0 CA-C-O 119.255 -0.747 . . . . 0.0 114.044 171.483 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -65.42 -35.55 81.26 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 119.41 1.605 . . . . 0.0 112.446 176.353 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 53.3 mt -73.05 -48.87 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 124.306 1.042 . . . . 0.0 109.724 176.035 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -67.07 -41.28 86.65 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 121.449 -0.782 . . . . 0.0 112.477 -174.561 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 77.4 mm-40 -69.07 -21.57 64.07 Favored 'General case' 0 CA--C 1.546 0.812 0 O-C-N 121.138 -0.976 . . . . 0.0 112.471 176.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -88.79 -29.78 19.49 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 177.804 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -140.4 -1.41 1.51 Allowed 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 116.075 1.88 . . . . 0.0 116.075 -170.044 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.5 mptt 45.75 48.32 11.72 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 125.922 1.689 . . . . 0.0 112.716 -165.38 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 60.2 t-80 -129.26 133.51 47.54 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 125.333 1.453 . . . . 0.0 110.471 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -142.27 -25.1 0.66 Allowed 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -160.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 60.6 p -77.78 151.97 33.78 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 121.727 -0.608 . . . . 0.0 111.603 168.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 13.6 m -104.55 155.95 36.62 Favored Pre-proline 0 N--CA 1.478 0.949 0 C-N-CA 124.673 1.189 . . . . 0.0 111.67 -176.687 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -75.04 154.31 99.58 Favored 'Cis proline' 0 CA--C 1.535 0.542 0 CA-C-N 119.071 0.704 . . . . 0.0 113.782 -6.037 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -99.23 138.08 36.83 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 159.005 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 60.9 mt -131.03 140.62 48.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 124.199 1.0 . . . . 0.0 109.35 -165.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -138.56 144.96 40.1 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.808 0.843 . . . . 0.0 111.982 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 65.8 mt -130.01 117.05 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.973 1.309 . . . . 0.0 109.186 175.465 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 46.13 44.64 12.12 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 125.565 1.546 . . . . 0.0 113.503 -176.33 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 82.46 -7.47 64.66 Favored Glycine 0 CA--C 1.534 1.229 0 N-CA-C 116.293 1.277 . . . . 0.0 116.293 -177.371 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -91.03 138.34 31.68 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 119.168 1.484 . . . . 0.0 110.578 -178.483 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 39.6 t80 -82.14 133.89 35.29 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.858 0.837 . . . . 0.0 112.915 -176.44 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 37.9 mm -113.98 119.73 61.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 126.656 1.983 . . . . 0.0 107.726 175.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -71.07 27.08 0.54 Allowed Glycine 0 N--CA 1.472 1.086 0 N-CA-C 119.137 2.415 . . . . 0.0 119.137 -167.579 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 116.21 -175.63 15.93 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 128.076 2.75 . . . . 0.0 114.552 175.057 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 25.1 t -64.54 -33.38 75.77 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.364 -1.08 . . . . 0.0 112.866 -179.122 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 37.0 m -70.01 -34.88 73.87 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 121.088 -1.007 . . . . 0.0 111.924 175.63 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.87 -39.04 90.33 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.452 1.101 . . . . 0.0 111.974 171.009 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 51.9 tp -62.93 -45.84 90.61 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.246 1.019 . . . . 0.0 111.196 175.275 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -64.77 -33.26 75.55 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.582 -0.699 . . . . 0.0 112.324 173.612 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.83 -29.84 71.0 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 121.008 -1.057 . . . . 0.0 111.954 177.176 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 83.6 mt -71.75 -30.03 65.15 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.441 1.096 . . . . 0.0 112.985 170.579 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -67.82 -41.13 83.52 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.698 0.799 . . . . 0.0 110.25 172.006 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -71.81 -39.75 69.62 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.113 0.965 . . . . 0.0 113.575 175.263 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -69.69 -18.27 63.54 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 119.547 1.067 . . . . 0.0 112.82 171.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 78.01 35.48 34.71 Favored Glycine 0 CA--C 1.531 1.083 0 CA-C-N 118.801 0.728 . . . . 0.0 113.65 175.457 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -116.19 -19.51 10.21 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 127.787 2.435 . . . . 0.0 113.351 -174.048 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 27.2 tp -63.21 -31.82 73.06 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.919 0.888 . . . . 0.0 111.684 -174.279 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -54.55 -53.6 52.34 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.526 1.131 . . . . 0.0 112.933 175.364 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -76.89 -23.4 69.45 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-O 119.446 -0.641 . . . . 0.0 113.862 -178.714 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 75.5 mt -69.91 -37.75 76.06 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 118.869 1.334 . . . . 0.0 112.012 172.531 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 92.8 mt -86.47 5.89 33.05 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -178.769 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 81.7 p . . . . . 0 C--O 1.255 1.387 0 C-N-CA 126.566 1.947 . . . . 0.0 115.973 -174.755 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 39.5 p . . . . . 0 C--O 1.239 0.502 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.586 HG23 HD12 ' A' ' 54' ' ' LEU . 19.6 pt -49.37 -25.3 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 125.981 1.712 . . . . 0.0 114.07 171.314 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.29 -28.48 69.22 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 118.935 0.789 . . . . 0.0 112.063 -176.459 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 96.4 p -72.32 -32.7 66.78 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 171.697 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 59.9 mtp -70.61 -30.65 67.38 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.15 0.98 . . . . 0.0 111.914 -176.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -64.88 -24.06 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 124.315 1.046 . . . . 0.0 111.573 -174.077 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -82.04 -9.54 59.52 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.063 1.745 . . . . 0.0 114.716 176.709 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -91.28 -22.06 33.32 Favored Glycine 0 CA--C 1.54 1.638 0 N-CA-C 117.451 1.741 . . . . 0.0 117.451 -166.425 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -135.86 170.04 16.61 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 118.941 1.37 . . . . 0.0 110.941 169.688 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 20.9 ttpt -66.59 -30.71 71.06 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 119.146 -0.454 . . . . 0.0 111.945 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 28.4 t -133.4 130.22 56.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.563 1.545 . . . . 0.0 109.394 177.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 42.9 t -134.21 127.67 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 124.245 1.018 . . . . 0.0 109.809 -177.168 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.1 t -128.35 146.92 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.295 1.038 . . . . 0.0 112.053 -170.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -125.97 106.88 9.95 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.797 1.239 . . . . 0.0 109.526 178.26 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 37.2 m -128.41 176.94 7.33 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 127.044 2.137 . . . . 0.0 112.371 -164.602 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.421 ' CD2' HG21 ' A' ' 67' ' ' VAL . 43.8 m0 -125.71 129.23 49.12 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.609 1.563 . . . . 0.0 108.335 163.5 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 46.6 t -53.63 -38.9 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 124.842 1.257 . . . . 0.0 114.325 -158.67 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.7 t -89.79 -6.99 55.4 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 -170.46 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 94.9 m -92.63 146.25 31.95 Favored Pre-proline 0 CA--C 1.537 0.456 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -160.303 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -69.59 -34.47 15.07 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 120.662 0.908 . . . . 0.0 114.057 -162.783 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -71.22 -42.12 69.31 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 124.073 0.949 . . . . 0.0 112.675 176.424 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -51.96 -54.65 27.23 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 169.667 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 53.3 t -60.23 -51.78 69.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 124.149 0.98 . . . . 0.0 111.63 -175.364 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . 0.272 7.7 ptp180 -61.67 -35.99 79.58 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 119.05 0.841 . . . . 0.0 112.164 -178.685 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.73 -55.91 8.63 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 118.226 -0.892 . . . . 0.0 112.716 173.647 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -48.02 -41.98 26.96 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 120.283 1.401 . . . . 0.0 112.584 176.149 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.28 -45.37 66.5 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 124.558 1.143 . . . . 0.0 111.577 -175.036 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.2 tt -70.4 -37.7 74.53 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.414 1.086 . . . . 0.0 112.021 176.027 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 80.7 mt -63.64 -41.71 98.21 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 120.923 -1.11 . . . . 0.0 111.461 176.556 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -64.41 -24.07 67.5 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 169.22 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.2 -16.07 53.85 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 119.974 1.261 . . . . 0.0 113.37 171.616 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 3.0 mmt180 -107.41 -36.69 6.43 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 115.972 1.842 . . . . 0.0 115.972 -173.434 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 13.9 t -155.04 150.56 27.41 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-N 120.312 1.415 . . . . 0.0 114.611 -176.265 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -84.03 -19.29 34.7 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.826 1.25 . . . . 0.0 113.02 170.398 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -85.97 37.1 0.7 Allowed 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -176.422 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -106.12 136.05 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 124.617 1.167 . . . . 0.0 111.984 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.3 m -128.6 142.25 51.1 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 126.489 1.915 . . . . 0.0 109.819 169.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.4 p -135.4 143.62 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 125.041 1.336 . . . . 0.0 113.315 177.41 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -118.99 135.98 54.34 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 127.187 2.195 . . . . 0.0 110.55 176.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -103.52 88.17 3.02 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.873 0.869 . . . . 0.0 111.604 -172.157 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 31.6 m -80.31 40.34 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 -168.277 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -141.92 -30.82 0.57 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 128.56 2.744 . . . . 0.0 109.879 171.186 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 26.4 mmmt -65.48 -31.29 72.29 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.088 1.355 . . . . 0.0 111.554 158.009 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -94.02 117.63 30.38 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.724 1.21 . . . . 0.0 109.387 178.869 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 73.8 m -70.89 -19.09 62.65 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 -163.231 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -92.39 5.96 48.75 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.453 1.501 . . . . 0.0 113.095 173.372 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -52.1 -25.23 17.16 Favored Glycine 0 CA--C 1.539 1.545 0 C-N-CA 125.524 1.535 . . . . 0.0 116.8 -173.343 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -64.24 -28.75 69.95 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 120.378 2.089 . . . . 0.0 112.802 172.426 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -80.11 -31.16 39.18 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.88 1.272 . . . . 0.0 112.441 176.034 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.586 HD12 HG23 ' A' ' 6' ' ' ILE . 2.8 mm? -78.15 -36.2 47.99 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.615 0.766 . . . . 0.0 110.768 174.613 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 57.3 mtp180 -54.93 -36.22 65.03 Favored 'General case' 0 N--CA 1.477 0.9 0 O-C-N 121.43 -0.794 . . . . 0.0 111.165 159.598 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.04 -44.08 97.61 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 124.498 1.047 . . . . 0.0 113.995 170.825 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -61.61 -32.3 72.42 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 119.745 1.772 . . . . 0.0 112.296 176.094 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 57.6 mt -74.48 -43.5 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.095 0.958 . . . . 0.0 110.08 174.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -64.83 -44.35 90.12 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 121.286 -0.884 . . . . 0.0 112.253 -179.373 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -57.05 -41.34 78.5 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.431 0.692 . . . . 0.0 111.674 -179.241 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -91.34 -28.26 17.84 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 -176.403 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -133.42 2.78 3.56 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 114.973 1.471 . . . . 0.0 114.973 -171.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 44.2 mmtm 54.12 33.65 18.3 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 127.039 2.136 . . . . 0.0 114.172 178.405 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -130.92 141.82 50.32 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 126.088 1.755 . . . . 0.0 110.759 -175.209 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -142.0 -20.22 0.72 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.742 1.217 . . . . 0.0 113.593 -164.124 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.8 p -68.54 153.31 44.01 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.716 1.607 . . . . 0.0 111.876 167.342 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.421 HG21 ' CD2' ' A' ' 20' ' ' TRP . 25.6 m -115.92 151.25 46.24 Favored Pre-proline 0 N--CA 1.476 0.856 0 C-N-CA 124.421 1.088 . . . . 0.0 112.736 177.591 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -74.58 147.33 89.12 Favored 'Cis proline' 0 N--CA 1.457 -0.62 0 CA-C-N 119.079 0.707 . . . . 0.0 113.884 0.016 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -99.02 138.35 36.25 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.414 158.426 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 44.4 mt -130.45 141.07 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 123.714 0.805 . . . . 0.0 109.089 -164.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -140.16 146.07 38.31 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.007 0.923 . . . . 0.0 111.555 -179.38 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 65.2 mt -128.85 127.19 66.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 125.384 1.474 . . . . 0.0 107.916 174.483 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 35.8 m120 50.54 28.17 3.28 Favored 'General case' 0 CA--C 1.56 1.355 0 N-CA-C 115.651 1.723 . . . . 0.0 115.651 -178.688 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 82.4 0.97 90.34 Favored Glycine 0 CA--C 1.544 1.891 0 O-C-N 120.397 -1.44 . . . . 0.0 115.047 -173.464 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -91.72 151.65 20.55 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 126.964 2.106 . . . . 0.0 110.387 172.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -93.97 142.37 27.46 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -174.53 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 31.7 mm -121.22 130.07 75.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 128.56 2.744 . . . . 0.0 107.512 176.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -71.38 23.37 0.62 Allowed Glycine 0 N--CA 1.472 1.034 0 C-N-CA 126.744 2.116 . . . . 0.0 118.101 -165.528 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 107.79 -171.9 16.79 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 127.941 2.686 . . . . 0.0 113.498 178.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 42.7 t -54.12 -41.94 68.89 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.821 1.248 . . . . 0.0 112.362 -178.298 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 10.4 m -82.58 -10.28 59.04 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -178.367 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -76.6 -42.68 41.57 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 120.002 1.273 . . . . 0.0 109.838 162.477 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 48.7 tp -64.13 -50.03 69.84 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.115 1.366 . . . . 0.0 112.395 177.588 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -70.01 -12.95 61.98 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 113.24 0.829 . . . . 0.0 113.24 178.185 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -85.89 -39.41 17.03 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 121.206 -0.934 . . . . 0.0 112.121 164.728 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 33.6 mt -64.42 -33.66 76.38 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 120.375 1.443 . . . . 0.0 113.29 175.659 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -62.98 -47.39 83.35 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.975 1.31 . . . . 0.0 111.352 171.276 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 6.8 mptt -73.44 -34.91 65.65 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.598 1.559 . . . . 0.0 112.319 -177.649 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -70.41 -11.58 61.01 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.231 1.813 . . . . 0.0 113.142 169.552 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 70.17 10.65 65.97 Favored Glycine 0 CA--C 1.534 1.258 0 CA-C-N 119.053 0.842 . . . . 0.0 114.301 -177.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 17.4 mtpt -81.5 -26.6 35.04 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 125.949 1.7 . . . . 0.0 112.103 -178.746 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 34.7 tp -59.51 -40.23 86.41 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.645 1.178 . . . . 0.0 112.126 170.045 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -60.66 -42.04 96.22 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.812 -0.555 . . . . 0.0 111.932 174.482 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -70.33 -14.08 71.28 Favored Glycine 0 CA--C 1.535 1.301 0 CA-C-O 119.16 -0.8 . . . . 0.0 114.959 176.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 88.7 mt -97.64 -21.99 16.73 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.065 1.746 . . . . 0.0 113.341 175.043 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 93.2 mt -103.8 -5.67 22.2 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.236 1.415 . . . . 0.0 114.447 -179.089 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 61.2 p . . . . . 0 C--O 1.25 1.1 0 C-N-CA 126.07 1.748 . . . . 0.0 114.159 173.465 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.07 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.81 -14.13 62.61 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 115.43 1.641 . . . . 0.0 115.43 -177.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 50.2 mtp -115.18 92.39 31.39 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 125.878 1.671 . . . . 0.0 113.02 -171.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -50.51 138.25 39.59 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 124.122 3.215 . . . . 0.0 116.191 -175.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.4 t -151.18 -147.89 0.25 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 127.939 2.495 . . . . 0.0 109.766 -175.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.6 pt -49.21 -24.82 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 126.741 2.016 . . . . 0.0 116.222 -165.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.26 -21.84 26.16 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.929 1.691 . . . . 0.0 114.264 -178.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.9 m -77.32 -32.74 55.49 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.81 1.244 . . . . 0.0 113.437 170.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 78.8 mtp -63.26 -33.76 76.19 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 121.306 -0.871 . . . . 0.0 111.371 -176.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.0 mm -62.35 -22.47 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 125.726 1.611 . . . . 0.0 112.767 -176.063 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -85.86 -17.74 34.77 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.24 1.416 . . . . 0.0 113.876 179.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -88.77 -7.5 71.15 Favored Glycine 0 CA--C 1.536 1.395 0 N-CA-C 115.933 1.133 . . . . 0.0 115.933 -173.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -145.04 161.16 40.09 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.292 1.437 . . . . 0.0 110.738 169.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -67.77 -48.33 66.65 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.091 0.956 . . . . 0.0 111.176 177.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.4 t -114.53 131.12 67.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.937 1.295 . . . . 0.0 110.961 171.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 85.3 t -131.06 130.74 63.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 125.014 1.326 . . . . 0.0 110.206 179.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 49.3 t -128.81 146.03 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 124.13 0.972 . . . . 0.0 112.421 -175.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -121.84 111.53 17.23 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.789 1.235 . . . . 0.0 109.099 173.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 18.7 m -121.14 172.68 7.8 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 126.728 2.011 . . . . 0.0 111.319 -173.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.486 ' CD1' ' HB3' ' A' ' 46' ' ' ASP . 23.6 m0 -120.31 135.88 54.86 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.57 1.148 . . . . 0.0 108.86 162.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 60.7 t -57.72 -35.54 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 CA-C-N 118.849 0.75 . . . . 0.0 111.13 -177.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.3 p -74.34 -10.82 59.96 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 127.308 2.243 . . . . 0.0 116.408 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 38.0 t -90.61 143.73 29.52 Favored Pre-proline 0 CA--C 1.537 0.48 0 O-C-N 121.264 -0.898 . . . . 0.0 110.513 -170.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.33 -39.05 0.61 Allowed 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 121.114 1.209 . . . . 0.0 112.655 173.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -59.01 -36.31 74.73 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.307 1.043 . . . . 0.0 113.744 178.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -48.44 -54.73 13.06 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.713 1.205 . . . . 0.0 109.584 168.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 57.5 t -65.2 -39.64 86.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.242 1.017 . . . . 0.0 112.139 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 79.6 mmt-85 -54.78 -41.67 70.8 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 118.687 0.676 . . . . 0.0 111.572 174.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.17 -54.27 8.88 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.608 0.763 . . . . 0.0 113.007 173.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -54.24 -31.94 54.67 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 119.498 1.044 . . . . 0.0 113.349 -177.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -69.32 -49.23 57.68 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.0 0.92 . . . . 0.0 112.669 176.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 8.0 tt -72.59 -36.74 68.22 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 124.651 1.181 . . . . 0.0 111.861 -177.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 93.2 mt -62.25 -44.78 95.77 Favored 'General case' 0 CA--C 1.53 0.175 0 O-C-N 121.607 -0.683 . . . . 0.0 111.395 177.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 14.8 m-70 -69.61 -20.88 63.61 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 172.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.61 -31.91 53.19 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 119.698 1.135 . . . . 0.0 113.203 173.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 39.6 mmt-85 -97.36 -23.79 15.94 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 114.827 1.418 . . . . 0.0 114.827 -176.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 14.6 t -153.78 170.25 21.39 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -177.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 77.6 mttt -112.68 3.82 16.81 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 126.411 1.884 . . . . 0.0 112.224 167.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -105.83 42.94 1.18 Allowed 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 126.081 1.752 . . . . 0.0 113.114 -171.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -119.54 134.97 61.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.858 1.663 . . . . 0.0 111.959 -177.048 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.0 m -119.19 141.85 48.51 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.803 2.041 . . . . 0.0 110.242 167.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.5 p -135.37 141.04 43.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 125.072 1.349 . . . . 0.0 113.308 176.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -112.77 134.68 54.17 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 127.414 2.286 . . . . 0.0 110.394 175.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -101.62 89.44 3.71 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 124.15 0.98 . . . . 0.0 110.509 -179.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.9 m -76.1 4.65 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -170.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.486 ' HB3' ' CD1' ' A' ' 20' ' ' TRP . 2.5 p-10 -85.23 -22.92 28.47 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.759 1.224 . . . . 0.0 112.038 167.467 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 30.0 mtmt -90.0 5.09 48.08 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.904 2.082 . . . . 0.0 113.41 176.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 12.2 tpt -120.63 124.25 44.79 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.975 1.71 . . . . 0.0 111.413 -165.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 10.5 m -65.21 -22.91 66.95 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.735 0.814 . . . . 0.0 112.847 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.4 5.58 51.36 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 126.16 1.784 . . . . 0.0 113.549 174.498 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -55.88 -30.57 57.14 Favored Glycine 0 CA--C 1.532 1.106 0 O-C-N 120.402 -1.436 . . . . 0.0 114.651 -174.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -70.23 -26.23 63.76 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 118.541 1.17 . . . . 0.0 113.043 175.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -72.21 -44.11 63.45 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.97 0.908 . . . . 0.0 110.53 170.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.23 -36.65 83.57 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.044 0.538 . . . . 0.0 110.459 178.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 43.0 mtp180 -63.93 -42.01 97.47 Favored 'General case' 0 N--CA 1.477 0.897 0 O-C-N 121.077 -1.014 . . . . 0.0 112.176 167.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -58.91 -38.38 92.49 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 124.225 0.917 . . . . 0.0 113.627 176.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -61.18 -32.29 72.03 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 118.597 1.199 . . . . 0.0 113.637 173.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 52.0 mt -81.28 -42.55 19.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 123.939 0.896 . . . . 0.0 109.214 177.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -71.93 -39.59 69.36 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 121.115 -0.991 . . . . 0.0 112.941 -176.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 42.2 mm-40 -68.63 -23.91 64.49 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 119.939 1.245 . . . . 0.0 113.069 177.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -98.75 -31.75 11.73 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.533 1.133 . . . . 0.0 113.827 -178.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -134.87 5.0 3.33 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -170.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 66.7 mmtt 47.37 38.94 8.14 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 126.565 1.946 . . . . 0.0 114.429 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -139.88 147.69 40.99 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.704 1.202 . . . . 0.0 111.446 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -140.29 2.47 1.88 Allowed 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.998 1.319 . . . . 0.0 113.861 -172.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 90.2 m -82.22 141.04 33.32 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.284 1.034 . . . . 0.0 111.851 175.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.9 m -101.97 156.06 35.68 Favored Pre-proline 0 N--CA 1.475 0.785 0 C-N-CA 124.826 1.251 . . . . 0.0 112.73 -176.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -73.69 150.96 96.42 Favored 'Cis proline' 0 C--N 1.348 0.546 0 CA-C-N 118.759 0.592 . . . . 0.0 113.013 -5.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -98.02 130.84 44.83 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 161.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 47.8 mt -126.28 141.39 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 C-N-CA 124.084 0.954 . . . . 0.0 109.294 -167.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -139.34 141.11 37.66 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.516 0.727 . . . . 0.0 111.736 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 43.4 mt -136.5 117.07 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.659 1.184 . . . . 0.0 109.508 -179.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 46.37 38.58 5.4 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 125.135 1.374 . . . . 0.0 114.165 -171.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 78.83 0.29 80.64 Favored Glycine 0 CA--C 1.54 1.654 0 N-CA-C 115.723 1.049 . . . . 0.0 115.723 -177.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 -88.61 145.84 25.46 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 119.088 1.444 . . . . 0.0 110.261 174.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -94.06 137.62 33.05 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -172.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 18.3 mm -130.75 115.46 30.95 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 C-N-CA 127.825 2.45 . . . . 0.0 107.663 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -70.97 -16.97 75.11 Favored Glycine 0 CA--C 1.537 1.461 0 N-CA-C 116.41 1.324 . . . . 0.0 116.41 -165.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 172.99 -173.87 45.72 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 124.558 1.075 . . . . 0.0 113.52 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 34.1 t -62.92 -35.63 80.73 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 122.262 -0.552 . . . . 0.0 111.469 174.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 43.5 t -60.96 -44.29 97.5 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.795 -0.565 . . . . 0.0 112.319 173.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -70.94 -31.11 67.61 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.51 1.124 . . . . 0.0 112.015 -179.081 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 42.5 tp -69.38 -50.82 42.55 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.815 1.646 . . . . 0.0 111.289 172.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -64.36 -31.45 72.66 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 121.422 -0.799 . . . . 0.0 112.521 178.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.43 -22.63 65.2 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 119.131 0.878 . . . . 0.0 112.771 175.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 68.7 mt -90.13 -29.81 18.06 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.987 1.315 . . . . 0.0 112.088 171.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -65.16 -45.4 85.09 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.041 0.936 . . . . 0.0 112.264 172.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -60.33 -22.52 63.32 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.747 1.619 . . . . 0.0 114.059 177.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -105.07 -7.81 18.9 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.061 1.344 . . . . 0.0 114.584 -176.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 84.08 6.11 86.88 Favored Glycine 0 CA--C 1.54 1.627 0 CA-C-N 118.881 0.764 . . . . 0.0 114.673 -176.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 34.0 mtmt -90.51 -25.68 20.15 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 125.662 1.585 . . . . 0.0 113.252 -171.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 52.4 tp -65.19 -38.55 90.85 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.283 1.033 . . . . 0.0 111.258 173.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -62.06 -23.6 66.59 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 173.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -85.2 -23.41 48.51 Favored Glycine 0 CA--C 1.532 1.123 0 O-C-N 121.545 -0.722 . . . . 0.0 114.141 172.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 41.9 mt -79.18 -35.03 42.53 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.893 1.277 . . . . 0.0 112.336 175.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 51.5 mt -81.01 -0.73 40.89 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 115.421 1.638 . . . . 0.0 115.421 -166.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 16.4 m . . . . . 0 C--O 1.254 1.34 0 C-N-CA 127.073 2.149 . . . . 0.0 113.027 -179.57 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.219 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -147.6 144.46 28.46 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.895 0.878 . . . . 0.0 112.234 177.087 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.76 90.03 42.73 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 126.03 1.732 . . . . 0.0 110.576 -178.125 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -60.77 108.62 0.56 Allowed 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 123.245 2.63 . . . . 0.0 112.938 176.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 53.8 p -149.66 -179.34 7.03 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 125.514 1.526 . . . . 0.0 109.557 165.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.464 HG23 HD12 ' A' ' 54' ' ' LEU . 21.3 pt -53.44 -27.55 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 123.344 0.658 . . . . 0.0 112.621 172.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.88 -25.12 64.46 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -172.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.1 m -81.07 -31.95 34.18 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 121.096 -1.003 . . . . 0.0 111.904 167.043 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 56.5 mtm -68.37 -17.97 64.36 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 178.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.5 mm -60.84 -31.16 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 CA-C-N 119.223 0.919 . . . . 0.0 111.99 171.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.2 mptt -75.53 -1.52 24.71 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -174.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -81.86 -38.03 14.78 Favored Glycine 0 CA--C 1.537 1.436 0 N-CA-C 115.659 1.024 . . . . 0.0 115.659 -172.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -140.84 171.92 13.41 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.304 1.442 . . . . 0.0 112.641 -174.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 29.0 ttpt -68.7 -39.29 80.56 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.849 1.26 . . . . 0.0 112.813 -178.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.1 t -122.47 134.44 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.031 0.932 . . . . 0.0 110.357 172.176 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 25.2 t -135.27 130.51 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 124.368 1.067 . . . . 0.0 109.985 177.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 54.8 t -127.4 149.12 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.472 1.109 . . . . 0.0 111.977 -173.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -127.31 114.33 17.45 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.408 1.483 . . . . 0.0 109.409 175.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.7 m -130.14 172.13 12.1 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 126.571 1.948 . . . . 0.0 111.444 -168.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 23.0 m0 -114.55 138.99 49.95 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 158.047 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.41 ' CG2' ' HE2' ' A' ' 47' ' ' LYS . 96.6 t -65.56 -22.82 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 CA-C-N 118.465 0.575 . . . . 0.0 111.208 175.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 76.6 p -68.54 -18.73 64.42 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.639 1.576 . . . . 0.0 115.001 172.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 49.9 t -93.14 143.3 26.53 Favored Pre-proline 0 CA--C 1.539 0.522 0 CA-C-N 119.698 1.135 . . . . 0.0 111.498 -165.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -82.92 -33.53 0.42 Allowed 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 121.217 1.278 . . . . 0.0 112.932 174.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -61.23 -36.64 80.5 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.67 1.188 . . . . 0.0 112.705 176.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -49.85 -55.13 15.43 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.382 1.473 . . . . 0.0 109.517 168.011 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 86.0 t -63.97 -39.02 83.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.221 1.008 . . . . 0.0 112.558 -176.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 25.4 mmm180 -53.89 -48.11 70.41 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 118.745 0.702 . . . . 0.0 111.029 173.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.81 -55.77 13.39 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.617 0.767 . . . . 0.0 112.342 175.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.79 -38.27 47.41 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.722 1.209 . . . . 0.0 113.698 -178.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -71.28 -51.08 26.47 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.394 0.678 . . . . 0.0 111.172 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.2 tt -66.19 -38.63 88.46 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 125.151 1.381 . . . . 0.0 111.754 -177.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 71.5 mt -61.86 -52.94 62.07 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.897 0.879 . . . . 0.0 111.172 176.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -63.43 -25.23 68.18 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 172.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.04 -13.27 60.22 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 120.514 -1.366 . . . . 0.0 113.514 175.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 12.3 mmp_? -99.87 -56.88 2.26 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.842 1.257 . . . . 0.0 112.433 171.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 25.4 p -150.02 143.15 24.98 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.556 1.142 . . . . 0.0 113.915 -164.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -83.73 -0.98 53.11 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 126.572 1.949 . . . . 0.0 113.528 175.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -83.29 29.35 0.5 Allowed 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.075 1.35 . . . . 0.0 113.383 -177.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -110.15 132.49 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 126.818 2.047 . . . . 0.0 111.089 -174.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 46.8 m -110.2 138.88 45.97 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 126.956 2.103 . . . . 0.0 108.89 166.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.1 p -134.6 139.61 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-O 122.537 1.161 . . . . 0.0 113.37 170.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 34.6 m-70 -116.23 145.95 42.72 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 127.939 2.496 . . . . 0.0 110.918 -178.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -123.58 90.77 3.34 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.967 0.889 . . . . 0.0 111.335 -168.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 34.9 m -68.24 -11.66 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -174.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.41 -23.58 54.03 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.865 0.866 . . . . 0.0 112.963 170.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.41 ' HE2' ' CG2' ' A' ' 21' ' ' VAL . 71.2 mmtt -86.43 -32.26 20.97 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.703 1.201 . . . . 0.0 111.977 175.392 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 67.1 mtt -61.75 143.83 55.62 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.122 0.969 . . . . 0.0 112.157 174.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 9.4 t -70.42 -37.58 74.46 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.835 0.854 . . . . 0.0 111.103 168.132 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -100.16 7.92 44.22 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.776 1.63 . . . . 0.0 114.026 -176.299 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -57.02 -27.41 57.12 Favored Glycine 0 CA--C 1.534 1.244 0 O-C-N 120.598 -1.314 . . . . 0.0 115.795 -172.014 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -67.6 -20.01 65.31 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.052 1.426 . . . . 0.0 112.82 174.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -80.34 -33.82 37.08 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.984 1.314 . . . . 0.0 112.0 170.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.464 HD12 HG23 ' A' ' 6' ' ' ILE . 3.0 mm? -77.9 -27.98 49.71 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 121.52 -0.737 . . . . 0.0 111.495 177.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 66.5 mtp180 -54.72 -39.74 68.53 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-N 119.633 1.106 . . . . 0.0 111.337 159.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.23 -28.02 73.06 Favored Glycine 0 CA--C 1.534 1.271 0 CA-C-O 119.095 -0.836 . . . . 0.0 115.033 175.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -65.0 -35.0 79.79 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 119.557 1.678 . . . . 0.0 112.398 174.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 27.9 mt -72.93 -41.3 60.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 124.44 1.096 . . . . 0.0 109.278 173.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -64.53 -46.29 83.5 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 121.49 -0.757 . . . . 0.0 112.947 -177.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 93.5 mm-40 -70.58 -18.02 62.9 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -92.74 -33.03 14.47 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 175.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -136.35 -0.73 2.41 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 115.678 1.733 . . . . 0.0 115.678 -168.179 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 53.06 41.35 32.16 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 126.803 2.041 . . . . 0.0 113.835 -169.124 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -128.72 140.61 51.65 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.592 1.157 . . . . 0.0 113.056 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -142.18 -18.03 0.73 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.684 1.194 . . . . 0.0 113.949 -169.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.7 p -72.68 164.55 26.34 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.49 1.116 . . . . 0.0 113.524 169.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 20.1 m -123.65 155.03 66.82 Favored Pre-proline 0 N--CA 1.478 0.955 0 C-N-CA 124.715 1.206 . . . . 0.0 113.597 -175.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -75.47 151.73 96.59 Favored 'Cis proline' 0 C--N 1.35 0.619 0 CA-C-N 118.793 0.605 . . . . 0.0 112.913 -4.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -100.12 132.5 45.45 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 162.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 69.3 mt -126.23 142.4 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 123.977 0.911 . . . . 0.0 108.725 -167.035 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -138.68 146.04 41.1 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.669 0.788 . . . . 0.0 112.08 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 51.8 mt -132.73 119.99 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.907 1.283 . . . . 0.0 109.994 176.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 48.05 29.75 1.86 Allowed 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 126.224 1.81 . . . . 0.0 114.57 -176.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 91.21 0.51 73.74 Favored Glycine 0 CA--C 1.541 1.703 0 C-N-CA 125.428 1.489 . . . . 0.0 116.759 -175.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -93.0 144.96 24.74 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 126.022 1.729 . . . . 0.0 110.744 175.162 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -91.96 141.56 28.5 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.704 1.202 . . . . 0.0 114.065 -176.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 26.4 mm -127.79 123.2 60.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 C-N-CA 128.076 2.55 . . . . 0.0 108.364 -178.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -72.02 16.63 1.51 Allowed Glycine 0 N--CA 1.475 1.274 0 N-CA-C 118.863 2.305 . . . . 0.0 118.863 -167.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 114.59 -159.8 13.53 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 126.831 2.158 . . . . 0.0 114.196 178.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 53.6 t -65.25 -42.22 93.5 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.796 0.838 . . . . 0.0 113.229 -172.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 21.5 m -61.27 -40.9 95.8 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 118.924 0.784 . . . . 0.0 112.025 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -66.03 -40.45 91.05 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.774 1.23 . . . . 0.0 112.107 176.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 56.1 tp -64.14 -50.83 66.68 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.326 1.45 . . . . 0.0 111.35 177.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -63.3 -39.51 94.77 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 118.108 0.413 . . . . 0.0 111.106 175.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.29 -38.67 90.26 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 121.541 -0.724 . . . . 0.0 111.869 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 29.4 mt -66.53 -27.38 67.71 Favored 'General case' 0 N--CA 1.468 0.425 0 O-C-N 121.302 -0.874 . . . . 0.0 112.151 176.089 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -75.04 -43.42 53.68 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 118.748 0.704 . . . . 0.0 111.634 174.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -65.87 -32.41 73.9 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.582 0.753 . . . . 0.0 112.083 175.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -78.84 -0.48 30.79 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 126.119 1.768 . . . . 0.0 113.601 172.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 73.22 23.0 78.38 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 124.461 1.029 . . . . 0.0 114.925 173.113 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 43.2 mtmt -113.59 -24.06 9.43 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 127.31 2.244 . . . . 0.0 113.877 -168.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 38.7 tp -63.24 -37.33 86.81 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 123.43 0.692 . . . . 0.0 111.825 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -54.92 -44.14 73.96 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.545 0.738 . . . . 0.0 112.375 175.171 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -73.53 -33.67 58.09 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 123.991 0.805 . . . . 0.0 113.894 177.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 82.3 mt -68.24 -36.39 79.39 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 118.764 1.282 . . . . 0.0 111.801 173.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 83.0 mt -83.9 6.2 22.55 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.932 1.293 . . . . 0.0 113.184 176.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 61.4 m . . . . . 0 C--O 1.253 1.286 0 C-N-CA 124.054 0.942 . . . . 0.0 111.1 171.891 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.929 0 N-CA-C 112.347 -0.301 . . . . 0.0 112.347 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.75 163.53 38.96 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.368 1.467 . . . . 0.0 112.752 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 28.3 ttt -149.18 95.11 3.88 Favored Pre-proline 0 CA--C 1.55 0.967 0 C-N-CA 125.34 1.456 . . . . 0.0 112.31 -174.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -78.09 179.76 29.78 Favored 'Cis proline' 0 C--N 1.351 0.661 0 CA-C-N 120.454 1.198 . . . . 0.0 111.421 0.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 7.8 p -143.64 -168.42 2.83 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 -174.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.429 HG23 HD12 ' A' ' 54' ' ' LEU . 21.8 pt -54.53 -23.15 10.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 125.072 1.349 . . . . 0.0 113.044 168.135 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.58 -22.19 66.9 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -174.133 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 70.5 m -79.12 -28.95 42.97 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 121.08 -1.013 . . . . 0.0 113.148 170.185 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 54.8 mtt -64.3 -30.97 72.0 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 121.382 -0.824 . . . . 0.0 111.723 -178.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.7 mm -60.74 -27.67 41.35 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 125.012 1.325 . . . . 0.0 112.279 -178.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.4 mptt -81.0 -11.39 59.57 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.996 1.318 . . . . 0.0 113.577 178.26 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -80.87 -32.71 32.04 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 124.12 0.866 . . . . 0.0 114.985 -176.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 55.0 m-80 -141.56 162.47 35.4 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 115.445 1.646 . . . . 0.0 115.445 -172.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -61.62 -42.36 98.77 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.958 1.303 . . . . 0.0 112.705 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.4 t -127.55 132.12 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.129 0.972 . . . . 0.0 110.317 175.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 48.0 t -132.08 131.17 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.015 0.926 . . . . 0.0 110.92 178.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.0 t -129.84 150.45 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.275 1.03 . . . . 0.0 113.029 -174.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -126.28 106.87 9.83 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.692 1.197 . . . . 0.0 109.992 175.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 60.9 m -125.02 167.33 14.89 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 126.058 1.743 . . . . 0.0 112.134 -169.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 41.7 m0 -113.66 121.55 44.49 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.046 1.338 . . . . 0.0 109.289 166.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 96.4 t -55.99 -27.61 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 C-N-CA 124.777 1.231 . . . . 0.0 112.772 -174.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.6 p -74.45 -17.04 60.84 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 126.998 2.119 . . . . 0.0 115.054 178.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 76.1 m -107.74 158.19 34.01 Favored Pre-proline 0 CA--C 1.54 0.591 0 CA-C-N 120.135 1.334 . . . . 0.0 114.02 -160.048 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -79.86 -48.11 0.08 OUTLIER 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.175 1.917 . . . . 0.0 112.879 -168.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -60.99 -36.31 79.13 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.067 0.947 . . . . 0.0 113.281 -179.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -43.61 -55.42 4.32 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.701 1.2 . . . . 0.0 110.128 165.18 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 54.5 t -68.3 -40.31 82.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 123.89 0.876 . . . . 0.0 111.967 -178.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 43.6 mmt-85 -56.14 -41.38 75.3 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 118.865 0.757 . . . . 0.0 111.828 175.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.94 -56.72 5.61 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.732 1.213 . . . . 0.0 112.909 173.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -51.44 -35.78 41.1 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 119.857 1.208 . . . . 0.0 113.243 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 25.3 ttpt -69.44 -50.35 46.52 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 124.203 1.001 . . . . 0.0 111.647 178.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.5 tt -65.72 -41.65 92.0 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 124.63 1.172 . . . . 0.0 111.006 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 53.0 mt -62.22 -50.05 73.31 Favored 'General case' 0 C--O 1.227 -0.095 0 CA-C-O 118.359 -0.829 . . . . 0.0 111.112 177.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 14.7 m170 -61.6 -21.81 64.67 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 118.74 0.7 . . . . 0.0 112.617 173.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -83.54 -14.16 52.87 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 119.79 1.177 . . . . 0.0 114.033 174.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.91 -36.99 4.96 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.109 1.364 . . . . 0.0 114.1 -178.253 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.0 m -147.97 138.98 23.3 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 126.312 1.845 . . . . 0.0 111.107 -171.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -97.37 -22.95 16.33 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.195 0.998 . . . . 0.0 112.665 174.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -78.3 52.5 1.13 Allowed 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 125.263 1.425 . . . . 0.0 112.921 172.183 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -112.3 136.36 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 127.665 2.386 . . . . 0.0 109.934 178.274 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.6 m -123.13 119.79 31.32 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.723 1.609 . . . . 0.0 110.185 172.063 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.3 p -110.26 133.66 54.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 123.772 0.829 . . . . 0.0 111.743 170.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -103.84 125.94 50.62 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.881 1.272 . . . . 0.0 109.802 170.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -95.74 101.83 13.57 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 121.866 0.841 . . . . 0.0 111.169 -176.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . 0.278 29.8 m -81.97 5.57 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 O-C-N 120.552 -1.342 . . . . 0.0 114.481 -173.036 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -92.04 -20.61 21.14 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 125.26 1.424 . . . . 0.0 112.163 161.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.4 mmmt -89.66 -37.04 14.9 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 126.784 2.034 . . . . 0.0 111.878 176.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 46.1 tpp -85.2 121.12 27.5 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.683 0.793 . . . . 0.0 110.236 177.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 73.2 m -64.46 -24.45 67.62 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 -168.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -86.78 1.46 52.16 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 126.911 2.085 . . . . 0.0 114.551 171.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -50.97 -27.35 13.45 Favored Glycine 0 CA--C 1.533 1.2 0 N-CA-C 116.92 1.528 . . . . 0.0 116.92 -169.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -73.98 -20.86 60.21 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 119.808 1.804 . . . . 0.0 113.157 177.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 63.2 mm-40 -83.3 -29.89 28.0 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 121.03 -1.043 . . . . 0.0 111.803 172.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.429 HD12 HG23 ' A' ' 6' ' ' ILE . 2.7 mm? -73.92 -34.34 64.32 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.777 0.831 . . . . 0.0 111.509 170.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 63.7 mtp85 -53.87 -39.16 65.45 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 119.606 1.094 . . . . 0.0 111.196 161.299 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -55.54 -42.01 82.95 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.054 0.835 . . . . 0.0 114.13 171.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -65.81 -25.64 67.32 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 119.697 1.748 . . . . 0.0 113.272 177.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.1 mt -79.66 -47.59 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 123.997 0.919 . . . . 0.0 109.477 172.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -66.64 -42.62 86.41 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.441 -0.787 . . . . 0.0 112.434 -175.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -60.76 -26.65 67.39 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 121.409 -0.807 . . . . 0.0 113.057 177.046 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -94.52 -36.65 11.75 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 -178.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -129.15 -4.03 5.01 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 115.045 1.498 . . . . 0.0 115.045 -168.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.5 mttt 43.9 61.68 2.22 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 127.939 2.496 . . . . 0.0 113.484 -174.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -135.16 109.0 8.07 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 112.428 -2.169 . . . . 0.0 110.896 -171.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -99.92 -5.9 27.56 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.68 1.592 . . . . 0.0 112.555 177.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.0 t -51.35 148.71 4.64 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 127.17 2.188 . . . . 0.0 113.452 162.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.2 m -136.8 141.12 33.92 Favored Pre-proline 0 N--CA 1.477 0.882 0 C-N-CA 125.962 1.705 . . . . 0.0 109.926 164.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -78.6 152.21 89.83 Favored 'Cis proline' 0 N--CA 1.46 -0.492 0 CA-C-N 119.862 0.986 . . . . 0.0 114.086 5.273 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -97.06 142.14 29.36 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.639 0.776 . . . . 0.0 109.535 161.193 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 53.6 mt -133.68 139.58 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 123.816 0.846 . . . . 0.0 110.016 -164.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -138.46 144.1 39.94 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.626 1.17 . . . . 0.0 111.468 179.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 66.5 mt -133.72 120.5 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 124.926 1.29 . . . . 0.0 109.029 177.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 45.91 38.96 4.98 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 125.85 1.66 . . . . 0.0 114.134 -176.316 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 82.36 -3.0 83.58 Favored Glycine 0 CA--C 1.539 1.535 0 N-CA-C 116.514 1.366 . . . . 0.0 116.514 -176.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -88.25 147.14 24.97 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.371 1.468 . . . . 0.0 109.675 174.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -89.65 143.74 26.56 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.809 0.844 . . . . 0.0 112.104 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 20.1 mm -126.92 115.44 41.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 127.039 2.135 . . . . 0.0 107.273 175.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.85 -16.1 61.09 Favored Glycine 0 CA--C 1.534 1.242 0 N-CA-C 116.908 1.523 . . . . 0.0 116.908 -167.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 173.46 177.74 42.91 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-N 118.796 1.298 . . . . 0.0 115.935 174.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 29.8 t -59.41 -35.19 73.52 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 122.904 0.482 . . . . 0.0 112.068 175.014 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 50.4 m -72.96 -16.91 61.52 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.647 1.179 . . . . 0.0 113.584 178.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -86.72 -39.13 16.3 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.446 1.098 . . . . 0.0 111.386 169.071 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 51.0 tp -61.06 -51.01 70.98 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.222 1.409 . . . . 0.0 111.514 174.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -55.57 -38.06 68.86 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.554 1.141 . . . . 0.0 111.028 173.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.04 -31.17 65.91 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.09 -1.006 . . . . 0.0 113.235 -177.165 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 32.1 mt -72.32 -30.94 65.24 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 119.227 0.921 . . . . 0.0 112.339 173.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -65.27 -33.83 76.92 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.791 1.236 . . . . 0.0 111.083 169.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 15.1 mmtt -80.23 -9.32 59.72 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 176.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -98.51 -11.7 21.99 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.92 1.288 . . . . 0.0 114.329 172.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 67.65 29.09 73.59 Favored Glycine 0 CA--C 1.539 1.569 0 C-N-CA 121.163 -0.541 . . . . 0.0 112.357 -171.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 31.8 mtmt -111.98 -16.32 13.12 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 126.547 1.939 . . . . 0.0 113.272 -176.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 42.9 tp -68.35 -36.9 79.91 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.748 0.819 . . . . 0.0 111.776 178.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -54.37 -48.41 71.51 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.269 1.028 . . . . 0.0 111.789 175.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -76.06 -15.6 81.28 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 125.274 1.416 . . . . 0.0 114.852 178.302 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 53.9 mt -78.18 -32.04 49.92 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 119.393 1.597 . . . . 0.0 111.495 167.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 81.2 mt -92.85 8.63 38.77 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.977 1.711 . . . . 0.0 114.089 -178.007 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 35.2 t . . . . . 0 C--O 1.252 1.211 0 C-N-CA 127.097 2.159 . . . . 0.0 113.655 178.921 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.156 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -89.89 10.54 23.42 Favored 'General case' 0 CA--C 1.551 1.004 0 N-CA-C 115.751 1.76 . . . . 0.0 115.751 -172.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 22.7 mmt -119.98 77.87 23.74 Favored Pre-proline 0 CA--C 1.55 0.957 0 CA-C-N 119.551 1.069 . . . . 0.0 113.212 -170.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -79.07 90.51 1.27 Allowed 'Trans proline' 0 CA--C 1.545 1.059 0 C-N-CA 123.638 2.892 . . . . 0.0 110.917 174.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.6 m -108.79 -151.18 0.47 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.704 1.202 . . . . 0.0 113.906 -166.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.7 pt -62.23 -20.86 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 -156.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -54.9 -26.44 35.84 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.553 1.541 . . . . 0.0 113.821 -178.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.4 m -72.08 -34.58 68.78 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.939 1.696 . . . . 0.0 113.205 174.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 58.7 mtt -64.39 -36.15 83.2 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.968 0.907 . . . . 0.0 111.247 -178.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.2 mm -62.89 -27.32 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.273 1.029 . . . . 0.0 111.919 -172.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -77.9 -20.53 52.76 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -173.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -78.29 -29.17 54.18 Favored Glycine 0 CA--C 1.533 1.187 0 CA-C-N 119.576 1.08 . . . . 0.0 114.819 -168.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -129.26 170.57 13.43 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.555 -0.967 . . . . 0.0 112.562 -167.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 29.9 ttpt -75.22 -38.38 60.71 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.273 0.629 . . . . 0.0 112.113 177.032 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.1 t -125.18 139.13 52.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.733 1.213 . . . . 0.0 110.158 168.193 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 60.9 t -130.82 125.43 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 124.634 1.174 . . . . 0.0 108.919 171.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 50.4 t -127.6 147.65 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 123.867 0.867 . . . . 0.0 111.909 -170.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -121.05 111.43 17.45 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.673 1.189 . . . . 0.0 109.012 174.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.454 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 71.9 m -127.77 168.6 14.9 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 126.447 1.899 . . . . 0.0 110.911 -172.219 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.528 ' CD1' ' HB3' ' A' ' 46' ' ' ASP . 18.3 m0 -116.06 132.23 56.71 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.521 1.129 . . . . 0.0 108.424 163.303 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 60.7 t -56.48 -29.14 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 CA-C-N 119.098 0.863 . . . . 0.0 112.288 -176.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.8 p -85.64 -11.09 54.73 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 127.464 2.306 . . . . 0.0 115.65 -175.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 8.5 t -90.04 141.43 27.94 Favored Pre-proline 0 CA--C 1.54 0.592 0 CA-C-N 119.77 1.168 . . . . 0.0 111.146 -170.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -69.62 -39.02 7.29 Favored 'Trans proline' 0 C--N 1.348 0.523 0 CA-C-N 120.584 1.244 . . . . 0.0 112.825 179.024 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -61.43 -31.83 71.78 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 126.485 1.914 . . . . 0.0 114.4 178.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.454 ' SG ' ' HB3' ' A' ' 19' ' ' SER . 0.1 OUTLIER -60.16 -63.48 1.28 Allowed 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 126.253 1.821 . . . . 0.0 108.856 174.037 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 63.4 t -59.09 -38.99 77.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 124.032 0.933 . . . . 0.0 110.998 -178.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 18.6 ttt180 -56.37 -31.66 64.02 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.259 1.824 . . . . 0.0 114.801 171.148 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -87.12 -50.97 6.26 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 119.511 1.051 . . . . 0.0 112.65 169.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -49.15 -36.78 20.17 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.232 1.413 . . . . 0.0 112.981 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -67.22 -45.86 75.53 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 123.632 0.773 . . . . 0.0 112.914 178.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.9 tt -76.73 -35.31 57.87 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.17 1.388 . . . . 0.0 111.364 -176.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 96.2 mt -62.6 -48.06 81.08 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.389 0.676 . . . . 0.0 111.37 174.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 16.7 m-70 -65.15 -23.29 67.08 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 173.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.42 -28.75 56.75 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 119.683 1.129 . . . . 0.0 112.758 172.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.83 -18.81 19.31 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 -177.518 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.8 t -162.25 173.72 13.83 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 -178.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -114.6 -30.03 6.63 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.889 1.276 . . . . 0.0 113.565 175.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -84.05 43.59 0.94 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.541 1.137 . . . . 0.0 113.337 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -101.85 118.29 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 126.361 1.864 . . . . 0.0 110.909 173.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 22.0 m -106.23 141.39 37.65 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.582 1.553 . . . . 0.0 110.005 172.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.4 p -131.19 146.46 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 124.574 1.15 . . . . 0.0 112.525 173.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -114.29 119.13 35.95 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.477 1.911 . . . . 0.0 108.98 173.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -87.44 90.96 8.56 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 122.157 0.98 . . . . 0.0 109.96 179.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.9 m -73.33 0.68 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -171.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.528 ' HB3' ' CD1' ' A' ' 20' ' ' TRP . 2.8 p-10 -88.74 -12.76 41.28 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.443 1.097 . . . . 0.0 113.138 167.336 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 38.0 mtmt -99.11 -26.22 14.28 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 126.118 1.767 . . . . 0.0 113.794 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 10.1 ttt -98.38 137.87 36.45 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.488 1.115 . . . . 0.0 112.202 178.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 66.1 m -64.42 -26.87 68.64 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 177.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -79.41 -0.29 32.3 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 121.029 -1.045 . . . . 0.0 113.376 175.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -52.2 -31.4 34.05 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 125.268 1.413 . . . . 0.0 115.329 -174.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -83.92 -16.29 44.83 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 118.263 1.031 . . . . 0.0 112.996 -178.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 7.8 mp0 -81.16 -39.28 25.78 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 121.04 -1.037 . . . . 0.0 110.238 167.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.78 -46.12 90.91 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.042 0.537 . . . . 0.0 110.526 171.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 67.2 mtp180 -59.76 -33.14 71.3 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.283 1.033 . . . . 0.0 112.96 170.066 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.78 -46.66 91.3 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.121 0.867 . . . . 0.0 112.407 174.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -59.46 -42.95 93.19 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 117.997 0.898 . . . . 0.0 112.591 175.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 73.2 mt -66.41 -42.37 90.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 123.483 0.713 . . . . 0.0 110.505 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -71.58 -41.43 69.02 Favored 'General case' 0 CA--C 1.535 0.404 0 O-C-N 121.463 -0.773 . . . . 0.0 112.862 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -63.37 -36.99 85.54 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.733 1.151 . . . . 0.0 112.448 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -82.99 -47.22 11.97 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 178.006 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -120.16 -4.15 10.03 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -164.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.7 mptt 49.89 53.53 12.63 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.886 1.674 . . . . 0.0 112.185 -177.013 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 23.2 t-80 -131.44 136.53 48.05 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.951 1.7 . . . . 0.0 109.863 173.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -141.81 -34.46 0.47 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.989 0.915 . . . . 0.0 112.667 -166.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.3 p -63.57 165.53 7.94 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.085 1.354 . . . . 0.0 111.588 156.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.425 ' HB ' ' HA ' ' A' ' 68' ' ' PRO . 23.1 m -122.33 159.44 52.34 Favored Pre-proline 0 N--CA 1.48 1.043 0 C-N-CA 124.803 1.241 . . . . 0.0 112.402 -174.269 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.425 ' HA ' ' HB ' ' A' ' 67' ' ' VAL . 63.2 Cg_endo -81.85 152.58 77.53 Favored 'Cis proline' 0 C--N 1.349 0.592 0 CA-C-N 119.389 0.817 . . . . 0.0 113.803 -4.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -106.32 136.44 46.05 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.393 1.477 . . . . 0.0 108.979 163.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 73.2 mt -131.16 142.83 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 123.866 0.866 . . . . 0.0 110.164 -163.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -136.98 140.85 42.47 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.349 1.06 . . . . 0.0 110.912 176.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 83.9 mt -128.11 122.11 57.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 125.829 1.652 . . . . 0.0 109.42 179.121 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 44.7 42.32 5.75 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 125.432 1.493 . . . . 0.0 114.203 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 86.27 -4.63 85.84 Favored Glycine 0 CA--C 1.541 1.713 0 C-N-CA 125.077 1.323 . . . . 0.0 116.219 -177.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -102.49 135.19 44.56 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.654 1.727 . . . . 0.0 111.479 -176.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -73.9 144.26 45.43 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.8 0.84 . . . . 0.0 112.378 178.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 32.2 mm -122.22 127.42 75.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 127.384 2.274 . . . . 0.0 107.995 177.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.81 -5.89 27.46 Favored Glycine 0 CA--C 1.536 1.37 0 N-CA-C 118.212 2.045 . . . . 0.0 118.212 -163.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 144.79 -171.85 25.88 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 126.478 1.99 . . . . 0.0 112.752 176.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 11.4 t -61.41 -32.73 72.69 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 122.067 -0.666 . . . . 0.0 112.441 173.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 35.6 t -67.17 -41.11 86.52 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.317 -0.865 . . . . 0.0 111.735 178.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -66.55 -37.15 84.37 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.273 1.029 . . . . 0.0 113.167 171.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 13.8 tp -63.7 -50.73 68.04 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.278 1.431 . . . . 0.0 110.908 177.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -64.46 -37.76 88.66 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 122.963 0.505 . . . . 0.0 110.836 176.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.55 -34.37 76.79 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 121.066 -1.021 . . . . 0.0 112.77 175.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 64.0 mt -70.99 -24.33 62.37 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.028 0.931 . . . . 0.0 113.186 172.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -77.09 -35.02 56.79 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 119.012 0.824 . . . . 0.0 111.946 172.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -69.35 -29.28 67.04 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.942 0.897 . . . . 0.0 112.906 169.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -81.76 -3.13 53.03 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 169.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.8 14.85 63.66 Favored Glycine 0 CA--C 1.541 1.675 0 CA-C-N 120.11 1.323 . . . . 0.0 114.72 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 34.3 mtpt -100.51 -29.31 12.43 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 126.472 1.909 . . . . 0.0 112.189 -171.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 46.3 tp -58.68 -39.6 81.18 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 118.718 0.69 . . . . 0.0 111.937 177.172 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -55.97 -48.46 75.77 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.499 0.72 . . . . 0.0 112.579 174.086 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -76.86 -37.97 32.28 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 123.884 0.754 . . . . 0.0 113.957 -177.043 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 69.3 mt -58.52 -26.41 63.47 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.767 1.227 . . . . 0.0 112.056 169.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 81.8 mt -103.95 16.77 25.54 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.324 1.45 . . . . 0.0 114.135 176.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 62.4 m . . . . . 0 C--O 1.252 1.229 0 C-N-CA 124.63 1.172 . . . . 0.0 111.989 172.899 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.14 0 N-CA-C 111.355 -0.698 . . . . 0.0 111.355 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 49.55 40.73 20.0 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 125.821 1.648 . . . . 0.0 114.836 -177.081 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 48.0 mtt -130.41 85.34 56.78 Favored Pre-proline 0 N--CA 1.474 0.74 0 C-N-CA 125.236 1.414 . . . . 0.0 111.529 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -81.7 59.1 7.07 Favored 'Trans proline' 0 CA--C 1.545 1.04 0 C-N-CA 123.066 2.511 . . . . 0.0 111.904 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 75.3 m -150.75 -159.65 1.06 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 126.765 2.026 . . . . 0.0 110.6 171.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.8 pt -55.76 -26.2 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 125.585 1.554 . . . . 0.0 115.13 -162.172 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -54.03 -32.15 53.52 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.591 1.557 . . . . 0.0 113.241 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 47.6 t -71.7 -34.15 69.38 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.096 1.358 . . . . 0.0 112.452 174.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 52.0 mtt -68.68 -34.32 75.48 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.346 1.058 . . . . 0.0 112.255 178.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.6 mm -59.48 -27.67 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 124.267 1.027 . . . . 0.0 111.679 -176.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 26.9 mttm -82.58 -8.08 59.62 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.034 1.734 . . . . 0.0 114.58 178.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -80.89 -17.78 71.68 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 124.005 0.812 . . . . 0.0 114.862 -175.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 22.3 m120 -149.53 164.92 33.74 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 127.087 2.155 . . . . 0.0 110.392 -177.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 30.7 ttpt -65.95 -47.42 74.71 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.235 0.614 . . . . 0.0 112.338 173.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.5 t -115.63 129.8 71.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.366 1.067 . . . . 0.0 110.621 176.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 60.3 t -133.51 131.6 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 124.806 1.243 . . . . 0.0 109.568 178.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 60.5 t -134.17 154.32 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 123.82 0.848 . . . . 0.0 111.736 -170.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -129.45 121.54 27.5 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.975 1.31 . . . . 0.0 110.488 175.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 67.2 m -140.93 172.27 12.92 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.354 1.062 . . . . 0.0 113.764 -162.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.447 ' CD1' ' HB3' ' A' ' 46' ' ' ASP . 45.7 m0 -120.73 128.91 53.36 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.944 1.298 . . . . 0.0 110.534 168.419 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 71.2 t -62.66 -23.32 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 CA-C-N 119.245 0.93 . . . . 0.0 111.854 175.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 51.3 p -72.62 -13.03 61.28 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 116.067 1.877 . . . . 0.0 116.067 -175.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 57.6 m -124.39 149.81 62.43 Favored Pre-proline 0 CA--C 1.551 1.015 0 N-CA-C 116.164 1.913 . . . . 0.0 116.164 -162.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -74.52 -36.72 2.79 Favored 'Trans proline' 0 C--N 1.356 0.947 0 C-N-CA 122.3 2.0 . . . . 0.0 114.317 -166.24 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -52.06 -41.09 62.07 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.274 1.43 . . . . 0.0 112.141 173.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 5.2 m -86.34 -13.4 46.62 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 113.056 -1.884 . . . . 0.0 111.587 -166.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 95.9 t -77.36 -54.41 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 124.487 1.115 . . . . 0.0 110.839 155.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -72.91 -26.89 61.57 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 115.643 1.72 . . . . 0.0 115.643 -166.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -77.6 -50.22 12.98 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 119.175 0.898 . . . . 0.0 109.656 173.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.19 -36.17 79.16 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.177 0.991 . . . . 0.0 111.987 -176.422 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -60.97 -47.06 88.2 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.484 0.714 . . . . 0.0 112.521 172.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.2 tt -69.0 -38.24 79.17 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.672 1.589 . . . . 0.0 111.695 -179.126 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 81.7 mt -62.48 -48.14 80.88 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.496 0.719 . . . . 0.0 110.772 173.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 11.6 m-70 -63.61 -30.91 71.96 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 172.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -67.32 -26.98 66.77 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 120.783 -1.198 . . . . 0.0 112.022 174.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -94.09 -35.87 12.35 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.009 1.724 . . . . 0.0 114.701 -173.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 14.0 t -153.16 158.08 41.27 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.19 0.996 . . . . 0.0 113.648 -172.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 36.4 mtmt -91.67 -10.78 39.03 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.206 1.402 . . . . 0.0 112.55 163.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -84.76 40.07 0.78 Allowed 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 124.335 1.054 . . . . 0.0 113.591 -173.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.63 131.88 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 125.437 1.495 . . . . 0.0 113.768 -170.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.7 m -123.82 139.77 53.64 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 126.996 2.118 . . . . 0.0 110.048 175.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.3 p -139.72 125.35 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 124.724 1.21 . . . . 0.0 112.749 178.163 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 8.3 t60 -94.25 126.25 39.39 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.587 0.755 . . . . 0.0 110.895 174.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -89.75 97.25 11.08 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 123.387 0.675 . . . . 0.0 109.307 178.005 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 19.9 m -75.45 -12.32 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-O 119.021 -0.514 . . . . 0.0 112.386 -174.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.447 ' HB3' ' CD1' ' A' ' 20' ' ' TRP . 0.4 OUTLIER -69.33 -15.26 63.29 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.785 1.234 . . . . 0.0 113.248 174.765 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -82.99 -19.1 37.67 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 127.289 2.236 . . . . 0.0 112.448 176.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 58.8 mmm 59.3 18.53 6.75 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 127.592 2.357 . . . . 0.0 116.932 160.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.1 t -61.74 -40.21 94.27 Favored 'General case' 0 N--CA 1.48 1.034 0 O-C-N 119.915 -1.74 . . . . 0.0 111.251 170.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -138.86 0.34 1.97 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.489 1.516 . . . . 0.0 112.414 167.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -48.45 -33.3 11.49 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.786 1.66 . . . . 0.0 116.526 -174.114 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -69.69 -37.5 76.63 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 119.996 1.898 . . . . 0.0 110.647 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -76.74 -30.02 56.41 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 121.777 -0.577 . . . . 0.0 111.576 179.002 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -70.78 -45.57 64.48 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.272 0.629 . . . . 0.0 110.787 172.557 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -57.65 -38.73 75.56 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.203 1.801 . . . . 0.0 111.503 171.426 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.37 -41.5 94.46 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 124.303 0.954 . . . . 0.0 113.438 175.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -58.04 -43.64 86.95 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 119.214 1.507 . . . . 0.0 112.408 173.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 77.1 mt -64.35 -45.93 94.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.15 0.98 . . . . 0.0 110.328 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -66.75 -41.08 88.38 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.636 -0.665 . . . . 0.0 112.004 176.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -66.75 -25.23 66.39 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 120.774 -1.204 . . . . 0.0 113.337 177.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -92.61 -39.42 11.33 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 119.534 1.061 . . . . 0.0 113.516 178.347 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -128.39 0.81 5.67 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.669 1.188 . . . . 0.0 114.161 -167.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 48.79 43.3 21.07 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 126.782 2.033 . . . . 0.0 113.258 -176.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 63.7 t-80 -131.82 141.6 49.49 Favored 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 125.701 1.6 . . . . 0.0 111.446 -176.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -142.5 -13.92 0.77 Allowed 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 -164.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 51.3 m -70.99 150.07 46.02 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.097 1.359 . . . . 0.0 111.069 167.08 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 10.5 m -122.46 152.99 62.2 Favored Pre-proline 0 N--CA 1.477 0.894 0 C-N-CA 126.0 1.72 . . . . 0.0 112.599 -175.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -73.03 154.45 99.56 Favored 'Cis proline' 0 C--N 1.35 0.652 0 CA-C-N 119.126 0.724 . . . . 0.0 113.815 -2.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -107.27 129.42 54.89 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.019 1.328 . . . . 0.0 108.613 167.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 98.5 mt -124.27 142.86 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 123.646 0.779 . . . . 0.0 109.981 -162.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -136.27 139.16 42.47 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.803 0.841 . . . . 0.0 111.795 179.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 62.4 mt -131.71 116.25 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 124.85 1.26 . . . . 0.0 109.75 179.243 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 45.43 39.04 4.18 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 126.015 1.726 . . . . 0.0 113.847 -173.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 79.95 12.31 83.55 Favored Glycine 0 CA--C 1.539 1.559 0 N-CA-C 116.403 1.321 . . . . 0.0 116.403 -176.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -103.36 137.92 40.82 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 119.549 1.674 . . . . 0.0 110.691 172.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -85.93 131.0 34.38 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 -176.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 15.3 mm -116.27 125.29 73.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 128.506 2.722 . . . . 0.0 108.561 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -69.23 -15.74 70.32 Favored Glycine 0 CA--C 1.537 1.421 0 N-CA-C 117.407 1.723 . . . . 0.0 117.407 -165.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 149.54 -165.29 29.54 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-N 118.847 1.323 . . . . 0.0 115.36 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 32.2 t -65.17 -37.56 87.77 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.355 1.062 . . . . 0.0 112.563 -175.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 72.6 p -74.39 -15.62 60.92 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 178.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -87.34 -43.17 12.34 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.667 1.187 . . . . 0.0 110.598 166.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 51.7 tp -59.41 -47.9 83.68 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.571 1.149 . . . . 0.0 111.872 177.141 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -74.75 -11.78 60.24 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.804 0.842 . . . . 0.0 112.968 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -78.79 -46.84 17.91 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.117 0.967 . . . . 0.0 111.516 163.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 88.5 mt -61.17 -28.98 69.52 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.286 1.035 . . . . 0.0 112.85 175.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -64.48 -52.89 55.61 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.405 1.082 . . . . 0.0 112.093 169.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 6.9 mptt -71.14 -30.77 66.89 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.725 1.21 . . . . 0.0 112.546 -173.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -82.56 -1.94 52.18 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.29 1.036 . . . . 0.0 113.452 169.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 73.84 8.11 76.84 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 124.727 1.156 . . . . 0.0 115.759 174.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 47.5 mtmt -82.18 -29.6 31.4 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 127.639 2.376 . . . . 0.0 112.453 -172.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 36.8 tp -52.39 -36.23 53.58 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.603 1.161 . . . . 0.0 112.169 175.162 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -73.88 -36.17 64.77 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -67.94 -29.5 73.62 Favored Glycine 0 CA--C 1.536 1.379 0 O-C-N 120.818 -1.176 . . . . 0.0 113.325 170.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 89.3 mt -74.96 -23.63 58.32 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.621 1.168 . . . . 0.0 112.582 173.095 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 81.0 mt -95.58 -2.2 48.84 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.853 1.661 . . . . 0.0 114.869 174.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 39.7 m . . . . . 0 C--O 1.252 1.206 0 C-N-CA 126.028 1.731 . . . . 0.0 114.289 -175.603 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.103 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.76 27.73 0.62 Allowed 'General case' 0 CA--C 1.552 1.029 0 N-CA-C 114.84 1.422 . . . . 0.0 114.84 -176.094 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 43.9 ttp -121.49 86.06 43.84 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 125.538 1.535 . . . . 0.0 108.821 174.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -81.18 -171.58 1.27 Allowed 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 123.91 3.074 . . . . 0.0 114.516 -161.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 61.4 m -80.61 -151.81 0.08 Allowed 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 126.541 1.937 . . . . 0.0 111.178 167.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.6 pt -56.17 -19.71 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 N-CA-C 116.083 1.883 . . . . 0.0 116.083 -161.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -49.7 -30.19 8.81 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.584 1.554 . . . . 0.0 113.005 175.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 45.4 p -70.04 -38.05 75.74 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.087 0.955 . . . . 0.0 112.998 173.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 54.5 mtt -66.56 -32.41 73.74 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.599 1.56 . . . . 0.0 111.493 -174.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.6 mm -57.62 -33.81 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 123.919 0.888 . . . . 0.0 111.249 176.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 46.9 mttm -81.3 -9.22 59.8 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.054 1.342 . . . . 0.0 113.215 -173.126 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -75.69 -27.04 63.76 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 124.264 0.935 . . . . 0.0 115.201 -173.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -145.7 165.83 27.61 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.714 1.605 . . . . 0.0 112.606 179.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -63.09 -38.18 90.16 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.946 0.898 . . . . 0.0 113.128 178.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.5 t -125.26 129.58 73.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.864 1.266 . . . . 0.0 111.007 175.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 58.5 t -133.26 129.79 57.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.552 1.141 . . . . 0.0 110.559 -179.065 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 42.4 t -128.69 147.65 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.202 1.001 . . . . 0.0 112.337 -177.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -118.15 123.86 46.57 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.572 1.149 . . . . 0.0 109.802 170.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.8 m -140.63 177.71 7.84 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 126.328 1.851 . . . . 0.0 112.458 -165.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 37.7 m0 -123.54 136.87 54.78 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.645 1.978 . . . . 0.0 107.016 159.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 82.3 t -54.22 -31.69 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 C-N-CA 125.763 1.625 . . . . 0.0 113.64 -165.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.7 t -105.62 -5.12 20.35 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 114.865 1.432 . . . . 0.0 114.865 -165.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 71.8 m -90.24 141.93 28.07 Favored Pre-proline 0 C--O 1.234 0.249 0 O-C-N 121.651 -0.655 . . . . 0.0 111.268 -165.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -70.82 -36.82 7.4 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 CA-C-N 119.114 0.719 . . . . 0.0 112.769 -160.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -59.91 -38.26 81.8 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 127.783 2.433 . . . . 0.0 114.207 174.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 1.6 t -59.12 -49.55 77.46 Favored 'General case' 0 C--O 1.222 -0.352 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 173.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 52.8 t -63.47 -40.42 88.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 123.948 0.899 . . . . 0.0 111.451 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -56.12 -46.11 79.27 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 118.789 0.722 . . . . 0.0 111.916 175.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.98 -55.47 9.53 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.658 0.783 . . . . 0.0 111.692 177.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -42.28 -48.56 4.99 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 126.739 2.016 . . . . 0.0 111.755 178.332 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.408 ' HE3' ' HB3' ' A' ' 31' ' ' LYS . 16.9 ttpp -76.07 -27.31 57.17 Favored 'General case' 0 C--O 1.225 -0.23 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 -171.482 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.1 tt -79.24 -38.18 36.23 Favored 'General case' 0 C--N 1.317 -0.825 0 O-C-N 121.257 -0.902 . . . . 0.0 111.133 173.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 17.8 mt -67.45 -59.71 3.16 Favored 'General case' 0 CA--C 1.514 -0.415 0 C-N-CA 125.867 1.667 . . . . 0.0 112.956 -176.028 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 3.0 p-80 -52.61 -28.93 23.36 Favored 'General case' 0 C--O 1.233 0.188 0 O-C-N 124.173 0.921 . . . . 0.0 110.217 176.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.0 -14.27 47.96 Favored 'General case' 0 N--CA 1.441 -0.876 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.814 -172.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -105.19 -40.47 5.85 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 126.533 1.933 . . . . 0.0 112.612 179.233 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 23.0 m -142.63 128.13 19.02 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.743 1.617 . . . . 0.0 110.807 -175.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 45.2 mtmt -76.5 -23.95 53.74 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.47 1.508 . . . . 0.0 112.768 177.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -79.2 54.26 1.62 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.417 1.087 . . . . 0.0 113.908 175.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.67 139.03 24.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 125.821 1.649 . . . . 0.0 110.872 173.086 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.4 m -127.24 132.72 50.33 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 126.783 2.033 . . . . 0.0 109.306 167.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.7 p -128.02 139.96 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-O 122.238 1.018 . . . . 0.0 113.029 171.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -109.12 119.64 40.12 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.385 1.874 . . . . 0.0 109.405 176.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -91.44 92.05 8.38 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.427 0.691 . . . . 0.0 110.079 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.6 m -77.02 14.65 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 N-CA-C 115.874 1.805 . . . . 0.0 115.874 -162.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -100.69 -20.74 15.48 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 120.693 -1.254 . . . . 0.0 112.252 160.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 23.4 mmmt -71.46 -36.77 71.31 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.146 0.978 . . . . 0.0 111.34 175.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -96.13 142.23 28.56 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.098 0.959 . . . . 0.0 112.885 -167.357 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 16.4 m -69.3 -7.96 41.85 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 115.598 1.703 . . . . 0.0 115.598 -172.508 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -113.46 8.86 17.98 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.978 1.711 . . . . 0.0 113.062 175.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -54.59 -32.51 53.62 Favored Glycine 0 CA--C 1.531 1.063 0 N-CA-C 116.211 1.244 . . . . 0.0 116.211 -173.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -72.92 -29.4 63.1 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 119.169 1.485 . . . . 0.0 112.581 176.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -79.62 -31.26 41.61 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 121.586 -0.696 . . . . 0.0 111.852 174.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.04 -41.91 81.35 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 121.657 -0.652 . . . . 0.0 110.491 170.568 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 59.6 mtp85 -53.89 -45.75 71.16 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 119.344 0.974 . . . . 0.0 111.56 166.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.17 -38.47 93.18 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 124.15 0.881 . . . . 0.0 114.472 178.137 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -68.49 -25.14 64.81 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 119.088 1.444 . . . . 0.0 113.709 176.358 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 57.7 mt -76.88 -45.19 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 123.505 0.722 . . . . 0.0 109.263 173.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -67.42 -36.93 82.22 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 121.525 -0.734 . . . . 0.0 112.66 -178.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -57.57 -51.61 68.8 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 121.403 -0.811 . . . . 0.0 112.12 176.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -81.1 -33.08 33.56 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 114.452 1.278 . . . . 0.0 114.452 -175.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -123.52 -7.53 8.05 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 -166.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.5 mmtm 50.13 47.28 23.77 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 126.824 2.05 . . . . 0.0 112.745 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 17.7 t60 -138.18 136.18 36.37 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 127.082 2.153 . . . . 0.0 109.028 -177.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -123.54 -22.66 4.95 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 -177.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.2 p -68.19 135.17 51.64 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.644 0.778 . . . . 0.0 112.507 -178.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.8 m -88.91 149.06 42.73 Favored Pre-proline 0 N--CA 1.478 0.952 0 N-CA-C 112.519 0.562 . . . . 0.0 112.519 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -83.82 160.73 71.09 Favored 'Cis proline' 0 CA--C 1.537 0.645 0 CA-C-N 119.654 0.912 . . . . 0.0 114.181 -2.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -104.2 142.23 34.88 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.49 1.116 . . . . 0.0 109.479 159.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 56.6 mt -131.76 139.92 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.084 0.954 . . . . 0.0 110.301 -166.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -140.44 145.65 37.26 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.141 0.976 . . . . 0.0 111.964 178.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 70.1 mt -136.73 124.35 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 125.111 1.364 . . . . 0.0 109.307 177.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 47.56 37.93 7.28 Favored 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 124.649 1.18 . . . . 0.0 113.967 -177.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 73.05 11.88 79.14 Favored Glycine 0 CA--C 1.541 1.659 0 O-C-N 120.013 -1.68 . . . . 0.0 115.864 -176.104 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 24.8 m-80 -97.61 143.82 27.9 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.008 1.723 . . . . 0.0 110.032 169.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -89.2 141.51 28.46 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.94 0.896 . . . . 0.0 112.982 176.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 22.4 mm -126.32 122.97 62.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 127.731 2.412 . . . . 0.0 108.331 -179.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.95 -2.72 6.89 Favored Glycine 0 CA--C 1.538 1.501 0 N-CA-C 118.981 2.352 . . . . 0.0 118.981 -166.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 137.45 -166.9 24.92 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 126.934 2.207 . . . . 0.0 112.988 176.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 16.6 t -66.63 -33.48 75.74 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 121.65 -0.912 . . . . 0.0 113.008 -175.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 68.1 m -76.76 -28.7 55.82 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 121.277 -0.89 . . . . 0.0 111.993 178.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.11 -35.71 71.89 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.089 0.859 . . . . 0.0 112.782 167.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 51.6 tp -61.84 -48.64 79.67 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.797 0.839 . . . . 0.0 111.106 170.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -69.83 -13.62 62.36 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.161 0.984 . . . . 0.0 113.305 175.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -82.65 -43.5 16.86 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 121.04 -1.038 . . . . 0.0 111.331 168.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 76.6 mt -66.5 -28.53 68.64 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 120.93 -1.106 . . . . 0.0 113.0 177.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -61.08 -39.51 90.18 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.678 1.591 . . . . 0.0 112.23 168.154 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 5.0 mptt -84.3 -34.33 23.76 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.403 1.481 . . . . 0.0 112.364 -178.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -75.07 -0.9 20.56 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.732 1.213 . . . . 0.0 113.606 174.063 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 75.76 22.23 75.18 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 124.457 1.027 . . . . 0.0 114.51 170.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 35.5 mtmt -113.96 -20.2 11.13 Favored 'General case' 0 C--N 1.341 0.231 0 C-N-CA 126.551 1.94 . . . . 0.0 113.263 -170.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 43.0 tp -60.9 -40.37 92.84 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 118.738 0.699 . . . . 0.0 111.449 178.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -65.2 -42.28 93.71 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 177.189 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -70.7 -26.75 73.53 Favored Glycine 0 CA--C 1.537 1.439 0 C-N-CA 124.323 0.963 . . . . 0.0 114.511 175.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 30.0 mt -71.03 -31.95 68.57 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 118.276 1.038 . . . . 0.0 112.187 172.339 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 85.1 mt -97.85 -27.11 14.44 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 114.487 1.291 . . . . 0.0 114.487 -174.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 56.9 m . . . . . 0 C--O 1.254 1.29 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 -170.964 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.226 0 N-CA-C 113.35 0.1 . . . . 0.0 113.35 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -67.92 151.84 46.49 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.092 1.757 . . . . 0.0 113.633 -178.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 4.6 mpp? 52.16 57.77 15.58 Favored Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 125.652 1.581 . . . . 0.0 112.56 -176.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -72.69 168.19 25.16 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 124.669 3.579 . . . . 0.0 115.435 -165.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 60.0 p -145.84 -154.66 0.56 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.608 1.963 . . . . 0.0 111.448 174.238 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.422 HG23 HD12 ' A' ' 54' ' ' LEU . 19.7 pt -56.35 -19.7 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 124.591 1.156 . . . . 0.0 113.264 170.052 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -58.88 -29.87 67.33 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.686 0.794 . . . . 0.0 112.816 -174.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 67.7 m -68.18 -24.45 64.97 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 173.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 54.4 mtt -72.5 -33.89 67.25 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 121.46 -0.775 . . . . 0.0 111.429 -178.26 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.8 mm -60.29 -30.78 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 123.681 0.792 . . . . 0.0 111.67 -175.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -80.36 -8.75 59.64 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.162 1.385 . . . . 0.0 114.148 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -80.03 -35.55 27.2 Favored Glycine 0 CA--C 1.535 1.292 0 N-CA-C 115.158 0.823 . . . . 0.0 115.158 -173.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 55.5 m-80 -145.08 164.13 32.17 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 118.626 1.213 . . . . 0.0 112.186 -172.057 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 21.7 ttpt -63.89 -42.25 97.52 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.285 1.034 . . . . 0.0 113.111 -178.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.9 t -119.84 130.62 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.251 1.021 . . . . 0.0 110.65 172.059 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 57.0 t -132.88 126.93 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.849 1.26 . . . . 0.0 109.744 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 40.4 t -127.1 149.29 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.129 0.972 . . . . 0.0 112.253 -173.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -123.15 114.4 20.25 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.355 1.462 . . . . 0.0 110.111 175.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.439 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 35.2 m -134.28 173.32 11.74 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.556 1.542 . . . . 0.0 112.754 -167.29 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 47.6 m0 -121.9 143.1 49.64 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.69 1.196 . . . . 0.0 110.237 166.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 76.7 t -65.18 -25.58 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 CA-C-O 120.771 0.32 . . . . 0.0 111.25 177.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.5 p -75.98 -18.49 59.29 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 126.196 1.798 . . . . 0.0 115.599 177.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.8 t -94.89 140.02 22.36 Favored Pre-proline 0 CA--C 1.538 0.501 0 CA-C-N 120.241 1.382 . . . . 0.0 112.571 -163.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -73.91 -37.17 3.0 Favored 'Trans proline' 0 CA--C 1.534 0.496 0 CA-C-N 120.704 1.287 . . . . 0.0 112.008 174.149 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -55.84 -37.66 69.02 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.164 1.386 . . . . 0.0 113.528 176.397 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.439 ' SG ' ' HB3' ' A' ' 19' ' ' SER . 0.5 OUTLIER -55.1 -51.89 64.98 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.192 0.997 . . . . 0.0 109.636 172.759 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.1 t -66.27 -37.53 79.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 123.943 0.897 . . . . 0.0 111.614 -177.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.1 mmt180 -54.06 -42.62 69.46 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 118.787 0.721 . . . . 0.0 112.115 173.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.93 -55.17 7.96 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.007 0.923 . . . . 0.0 112.463 173.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -54.18 -35.05 61.91 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 119.506 1.048 . . . . 0.0 113.398 -177.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.95 -38.25 69.83 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.273 1.029 . . . . 0.0 112.598 -178.34 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.4 tt -74.49 -46.18 41.11 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 126.499 1.92 . . . . 0.0 110.892 178.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 68.0 mt -64.69 -38.21 90.22 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.556 0.742 . . . . 0.0 112.765 -176.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 45.7 m-70 -74.74 -22.07 59.01 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 170.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -73.39 -36.38 66.04 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 119.894 1.225 . . . . 0.0 112.062 172.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 13.5 mmp_? -73.52 -52.64 12.85 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.378 1.471 . . . . 0.0 113.247 175.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.2 p -140.68 166.24 25.29 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 116.167 1.914 . . . . 0.0 116.167 -157.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 71.5 mttt -109.51 -27.74 9.27 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 127.976 2.511 . . . . 0.0 113.108 173.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -84.5 43.55 0.97 Allowed 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 125.205 1.402 . . . . 0.0 112.274 -178.121 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -113.43 129.13 69.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 126.558 1.943 . . . . 0.0 111.982 178.309 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.9 m -122.3 141.83 51.11 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 126.644 1.978 . . . . 0.0 111.169 174.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.4 p -135.72 136.27 50.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 124.441 1.096 . . . . 0.0 113.232 178.328 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 38.6 t60 -105.48 122.4 45.92 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.957 2.103 . . . . 0.0 109.752 175.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -92.22 89.12 6.74 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 123.689 0.796 . . . . 0.0 108.986 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 35.7 m -65.2 -18.69 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -175.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -55.88 -43.13 76.88 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.409 1.484 . . . . 0.0 111.572 164.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 34.1 mtmt -86.68 7.87 24.79 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 127.188 2.195 . . . . 0.0 113.756 179.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -114.68 129.9 56.74 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.192 1.397 . . . . 0.0 110.229 178.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 11.8 p -64.52 -20.24 66.09 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 115.753 1.76 . . . . 0.0 115.753 -170.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -113.95 8.4 17.17 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.502 1.921 . . . . 0.0 112.389 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -51.95 -25.19 16.04 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 125.807 1.67 . . . . 0.0 116.896 -168.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -69.05 -27.94 66.1 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 118.947 1.373 . . . . 0.0 112.853 174.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -80.48 -25.56 38.74 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 120.573 -1.33 . . . . 0.0 112.083 172.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.422 HD12 HG23 ' A' ' 6' ' ' ILE . 2.7 mm? -79.72 -32.65 41.21 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.722 0.809 . . . . 0.0 111.883 174.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 55.4 mtp180 -52.79 -43.32 65.8 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 119.119 0.872 . . . . 0.0 110.769 158.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.56 -35.78 89.96 Favored Glycine 0 CA--C 1.539 1.557 0 CA-C-O 118.972 -0.904 . . . . 0.0 115.21 173.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -63.47 -31.84 73.11 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 119.828 1.814 . . . . 0.0 112.914 176.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 65.2 mt -79.57 -45.73 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 C-N-CA 125.806 1.642 . . . . 0.0 109.608 175.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -64.77 -41.21 96.05 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.458 -0.776 . . . . 0.0 112.483 -178.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 76.6 mm-40 -72.14 -16.11 61.99 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 120.898 -1.126 . . . . 0.0 113.617 177.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -89.88 -41.49 11.77 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 169.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -135.0 0.43 2.88 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 115.329 1.603 . . . . 0.0 115.329 -163.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp 55.55 26.0 8.57 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 126.402 1.881 . . . . 0.0 115.513 177.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 37.2 t60 -114.96 140.03 49.35 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.391 1.077 . . . . 0.0 111.196 167.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -125.79 -27.42 3.35 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.167 0.987 . . . . 0.0 112.644 -163.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.2 p -85.96 144.09 27.81 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.474 1.11 . . . . 0.0 113.907 -178.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.3 m -89.35 153.76 48.62 Favored Pre-proline 0 N--CA 1.481 1.087 0 C-N-CA 125.017 1.327 . . . . 0.0 113.292 -173.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -79.49 158.08 89.75 Favored 'Cis proline' 0 C--N 1.349 0.577 0 CA-C-N 119.441 0.836 . . . . 0.0 113.4 -3.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -109.55 136.84 48.29 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.089 1.356 . . . . 0.0 108.709 162.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.9 mt -126.21 144.27 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 124.243 1.017 . . . . 0.0 109.444 -169.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -137.53 143.94 41.88 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.23 1.012 . . . . 0.0 110.967 177.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 48.9 mt -135.3 118.47 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.879 1.272 . . . . 0.0 109.059 179.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 47.44 43.78 15.95 Favored 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 125.023 1.329 . . . . 0.0 113.831 -175.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.18 1.17 59.46 Favored Glycine 0 CA--C 1.544 1.893 0 O-C-N 120.709 -1.245 . . . . 0.0 116.015 -176.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -92.26 134.84 34.51 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.223 1.409 . . . . 0.0 109.759 175.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -84.33 137.7 33.29 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.897 0.879 . . . . 0.0 112.831 -178.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 36.0 mm -118.1 122.84 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 127.662 2.385 . . . . 0.0 108.538 177.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.37 -6.19 39.52 Favored Glycine 0 CA--C 1.536 1.371 0 N-CA-C 118.252 2.061 . . . . 0.0 118.252 -162.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 152.91 -174.53 31.68 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 125.851 1.691 . . . . 0.0 112.99 176.272 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 12.8 t -65.32 -31.53 72.72 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.975 -0.721 . . . . 0.0 112.373 177.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 12.5 m -69.01 -32.63 72.32 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.732 -0.605 . . . . 0.0 111.829 -177.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -76.41 -40.65 50.26 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.122 1.369 . . . . 0.0 112.458 170.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 56.9 tp -59.48 -45.27 92.13 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.334 1.054 . . . . 0.0 111.488 175.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -64.92 -37.66 88.39 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.822 0.849 . . . . 0.0 111.35 173.019 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.45 -23.58 66.31 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 120.914 -1.116 . . . . 0.0 113.223 177.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 40.3 mt -84.69 -32.33 23.64 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.038 1.735 . . . . 0.0 112.709 170.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -67.46 -46.92 71.61 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.154 0.982 . . . . 0.0 112.38 175.079 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.2 mptt -62.25 -42.24 99.16 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.796 1.238 . . . . 0.0 111.772 178.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -76.16 -6.75 52.68 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 176.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 72.21 22.88 78.69 Favored Glycine 0 CA--C 1.535 1.293 0 CA-C-N 119.375 0.989 . . . . 0.0 114.88 174.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 40.7 mtmt -102.37 -14.21 17.0 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 127.995 2.518 . . . . 0.0 112.381 -172.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 30.5 tp -64.75 -31.75 73.12 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.047 1.739 . . . . 0.0 112.067 175.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -57.0 -46.28 82.41 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.703 -0.623 . . . . 0.0 112.281 174.111 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -66.39 -27.61 73.19 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 123.918 0.77 . . . . 0.0 113.677 176.014 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 83.3 mt -76.74 -26.11 54.24 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.475 1.11 . . . . 0.0 113.416 174.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 84.9 mt -102.93 -9.65 19.67 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 115.602 1.704 . . . . 0.0 115.602 -172.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 16.1 m . . . . . 0 N--CA 1.486 1.365 0 C-N-CA 127.25 2.22 . . . . 0.0 115.642 167.81 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.119 0 N-CA-C 111.526 -0.629 . . . . 0.0 111.526 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 51.3 -153.78 0.17 Allowed 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 126.752 2.021 . . . . 0.0 114.739 176.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -122.9 145.87 46.83 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 125.037 1.335 . . . . 0.0 110.485 173.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -80.17 71.99 6.76 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 124.032 3.154 . . . . 0.0 110.33 175.274 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 54.5 p -158.22 -167.15 2.11 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.035 1.734 . . . . 0.0 110.222 179.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.522 HG23 HD12 ' A' ' 54' ' ' LEU . 14.0 pt -45.33 -28.64 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 124.846 1.259 . . . . 0.0 113.115 168.274 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -57.13 -33.32 67.26 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 25.9 m -84.34 -20.08 32.62 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 175.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 45.1 mtt -68.39 -28.05 66.76 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 119.639 1.108 . . . . 0.0 112.063 173.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.491 HG21 ' HA2' ' A' ' 74' ' ' GLY . 83.8 mt -67.17 -22.4 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 CA-C-O 122.457 1.122 . . . . 0.0 112.165 -171.25 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -82.55 3.63 27.8 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.354 1.861 . . . . 0.0 114.482 174.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -87.87 -13.62 64.3 Favored Glycine 0 CA--C 1.541 1.682 0 C-N-CA 125.153 1.358 . . . . 0.0 116.365 -178.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -156.87 175.78 13.62 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 119.285 1.543 . . . . 0.0 112.318 177.379 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -72.61 -33.33 66.6 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 121.805 -0.56 . . . . 0.0 112.234 174.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.4 t -125.72 130.18 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 124.894 1.278 . . . . 0.0 110.151 173.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 62.1 t -131.49 130.49 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 123.842 0.857 . . . . 0.0 110.636 178.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 47.0 t -130.43 148.11 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.321 1.048 . . . . 0.0 112.277 -170.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -126.18 113.67 17.32 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.917 1.287 . . . . 0.0 110.097 177.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 59.8 m -132.25 167.32 20.03 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 126.0 1.72 . . . . 0.0 111.879 -166.448 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.463 ' CD1' ' HB3' ' A' ' 46' ' ' ASP . 34.6 m0 -117.66 126.12 51.93 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.763 1.225 . . . . 0.0 109.389 166.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 89.3 t -56.42 -39.61 62.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -166.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.7 t -74.87 -12.57 60.4 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 127.66 2.384 . . . . 0.0 115.716 -179.069 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.9 t -88.6 139.51 29.72 Favored Pre-proline 0 CA--C 1.539 0.523 0 O-C-N 121.395 -0.816 . . . . 0.0 110.87 -165.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -66.75 -38.25 18.45 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 CA-C-N 120.327 1.152 . . . . 0.0 112.943 -178.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 51.9 m-85 -62.24 -36.72 82.87 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.263 1.425 . . . . 0.0 114.225 178.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -56.13 -54.49 44.51 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.3 1.04 . . . . 0.0 108.989 169.415 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 73.2 t -62.74 -37.5 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 124.291 1.037 . . . . 0.0 112.388 -178.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 71.0 mmt-85 -52.95 -45.94 67.95 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 119.205 0.911 . . . . 0.0 112.001 172.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.75 -53.26 10.72 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.885 0.874 . . . . 0.0 112.113 178.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -59.32 -25.57 64.28 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -177.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -71.44 -46.39 60.17 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.637 0.775 . . . . 0.0 112.615 173.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.7 tt -74.26 -38.32 63.48 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.59 1.556 . . . . 0.0 111.808 -177.017 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 87.0 mt -63.56 -46.5 85.63 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.073 0.549 . . . . 0.0 111.047 178.037 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -64.32 -22.6 67.01 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 172.103 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -80.9 -17.2 51.41 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 176.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 10.6 mmt180 -131.94 -10.27 3.43 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 117.078 2.251 . . . . 0.0 117.078 -168.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 14.9 t -152.54 155.8 38.12 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 170.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 8.8 mptt -105.91 0.82 26.18 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.385 1.474 . . . . 0.0 112.722 166.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -105.07 40.76 1.45 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.536 1.535 . . . . 0.0 112.411 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -113.88 141.63 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 126.199 1.8 . . . . 0.0 111.695 177.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.9 m -129.33 129.39 44.76 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 127.363 2.265 . . . . 0.0 109.29 172.278 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -121.32 136.49 58.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 125.027 1.331 . . . . 0.0 112.784 172.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -108.99 130.97 55.49 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 125.295 1.438 . . . . 0.0 110.569 173.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -97.81 94.43 6.91 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.708 -0.62 . . . . 0.0 110.821 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.8 m -73.77 -6.59 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -176.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.463 ' HB3' ' CD1' ' A' ' 20' ' ' TRP . 0.0 OUTLIER -80.73 -19.28 45.34 Favored 'General case' 0 CA--C 1.545 0.766 0 O-C-N 121.15 -0.969 . . . . 0.0 112.004 169.161 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 39.9 mtmt -95.96 11.07 35.25 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 127.468 2.307 . . . . 0.0 113.772 175.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 12.8 ttt -125.32 128.78 48.74 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 127.584 2.353 . . . . 0.0 110.502 -167.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 25.8 m -68.49 -36.7 79.31 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.972 0.909 . . . . 0.0 113.232 -176.057 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.4 mp0 -84.7 -0.58 54.08 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.845 1.258 . . . . 0.0 113.289 173.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -56.35 -24.44 45.4 Favored Glycine 0 CA--C 1.535 1.321 0 O-C-N 120.471 -1.393 . . . . 0.0 115.879 -169.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 60.7 mt-10 -73.58 -28.71 61.98 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 118.714 1.257 . . . . 0.0 112.649 174.017 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -74.42 -37.24 63.38 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 120.908 -1.12 . . . . 0.0 111.403 172.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.522 HD12 HG23 ' A' ' 6' ' ' ILE . 3.0 mm? -69.56 -32.1 70.68 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.77 0.828 . . . . 0.0 112.765 173.258 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 60.6 mtp180 -56.16 -38.17 70.53 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 120.004 1.274 . . . . 0.0 111.511 164.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -64.1 -38.4 95.93 Favored Glycine 0 CA--C 1.539 1.546 0 CA-C-O 118.744 -1.031 . . . . 0.0 114.176 169.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -61.5 -29.55 70.05 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 119.988 1.894 . . . . 0.0 113.06 173.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 38.6 mt -77.38 -46.78 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 118.549 0.613 . . . . 0.0 109.973 171.231 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -65.83 -42.18 90.86 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 120.868 -1.145 . . . . 0.0 113.183 -175.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -73.92 -9.83 59.04 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -178.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -108.04 -32.98 7.32 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.705 1.202 . . . . 0.0 114.197 173.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -133.4 -0.11 3.29 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 114.879 1.437 . . . . 0.0 114.879 -171.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.5 mptt 48.02 51.94 13.81 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 126.033 1.733 . . . . 0.0 113.256 -177.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 33.9 t-80 -134.79 131.75 37.89 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.251 1.42 . . . . 0.0 110.587 175.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -135.82 11.94 3.4 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 126.193 1.797 . . . . 0.0 112.595 -166.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.447 HG22 ' H ' ' A' ' 67' ' ' VAL . 0.3 OUTLIER -106.59 -172.04 2.01 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 126.438 1.895 . . . . 0.0 110.266 173.414 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.447 ' H ' HG22 ' A' ' 66' ' ' THR . 21.4 m -137.93 158.47 71.3 Favored Pre-proline 0 N--CA 1.48 1.026 0 O-C-N 120.53 -1.356 . . . . 0.0 113.025 175.651 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -71.77 155.08 97.95 Favored 'Cis proline' 0 C--N 1.348 0.548 0 CA-C-N 118.486 0.495 . . . . 0.0 112.673 -11.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -102.57 134.01 46.62 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.437 1.095 . . . . 0.0 108.391 161.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 46.9 mt -128.59 141.39 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 123.542 0.737 . . . . 0.0 109.916 -165.156 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -137.95 145.56 42.17 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.983 0.913 . . . . 0.0 112.102 179.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 64.7 mt -130.28 114.06 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.214 1.405 . . . . 0.0 108.675 174.287 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 49.91 41.53 22.92 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.0 1.32 . . . . 0.0 113.951 -172.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.491 ' HA2' HG21 ' A' ' 10' ' ' ILE . . . 75.31 4.11 72.76 Favored Glycine 0 CA--C 1.54 1.651 0 O-C-N 120.606 -1.309 . . . . 0.0 115.128 -178.643 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -97.07 133.98 41.02 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.157 1.383 . . . . 0.0 109.896 173.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -83.31 146.61 28.42 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.694 1.198 . . . . 0.0 113.691 -170.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 28.6 mm -130.56 120.3 47.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 128.365 2.666 . . . . 0.0 108.131 -178.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.11 -9.87 43.87 Favored Glycine 0 CA--C 1.534 1.28 0 N-CA-C 119.084 2.393 . . . . 0.0 119.084 -163.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 158.13 -175.35 35.34 Favored Glycine 0 CA--C 1.532 1.127 0 CA-C-N 118.936 1.368 . . . . 0.0 113.766 176.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 30.1 t -65.65 -37.66 87.16 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.97 -0.724 . . . . 0.0 112.474 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 66.5 m -70.47 -32.14 69.55 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.436 -0.79 . . . . 0.0 112.097 177.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -68.62 -41.37 79.61 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.363 0.983 . . . . 0.0 112.108 172.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 15.1 tp -58.45 -50.92 71.99 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.731 1.612 . . . . 0.0 110.843 173.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -64.37 -36.32 83.75 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.934 -0.479 . . . . 0.0 112.056 175.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.04 -34.56 77.98 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 121.147 -0.971 . . . . 0.0 111.824 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 92.4 mt -70.78 -31.19 67.88 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.815 0.846 . . . . 0.0 112.052 169.121 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -69.45 -39.1 77.96 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 176.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -63.79 -32.96 74.63 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.986 0.914 . . . . 0.0 112.59 174.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -75.51 -13.03 60.35 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 114.29 1.218 . . . . 0.0 114.29 169.106 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 78.74 6.32 88.43 Favored Glycine 0 CA--C 1.538 1.494 0 CA-C-N 118.84 0.746 . . . . 0.0 114.078 -173.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 35.4 mtpt -81.66 -27.65 33.96 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 126.823 2.049 . . . . 0.0 112.15 -171.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 59.2 tp -64.78 -43.73 92.27 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.081 0.952 . . . . 0.0 111.559 172.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 -59.07 -34.89 72.48 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.788 -0.57 . . . . 0.0 111.622 177.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -77.11 -18.71 78.21 Favored Glycine 0 CA--C 1.536 1.354 0 N-CA-C 115.605 1.002 . . . . 0.0 115.605 175.37 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 39.0 mt -81.61 -35.57 29.92 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.965 1.306 . . . . 0.0 111.533 168.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 84.2 mt -72.76 -3.28 24.33 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.386 1.474 . . . . 0.0 113.893 177.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.1 t . . . . . 0 C--O 1.252 1.217 0 C-N-CA 127.454 2.301 . . . . 0.0 112.333 177.492 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.012 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.63 159.43 21.96 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 -171.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 34.7 ttp 54.9 64.77 5.56 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 127.384 2.273 . . . . 0.0 113.059 -168.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -71.09 -26.19 21.71 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 123.075 2.517 . . . . 0.0 114.299 -173.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 53.8 p -164.08 -170.27 2.07 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 127.314 2.246 . . . . 0.0 111.579 166.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.571 HG23 HD12 ' A' ' 54' ' ' LEU . 23.5 pt -59.47 -23.94 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 123.846 0.859 . . . . 0.0 113.295 174.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.52 -32.62 72.67 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 118.244 0.474 . . . . 0.0 111.944 -175.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 83.4 p -69.26 -33.59 73.48 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.729 1.212 . . . . 0.0 113.319 170.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 43.3 mtt -67.19 -31.39 71.76 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.023 0.929 . . . . 0.0 111.516 -178.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.3 mm -56.47 -35.87 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 123.592 0.757 . . . . 0.0 111.834 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -73.61 -19.01 60.98 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.08 0.952 . . . . 0.0 113.263 -175.074 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -77.79 -26.92 59.7 Favored Glycine 0 CA--C 1.533 1.202 0 N-CA-C 115.998 1.159 . . . . 0.0 115.998 -166.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 26.7 m-80 -134.69 172.32 13.12 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.896 1.278 . . . . 0.0 111.993 -177.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -70.03 -40.72 75.01 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.233 1.013 . . . . 0.0 112.208 178.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.0 t -128.37 136.36 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 124.774 1.23 . . . . 0.0 110.172 174.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 43.5 t -132.7 130.34 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.4 1.08 . . . . 0.0 109.997 176.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 37.6 t -127.93 145.92 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 124.279 1.032 . . . . 0.0 111.94 -176.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -120.35 116.51 25.65 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.894 1.278 . . . . 0.0 108.54 172.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 14.7 m -130.64 169.14 16.02 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.911 1.684 . . . . 0.0 111.492 -169.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.412 ' CD1' ' HB3' ' A' ' 46' ' ' ASP . 25.6 m0 -115.59 135.88 53.63 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.197 0.999 . . . . 0.0 108.975 162.295 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.421 HG21 ' HE2' ' A' ' 47' ' ' LYS . 54.9 t -58.28 -28.54 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 CA-C-O 121.295 0.569 . . . . 0.0 111.071 176.143 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.7 p -82.72 -6.87 59.61 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 116.284 1.957 . . . . 0.0 116.284 178.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.9 t -92.47 140.15 24.03 Favored Pre-proline 0 CA--C 1.544 0.717 0 CA-C-N 120.55 1.523 . . . . 0.0 111.339 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -75.13 -34.75 3.48 Favored 'Trans proline' 0 CA--C 1.534 0.489 0 C-N-CA 121.855 1.704 . . . . 0.0 112.871 173.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -59.29 -38.12 79.4 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.611 1.164 . . . . 0.0 113.408 176.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -49.98 -52.65 32.09 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.288 1.035 . . . . 0.0 109.746 171.027 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 57.5 t -63.29 -40.46 89.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 124.005 0.922 . . . . 0.0 111.63 -176.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 37.0 mmt-85 -53.98 -48.74 70.05 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 118.997 0.817 . . . . 0.0 111.098 175.196 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.34 -54.14 23.28 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.896 0.878 . . . . 0.0 112.455 177.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -48.94 -40.48 30.39 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.544 1.138 . . . . 0.0 113.142 178.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.05 -45.22 58.76 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 124.676 1.19 . . . . 0.0 112.154 -175.055 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.9 tt -68.72 -41.1 79.51 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.538 1.535 . . . . 0.0 111.558 176.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 63.0 mt -63.02 -46.46 87.5 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 123.282 0.633 . . . . 0.0 111.197 175.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -64.81 -20.11 66.21 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 174.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.33 -12.87 57.71 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 173.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -116.47 -30.51 5.85 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.762 1.225 . . . . 0.0 114.302 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.7 m -146.9 134.77 21.3 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 119.678 1.126 . . . . 0.0 112.577 -168.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 10.6 mmpt? -86.87 -32.38 20.26 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.242 1.417 . . . . 0.0 112.717 169.186 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -77.33 47.56 0.58 Allowed 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 125.579 1.552 . . . . 0.0 113.296 177.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -110.46 128.44 66.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 127.265 2.226 . . . . 0.0 109.833 175.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.5 m -112.17 129.0 56.39 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.494 1.918 . . . . 0.0 108.728 174.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.5 p -125.55 142.54 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-O 122.117 0.96 . . . . 0.0 113.042 172.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 33.0 m-70 -120.09 121.68 39.39 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 127.302 2.241 . . . . 0.0 110.51 -174.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -94.63 90.99 6.34 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 122.558 1.17 . . . . 0.0 110.513 -177.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 34.4 m -70.18 -16.13 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-N 115.154 -0.93 . . . . 0.0 112.735 -176.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.412 ' HB3' ' CD1' ' A' ' 20' ' ' TRP . 0.2 OUTLIER -69.13 -32.97 72.72 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.396 -0.815 . . . . 0.0 112.123 174.377 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.421 ' HE2' HG21 ' A' ' 21' ' ' VAL . 70.4 mmtt -77.58 -27.57 51.42 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.52 1.928 . . . . 0.0 112.244 174.266 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.411 ' HG2' ' H ' ' A' ' 50' ' ' GLU . 21.2 ttt -71.43 142.18 50.26 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.612 1.565 . . . . 0.0 112.48 -177.543 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 4.9 m -76.34 -12.28 60.04 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 177.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.411 ' H ' ' HG2' ' A' ' 48' ' ' MET . 2.0 mt-10 -125.21 9.9 8.02 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 126.116 1.766 . . . . 0.0 113.825 178.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -53.5 -29.01 38.27 Favored Glycine 0 CA--C 1.539 1.566 0 N-CA-C 116.457 1.343 . . . . 0.0 116.457 -171.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -69.19 -28.91 66.81 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 118.829 1.315 . . . . 0.0 112.869 174.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -67.39 -28.97 68.37 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.937 0.895 . . . . 0.0 111.424 169.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.571 HD12 HG23 ' A' ' 6' ' ' ILE . 2.9 mm? -83.57 -31.89 26.1 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.012 0.925 . . . . 0.0 111.961 178.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 49.5 mtp85 -53.36 -41.71 66.11 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 119.628 1.104 . . . . 0.0 111.058 154.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -57.93 -38.17 87.85 Favored Glycine 0 CA--C 1.536 1.405 0 CA-C-O 118.631 -1.094 . . . . 0.0 114.445 172.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -62.19 -41.8 98.68 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 120.299 2.049 . . . . 0.0 111.864 176.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 52.1 mt -70.13 -42.43 79.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.243 1.417 . . . . 0.0 110.069 179.028 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -67.84 -43.22 80.02 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 121.8 -0.563 . . . . 0.0 111.895 179.388 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -64.09 -33.94 76.91 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.459 -0.776 . . . . 0.0 111.812 177.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -79.35 -48.88 13.3 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 176.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -125.58 -1.45 7.42 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 114.552 1.316 . . . . 0.0 114.552 -164.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.2 mmtp 55.25 36.11 26.33 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 126.83 2.052 . . . . 0.0 114.148 -178.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 25.1 m80 -119.84 140.81 50.22 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 128.128 2.571 . . . . 0.0 109.367 176.397 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -125.88 -32.0 2.85 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.508 1.523 . . . . 0.0 114.395 -176.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 77.7 p -67.76 147.93 51.94 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 -169.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.3 m -99.46 152.68 37.88 Favored Pre-proline 0 N--CA 1.474 0.75 0 C-N-CA 123.726 0.811 . . . . 0.0 112.34 177.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -70.32 149.37 89.8 Favored 'Cis proline' 0 N--CA 1.458 -0.597 0 CA-C-N 119.029 0.689 . . . . 0.0 111.28 -9.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -102.85 130.78 49.98 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.219 1.007 . . . . 0.0 108.346 166.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 13.2 mt -124.62 142.28 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 124.163 0.985 . . . . 0.0 109.338 -164.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -138.36 141.21 39.68 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 123.764 0.826 . . . . 0.0 111.052 177.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 55.8 mt -133.7 117.44 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 124.467 1.107 . . . . 0.0 109.428 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 74.9 m-80 48.83 35.98 7.39 Favored 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 125.633 1.573 . . . . 0.0 114.092 -174.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 80.35 5.65 89.66 Favored Glycine 0 CA--C 1.537 1.423 0 N-CA-C 116.737 1.455 . . . . 0.0 116.737 -176.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 -95.76 139.33 32.15 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 118.834 1.317 . . . . 0.0 110.77 168.148 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -81.32 137.93 35.72 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.074 0.949 . . . . 0.0 112.181 178.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 28.6 mm -116.97 121.93 68.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 127.349 2.259 . . . . 0.0 107.416 174.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.9 -22.81 68.84 Favored Glycine 0 CA--C 1.534 1.223 0 N-CA-C 116.211 1.244 . . . . 0.0 116.211 -162.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 168.93 -171.47 42.92 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-N 118.193 0.997 . . . . 0.0 113.785 179.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 49.1 t -61.87 -37.85 86.08 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.784 1.234 . . . . 0.0 112.174 175.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 71.1 m -56.46 -44.66 80.74 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 118.908 0.777 . . . . 0.0 112.486 176.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -72.45 -39.14 68.02 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.998 0.919 . . . . 0.0 111.589 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 67.2 tp -62.42 -50.21 72.42 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.035 0.934 . . . . 0.0 112.168 174.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -68.67 -15.15 63.43 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 121.754 -0.591 . . . . 0.0 112.508 176.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -81.68 -47.12 13.38 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.417 -0.802 . . . . 0.0 111.49 169.137 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 66.5 mt -62.42 -32.58 73.44 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 120.831 -1.168 . . . . 0.0 112.783 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -64.72 -29.68 70.67 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.707 1.603 . . . . 0.0 113.467 173.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.1 mptt -93.36 -37.08 12.19 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 126.58 1.952 . . . . 0.0 112.089 -178.041 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -71.33 -6.2 38.22 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.996 1.318 . . . . 0.0 113.582 171.091 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 76.2 17.63 79.86 Favored Glycine 0 CA--C 1.534 1.256 0 O-C-N 120.942 -1.099 . . . . 0.0 113.945 177.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 44.6 mtmt -99.5 -21.45 15.93 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 126.27 1.828 . . . . 0.0 113.061 -172.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 31.1 tp -66.34 -34.82 78.84 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.861 0.865 . . . . 0.0 111.615 176.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -53.27 -41.77 65.87 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.694 1.198 . . . . 0.0 112.068 173.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -85.45 -6.9 83.15 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 125.966 1.746 . . . . 0.0 114.794 179.088 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 69.7 mt -95.73 -26.16 15.8 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.144 1.378 . . . . 0.0 112.471 172.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 76.6 mt -105.69 -16.13 14.77 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 114.838 1.422 . . . . 0.0 114.838 -177.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 63.3 p . . . . . 0 N--CA 1.479 1.009 0 C-N-CA 126.229 1.812 . . . . 0.0 114.836 178.479 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.97 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -58.5 -31.49 67.93 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.246 1.018 . . . . 0.0 112.595 170.157 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 5.3 mpp? -74.34 98.34 0.22 Allowed Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 126.934 2.094 . . . . 0.0 108.875 158.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -31.71 124.26 0.09 OUTLIER 'Trans proline' 0 C--N 1.354 0.821 1 C-N-CA 127.223 5.282 . . . . 0.0 117.96 -160.397 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 74.1 p -152.63 -164.07 1.86 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.359 1.864 . . . . 0.0 110.462 174.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.567 HG23 HD12 ' A' ' 54' ' ' LEU . 27.5 pt -51.53 -23.0 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 124.181 0.993 . . . . 0.0 113.493 173.387 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.28 -18.59 61.69 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.477 1.111 . . . . 0.0 113.407 -175.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.5 m -84.16 -19.39 34.2 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 171.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 64.7 mtt -64.2 -37.28 86.91 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 119.557 1.072 . . . . 0.0 110.851 175.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.4 mm -59.64 -20.63 19.28 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 124.004 0.921 . . . . 0.0 113.069 -173.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.3 mptt -91.74 -7.67 49.06 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.452 1.501 . . . . 0.0 114.143 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -96.82 -18.65 29.16 Favored Glycine 0 CA--C 1.539 1.579 0 N-CA-C 116.754 1.462 . . . . 0.0 116.754 -174.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 27.7 m120 -141.33 151.0 43.21 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 118.894 1.347 . . . . 0.0 112.164 -176.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt -54.85 -40.9 70.12 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.008 1.323 . . . . 0.0 112.992 176.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.6 t -129.83 134.43 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.131 0.972 . . . . 0.0 110.175 174.037 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 58.9 t -131.8 129.85 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.065 1.346 . . . . 0.0 109.751 177.073 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 47.0 t -127.33 146.9 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 124.294 1.038 . . . . 0.0 111.855 -175.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -121.72 113.48 19.77 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.696 1.198 . . . . 0.0 109.971 173.036 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.4 m -131.17 170.83 14.02 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.529 1.532 . . . . 0.0 112.092 -167.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.437 ' CD1' ' HB3' ' A' ' 46' ' ' ASP . 33.2 m0 -117.36 133.85 55.5 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.571 1.149 . . . . 0.0 108.867 162.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 71.4 t -58.55 -30.43 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 C-N-CA 123.567 0.747 . . . . 0.0 111.887 -175.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.8 p -82.56 -8.49 59.61 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 126.496 1.919 . . . . 0.0 116.08 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.7 t -91.62 141.4 25.74 Favored Pre-proline 0 CA--C 1.54 0.567 0 CA-C-N 120.372 1.442 . . . . 0.0 112.394 -168.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -69.26 -39.58 7.27 Favored 'Trans proline' 0 C--N 1.349 0.576 0 CA-C-N 120.343 1.158 . . . . 0.0 112.058 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -62.45 -36.47 82.52 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 126.166 1.786 . . . . 0.0 113.083 -178.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -55.1 -53.15 59.61 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.265 1.026 . . . . 0.0 109.125 169.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 94.8 t -64.32 -39.8 86.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 123.716 0.806 . . . . 0.0 111.871 -178.091 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.5 mmt85 -53.37 -43.4 67.75 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 118.87 0.759 . . . . 0.0 111.566 172.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.75 -54.27 9.37 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.487 0.715 . . . . 0.0 112.839 175.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.38 -33.32 58.96 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.671 1.188 . . . . 0.0 113.395 -179.005 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -68.68 -49.94 54.99 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.512 0.725 . . . . 0.0 111.58 177.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.6 tt -65.66 -43.32 89.74 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.796 1.639 . . . . 0.0 111.378 -178.431 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 95.0 mt -64.0 -40.07 95.54 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.633 0.773 . . . . 0.0 111.921 -178.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 54.3 m-70 -78.48 -13.38 59.86 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 171.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -80.37 -39.35 28.65 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 119.208 0.913 . . . . 0.0 111.952 172.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -87.46 -28.56 22.01 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 125.053 1.341 . . . . 0.0 114.267 -178.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.2 p -151.15 170.38 19.58 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 125.118 1.367 . . . . 0.0 112.628 -168.181 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -116.85 -19.33 9.91 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 126.562 1.945 . . . . 0.0 114.047 164.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -78.35 27.82 0.2 Allowed 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -171.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.21 132.47 44.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.365 0 C-N-CA 126.887 2.075 . . . . 0.0 111.563 -178.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 16.5 m -112.81 141.53 46.51 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 126.107 1.763 . . . . 0.0 109.65 168.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.4 p -132.85 140.24 47.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 125.259 1.424 . . . . 0.0 111.883 173.091 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -116.06 127.85 55.22 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.975 1.31 . . . . 0.0 110.46 176.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -95.99 87.95 4.74 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 122.06 0.933 . . . . 0.0 111.714 -172.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.0 m -71.79 3.61 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 -174.161 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.437 ' HB3' ' CD1' ' A' ' 20' ' ' TRP . 0.0 OUTLIER -87.33 -31.03 20.39 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 121.294 -0.879 . . . . 0.0 111.732 165.873 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 25.1 mtmt -81.42 -23.81 37.3 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.822 1.249 . . . . 0.0 113.367 176.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 21.0 ttt -85.2 121.97 28.71 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.212 1.805 . . . . 0.0 110.955 173.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 72.5 m -63.55 -31.6 72.81 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -176.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -83.32 1.48 40.93 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 175.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -56.12 -21.71 33.03 Favored Glycine 0 CA--C 1.535 1.311 0 N-CA-C 116.663 1.425 . . . . 0.0 116.663 -169.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -67.11 -29.07 68.72 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 119.365 1.582 . . . . 0.0 112.576 173.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -76.9 -25.37 52.93 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 121.103 -0.998 . . . . 0.0 111.724 174.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.567 HD12 HG23 ' A' ' 6' ' ' ILE . 2.8 mm? -84.48 -30.07 25.51 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.438 1.095 . . . . 0.0 111.57 175.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 41.1 mtp180 -54.18 -41.96 69.14 Favored 'General case' 0 N--CA 1.484 1.241 0 O-C-N 120.977 -1.077 . . . . 0.0 110.666 154.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.13 -38.86 93.68 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 124.329 0.966 . . . . 0.0 114.203 171.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -65.37 -31.66 72.88 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 120.038 1.919 . . . . 0.0 113.501 176.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 28.2 mt -71.68 -46.89 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 172.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -62.9 -39.58 94.92 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 121.109 -0.995 . . . . 0.0 113.039 -178.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 38.6 mm-40 -71.81 -10.74 60.21 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.865 1.266 . . . . 0.0 114.135 -179.315 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -113.99 -26.12 8.26 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 114.217 1.192 . . . . 0.0 114.217 173.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -135.31 0.87 2.85 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 115.255 1.576 . . . . 0.0 115.255 -170.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp 49.49 35.23 7.87 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 127.089 2.155 . . . . 0.0 115.226 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -141.06 153.79 45.65 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 125.148 1.379 . . . . 0.0 110.311 175.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -141.35 -24.33 0.73 Allowed 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -160.239 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 22.0 m -77.36 131.99 38.34 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.988 1.315 . . . . 0.0 112.353 -173.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 14.1 m -81.22 158.43 69.53 Favored Pre-proline 0 CA--C 1.547 0.857 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 -171.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -68.63 153.18 89.74 Favored 'Cis proline' 0 CA--C 1.534 0.503 0 CA-C-N 118.528 0.51 . . . . 0.0 112.219 -15.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -98.6 135.63 39.84 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 159.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 69.4 mt -129.61 142.52 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 123.599 0.759 . . . . 0.0 109.28 -166.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -138.22 140.67 39.82 Favored 'General case' 0 C--N 1.332 -0.152 0 C-N-CA 123.934 0.894 . . . . 0.0 111.145 177.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 73.8 mt -128.5 115.03 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.994 1.318 . . . . 0.0 108.202 176.048 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 45.69 47.83 11.59 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.547 1.539 . . . . 0.0 113.54 -174.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 79.54 -10.48 37.11 Favored Glycine 0 CA--C 1.535 1.302 0 N-CA-C 115.793 1.077 . . . . 0.0 115.793 -178.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 26.8 m-80 -86.65 132.77 33.79 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 118.887 1.343 . . . . 0.0 109.541 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -82.65 143.01 31.26 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.531 1.132 . . . . 0.0 113.056 -174.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 20.2 mm -132.5 119.58 39.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 127.93 2.492 . . . . 0.0 107.246 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.97 -22.75 65.05 Favored Glycine 0 CA--C 1.537 1.426 0 N-CA-C 116.785 1.474 . . . . 0.0 116.785 -164.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 156.64 -152.51 23.89 Favored Glycine 0 CA--C 1.527 0.79 0 CA-C-N 118.058 0.929 . . . . 0.0 114.154 173.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 8.2 t -54.91 -56.23 21.88 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.196 0.998 . . . . 0.0 112.593 -175.015 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 65.6 m -75.27 3.16 9.4 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -95.73 -43.09 8.05 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.357 1.063 . . . . 0.0 111.646 165.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 28.6 tp -63.39 -51.21 66.8 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.188 1.395 . . . . 0.0 111.003 175.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -57.39 -43.81 83.99 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.5 0.72 . . . . 0.0 110.24 174.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.16 -35.36 78.54 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.351 -0.843 . . . . 0.0 112.861 -177.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 42.8 mt -73.65 -26.74 60.9 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.681 0.792 . . . . 0.0 112.91 173.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -72.75 -38.92 67.23 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 119.24 0.927 . . . . 0.0 111.601 169.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -64.21 -38.64 91.77 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.565 0.746 . . . . 0.0 111.549 173.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -73.32 -7.68 52.64 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 171.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.95 28.94 74.08 Favored Glycine 0 CA--C 1.539 1.534 0 CA-C-N 120.617 1.553 . . . . 0.0 112.993 -176.127 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 21.2 mtpp -110.09 -30.19 7.88 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.882 2.073 . . . . 0.0 112.392 -176.295 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 50.2 tp -56.36 -37.51 70.14 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.444 0.697 . . . . 0.0 111.837 172.224 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -51.13 -46.44 61.95 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.695 1.598 . . . . 0.0 112.577 174.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -78.23 -25.42 61.62 Favored Glycine 0 CA--C 1.531 1.061 0 O-C-N 121.616 -0.677 . . . . 0.0 114.279 177.097 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 79.6 mt -71.19 -37.6 72.13 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 118.642 1.221 . . . . 0.0 111.734 175.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 87.3 mt -86.89 -8.26 57.43 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.166 0.987 . . . . 0.0 112.973 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.9 t . . . . . 0 C--O 1.253 1.246 0 C-N-CA 126.695 1.998 . . . . 0.0 111.224 173.456 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.902 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -70.19 159.72 33.44 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.402 1.481 . . . . 0.0 114.345 -171.28 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 79.0 mmm -113.43 78.23 3.45 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 125.949 1.699 . . . . 0.0 110.673 178.294 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -68.82 158.14 59.04 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 122.868 2.379 . . . . 0.0 112.806 -176.3 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 51.0 m -97.09 -170.71 2.08 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.495 1.518 . . . . 0.0 111.549 172.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.481 HG23 HD12 ' A' ' 54' ' ' LEU . 13.2 pt -54.81 -22.25 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 N-CA-C 115.198 1.555 . . . . 0.0 115.198 -168.136 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.36 -22.03 60.72 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 93.4 p -80.48 -25.89 38.54 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.668 1.587 . . . . 0.0 113.923 172.316 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 62.1 mtt -65.12 -33.62 76.47 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 120.624 -1.297 . . . . 0.0 111.704 176.344 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.403 HG22 ' HA2' ' A' ' 74' ' ' GLY . 1.5 mm -61.89 -24.49 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 124.017 0.927 . . . . 0.0 112.222 -174.725 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -75.75 -11.02 59.91 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.356 1.462 . . . . 0.0 114.265 177.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -95.73 -26.38 11.86 Favored Glycine 0 CA--C 1.536 1.346 0 N-CA-C 117.8 1.88 . . . . 0.0 117.8 -164.398 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -143.35 158.72 43.4 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 119.335 1.568 . . . . 0.0 111.918 -173.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -59.69 -38.73 82.35 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.837 1.255 . . . . 0.0 112.931 -176.148 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.4 t -131.54 134.66 60.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.322 1.449 . . . . 0.0 109.446 173.068 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 56.1 t -132.26 128.48 58.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.702 1.201 . . . . 0.0 110.075 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 44.9 t -131.33 153.03 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.49 1.116 . . . . 0.0 111.981 -173.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -128.37 105.95 8.68 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.582 1.153 . . . . 0.0 109.393 176.468 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 68.9 m -126.46 171.23 11.21 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 125.744 1.618 . . . . 0.0 111.816 -170.649 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 47.3 m0 -118.94 129.4 55.15 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.847 1.259 . . . . 0.0 109.399 168.02 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 31.6 t -61.61 -20.33 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 C-N-CA 124.864 1.266 . . . . 0.0 112.661 -168.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.7 p -83.08 -22.26 33.5 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 128.671 2.788 . . . . 0.0 115.485 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 66.3 m -105.24 153.97 39.23 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 120.154 1.343 . . . . 0.0 114.06 -154.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -71.8 -49.48 0.32 Allowed 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 121.382 1.388 . . . . 0.0 114.023 -168.087 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -62.16 -37.37 84.99 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 -177.319 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -42.73 -58.29 2.4 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.973 1.709 . . . . 0.0 110.341 164.049 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 61.4 t -66.34 -38.45 81.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 O-C-N 121.5 -0.75 . . . . 0.0 112.125 -177.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 37.6 mmt-85 -54.37 -39.74 67.48 Favored 'General case' 0 N--CA 1.484 1.258 0 CA-C-N 119.12 0.873 . . . . 0.0 111.915 174.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.64 -54.74 6.5 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.55 1.14 . . . . 0.0 112.988 174.026 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -54.3 -30.4 50.83 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 119.392 0.997 . . . . 0.0 113.27 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.6 ttpt -69.53 -50.58 43.61 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.675 0.79 . . . . 0.0 112.21 175.143 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.1 tt -64.13 -43.04 96.46 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.521 1.528 . . . . 0.0 111.132 -177.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 90.5 mt -66.45 -24.27 66.41 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.263 1.025 . . . . 0.0 113.335 -177.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 44.1 m-70 -92.46 -16.3 26.02 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 168.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.0 -27.44 22.05 Favored 'General case' 0 CA--C 1.545 0.76 0 O-C-N 120.793 -1.192 . . . . 0.0 113.967 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 7.5 mmm-85 -103.2 -18.93 14.69 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 125.23 1.412 . . . . 0.0 113.973 177.377 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -153.02 174.49 14.1 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 127.037 2.135 . . . . 0.0 111.739 -171.13 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -129.78 -7.81 4.52 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 125.309 1.444 . . . . 0.0 114.532 170.096 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -97.76 87.69 4.1 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 119.506 1.048 . . . . 0.0 111.454 179.459 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.42 129.55 22.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 125.073 1.349 . . . . 0.0 110.641 -179.37 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 22.7 m -104.49 127.53 52.22 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.319 1.448 . . . . 0.0 108.632 168.158 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.5 p -125.18 134.29 67.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 118.957 0.798 . . . . 0.0 112.264 170.013 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -104.06 122.93 46.29 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.941 1.296 . . . . 0.0 110.3 175.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -93.7 82.91 4.36 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.568 0.699 . . . . 0.0 111.964 -172.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 29.6 m -76.08 33.32 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 -169.023 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -129.04 -16.67 4.03 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 126.449 1.9 . . . . 0.0 111.708 161.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 20.4 mtmt -80.2 -24.7 40.1 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.445 1.098 . . . . 0.0 112.229 162.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -92.21 127.62 37.76 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.677 1.591 . . . . 0.0 110.781 177.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 58.1 m -71.55 -20.95 61.96 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 -165.53 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -97.85 7.49 46.29 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 126.028 1.731 . . . . 0.0 112.686 174.236 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -49.51 -30.83 13.46 Favored Glycine 0 CA--C 1.537 1.416 0 CA-C-N 119.743 1.156 . . . . 0.0 115.028 -175.617 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -58.4 -35.34 71.89 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.368 1.867 . . . . 0.0 114.907 171.444 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -80.36 -36.14 34.48 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.809 1.244 . . . . 0.0 112.08 175.127 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.481 HD12 HG23 ' A' ' 6' ' ' ILE . 2.5 mm? -69.67 -36.11 75.73 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.715 -0.615 . . . . 0.0 111.075 176.229 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 42.2 mtp180 -53.14 -38.83 63.05 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.834 1.254 . . . . 0.0 112.258 165.393 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -57.94 -40.08 92.71 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 123.974 0.797 . . . . 0.0 113.797 173.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 56.7 mm-40 -66.55 -24.87 66.43 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 118.841 1.321 . . . . 0.0 112.984 175.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 26.1 mt -74.72 -45.45 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 O-C-N 121.498 -0.751 . . . . 0.0 109.722 172.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -68.88 -39.11 79.97 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 121.618 -0.677 . . . . 0.0 112.671 -177.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -59.58 -35.31 74.03 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 121.456 -0.777 . . . . 0.0 112.834 176.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -94.61 -32.13 13.56 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 114.293 1.219 . . . . 0.0 114.293 -175.618 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -134.69 4.02 3.3 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 114.741 1.386 . . . . 0.0 114.741 -169.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt 52.96 31.48 11.0 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 126.513 1.925 . . . . 0.0 114.903 176.059 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 -116.71 111.31 19.62 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 127.745 2.418 . . . . 0.0 110.466 -166.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -100.13 -5.37 27.93 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 115.942 1.83 . . . . 0.0 115.942 -177.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 44.7 p -81.29 171.13 15.2 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 124.895 1.278 . . . . 0.0 113.51 178.01 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.3 m -125.7 143.58 45.49 Favored Pre-proline 0 N--CA 1.481 1.119 0 C-N-CA 124.189 0.996 . . . . 0.0 111.748 169.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -88.64 162.62 41.42 Favored 'Cis proline' 0 N--CA 1.457 -0.621 0 CA-C-N 119.525 0.866 . . . . 0.0 113.976 5.042 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -100.14 143.25 30.56 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.81 0.844 . . . . 0.0 109.476 159.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 15.8 mt -133.03 141.71 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 124.21 1.004 . . . . 0.0 110.137 -167.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -142.77 147.63 35.85 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.119 0.968 . . . . 0.0 112.253 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 79.8 mt -130.65 122.79 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 125.731 1.613 . . . . 0.0 109.765 177.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 62.9 m-80 44.78 39.5 3.53 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 125.645 1.578 . . . . 0.0 114.305 -178.313 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.403 ' HA2' HG22 ' A' ' 10' ' ' ILE . . . 92.72 -6.25 77.05 Favored Glycine 0 CA--C 1.539 1.574 0 O-C-N 120.208 -1.558 . . . . 0.0 116.231 -176.463 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -104.77 134.79 47.32 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.292 1.437 . . . . 0.0 111.755 -173.092 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -75.42 143.83 42.51 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 27.0 mm -125.61 133.19 69.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 128.266 2.627 . . . . 0.0 108.522 178.08 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -72.95 53.63 1.73 Allowed Glycine 0 N--CA 1.474 1.226 0 C-N-CA 126.324 1.916 . . . . 0.0 117.353 -177.297 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 78.21 -164.63 51.36 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 128.075 2.75 . . . . 0.0 113.459 175.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 18.6 t -62.15 -29.39 70.32 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 122.087 -0.655 . . . . 0.0 111.672 175.421 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 36.6 m -64.1 -45.01 90.54 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.338 1.055 . . . . 0.0 112.664 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -72.79 -37.83 67.45 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 118.823 0.738 . . . . 0.0 112.205 172.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 50.6 tp -58.67 -50.07 75.23 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.74 0.816 . . . . 0.0 111.38 176.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -61.55 -43.55 98.66 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.845 0.858 . . . . 0.0 110.697 173.178 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.98 -33.68 75.91 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 120.848 -1.158 . . . . 0.0 112.806 -176.53 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 98.7 mt -78.34 -23.82 46.81 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.511 1.124 . . . . 0.0 113.345 173.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -70.51 -41.24 72.89 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 119.566 1.076 . . . . 0.0 110.85 166.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -65.02 -28.85 69.78 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.564 1.146 . . . . 0.0 113.148 175.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.447 ' HB3' ' HE2' ' A' ' 91' ' ' LYS . 7.3 mt-10 -91.28 2.1 56.62 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 114.641 1.349 . . . . 0.0 114.641 169.019 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 67.77 4.7 34.62 Favored Glycine 0 CA--C 1.537 1.41 0 O-C-N 120.948 -1.095 . . . . 0.0 115.261 179.084 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.447 ' HE2' ' HB3' ' A' ' 89' ' ' GLU . 44.2 mtmt -78.57 -28.13 45.85 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 126.178 1.791 . . . . 0.0 111.949 -174.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 35.4 tp -56.07 -36.15 67.78 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.528 1.131 . . . . 0.0 112.361 172.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -65.75 -28.38 69.0 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 178.007 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -76.19 -36.88 38.77 Favored Glycine 0 CA--C 1.53 0.974 0 O-C-N 121.584 -0.698 . . . . 0.0 111.992 171.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 90.4 mt -70.52 -25.87 63.32 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.986 0.914 . . . . 0.0 113.367 -178.283 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 85.2 mt -105.42 2.14 28.4 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 -173.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 41.6 m . . . . . 0 C--O 1.255 1.351 0 C-N-CA 125.645 1.578 . . . . 0.0 114.487 -174.619 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.144 0 N-CA-C 112.182 -0.367 . . . . 0.0 112.182 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 50.12 39.98 20.64 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 125.215 1.406 . . . . 0.0 114.503 -177.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 52.5 mtt -136.29 86.96 23.52 Favored Pre-proline 0 CA--C 1.542 0.648 0 C-N-CA 126.13 1.772 . . . . 0.0 109.684 -175.206 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -67.87 148.08 75.98 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 122.575 2.183 . . . . 0.0 112.841 -178.398 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 60.6 p -110.75 -152.21 0.49 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 127.253 2.221 . . . . 0.0 111.244 -178.213 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.584 HG23 HD12 ' A' ' 54' ' ' LEU . 12.4 pt -53.22 -22.88 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 125.136 1.374 . . . . 0.0 113.89 174.57 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.62 -32.39 72.53 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 118.868 0.758 . . . . 0.0 112.574 -174.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 62.9 m -76.84 -19.3 57.67 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 173.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 38.4 mtt -73.68 -25.72 60.39 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.036 -1.04 . . . . 0.0 112.01 176.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.8 mm -63.54 -33.13 59.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.862 0.865 . . . . 0.0 111.615 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -76.45 1.41 16.56 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.884 1.274 . . . . 0.0 113.416 175.469 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -86.03 -18.82 58.78 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 125.115 1.341 . . . . 0.0 115.385 -177.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -151.37 170.56 19.25 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 126.133 1.773 . . . . 0.0 111.943 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -70.19 -36.8 74.87 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.257 0.623 . . . . 0.0 112.651 174.204 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.3 t -128.09 135.09 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.842 1.257 . . . . 0.0 110.574 172.145 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 47.2 t -131.48 129.18 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 124.411 1.084 . . . . 0.0 110.069 174.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.0 t -124.9 144.73 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 124.565 1.146 . . . . 0.0 111.883 -176.364 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -120.2 113.01 19.8 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.17 1.388 . . . . 0.0 108.692 173.238 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.412 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 14.2 m -130.63 -179.06 5.07 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 127.279 2.232 . . . . 0.0 110.58 -169.158 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 19.7 m0 -126.82 138.08 53.29 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.491 1.116 . . . . 0.0 108.425 159.173 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 40.6 t -59.36 -31.07 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 CA-C-O 122.06 0.933 . . . . 0.0 111.619 -170.226 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.6 p -81.96 -11.08 59.05 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 127.349 2.26 . . . . 0.0 115.526 -177.359 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 8.2 t -89.01 141.9 29.83 Favored Pre-proline 0 CA--C 1.542 0.653 0 CA-C-N 120.373 1.442 . . . . 0.0 110.384 -168.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -75.75 -31.39 5.34 Favored 'Trans proline' 0 C--N 1.347 0.467 0 CA-C-N 120.605 1.252 . . . . 0.0 113.361 179.357 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -62.65 -41.45 99.06 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.532 1.133 . . . . 0.0 113.264 174.37 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.412 ' SG ' ' HB3' ' A' ' 19' ' ' SER . 0.2 OUTLIER -50.72 -56.51 11.65 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.597 1.159 . . . . 0.0 109.55 171.924 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 81.3 t -63.23 -40.92 90.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 118.761 -0.637 . . . . 0.0 112.579 -173.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -66.94 -20.19 65.85 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 176.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.2 -54.42 5.53 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 118.448 -0.787 . . . . 0.0 111.042 165.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -46.36 -46.76 18.55 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.438 1.095 . . . . 0.0 112.756 178.198 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -67.37 -36.31 81.1 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.005 1.322 . . . . 0.0 113.01 -176.179 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.27 -35.72 54.99 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.225 1.01 . . . . 0.0 111.402 175.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 96.7 mt -64.94 -34.54 78.66 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 121.126 -0.984 . . . . 0.0 111.409 171.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -70.25 -27.08 64.16 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.912 1.078 . . . . 0.0 113.912 167.425 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -74.11 -36.74 64.23 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 119.69 1.132 . . . . 0.0 112.711 174.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 73.7 mmt-85 -99.31 -28.02 13.5 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 -172.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.417 HG22 HD13 ' A' ' 96' ' ' LEU . 1.3 p -136.76 163.89 29.55 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.313 1.045 . . . . 0.0 113.442 -162.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -122.88 -26.04 4.5 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.949 1.3 . . . . 0.0 113.189 165.548 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -85.44 48.16 1.54 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 125.427 1.491 . . . . 0.0 113.569 -178.092 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.04 134.17 58.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 126.128 1.771 . . . . 0.0 112.083 -176.784 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.1 m -121.09 136.87 54.89 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.817 1.647 . . . . 0.0 110.66 171.254 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.1 p -127.17 141.29 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 125.013 1.325 . . . . 0.0 113.002 173.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 56.9 m-70 -119.43 135.82 54.58 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 128.641 2.776 . . . . 0.0 109.804 -176.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -109.25 93.18 4.38 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.251 0.62 . . . . 0.0 111.668 -173.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . 0.266 34.5 m -79.76 44.81 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 CA-C-O 123.117 1.437 . . . . 0.0 114.578 -173.323 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -145.84 -27.3 0.44 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 129.057 2.943 . . . . 0.0 110.217 172.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 28.2 mmmt -70.45 -39.06 74.56 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.444 1.098 . . . . 0.0 110.478 155.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 14.3 ttt -69.71 127.94 34.71 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.703 0.801 . . . . 0.0 111.579 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 9.1 m -78.92 -18.78 53.26 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.725 1.21 . . . . 0.0 113.927 179.014 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -95.54 -5.29 43.09 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.944 1.297 . . . . 0.0 112.807 167.226 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -51.34 -25.54 12.43 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 126.067 1.794 . . . . 0.0 116.841 -169.451 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -73.22 -28.13 61.99 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 118.871 1.336 . . . . 0.0 112.673 177.182 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 14.4 tm0? -70.04 -37.36 75.54 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.409 1.084 . . . . 0.0 110.714 172.004 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.584 HD12 HG23 ' A' ' 6' ' ' ILE . 2.2 mm? -74.43 -36.19 63.39 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.825 1.25 . . . . 0.0 112.52 177.074 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 72.0 mtp180 -54.13 -40.17 67.14 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 119.097 0.862 . . . . 0.0 111.158 162.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.45 -33.36 86.24 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 125.256 1.408 . . . . 0.0 114.631 172.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -63.51 -42.56 98.47 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 120.414 2.107 . . . . 0.0 111.088 175.136 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 26.4 mt -69.64 -39.47 78.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 123.828 0.851 . . . . 0.0 110.308 177.253 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -70.28 -44.23 68.8 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 121.148 -0.97 . . . . 0.0 112.808 -179.593 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -62.6 -30.66 71.51 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 118.93 0.786 . . . . 0.0 112.477 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -83.47 -55.09 4.5 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 174.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -117.84 -1.74 11.48 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.446 1.098 . . . . 0.0 113.918 -161.277 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.5 mmtp 54.21 29.74 11.08 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 126.364 1.866 . . . . 0.0 114.102 -178.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -99.74 119.88 38.84 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.087 1.755 . . . . 0.0 109.939 -179.547 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -115.37 -17.75 11.2 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.01 1.324 . . . . 0.0 114.502 -172.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.3 p -75.2 166.48 23.57 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.564 1.146 . . . . 0.0 112.419 172.478 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 21.6 m -120.52 151.27 53.73 Favored Pre-proline 0 N--CA 1.475 0.783 0 C-N-CA 124.912 1.285 . . . . 0.0 110.609 166.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -78.32 154.56 93.03 Favored 'Cis proline' 0 C--N 1.349 0.56 0 CA-C-N 118.986 0.673 . . . . 0.0 113.561 -0.083 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -104.84 135.25 46.56 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.144 1.378 . . . . 0.0 108.776 161.127 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.9 mt -126.69 142.78 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.391 1.076 . . . . 0.0 109.514 -167.228 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -139.9 136.41 33.87 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.274 1.03 . . . . 0.0 110.272 178.648 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 52.5 mt -133.84 122.03 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.02 0.928 . . . . 0.0 110.403 -176.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 48.5 m-20 49.75 30.91 4.02 Favored 'General case' 0 CA--C 1.554 1.114 0 O-C-N 121.238 -0.914 . . . . 0.0 113.257 -175.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 95.21 -8.99 69.91 Favored Glycine 0 CA--C 1.54 1.602 0 N-CA-C 117.606 1.802 . . . . 0.0 117.606 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 25.4 p30 -76.33 169.28 18.53 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 121.248 2.524 . . . . 0.0 113.482 175.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -108.16 129.45 55.18 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.447 0.699 . . . . 0.0 111.808 169.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 45.5 mm -113.99 121.88 67.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 126.611 1.964 . . . . 0.0 108.64 -178.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -74.14 21.77 1.34 Allowed Glycine 0 N--CA 1.472 1.073 0 N-CA-C 118.569 2.188 . . . . 0.0 118.569 -164.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 121.39 -172.03 15.18 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 126.639 2.066 . . . . 0.0 115.058 174.36 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 29.9 t -66.49 -38.51 87.43 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 121.853 -0.792 . . . . 0.0 113.033 -174.275 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 63.4 m -63.1 -20.27 65.21 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 176.444 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -90.13 -43.6 10.35 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.763 1.225 . . . . 0.0 111.008 175.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 48.4 tp -57.43 -49.48 76.1 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.442 1.097 . . . . 0.0 111.435 174.151 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -67.28 -29.43 69.03 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.26 0.624 . . . . 0.0 111.825 177.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -73.3 -40.2 64.72 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 121.025 -1.047 . . . . 0.0 112.672 176.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 75.8 mt -65.29 -28.2 69.16 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.083 0.953 . . . . 0.0 112.616 177.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -59.78 -47.44 85.69 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.535 1.134 . . . . 0.0 111.515 171.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -68.71 -40.74 79.83 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.199 1.0 . . . . 0.0 112.944 178.366 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -73.3 2.87 6.62 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 70.0 16.5 72.78 Favored Glycine 0 CA--C 1.538 1.508 0 O-C-N 120.332 -1.48 . . . . 0.0 114.145 178.189 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 44.4 mtmt -100.29 -34.23 10.08 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.874 1.669 . . . . 0.0 112.592 -175.367 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 54.4 tp -59.39 -41.36 89.23 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.244 0.929 . . . . 0.0 111.411 175.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -57.21 -41.0 78.59 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.805 0.842 . . . . 0.0 113.134 176.142 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -76.58 -34.05 45.59 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 124.542 1.068 . . . . 0.0 113.376 178.198 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 62.9 mt -65.07 -23.21 67.1 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.909 0.884 . . . . 0.0 112.483 172.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.417 HD13 HG22 ' A' ' 37' ' ' THR . 46.5 mt -100.65 -3.29 30.63 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 126.069 1.748 . . . . 0.0 113.751 177.062 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 69.3 m . . . . . 0 C--O 1.253 1.277 0 C-N-CA 125.311 1.445 . . . . 0.0 112.091 -179.284 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.257 0 N-CA-C 110.731 -0.948 . . . . 0.0 110.731 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.69 138.58 37.39 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 117.767 0.784 . . . . 0.0 110.679 172.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 3.0 tpt 49.88 57.23 17.96 Favored Pre-proline 0 CA--C 1.554 1.107 0 C-N-CA 124.711 1.204 . . . . 0.0 112.286 -172.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.5 139.7 41.78 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 123.699 2.933 . . . . 0.0 113.061 -167.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 25.5 p -151.51 -167.63 2.85 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.175 0.99 . . . . 0.0 112.224 177.097 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.634 HG23 HD12 ' A' ' 54' ' ' LEU . 26.8 pt -57.21 -22.46 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 124.068 0.947 . . . . 0.0 113.127 169.456 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.47 -21.28 64.63 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -173.097 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 74.0 m -83.28 -33.02 26.08 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.291 1.037 . . . . 0.0 112.48 166.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 73.4 mtp -61.78 -25.93 67.77 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.081 0.952 . . . . 0.0 112.736 178.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.9 mm -57.66 -34.59 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.283 1.033 . . . . 0.0 112.039 175.017 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.3 mptt -76.95 -3.41 38.73 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.29 1.036 . . . . 0.0 113.427 -178.054 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -76.11 -26.51 64.03 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.791 1.186 . . . . 0.0 114.96 -176.388 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -146.52 171.89 14.38 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 118.662 1.231 . . . . 0.0 114.026 -173.282 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -66.57 -35.9 81.34 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.286 1.034 . . . . 0.0 111.886 172.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.9 t -134.57 131.49 54.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 124.857 1.263 . . . . 0.0 110.23 177.278 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 39.5 t -134.85 130.0 52.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.467 1.107 . . . . 0.0 110.005 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 48.8 t -131.67 148.75 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 124.224 1.01 . . . . 0.0 112.513 -171.36 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -125.59 110.58 14.0 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.252 1.421 . . . . 0.0 109.423 175.028 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 58.3 m -130.61 173.66 10.67 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.604 1.562 . . . . 0.0 111.698 -169.1 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 47.8 m0 -122.73 129.63 51.99 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.809 1.244 . . . . 0.0 108.63 166.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 49.0 t -63.45 -23.88 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 123.361 0.664 . . . . 0.0 112.689 -164.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.4 p -78.07 -16.49 57.98 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 177.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 84.0 m -99.51 148.37 34.62 Favored Pre-proline 0 CA--C 1.537 0.45 0 CA-C-N 120.346 1.43 . . . . 0.0 114.212 -154.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -67.76 -48.68 1.37 Allowed 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 121.282 1.321 . . . . 0.0 113.964 -165.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -69.47 -31.44 69.73 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.463 1.105 . . . . 0.0 113.364 -178.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -50.71 -54.3 24.31 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.829 0.852 . . . . 0.0 109.641 168.463 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.7 t -66.93 -39.07 82.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 123.284 0.634 . . . . 0.0 111.658 -177.475 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 17.3 mmt85 -54.26 -49.2 70.1 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 118.612 0.642 . . . . 0.0 111.565 172.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.71 -57.94 7.64 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.93 0.892 . . . . 0.0 112.429 176.412 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -48.19 -44.51 32.79 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.538 1.135 . . . . 0.0 112.963 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -65.85 -43.34 88.75 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 123.727 0.811 . . . . 0.0 111.943 -177.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.6 tt -72.76 -34.36 66.94 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.995 1.318 . . . . 0.0 111.969 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 76.5 mt -67.47 -42.95 82.17 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.529 0.732 . . . . 0.0 111.282 172.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -60.92 -28.2 68.76 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 118.472 0.578 . . . . 0.0 112.301 167.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.73 4.07 38.37 Favored 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 114.877 1.436 . . . . 0.0 114.877 175.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -126.68 -39.72 1.97 Allowed 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 174.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 17.9 p -143.15 131.96 22.7 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 119.236 0.925 . . . . 0.0 113.343 -166.412 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 39.4 mtmt -70.05 -27.0 64.29 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 163.397 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -88.05 60.4 5.8 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.224 1.01 . . . . 0.0 113.059 -175.038 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.83 137.86 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 125.759 1.624 . . . . 0.0 111.622 178.499 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 75.6 m -120.82 135.13 55.24 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 127.288 2.235 . . . . 0.0 109.434 172.605 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.7 p -133.8 141.76 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 169.081 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 33.3 t60 -121.13 119.22 31.77 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.837 2.055 . . . . 0.0 109.632 -178.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -94.93 91.32 6.35 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.223 -0.923 . . . . 0.0 112.387 -168.224 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . 0.252 32.0 m -78.26 36.73 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 115.735 1.754 . . . . 0.0 115.735 -168.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -134.68 -28.68 1.22 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 127.91 2.484 . . . . 0.0 110.473 163.395 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 20.0 mmmt -64.09 -25.93 68.32 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.592 1.157 . . . . 0.0 112.086 160.087 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 91.6 mmm -91.02 144.22 25.89 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.039 1.336 . . . . 0.0 110.922 176.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.9 m -82.55 -27.09 31.85 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -174.198 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -99.12 8.02 45.29 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.255 1.822 . . . . 0.0 112.877 178.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -52.35 -26.56 22.4 Favored Glycine 0 CA--C 1.537 1.467 0 N-CA-C 116.751 1.46 . . . . 0.0 116.751 -173.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 70.2 mt-10 -70.39 -26.67 63.81 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 120.76 2.28 . . . . 0.0 112.895 174.337 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -78.08 -28.26 48.71 Favored 'General case' 0 N--CA 1.469 0.488 0 O-C-N 120.98 -1.075 . . . . 0.0 111.611 173.056 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.634 HD12 HG23 ' A' ' 6' ' ' ILE . 3.0 mm? -80.88 -33.21 34.5 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.539 -0.726 . . . . 0.0 111.343 175.003 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 56.5 mtp180 -58.82 -33.53 70.48 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 120.852 -1.155 . . . . 0.0 111.521 161.475 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -56.31 -40.18 84.36 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 124.013 0.816 . . . . 0.0 113.919 168.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -66.55 -24.8 66.42 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 119.442 1.621 . . . . 0.0 113.172 175.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 52.3 mt -81.43 -46.07 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 124.565 1.146 . . . . 0.0 109.725 175.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -69.38 -44.2 71.96 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 121.42 -0.8 . . . . 0.0 112.192 -178.473 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -58.11 -41.2 83.06 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.415 -0.803 . . . . 0.0 112.216 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -89.11 -37.83 14.79 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 114.247 1.202 . . . . 0.0 114.247 -175.496 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -124.25 -2.01 8.12 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 -170.084 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 53.71 47.99 22.51 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 126.703 2.001 . . . . 0.0 113.369 -176.171 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -132.2 142.39 49.42 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.679 1.192 . . . . 0.0 111.781 175.489 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -135.71 -28.83 1.08 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.076 1.35 . . . . 0.0 112.996 -157.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 20.8 p -79.12 167.05 21.57 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 128.023 2.529 . . . . 0.0 113.265 177.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 26.8 m -114.99 152.92 47.02 Favored Pre-proline 0 N--CA 1.48 1.063 0 C-N-CA 124.173 0.989 . . . . 0.0 112.694 173.17 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -77.28 143.28 74.54 Favored 'Cis proline' 0 C--N 1.349 0.592 0 CA-C-N 119.18 0.743 . . . . 0.0 112.498 -6.391 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -97.63 127.9 43.93 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 165.519 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 35.4 mt -123.73 142.37 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 124.128 0.971 . . . . 0.0 109.527 -165.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -137.63 143.03 41.22 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.813 0.845 . . . . 0.0 111.666 177.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 89.1 mt -130.01 119.65 47.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 125.165 1.386 . . . . 0.0 108.753 176.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 44.2 46.1 7.28 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 125.112 1.365 . . . . 0.0 113.178 -177.005 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 77.65 -2.35 63.72 Favored Glycine 0 CA--C 1.541 1.716 0 N-CA-C 117.066 1.586 . . . . 0.0 117.066 -178.006 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 25.7 m-80 -88.5 138.09 31.74 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 120.291 2.046 . . . . 0.0 110.326 175.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -82.61 136.11 34.89 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 118.994 0.816 . . . . 0.0 112.37 176.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 40.6 mm -115.98 124.97 72.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 127.016 2.126 . . . . 0.0 108.928 -178.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -68.72 2.63 7.63 Favored Glycine 0 CA--C 1.535 1.313 0 N-CA-C 119.25 2.46 . . . . 0.0 119.25 -163.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 142.6 -171.25 24.83 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 126.137 1.827 . . . . 0.0 113.216 175.092 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 42.4 t -64.07 -40.87 97.2 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 121.757 -0.849 . . . . 0.0 112.4 -177.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 68.1 m -72.89 -21.06 60.98 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.131 -0.981 . . . . 0.0 113.374 178.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -73.26 -42.65 62.24 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.262 0.937 . . . . 0.0 111.882 167.027 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 53.5 tp -61.06 -45.17 95.83 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.956 0.902 . . . . 0.0 110.988 175.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -64.71 -38.98 92.85 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 122.065 -0.397 . . . . 0.0 111.823 173.103 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.08 -36.95 83.23 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.081 -1.012 . . . . 0.0 112.106 178.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 92.4 mt -67.79 -28.69 67.81 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.69 -0.631 . . . . 0.0 112.173 175.58 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -69.7 -43.82 71.67 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.313 0.645 . . . . 0.0 111.098 173.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -69.93 -36.19 75.12 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.299 1.039 . . . . 0.0 113.065 175.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -73.15 -7.68 52.45 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.157 1.383 . . . . 0.0 113.299 175.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 79.37 10.13 86.27 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 123.846 0.736 . . . . 0.0 114.523 177.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 40.7 mtmt -91.11 -30.62 16.62 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 126.424 1.89 . . . . 0.0 112.527 -174.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 19.5 tp -61.97 -35.91 79.88 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 119.147 0.885 . . . . 0.0 111.392 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -65.55 -35.62 81.38 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.19 0.996 . . . . 0.0 112.318 171.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -77.36 -23.77 67.33 Favored Glycine 0 CA--C 1.532 1.121 0 O-C-N 120.879 -1.138 . . . . 0.0 114.566 177.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 86.8 mt -86.95 -27.38 23.34 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.412 1.485 . . . . 0.0 113.021 176.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 74.8 mt -117.93 -16.84 9.86 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 -170.24 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.7 m . . . . . 0 C--O 1.254 1.322 0 C-N-CA 126.625 1.97 . . . . 0.0 114.152 177.278 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.062 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.37 156.32 31.3 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -175.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.4 ttt -116.52 85.57 16.74 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 124.857 1.263 . . . . 0.0 111.789 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -76.76 146.53 26.68 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.785 2.323 . . . . 0.0 112.833 177.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 44.1 p -86.6 -169.88 2.83 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.453 1.501 . . . . 0.0 111.786 169.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.557 HG23 HD12 ' A' ' 54' ' ' LEU . 11.5 pt -50.98 -23.32 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.841 1.256 . . . . 0.0 113.553 168.269 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.69 -27.27 69.13 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -175.211 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.6 m -85.4 -11.44 54.46 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 172.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 55.7 mtt -68.79 -32.7 72.63 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 120.795 -1.19 . . . . 0.0 111.176 170.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.3 mm -60.51 -30.41 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 123.788 0.835 . . . . 0.0 111.905 -176.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.0 mttm -74.28 -8.9 57.82 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.825 1.25 . . . . 0.0 113.725 -177.435 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -89.8 -28.37 18.86 Favored Glycine 0 CA--C 1.537 1.41 0 N-CA-C 116.961 1.544 . . . . 0.0 116.961 -166.151 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -145.07 159.27 43.22 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.504 1.522 . . . . 0.0 111.05 -178.311 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -52.91 -42.29 65.23 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.711 1.605 . . . . 0.0 113.63 178.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.2 t -125.09 135.68 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.809 1.244 . . . . 0.0 110.464 174.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 48.4 t -133.85 131.73 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.394 1.078 . . . . 0.0 110.46 178.083 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.4 t -129.36 147.43 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 125.265 1.426 . . . . 0.0 111.545 -172.147 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -124.3 115.39 20.94 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.18 0.992 . . . . 0.0 109.212 172.172 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.407 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 21.0 m -130.19 168.22 17.17 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 126.18 1.792 . . . . 0.0 111.022 -168.493 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.45 ' CD1' ' HB3' ' A' ' 46' ' ' ASP . 19.5 m0 -111.81 135.79 51.96 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 157.232 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 72.2 t -59.22 -28.23 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 O-C-N 123.189 0.305 . . . . 0.0 111.109 175.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 48.7 p -67.65 -20.33 65.31 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 175.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 46.0 t -89.76 143.81 30.8 Favored Pre-proline 0 CA--C 1.538 0.491 0 O-C-N 121.281 -0.887 . . . . 0.0 111.193 -163.127 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -77.05 -39.48 0.6 Allowed 'Trans proline' 0 N--CA 1.459 -0.544 0 CA-C-N 119.656 0.913 . . . . 0.0 114.122 177.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -58.82 -36.33 74.32 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.049 1.739 . . . . 0.0 113.4 175.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.407 ' SG ' ' HB3' ' A' ' 19' ' ' SER . 0.3 OUTLIER -52.63 -55.67 20.82 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.949 1.3 . . . . 0.0 109.14 171.847 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.8 t -65.9 -39.99 86.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 123.53 0.732 . . . . 0.0 111.124 -178.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . 0.288 2.4 ttp180 -54.22 -28.84 43.67 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.012 1.725 . . . . 0.0 115.369 167.036 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -85.38 -55.53 3.97 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 119.911 1.232 . . . . 0.0 111.883 167.304 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -48.37 -38.33 19.06 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.96 1.704 . . . . 0.0 113.776 -178.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -75.0 -43.69 52.45 Favored 'General case' 0 C--O 1.231 0.081 0 C-N-CA 124.385 1.074 . . . . 0.0 111.889 -177.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 8.4 tt -71.53 -39.56 70.67 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 124.714 1.206 . . . . 0.0 110.888 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 88.8 mt -61.75 -51.77 66.97 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.56 0.744 . . . . 0.0 110.746 176.013 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 24.2 m-70 -65.87 -15.92 63.37 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 172.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.72 -43.84 24.87 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 119.844 1.202 . . . . 0.0 111.43 169.182 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 68.7 mmt-85 -82.0 -50.41 9.15 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.219 1.008 . . . . 0.0 113.43 -171.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 21.9 m -160.54 129.09 4.7 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 125.106 1.362 . . . . 0.0 111.95 177.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 42.9 mttm -85.98 2.25 46.99 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 126.007 1.723 . . . . 0.0 115.228 -166.213 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -82.31 53.83 2.39 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.534 1.133 . . . . 0.0 112.04 172.389 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -118.87 127.43 75.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 126.567 1.947 . . . . 0.0 111.14 -177.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.6 m -110.78 141.31 44.28 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 126.067 1.747 . . . . 0.0 110.44 171.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.6 p -137.47 135.92 46.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 C-N-CA 124.535 1.134 . . . . 0.0 112.766 175.229 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -110.79 125.9 54.04 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.379 1.472 . . . . 0.0 109.45 175.613 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -97.21 88.27 4.41 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 122.526 1.155 . . . . 0.0 110.966 -174.333 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 22.1 m -64.6 -12.86 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 -174.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.45 ' HB3' ' CD1' ' A' ' 20' ' ' TRP . 0.1 OUTLIER -73.69 -21.37 60.27 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.619 1.168 . . . . 0.0 113.323 172.612 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -86.78 -27.1 23.8 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.257 1.423 . . . . 0.0 113.14 177.087 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 90.7 mtp -69.55 154.28 42.24 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.724 1.61 . . . . 0.0 112.117 175.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 8.6 t -84.02 -24.85 30.34 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.902 0.881 . . . . 0.0 111.691 163.308 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -93.47 -5.38 49.33 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.49 1.516 . . . . 0.0 114.779 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -57.41 -24.16 51.09 Favored Glycine 0 CA--C 1.536 1.386 0 N-CA-C 116.147 1.219 . . . . 0.0 116.147 -172.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -69.65 -22.49 63.46 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 118.687 1.243 . . . . 0.0 112.898 174.492 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -82.0 -35.63 28.68 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.937 0.895 . . . . 0.0 111.345 170.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.557 HD12 HG23 ' A' ' 6' ' ' ILE . 2.9 mm? -74.45 -32.94 62.78 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.132 -0.98 . . . . 0.0 111.996 177.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 62.0 mtp180 -53.71 -39.97 65.67 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 121.123 -0.985 . . . . 0.0 111.632 162.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -67.83 -37.06 88.05 Favored Glycine 0 CA--C 1.535 1.321 0 CA-C-O 118.3 -1.278 . . . . 0.0 114.155 172.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -60.72 -32.32 71.59 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 120.746 2.273 . . . . 0.0 113.296 174.024 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 57.2 mt -75.53 -43.99 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 123.904 0.882 . . . . 0.0 109.95 174.032 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 19.0 t80 -67.7 -43.19 80.68 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.026 -1.046 . . . . 0.0 112.728 -177.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -67.38 -15.2 63.55 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 113.944 1.091 . . . . 0.0 113.944 178.283 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -106.71 -26.54 11.27 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 177.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -143.44 4.84 1.4 Allowed 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 115.858 1.799 . . . . 0.0 115.858 -170.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm 54.42 24.49 5.26 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 127.608 2.363 . . . . 0.0 116.952 178.565 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 -101.52 111.13 23.27 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.057 1.343 . . . . 0.0 111.615 -174.154 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -96.36 -17.16 20.85 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 178.331 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 98.3 m -72.52 153.71 41.19 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.682 1.593 . . . . 0.0 111.862 176.193 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.7 m -115.99 151.74 46.85 Favored Pre-proline 0 N--CA 1.477 0.904 0 C-N-CA 123.713 0.805 . . . . 0.0 111.546 165.469 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -74.19 155.62 99.84 Favored 'Cis proline' 0 N--CA 1.459 -0.539 0 CA-C-N 119.207 0.753 . . . . 0.0 112.944 -3.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -98.13 139.33 34.1 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.542 1.137 . . . . 0.0 108.447 159.058 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 53.0 mt -129.91 140.81 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 123.972 0.909 . . . . 0.0 109.487 -165.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -138.13 143.13 40.2 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.126 0.97 . . . . 0.0 111.18 178.187 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 72.4 mt -135.22 123.13 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 125.346 1.458 . . . . 0.0 109.17 -178.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 45.27 48.33 10.26 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 124.902 1.281 . . . . 0.0 113.371 -179.306 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 75.04 10.92 84.19 Favored Glycine 0 CA--C 1.539 1.545 0 N-CA-C 116.066 1.186 . . . . 0.0 116.066 179.434 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 21.1 m-80 -116.04 140.39 49.32 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.472 1.509 . . . . 0.0 111.683 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -82.47 131.9 35.21 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.596 1.158 . . . . 0.0 112.944 179.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 41.1 mm -107.25 123.43 62.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 127.047 2.139 . . . . 0.0 108.288 177.401 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.18 12.02 0.66 Allowed Glycine 0 CA--C 1.531 1.055 0 N-CA-C 119.089 2.395 . . . . 0.0 119.089 -166.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 142.36 -177.1 21.83 Favored Glycine 0 CA--C 1.535 1.316 0 C-N-CA 127.582 2.515 . . . . 0.0 113.643 170.324 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 39.1 t -57.09 -42.86 81.52 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.721 -0.87 . . . . 0.0 111.458 173.247 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 68.5 m -65.53 -26.06 67.72 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 178.151 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.44 -40.56 64.13 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 119.703 1.138 . . . . 0.0 111.768 172.08 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 40.1 tp -60.55 -48.96 79.45 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.865 0.866 . . . . 0.0 110.738 173.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -66.19 -34.36 77.86 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.522 0.729 . . . . 0.0 111.438 177.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.85 -35.66 74.9 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 120.227 -1.546 . . . . 0.0 112.79 175.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 84.0 mt -72.55 -31.05 64.97 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.216 1.007 . . . . 0.0 112.777 173.265 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -59.4 -48.55 81.2 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.788 0.835 . . . . 0.0 110.109 166.408 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.92 -34.4 75.33 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 -178.681 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -75.74 0.72 16.86 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 172.492 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 71.05 21.47 78.36 Favored Glycine 0 CA--C 1.534 1.219 0 O-C-N 121.322 -0.861 . . . . 0.0 113.445 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt -101.38 -25.96 13.76 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 125.688 1.595 . . . . 0.0 113.107 -174.114 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 39.4 tp -64.2 -37.4 87.33 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.267 1.027 . . . . 0.0 112.189 176.172 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -52.8 -44.09 66.39 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.002 0.921 . . . . 0.0 111.973 173.201 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -75.01 -29.78 60.2 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.044 0.831 . . . . 0.0 114.525 178.3 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 85.1 mt -66.09 -40.84 91.13 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 118.382 1.091 . . . . 0.0 111.356 170.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 86.4 mt -90.53 -18.87 24.51 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 -170.154 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 72.7 m . . . . . 0 C--O 1.252 1.205 0 C-N-CA 124.506 1.122 . . . . 0.0 113.385 -179.286 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.105 0 N-CA-C 111.261 -0.736 . . . . 0.0 111.261 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -81.66 161.47 23.4 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.651 1.18 . . . . 0.0 113.068 -176.093 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 16.6 tpt -70.06 140.48 88.4 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 124.062 0.945 . . . . 0.0 110.796 176.43 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -75.5 130.24 12.6 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.502 2.135 . . . . 0.0 111.129 171.514 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 17.5 p -132.05 -162.48 1.23 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.323 1.049 . . . . 0.0 111.865 176.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.493 HG23 HD12 ' A' ' 54' ' ' LEU . 16.2 pt -51.03 -24.04 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 124.496 1.118 . . . . 0.0 113.589 173.107 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.86 -27.99 67.14 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.87 0.868 . . . . 0.0 113.094 -175.037 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.1 p -80.65 -28.82 36.78 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 121.242 -0.911 . . . . 0.0 113.426 174.354 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 43.3 mtt -63.97 -35.47 80.79 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.29 1.036 . . . . 0.0 110.478 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -62.88 -27.39 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 125.89 1.676 . . . . 0.0 111.826 -176.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 45.2 mmtm -79.21 -17.04 55.61 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.018 1.327 . . . . 0.0 113.779 -175.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -87.34 -26.77 29.64 Favored Glycine 0 CA--C 1.533 1.198 0 N-CA-C 116.331 1.292 . . . . 0.0 116.331 -167.24 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -134.05 153.77 51.59 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.694 1.197 . . . . 0.0 111.628 -178.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -62.77 -34.62 77.62 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.002 0.741 . . . . 0.0 113.002 -174.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.4 t -122.27 131.53 72.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.373 1.069 . . . . 0.0 109.896 167.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 65.1 t -132.01 127.77 58.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.158 0.983 . . . . 0.0 109.571 176.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 37.5 t -126.28 147.3 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 123.929 0.892 . . . . 0.0 111.773 -175.484 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -122.55 108.81 13.56 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.568 1.147 . . . . 0.0 109.44 176.238 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 37.1 m -128.93 173.88 10.01 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 126.638 1.975 . . . . 0.0 111.458 -167.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 28.9 m0 -120.11 144.58 47.54 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.367 1.067 . . . . 0.0 109.699 163.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.5 t -68.73 -17.2 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 CA-C-O 120.934 0.397 . . . . 0.0 111.079 178.123 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.3 p -86.31 -10.81 53.75 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 128.066 2.547 . . . . 0.0 116.579 178.063 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.9 t -96.45 143.42 26.08 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-N 120.017 1.28 . . . . 0.0 112.731 -170.291 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -72.21 -40.19 2.55 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 121.28 1.32 . . . . 0.0 113.634 173.409 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -58.0 -36.81 73.18 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.334 1.453 . . . . 0.0 113.802 179.012 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -54.02 -61.22 2.45 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.477 1.911 . . . . 0.0 109.573 174.751 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 92.0 t -60.9 -39.37 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.346 1.058 . . . . 0.0 111.104 -179.296 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.2 ttt180 -52.54 -38.57 60.02 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.684 1.594 . . . . 0.0 114.901 169.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -79.53 -54.59 5.75 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 119.079 0.854 . . . . 0.0 111.79 171.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -48.19 -43.35 31.72 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.386 1.474 . . . . 0.0 113.137 -178.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -62.3 -40.22 95.57 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 123.722 0.809 . . . . 0.0 112.35 -175.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.4 tt -79.08 -42.34 26.59 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 126.538 1.935 . . . . 0.0 110.867 -178.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 91.5 mt -62.07 -40.66 96.56 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 121.868 -0.52 . . . . 0.0 111.665 177.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -71.27 -24.48 62.17 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 172.377 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.56 -25.04 53.62 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 120.144 1.338 . . . . 0.0 112.921 174.028 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 7.5 tpt180 -106.88 -31.98 8.12 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.868 1.667 . . . . 0.0 114.823 -170.265 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 13.6 p -134.05 154.44 51.15 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 -166.247 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -103.81 -31.91 9.58 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 127.406 2.282 . . . . 0.0 112.455 174.65 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -93.06 38.52 1.03 Allowed 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 125.451 1.5 . . . . 0.0 113.186 -171.035 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.14 122.4 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 124.974 1.309 . . . . 0.0 112.96 -175.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.9 m -113.3 135.28 54.02 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.811 1.645 . . . . 0.0 109.847 170.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.3 p -124.21 138.05 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.457 1.103 . . . . 0.0 112.304 171.202 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -109.37 125.95 52.91 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.015 1.726 . . . . 0.0 110.637 177.15 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -98.17 79.82 2.62 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.351 1.061 . . . . 0.0 110.233 -177.174 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 31.0 m -56.89 -28.55 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -167.502 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -70.66 -14.25 62.4 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 124.329 1.052 . . . . 0.0 113.693 176.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.2 mmmt -83.0 -13.02 56.76 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 126.3 1.84 . . . . 0.0 112.559 173.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 22.3 mmt -101.5 172.26 7.07 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.178 1.791 . . . . 0.0 111.787 -178.381 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.0 m -81.19 -18.75 45.12 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 121.063 -1.023 . . . . 0.0 113.331 -177.135 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -122.05 8.29 9.82 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.702 1.601 . . . . 0.0 114.42 -163.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -55.45 -27.98 49.51 Favored Glycine 0 CA--C 1.538 1.523 0 CA-C-N 120.035 1.289 . . . . 0.0 115.18 -172.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -67.82 -31.65 71.65 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 119.973 1.886 . . . . 0.0 113.088 171.002 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 63.8 mt-30 -73.69 -38.55 64.85 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.686 1.194 . . . . 0.0 111.344 173.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.493 HD12 HG23 ' A' ' 6' ' ' ILE . 2.7 mm? -75.18 -33.9 61.49 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.484 1.038 . . . . 0.0 111.962 177.691 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 15.7 mtp85 -55.32 -41.06 71.93 Favored 'General case' 0 N--CA 1.478 0.965 0 O-C-N 120.953 -1.092 . . . . 0.0 111.303 161.358 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.38 -24.16 67.27 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 124.444 1.021 . . . . 0.0 115.127 171.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 -71.45 -37.29 71.41 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 120.471 2.136 . . . . 0.0 111.72 172.131 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 44.1 mt -72.35 -43.55 64.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 123.948 0.899 . . . . 0.0 109.539 179.225 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -67.76 -42.75 81.27 Favored 'General case' 0 CA--C 1.532 0.262 0 O-C-N 121.298 -0.876 . . . . 0.0 112.914 -178.031 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -65.7 -26.06 67.6 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -177.668 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -100.19 -29.55 12.42 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -131.58 -2.41 3.81 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 114.752 1.39 . . . . 0.0 114.752 -172.206 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt 51.33 39.0 23.11 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 126.152 1.781 . . . . 0.0 113.629 -175.355 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -123.52 138.66 54.52 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 126.828 2.051 . . . . 0.0 110.701 -178.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -142.39 -33.17 0.48 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.603 1.561 . . . . 0.0 111.966 -155.302 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.7 p -84.03 113.18 20.83 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.43 1.492 . . . . 0.0 113.102 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.2 m -66.77 153.54 93.64 Favored Pre-proline 0 N--CA 1.484 1.245 0 C-N-CA 124.811 1.245 . . . . 0.0 113.1 -179.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -75.89 151.94 96.21 Favored 'Cis proline' 0 C--N 1.352 0.715 0 CA-C-N 119.327 0.795 . . . . 0.0 113.918 -6.372 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -93.79 137.05 33.44 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 159.372 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 46.3 mt -125.1 141.64 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 124.209 1.004 . . . . 0.0 109.243 -168.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -142.41 147.09 35.62 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.391 0.676 . . . . 0.0 111.587 179.147 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 74.9 mt -127.91 123.37 60.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 125.277 1.431 . . . . 0.0 108.099 175.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 50.62 27.57 3.02 Favored 'General case' 0 CA--C 1.555 1.149 0 N-CA-C 115.257 1.577 . . . . 0.0 115.257 -177.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 89.89 -7.39 81.81 Favored Glycine 0 CA--C 1.543 1.827 0 O-C-N 120.697 -1.252 . . . . 0.0 115.257 -173.468 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -90.86 143.3 26.87 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.103 1.761 . . . . 0.0 110.336 179.13 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -90.19 142.6 27.56 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 -167.188 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 15.9 mm -130.84 125.49 58.36 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 C-N-CA 128.245 2.618 . . . . 0.0 108.981 176.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.7 -13.94 64.3 Favored Glycine 0 CA--C 1.538 1.488 0 N-CA-C 117.166 1.627 . . . . 0.0 117.166 -168.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 158.25 -175.24 35.44 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-N 118.271 1.035 . . . . 0.0 113.528 175.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 14.7 t -63.43 -35.36 80.18 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.507 -0.996 . . . . 0.0 112.943 -178.382 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 52.2 m -64.65 -23.1 67.15 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 121.113 -0.992 . . . . 0.0 113.271 176.564 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -88.17 -39.74 14.28 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.504 1.522 . . . . 0.0 112.702 174.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 37.7 tp -58.21 -51.93 67.68 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.38 1.472 . . . . 0.0 111.502 171.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -63.17 -24.52 67.93 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.041 0.536 . . . . 0.0 111.714 178.483 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -78.84 -31.96 45.9 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 121.304 -0.872 . . . . 0.0 113.334 176.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 14.2 mt -65.34 -34.91 79.43 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 119.278 0.944 . . . . 0.0 112.059 169.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -61.6 -44.87 96.2 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.861 0.864 . . . . 0.0 110.932 171.176 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.1 mmtt -71.54 -30.4 65.85 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -177.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -72.86 -10.88 60.3 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 172.199 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 74.89 30.24 59.73 Favored Glycine 0 CA--C 1.533 1.19 0 O-C-N 121.292 -0.88 . . . . 0.0 113.649 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 45.8 mtmt -118.97 -16.0 9.25 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 126.668 1.987 . . . . 0.0 113.021 -169.084 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 35.1 tp -71.35 -38.94 71.58 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.857 1.263 . . . . 0.0 111.915 -175.08 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -65.46 -28.42 69.2 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 178.45 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -85.31 -12.7 72.62 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 125.622 1.582 . . . . 0.0 115.22 172.387 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 24.9 mt -81.2 -39.31 25.62 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 119.377 1.589 . . . . 0.0 111.055 165.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 79.3 mt -89.29 26.25 1.7 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 126.328 1.851 . . . . 0.0 113.035 -175.548 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 10.7 p . . . . . 0 C--O 1.251 1.143 0 C-N-CA 127.099 2.159 . . . . 0.0 114.673 -177.502 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.861 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -58.72 -23.44 59.71 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.86 1.264 . . . . 0.0 114.378 179.071 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 63.7 mtt -121.65 156.9 58.15 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 125.798 1.639 . . . . 0.0 109.021 158.218 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -64.5 112.04 1.83 Allowed 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.02 1.813 . . . . 0.0 112.192 -175.58 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 59.8 p -107.52 -161.57 0.79 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 126.082 1.753 . . . . 0.0 110.616 179.334 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.516 HG23 HD12 ' A' ' 54' ' ' LEU . 29.9 pt -56.08 -25.68 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 O-C-N 120.762 -1.211 . . . . 0.0 112.49 168.342 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.96 -19.77 65.98 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -173.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.3 m -89.08 -19.84 25.07 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.425 1.09 . . . . 0.0 113.256 173.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 66.4 mtp -62.53 -33.35 74.72 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 119.39 0.995 . . . . 0.0 111.804 172.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.2 mm -60.47 -18.09 15.99 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 124.672 1.189 . . . . 0.0 112.267 -177.105 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.2 mptt -91.37 -9.02 46.34 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.245 1.418 . . . . 0.0 113.859 177.09 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -88.19 -39.04 7.02 Favored Glycine 0 CA--C 1.538 1.528 0 C-N-CA 124.715 1.15 . . . . 0.0 115.814 -175.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 29.1 m120 -120.96 167.33 12.69 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.369 1.467 . . . . 0.0 112.072 -178.433 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -68.83 -42.02 77.74 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.57 0.748 . . . . 0.0 112.67 176.512 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.9 t -125.5 134.17 67.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.95 1.3 . . . . 0.0 110.2 176.48 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 27.1 t -134.74 135.1 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.249 1.02 . . . . 0.0 110.361 177.234 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 53.0 t -134.42 149.24 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 124.55 1.14 . . . . 0.0 112.085 -171.116 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -129.69 123.1 30.32 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.993 1.317 . . . . 0.0 110.873 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 54.1 m -143.9 169.92 16.88 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 114.452 1.278 . . . . 0.0 114.452 -159.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.484 ' CD1' ' HB3' ' A' ' 46' ' ' ASP . 40.5 m0 -115.17 139.5 49.87 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.547 1.539 . . . . 0.0 109.616 161.224 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 24.8 t -60.21 -53.72 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 -161.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.7 t -94.23 3.43 55.26 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 -164.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.447 ' HA ' ' HD3' ' A' ' 24' ' ' PRO . 96.4 m -88.76 142.31 30.6 Favored Pre-proline 0 CA--C 1.542 0.667 0 C-N-CA 124.328 1.051 . . . . 0.0 112.599 -165.005 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 23' ' ' CYS . 65.8 Cg_exo -68.0 -36.97 16.09 Favored 'Trans proline' 0 C--N 1.351 0.68 0 N-CA-C 115.677 1.376 . . . . 0.0 115.677 -162.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -52.93 -41.83 64.83 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 122.24 1.019 . . . . 0.0 113.075 171.102 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 3.8 m -81.73 -32.52 31.53 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.359 -162.141 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 99.6 t -62.46 -53.07 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 124.954 1.301 . . . . 0.0 111.51 161.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . 0.263 7.2 ptp180 -67.45 -29.27 68.69 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -173.032 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.28 -53.24 13.05 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.438 1.095 . . . . 0.0 111.685 171.556 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -46.65 -44.88 18.8 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-N 119.91 1.232 . . . . 0.0 112.879 175.155 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -64.07 -45.58 88.13 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.501 0.72 . . . . 0.0 112.595 -179.344 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.2 tt -72.4 -36.55 68.68 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.446 1.098 . . . . 0.0 111.206 -178.486 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 95.9 mt -61.1 -46.54 90.19 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.443 -0.785 . . . . 0.0 110.735 171.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 8.7 m-70 -66.83 -21.71 66.02 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 173.254 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -73.0 -18.44 61.35 Favored 'General case' 0 CA--C 1.545 0.782 0 O-C-N 120.716 -1.24 . . . . 0.0 113.069 173.227 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 21.7 mmt85 -115.73 -19.83 10.34 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 -179.193 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 48.8 p -147.32 166.89 25.74 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 115.394 1.627 . . . . 0.0 115.394 -166.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 28.9 mtmm -116.69 -32.05 5.29 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 127.165 2.186 . . . . 0.0 113.623 162.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -82.73 50.59 1.71 Allowed 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -175.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.2 113.07 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 126.16 1.784 . . . . 0.0 111.964 177.116 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.4 m -100.49 142.91 31.32 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 127.014 2.125 . . . . 0.0 110.097 175.355 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.7 p -145.24 140.58 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -178.524 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 38.8 t60 -116.67 131.8 56.85 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 126.595 1.958 . . . . 0.0 110.98 -176.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -101.93 96.62 7.16 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 122.761 1.267 . . . . 0.0 111.973 -177.586 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 22.4 m -80.43 -1.63 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -174.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.484 ' HB3' ' CD1' ' A' ' 20' ' ' TRP . 0.0 OUTLIER -83.64 -12.11 56.4 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.146 0.978 . . . . 0.0 112.085 162.855 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -107.29 -44.07 4.43 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.588 1.555 . . . . 0.0 112.013 179.064 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 29.2 tpp -67.97 127.23 32.07 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 118.833 0.742 . . . . 0.0 110.224 176.47 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 62.8 m -68.42 -29.49 68.17 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 119.373 0.988 . . . . 0.0 113.354 -174.257 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 20.5 tp10 -79.74 -3.09 46.01 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.021 0.928 . . . . 0.0 112.648 170.314 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -56.53 -26.27 51.93 Favored Glycine 0 CA--C 1.529 0.914 0 O-C-N 120.489 -1.382 . . . . 0.0 114.511 -171.573 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -70.18 -24.11 63.08 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 118.537 1.169 . . . . 0.0 112.67 176.03 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 16.8 tm0? -86.72 -34.58 19.64 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.126 1.37 . . . . 0.0 111.811 170.465 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.516 HD12 HG23 ' A' ' 6' ' ' ILE . 3.0 mm? -67.16 -33.76 76.11 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 119.572 1.078 . . . . 0.0 112.293 171.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 30.1 ttt180 -62.01 -29.93 70.6 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.405 1.482 . . . . 0.0 110.937 165.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.29 -24.7 75.94 Favored Glycine 0 CA--C 1.542 1.72 0 C-N-CA 125.632 1.587 . . . . 0.0 115.784 165.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -71.96 -25.78 62.01 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 121.19 2.495 . . . . 0.0 112.017 169.457 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 23.8 mt -74.66 -46.46 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 123.253 0.621 . . . . 0.0 109.461 166.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -63.69 -42.21 98.02 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.14 -0.975 . . . . 0.0 113.398 -176.531 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 95.0 mm-40 -71.87 -10.0 59.14 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 178.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -107.54 -35.64 6.68 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.536 1.135 . . . . 0.0 113.547 176.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -137.49 4.7 2.64 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.349 1.459 . . . . 0.0 114.703 -169.572 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 50.71 42.3 27.18 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 127.006 2.122 . . . . 0.0 114.516 176.589 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 61.8 t60 -127.44 129.92 48.36 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.847 1.259 . . . . 0.0 111.119 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -119.91 -1.33 10.47 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.621 1.568 . . . . 0.0 113.759 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.3 m -86.06 173.45 9.87 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.998 1.719 . . . . 0.0 110.468 175.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.7 m -132.73 156.95 79.51 Favored Pre-proline 0 N--CA 1.48 1.025 0 O-C-N 120.631 -1.293 . . . . 0.0 113.917 -175.503 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -73.16 159.8 96.73 Favored 'Cis proline' 0 C--N 1.349 0.591 0 CA-C-N 118.588 0.531 . . . . 0.0 112.471 -13.346 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -101.9 141.02 35.39 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.972 0.909 . . . . 0.0 108.986 159.42 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 82.0 mt -130.68 144.15 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 123.726 0.811 . . . . 0.0 109.65 -168.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -140.5 146.37 38.07 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.243 1.017 . . . . 0.0 111.998 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 71.5 mt -129.26 118.98 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 125.367 1.467 . . . . 0.0 108.241 172.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 47.49 38.23 7.5 Favored 'General case' 0 CA--C 1.552 1.056 0 N-CA-C 115.821 1.785 . . . . 0.0 115.821 176.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 93.48 -7.51 74.9 Favored Glycine 0 CA--C 1.538 1.477 0 C-N-CA 124.593 1.092 . . . . 0.0 115.312 -178.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -102.47 138.03 39.93 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.939 1.696 . . . . 0.0 110.406 -174.154 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -85.23 147.73 26.43 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.073 0.949 . . . . 0.0 113.076 -170.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 20.6 mm -133.34 120.64 39.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 128.473 2.709 . . . . 0.0 106.279 177.041 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.88 -15.66 55.68 Favored Glycine 0 CA--C 1.533 1.182 0 N-CA-C 116.851 1.5 . . . . 0.0 116.851 -160.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 138.8 -152.14 22.01 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 125.609 1.576 . . . . 0.0 112.739 179.138 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 8.6 t -72.25 -20.48 61.53 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -173.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.8 m -83.38 -38.52 21.87 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 121.254 -0.904 . . . . 0.0 112.012 171.324 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -70.7 -36.38 73.23 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.148 0.979 . . . . 0.0 111.641 177.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 47.5 tp -59.82 -57.49 12.68 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.405 1.482 . . . . 0.0 111.645 -179.434 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -69.59 -30.58 68.38 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.892 -0.505 . . . . 0.0 111.305 178.262 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.02 -38.25 87.98 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 119.474 1.034 . . . . 0.0 112.49 176.39 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 85.4 mt -73.81 -25.24 60.0 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.917 0.887 . . . . 0.0 112.702 176.109 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -73.08 -40.12 65.29 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 118.779 0.718 . . . . 0.0 111.609 169.173 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.1 mptt -65.19 -30.4 71.3 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.371 1.068 . . . . 0.0 112.889 173.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -80.34 1.97 26.69 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.083 1.353 . . . . 0.0 113.851 169.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 71.21 24.13 77.34 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 124.732 1.158 . . . . 0.0 114.761 175.069 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -113.2 -31.74 6.52 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 126.051 1.74 . . . . 0.0 113.365 -170.422 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 36.7 tp -57.23 -42.7 81.92 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 122.618 0.367 . . . . 0.0 111.467 -175.405 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -63.56 -42.73 98.33 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -178.459 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -73.05 -29.45 64.72 Favored Glycine 0 CA--C 1.528 0.876 0 CA-C-O 119.123 -0.821 . . . . 0.0 114.439 177.533 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 81.8 mt -72.8 -34.21 66.74 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 118.332 1.066 . . . . 0.0 112.188 172.202 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 66.5 mt -86.7 -16.32 36.83 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.294 1.038 . . . . 0.0 113.607 179.144 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 58.7 m . . . . . 0 C--O 1.254 1.314 0 C-N-CA 124.976 1.31 . . . . 0.0 111.714 175.031 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.893 0 N-CA-C 111.62 -0.592 . . . . 0.0 111.62 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 55.73 21.24 4.52 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 126.838 2.055 . . . . 0.0 115.834 178.676 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 7.4 tpt -142.08 86.62 10.2 Favored Pre-proline 0 CA--C 1.547 0.857 0 C-N-CA 124.538 1.135 . . . . 0.0 110.868 -167.102 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_exo -53.99 -31.91 65.99 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 123.954 3.103 . . . . 0.0 116.091 -171.501 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.0 m 57.44 -152.0 0.41 Allowed 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.071 1.348 . . . . 0.0 114.594 168.462 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.5 pt -60.99 -23.09 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 124.529 1.131 . . . . 0.0 113.941 -168.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -54.58 -27.25 37.65 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.729 1.212 . . . . 0.0 112.177 178.034 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 92.9 p -68.56 -36.37 78.68 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.765 1.226 . . . . 0.0 113.444 172.326 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 45.3 mtt -72.45 -38.56 68.25 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.385 1.474 . . . . 0.0 111.59 -177.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -66.52 -25.59 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 124.074 0.95 . . . . 0.0 111.551 -171.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -70.75 -11.13 60.76 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.826 1.65 . . . . 0.0 114.123 179.261 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -84.48 -31.27 25.2 Favored Glycine 0 CA--C 1.534 1.258 0 N-CA-C 115.944 1.137 . . . . 0.0 115.944 -167.676 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -136.71 156.72 48.15 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 119.499 1.649 . . . . 0.0 112.568 -174.243 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 28.4 ttpt -62.54 -39.41 93.52 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.986 0.914 . . . . 0.0 112.657 -176.139 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.9 t -124.96 129.08 73.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.524 1.13 . . . . 0.0 109.821 167.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 83.1 t -126.11 127.09 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.389 1.476 . . . . 0.0 109.04 178.478 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 40.3 t -123.53 144.55 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 123.611 0.765 . . . . 0.0 111.169 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -118.3 113.18 21.07 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.672 1.189 . . . . 0.0 109.018 171.401 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 28.4 m -131.35 168.17 18.01 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.384 1.474 . . . . 0.0 112.281 -170.159 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 51.7 m0 -107.92 126.12 52.31 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.644 1.178 . . . . 0.0 107.872 159.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 25.9 t -49.95 -36.48 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 126.49 1.916 . . . . 0.0 113.237 -164.167 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.5 t -93.3 -8.91 40.76 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 127.175 2.19 . . . . 0.0 115.137 -167.476 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 95.6 m -94.28 149.31 36.53 Favored Pre-proline 0 CA--C 1.535 0.374 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -159.348 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -67.39 -47.34 2.23 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 CA-C-N 119.127 0.724 . . . . 0.0 113.603 -163.639 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -68.22 -33.43 74.39 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.438 1.095 . . . . 0.0 113.243 -179.011 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -51.25 -53.37 36.07 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.776 0.83 . . . . 0.0 109.246 167.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 62.6 t -68.75 -36.36 73.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 O-C-N 121.714 -0.617 . . . . 0.0 112.244 -177.409 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 27.7 mmt85 -52.79 -42.07 64.71 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 119.227 0.922 . . . . 0.0 112.046 170.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.64 -56.56 5.14 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.396 0.678 . . . . 0.0 111.878 173.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -50.82 -39.52 53.35 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 119.435 1.016 . . . . 0.0 113.028 -177.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -69.6 -43.64 72.38 Favored 'General case' 0 C--O 1.233 0.184 0 C-N-CA 123.892 0.877 . . . . 0.0 112.312 -178.01 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.4 tt -73.77 -37.62 64.95 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 124.309 1.044 . . . . 0.0 111.464 -178.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 98.0 mt -62.61 -42.84 99.81 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.239 0.616 . . . . 0.0 110.9 174.666 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -67.93 -13.15 61.93 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 171.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -95.6 -13.03 24.7 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.301 1.041 . . . . 0.0 113.751 170.723 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 20.1 mmt180 -111.67 -30.34 7.37 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 114.981 1.474 . . . . 0.0 114.981 -173.572 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.0 t -149.03 156.6 42.48 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -173.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 48.1 mtmt -91.6 -9.13 45.24 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 126.785 2.034 . . . . 0.0 112.499 166.042 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -105.51 20.49 18.81 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -162.02 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.26 136.81 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 125.481 1.513 . . . . 0.0 112.692 -178.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.9 m -125.44 133.7 52.36 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 126.696 1.999 . . . . 0.0 110.014 168.549 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.4 p -121.29 136.11 59.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 125.013 1.325 . . . . 0.0 112.998 173.632 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -104.1 116.65 32.6 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.917 2.087 . . . . 0.0 108.989 174.222 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -88.56 96.37 10.6 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 121.0 -1.063 . . . . 0.0 111.2 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 22.0 m -73.74 1.65 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 -172.463 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -85.29 -22.44 28.56 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.437 1.095 . . . . 0.0 112.756 163.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.5 mmmt -90.34 -35.08 15.43 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.035 1.734 . . . . 0.0 111.667 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -89.35 130.44 35.73 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.692 0.797 . . . . 0.0 110.962 -177.122 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 74.4 m -70.69 -16.09 62.77 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 115.235 1.569 . . . . 0.0 115.235 -169.031 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -93.02 6.67 47.11 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.843 1.657 . . . . 0.0 112.908 173.303 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -51.7 -29.03 24.56 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 125.368 1.461 . . . . 0.0 116.385 -174.247 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -79.73 -25.13 41.2 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.052 1.426 . . . . 0.0 113.358 178.035 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -74.81 -33.95 62.29 Favored 'General case' 0 N--CA 1.469 0.489 0 O-C-N 121.462 -0.774 . . . . 0.0 111.052 168.316 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.54 -42.79 86.63 Favored 'General case' 0 CA--C 1.548 0.882 0 O-C-N 121.716 -0.615 . . . . 0.0 110.342 171.613 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 56.3 mtp85 -54.76 -43.96 73.21 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 119.397 0.999 . . . . 0.0 111.936 167.226 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.41 -42.94 99.14 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 124.24 0.924 . . . . 0.0 113.732 178.547 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 51.2 mm-40 -63.44 -38.18 90.16 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 118.413 1.107 . . . . 0.0 113.449 173.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 65.9 mt -66.46 -44.58 90.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 118.573 0.624 . . . . 0.0 109.621 175.464 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -64.26 -40.35 95.81 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 121.432 -0.793 . . . . 0.0 112.059 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -69.46 -24.88 63.86 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 121.092 -1.005 . . . . 0.0 113.363 -179.109 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -99.53 -25.17 14.52 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 115.008 1.485 . . . . 0.0 115.008 176.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -135.92 0.52 2.66 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 114.741 1.386 . . . . 0.0 114.741 -171.229 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp 48.6 46.05 21.19 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 126.525 1.93 . . . . 0.0 113.729 175.599 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 8.5 t60 -140.39 134.2 30.5 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.283 1.833 . . . . 0.0 109.46 -175.615 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -117.3 -25.38 7.08 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.696 1.599 . . . . 0.0 113.418 -178.177 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.3 p -77.8 129.02 34.93 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.047 0.939 . . . . 0.0 112.621 -171.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.6 m -83.77 151.11 60.66 Favored Pre-proline 0 N--CA 1.478 0.93 0 C-N-CA 123.652 0.781 . . . . 0.0 112.109 -173.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -80.2 156.55 87.12 Favored 'Cis proline' 0 C--N 1.352 0.717 0 N-CA-C 114.118 0.776 . . . . 0.0 114.118 -0.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -101.34 135.35 42.96 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.907 0.883 . . . . 0.0 108.856 159.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 50.9 mt -128.28 139.53 51.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 123.984 0.914 . . . . 0.0 109.149 -166.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -140.0 148.23 41.57 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.62 0.768 . . . . 0.0 112.467 -179.198 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 62.1 mt -130.28 120.19 48.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.445 1.498 . . . . 0.0 108.633 174.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 45.3 40.62 5.4 Favored 'General case' 0 CA--C 1.558 1.269 0 C-N-CA 125.599 1.559 . . . . 0.0 114.625 -176.588 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 82.16 0.85 90.1 Favored Glycine 0 CA--C 1.542 1.762 0 O-C-N 120.822 -1.174 . . . . 0.0 115.629 -178.056 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -95.62 140.12 30.89 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.885 1.674 . . . . 0.0 110.416 176.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -85.07 144.85 27.98 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 119.253 0.933 . . . . 0.0 113.444 -177.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 31.5 mm -123.44 127.44 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 128.764 2.826 . . . . 0.0 107.023 177.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -69.82 18.28 0.64 Allowed Glycine 0 CA--C 1.532 1.118 0 N-CA-C 119.135 2.414 . . . . 0.0 119.135 -163.101 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 114.82 -173.15 14.61 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 128.85 3.119 . . . . 0.0 112.666 -178.125 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 12.9 t -63.5 -33.71 76.18 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 121.485 -1.009 . . . . 0.0 111.688 179.056 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 67.4 m -61.78 -21.99 65.05 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 172.166 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -88.88 -43.8 10.93 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.652 1.181 . . . . 0.0 110.903 174.271 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 48.8 tp -57.24 -48.24 79.33 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.027 1.331 . . . . 0.0 111.683 176.113 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -72.47 -25.96 61.63 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 121.734 -0.604 . . . . 0.0 112.054 179.514 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.48 -28.98 63.24 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.196 -0.94 . . . . 0.0 112.54 175.341 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 52.2 mt -73.78 -26.73 60.79 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.124 1.37 . . . . 0.0 112.808 171.687 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -64.58 -44.43 90.7 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 118.616 0.644 . . . . 0.0 110.343 162.225 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 20.3 mmtt -68.74 -34.18 75.17 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 121.828 -0.545 . . . . 0.0 112.28 -177.172 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.42 ' HB3' ' HE2' ' A' ' 91' ' ' LYS . 6.4 mt-10 -79.83 -3.23 46.93 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 168.322 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.18 44.64 93.64 Favored Glycine 0 CA--C 1.532 1.105 0 CA-C-N 120.262 1.392 . . . . 0.0 112.983 172.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.42 ' HE2' ' HB3' ' A' ' 89' ' ' GLU . 36.6 mtmt -131.18 -8.68 3.81 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 126.996 2.118 . . . . 0.0 113.487 -170.676 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 29.8 tp -66.08 -34.66 78.58 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 122.205 1.002 . . . . 0.0 110.663 -176.145 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -60.87 -48.05 83.57 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 127.577 2.351 . . . . 0.0 114.053 171.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -69.42 -22.68 76.5 Favored Glycine 0 CA--C 1.53 1.012 0 O-C-N 121.131 -0.98 . . . . 0.0 113.697 175.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 36.7 mt -74.03 -37.33 64.37 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 117.663 0.731 . . . . 0.0 111.3 172.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 69.4 mt -75.47 -7.01 53.0 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.603 1.561 . . . . 0.0 114.29 176.495 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 19.6 m . . . . . 0 C--O 1.249 1.03 0 C-N-CA 127.15 2.18 . . . . 0.0 113.739 177.691 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.533 0 N-CA-C 111.718 -0.553 . . . . 0.0 111.718 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -128.45 -26.4 2.78 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 115.073 1.508 . . . . 0.0 115.073 -177.294 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.5 mpt? 47.61 59.36 16.7 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 127.867 2.467 . . . . 0.0 114.346 175.101 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -62.08 146.26 96.22 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 123.097 2.531 . . . . 0.0 112.274 179.138 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 89.4 p -159.8 -167.14 1.9 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.344 1.458 . . . . 0.0 110.79 178.382 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.571 HG23 HD12 ' A' ' 54' ' ' LEU . 20.5 pt -55.02 -21.32 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 179.679 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.14 -18.93 51.07 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 123.817 0.847 . . . . 0.0 113.203 -178.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 40.9 m -83.78 -25.76 30.19 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.807 1.243 . . . . 0.0 113.486 172.146 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 76.9 mtp -69.49 -28.69 66.29 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.281 1.032 . . . . 0.0 112.09 178.185 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.1 mm -64.11 -21.17 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 124.248 1.019 . . . . 0.0 112.342 179.037 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -81.77 -28.24 33.37 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 121.113 -0.992 . . . . 0.0 113.058 173.094 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -87.41 -8.03 75.08 Favored Glycine 0 CA--C 1.53 1.02 0 N-CA-C 116.742 1.457 . . . . 0.0 116.742 -166.295 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -143.61 151.83 40.64 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 119.354 1.577 . . . . 0.0 111.431 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -67.41 -42.56 83.03 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.941 1.296 . . . . 0.0 112.413 -178.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.6 t -121.4 130.94 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 124.878 1.271 . . . . 0.0 110.065 170.262 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.6 t -129.7 128.1 65.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.528 1.131 . . . . 0.0 110.167 178.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 42.2 t -127.43 148.11 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 123.785 0.834 . . . . 0.0 111.715 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -123.64 116.56 23.29 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.798 1.239 . . . . 0.0 109.208 173.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 25.2 m -134.09 172.73 12.43 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.28 1.432 . . . . 0.0 112.203 -167.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.438 ' CD1' ' HB3' ' A' ' 46' ' ' ASP . 28.0 m0 -120.42 142.28 49.36 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.266 1.026 . . . . 0.0 109.784 161.285 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 75.4 t -59.91 -31.6 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 123.042 0.537 . . . . 0.0 111.332 172.722 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -69.09 -15.31 63.41 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 175.177 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 44.1 t -92.99 143.16 26.37 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-N 120.385 1.448 . . . . 0.0 111.278 -167.207 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -83.57 -31.32 0.62 Allowed 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 121.498 1.465 . . . . 0.0 113.157 174.056 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -69.05 -33.56 73.78 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.29 1.436 . . . . 0.0 113.54 178.216 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -45.74 -55.55 6.38 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.363 1.065 . . . . 0.0 109.356 164.703 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 85.9 t -63.91 -38.84 83.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 123.983 0.913 . . . . 0.0 112.068 -179.56 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.4 mmt85 -54.9 -37.82 66.81 Favored 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 119.536 1.062 . . . . 0.0 112.777 174.595 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -76.37 -59.18 2.88 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 123.735 0.647 . . . . 0.0 111.859 172.012 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -44.75 -47.56 10.78 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.854 1.262 . . . . 0.0 112.583 -179.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -65.53 -44.22 87.58 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 123.689 0.796 . . . . 0.0 111.627 -173.074 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.9 tt -69.6 -41.24 76.0 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.632 1.573 . . . . 0.0 110.775 179.489 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 92.2 mt -60.99 -50.43 73.42 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.095 0.558 . . . . 0.0 110.816 176.27 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 69.2 m-70 -66.64 -18.0 65.14 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 173.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.73 -13.73 59.66 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 119.908 1.231 . . . . 0.0 113.702 174.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 26.5 mmt85 -119.63 -25.89 5.85 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.73 1.612 . . . . 0.0 114.558 -178.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 19.3 m -145.98 150.39 35.95 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.605 1.162 . . . . 0.0 112.909 -157.665 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? -108.53 -23.52 11.8 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 126.766 2.027 . . . . 0.0 112.654 165.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -79.76 50.58 1.18 Allowed 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 125.317 1.447 . . . . 0.0 112.762 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -121.99 130.78 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 126.19 1.796 . . . . 0.0 111.013 -178.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.1 m -123.07 123.85 41.77 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.861 1.664 . . . . 0.0 109.57 176.391 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.5 p -119.49 143.43 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 123.938 0.895 . . . . 0.0 112.375 175.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 30.0 t60 -111.55 117.28 32.54 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.515 1.526 . . . . 0.0 110.236 173.298 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -86.67 91.89 8.75 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 175.49 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 27.6 m -67.09 -17.41 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -176.593 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.438 ' HB3' ' CD1' ' A' ' 20' ' ' TRP . 0.3 OUTLIER -68.47 -26.48 65.5 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 121.174 -0.953 . . . . 0.0 111.995 172.646 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 20.1 mtmt -98.67 -5.71 31.12 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 126.275 1.83 . . . . 0.0 114.227 -179.088 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.43 ' HG3' ' H ' ' A' ' 50' ' ' GLU . 13.1 tpt -93.28 133.04 36.92 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.246 1.418 . . . . 0.0 111.467 -178.751 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 17.0 p -63.76 2.14 0.52 Allowed 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 126.657 1.983 . . . . 0.0 116.184 -179.168 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.43 ' H ' ' HG3' ' A' ' 48' ' ' MET . 7.0 tp10 -143.98 13.69 1.67 Allowed 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.522 1.529 . . . . 0.0 112.804 170.341 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -57.77 -24.58 53.9 Favored Glycine 0 CA--C 1.53 1.012 0 O-C-N 120.52 -1.363 . . . . 0.0 116.121 -167.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -63.66 -30.98 72.01 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 119.518 1.659 . . . . 0.0 112.096 174.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -74.89 -29.11 60.9 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.7 0.8 . . . . 0.0 111.941 176.452 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.571 HD12 HG23 ' A' ' 6' ' ' ILE . 2.8 mm? -81.02 -32.68 34.05 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.687 1.195 . . . . 0.0 111.602 176.713 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.8 ttt85 -56.87 -36.43 70.07 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.904 1.281 . . . . 0.0 110.667 159.154 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.53 -35.15 90.88 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 124.495 1.045 . . . . 0.0 115.465 167.358 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -64.98 -32.23 73.86 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 120.394 2.097 . . . . 0.0 112.267 176.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.2 mt -70.5 -42.13 78.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 123.682 0.793 . . . . 0.0 109.643 171.326 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -62.92 -41.44 99.47 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 178.469 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 33.0 mm-40 -62.09 -30.08 70.76 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 120.923 -1.111 . . . . 0.0 112.844 176.13 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -88.83 -38.41 14.62 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 179.298 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -133.76 0.82 3.28 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 -168.196 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.5 mptt 44.66 50.27 8.5 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 127.016 2.126 . . . . 0.0 113.126 -177.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 48.9 t60 -129.25 127.09 40.52 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 127.53 2.332 . . . . 0.0 108.102 178.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -108.13 -14.03 14.81 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.208 1.003 . . . . 0.0 113.53 178.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.9 m -74.82 141.86 44.25 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.3 1.04 . . . . 0.0 111.685 -176.631 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.0 m -97.88 150.81 37.15 Favored Pre-proline 0 N--CA 1.477 0.904 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 172.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -81.08 161.71 81.73 Favored 'Cis proline' 0 C--N 1.351 0.703 0 CA-C-N 118.686 0.566 . . . . 0.0 113.556 -3.354 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -107.61 139.45 42.14 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.093 0.957 . . . . 0.0 109.13 158.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 75.7 mt -131.88 139.08 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 124.22 1.008 . . . . 0.0 109.374 -165.311 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -140.98 145.39 35.91 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.937 0.895 . . . . 0.0 112.432 -178.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 58.2 mt -132.19 122.28 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 124.702 1.201 . . . . 0.0 109.405 172.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 32.0 m120 44.31 45.13 7.16 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 125.017 1.327 . . . . 0.0 113.327 -177.235 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 86.02 -12.96 58.64 Favored Glycine 0 CA--C 1.539 1.553 0 O-C-N 120.463 -1.398 . . . . 0.0 116.284 -178.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 59.8 m-80 -86.6 141.13 29.23 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.353 1.576 . . . . 0.0 110.634 -177.22 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -86.47 136.95 32.9 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.32 0.648 . . . . 0.0 112.177 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 38.5 mm -115.1 117.97 57.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 126.937 2.095 . . . . 0.0 107.099 178.249 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -70.55 3.58 11.47 Favored Glycine 0 N--CA 1.475 1.281 0 N-CA-C 117.919 1.928 . . . . 0.0 117.919 -159.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 155.64 173.91 24.86 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 128.072 2.749 . . . . 0.0 111.048 178.135 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 39.4 t -58.56 -32.79 69.24 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 121.317 -1.108 . . . . 0.0 112.494 171.436 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 69.7 m -66.61 -28.54 68.58 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 120.654 -1.279 . . . . 0.0 112.957 173.424 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -74.47 -36.21 63.3 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 119.516 1.053 . . . . 0.0 111.632 173.421 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 43.5 tp -62.91 -50.84 69.25 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.877 1.271 . . . . 0.0 110.794 172.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -59.5 -37.93 79.58 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.689 0.796 . . . . 0.0 111.481 176.473 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.98 -29.7 68.8 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.019 0.928 . . . . 0.0 113.483 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 35.7 mt -70.96 -25.48 62.74 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.066 0.848 . . . . 0.0 112.303 172.166 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -73.52 -37.54 65.6 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 118.56 0.618 . . . . 0.0 111.036 170.093 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 43.3 mmtt -66.57 -34.7 78.49 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 176.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -73.43 -9.36 58.61 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 169.169 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 79.46 22.36 64.96 Favored Glycine 0 CA--C 1.535 1.282 0 CA-C-N 119.686 1.13 . . . . 0.0 114.579 178.629 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -107.29 -32.01 7.96 Favored 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 125.678 1.591 . . . . 0.0 112.305 -172.603 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 46.0 tp -57.71 -41.76 82.38 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 118.454 0.57 . . . . 0.0 112.432 -176.2 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -60.44 -43.64 96.61 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 118.928 -0.558 . . . . 0.0 112.437 -178.062 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -74.77 -38.09 43.3 Favored Glycine 0 CA--C 1.535 1.306 0 O-C-N 123.556 0.535 . . . . 0.0 113.324 177.027 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 37.6 mt -57.66 -36.42 71.87 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.404 1.082 . . . . 0.0 112.309 177.106 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 86.5 mt -73.92 -4.03 32.56 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 114.895 1.442 . . . . 0.0 114.895 -179.542 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 6.8 t . . . . . 0 C--O 1.257 1.495 0 C-N-CA 125.146 1.378 . . . . 0.0 112.733 -178.993 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.935 0 N-CA-C 110.879 -0.888 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -89.69 -14.22 35.22 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.576 1.15 . . . . 0.0 114.005 -177.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 25.6 ttt -128.75 87.42 54.84 Favored Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 125.446 1.498 . . . . 0.0 111.273 -166.237 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -57.79 130.86 40.65 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 122.024 1.816 . . . . 0.0 109.899 168.013 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 15.8 p -153.88 -164.86 1.97 Allowed 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 122.108 0.956 . . . . 0.0 112.844 -164.553 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.458 HG23 HD12 ' A' ' 54' ' ' LEU . 25.4 pt -55.71 -25.21 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.471 1.108 . . . . 0.0 112.717 170.311 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.38 -23.85 66.4 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -171.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.1 t -87.96 -20.04 26.43 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 121.238 -0.914 . . . . 0.0 113.424 170.064 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 41.3 mtt -68.39 -26.09 65.38 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 121.27 -0.894 . . . . 0.0 112.334 175.084 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.6 mm -58.06 -31.4 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.953 0.901 . . . . 0.0 111.667 177.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.1 mptt -80.56 -4.23 53.24 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.899 1.28 . . . . 0.0 114.039 -173.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -82.99 -28.4 37.68 Favored Glycine 0 CA--C 1.538 1.496 0 N-CA-C 115.953 1.141 . . . . 0.0 115.953 -173.53 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -145.35 163.71 33.73 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.597 1.199 . . . . 0.0 112.526 -173.264 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -63.16 -43.58 97.9 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.298 1.439 . . . . 0.0 112.723 -179.46 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.3 t -121.88 131.89 72.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 123.798 0.839 . . . . 0.0 110.26 171.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 54.4 t -132.56 127.39 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 125.006 1.322 . . . . 0.0 109.263 179.141 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 42.4 t -124.56 148.24 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 124.337 1.055 . . . . 0.0 111.624 -177.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -121.92 112.3 18.14 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.202 1.401 . . . . 0.0 108.869 172.129 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 10.7 m -126.5 174.14 8.87 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 126.646 1.978 . . . . 0.0 111.356 -171.178 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 20.8 m0 -118.78 137.75 53.16 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.317 1.047 . . . . 0.0 109.078 161.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.407 ' CG2' ' HE2' ' A' ' 47' ' ' LYS . 82.6 t -62.67 -15.86 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.013 0.925 . . . . 0.0 112.378 177.823 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.4 p -89.7 -9.68 48.57 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.484 1.914 . . . . 0.0 116.046 175.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 8.0 t -94.2 142.03 24.38 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-N 119.424 1.011 . . . . 0.0 111.565 -170.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -79.67 -32.58 1.53 Allowed 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 121.812 1.675 . . . . 0.0 112.226 173.545 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -62.85 -35.28 79.45 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.122 1.369 . . . . 0.0 113.543 177.426 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -49.04 -54.24 16.73 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.518 1.127 . . . . 0.0 109.451 165.285 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.2 t -64.88 -39.47 85.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.117 0.967 . . . . 0.0 112.766 -179.05 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 78.4 mmt-85 -53.35 -41.78 66.15 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-N 119.118 0.872 . . . . 0.0 111.811 173.378 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.86 -53.7 8.61 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.123 0.969 . . . . 0.0 112.592 174.547 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -52.41 -32.99 41.69 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.608 1.163 . . . . 0.0 112.992 -179.398 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -72.36 -47.37 50.05 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.838 0.855 . . . . 0.0 112.581 177.63 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.8 tt -72.81 -36.75 67.62 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.582 1.153 . . . . 0.0 111.465 -176.389 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 70.3 mt -63.47 -47.65 80.91 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.401 0.68 . . . . 0.0 111.283 173.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -64.76 -14.82 60.31 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 172.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.21 -17.74 58.26 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 120.158 1.344 . . . . 0.0 113.828 175.405 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 87.2 mmt-85 -131.97 -13.09 3.23 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 -177.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 29.0 m -138.62 136.99 36.51 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.315 1.046 . . . . 0.0 112.601 -172.175 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.24 -30.48 12.59 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 126.868 2.067 . . . . 0.0 111.207 166.321 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -79.26 48.09 0.85 Allowed 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.507 1.523 . . . . 0.0 113.409 177.365 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.28 118.89 60.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 125.758 1.623 . . . . 0.0 110.688 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 54.9 m -101.48 135.47 42.92 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 126.205 1.802 . . . . 0.0 109.672 172.516 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.6 p -128.1 141.6 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-O 122.277 1.037 . . . . 0.0 112.961 169.159 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -113.6 133.27 55.38 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 129.12 2.968 . . . . 0.0 109.523 -177.341 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -111.06 90.59 3.38 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 122.04 0.924 . . . . 0.0 111.52 -176.44 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 16.7 m -67.8 -8.94 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 O-C-N 121.341 -0.849 . . . . 0.0 113.17 -178.073 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.45 -18.35 61.14 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 119.042 0.837 . . . . 0.0 112.657 170.155 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.407 ' HE2' ' CG2' ' A' ' 21' ' ' VAL . 57.3 mmtt -102.44 -32.24 10.07 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 127.156 2.182 . . . . 0.0 113.009 179.1 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 58.9 mtt -65.03 126.64 28.67 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.193 0.997 . . . . 0.0 110.783 177.584 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 18.2 m -74.87 20.31 0.13 Allowed 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 114.614 1.338 . . . . 0.0 114.614 -172.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -150.24 10.26 0.68 Allowed 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 127.395 2.278 . . . . 0.0 111.528 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -53.96 -25.87 32.32 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 125.81 1.672 . . . . 0.0 116.954 -172.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -66.22 -28.04 68.44 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 120.079 1.939 . . . . 0.0 111.698 173.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -82.27 -28.75 31.6 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 121.03 -1.044 . . . . 0.0 112.005 177.084 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.458 HD12 HG23 ' A' ' 6' ' ' ILE . 2.7 mm? -78.16 -32.21 50.12 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.624 0.77 . . . . 0.0 111.559 172.826 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 67.0 mtp180 -55.25 -40.34 70.82 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 119.524 1.056 . . . . 0.0 111.257 162.183 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -58.78 -36.25 85.85 Favored Glycine 0 CA--C 1.536 1.37 0 CA-C-O 119.255 -0.747 . . . . 0.0 114.044 171.483 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -65.42 -35.55 81.26 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 119.41 1.605 . . . . 0.0 112.446 176.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 53.3 mt -73.05 -48.87 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 124.306 1.042 . . . . 0.0 109.724 176.035 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -67.07 -41.28 86.65 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 121.449 -0.782 . . . . 0.0 112.477 -174.561 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 77.4 mm-40 -69.07 -21.57 64.07 Favored 'General case' 0 CA--C 1.546 0.812 0 O-C-N 121.138 -0.976 . . . . 0.0 112.471 176.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -88.79 -29.78 19.49 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 177.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -140.4 -1.41 1.51 Allowed 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 116.075 1.88 . . . . 0.0 116.075 -170.044 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.5 mptt 45.75 48.32 11.72 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 125.922 1.689 . . . . 0.0 112.716 -165.38 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 60.2 t-80 -129.26 133.51 47.54 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 125.333 1.453 . . . . 0.0 110.471 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -142.27 -25.1 0.66 Allowed 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -160.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 60.6 p -77.78 151.97 33.78 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 121.727 -0.608 . . . . 0.0 111.603 168.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 13.6 m -104.55 155.95 36.62 Favored Pre-proline 0 N--CA 1.478 0.949 0 C-N-CA 124.673 1.189 . . . . 0.0 111.67 -176.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -75.04 154.31 99.58 Favored 'Cis proline' 0 CA--C 1.535 0.542 0 CA-C-N 119.071 0.704 . . . . 0.0 113.782 -6.037 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -99.23 138.08 36.83 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 159.005 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 60.9 mt -131.03 140.62 48.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 124.199 1.0 . . . . 0.0 109.35 -165.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -138.56 144.96 40.1 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.808 0.843 . . . . 0.0 111.982 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 65.8 mt -130.01 117.05 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.973 1.309 . . . . 0.0 109.186 175.465 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 46.13 44.64 12.12 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 125.565 1.546 . . . . 0.0 113.503 -176.33 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 82.46 -7.47 64.66 Favored Glycine 0 CA--C 1.534 1.229 0 N-CA-C 116.293 1.277 . . . . 0.0 116.293 -177.371 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -91.03 138.34 31.68 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 119.168 1.484 . . . . 0.0 110.578 -178.483 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 39.6 t80 -82.14 133.89 35.29 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.858 0.837 . . . . 0.0 112.915 -176.44 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 37.9 mm -113.98 119.73 61.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 126.656 1.983 . . . . 0.0 107.726 175.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -71.07 27.08 0.54 Allowed Glycine 0 N--CA 1.472 1.086 0 N-CA-C 119.137 2.415 . . . . 0.0 119.137 -167.579 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 116.21 -175.63 15.93 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 128.076 2.75 . . . . 0.0 114.552 175.057 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 25.1 t -64.54 -33.38 75.77 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.364 -1.08 . . . . 0.0 112.866 -179.122 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 37.0 m -70.01 -34.88 73.87 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 121.088 -1.007 . . . . 0.0 111.924 175.63 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.87 -39.04 90.33 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.452 1.101 . . . . 0.0 111.974 171.009 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 51.9 tp -62.93 -45.84 90.61 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.246 1.019 . . . . 0.0 111.196 175.275 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -64.77 -33.26 75.55 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.582 -0.699 . . . . 0.0 112.324 173.612 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.83 -29.84 71.0 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 121.008 -1.057 . . . . 0.0 111.954 177.176 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 83.6 mt -71.75 -30.03 65.15 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.441 1.096 . . . . 0.0 112.985 170.579 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -67.82 -41.13 83.52 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.698 0.799 . . . . 0.0 110.25 172.006 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -71.81 -39.75 69.62 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.113 0.965 . . . . 0.0 113.575 175.263 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -69.69 -18.27 63.54 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 119.547 1.067 . . . . 0.0 112.82 171.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 78.01 35.48 34.71 Favored Glycine 0 CA--C 1.531 1.083 0 CA-C-N 118.801 0.728 . . . . 0.0 113.65 175.457 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -116.19 -19.51 10.21 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 127.787 2.435 . . . . 0.0 113.351 -174.048 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 27.2 tp -63.21 -31.82 73.06 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.919 0.888 . . . . 0.0 111.684 -174.279 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -54.55 -53.6 52.34 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.526 1.131 . . . . 0.0 112.933 175.364 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -76.89 -23.4 69.45 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-O 119.446 -0.641 . . . . 0.0 113.862 -178.714 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 75.5 mt -69.91 -37.75 76.06 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 118.869 1.334 . . . . 0.0 112.012 172.531 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 92.8 mt -86.47 5.89 33.05 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -178.769 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 81.7 p . . . . . 0 C--O 1.255 1.387 0 C-N-CA 126.566 1.947 . . . . 0.0 115.973 -174.755 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.998 0 N-CA-C 110.401 -1.08 . . . . 0.0 110.401 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -142.65 -3.45 1.01 Allowed 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 -176.352 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 21.2 mmt -113.76 77.43 3.5 Favored Pre-proline 0 CA--C 1.548 0.877 0 CA-C-N 119.737 1.153 . . . . 0.0 111.426 -177.557 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -71.63 156.34 57.73 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 123.85 3.034 . . . . 0.0 113.239 -175.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 39.5 p -157.39 173.22 17.25 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 -174.484 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.586 HG23 HD12 ' A' ' 54' ' ' LEU . 19.6 pt -49.37 -25.3 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 125.981 1.712 . . . . 0.0 114.07 171.314 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.29 -28.48 69.22 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 118.935 0.789 . . . . 0.0 112.063 -176.459 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 96.4 p -72.32 -32.7 66.78 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 171.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 59.9 mtp -70.61 -30.65 67.38 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.15 0.98 . . . . 0.0 111.914 -176.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -64.88 -24.06 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 124.315 1.046 . . . . 0.0 111.573 -174.077 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -82.04 -9.54 59.52 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.063 1.745 . . . . 0.0 114.716 176.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -91.28 -22.06 33.32 Favored Glycine 0 CA--C 1.54 1.638 0 N-CA-C 117.451 1.741 . . . . 0.0 117.451 -166.425 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -135.86 170.04 16.61 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 118.941 1.37 . . . . 0.0 110.941 169.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 20.9 ttpt -66.59 -30.71 71.06 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 119.146 -0.454 . . . . 0.0 111.945 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 28.4 t -133.4 130.22 56.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.563 1.545 . . . . 0.0 109.394 177.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 42.9 t -134.21 127.67 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 124.245 1.018 . . . . 0.0 109.809 -177.168 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.1 t -128.35 146.92 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.295 1.038 . . . . 0.0 112.053 -170.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -125.97 106.88 9.95 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.797 1.239 . . . . 0.0 109.526 178.26 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 37.2 m -128.41 176.94 7.33 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 127.044 2.137 . . . . 0.0 112.371 -164.602 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.421 ' CD2' HG21 ' A' ' 67' ' ' VAL . 43.8 m0 -125.71 129.23 49.12 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.609 1.563 . . . . 0.0 108.335 163.5 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 46.6 t -53.63 -38.9 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 124.842 1.257 . . . . 0.0 114.325 -158.67 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.7 t -89.79 -6.99 55.4 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 -170.46 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 94.9 m -92.63 146.25 31.95 Favored Pre-proline 0 CA--C 1.537 0.456 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -160.303 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -69.59 -34.47 15.07 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 120.662 0.908 . . . . 0.0 114.057 -162.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -71.22 -42.12 69.31 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 124.073 0.949 . . . . 0.0 112.675 176.424 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -51.96 -54.65 27.23 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 169.667 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 53.3 t -60.23 -51.78 69.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 124.149 0.98 . . . . 0.0 111.63 -175.364 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . 0.272 7.7 ptp180 -61.67 -35.99 79.58 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 119.05 0.841 . . . . 0.0 112.164 -178.685 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.73 -55.91 8.63 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 118.226 -0.892 . . . . 0.0 112.716 173.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -48.02 -41.98 26.96 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 120.283 1.401 . . . . 0.0 112.584 176.149 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.28 -45.37 66.5 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 124.558 1.143 . . . . 0.0 111.577 -175.036 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.2 tt -70.4 -37.7 74.53 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.414 1.086 . . . . 0.0 112.021 176.027 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 80.7 mt -63.64 -41.71 98.21 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 120.923 -1.11 . . . . 0.0 111.461 176.556 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -64.41 -24.07 67.5 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 169.22 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.2 -16.07 53.85 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 119.974 1.261 . . . . 0.0 113.37 171.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 3.0 mmt180 -107.41 -36.69 6.43 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 115.972 1.842 . . . . 0.0 115.972 -173.434 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 13.9 t -155.04 150.56 27.41 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-N 120.312 1.415 . . . . 0.0 114.611 -176.265 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -84.03 -19.29 34.7 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.826 1.25 . . . . 0.0 113.02 170.398 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -85.97 37.1 0.7 Allowed 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -176.422 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -106.12 136.05 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 124.617 1.167 . . . . 0.0 111.984 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.3 m -128.6 142.25 51.1 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 126.489 1.915 . . . . 0.0 109.819 169.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.4 p -135.4 143.62 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 125.041 1.336 . . . . 0.0 113.315 177.41 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -118.99 135.98 54.34 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 127.187 2.195 . . . . 0.0 110.55 176.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -103.52 88.17 3.02 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.873 0.869 . . . . 0.0 111.604 -172.157 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 31.6 m -80.31 40.34 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 -168.277 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -141.92 -30.82 0.57 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 128.56 2.744 . . . . 0.0 109.879 171.186 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 26.4 mmmt -65.48 -31.29 72.29 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.088 1.355 . . . . 0.0 111.554 158.009 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -94.02 117.63 30.38 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.724 1.21 . . . . 0.0 109.387 178.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 73.8 m -70.89 -19.09 62.65 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 -163.231 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -92.39 5.96 48.75 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.453 1.501 . . . . 0.0 113.095 173.372 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -52.1 -25.23 17.16 Favored Glycine 0 CA--C 1.539 1.545 0 C-N-CA 125.524 1.535 . . . . 0.0 116.8 -173.343 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -64.24 -28.75 69.95 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 120.378 2.089 . . . . 0.0 112.802 172.426 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -80.11 -31.16 39.18 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.88 1.272 . . . . 0.0 112.441 176.034 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.586 HD12 HG23 ' A' ' 6' ' ' ILE . 2.8 mm? -78.15 -36.2 47.99 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.615 0.766 . . . . 0.0 110.768 174.613 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 57.3 mtp180 -54.93 -36.22 65.03 Favored 'General case' 0 N--CA 1.477 0.9 0 O-C-N 121.43 -0.794 . . . . 0.0 111.165 159.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.04 -44.08 97.61 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 124.498 1.047 . . . . 0.0 113.995 170.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -61.61 -32.3 72.42 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 119.745 1.772 . . . . 0.0 112.296 176.094 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 57.6 mt -74.48 -43.5 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.095 0.958 . . . . 0.0 110.08 174.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -64.83 -44.35 90.12 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 121.286 -0.884 . . . . 0.0 112.253 -179.373 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -57.05 -41.34 78.5 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.431 0.692 . . . . 0.0 111.674 -179.241 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -91.34 -28.26 17.84 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 -176.403 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -133.42 2.78 3.56 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 114.973 1.471 . . . . 0.0 114.973 -171.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 44.2 mmtm 54.12 33.65 18.3 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 127.039 2.136 . . . . 0.0 114.172 178.405 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 7.4 t60 -130.92 141.82 50.32 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 126.088 1.755 . . . . 0.0 110.759 -175.209 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -142.0 -20.22 0.72 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.742 1.217 . . . . 0.0 113.593 -164.124 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.8 p -68.54 153.31 44.01 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.716 1.607 . . . . 0.0 111.876 167.342 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.421 HG21 ' CD2' ' A' ' 20' ' ' TRP . 25.6 m -115.92 151.25 46.24 Favored Pre-proline 0 N--CA 1.476 0.856 0 C-N-CA 124.421 1.088 . . . . 0.0 112.736 177.591 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -74.58 147.33 89.12 Favored 'Cis proline' 0 N--CA 1.457 -0.62 0 CA-C-N 119.079 0.707 . . . . 0.0 113.884 0.016 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -99.02 138.35 36.25 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.414 158.426 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 44.4 mt -130.45 141.07 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 123.714 0.805 . . . . 0.0 109.089 -164.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -140.16 146.07 38.31 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.007 0.923 . . . . 0.0 111.555 -179.38 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 65.2 mt -128.85 127.19 66.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 125.384 1.474 . . . . 0.0 107.916 174.483 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 35.8 m120 50.54 28.17 3.28 Favored 'General case' 0 CA--C 1.56 1.355 0 N-CA-C 115.651 1.723 . . . . 0.0 115.651 -178.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 82.4 0.97 90.34 Favored Glycine 0 CA--C 1.544 1.891 0 O-C-N 120.397 -1.44 . . . . 0.0 115.047 -173.464 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -91.72 151.65 20.55 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 126.964 2.106 . . . . 0.0 110.387 172.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -93.97 142.37 27.46 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -174.53 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 31.7 mm -121.22 130.07 75.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 128.56 2.744 . . . . 0.0 107.512 176.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -71.38 23.37 0.62 Allowed Glycine 0 N--CA 1.472 1.034 0 C-N-CA 126.744 2.116 . . . . 0.0 118.101 -165.528 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 107.79 -171.9 16.79 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 127.941 2.686 . . . . 0.0 113.498 178.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 42.7 t -54.12 -41.94 68.89 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.821 1.248 . . . . 0.0 112.362 -178.298 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 10.4 m -82.58 -10.28 59.04 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -178.367 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -76.6 -42.68 41.57 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 120.002 1.273 . . . . 0.0 109.838 162.477 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 48.7 tp -64.13 -50.03 69.84 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.115 1.366 . . . . 0.0 112.395 177.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -70.01 -12.95 61.98 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 113.24 0.829 . . . . 0.0 113.24 178.185 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -85.89 -39.41 17.03 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 121.206 -0.934 . . . . 0.0 112.121 164.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 33.6 mt -64.42 -33.66 76.38 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 120.375 1.443 . . . . 0.0 113.29 175.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -62.98 -47.39 83.35 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.975 1.31 . . . . 0.0 111.352 171.276 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 6.8 mptt -73.44 -34.91 65.65 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.598 1.559 . . . . 0.0 112.319 -177.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -70.41 -11.58 61.01 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.231 1.813 . . . . 0.0 113.142 169.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 70.17 10.65 65.97 Favored Glycine 0 CA--C 1.534 1.258 0 CA-C-N 119.053 0.842 . . . . 0.0 114.301 -177.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 17.4 mtpt -81.5 -26.6 35.04 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 125.949 1.7 . . . . 0.0 112.103 -178.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 34.7 tp -59.51 -40.23 86.41 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.645 1.178 . . . . 0.0 112.126 170.045 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -60.66 -42.04 96.22 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.812 -0.555 . . . . 0.0 111.932 174.482 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -70.33 -14.08 71.28 Favored Glycine 0 CA--C 1.535 1.301 0 CA-C-O 119.16 -0.8 . . . . 0.0 114.959 176.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 88.7 mt -97.64 -21.99 16.73 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.065 1.746 . . . . 0.0 113.341 175.043 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 93.2 mt -103.8 -5.67 22.2 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.236 1.415 . . . . 0.0 114.447 -179.089 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 61.2 p . . . . . 0 C--O 1.25 1.1 0 C-N-CA 126.07 1.748 . . . . 0.0 114.159 173.465 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.4 t . . . . . 0 CA--C 1.547 0.865 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.6 pt -49.21 -24.82 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 126.741 2.016 . . . . 0.0 116.222 -165.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.26 -21.84 26.16 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.929 1.691 . . . . 0.0 114.264 -178.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.9 m -77.32 -32.74 55.49 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.81 1.244 . . . . 0.0 113.437 170.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 78.8 mtp -63.26 -33.76 76.19 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 121.306 -0.871 . . . . 0.0 111.371 -176.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.0 mm -62.35 -22.47 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 125.726 1.611 . . . . 0.0 112.767 -176.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -85.86 -17.74 34.77 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.24 1.416 . . . . 0.0 113.876 179.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -88.77 -7.5 71.15 Favored Glycine 0 CA--C 1.536 1.395 0 N-CA-C 115.933 1.133 . . . . 0.0 115.933 -173.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -145.04 161.16 40.09 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.292 1.437 . . . . 0.0 110.738 169.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -67.77 -48.33 66.65 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.091 0.956 . . . . 0.0 111.176 177.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.4 t -114.53 131.12 67.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.937 1.295 . . . . 0.0 110.961 171.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 85.3 t -131.06 130.74 63.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 125.014 1.326 . . . . 0.0 110.206 179.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 49.3 t -128.81 146.03 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 124.13 0.972 . . . . 0.0 112.421 -175.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -121.84 111.53 17.23 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.789 1.235 . . . . 0.0 109.099 173.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 18.7 m -121.14 172.68 7.8 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 126.728 2.011 . . . . 0.0 111.319 -173.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.486 ' CD1' ' HB3' ' A' ' 46' ' ' ASP . 23.6 m0 -120.31 135.88 54.86 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.57 1.148 . . . . 0.0 108.86 162.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 60.7 t -57.72 -35.54 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 CA-C-N 118.849 0.75 . . . . 0.0 111.13 -177.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.3 p -74.34 -10.82 59.96 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 127.308 2.243 . . . . 0.0 116.408 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 38.0 t -90.61 143.73 29.52 Favored Pre-proline 0 CA--C 1.537 0.48 0 O-C-N 121.264 -0.898 . . . . 0.0 110.513 -170.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.33 -39.05 0.61 Allowed 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 121.114 1.209 . . . . 0.0 112.655 173.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -59.01 -36.31 74.73 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.307 1.043 . . . . 0.0 113.744 178.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -48.44 -54.73 13.06 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.713 1.205 . . . . 0.0 109.584 168.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 57.5 t -65.2 -39.64 86.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.242 1.017 . . . . 0.0 112.139 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 79.6 mmt-85 -54.78 -41.67 70.8 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 118.687 0.676 . . . . 0.0 111.572 174.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.17 -54.27 8.88 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.608 0.763 . . . . 0.0 113.007 173.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -54.24 -31.94 54.67 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 119.498 1.044 . . . . 0.0 113.349 -177.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -69.32 -49.23 57.68 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.0 0.92 . . . . 0.0 112.669 176.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 8.0 tt -72.59 -36.74 68.22 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 124.651 1.181 . . . . 0.0 111.861 -177.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 93.2 mt -62.25 -44.78 95.77 Favored 'General case' 0 CA--C 1.53 0.175 0 O-C-N 121.607 -0.683 . . . . 0.0 111.395 177.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 14.8 m-70 -69.61 -20.88 63.61 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 172.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.61 -31.91 53.19 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 119.698 1.135 . . . . 0.0 113.203 173.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 39.6 mmt-85 -97.36 -23.79 15.94 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 114.827 1.418 . . . . 0.0 114.827 -176.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 14.6 t -153.78 170.25 21.39 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -177.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 77.6 mttt -112.68 3.82 16.81 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 126.411 1.884 . . . . 0.0 112.224 167.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -105.83 42.94 1.18 Allowed 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 126.081 1.752 . . . . 0.0 113.114 -171.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -119.54 134.97 61.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.858 1.663 . . . . 0.0 111.959 -177.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.0 m -119.19 141.85 48.51 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.803 2.041 . . . . 0.0 110.242 167.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.5 p -135.37 141.04 43.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 125.072 1.349 . . . . 0.0 113.308 176.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -112.77 134.68 54.17 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 127.414 2.286 . . . . 0.0 110.394 175.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -101.62 89.44 3.71 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 124.15 0.98 . . . . 0.0 110.509 -179.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.9 m -76.1 4.65 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -170.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.486 ' HB3' ' CD1' ' A' ' 20' ' ' TRP . 2.5 p-10 -85.23 -22.92 28.47 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.759 1.224 . . . . 0.0 112.038 167.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 30.0 mtmt -90.0 5.09 48.08 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.904 2.082 . . . . 0.0 113.41 176.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 12.2 tpt -120.63 124.25 44.79 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.975 1.71 . . . . 0.0 111.413 -165.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 10.5 m -65.21 -22.91 66.95 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.735 0.814 . . . . 0.0 112.847 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.4 5.58 51.36 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 126.16 1.784 . . . . 0.0 113.549 174.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -55.88 -30.57 57.14 Favored Glycine 0 CA--C 1.532 1.106 0 O-C-N 120.402 -1.436 . . . . 0.0 114.651 -174.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -70.23 -26.23 63.76 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 118.541 1.17 . . . . 0.0 113.043 175.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -72.21 -44.11 63.45 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.97 0.908 . . . . 0.0 110.53 170.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.23 -36.65 83.57 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.044 0.538 . . . . 0.0 110.459 178.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 43.0 mtp180 -63.93 -42.01 97.47 Favored 'General case' 0 N--CA 1.477 0.897 0 O-C-N 121.077 -1.014 . . . . 0.0 112.176 167.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -58.91 -38.38 92.49 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 124.225 0.917 . . . . 0.0 113.627 176.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -61.18 -32.29 72.03 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 118.597 1.199 . . . . 0.0 113.637 173.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 52.0 mt -81.28 -42.55 19.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 123.939 0.896 . . . . 0.0 109.214 177.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -71.93 -39.59 69.36 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 121.115 -0.991 . . . . 0.0 112.941 -176.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 42.2 mm-40 -68.63 -23.91 64.49 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 119.939 1.245 . . . . 0.0 113.069 177.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -98.75 -31.75 11.73 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.533 1.133 . . . . 0.0 113.827 -178.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -134.87 5.0 3.33 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -170.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 66.7 mmtt 47.37 38.94 8.14 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 126.565 1.946 . . . . 0.0 114.429 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -139.88 147.69 40.99 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.704 1.202 . . . . 0.0 111.446 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -140.29 2.47 1.88 Allowed 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.998 1.319 . . . . 0.0 113.861 -172.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 90.2 m -82.22 141.04 33.32 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.284 1.034 . . . . 0.0 111.851 175.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.9 m -101.97 156.06 35.68 Favored Pre-proline 0 N--CA 1.475 0.785 0 C-N-CA 124.826 1.251 . . . . 0.0 112.73 -176.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -73.69 150.96 96.42 Favored 'Cis proline' 0 C--N 1.348 0.546 0 CA-C-N 118.759 0.592 . . . . 0.0 113.013 -5.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -98.02 130.84 44.83 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 161.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 47.8 mt -126.28 141.39 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 C-N-CA 124.084 0.954 . . . . 0.0 109.294 -167.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -139.34 141.11 37.66 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.516 0.727 . . . . 0.0 111.736 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 43.4 mt -136.5 117.07 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.659 1.184 . . . . 0.0 109.508 -179.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 46.37 38.58 5.4 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 125.135 1.374 . . . . 0.0 114.165 -171.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 78.83 0.29 80.64 Favored Glycine 0 CA--C 1.54 1.654 0 N-CA-C 115.723 1.049 . . . . 0.0 115.723 -177.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 -88.61 145.84 25.46 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 119.088 1.444 . . . . 0.0 110.261 174.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -94.06 137.62 33.05 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -172.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 18.3 mm -130.75 115.46 30.95 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 C-N-CA 127.825 2.45 . . . . 0.0 107.663 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -70.97 -16.97 75.11 Favored Glycine 0 CA--C 1.537 1.461 0 N-CA-C 116.41 1.324 . . . . 0.0 116.41 -165.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 172.99 -173.87 45.72 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 124.558 1.075 . . . . 0.0 113.52 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 34.1 t -62.92 -35.63 80.73 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 122.262 -0.552 . . . . 0.0 111.469 174.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 43.5 t -60.96 -44.29 97.5 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.795 -0.565 . . . . 0.0 112.319 173.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -70.94 -31.11 67.61 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.51 1.124 . . . . 0.0 112.015 -179.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 42.5 tp -69.38 -50.82 42.55 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.815 1.646 . . . . 0.0 111.289 172.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -64.36 -31.45 72.66 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 121.422 -0.799 . . . . 0.0 112.521 178.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.43 -22.63 65.2 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 119.131 0.878 . . . . 0.0 112.771 175.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 68.7 mt -90.13 -29.81 18.06 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.987 1.315 . . . . 0.0 112.088 171.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -65.16 -45.4 85.09 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.041 0.936 . . . . 0.0 112.264 172.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -60.33 -22.52 63.32 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.747 1.619 . . . . 0.0 114.059 177.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -105.07 -7.81 18.9 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.061 1.344 . . . . 0.0 114.584 -176.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 84.08 6.11 86.88 Favored Glycine 0 CA--C 1.54 1.627 0 CA-C-N 118.881 0.764 . . . . 0.0 114.673 -176.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 34.0 mtmt -90.51 -25.68 20.15 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 125.662 1.585 . . . . 0.0 113.252 -171.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 52.4 tp -65.19 -38.55 90.85 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.283 1.033 . . . . 0.0 111.258 173.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -62.06 -23.6 66.59 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 173.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -85.2 -23.41 48.51 Favored Glycine 0 CA--C 1.532 1.123 0 O-C-N 121.545 -0.722 . . . . 0.0 114.141 172.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 41.9 mt -79.18 -35.03 42.53 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.893 1.277 . . . . 0.0 112.336 175.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 51.5 mt -81.01 -0.73 40.89 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 115.421 1.638 . . . . 0.0 115.421 -166.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 16.4 m . . . . . 0 C--O 1.254 1.34 0 C-N-CA 127.073 2.149 . . . . 0.0 113.027 -179.57 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 53.8 p . . . . . 0 C--O 1.238 0.498 0 CA-C-O 121.422 0.63 . . . . 0.0 109.557 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.464 HG23 HD12 ' A' ' 54' ' ' LEU . 21.3 pt -53.44 -27.55 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 123.344 0.658 . . . . 0.0 112.621 172.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.88 -25.12 64.46 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -172.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.1 m -81.07 -31.95 34.18 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 121.096 -1.003 . . . . 0.0 111.904 167.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 56.5 mtm -68.37 -17.97 64.36 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 178.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.5 mm -60.84 -31.16 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 CA-C-N 119.223 0.919 . . . . 0.0 111.99 171.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.2 mptt -75.53 -1.52 24.71 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -174.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -81.86 -38.03 14.78 Favored Glycine 0 CA--C 1.537 1.436 0 N-CA-C 115.659 1.024 . . . . 0.0 115.659 -172.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -140.84 171.92 13.41 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.304 1.442 . . . . 0.0 112.641 -174.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 29.0 ttpt -68.7 -39.29 80.56 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.849 1.26 . . . . 0.0 112.813 -178.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.1 t -122.47 134.44 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.031 0.932 . . . . 0.0 110.357 172.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 25.2 t -135.27 130.51 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 124.368 1.067 . . . . 0.0 109.985 177.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 54.8 t -127.4 149.12 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.472 1.109 . . . . 0.0 111.977 -173.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -127.31 114.33 17.45 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.408 1.483 . . . . 0.0 109.409 175.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.7 m -130.14 172.13 12.1 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 126.571 1.948 . . . . 0.0 111.444 -168.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 23.0 m0 -114.55 138.99 49.95 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 158.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.41 ' CG2' ' HE2' ' A' ' 47' ' ' LYS . 96.6 t -65.56 -22.82 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 CA-C-N 118.465 0.575 . . . . 0.0 111.208 175.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 76.6 p -68.54 -18.73 64.42 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.639 1.576 . . . . 0.0 115.001 172.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 49.9 t -93.14 143.3 26.53 Favored Pre-proline 0 CA--C 1.539 0.522 0 CA-C-N 119.698 1.135 . . . . 0.0 111.498 -165.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -82.92 -33.53 0.42 Allowed 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 121.217 1.278 . . . . 0.0 112.932 174.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -61.23 -36.64 80.5 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.67 1.188 . . . . 0.0 112.705 176.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -49.85 -55.13 15.43 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.382 1.473 . . . . 0.0 109.517 168.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 86.0 t -63.97 -39.02 83.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.221 1.008 . . . . 0.0 112.558 -176.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 25.4 mmm180 -53.89 -48.11 70.41 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 118.745 0.702 . . . . 0.0 111.029 173.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.81 -55.77 13.39 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.617 0.767 . . . . 0.0 112.342 175.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.79 -38.27 47.41 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.722 1.209 . . . . 0.0 113.698 -178.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -71.28 -51.08 26.47 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.394 0.678 . . . . 0.0 111.172 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.2 tt -66.19 -38.63 88.46 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 125.151 1.381 . . . . 0.0 111.754 -177.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 71.5 mt -61.86 -52.94 62.07 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.897 0.879 . . . . 0.0 111.172 176.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -63.43 -25.23 68.18 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 172.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.04 -13.27 60.22 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 120.514 -1.366 . . . . 0.0 113.514 175.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 12.3 mmp_? -99.87 -56.88 2.26 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.842 1.257 . . . . 0.0 112.433 171.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 25.4 p -150.02 143.15 24.98 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.556 1.142 . . . . 0.0 113.915 -164.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -83.73 -0.98 53.11 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 126.572 1.949 . . . . 0.0 113.528 175.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -83.29 29.35 0.5 Allowed 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.075 1.35 . . . . 0.0 113.383 -177.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -110.15 132.49 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 126.818 2.047 . . . . 0.0 111.089 -174.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 46.8 m -110.2 138.88 45.97 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 126.956 2.103 . . . . 0.0 108.89 166.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.1 p -134.6 139.61 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-O 122.537 1.161 . . . . 0.0 113.37 170.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 34.6 m-70 -116.23 145.95 42.72 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 127.939 2.496 . . . . 0.0 110.918 -178.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -123.58 90.77 3.34 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.967 0.889 . . . . 0.0 111.335 -168.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 34.9 m -68.24 -11.66 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -174.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.41 -23.58 54.03 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.865 0.866 . . . . 0.0 112.963 170.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.41 ' HE2' ' CG2' ' A' ' 21' ' ' VAL . 71.2 mmtt -86.43 -32.26 20.97 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.703 1.201 . . . . 0.0 111.977 175.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 67.1 mtt -61.75 143.83 55.62 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.122 0.969 . . . . 0.0 112.157 174.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 9.4 t -70.42 -37.58 74.46 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.835 0.854 . . . . 0.0 111.103 168.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -100.16 7.92 44.22 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.776 1.63 . . . . 0.0 114.026 -176.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -57.02 -27.41 57.12 Favored Glycine 0 CA--C 1.534 1.244 0 O-C-N 120.598 -1.314 . . . . 0.0 115.795 -172.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -67.6 -20.01 65.31 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.052 1.426 . . . . 0.0 112.82 174.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -80.34 -33.82 37.08 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.984 1.314 . . . . 0.0 112.0 170.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.464 HD12 HG23 ' A' ' 6' ' ' ILE . 3.0 mm? -77.9 -27.98 49.71 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 121.52 -0.737 . . . . 0.0 111.495 177.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 66.5 mtp180 -54.72 -39.74 68.53 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-N 119.633 1.106 . . . . 0.0 111.337 159.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.23 -28.02 73.06 Favored Glycine 0 CA--C 1.534 1.271 0 CA-C-O 119.095 -0.836 . . . . 0.0 115.033 175.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -65.0 -35.0 79.79 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 119.557 1.678 . . . . 0.0 112.398 174.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 27.9 mt -72.93 -41.3 60.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 124.44 1.096 . . . . 0.0 109.278 173.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -64.53 -46.29 83.5 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 121.49 -0.757 . . . . 0.0 112.947 -177.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 93.5 mm-40 -70.58 -18.02 62.9 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -92.74 -33.03 14.47 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 175.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -136.35 -0.73 2.41 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 115.678 1.733 . . . . 0.0 115.678 -168.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 53.06 41.35 32.16 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 126.803 2.041 . . . . 0.0 113.835 -169.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -128.72 140.61 51.65 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.592 1.157 . . . . 0.0 113.056 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -142.18 -18.03 0.73 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.684 1.194 . . . . 0.0 113.949 -169.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.7 p -72.68 164.55 26.34 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.49 1.116 . . . . 0.0 113.524 169.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 20.1 m -123.65 155.03 66.82 Favored Pre-proline 0 N--CA 1.478 0.955 0 C-N-CA 124.715 1.206 . . . . 0.0 113.597 -175.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -75.47 151.73 96.59 Favored 'Cis proline' 0 C--N 1.35 0.619 0 CA-C-N 118.793 0.605 . . . . 0.0 112.913 -4.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -100.12 132.5 45.45 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 162.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 69.3 mt -126.23 142.4 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 123.977 0.911 . . . . 0.0 108.725 -167.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -138.68 146.04 41.1 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.669 0.788 . . . . 0.0 112.08 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 51.8 mt -132.73 119.99 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.907 1.283 . . . . 0.0 109.994 176.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 48.05 29.75 1.86 Allowed 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 126.224 1.81 . . . . 0.0 114.57 -176.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 91.21 0.51 73.74 Favored Glycine 0 CA--C 1.541 1.703 0 C-N-CA 125.428 1.489 . . . . 0.0 116.759 -175.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -93.0 144.96 24.74 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 126.022 1.729 . . . . 0.0 110.744 175.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -91.96 141.56 28.5 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.704 1.202 . . . . 0.0 114.065 -176.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 26.4 mm -127.79 123.2 60.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 C-N-CA 128.076 2.55 . . . . 0.0 108.364 -178.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -72.02 16.63 1.51 Allowed Glycine 0 N--CA 1.475 1.274 0 N-CA-C 118.863 2.305 . . . . 0.0 118.863 -167.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 114.59 -159.8 13.53 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 126.831 2.158 . . . . 0.0 114.196 178.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 53.6 t -65.25 -42.22 93.5 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.796 0.838 . . . . 0.0 113.229 -172.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 21.5 m -61.27 -40.9 95.8 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 118.924 0.784 . . . . 0.0 112.025 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -66.03 -40.45 91.05 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.774 1.23 . . . . 0.0 112.107 176.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 56.1 tp -64.14 -50.83 66.68 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.326 1.45 . . . . 0.0 111.35 177.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -63.3 -39.51 94.77 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 118.108 0.413 . . . . 0.0 111.106 175.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.29 -38.67 90.26 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 121.541 -0.724 . . . . 0.0 111.869 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 29.4 mt -66.53 -27.38 67.71 Favored 'General case' 0 N--CA 1.468 0.425 0 O-C-N 121.302 -0.874 . . . . 0.0 112.151 176.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -75.04 -43.42 53.68 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 118.748 0.704 . . . . 0.0 111.634 174.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -65.87 -32.41 73.9 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.582 0.753 . . . . 0.0 112.083 175.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -78.84 -0.48 30.79 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 126.119 1.768 . . . . 0.0 113.601 172.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 73.22 23.0 78.38 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 124.461 1.029 . . . . 0.0 114.925 173.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 43.2 mtmt -113.59 -24.06 9.43 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 127.31 2.244 . . . . 0.0 113.877 -168.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 38.7 tp -63.24 -37.33 86.81 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 123.43 0.692 . . . . 0.0 111.825 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -54.92 -44.14 73.96 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.545 0.738 . . . . 0.0 112.375 175.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -73.53 -33.67 58.09 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 123.991 0.805 . . . . 0.0 113.894 177.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 82.3 mt -68.24 -36.39 79.39 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 118.764 1.282 . . . . 0.0 111.801 173.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 83.0 mt -83.9 6.2 22.55 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.932 1.293 . . . . 0.0 113.184 176.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 61.4 m . . . . . 0 C--O 1.253 1.286 0 C-N-CA 124.054 0.942 . . . . 0.0 111.1 171.891 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 7.8 p . . . . . 0 CA--C 1.534 0.354 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.429 HG23 HD12 ' A' ' 54' ' ' LEU . 21.8 pt -54.53 -23.15 10.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 125.072 1.349 . . . . 0.0 113.044 168.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.58 -22.19 66.9 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -174.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 70.5 m -79.12 -28.95 42.97 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 121.08 -1.013 . . . . 0.0 113.148 170.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 54.8 mtt -64.3 -30.97 72.0 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 121.382 -0.824 . . . . 0.0 111.723 -178.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.7 mm -60.74 -27.67 41.35 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 125.012 1.325 . . . . 0.0 112.279 -178.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.4 mptt -81.0 -11.39 59.57 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.996 1.318 . . . . 0.0 113.577 178.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -80.87 -32.71 32.04 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 124.12 0.866 . . . . 0.0 114.985 -176.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 55.0 m-80 -141.56 162.47 35.4 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 115.445 1.646 . . . . 0.0 115.445 -172.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -61.62 -42.36 98.77 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.958 1.303 . . . . 0.0 112.705 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.4 t -127.55 132.12 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.129 0.972 . . . . 0.0 110.317 175.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 48.0 t -132.08 131.17 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.015 0.926 . . . . 0.0 110.92 178.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.0 t -129.84 150.45 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.275 1.03 . . . . 0.0 113.029 -174.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -126.28 106.87 9.83 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.692 1.197 . . . . 0.0 109.992 175.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 60.9 m -125.02 167.33 14.89 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 126.058 1.743 . . . . 0.0 112.134 -169.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 41.7 m0 -113.66 121.55 44.49 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.046 1.338 . . . . 0.0 109.289 166.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 96.4 t -55.99 -27.61 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 C-N-CA 124.777 1.231 . . . . 0.0 112.772 -174.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.6 p -74.45 -17.04 60.84 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 126.998 2.119 . . . . 0.0 115.054 178.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 76.1 m -107.74 158.19 34.01 Favored Pre-proline 0 CA--C 1.54 0.591 0 CA-C-N 120.135 1.334 . . . . 0.0 114.02 -160.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -79.86 -48.11 0.08 OUTLIER 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.175 1.917 . . . . 0.0 112.879 -168.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -60.99 -36.31 79.13 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.067 0.947 . . . . 0.0 113.281 -179.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -43.61 -55.42 4.32 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.701 1.2 . . . . 0.0 110.128 165.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 54.5 t -68.3 -40.31 82.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 123.89 0.876 . . . . 0.0 111.967 -178.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 43.6 mmt-85 -56.14 -41.38 75.3 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 118.865 0.757 . . . . 0.0 111.828 175.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.94 -56.72 5.61 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.732 1.213 . . . . 0.0 112.909 173.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -51.44 -35.78 41.1 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 119.857 1.208 . . . . 0.0 113.243 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 25.3 ttpt -69.44 -50.35 46.52 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 124.203 1.001 . . . . 0.0 111.647 178.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.5 tt -65.72 -41.65 92.0 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 124.63 1.172 . . . . 0.0 111.006 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 53.0 mt -62.22 -50.05 73.31 Favored 'General case' 0 C--O 1.227 -0.095 0 CA-C-O 118.359 -0.829 . . . . 0.0 111.112 177.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 14.7 m170 -61.6 -21.81 64.67 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 118.74 0.7 . . . . 0.0 112.617 173.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -83.54 -14.16 52.87 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 119.79 1.177 . . . . 0.0 114.033 174.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.91 -36.99 4.96 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.109 1.364 . . . . 0.0 114.1 -178.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.0 m -147.97 138.98 23.3 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 126.312 1.845 . . . . 0.0 111.107 -171.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -97.37 -22.95 16.33 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.195 0.998 . . . . 0.0 112.665 174.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -78.3 52.5 1.13 Allowed 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 125.263 1.425 . . . . 0.0 112.921 172.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -112.3 136.36 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 127.665 2.386 . . . . 0.0 109.934 178.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.6 m -123.13 119.79 31.32 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.723 1.609 . . . . 0.0 110.185 172.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.3 p -110.26 133.66 54.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 123.772 0.829 . . . . 0.0 111.743 170.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -103.84 125.94 50.62 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.881 1.272 . . . . 0.0 109.802 170.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -95.74 101.83 13.57 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 121.866 0.841 . . . . 0.0 111.169 -176.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . 0.278 29.8 m -81.97 5.57 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 O-C-N 120.552 -1.342 . . . . 0.0 114.481 -173.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -92.04 -20.61 21.14 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 125.26 1.424 . . . . 0.0 112.163 161.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.4 mmmt -89.66 -37.04 14.9 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 126.784 2.034 . . . . 0.0 111.878 176.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 46.1 tpp -85.2 121.12 27.5 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.683 0.793 . . . . 0.0 110.236 177.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 73.2 m -64.46 -24.45 67.62 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 -168.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -86.78 1.46 52.16 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 126.911 2.085 . . . . 0.0 114.551 171.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -50.97 -27.35 13.45 Favored Glycine 0 CA--C 1.533 1.2 0 N-CA-C 116.92 1.528 . . . . 0.0 116.92 -169.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -73.98 -20.86 60.21 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 119.808 1.804 . . . . 0.0 113.157 177.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 63.2 mm-40 -83.3 -29.89 28.0 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 121.03 -1.043 . . . . 0.0 111.803 172.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.429 HD12 HG23 ' A' ' 6' ' ' ILE . 2.7 mm? -73.92 -34.34 64.32 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.777 0.831 . . . . 0.0 111.509 170.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 63.7 mtp85 -53.87 -39.16 65.45 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 119.606 1.094 . . . . 0.0 111.196 161.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -55.54 -42.01 82.95 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.054 0.835 . . . . 0.0 114.13 171.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -65.81 -25.64 67.32 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 119.697 1.748 . . . . 0.0 113.272 177.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.1 mt -79.66 -47.59 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 123.997 0.919 . . . . 0.0 109.477 172.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -66.64 -42.62 86.41 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.441 -0.787 . . . . 0.0 112.434 -175.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -60.76 -26.65 67.39 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 121.409 -0.807 . . . . 0.0 113.057 177.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -94.52 -36.65 11.75 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 -178.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -129.15 -4.03 5.01 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 115.045 1.498 . . . . 0.0 115.045 -168.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.5 mttt 43.9 61.68 2.22 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 127.939 2.496 . . . . 0.0 113.484 -174.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -135.16 109.0 8.07 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 112.428 -2.169 . . . . 0.0 110.896 -171.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -99.92 -5.9 27.56 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.68 1.592 . . . . 0.0 112.555 177.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.0 t -51.35 148.71 4.64 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 127.17 2.188 . . . . 0.0 113.452 162.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.2 m -136.8 141.12 33.92 Favored Pre-proline 0 N--CA 1.477 0.882 0 C-N-CA 125.962 1.705 . . . . 0.0 109.926 164.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -78.6 152.21 89.83 Favored 'Cis proline' 0 N--CA 1.46 -0.492 0 CA-C-N 119.862 0.986 . . . . 0.0 114.086 5.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -97.06 142.14 29.36 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.639 0.776 . . . . 0.0 109.535 161.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 53.6 mt -133.68 139.58 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 123.816 0.846 . . . . 0.0 110.016 -164.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -138.46 144.1 39.94 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.626 1.17 . . . . 0.0 111.468 179.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 66.5 mt -133.72 120.5 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 124.926 1.29 . . . . 0.0 109.029 177.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 45.91 38.96 4.98 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 125.85 1.66 . . . . 0.0 114.134 -176.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 82.36 -3.0 83.58 Favored Glycine 0 CA--C 1.539 1.535 0 N-CA-C 116.514 1.366 . . . . 0.0 116.514 -176.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -88.25 147.14 24.97 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.371 1.468 . . . . 0.0 109.675 174.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -89.65 143.74 26.56 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.809 0.844 . . . . 0.0 112.104 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 20.1 mm -126.92 115.44 41.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 127.039 2.135 . . . . 0.0 107.273 175.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.85 -16.1 61.09 Favored Glycine 0 CA--C 1.534 1.242 0 N-CA-C 116.908 1.523 . . . . 0.0 116.908 -167.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 173.46 177.74 42.91 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-N 118.796 1.298 . . . . 0.0 115.935 174.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 29.8 t -59.41 -35.19 73.52 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 122.904 0.482 . . . . 0.0 112.068 175.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 50.4 m -72.96 -16.91 61.52 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.647 1.179 . . . . 0.0 113.584 178.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -86.72 -39.13 16.3 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.446 1.098 . . . . 0.0 111.386 169.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 51.0 tp -61.06 -51.01 70.98 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.222 1.409 . . . . 0.0 111.514 174.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -55.57 -38.06 68.86 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.554 1.141 . . . . 0.0 111.028 173.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.04 -31.17 65.91 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.09 -1.006 . . . . 0.0 113.235 -177.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 32.1 mt -72.32 -30.94 65.24 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 119.227 0.921 . . . . 0.0 112.339 173.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -65.27 -33.83 76.92 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.791 1.236 . . . . 0.0 111.083 169.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 15.1 mmtt -80.23 -9.32 59.72 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 176.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -98.51 -11.7 21.99 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.92 1.288 . . . . 0.0 114.329 172.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 67.65 29.09 73.59 Favored Glycine 0 CA--C 1.539 1.569 0 C-N-CA 121.163 -0.541 . . . . 0.0 112.357 -171.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 31.8 mtmt -111.98 -16.32 13.12 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 126.547 1.939 . . . . 0.0 113.272 -176.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 42.9 tp -68.35 -36.9 79.91 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.748 0.819 . . . . 0.0 111.776 178.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -54.37 -48.41 71.51 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.269 1.028 . . . . 0.0 111.789 175.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -76.06 -15.6 81.28 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 125.274 1.416 . . . . 0.0 114.852 178.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 53.9 mt -78.18 -32.04 49.92 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 119.393 1.597 . . . . 0.0 111.495 167.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 81.2 mt -92.85 8.63 38.77 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.977 1.711 . . . . 0.0 114.089 -178.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 35.2 t . . . . . 0 C--O 1.252 1.211 0 C-N-CA 127.097 2.159 . . . . 0.0 113.655 178.921 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.6 m . . . . . 0 N--CA 1.477 0.883 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.7 pt -62.23 -20.86 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 -156.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -54.9 -26.44 35.84 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.553 1.541 . . . . 0.0 113.821 -178.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.4 m -72.08 -34.58 68.78 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.939 1.696 . . . . 0.0 113.205 174.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 58.7 mtt -64.39 -36.15 83.2 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.968 0.907 . . . . 0.0 111.247 -178.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.2 mm -62.89 -27.32 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.273 1.029 . . . . 0.0 111.919 -172.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -77.9 -20.53 52.76 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -173.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -78.29 -29.17 54.18 Favored Glycine 0 CA--C 1.533 1.187 0 CA-C-N 119.576 1.08 . . . . 0.0 114.819 -168.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -129.26 170.57 13.43 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.555 -0.967 . . . . 0.0 112.562 -167.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 29.9 ttpt -75.22 -38.38 60.71 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.273 0.629 . . . . 0.0 112.113 177.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.1 t -125.18 139.13 52.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.733 1.213 . . . . 0.0 110.158 168.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 60.9 t -130.82 125.43 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 124.634 1.174 . . . . 0.0 108.919 171.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 50.4 t -127.6 147.65 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 123.867 0.867 . . . . 0.0 111.909 -170.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -121.05 111.43 17.45 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.673 1.189 . . . . 0.0 109.012 174.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.454 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 71.9 m -127.77 168.6 14.9 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 126.447 1.899 . . . . 0.0 110.911 -172.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.528 ' CD1' ' HB3' ' A' ' 46' ' ' ASP . 18.3 m0 -116.06 132.23 56.71 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.521 1.129 . . . . 0.0 108.424 163.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 60.7 t -56.48 -29.14 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 CA-C-N 119.098 0.863 . . . . 0.0 112.288 -176.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.8 p -85.64 -11.09 54.73 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 127.464 2.306 . . . . 0.0 115.65 -175.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 8.5 t -90.04 141.43 27.94 Favored Pre-proline 0 CA--C 1.54 0.592 0 CA-C-N 119.77 1.168 . . . . 0.0 111.146 -170.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -69.62 -39.02 7.29 Favored 'Trans proline' 0 C--N 1.348 0.523 0 CA-C-N 120.584 1.244 . . . . 0.0 112.825 179.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -61.43 -31.83 71.78 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 126.485 1.914 . . . . 0.0 114.4 178.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.454 ' SG ' ' HB3' ' A' ' 19' ' ' SER . 0.1 OUTLIER -60.16 -63.48 1.28 Allowed 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 126.253 1.821 . . . . 0.0 108.856 174.037 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 63.4 t -59.09 -38.99 77.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 124.032 0.933 . . . . 0.0 110.998 -178.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 18.6 ttt180 -56.37 -31.66 64.02 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.259 1.824 . . . . 0.0 114.801 171.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -87.12 -50.97 6.26 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 119.511 1.051 . . . . 0.0 112.65 169.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -49.15 -36.78 20.17 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.232 1.413 . . . . 0.0 112.981 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -67.22 -45.86 75.53 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 123.632 0.773 . . . . 0.0 112.914 178.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.9 tt -76.73 -35.31 57.87 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.17 1.388 . . . . 0.0 111.364 -176.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 96.2 mt -62.6 -48.06 81.08 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.389 0.676 . . . . 0.0 111.37 174.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 16.7 m-70 -65.15 -23.29 67.08 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 173.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.42 -28.75 56.75 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 119.683 1.129 . . . . 0.0 112.758 172.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.83 -18.81 19.31 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 -177.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.8 t -162.25 173.72 13.83 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 -178.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -114.6 -30.03 6.63 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.889 1.276 . . . . 0.0 113.565 175.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -84.05 43.59 0.94 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.541 1.137 . . . . 0.0 113.337 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -101.85 118.29 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 126.361 1.864 . . . . 0.0 110.909 173.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 22.0 m -106.23 141.39 37.65 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.582 1.553 . . . . 0.0 110.005 172.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.4 p -131.19 146.46 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 124.574 1.15 . . . . 0.0 112.525 173.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -114.29 119.13 35.95 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.477 1.911 . . . . 0.0 108.98 173.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -87.44 90.96 8.56 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 122.157 0.98 . . . . 0.0 109.96 179.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.9 m -73.33 0.68 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -171.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.528 ' HB3' ' CD1' ' A' ' 20' ' ' TRP . 2.8 p-10 -88.74 -12.76 41.28 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.443 1.097 . . . . 0.0 113.138 167.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 38.0 mtmt -99.11 -26.22 14.28 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 126.118 1.767 . . . . 0.0 113.794 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 10.1 ttt -98.38 137.87 36.45 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.488 1.115 . . . . 0.0 112.202 178.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 66.1 m -64.42 -26.87 68.64 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 177.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -79.41 -0.29 32.3 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 121.029 -1.045 . . . . 0.0 113.376 175.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -52.2 -31.4 34.05 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 125.268 1.413 . . . . 0.0 115.329 -174.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -83.92 -16.29 44.83 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 118.263 1.031 . . . . 0.0 112.996 -178.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 7.8 mp0 -81.16 -39.28 25.78 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 121.04 -1.037 . . . . 0.0 110.238 167.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.78 -46.12 90.91 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.042 0.537 . . . . 0.0 110.526 171.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 67.2 mtp180 -59.76 -33.14 71.3 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.283 1.033 . . . . 0.0 112.96 170.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.78 -46.66 91.3 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.121 0.867 . . . . 0.0 112.407 174.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -59.46 -42.95 93.19 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 117.997 0.898 . . . . 0.0 112.591 175.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 73.2 mt -66.41 -42.37 90.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 123.483 0.713 . . . . 0.0 110.505 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -71.58 -41.43 69.02 Favored 'General case' 0 CA--C 1.535 0.404 0 O-C-N 121.463 -0.773 . . . . 0.0 112.862 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -63.37 -36.99 85.54 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.733 1.151 . . . . 0.0 112.448 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -82.99 -47.22 11.97 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 178.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -120.16 -4.15 10.03 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -164.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.7 mptt 49.89 53.53 12.63 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.886 1.674 . . . . 0.0 112.185 -177.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 23.2 t-80 -131.44 136.53 48.05 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.951 1.7 . . . . 0.0 109.863 173.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -141.81 -34.46 0.47 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.989 0.915 . . . . 0.0 112.667 -166.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.3 p -63.57 165.53 7.94 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.085 1.354 . . . . 0.0 111.588 156.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.425 ' HB ' ' HA ' ' A' ' 68' ' ' PRO . 23.1 m -122.33 159.44 52.34 Favored Pre-proline 0 N--CA 1.48 1.043 0 C-N-CA 124.803 1.241 . . . . 0.0 112.402 -174.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.425 ' HA ' ' HB ' ' A' ' 67' ' ' VAL . 63.2 Cg_endo -81.85 152.58 77.53 Favored 'Cis proline' 0 C--N 1.349 0.592 0 CA-C-N 119.389 0.817 . . . . 0.0 113.803 -4.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -106.32 136.44 46.05 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.393 1.477 . . . . 0.0 108.979 163.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 73.2 mt -131.16 142.83 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 123.866 0.866 . . . . 0.0 110.164 -163.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -136.98 140.85 42.47 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.349 1.06 . . . . 0.0 110.912 176.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 83.9 mt -128.11 122.11 57.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 125.829 1.652 . . . . 0.0 109.42 179.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 44.7 42.32 5.75 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 125.432 1.493 . . . . 0.0 114.203 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 86.27 -4.63 85.84 Favored Glycine 0 CA--C 1.541 1.713 0 C-N-CA 125.077 1.323 . . . . 0.0 116.219 -177.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -102.49 135.19 44.56 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.654 1.727 . . . . 0.0 111.479 -176.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -73.9 144.26 45.43 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.8 0.84 . . . . 0.0 112.378 178.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 32.2 mm -122.22 127.42 75.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 127.384 2.274 . . . . 0.0 107.995 177.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.81 -5.89 27.46 Favored Glycine 0 CA--C 1.536 1.37 0 N-CA-C 118.212 2.045 . . . . 0.0 118.212 -163.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 144.79 -171.85 25.88 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 126.478 1.99 . . . . 0.0 112.752 176.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 11.4 t -61.41 -32.73 72.69 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 122.067 -0.666 . . . . 0.0 112.441 173.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 35.6 t -67.17 -41.11 86.52 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.317 -0.865 . . . . 0.0 111.735 178.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -66.55 -37.15 84.37 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.273 1.029 . . . . 0.0 113.167 171.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 13.8 tp -63.7 -50.73 68.04 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.278 1.431 . . . . 0.0 110.908 177.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -64.46 -37.76 88.66 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 122.963 0.505 . . . . 0.0 110.836 176.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.55 -34.37 76.79 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 121.066 -1.021 . . . . 0.0 112.77 175.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 64.0 mt -70.99 -24.33 62.37 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.028 0.931 . . . . 0.0 113.186 172.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -77.09 -35.02 56.79 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 119.012 0.824 . . . . 0.0 111.946 172.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -69.35 -29.28 67.04 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.942 0.897 . . . . 0.0 112.906 169.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -81.76 -3.13 53.03 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 169.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.8 14.85 63.66 Favored Glycine 0 CA--C 1.541 1.675 0 CA-C-N 120.11 1.323 . . . . 0.0 114.72 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 34.3 mtpt -100.51 -29.31 12.43 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 126.472 1.909 . . . . 0.0 112.189 -171.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 46.3 tp -58.68 -39.6 81.18 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 118.718 0.69 . . . . 0.0 111.937 177.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -55.97 -48.46 75.77 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.499 0.72 . . . . 0.0 112.579 174.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -76.86 -37.97 32.28 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 123.884 0.754 . . . . 0.0 113.957 -177.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 69.3 mt -58.52 -26.41 63.47 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.767 1.227 . . . . 0.0 112.056 169.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 81.8 mt -103.95 16.77 25.54 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.324 1.45 . . . . 0.0 114.135 176.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 62.4 m . . . . . 0 C--O 1.252 1.229 0 C-N-CA 124.63 1.172 . . . . 0.0 111.989 172.899 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 75.3 m . . . . . 0 N--CA 1.474 0.765 0 CA-C-O 120.694 0.283 . . . . 0.0 110.6 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.8 pt -55.76 -26.2 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 125.585 1.554 . . . . 0.0 115.13 -162.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -54.03 -32.15 53.52 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.591 1.557 . . . . 0.0 113.241 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 47.6 t -71.7 -34.15 69.38 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.096 1.358 . . . . 0.0 112.452 174.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 52.0 mtt -68.68 -34.32 75.48 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.346 1.058 . . . . 0.0 112.255 178.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.6 mm -59.48 -27.67 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 124.267 1.027 . . . . 0.0 111.679 -176.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 26.9 mttm -82.58 -8.08 59.62 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.034 1.734 . . . . 0.0 114.58 178.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -80.89 -17.78 71.68 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 124.005 0.812 . . . . 0.0 114.862 -175.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 60.7 m-80 -149.53 164.92 33.74 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 127.087 2.155 . . . . 0.0 110.392 -177.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 30.7 ttpt -65.95 -47.42 74.71 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.235 0.614 . . . . 0.0 112.338 173.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.5 t -115.63 129.8 71.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.366 1.067 . . . . 0.0 110.621 176.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 60.3 t -133.51 131.6 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 124.806 1.243 . . . . 0.0 109.568 178.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 60.5 t -134.17 154.32 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 123.82 0.848 . . . . 0.0 111.736 -170.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -129.45 121.54 27.5 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.975 1.31 . . . . 0.0 110.488 175.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 67.2 m -140.93 172.27 12.92 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.354 1.062 . . . . 0.0 113.764 -162.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.447 ' CD1' ' HB3' ' A' ' 46' ' ' ASP . 45.7 m0 -120.73 128.91 53.36 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.944 1.298 . . . . 0.0 110.534 168.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 71.2 t -62.66 -23.32 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 CA-C-N 119.245 0.93 . . . . 0.0 111.854 175.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 51.3 p -72.62 -13.03 61.28 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 116.067 1.877 . . . . 0.0 116.067 -175.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 57.6 m -124.39 149.81 62.43 Favored Pre-proline 0 CA--C 1.551 1.015 0 N-CA-C 116.164 1.913 . . . . 0.0 116.164 -162.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -74.52 -36.72 2.79 Favored 'Trans proline' 0 C--N 1.356 0.947 0 C-N-CA 122.3 2.0 . . . . 0.0 114.317 -166.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -52.06 -41.09 62.07 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.274 1.43 . . . . 0.0 112.141 173.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 5.2 m -86.34 -13.4 46.62 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 113.056 -1.884 . . . . 0.0 111.587 -166.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 95.9 t -77.36 -54.41 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 124.487 1.115 . . . . 0.0 110.839 155.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -72.91 -26.89 61.57 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 115.643 1.72 . . . . 0.0 115.643 -166.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -77.6 -50.22 12.98 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 119.175 0.898 . . . . 0.0 109.656 173.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.19 -36.17 79.16 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.177 0.991 . . . . 0.0 111.987 -176.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -60.97 -47.06 88.2 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.484 0.714 . . . . 0.0 112.521 172.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.2 tt -69.0 -38.24 79.17 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.672 1.589 . . . . 0.0 111.695 -179.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 81.7 mt -62.48 -48.14 80.88 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.496 0.719 . . . . 0.0 110.772 173.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 11.6 m-70 -63.61 -30.91 71.96 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 172.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -67.32 -26.98 66.77 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 120.783 -1.198 . . . . 0.0 112.022 174.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -94.09 -35.87 12.35 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.009 1.724 . . . . 0.0 114.701 -173.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 14.0 t -153.16 158.08 41.27 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.19 0.996 . . . . 0.0 113.648 -172.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 36.4 mtmt -91.67 -10.78 39.03 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.206 1.402 . . . . 0.0 112.55 163.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -84.76 40.07 0.78 Allowed 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 124.335 1.054 . . . . 0.0 113.591 -173.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.63 131.88 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 125.437 1.495 . . . . 0.0 113.768 -170.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.7 m -123.82 139.77 53.64 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 126.996 2.118 . . . . 0.0 110.048 175.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.3 p -139.72 125.35 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 124.724 1.21 . . . . 0.0 112.749 178.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 8.3 t60 -94.25 126.25 39.39 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.587 0.755 . . . . 0.0 110.895 174.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -89.75 97.25 11.08 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 123.387 0.675 . . . . 0.0 109.307 178.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 19.9 m -75.45 -12.32 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-O 119.021 -0.514 . . . . 0.0 112.386 -174.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.447 ' HB3' ' CD1' ' A' ' 20' ' ' TRP . 0.4 OUTLIER -69.33 -15.26 63.29 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.785 1.234 . . . . 0.0 113.248 174.765 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -82.99 -19.1 37.67 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 127.289 2.236 . . . . 0.0 112.448 176.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 58.8 mmm 59.3 18.53 6.75 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 127.592 2.357 . . . . 0.0 116.932 160.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.1 t -61.74 -40.21 94.27 Favored 'General case' 0 N--CA 1.48 1.034 0 O-C-N 119.915 -1.74 . . . . 0.0 111.251 170.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -138.86 0.34 1.97 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.489 1.516 . . . . 0.0 112.414 167.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -48.45 -33.3 11.49 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.786 1.66 . . . . 0.0 116.526 -174.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -69.69 -37.5 76.63 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 119.996 1.898 . . . . 0.0 110.647 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -76.74 -30.02 56.41 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 121.777 -0.577 . . . . 0.0 111.576 179.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -70.78 -45.57 64.48 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.272 0.629 . . . . 0.0 110.787 172.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -57.65 -38.73 75.56 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.203 1.801 . . . . 0.0 111.503 171.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.37 -41.5 94.46 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 124.303 0.954 . . . . 0.0 113.438 175.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -58.04 -43.64 86.95 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 119.214 1.507 . . . . 0.0 112.408 173.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 77.1 mt -64.35 -45.93 94.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.15 0.98 . . . . 0.0 110.328 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -66.75 -41.08 88.38 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.636 -0.665 . . . . 0.0 112.004 176.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -66.75 -25.23 66.39 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 120.774 -1.204 . . . . 0.0 113.337 177.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -92.61 -39.42 11.33 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 119.534 1.061 . . . . 0.0 113.516 178.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -128.39 0.81 5.67 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.669 1.188 . . . . 0.0 114.161 -167.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 48.79 43.3 21.07 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 126.782 2.033 . . . . 0.0 113.258 -176.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 63.7 t-80 -131.82 141.6 49.49 Favored 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 125.701 1.6 . . . . 0.0 111.446 -176.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -142.5 -13.92 0.77 Allowed 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 -164.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 51.3 m -70.99 150.07 46.02 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.097 1.359 . . . . 0.0 111.069 167.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 10.5 m -122.46 152.99 62.2 Favored Pre-proline 0 N--CA 1.477 0.894 0 C-N-CA 126.0 1.72 . . . . 0.0 112.599 -175.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -73.03 154.45 99.56 Favored 'Cis proline' 0 C--N 1.35 0.652 0 CA-C-N 119.126 0.724 . . . . 0.0 113.815 -2.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -107.27 129.42 54.89 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.019 1.328 . . . . 0.0 108.613 167.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 98.5 mt -124.27 142.86 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 123.646 0.779 . . . . 0.0 109.981 -162.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -136.27 139.16 42.47 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.803 0.841 . . . . 0.0 111.795 179.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 62.4 mt -131.71 116.25 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 124.85 1.26 . . . . 0.0 109.75 179.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 45.43 39.04 4.18 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 126.015 1.726 . . . . 0.0 113.847 -173.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 79.95 12.31 83.55 Favored Glycine 0 CA--C 1.539 1.559 0 N-CA-C 116.403 1.321 . . . . 0.0 116.403 -176.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -103.36 137.92 40.82 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 119.549 1.674 . . . . 0.0 110.691 172.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -85.93 131.0 34.38 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 -176.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 15.3 mm -116.27 125.29 73.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 128.506 2.722 . . . . 0.0 108.561 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -69.23 -15.74 70.32 Favored Glycine 0 CA--C 1.537 1.421 0 N-CA-C 117.407 1.723 . . . . 0.0 117.407 -165.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 149.54 -165.29 29.54 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-N 118.847 1.323 . . . . 0.0 115.36 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 32.2 t -65.17 -37.56 87.77 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.355 1.062 . . . . 0.0 112.563 -175.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 72.6 p -74.39 -15.62 60.92 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 178.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -87.34 -43.17 12.34 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.667 1.187 . . . . 0.0 110.598 166.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 51.7 tp -59.41 -47.9 83.68 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.571 1.149 . . . . 0.0 111.872 177.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -74.75 -11.78 60.24 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.804 0.842 . . . . 0.0 112.968 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -78.79 -46.84 17.91 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.117 0.967 . . . . 0.0 111.516 163.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 88.5 mt -61.17 -28.98 69.52 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.286 1.035 . . . . 0.0 112.85 175.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -64.48 -52.89 55.61 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.405 1.082 . . . . 0.0 112.093 169.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 6.9 mptt -71.14 -30.77 66.89 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.725 1.21 . . . . 0.0 112.546 -173.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -82.56 -1.94 52.18 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.29 1.036 . . . . 0.0 113.452 169.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 73.84 8.11 76.84 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 124.727 1.156 . . . . 0.0 115.759 174.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 47.5 mtmt -82.18 -29.6 31.4 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 127.639 2.376 . . . . 0.0 112.453 -172.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 36.8 tp -52.39 -36.23 53.58 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.603 1.161 . . . . 0.0 112.169 175.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -73.88 -36.17 64.77 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -67.94 -29.5 73.62 Favored Glycine 0 CA--C 1.536 1.379 0 O-C-N 120.818 -1.176 . . . . 0.0 113.325 170.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 89.3 mt -74.96 -23.63 58.32 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.621 1.168 . . . . 0.0 112.582 173.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 81.0 mt -95.58 -2.2 48.84 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.853 1.661 . . . . 0.0 114.869 174.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 39.7 m . . . . . 0 C--O 1.252 1.206 0 C-N-CA 126.028 1.731 . . . . 0.0 114.289 -175.603 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 61.4 m . . . . . 0 CA--C 1.548 0.897 0 CA-C-O 119.61 -0.233 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.6 pt -56.17 -19.71 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 N-CA-C 116.083 1.883 . . . . 0.0 116.083 -161.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -49.7 -30.19 8.81 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.584 1.554 . . . . 0.0 113.005 175.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 45.4 p -70.04 -38.05 75.74 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.087 0.955 . . . . 0.0 112.998 173.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 54.5 mtt -66.56 -32.41 73.74 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.599 1.56 . . . . 0.0 111.493 -174.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.6 mm -57.62 -33.81 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 123.919 0.888 . . . . 0.0 111.249 176.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 46.9 mttm -81.3 -9.22 59.8 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.054 1.342 . . . . 0.0 113.215 -173.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -75.69 -27.04 63.76 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 124.264 0.935 . . . . 0.0 115.201 -173.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -145.7 165.83 27.61 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.714 1.605 . . . . 0.0 112.606 179.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -63.09 -38.18 90.16 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.946 0.898 . . . . 0.0 113.128 178.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.5 t -125.26 129.58 73.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.864 1.266 . . . . 0.0 111.007 175.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 58.5 t -133.26 129.79 57.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.552 1.141 . . . . 0.0 110.559 -179.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 42.4 t -128.69 147.65 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.202 1.001 . . . . 0.0 112.337 -177.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -118.15 123.86 46.57 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.572 1.149 . . . . 0.0 109.802 170.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.8 m -140.63 177.71 7.84 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 126.328 1.851 . . . . 0.0 112.458 -165.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 37.7 m0 -123.54 136.87 54.78 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.645 1.978 . . . . 0.0 107.016 159.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 82.3 t -54.22 -31.69 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 C-N-CA 125.763 1.625 . . . . 0.0 113.64 -165.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.7 t -105.62 -5.12 20.35 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 114.865 1.432 . . . . 0.0 114.865 -165.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 71.8 m -90.24 141.93 28.07 Favored Pre-proline 0 C--O 1.234 0.249 0 O-C-N 121.651 -0.655 . . . . 0.0 111.268 -165.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -70.82 -36.82 7.4 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 CA-C-N 119.114 0.719 . . . . 0.0 112.769 -160.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -59.91 -38.26 81.8 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 127.783 2.433 . . . . 0.0 114.207 174.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 1.6 t -59.12 -49.55 77.46 Favored 'General case' 0 C--O 1.222 -0.352 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 173.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 52.8 t -63.47 -40.42 88.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 123.948 0.899 . . . . 0.0 111.451 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -56.12 -46.11 79.27 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 118.789 0.722 . . . . 0.0 111.916 175.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.98 -55.47 9.53 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.658 0.783 . . . . 0.0 111.692 177.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -42.28 -48.56 4.99 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 126.739 2.016 . . . . 0.0 111.755 178.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.53 ' HA ' ' CD2' ' A' ' 34' ' ' HIS . 16.9 ttpp -76.07 -27.31 57.17 Favored 'General case' 0 C--O 1.225 -0.23 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 -171.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.1 tt -79.24 -38.18 36.23 Favored 'General case' 0 C--N 1.317 -0.825 0 O-C-N 121.257 -0.902 . . . . 0.0 111.133 173.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 17.8 mt -67.45 -59.71 3.16 Favored 'General case' 0 CA--C 1.514 -0.415 0 C-N-CA 125.867 1.667 . . . . 0.0 112.956 -176.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.53 ' CD2' ' HA ' ' A' ' 31' ' ' LYS . 0.1 OUTLIER -52.61 -28.93 23.36 Favored 'General case' 0 C--O 1.233 0.188 0 O-C-N 124.173 0.921 . . . . 0.0 110.217 176.244 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.0 -14.27 47.96 Favored 'General case' 0 N--CA 1.441 -0.876 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.814 -172.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -105.19 -40.47 5.85 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 126.533 1.933 . . . . 0.0 112.612 179.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 23.0 m -142.63 128.13 19.02 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.743 1.617 . . . . 0.0 110.807 -175.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 45.2 mtmt -76.5 -23.95 53.74 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.47 1.508 . . . . 0.0 112.768 177.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -79.2 54.26 1.62 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.417 1.087 . . . . 0.0 113.908 175.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.67 139.03 24.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 125.821 1.649 . . . . 0.0 110.872 173.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.4 m -127.24 132.72 50.33 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 126.783 2.033 . . . . 0.0 109.306 167.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.7 p -128.02 139.96 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-O 122.238 1.018 . . . . 0.0 113.029 171.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -109.12 119.64 40.12 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.385 1.874 . . . . 0.0 109.405 176.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -91.44 92.05 8.38 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.427 0.691 . . . . 0.0 110.079 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.6 m -77.02 14.65 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 N-CA-C 115.874 1.805 . . . . 0.0 115.874 -162.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -100.69 -20.74 15.48 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 120.693 -1.254 . . . . 0.0 112.252 160.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 23.4 mmmt -71.46 -36.77 71.31 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.146 0.978 . . . . 0.0 111.34 175.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -96.13 142.23 28.56 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.098 0.959 . . . . 0.0 112.885 -167.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 16.4 m -69.3 -7.96 41.85 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 115.598 1.703 . . . . 0.0 115.598 -172.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -113.46 8.86 17.98 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.978 1.711 . . . . 0.0 113.062 175.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -54.59 -32.51 53.62 Favored Glycine 0 CA--C 1.531 1.063 0 N-CA-C 116.211 1.244 . . . . 0.0 116.211 -173.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -72.92 -29.4 63.1 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 119.169 1.485 . . . . 0.0 112.581 176.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -79.62 -31.26 41.61 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 121.586 -0.696 . . . . 0.0 111.852 174.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.04 -41.91 81.35 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 121.657 -0.652 . . . . 0.0 110.491 170.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 59.6 mtp85 -53.89 -45.75 71.16 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 119.344 0.974 . . . . 0.0 111.56 166.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.17 -38.47 93.18 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 124.15 0.881 . . . . 0.0 114.472 178.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -68.49 -25.14 64.81 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 119.088 1.444 . . . . 0.0 113.709 176.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 57.7 mt -76.88 -45.19 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 123.505 0.722 . . . . 0.0 109.263 173.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -67.42 -36.93 82.22 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 121.525 -0.734 . . . . 0.0 112.66 -178.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -57.57 -51.61 68.8 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 121.403 -0.811 . . . . 0.0 112.12 176.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -81.1 -33.08 33.56 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 114.452 1.278 . . . . 0.0 114.452 -175.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -123.52 -7.53 8.05 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 -166.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.5 mmtm 50.13 47.28 23.77 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 126.824 2.05 . . . . 0.0 112.745 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 17.7 t60 -138.18 136.18 36.37 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 127.082 2.153 . . . . 0.0 109.028 -177.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -123.54 -22.66 4.95 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 -177.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.2 p -68.19 135.17 51.64 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.644 0.778 . . . . 0.0 112.507 -178.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.8 m -88.91 149.06 42.73 Favored Pre-proline 0 N--CA 1.478 0.952 0 N-CA-C 112.519 0.562 . . . . 0.0 112.519 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -83.82 160.73 71.09 Favored 'Cis proline' 0 CA--C 1.537 0.645 0 CA-C-N 119.654 0.912 . . . . 0.0 114.181 -2.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -104.2 142.23 34.88 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.49 1.116 . . . . 0.0 109.479 159.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 56.6 mt -131.76 139.92 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.084 0.954 . . . . 0.0 110.301 -166.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -140.44 145.65 37.26 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.141 0.976 . . . . 0.0 111.964 178.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 70.1 mt -136.73 124.35 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 125.111 1.364 . . . . 0.0 109.307 177.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 47.56 37.93 7.28 Favored 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 124.649 1.18 . . . . 0.0 113.967 -177.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 73.05 11.88 79.14 Favored Glycine 0 CA--C 1.541 1.659 0 O-C-N 120.013 -1.68 . . . . 0.0 115.864 -176.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 24.8 m-80 -97.61 143.82 27.9 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.008 1.723 . . . . 0.0 110.032 169.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -89.2 141.51 28.46 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.94 0.896 . . . . 0.0 112.982 176.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 22.4 mm -126.32 122.97 62.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 127.731 2.412 . . . . 0.0 108.331 -179.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.95 -2.72 6.89 Favored Glycine 0 CA--C 1.538 1.501 0 N-CA-C 118.981 2.352 . . . . 0.0 118.981 -166.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 137.45 -166.9 24.92 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 126.934 2.207 . . . . 0.0 112.988 176.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 16.6 t -66.63 -33.48 75.74 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 121.65 -0.912 . . . . 0.0 113.008 -175.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 68.1 m -76.76 -28.7 55.82 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 121.277 -0.89 . . . . 0.0 111.993 178.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.11 -35.71 71.89 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.089 0.859 . . . . 0.0 112.782 167.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 51.6 tp -61.84 -48.64 79.67 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.797 0.839 . . . . 0.0 111.106 170.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -69.83 -13.62 62.36 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.161 0.984 . . . . 0.0 113.305 175.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -82.65 -43.5 16.86 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 121.04 -1.038 . . . . 0.0 111.331 168.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 76.6 mt -66.5 -28.53 68.64 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 120.93 -1.106 . . . . 0.0 113.0 177.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -61.08 -39.51 90.18 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.678 1.591 . . . . 0.0 112.23 168.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 5.0 mptt -84.3 -34.33 23.76 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.403 1.481 . . . . 0.0 112.364 -178.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -75.07 -0.9 20.56 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.732 1.213 . . . . 0.0 113.606 174.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 75.76 22.23 75.18 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 124.457 1.027 . . . . 0.0 114.51 170.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 35.5 mtmt -113.96 -20.2 11.13 Favored 'General case' 0 C--N 1.341 0.231 0 C-N-CA 126.551 1.94 . . . . 0.0 113.263 -170.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 43.0 tp -60.9 -40.37 92.84 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 118.738 0.699 . . . . 0.0 111.449 178.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -65.2 -42.28 93.71 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 177.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -70.7 -26.75 73.53 Favored Glycine 0 CA--C 1.537 1.439 0 C-N-CA 124.323 0.963 . . . . 0.0 114.511 175.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 30.0 mt -71.03 -31.95 68.57 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 118.276 1.038 . . . . 0.0 112.187 172.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 85.1 mt -97.85 -27.11 14.44 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 114.487 1.291 . . . . 0.0 114.487 -174.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 56.9 m . . . . . 0 C--O 1.254 1.29 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 -170.964 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 60.0 p . . . . . 0 CA--C 1.542 0.648 0 CA-C-O 120.758 0.313 . . . . 0.0 111.448 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.422 HG23 HD12 ' A' ' 54' ' ' LEU . 19.7 pt -56.35 -19.7 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 124.591 1.156 . . . . 0.0 113.264 170.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -58.88 -29.87 67.33 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.686 0.794 . . . . 0.0 112.816 -174.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 67.7 m -68.18 -24.45 64.97 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 173.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 54.4 mtt -72.5 -33.89 67.25 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 121.46 -0.775 . . . . 0.0 111.429 -178.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.8 mm -60.29 -30.78 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 123.681 0.792 . . . . 0.0 111.67 -175.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -80.36 -8.75 59.64 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.162 1.385 . . . . 0.0 114.148 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -80.03 -35.55 27.2 Favored Glycine 0 CA--C 1.535 1.292 0 N-CA-C 115.158 0.823 . . . . 0.0 115.158 -173.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 55.5 m-80 -145.08 164.13 32.17 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 118.626 1.213 . . . . 0.0 112.186 -172.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 21.7 ttpt -63.89 -42.25 97.52 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.285 1.034 . . . . 0.0 113.111 -178.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.9 t -119.84 130.62 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.251 1.021 . . . . 0.0 110.65 172.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 57.0 t -132.88 126.93 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.849 1.26 . . . . 0.0 109.744 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 40.4 t -127.1 149.29 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.129 0.972 . . . . 0.0 112.253 -173.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -123.15 114.4 20.25 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.355 1.462 . . . . 0.0 110.111 175.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.439 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 35.2 m -134.28 173.32 11.74 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.556 1.542 . . . . 0.0 112.754 -167.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 47.6 m0 -121.9 143.1 49.64 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.69 1.196 . . . . 0.0 110.237 166.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 76.7 t -65.18 -25.58 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 CA-C-O 120.771 0.32 . . . . 0.0 111.25 177.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.5 p -75.98 -18.49 59.29 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 126.196 1.798 . . . . 0.0 115.599 177.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.8 t -94.89 140.02 22.36 Favored Pre-proline 0 CA--C 1.538 0.501 0 CA-C-N 120.241 1.382 . . . . 0.0 112.571 -163.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -73.91 -37.17 3.0 Favored 'Trans proline' 0 CA--C 1.534 0.496 0 CA-C-N 120.704 1.287 . . . . 0.0 112.008 174.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -55.84 -37.66 69.02 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.164 1.386 . . . . 0.0 113.528 176.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.439 ' SG ' ' HB3' ' A' ' 19' ' ' SER . 0.5 OUTLIER -55.1 -51.89 64.98 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.192 0.997 . . . . 0.0 109.636 172.759 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.1 t -66.27 -37.53 79.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 123.943 0.897 . . . . 0.0 111.614 -177.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.1 mmt180 -54.06 -42.62 69.46 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 118.787 0.721 . . . . 0.0 112.115 173.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.93 -55.17 7.96 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.007 0.923 . . . . 0.0 112.463 173.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -54.18 -35.05 61.91 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 119.506 1.048 . . . . 0.0 113.398 -177.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.95 -38.25 69.83 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.273 1.029 . . . . 0.0 112.598 -178.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.4 tt -74.49 -46.18 41.11 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 126.499 1.92 . . . . 0.0 110.892 178.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 68.0 mt -64.69 -38.21 90.22 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.556 0.742 . . . . 0.0 112.765 -176.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 45.7 m-70 -74.74 -22.07 59.01 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 170.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -73.39 -36.38 66.04 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 119.894 1.225 . . . . 0.0 112.062 172.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 13.5 mmp_? -73.52 -52.64 12.85 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.378 1.471 . . . . 0.0 113.247 175.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.2 p -140.68 166.24 25.29 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 116.167 1.914 . . . . 0.0 116.167 -157.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 71.5 mttt -109.51 -27.74 9.27 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 127.976 2.511 . . . . 0.0 113.108 173.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -84.5 43.55 0.97 Allowed 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 125.205 1.402 . . . . 0.0 112.274 -178.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -113.43 129.13 69.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 126.558 1.943 . . . . 0.0 111.982 178.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.9 m -122.3 141.83 51.11 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 126.644 1.978 . . . . 0.0 111.169 174.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.4 p -135.72 136.27 50.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 124.441 1.096 . . . . 0.0 113.232 178.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 38.6 t60 -105.48 122.4 45.92 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.957 2.103 . . . . 0.0 109.752 175.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -92.22 89.12 6.74 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 123.689 0.796 . . . . 0.0 108.986 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 35.7 m -65.2 -18.69 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -175.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -55.88 -43.13 76.88 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.409 1.484 . . . . 0.0 111.572 164.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 34.1 mtmt -86.68 7.87 24.79 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 127.188 2.195 . . . . 0.0 113.756 179.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -114.68 129.9 56.74 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.192 1.397 . . . . 0.0 110.229 178.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 11.8 p -64.52 -20.24 66.09 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 115.753 1.76 . . . . 0.0 115.753 -170.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -113.95 8.4 17.17 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.502 1.921 . . . . 0.0 112.389 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -51.95 -25.19 16.04 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 125.807 1.67 . . . . 0.0 116.896 -168.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -69.05 -27.94 66.1 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 118.947 1.373 . . . . 0.0 112.853 174.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -80.48 -25.56 38.74 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 120.573 -1.33 . . . . 0.0 112.083 172.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.422 HD12 HG23 ' A' ' 6' ' ' ILE . 2.7 mm? -79.72 -32.65 41.21 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.722 0.809 . . . . 0.0 111.883 174.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 55.4 mtp180 -52.79 -43.32 65.8 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 119.119 0.872 . . . . 0.0 110.769 158.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.56 -35.78 89.96 Favored Glycine 0 CA--C 1.539 1.557 0 CA-C-O 118.972 -0.904 . . . . 0.0 115.21 173.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -63.47 -31.84 73.11 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 119.828 1.814 . . . . 0.0 112.914 176.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 65.2 mt -79.57 -45.73 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 C-N-CA 125.806 1.642 . . . . 0.0 109.608 175.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -64.77 -41.21 96.05 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.458 -0.776 . . . . 0.0 112.483 -178.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 76.6 mm-40 -72.14 -16.11 61.99 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 120.898 -1.126 . . . . 0.0 113.617 177.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -89.88 -41.49 11.77 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 169.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -135.0 0.43 2.88 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 115.329 1.603 . . . . 0.0 115.329 -163.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp 55.55 26.0 8.57 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 126.402 1.881 . . . . 0.0 115.513 177.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 37.2 t60 -114.96 140.03 49.35 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.391 1.077 . . . . 0.0 111.196 167.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -125.79 -27.42 3.35 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.167 0.987 . . . . 0.0 112.644 -163.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.2 p -85.96 144.09 27.81 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.474 1.11 . . . . 0.0 113.907 -178.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.3 m -89.35 153.76 48.62 Favored Pre-proline 0 N--CA 1.481 1.087 0 C-N-CA 125.017 1.327 . . . . 0.0 113.292 -173.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -79.49 158.08 89.75 Favored 'Cis proline' 0 C--N 1.349 0.577 0 CA-C-N 119.441 0.836 . . . . 0.0 113.4 -3.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -109.55 136.84 48.29 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.089 1.356 . . . . 0.0 108.709 162.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.9 mt -126.21 144.27 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 124.243 1.017 . . . . 0.0 109.444 -169.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -137.53 143.94 41.88 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.23 1.012 . . . . 0.0 110.967 177.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 48.9 mt -135.3 118.47 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.879 1.272 . . . . 0.0 109.059 179.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 47.44 43.78 15.95 Favored 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 125.023 1.329 . . . . 0.0 113.831 -175.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.18 1.17 59.46 Favored Glycine 0 CA--C 1.544 1.893 0 O-C-N 120.709 -1.245 . . . . 0.0 116.015 -176.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -92.26 134.84 34.51 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.223 1.409 . . . . 0.0 109.759 175.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -84.33 137.7 33.29 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.897 0.879 . . . . 0.0 112.831 -178.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 36.0 mm -118.1 122.84 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 127.662 2.385 . . . . 0.0 108.538 177.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.37 -6.19 39.52 Favored Glycine 0 CA--C 1.536 1.371 0 N-CA-C 118.252 2.061 . . . . 0.0 118.252 -162.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 152.91 -174.53 31.68 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 125.851 1.691 . . . . 0.0 112.99 176.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 12.8 t -65.32 -31.53 72.72 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.975 -0.721 . . . . 0.0 112.373 177.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 12.5 m -69.01 -32.63 72.32 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.732 -0.605 . . . . 0.0 111.829 -177.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -76.41 -40.65 50.26 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.122 1.369 . . . . 0.0 112.458 170.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 56.9 tp -59.48 -45.27 92.13 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.334 1.054 . . . . 0.0 111.488 175.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -64.92 -37.66 88.39 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.822 0.849 . . . . 0.0 111.35 173.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.45 -23.58 66.31 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 120.914 -1.116 . . . . 0.0 113.223 177.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 40.3 mt -84.69 -32.33 23.64 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.038 1.735 . . . . 0.0 112.709 170.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -67.46 -46.92 71.61 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.154 0.982 . . . . 0.0 112.38 175.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.2 mptt -62.25 -42.24 99.16 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.796 1.238 . . . . 0.0 111.772 178.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -76.16 -6.75 52.68 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 176.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 72.21 22.88 78.69 Favored Glycine 0 CA--C 1.535 1.293 0 CA-C-N 119.375 0.989 . . . . 0.0 114.88 174.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 40.7 mtmt -102.37 -14.21 17.0 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 127.995 2.518 . . . . 0.0 112.381 -172.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 30.5 tp -64.75 -31.75 73.12 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.047 1.739 . . . . 0.0 112.067 175.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -57.0 -46.28 82.41 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.703 -0.623 . . . . 0.0 112.281 174.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -66.39 -27.61 73.19 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 123.918 0.77 . . . . 0.0 113.677 176.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 83.3 mt -76.74 -26.11 54.24 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.475 1.11 . . . . 0.0 113.416 174.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 84.9 mt -102.93 -9.65 19.67 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 115.602 1.704 . . . . 0.0 115.602 -172.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 16.1 m . . . . . 0 N--CA 1.486 1.365 0 C-N-CA 127.25 2.22 . . . . 0.0 115.642 167.81 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 54.5 p . . . . . 0 N--CA 1.47 0.565 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.522 HG23 HD12 ' A' ' 54' ' ' LEU . 14.0 pt -45.33 -28.64 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 124.846 1.259 . . . . 0.0 113.115 168.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -57.13 -33.32 67.26 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 25.9 m -84.34 -20.08 32.62 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 175.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 45.1 mtt -68.39 -28.05 66.76 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 119.639 1.108 . . . . 0.0 112.063 173.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.491 HG21 ' HA2' ' A' ' 74' ' ' GLY . 83.8 mt -67.17 -22.4 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 CA-C-O 122.457 1.122 . . . . 0.0 112.165 -171.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -82.55 3.63 27.8 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.354 1.861 . . . . 0.0 114.482 174.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -87.87 -13.62 64.3 Favored Glycine 0 CA--C 1.541 1.682 0 C-N-CA 125.153 1.358 . . . . 0.0 116.365 -178.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -156.87 175.78 13.62 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 119.285 1.543 . . . . 0.0 112.318 177.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -72.61 -33.33 66.6 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 121.805 -0.56 . . . . 0.0 112.234 174.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.4 t -125.72 130.18 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 124.894 1.278 . . . . 0.0 110.151 173.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 62.1 t -131.49 130.49 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 123.842 0.857 . . . . 0.0 110.636 178.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 47.0 t -130.43 148.11 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.321 1.048 . . . . 0.0 112.277 -170.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -126.18 113.67 17.32 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.917 1.287 . . . . 0.0 110.097 177.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 59.8 m -132.25 167.32 20.03 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 126.0 1.72 . . . . 0.0 111.879 -166.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.463 ' CD1' ' HB3' ' A' ' 46' ' ' ASP . 34.6 m0 -117.66 126.12 51.93 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.763 1.225 . . . . 0.0 109.389 166.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 89.3 t -56.42 -39.61 62.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -166.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.7 t -74.87 -12.57 60.4 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 127.66 2.384 . . . . 0.0 115.716 -179.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.9 t -88.6 139.51 29.72 Favored Pre-proline 0 CA--C 1.539 0.523 0 O-C-N 121.395 -0.816 . . . . 0.0 110.87 -165.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -66.75 -38.25 18.45 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 CA-C-N 120.327 1.152 . . . . 0.0 112.943 -178.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 51.9 m-85 -62.24 -36.72 82.87 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.263 1.425 . . . . 0.0 114.225 178.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -56.13 -54.49 44.51 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.3 1.04 . . . . 0.0 108.989 169.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 73.2 t -62.74 -37.5 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 124.291 1.037 . . . . 0.0 112.388 -178.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 71.0 mmt-85 -52.95 -45.94 67.95 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 119.205 0.911 . . . . 0.0 112.001 172.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.75 -53.26 10.72 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.885 0.874 . . . . 0.0 112.113 178.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -59.32 -25.57 64.28 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -177.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -71.44 -46.39 60.17 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.637 0.775 . . . . 0.0 112.615 173.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.7 tt -74.26 -38.32 63.48 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.59 1.556 . . . . 0.0 111.808 -177.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 87.0 mt -63.56 -46.5 85.63 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.073 0.549 . . . . 0.0 111.047 178.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -64.32 -22.6 67.01 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 172.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -80.9 -17.2 51.41 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 176.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 10.6 mmt180 -131.94 -10.27 3.43 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 117.078 2.251 . . . . 0.0 117.078 -168.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 14.9 t -152.54 155.8 38.12 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 170.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 8.8 mptt -105.91 0.82 26.18 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.385 1.474 . . . . 0.0 112.722 166.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -105.07 40.76 1.45 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.536 1.535 . . . . 0.0 112.411 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -113.88 141.63 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 126.199 1.8 . . . . 0.0 111.695 177.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.9 m -129.33 129.39 44.76 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 127.363 2.265 . . . . 0.0 109.29 172.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -121.32 136.49 58.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 125.027 1.331 . . . . 0.0 112.784 172.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -108.99 130.97 55.49 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 125.295 1.438 . . . . 0.0 110.569 173.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -97.81 94.43 6.91 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.708 -0.62 . . . . 0.0 110.821 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.8 m -73.77 -6.59 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -176.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.463 ' HB3' ' CD1' ' A' ' 20' ' ' TRP . 0.0 OUTLIER -80.73 -19.28 45.34 Favored 'General case' 0 CA--C 1.545 0.766 0 O-C-N 121.15 -0.969 . . . . 0.0 112.004 169.161 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 39.9 mtmt -95.96 11.07 35.25 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 127.468 2.307 . . . . 0.0 113.772 175.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 12.8 ttt -125.32 128.78 48.74 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 127.584 2.353 . . . . 0.0 110.502 -167.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 25.8 m -68.49 -36.7 79.31 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.972 0.909 . . . . 0.0 113.232 -176.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.4 mp0 -84.7 -0.58 54.08 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.845 1.258 . . . . 0.0 113.289 173.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -56.35 -24.44 45.4 Favored Glycine 0 CA--C 1.535 1.321 0 O-C-N 120.471 -1.393 . . . . 0.0 115.879 -169.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 60.7 mt-10 -73.58 -28.71 61.98 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 118.714 1.257 . . . . 0.0 112.649 174.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -74.42 -37.24 63.38 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 120.908 -1.12 . . . . 0.0 111.403 172.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.522 HD12 HG23 ' A' ' 6' ' ' ILE . 3.0 mm? -69.56 -32.1 70.68 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.77 0.828 . . . . 0.0 112.765 173.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 60.6 mtp180 -56.16 -38.17 70.53 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 120.004 1.274 . . . . 0.0 111.511 164.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -64.1 -38.4 95.93 Favored Glycine 0 CA--C 1.539 1.546 0 CA-C-O 118.744 -1.031 . . . . 0.0 114.176 169.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -61.5 -29.55 70.05 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 119.988 1.894 . . . . 0.0 113.06 173.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 38.6 mt -77.38 -46.78 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 118.549 0.613 . . . . 0.0 109.973 171.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -65.83 -42.18 90.86 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 120.868 -1.145 . . . . 0.0 113.183 -175.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -73.92 -9.83 59.04 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -178.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -108.04 -32.98 7.32 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.705 1.202 . . . . 0.0 114.197 173.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -133.4 -0.11 3.29 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 114.879 1.437 . . . . 0.0 114.879 -171.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.5 mptt 48.02 51.94 13.81 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 126.033 1.733 . . . . 0.0 113.256 -177.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 33.9 t-80 -134.79 131.75 37.89 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.251 1.42 . . . . 0.0 110.587 175.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -135.82 11.94 3.4 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 126.193 1.797 . . . . 0.0 112.595 -166.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.447 HG22 ' H ' ' A' ' 67' ' ' VAL . 0.3 OUTLIER -106.59 -172.04 2.01 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 126.438 1.895 . . . . 0.0 110.266 173.414 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.447 ' H ' HG22 ' A' ' 66' ' ' THR . 21.4 m -137.93 158.47 71.3 Favored Pre-proline 0 N--CA 1.48 1.026 0 O-C-N 120.53 -1.356 . . . . 0.0 113.025 175.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -71.77 155.08 97.95 Favored 'Cis proline' 0 C--N 1.348 0.548 0 CA-C-N 118.486 0.495 . . . . 0.0 112.673 -11.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -102.57 134.01 46.62 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.437 1.095 . . . . 0.0 108.391 161.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 46.9 mt -128.59 141.39 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 123.542 0.737 . . . . 0.0 109.916 -165.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -137.95 145.56 42.17 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.983 0.913 . . . . 0.0 112.102 179.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 64.7 mt -130.28 114.06 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.214 1.405 . . . . 0.0 108.675 174.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 49.91 41.53 22.92 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.0 1.32 . . . . 0.0 113.951 -172.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.491 ' HA2' HG21 ' A' ' 10' ' ' ILE . . . 75.31 4.11 72.76 Favored Glycine 0 CA--C 1.54 1.651 0 O-C-N 120.606 -1.309 . . . . 0.0 115.128 -178.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -97.07 133.98 41.02 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.157 1.383 . . . . 0.0 109.896 173.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -83.31 146.61 28.42 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.694 1.198 . . . . 0.0 113.691 -170.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 28.6 mm -130.56 120.3 47.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 128.365 2.666 . . . . 0.0 108.131 -178.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.11 -9.87 43.87 Favored Glycine 0 CA--C 1.534 1.28 0 N-CA-C 119.084 2.393 . . . . 0.0 119.084 -163.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 158.13 -175.35 35.34 Favored Glycine 0 CA--C 1.532 1.127 0 CA-C-N 118.936 1.368 . . . . 0.0 113.766 176.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 30.1 t -65.65 -37.66 87.16 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.97 -0.724 . . . . 0.0 112.474 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 66.5 m -70.47 -32.14 69.55 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.436 -0.79 . . . . 0.0 112.097 177.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -68.62 -41.37 79.61 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.363 0.983 . . . . 0.0 112.108 172.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 15.1 tp -58.45 -50.92 71.99 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.731 1.612 . . . . 0.0 110.843 173.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -64.37 -36.32 83.75 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.934 -0.479 . . . . 0.0 112.056 175.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.04 -34.56 77.98 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 121.147 -0.971 . . . . 0.0 111.824 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 92.4 mt -70.78 -31.19 67.88 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.815 0.846 . . . . 0.0 112.052 169.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -69.45 -39.1 77.96 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 176.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -63.79 -32.96 74.63 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.986 0.914 . . . . 0.0 112.59 174.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -75.51 -13.03 60.35 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 114.29 1.218 . . . . 0.0 114.29 169.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 78.74 6.32 88.43 Favored Glycine 0 CA--C 1.538 1.494 0 CA-C-N 118.84 0.746 . . . . 0.0 114.078 -173.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 35.4 mtpt -81.66 -27.65 33.96 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 126.823 2.049 . . . . 0.0 112.15 -171.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 59.2 tp -64.78 -43.73 92.27 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.081 0.952 . . . . 0.0 111.559 172.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 -59.07 -34.89 72.48 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.788 -0.57 . . . . 0.0 111.622 177.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -77.11 -18.71 78.21 Favored Glycine 0 CA--C 1.536 1.354 0 N-CA-C 115.605 1.002 . . . . 0.0 115.605 175.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 39.0 mt -81.61 -35.57 29.92 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.965 1.306 . . . . 0.0 111.533 168.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 84.2 mt -72.76 -3.28 24.33 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.386 1.474 . . . . 0.0 113.893 177.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.1 t . . . . . 0 C--O 1.252 1.217 0 C-N-CA 127.454 2.301 . . . . 0.0 112.333 177.492 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 53.8 p . . . . . 0 CA--C 1.54 0.583 0 CA-C-O 121.175 0.512 . . . . 0.0 111.579 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.571 HG23 HD12 ' A' ' 54' ' ' LEU . 23.5 pt -59.47 -23.94 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 123.846 0.859 . . . . 0.0 113.295 174.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.52 -32.62 72.67 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 118.244 0.474 . . . . 0.0 111.944 -175.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 83.4 p -69.26 -33.59 73.48 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.729 1.212 . . . . 0.0 113.319 170.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 43.3 mtt -67.19 -31.39 71.76 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.023 0.929 . . . . 0.0 111.516 -178.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.3 mm -56.47 -35.87 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 123.592 0.757 . . . . 0.0 111.834 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -73.61 -19.01 60.98 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.08 0.952 . . . . 0.0 113.263 -175.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -77.79 -26.92 59.7 Favored Glycine 0 CA--C 1.533 1.202 0 N-CA-C 115.998 1.159 . . . . 0.0 115.998 -166.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 26.7 m-80 -134.69 172.32 13.12 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.896 1.278 . . . . 0.0 111.993 -177.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -70.03 -40.72 75.01 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.233 1.013 . . . . 0.0 112.208 178.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.0 t -128.37 136.36 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 124.774 1.23 . . . . 0.0 110.172 174.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 43.5 t -132.7 130.34 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.4 1.08 . . . . 0.0 109.997 176.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 37.6 t -127.93 145.92 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 124.279 1.032 . . . . 0.0 111.94 -176.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -120.35 116.51 25.65 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.894 1.278 . . . . 0.0 108.54 172.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 14.7 m -130.64 169.14 16.02 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.911 1.684 . . . . 0.0 111.492 -169.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.412 ' CD1' ' HB3' ' A' ' 46' ' ' ASP . 25.6 m0 -115.59 135.88 53.63 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.197 0.999 . . . . 0.0 108.975 162.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.421 HG21 ' HE2' ' A' ' 47' ' ' LYS . 54.9 t -58.28 -28.54 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 CA-C-O 121.295 0.569 . . . . 0.0 111.071 176.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.7 p -82.72 -6.87 59.61 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 116.284 1.957 . . . . 0.0 116.284 178.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.9 t -92.47 140.15 24.03 Favored Pre-proline 0 CA--C 1.544 0.717 0 CA-C-N 120.55 1.523 . . . . 0.0 111.339 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -75.13 -34.75 3.48 Favored 'Trans proline' 0 CA--C 1.534 0.489 0 C-N-CA 121.855 1.704 . . . . 0.0 112.871 173.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -59.29 -38.12 79.4 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.611 1.164 . . . . 0.0 113.408 176.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -49.98 -52.65 32.09 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.288 1.035 . . . . 0.0 109.746 171.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 57.5 t -63.29 -40.46 89.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 124.005 0.922 . . . . 0.0 111.63 -176.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 37.0 mmt-85 -53.98 -48.74 70.05 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 118.997 0.817 . . . . 0.0 111.098 175.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.34 -54.14 23.28 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.896 0.878 . . . . 0.0 112.455 177.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -48.94 -40.48 30.39 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.544 1.138 . . . . 0.0 113.142 178.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.05 -45.22 58.76 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 124.676 1.19 . . . . 0.0 112.154 -175.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.9 tt -68.72 -41.1 79.51 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.538 1.535 . . . . 0.0 111.558 176.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 63.0 mt -63.02 -46.46 87.5 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 123.282 0.633 . . . . 0.0 111.197 175.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -64.81 -20.11 66.21 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 174.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.33 -12.87 57.71 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 173.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -116.47 -30.51 5.85 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.762 1.225 . . . . 0.0 114.302 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.7 m -146.9 134.77 21.3 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 119.678 1.126 . . . . 0.0 112.577 -168.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 10.6 mmpt? -86.87 -32.38 20.26 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.242 1.417 . . . . 0.0 112.717 169.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -77.33 47.56 0.58 Allowed 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 125.579 1.552 . . . . 0.0 113.296 177.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -110.46 128.44 66.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 127.265 2.226 . . . . 0.0 109.833 175.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.5 m -112.17 129.0 56.39 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.494 1.918 . . . . 0.0 108.728 174.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.5 p -125.55 142.54 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-O 122.117 0.96 . . . . 0.0 113.042 172.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 33.0 m-70 -120.09 121.68 39.39 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 127.302 2.241 . . . . 0.0 110.51 -174.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -94.63 90.99 6.34 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 122.558 1.17 . . . . 0.0 110.513 -177.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 34.4 m -70.18 -16.13 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-N 115.154 -0.93 . . . . 0.0 112.735 -176.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.412 ' HB3' ' CD1' ' A' ' 20' ' ' TRP . 0.2 OUTLIER -69.13 -32.97 72.72 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.396 -0.815 . . . . 0.0 112.123 174.377 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.421 ' HE2' HG21 ' A' ' 21' ' ' VAL . 70.4 mmtt -77.58 -27.57 51.42 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.52 1.928 . . . . 0.0 112.244 174.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.411 ' HG2' ' H ' ' A' ' 50' ' ' GLU . 21.2 ttt -71.43 142.18 50.26 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.612 1.565 . . . . 0.0 112.48 -177.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 4.9 m -76.34 -12.28 60.04 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 177.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.411 ' H ' ' HG2' ' A' ' 48' ' ' MET . 2.0 mt-10 -125.21 9.9 8.02 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 126.116 1.766 . . . . 0.0 113.825 178.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -53.5 -29.01 38.27 Favored Glycine 0 CA--C 1.539 1.566 0 N-CA-C 116.457 1.343 . . . . 0.0 116.457 -171.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -69.19 -28.91 66.81 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 118.829 1.315 . . . . 0.0 112.869 174.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -67.39 -28.97 68.37 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.937 0.895 . . . . 0.0 111.424 169.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.571 HD12 HG23 ' A' ' 6' ' ' ILE . 2.9 mm? -83.57 -31.89 26.1 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.012 0.925 . . . . 0.0 111.961 178.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 49.5 mtp85 -53.36 -41.71 66.11 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 119.628 1.104 . . . . 0.0 111.058 154.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -57.93 -38.17 87.85 Favored Glycine 0 CA--C 1.536 1.405 0 CA-C-O 118.631 -1.094 . . . . 0.0 114.445 172.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -62.19 -41.8 98.68 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 120.299 2.049 . . . . 0.0 111.864 176.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 52.1 mt -70.13 -42.43 79.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.243 1.417 . . . . 0.0 110.069 179.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -67.84 -43.22 80.02 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 121.8 -0.563 . . . . 0.0 111.895 179.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -64.09 -33.94 76.91 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.459 -0.776 . . . . 0.0 111.812 177.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -79.35 -48.88 13.3 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 176.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -125.58 -1.45 7.42 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 114.552 1.316 . . . . 0.0 114.552 -164.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.2 mmtp 55.25 36.11 26.33 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 126.83 2.052 . . . . 0.0 114.148 -178.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 25.1 m80 -119.84 140.81 50.22 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 128.128 2.571 . . . . 0.0 109.367 176.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -125.88 -32.0 2.85 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.508 1.523 . . . . 0.0 114.395 -176.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 77.7 p -67.76 147.93 51.94 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 -169.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.3 m -99.46 152.68 37.88 Favored Pre-proline 0 N--CA 1.474 0.75 0 C-N-CA 123.726 0.811 . . . . 0.0 112.34 177.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -70.32 149.37 89.8 Favored 'Cis proline' 0 N--CA 1.458 -0.597 0 CA-C-N 119.029 0.689 . . . . 0.0 111.28 -9.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -102.85 130.78 49.98 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.219 1.007 . . . . 0.0 108.346 166.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 13.2 mt -124.62 142.28 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 124.163 0.985 . . . . 0.0 109.338 -164.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -138.36 141.21 39.68 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 123.764 0.826 . . . . 0.0 111.052 177.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 55.8 mt -133.7 117.44 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 124.467 1.107 . . . . 0.0 109.428 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 74.9 m-80 48.83 35.98 7.39 Favored 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 125.633 1.573 . . . . 0.0 114.092 -174.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 80.35 5.65 89.66 Favored Glycine 0 CA--C 1.537 1.423 0 N-CA-C 116.737 1.455 . . . . 0.0 116.737 -176.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 -95.76 139.33 32.15 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 118.834 1.317 . . . . 0.0 110.77 168.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -81.32 137.93 35.72 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.074 0.949 . . . . 0.0 112.181 178.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 28.6 mm -116.97 121.93 68.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 127.349 2.259 . . . . 0.0 107.416 174.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.9 -22.81 68.84 Favored Glycine 0 CA--C 1.534 1.223 0 N-CA-C 116.211 1.244 . . . . 0.0 116.211 -162.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 168.93 -171.47 42.92 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-N 118.193 0.997 . . . . 0.0 113.785 179.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 49.1 t -61.87 -37.85 86.08 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.784 1.234 . . . . 0.0 112.174 175.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 71.1 m -56.46 -44.66 80.74 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 118.908 0.777 . . . . 0.0 112.486 176.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -72.45 -39.14 68.02 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.998 0.919 . . . . 0.0 111.589 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 67.2 tp -62.42 -50.21 72.42 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.035 0.934 . . . . 0.0 112.168 174.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -68.67 -15.15 63.43 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 121.754 -0.591 . . . . 0.0 112.508 176.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -81.68 -47.12 13.38 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.417 -0.802 . . . . 0.0 111.49 169.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 66.5 mt -62.42 -32.58 73.44 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 120.831 -1.168 . . . . 0.0 112.783 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -64.72 -29.68 70.67 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.707 1.603 . . . . 0.0 113.467 173.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.1 mptt -93.36 -37.08 12.19 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 126.58 1.952 . . . . 0.0 112.089 -178.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -71.33 -6.2 38.22 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.996 1.318 . . . . 0.0 113.582 171.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 76.2 17.63 79.86 Favored Glycine 0 CA--C 1.534 1.256 0 O-C-N 120.942 -1.099 . . . . 0.0 113.945 177.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 44.6 mtmt -99.5 -21.45 15.93 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 126.27 1.828 . . . . 0.0 113.061 -172.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 31.1 tp -66.34 -34.82 78.84 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.861 0.865 . . . . 0.0 111.615 176.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -53.27 -41.77 65.87 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.694 1.198 . . . . 0.0 112.068 173.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -85.45 -6.9 83.15 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 125.966 1.746 . . . . 0.0 114.794 179.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 69.7 mt -95.73 -26.16 15.8 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.144 1.378 . . . . 0.0 112.471 172.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 76.6 mt -105.69 -16.13 14.77 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 114.838 1.422 . . . . 0.0 114.838 -177.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 63.3 p . . . . . 0 N--CA 1.479 1.009 0 C-N-CA 126.229 1.812 . . . . 0.0 114.836 178.479 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 74.1 p . . . . . 0 CA--C 1.54 0.578 0 N-CA-C 110.462 -0.199 . . . . 0.0 110.462 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.567 HG23 HD12 ' A' ' 54' ' ' LEU . 27.5 pt -51.53 -23.0 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 124.181 0.993 . . . . 0.0 113.493 173.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.28 -18.59 61.69 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.477 1.111 . . . . 0.0 113.407 -175.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.5 m -84.16 -19.39 34.2 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 171.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 64.7 mtt -64.2 -37.28 86.91 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 119.557 1.072 . . . . 0.0 110.851 175.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.4 mm -59.64 -20.63 19.28 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 124.004 0.921 . . . . 0.0 113.069 -173.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.3 mptt -91.74 -7.67 49.06 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.452 1.501 . . . . 0.0 114.143 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -96.82 -18.65 29.16 Favored Glycine 0 CA--C 1.539 1.579 0 N-CA-C 116.754 1.462 . . . . 0.0 116.754 -174.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 27.7 m120 -141.33 151.0 43.21 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 118.894 1.347 . . . . 0.0 112.164 -176.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt -54.85 -40.9 70.12 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.008 1.323 . . . . 0.0 112.992 176.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.6 t -129.83 134.43 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.131 0.972 . . . . 0.0 110.175 174.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 58.9 t -131.8 129.85 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.065 1.346 . . . . 0.0 109.751 177.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 47.0 t -127.33 146.9 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 124.294 1.038 . . . . 0.0 111.855 -175.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -121.72 113.48 19.77 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.696 1.198 . . . . 0.0 109.971 173.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.4 m -131.17 170.83 14.02 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.529 1.532 . . . . 0.0 112.092 -167.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.437 ' CD1' ' HB3' ' A' ' 46' ' ' ASP . 33.2 m0 -117.36 133.85 55.5 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.571 1.149 . . . . 0.0 108.867 162.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 71.4 t -58.55 -30.43 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 C-N-CA 123.567 0.747 . . . . 0.0 111.887 -175.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.8 p -82.56 -8.49 59.61 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 126.496 1.919 . . . . 0.0 116.08 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.7 t -91.62 141.4 25.74 Favored Pre-proline 0 CA--C 1.54 0.567 0 CA-C-N 120.372 1.442 . . . . 0.0 112.394 -168.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -69.26 -39.58 7.27 Favored 'Trans proline' 0 C--N 1.349 0.576 0 CA-C-N 120.343 1.158 . . . . 0.0 112.058 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -62.45 -36.47 82.52 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 126.166 1.786 . . . . 0.0 113.083 -178.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -55.1 -53.15 59.61 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.265 1.026 . . . . 0.0 109.125 169.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 94.8 t -64.32 -39.8 86.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 123.716 0.806 . . . . 0.0 111.871 -178.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.5 mmt85 -53.37 -43.4 67.75 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 118.87 0.759 . . . . 0.0 111.566 172.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.75 -54.27 9.37 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.487 0.715 . . . . 0.0 112.839 175.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.38 -33.32 58.96 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.671 1.188 . . . . 0.0 113.395 -179.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -68.68 -49.94 54.99 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.512 0.725 . . . . 0.0 111.58 177.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.6 tt -65.66 -43.32 89.74 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.796 1.639 . . . . 0.0 111.378 -178.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 95.0 mt -64.0 -40.07 95.54 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.633 0.773 . . . . 0.0 111.921 -178.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 54.3 m-70 -78.48 -13.38 59.86 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 171.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -80.37 -39.35 28.65 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 119.208 0.913 . . . . 0.0 111.952 172.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -87.46 -28.56 22.01 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 125.053 1.341 . . . . 0.0 114.267 -178.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.2 p -151.15 170.38 19.58 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 125.118 1.367 . . . . 0.0 112.628 -168.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -116.85 -19.33 9.91 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 126.562 1.945 . . . . 0.0 114.047 164.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -78.35 27.82 0.2 Allowed 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -171.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.21 132.47 44.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.365 0 C-N-CA 126.887 2.075 . . . . 0.0 111.563 -178.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 16.5 m -112.81 141.53 46.51 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 126.107 1.763 . . . . 0.0 109.65 168.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.4 p -132.85 140.24 47.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 125.259 1.424 . . . . 0.0 111.883 173.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -116.06 127.85 55.22 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.975 1.31 . . . . 0.0 110.46 176.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -95.99 87.95 4.74 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 122.06 0.933 . . . . 0.0 111.714 -172.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.0 m -71.79 3.61 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 -174.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.437 ' HB3' ' CD1' ' A' ' 20' ' ' TRP . 0.0 OUTLIER -87.33 -31.03 20.39 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 121.294 -0.879 . . . . 0.0 111.732 165.873 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 25.1 mtmt -81.42 -23.81 37.3 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.822 1.249 . . . . 0.0 113.367 176.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 21.0 ttt -85.2 121.97 28.71 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.212 1.805 . . . . 0.0 110.955 173.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 72.5 m -63.55 -31.6 72.81 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -176.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -83.32 1.48 40.93 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 175.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -56.12 -21.71 33.03 Favored Glycine 0 CA--C 1.535 1.311 0 N-CA-C 116.663 1.425 . . . . 0.0 116.663 -169.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -67.11 -29.07 68.72 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 119.365 1.582 . . . . 0.0 112.576 173.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -76.9 -25.37 52.93 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 121.103 -0.998 . . . . 0.0 111.724 174.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.567 HD12 HG23 ' A' ' 6' ' ' ILE . 2.8 mm? -84.48 -30.07 25.51 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.438 1.095 . . . . 0.0 111.57 175.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 41.1 mtp180 -54.18 -41.96 69.14 Favored 'General case' 0 N--CA 1.484 1.241 0 O-C-N 120.977 -1.077 . . . . 0.0 110.666 154.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.13 -38.86 93.68 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 124.329 0.966 . . . . 0.0 114.203 171.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -65.37 -31.66 72.88 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 120.038 1.919 . . . . 0.0 113.501 176.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 28.2 mt -71.68 -46.89 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 172.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -62.9 -39.58 94.92 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 121.109 -0.995 . . . . 0.0 113.039 -178.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 38.6 mm-40 -71.81 -10.74 60.21 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.865 1.266 . . . . 0.0 114.135 -179.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -113.99 -26.12 8.26 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 114.217 1.192 . . . . 0.0 114.217 173.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -135.31 0.87 2.85 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 115.255 1.576 . . . . 0.0 115.255 -170.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp 49.49 35.23 7.87 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 127.089 2.155 . . . . 0.0 115.226 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -141.06 153.79 45.65 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 125.148 1.379 . . . . 0.0 110.311 175.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -141.35 -24.33 0.73 Allowed 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -160.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 22.0 m -77.36 131.99 38.34 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.988 1.315 . . . . 0.0 112.353 -173.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 14.1 m -81.22 158.43 69.53 Favored Pre-proline 0 CA--C 1.547 0.857 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 -171.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -68.63 153.18 89.74 Favored 'Cis proline' 0 CA--C 1.534 0.503 0 CA-C-N 118.528 0.51 . . . . 0.0 112.219 -15.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -98.6 135.63 39.84 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 159.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 69.4 mt -129.61 142.52 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 123.599 0.759 . . . . 0.0 109.28 -166.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -138.22 140.67 39.82 Favored 'General case' 0 C--N 1.332 -0.152 0 C-N-CA 123.934 0.894 . . . . 0.0 111.145 177.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 73.8 mt -128.5 115.03 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.994 1.318 . . . . 0.0 108.202 176.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 45.69 47.83 11.59 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.547 1.539 . . . . 0.0 113.54 -174.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 79.54 -10.48 37.11 Favored Glycine 0 CA--C 1.535 1.302 0 N-CA-C 115.793 1.077 . . . . 0.0 115.793 -178.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 26.8 m-80 -86.65 132.77 33.79 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 118.887 1.343 . . . . 0.0 109.541 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -82.65 143.01 31.26 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.531 1.132 . . . . 0.0 113.056 -174.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 20.2 mm -132.5 119.58 39.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 127.93 2.492 . . . . 0.0 107.246 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.97 -22.75 65.05 Favored Glycine 0 CA--C 1.537 1.426 0 N-CA-C 116.785 1.474 . . . . 0.0 116.785 -164.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 156.64 -152.51 23.89 Favored Glycine 0 CA--C 1.527 0.79 0 CA-C-N 118.058 0.929 . . . . 0.0 114.154 173.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 8.2 t -54.91 -56.23 21.88 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.196 0.998 . . . . 0.0 112.593 -175.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 65.6 m -75.27 3.16 9.4 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -95.73 -43.09 8.05 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.357 1.063 . . . . 0.0 111.646 165.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 28.6 tp -63.39 -51.21 66.8 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.188 1.395 . . . . 0.0 111.003 175.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -57.39 -43.81 83.99 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.5 0.72 . . . . 0.0 110.24 174.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.16 -35.36 78.54 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.351 -0.843 . . . . 0.0 112.861 -177.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 42.8 mt -73.65 -26.74 60.9 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.681 0.792 . . . . 0.0 112.91 173.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -72.75 -38.92 67.23 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 119.24 0.927 . . . . 0.0 111.601 169.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -64.21 -38.64 91.77 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.565 0.746 . . . . 0.0 111.549 173.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -73.32 -7.68 52.64 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 171.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.95 28.94 74.08 Favored Glycine 0 CA--C 1.539 1.534 0 CA-C-N 120.617 1.553 . . . . 0.0 112.993 -176.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 21.2 mtpp -110.09 -30.19 7.88 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.882 2.073 . . . . 0.0 112.392 -176.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 50.2 tp -56.36 -37.51 70.14 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.444 0.697 . . . . 0.0 111.837 172.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -51.13 -46.44 61.95 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.695 1.598 . . . . 0.0 112.577 174.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -78.23 -25.42 61.62 Favored Glycine 0 CA--C 1.531 1.061 0 O-C-N 121.616 -0.677 . . . . 0.0 114.279 177.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 79.6 mt -71.19 -37.6 72.13 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 118.642 1.221 . . . . 0.0 111.734 175.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 87.3 mt -86.89 -8.26 57.43 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.166 0.987 . . . . 0.0 112.973 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.9 t . . . . . 0 C--O 1.253 1.246 0 C-N-CA 126.695 1.998 . . . . 0.0 111.224 173.456 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 51.0 m . . . . . 0 CA--C 1.543 0.702 0 CA-C-O 121.022 0.439 . . . . 0.0 111.549 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.481 HG23 HD12 ' A' ' 54' ' ' LEU . 13.2 pt -54.81 -22.25 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 N-CA-C 115.198 1.555 . . . . 0.0 115.198 -168.136 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.36 -22.03 60.72 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 93.4 p -80.48 -25.89 38.54 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.668 1.587 . . . . 0.0 113.923 172.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 62.1 mtt -65.12 -33.62 76.47 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 120.624 -1.297 . . . . 0.0 111.704 176.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.403 HG22 ' HA2' ' A' ' 74' ' ' GLY . 1.5 mm -61.89 -24.49 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 124.017 0.927 . . . . 0.0 112.222 -174.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -75.75 -11.02 59.91 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.356 1.462 . . . . 0.0 114.265 177.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -95.73 -26.38 11.86 Favored Glycine 0 CA--C 1.536 1.346 0 N-CA-C 117.8 1.88 . . . . 0.0 117.8 -164.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -143.35 158.72 43.4 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 119.335 1.568 . . . . 0.0 111.918 -173.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -59.69 -38.73 82.35 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.837 1.255 . . . . 0.0 112.931 -176.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.4 t -131.54 134.66 60.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.322 1.449 . . . . 0.0 109.446 173.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 56.1 t -132.26 128.48 58.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.702 1.201 . . . . 0.0 110.075 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 44.9 t -131.33 153.03 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.49 1.116 . . . . 0.0 111.981 -173.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -128.37 105.95 8.68 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.582 1.153 . . . . 0.0 109.393 176.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 68.9 m -126.46 171.23 11.21 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 125.744 1.618 . . . . 0.0 111.816 -170.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 47.3 m0 -118.94 129.4 55.15 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.847 1.259 . . . . 0.0 109.399 168.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 31.6 t -61.61 -20.33 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 C-N-CA 124.864 1.266 . . . . 0.0 112.661 -168.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.7 p -83.08 -22.26 33.5 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 128.671 2.788 . . . . 0.0 115.485 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 66.3 m -105.24 153.97 39.23 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 120.154 1.343 . . . . 0.0 114.06 -154.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -71.8 -49.48 0.32 Allowed 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 121.382 1.388 . . . . 0.0 114.023 -168.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -62.16 -37.37 84.99 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 -177.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -42.73 -58.29 2.4 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.973 1.709 . . . . 0.0 110.341 164.049 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 61.4 t -66.34 -38.45 81.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 O-C-N 121.5 -0.75 . . . . 0.0 112.125 -177.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 37.6 mmt-85 -54.37 -39.74 67.48 Favored 'General case' 0 N--CA 1.484 1.258 0 CA-C-N 119.12 0.873 . . . . 0.0 111.915 174.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.64 -54.74 6.5 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.55 1.14 . . . . 0.0 112.988 174.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -54.3 -30.4 50.83 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 119.392 0.997 . . . . 0.0 113.27 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.6 ttpt -69.53 -50.58 43.61 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.675 0.79 . . . . 0.0 112.21 175.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.1 tt -64.13 -43.04 96.46 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.521 1.528 . . . . 0.0 111.132 -177.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 90.5 mt -66.45 -24.27 66.41 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.263 1.025 . . . . 0.0 113.335 -177.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 44.1 m-70 -92.46 -16.3 26.02 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 168.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.0 -27.44 22.05 Favored 'General case' 0 CA--C 1.545 0.76 0 O-C-N 120.793 -1.192 . . . . 0.0 113.967 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 7.5 mmm-85 -103.2 -18.93 14.69 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 125.23 1.412 . . . . 0.0 113.973 177.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -153.02 174.49 14.1 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 127.037 2.135 . . . . 0.0 111.739 -171.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -129.78 -7.81 4.52 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 125.309 1.444 . . . . 0.0 114.532 170.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -97.76 87.69 4.1 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 119.506 1.048 . . . . 0.0 111.454 179.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.42 129.55 22.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 125.073 1.349 . . . . 0.0 110.641 -179.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 22.7 m -104.49 127.53 52.22 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.319 1.448 . . . . 0.0 108.632 168.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.5 p -125.18 134.29 67.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 118.957 0.798 . . . . 0.0 112.264 170.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -104.06 122.93 46.29 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.941 1.296 . . . . 0.0 110.3 175.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -93.7 82.91 4.36 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.568 0.699 . . . . 0.0 111.964 -172.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 29.6 m -76.08 33.32 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 -169.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -129.04 -16.67 4.03 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 126.449 1.9 . . . . 0.0 111.708 161.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 20.4 mtmt -80.2 -24.7 40.1 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.445 1.098 . . . . 0.0 112.229 162.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -92.21 127.62 37.76 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.677 1.591 . . . . 0.0 110.781 177.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 58.1 m -71.55 -20.95 61.96 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 -165.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -97.85 7.49 46.29 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 126.028 1.731 . . . . 0.0 112.686 174.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -49.51 -30.83 13.46 Favored Glycine 0 CA--C 1.537 1.416 0 CA-C-N 119.743 1.156 . . . . 0.0 115.028 -175.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -58.4 -35.34 71.89 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.368 1.867 . . . . 0.0 114.907 171.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -80.36 -36.14 34.48 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.809 1.244 . . . . 0.0 112.08 175.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.481 HD12 HG23 ' A' ' 6' ' ' ILE . 2.5 mm? -69.67 -36.11 75.73 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.715 -0.615 . . . . 0.0 111.075 176.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 42.2 mtp180 -53.14 -38.83 63.05 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.834 1.254 . . . . 0.0 112.258 165.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -57.94 -40.08 92.71 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 123.974 0.797 . . . . 0.0 113.797 173.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 56.7 mm-40 -66.55 -24.87 66.43 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 118.841 1.321 . . . . 0.0 112.984 175.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 26.1 mt -74.72 -45.45 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 O-C-N 121.498 -0.751 . . . . 0.0 109.722 172.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -68.88 -39.11 79.97 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 121.618 -0.677 . . . . 0.0 112.671 -177.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -59.58 -35.31 74.03 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 121.456 -0.777 . . . . 0.0 112.834 176.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -94.61 -32.13 13.56 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 114.293 1.219 . . . . 0.0 114.293 -175.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -134.69 4.02 3.3 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 114.741 1.386 . . . . 0.0 114.741 -169.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt 52.96 31.48 11.0 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 126.513 1.925 . . . . 0.0 114.903 176.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 -116.71 111.31 19.62 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 127.745 2.418 . . . . 0.0 110.466 -166.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -100.13 -5.37 27.93 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 115.942 1.83 . . . . 0.0 115.942 -177.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 44.7 p -81.29 171.13 15.2 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 124.895 1.278 . . . . 0.0 113.51 178.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.3 m -125.7 143.58 45.49 Favored Pre-proline 0 N--CA 1.481 1.119 0 C-N-CA 124.189 0.996 . . . . 0.0 111.748 169.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -88.64 162.62 41.42 Favored 'Cis proline' 0 N--CA 1.457 -0.621 0 CA-C-N 119.525 0.866 . . . . 0.0 113.976 5.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -100.14 143.25 30.56 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.81 0.844 . . . . 0.0 109.476 159.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 15.8 mt -133.03 141.71 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 124.21 1.004 . . . . 0.0 110.137 -167.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -142.77 147.63 35.85 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.119 0.968 . . . . 0.0 112.253 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 79.8 mt -130.65 122.79 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 125.731 1.613 . . . . 0.0 109.765 177.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 31.2 m120 44.78 39.5 3.53 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 125.645 1.578 . . . . 0.0 114.305 -178.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.403 ' HA2' HG22 ' A' ' 10' ' ' ILE . . . 92.72 -6.25 77.05 Favored Glycine 0 CA--C 1.539 1.574 0 O-C-N 120.208 -1.558 . . . . 0.0 116.231 -176.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -104.77 134.79 47.32 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.292 1.437 . . . . 0.0 111.755 -173.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -75.42 143.83 42.51 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 27.0 mm -125.61 133.19 69.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 128.266 2.627 . . . . 0.0 108.522 178.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -72.95 53.63 1.73 Allowed Glycine 0 N--CA 1.474 1.226 0 C-N-CA 126.324 1.916 . . . . 0.0 117.353 -177.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 78.21 -164.63 51.36 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 128.075 2.75 . . . . 0.0 113.459 175.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 18.6 t -62.15 -29.39 70.32 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 122.087 -0.655 . . . . 0.0 111.672 175.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 36.6 m -64.1 -45.01 90.54 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.338 1.055 . . . . 0.0 112.664 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -72.79 -37.83 67.45 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 118.823 0.738 . . . . 0.0 112.205 172.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 50.6 tp -58.67 -50.07 75.23 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.74 0.816 . . . . 0.0 111.38 176.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -61.55 -43.55 98.66 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.845 0.858 . . . . 0.0 110.697 173.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.98 -33.68 75.91 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 120.848 -1.158 . . . . 0.0 112.806 -176.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 98.7 mt -78.34 -23.82 46.81 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.511 1.124 . . . . 0.0 113.345 173.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -70.51 -41.24 72.89 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 119.566 1.076 . . . . 0.0 110.85 166.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -65.02 -28.85 69.78 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.564 1.146 . . . . 0.0 113.148 175.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.447 ' HB3' ' HE2' ' A' ' 91' ' ' LYS . 7.3 mt-10 -91.28 2.1 56.62 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 114.641 1.349 . . . . 0.0 114.641 169.019 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 67.77 4.7 34.62 Favored Glycine 0 CA--C 1.537 1.41 0 O-C-N 120.948 -1.095 . . . . 0.0 115.261 179.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.447 ' HE2' ' HB3' ' A' ' 89' ' ' GLU . 44.2 mtmt -78.57 -28.13 45.85 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 126.178 1.791 . . . . 0.0 111.949 -174.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 35.4 tp -56.07 -36.15 67.78 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.528 1.131 . . . . 0.0 112.361 172.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -65.75 -28.38 69.0 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 178.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -76.19 -36.88 38.77 Favored Glycine 0 CA--C 1.53 0.974 0 O-C-N 121.584 -0.698 . . . . 0.0 111.992 171.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 90.4 mt -70.52 -25.87 63.32 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.986 0.914 . . . . 0.0 113.367 -178.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 85.2 mt -105.42 2.14 28.4 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 -173.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 41.6 m . . . . . 0 C--O 1.255 1.351 0 C-N-CA 125.645 1.578 . . . . 0.0 114.487 -174.619 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 60.6 p . . . . . 0 CA--C 1.543 0.674 0 CA-C-O 120.888 0.375 . . . . 0.0 111.244 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.584 HG23 HD12 ' A' ' 54' ' ' LEU . 12.4 pt -53.22 -22.88 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 125.136 1.374 . . . . 0.0 113.89 174.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.62 -32.39 72.53 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 118.868 0.758 . . . . 0.0 112.574 -174.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 62.9 m -76.84 -19.3 57.67 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 173.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 38.4 mtt -73.68 -25.72 60.39 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.036 -1.04 . . . . 0.0 112.01 176.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.8 mm -63.54 -33.13 59.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.862 0.865 . . . . 0.0 111.615 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -76.45 1.41 16.56 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.884 1.274 . . . . 0.0 113.416 175.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -86.03 -18.82 58.78 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 125.115 1.341 . . . . 0.0 115.385 -177.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 22.2 m-80 -151.37 170.56 19.25 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 126.133 1.773 . . . . 0.0 111.943 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -70.19 -36.8 74.87 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.257 0.623 . . . . 0.0 112.651 174.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.3 t -128.09 135.09 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.842 1.257 . . . . 0.0 110.574 172.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 47.2 t -131.48 129.18 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 124.411 1.084 . . . . 0.0 110.069 174.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.0 t -124.9 144.73 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 124.565 1.146 . . . . 0.0 111.883 -176.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -120.2 113.01 19.8 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.17 1.388 . . . . 0.0 108.692 173.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.412 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 14.2 m -130.63 -179.06 5.07 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 127.279 2.232 . . . . 0.0 110.58 -169.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 19.7 m0 -126.82 138.08 53.29 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.491 1.116 . . . . 0.0 108.425 159.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 40.6 t -59.36 -31.07 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 CA-C-O 122.06 0.933 . . . . 0.0 111.619 -170.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.6 p -81.96 -11.08 59.05 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 127.349 2.26 . . . . 0.0 115.526 -177.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 8.2 t -89.01 141.9 29.83 Favored Pre-proline 0 CA--C 1.542 0.653 0 CA-C-N 120.373 1.442 . . . . 0.0 110.384 -168.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -75.75 -31.39 5.34 Favored 'Trans proline' 0 C--N 1.347 0.467 0 CA-C-N 120.605 1.252 . . . . 0.0 113.361 179.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -62.65 -41.45 99.06 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.532 1.133 . . . . 0.0 113.264 174.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.412 ' SG ' ' HB3' ' A' ' 19' ' ' SER . 0.2 OUTLIER -50.72 -56.51 11.65 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.597 1.159 . . . . 0.0 109.55 171.924 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 81.3 t -63.23 -40.92 90.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 118.761 -0.637 . . . . 0.0 112.579 -173.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -66.94 -20.19 65.85 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 176.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.2 -54.42 5.53 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 118.448 -0.787 . . . . 0.0 111.042 165.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -46.36 -46.76 18.55 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.438 1.095 . . . . 0.0 112.756 178.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -67.37 -36.31 81.1 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.005 1.322 . . . . 0.0 113.01 -176.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.27 -35.72 54.99 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.225 1.01 . . . . 0.0 111.402 175.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 96.7 mt -64.94 -34.54 78.66 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 121.126 -0.984 . . . . 0.0 111.409 171.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -70.25 -27.08 64.16 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.912 1.078 . . . . 0.0 113.912 167.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -74.11 -36.74 64.23 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 119.69 1.132 . . . . 0.0 112.711 174.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 73.7 mmt-85 -99.31 -28.02 13.5 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 -172.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.417 HG22 HD13 ' A' ' 96' ' ' LEU . 1.3 p -136.76 163.89 29.55 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.313 1.045 . . . . 0.0 113.442 -162.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -122.88 -26.04 4.5 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.949 1.3 . . . . 0.0 113.189 165.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -85.44 48.16 1.54 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 125.427 1.491 . . . . 0.0 113.569 -178.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.04 134.17 58.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 126.128 1.771 . . . . 0.0 112.083 -176.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.1 m -121.09 136.87 54.89 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.817 1.647 . . . . 0.0 110.66 171.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.1 p -127.17 141.29 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 125.013 1.325 . . . . 0.0 113.002 173.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 56.9 m-70 -119.43 135.82 54.58 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 128.641 2.776 . . . . 0.0 109.804 -176.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -109.25 93.18 4.38 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.251 0.62 . . . . 0.0 111.668 -173.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . 0.266 34.5 m -79.76 44.81 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 CA-C-O 123.117 1.437 . . . . 0.0 114.578 -173.323 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -145.84 -27.3 0.44 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 129.057 2.943 . . . . 0.0 110.217 172.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 28.2 mmmt -70.45 -39.06 74.56 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.444 1.098 . . . . 0.0 110.478 155.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 14.3 ttt -69.71 127.94 34.71 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.703 0.801 . . . . 0.0 111.579 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 9.1 m -78.92 -18.78 53.26 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.725 1.21 . . . . 0.0 113.927 179.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -95.54 -5.29 43.09 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.944 1.297 . . . . 0.0 112.807 167.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -51.34 -25.54 12.43 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 126.067 1.794 . . . . 0.0 116.841 -169.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -73.22 -28.13 61.99 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 118.871 1.336 . . . . 0.0 112.673 177.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 14.4 tm0? -70.04 -37.36 75.54 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.409 1.084 . . . . 0.0 110.714 172.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.584 HD12 HG23 ' A' ' 6' ' ' ILE . 2.2 mm? -74.43 -36.19 63.39 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.825 1.25 . . . . 0.0 112.52 177.074 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 72.0 mtp180 -54.13 -40.17 67.14 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 119.097 0.862 . . . . 0.0 111.158 162.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.45 -33.36 86.24 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 125.256 1.408 . . . . 0.0 114.631 172.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -63.51 -42.56 98.47 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 120.414 2.107 . . . . 0.0 111.088 175.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 26.4 mt -69.64 -39.47 78.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 123.828 0.851 . . . . 0.0 110.308 177.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -70.28 -44.23 68.8 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 121.148 -0.97 . . . . 0.0 112.808 -179.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -62.6 -30.66 71.51 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 118.93 0.786 . . . . 0.0 112.477 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -83.47 -55.09 4.5 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 174.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -117.84 -1.74 11.48 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.446 1.098 . . . . 0.0 113.918 -161.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.5 mmtp 54.21 29.74 11.08 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 126.364 1.866 . . . . 0.0 114.102 -178.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -99.74 119.88 38.84 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.087 1.755 . . . . 0.0 109.939 -179.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -115.37 -17.75 11.2 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.01 1.324 . . . . 0.0 114.502 -172.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.3 p -75.2 166.48 23.57 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.564 1.146 . . . . 0.0 112.419 172.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 21.6 m -120.52 151.27 53.73 Favored Pre-proline 0 N--CA 1.475 0.783 0 C-N-CA 124.912 1.285 . . . . 0.0 110.609 166.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -78.32 154.56 93.03 Favored 'Cis proline' 0 C--N 1.349 0.56 0 CA-C-N 118.986 0.673 . . . . 0.0 113.561 -0.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -104.84 135.25 46.56 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.144 1.378 . . . . 0.0 108.776 161.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.9 mt -126.69 142.78 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.391 1.076 . . . . 0.0 109.514 -167.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -139.9 136.41 33.87 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.274 1.03 . . . . 0.0 110.272 178.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 52.5 mt -133.84 122.03 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.02 0.928 . . . . 0.0 110.403 -176.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 48.5 m-20 49.75 30.91 4.02 Favored 'General case' 0 CA--C 1.554 1.114 0 O-C-N 121.238 -0.914 . . . . 0.0 113.257 -175.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 95.21 -8.99 69.91 Favored Glycine 0 CA--C 1.54 1.602 0 N-CA-C 117.606 1.802 . . . . 0.0 117.606 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 25.4 p30 -76.33 169.28 18.53 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 121.248 2.524 . . . . 0.0 113.482 175.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -108.16 129.45 55.18 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.447 0.699 . . . . 0.0 111.808 169.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 45.5 mm -113.99 121.88 67.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 126.611 1.964 . . . . 0.0 108.64 -178.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -74.14 21.77 1.34 Allowed Glycine 0 N--CA 1.472 1.073 0 N-CA-C 118.569 2.188 . . . . 0.0 118.569 -164.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 121.39 -172.03 15.18 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 126.639 2.066 . . . . 0.0 115.058 174.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 29.9 t -66.49 -38.51 87.43 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 121.853 -0.792 . . . . 0.0 113.033 -174.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 63.4 m -63.1 -20.27 65.21 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 176.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -90.13 -43.6 10.35 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.763 1.225 . . . . 0.0 111.008 175.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 48.4 tp -57.43 -49.48 76.1 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.442 1.097 . . . . 0.0 111.435 174.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -67.28 -29.43 69.03 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.26 0.624 . . . . 0.0 111.825 177.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -73.3 -40.2 64.72 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 121.025 -1.047 . . . . 0.0 112.672 176.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 75.8 mt -65.29 -28.2 69.16 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.083 0.953 . . . . 0.0 112.616 177.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -59.78 -47.44 85.69 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.535 1.134 . . . . 0.0 111.515 171.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -68.71 -40.74 79.83 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.199 1.0 . . . . 0.0 112.944 178.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -73.3 2.87 6.62 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 70.0 16.5 72.78 Favored Glycine 0 CA--C 1.538 1.508 0 O-C-N 120.332 -1.48 . . . . 0.0 114.145 178.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 44.4 mtmt -100.29 -34.23 10.08 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.874 1.669 . . . . 0.0 112.592 -175.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 54.4 tp -59.39 -41.36 89.23 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.244 0.929 . . . . 0.0 111.411 175.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -57.21 -41.0 78.59 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.805 0.842 . . . . 0.0 113.134 176.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -76.58 -34.05 45.59 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 124.542 1.068 . . . . 0.0 113.376 178.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 62.9 mt -65.07 -23.21 67.1 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.909 0.884 . . . . 0.0 112.483 172.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.417 HD13 HG22 ' A' ' 37' ' ' THR . 46.5 mt -100.65 -3.29 30.63 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 126.069 1.748 . . . . 0.0 113.751 177.062 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 69.3 m . . . . . 0 C--O 1.253 1.277 0 C-N-CA 125.311 1.445 . . . . 0.0 112.091 -179.284 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 25.5 p . . . . . 0 N--CA 1.472 0.631 0 CA-C-O 121.607 0.718 . . . . 0.0 112.224 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.634 HG23 HD12 ' A' ' 54' ' ' LEU . 26.8 pt -57.21 -22.46 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 124.068 0.947 . . . . 0.0 113.127 169.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.47 -21.28 64.63 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -173.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 74.0 m -83.28 -33.02 26.08 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.291 1.037 . . . . 0.0 112.48 166.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 73.4 mtp -61.78 -25.93 67.77 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.081 0.952 . . . . 0.0 112.736 178.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.9 mm -57.66 -34.59 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.283 1.033 . . . . 0.0 112.039 175.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.3 mptt -76.95 -3.41 38.73 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.29 1.036 . . . . 0.0 113.427 -178.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -76.11 -26.51 64.03 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.791 1.186 . . . . 0.0 114.96 -176.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -146.52 171.89 14.38 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 118.662 1.231 . . . . 0.0 114.026 -173.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -66.57 -35.9 81.34 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.286 1.034 . . . . 0.0 111.886 172.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.9 t -134.57 131.49 54.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 124.857 1.263 . . . . 0.0 110.23 177.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 39.5 t -134.85 130.0 52.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.467 1.107 . . . . 0.0 110.005 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 48.8 t -131.67 148.75 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 124.224 1.01 . . . . 0.0 112.513 -171.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -125.59 110.58 14.0 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.252 1.421 . . . . 0.0 109.423 175.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 58.3 m -130.61 173.66 10.67 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.604 1.562 . . . . 0.0 111.698 -169.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 47.8 m0 -122.73 129.63 51.99 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.809 1.244 . . . . 0.0 108.63 166.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 49.0 t -63.45 -23.88 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 123.361 0.664 . . . . 0.0 112.689 -164.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.4 p -78.07 -16.49 57.98 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 177.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 84.0 m -99.51 148.37 34.62 Favored Pre-proline 0 CA--C 1.537 0.45 0 CA-C-N 120.346 1.43 . . . . 0.0 114.212 -154.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -67.76 -48.68 1.37 Allowed 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 121.282 1.321 . . . . 0.0 113.964 -165.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -69.47 -31.44 69.73 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.463 1.105 . . . . 0.0 113.364 -178.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -50.71 -54.3 24.31 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.829 0.852 . . . . 0.0 109.641 168.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.7 t -66.93 -39.07 82.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 123.284 0.634 . . . . 0.0 111.658 -177.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 17.3 mmt85 -54.26 -49.2 70.1 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 118.612 0.642 . . . . 0.0 111.565 172.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.71 -57.94 7.64 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.93 0.892 . . . . 0.0 112.429 176.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -48.19 -44.51 32.79 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.538 1.135 . . . . 0.0 112.963 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -65.85 -43.34 88.75 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 123.727 0.811 . . . . 0.0 111.943 -177.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.6 tt -72.76 -34.36 66.94 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.995 1.318 . . . . 0.0 111.969 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 76.5 mt -67.47 -42.95 82.17 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.529 0.732 . . . . 0.0 111.282 172.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -60.92 -28.2 68.76 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 118.472 0.578 . . . . 0.0 112.301 167.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.73 4.07 38.37 Favored 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 114.877 1.436 . . . . 0.0 114.877 175.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -126.68 -39.72 1.97 Allowed 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 174.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 17.9 p -143.15 131.96 22.7 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 119.236 0.925 . . . . 0.0 113.343 -166.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 39.4 mtmt -70.05 -27.0 64.29 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 163.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -88.05 60.4 5.8 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.224 1.01 . . . . 0.0 113.059 -175.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.83 137.86 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 125.759 1.624 . . . . 0.0 111.622 178.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 75.6 m -120.82 135.13 55.24 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 127.288 2.235 . . . . 0.0 109.434 172.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.7 p -133.8 141.76 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 169.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 33.3 t60 -121.13 119.22 31.77 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.837 2.055 . . . . 0.0 109.632 -178.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -94.93 91.32 6.35 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.223 -0.923 . . . . 0.0 112.387 -168.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . 0.252 32.0 m -78.26 36.73 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 115.735 1.754 . . . . 0.0 115.735 -168.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -134.68 -28.68 1.22 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 127.91 2.484 . . . . 0.0 110.473 163.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 20.0 mmmt -64.09 -25.93 68.32 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.592 1.157 . . . . 0.0 112.086 160.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 91.6 mmm -91.02 144.22 25.89 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.039 1.336 . . . . 0.0 110.922 176.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.9 m -82.55 -27.09 31.85 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -174.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -99.12 8.02 45.29 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.255 1.822 . . . . 0.0 112.877 178.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -52.35 -26.56 22.4 Favored Glycine 0 CA--C 1.537 1.467 0 N-CA-C 116.751 1.46 . . . . 0.0 116.751 -173.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 70.2 mt-10 -70.39 -26.67 63.81 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 120.76 2.28 . . . . 0.0 112.895 174.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -78.08 -28.26 48.71 Favored 'General case' 0 N--CA 1.469 0.488 0 O-C-N 120.98 -1.075 . . . . 0.0 111.611 173.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.634 HD12 HG23 ' A' ' 6' ' ' ILE . 3.0 mm? -80.88 -33.21 34.5 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.539 -0.726 . . . . 0.0 111.343 175.003 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 56.5 mtp180 -58.82 -33.53 70.48 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 120.852 -1.155 . . . . 0.0 111.521 161.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -56.31 -40.18 84.36 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 124.013 0.816 . . . . 0.0 113.919 168.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -66.55 -24.8 66.42 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 119.442 1.621 . . . . 0.0 113.172 175.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 52.3 mt -81.43 -46.07 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 124.565 1.146 . . . . 0.0 109.725 175.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -69.38 -44.2 71.96 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 121.42 -0.8 . . . . 0.0 112.192 -178.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -58.11 -41.2 83.06 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.415 -0.803 . . . . 0.0 112.216 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -89.11 -37.83 14.79 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 114.247 1.202 . . . . 0.0 114.247 -175.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -124.25 -2.01 8.12 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 -170.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 53.71 47.99 22.51 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 126.703 2.001 . . . . 0.0 113.369 -176.171 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -132.2 142.39 49.42 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.679 1.192 . . . . 0.0 111.781 175.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -135.71 -28.83 1.08 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.076 1.35 . . . . 0.0 112.996 -157.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 20.8 p -79.12 167.05 21.57 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 128.023 2.529 . . . . 0.0 113.265 177.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 26.8 m -114.99 152.92 47.02 Favored Pre-proline 0 N--CA 1.48 1.063 0 C-N-CA 124.173 0.989 . . . . 0.0 112.694 173.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -77.28 143.28 74.54 Favored 'Cis proline' 0 C--N 1.349 0.592 0 CA-C-N 119.18 0.743 . . . . 0.0 112.498 -6.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -97.63 127.9 43.93 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 165.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 35.4 mt -123.73 142.37 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 124.128 0.971 . . . . 0.0 109.527 -165.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -137.63 143.03 41.22 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.813 0.845 . . . . 0.0 111.666 177.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 89.1 mt -130.01 119.65 47.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 125.165 1.386 . . . . 0.0 108.753 176.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 44.2 46.1 7.28 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 125.112 1.365 . . . . 0.0 113.178 -177.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 77.65 -2.35 63.72 Favored Glycine 0 CA--C 1.541 1.716 0 N-CA-C 117.066 1.586 . . . . 0.0 117.066 -178.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 25.7 m-80 -88.5 138.09 31.74 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 120.291 2.046 . . . . 0.0 110.326 175.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -82.61 136.11 34.89 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 118.994 0.816 . . . . 0.0 112.37 176.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 40.6 mm -115.98 124.97 72.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 127.016 2.126 . . . . 0.0 108.928 -178.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -68.72 2.63 7.63 Favored Glycine 0 CA--C 1.535 1.313 0 N-CA-C 119.25 2.46 . . . . 0.0 119.25 -163.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 142.6 -171.25 24.83 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 126.137 1.827 . . . . 0.0 113.216 175.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 42.4 t -64.07 -40.87 97.2 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 121.757 -0.849 . . . . 0.0 112.4 -177.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 68.1 m -72.89 -21.06 60.98 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.131 -0.981 . . . . 0.0 113.374 178.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -73.26 -42.65 62.24 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.262 0.937 . . . . 0.0 111.882 167.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 53.5 tp -61.06 -45.17 95.83 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.956 0.902 . . . . 0.0 110.988 175.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -64.71 -38.98 92.85 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 122.065 -0.397 . . . . 0.0 111.823 173.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.08 -36.95 83.23 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.081 -1.012 . . . . 0.0 112.106 178.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 92.4 mt -67.79 -28.69 67.81 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.69 -0.631 . . . . 0.0 112.173 175.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -69.7 -43.82 71.67 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.313 0.645 . . . . 0.0 111.098 173.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -69.93 -36.19 75.12 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.299 1.039 . . . . 0.0 113.065 175.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -73.15 -7.68 52.45 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.157 1.383 . . . . 0.0 113.299 175.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 79.37 10.13 86.27 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 123.846 0.736 . . . . 0.0 114.523 177.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 40.7 mtmt -91.11 -30.62 16.62 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 126.424 1.89 . . . . 0.0 112.527 -174.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 19.5 tp -61.97 -35.91 79.88 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 119.147 0.885 . . . . 0.0 111.392 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -65.55 -35.62 81.38 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.19 0.996 . . . . 0.0 112.318 171.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -77.36 -23.77 67.33 Favored Glycine 0 CA--C 1.532 1.121 0 O-C-N 120.879 -1.138 . . . . 0.0 114.566 177.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 86.8 mt -86.95 -27.38 23.34 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.412 1.485 . . . . 0.0 113.021 176.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 74.8 mt -117.93 -16.84 9.86 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 -170.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.7 m . . . . . 0 C--O 1.254 1.322 0 C-N-CA 126.625 1.97 . . . . 0.0 114.152 177.278 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 44.1 p . . . . . 0 CA--C 1.537 0.448 0 CA-C-O 121.703 0.763 . . . . 0.0 111.786 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.557 HG23 HD12 ' A' ' 54' ' ' LEU . 11.5 pt -50.98 -23.32 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.841 1.256 . . . . 0.0 113.553 168.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.69 -27.27 69.13 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -175.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.6 m -85.4 -11.44 54.46 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 172.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 55.7 mtt -68.79 -32.7 72.63 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 120.795 -1.19 . . . . 0.0 111.176 170.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.3 mm -60.51 -30.41 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 123.788 0.835 . . . . 0.0 111.905 -176.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.0 mttm -74.28 -8.9 57.82 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.825 1.25 . . . . 0.0 113.725 -177.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -89.8 -28.37 18.86 Favored Glycine 0 CA--C 1.537 1.41 0 N-CA-C 116.961 1.544 . . . . 0.0 116.961 -166.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -145.07 159.27 43.22 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.504 1.522 . . . . 0.0 111.05 -178.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -52.91 -42.29 65.23 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.711 1.605 . . . . 0.0 113.63 178.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.2 t -125.09 135.68 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.809 1.244 . . . . 0.0 110.464 174.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 48.4 t -133.85 131.73 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.394 1.078 . . . . 0.0 110.46 178.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.4 t -129.36 147.43 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 125.265 1.426 . . . . 0.0 111.545 -172.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -124.3 115.39 20.94 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.18 0.992 . . . . 0.0 109.212 172.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.407 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 21.0 m -130.19 168.22 17.17 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 126.18 1.792 . . . . 0.0 111.022 -168.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.45 ' CD1' ' HB3' ' A' ' 46' ' ' ASP . 19.5 m0 -111.81 135.79 51.96 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 157.232 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 72.2 t -59.22 -28.23 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 O-C-N 123.189 0.305 . . . . 0.0 111.109 175.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 48.7 p -67.65 -20.33 65.31 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 175.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 46.0 t -89.76 143.81 30.8 Favored Pre-proline 0 CA--C 1.538 0.491 0 O-C-N 121.281 -0.887 . . . . 0.0 111.193 -163.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -77.05 -39.48 0.6 Allowed 'Trans proline' 0 N--CA 1.459 -0.544 0 CA-C-N 119.656 0.913 . . . . 0.0 114.122 177.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -58.82 -36.33 74.32 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.049 1.739 . . . . 0.0 113.4 175.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.407 ' SG ' ' HB3' ' A' ' 19' ' ' SER . 0.3 OUTLIER -52.63 -55.67 20.82 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.949 1.3 . . . . 0.0 109.14 171.847 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.8 t -65.9 -39.99 86.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 123.53 0.732 . . . . 0.0 111.124 -178.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . 0.288 2.4 ttp180 -54.22 -28.84 43.67 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.012 1.725 . . . . 0.0 115.369 167.036 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -85.38 -55.53 3.97 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 119.911 1.232 . . . . 0.0 111.883 167.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -48.37 -38.33 19.06 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.96 1.704 . . . . 0.0 113.776 -178.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -75.0 -43.69 52.45 Favored 'General case' 0 C--O 1.231 0.081 0 C-N-CA 124.385 1.074 . . . . 0.0 111.889 -177.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 8.4 tt -71.53 -39.56 70.67 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 124.714 1.206 . . . . 0.0 110.888 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 88.8 mt -61.75 -51.77 66.97 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.56 0.744 . . . . 0.0 110.746 176.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 24.2 m-70 -65.87 -15.92 63.37 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 172.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.72 -43.84 24.87 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 119.844 1.202 . . . . 0.0 111.43 169.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 68.7 mmt-85 -82.0 -50.41 9.15 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.219 1.008 . . . . 0.0 113.43 -171.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 21.9 m -160.54 129.09 4.7 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 125.106 1.362 . . . . 0.0 111.95 177.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 42.9 mttm -85.98 2.25 46.99 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 126.007 1.723 . . . . 0.0 115.228 -166.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -82.31 53.83 2.39 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.534 1.133 . . . . 0.0 112.04 172.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -118.87 127.43 75.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 126.567 1.947 . . . . 0.0 111.14 -177.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.6 m -110.78 141.31 44.28 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 126.067 1.747 . . . . 0.0 110.44 171.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.6 p -137.47 135.92 46.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 C-N-CA 124.535 1.134 . . . . 0.0 112.766 175.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -110.79 125.9 54.04 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.379 1.472 . . . . 0.0 109.45 175.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -97.21 88.27 4.41 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 122.526 1.155 . . . . 0.0 110.966 -174.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 22.1 m -64.6 -12.86 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 -174.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.45 ' HB3' ' CD1' ' A' ' 20' ' ' TRP . 0.1 OUTLIER -73.69 -21.37 60.27 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.619 1.168 . . . . 0.0 113.323 172.612 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -86.78 -27.1 23.8 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.257 1.423 . . . . 0.0 113.14 177.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 90.7 mtp -69.55 154.28 42.24 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.724 1.61 . . . . 0.0 112.117 175.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 8.6 t -84.02 -24.85 30.34 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.902 0.881 . . . . 0.0 111.691 163.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -93.47 -5.38 49.33 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.49 1.516 . . . . 0.0 114.779 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -57.41 -24.16 51.09 Favored Glycine 0 CA--C 1.536 1.386 0 N-CA-C 116.147 1.219 . . . . 0.0 116.147 -172.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -69.65 -22.49 63.46 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 118.687 1.243 . . . . 0.0 112.898 174.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -82.0 -35.63 28.68 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.937 0.895 . . . . 0.0 111.345 170.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.557 HD12 HG23 ' A' ' 6' ' ' ILE . 2.9 mm? -74.45 -32.94 62.78 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.132 -0.98 . . . . 0.0 111.996 177.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 62.0 mtp180 -53.71 -39.97 65.67 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 121.123 -0.985 . . . . 0.0 111.632 162.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -67.83 -37.06 88.05 Favored Glycine 0 CA--C 1.535 1.321 0 CA-C-O 118.3 -1.278 . . . . 0.0 114.155 172.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -60.72 -32.32 71.59 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 120.746 2.273 . . . . 0.0 113.296 174.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 57.2 mt -75.53 -43.99 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 123.904 0.882 . . . . 0.0 109.95 174.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 19.0 t80 -67.7 -43.19 80.68 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.026 -1.046 . . . . 0.0 112.728 -177.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -67.38 -15.2 63.55 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 113.944 1.091 . . . . 0.0 113.944 178.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -106.71 -26.54 11.27 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 177.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -143.44 4.84 1.4 Allowed 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 115.858 1.799 . . . . 0.0 115.858 -170.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm 54.42 24.49 5.26 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 127.608 2.363 . . . . 0.0 116.952 178.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 -101.52 111.13 23.27 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.057 1.343 . . . . 0.0 111.615 -174.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -96.36 -17.16 20.85 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 178.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 98.3 m -72.52 153.71 41.19 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.682 1.593 . . . . 0.0 111.862 176.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.7 m -115.99 151.74 46.85 Favored Pre-proline 0 N--CA 1.477 0.904 0 C-N-CA 123.713 0.805 . . . . 0.0 111.546 165.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -74.19 155.62 99.84 Favored 'Cis proline' 0 N--CA 1.459 -0.539 0 CA-C-N 119.207 0.753 . . . . 0.0 112.944 -3.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -98.13 139.33 34.1 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.542 1.137 . . . . 0.0 108.447 159.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 53.0 mt -129.91 140.81 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 123.972 0.909 . . . . 0.0 109.487 -165.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -138.13 143.13 40.2 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.126 0.97 . . . . 0.0 111.18 178.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 72.4 mt -135.22 123.13 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 125.346 1.458 . . . . 0.0 109.17 -178.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 45.27 48.33 10.26 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 124.902 1.281 . . . . 0.0 113.371 -179.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 75.04 10.92 84.19 Favored Glycine 0 CA--C 1.539 1.545 0 N-CA-C 116.066 1.186 . . . . 0.0 116.066 179.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 21.1 m-80 -116.04 140.39 49.32 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.472 1.509 . . . . 0.0 111.683 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -82.47 131.9 35.21 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.596 1.158 . . . . 0.0 112.944 179.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 41.1 mm -107.25 123.43 62.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 127.047 2.139 . . . . 0.0 108.288 177.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.18 12.02 0.66 Allowed Glycine 0 CA--C 1.531 1.055 0 N-CA-C 119.089 2.395 . . . . 0.0 119.089 -166.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 142.36 -177.1 21.83 Favored Glycine 0 CA--C 1.535 1.316 0 C-N-CA 127.582 2.515 . . . . 0.0 113.643 170.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 39.1 t -57.09 -42.86 81.52 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.721 -0.87 . . . . 0.0 111.458 173.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 68.5 m -65.53 -26.06 67.72 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 178.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.44 -40.56 64.13 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 119.703 1.138 . . . . 0.0 111.768 172.08 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 40.1 tp -60.55 -48.96 79.45 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.865 0.866 . . . . 0.0 110.738 173.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -66.19 -34.36 77.86 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.522 0.729 . . . . 0.0 111.438 177.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.85 -35.66 74.9 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 120.227 -1.546 . . . . 0.0 112.79 175.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 84.0 mt -72.55 -31.05 64.97 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.216 1.007 . . . . 0.0 112.777 173.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -59.4 -48.55 81.2 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.788 0.835 . . . . 0.0 110.109 166.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.92 -34.4 75.33 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 -178.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -75.74 0.72 16.86 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 172.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 71.05 21.47 78.36 Favored Glycine 0 CA--C 1.534 1.219 0 O-C-N 121.322 -0.861 . . . . 0.0 113.445 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt -101.38 -25.96 13.76 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 125.688 1.595 . . . . 0.0 113.107 -174.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 39.4 tp -64.2 -37.4 87.33 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.267 1.027 . . . . 0.0 112.189 176.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -52.8 -44.09 66.39 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.002 0.921 . . . . 0.0 111.973 173.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -75.01 -29.78 60.2 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.044 0.831 . . . . 0.0 114.525 178.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 85.1 mt -66.09 -40.84 91.13 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 118.382 1.091 . . . . 0.0 111.356 170.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 86.4 mt -90.53 -18.87 24.51 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 -170.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 72.7 m . . . . . 0 C--O 1.252 1.205 0 C-N-CA 124.506 1.122 . . . . 0.0 113.385 -179.286 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 17.5 p . . . . . 0 N--CA 1.476 0.854 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.493 HG23 HD12 ' A' ' 54' ' ' LEU . 16.2 pt -51.03 -24.04 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 124.496 1.118 . . . . 0.0 113.589 173.107 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.86 -27.99 67.14 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.87 0.868 . . . . 0.0 113.094 -175.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.1 p -80.65 -28.82 36.78 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 121.242 -0.911 . . . . 0.0 113.426 174.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 43.3 mtt -63.97 -35.47 80.79 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.29 1.036 . . . . 0.0 110.478 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -62.88 -27.39 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 125.89 1.676 . . . . 0.0 111.826 -176.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 45.2 mmtm -79.21 -17.04 55.61 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.018 1.327 . . . . 0.0 113.779 -175.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -87.34 -26.77 29.64 Favored Glycine 0 CA--C 1.533 1.198 0 N-CA-C 116.331 1.292 . . . . 0.0 116.331 -167.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -134.05 153.77 51.59 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.694 1.197 . . . . 0.0 111.628 -178.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -62.77 -34.62 77.62 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.002 0.741 . . . . 0.0 113.002 -174.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.4 t -122.27 131.53 72.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.373 1.069 . . . . 0.0 109.896 167.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 65.1 t -132.01 127.77 58.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.158 0.983 . . . . 0.0 109.571 176.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 37.5 t -126.28 147.3 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 123.929 0.892 . . . . 0.0 111.773 -175.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -122.55 108.81 13.56 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.568 1.147 . . . . 0.0 109.44 176.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 37.1 m -128.93 173.88 10.01 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 126.638 1.975 . . . . 0.0 111.458 -167.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 28.9 m0 -120.11 144.58 47.54 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.367 1.067 . . . . 0.0 109.699 163.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.5 t -68.73 -17.2 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 CA-C-O 120.934 0.397 . . . . 0.0 111.079 178.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.3 p -86.31 -10.81 53.75 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 128.066 2.547 . . . . 0.0 116.579 178.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.9 t -96.45 143.42 26.08 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-N 120.017 1.28 . . . . 0.0 112.731 -170.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -72.21 -40.19 2.55 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 121.28 1.32 . . . . 0.0 113.634 173.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -58.0 -36.81 73.18 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.334 1.453 . . . . 0.0 113.802 179.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -54.02 -61.22 2.45 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.477 1.911 . . . . 0.0 109.573 174.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 92.0 t -60.9 -39.37 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.346 1.058 . . . . 0.0 111.104 -179.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.2 ttt180 -52.54 -38.57 60.02 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.684 1.594 . . . . 0.0 114.901 169.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -79.53 -54.59 5.75 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 119.079 0.854 . . . . 0.0 111.79 171.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -48.19 -43.35 31.72 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.386 1.474 . . . . 0.0 113.137 -178.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -62.3 -40.22 95.57 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 123.722 0.809 . . . . 0.0 112.35 -175.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.4 tt -79.08 -42.34 26.59 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 126.538 1.935 . . . . 0.0 110.867 -178.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 91.5 mt -62.07 -40.66 96.56 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 121.868 -0.52 . . . . 0.0 111.665 177.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -71.27 -24.48 62.17 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 172.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.56 -25.04 53.62 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 120.144 1.338 . . . . 0.0 112.921 174.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 7.5 tpt180 -106.88 -31.98 8.12 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.868 1.667 . . . . 0.0 114.823 -170.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 13.6 p -134.05 154.44 51.15 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 -166.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -103.81 -31.91 9.58 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 127.406 2.282 . . . . 0.0 112.455 174.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -93.06 38.52 1.03 Allowed 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 125.451 1.5 . . . . 0.0 113.186 -171.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.14 122.4 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 124.974 1.309 . . . . 0.0 112.96 -175.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.9 m -113.3 135.28 54.02 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.811 1.645 . . . . 0.0 109.847 170.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.3 p -124.21 138.05 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.457 1.103 . . . . 0.0 112.304 171.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -109.37 125.95 52.91 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.015 1.726 . . . . 0.0 110.637 177.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -98.17 79.82 2.62 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.351 1.061 . . . . 0.0 110.233 -177.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 31.0 m -56.89 -28.55 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -167.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -70.66 -14.25 62.4 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 124.329 1.052 . . . . 0.0 113.693 176.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.2 mmmt -83.0 -13.02 56.76 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 126.3 1.84 . . . . 0.0 112.559 173.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 22.3 mmt -101.5 172.26 7.07 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.178 1.791 . . . . 0.0 111.787 -178.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.0 m -81.19 -18.75 45.12 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 121.063 -1.023 . . . . 0.0 113.331 -177.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -122.05 8.29 9.82 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.702 1.601 . . . . 0.0 114.42 -163.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -55.45 -27.98 49.51 Favored Glycine 0 CA--C 1.538 1.523 0 CA-C-N 120.035 1.289 . . . . 0.0 115.18 -172.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -67.82 -31.65 71.65 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 119.973 1.886 . . . . 0.0 113.088 171.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 63.8 mt-30 -73.69 -38.55 64.85 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.686 1.194 . . . . 0.0 111.344 173.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.493 HD12 HG23 ' A' ' 6' ' ' ILE . 2.7 mm? -75.18 -33.9 61.49 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.484 1.038 . . . . 0.0 111.962 177.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 15.7 mtp85 -55.32 -41.06 71.93 Favored 'General case' 0 N--CA 1.478 0.965 0 O-C-N 120.953 -1.092 . . . . 0.0 111.303 161.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.38 -24.16 67.27 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 124.444 1.021 . . . . 0.0 115.127 171.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 -71.45 -37.29 71.41 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 120.471 2.136 . . . . 0.0 111.72 172.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 44.1 mt -72.35 -43.55 64.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 123.948 0.899 . . . . 0.0 109.539 179.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -67.76 -42.75 81.27 Favored 'General case' 0 CA--C 1.532 0.262 0 O-C-N 121.298 -0.876 . . . . 0.0 112.914 -178.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -65.7 -26.06 67.6 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -177.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -100.19 -29.55 12.42 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -131.58 -2.41 3.81 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 114.752 1.39 . . . . 0.0 114.752 -172.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt 51.33 39.0 23.11 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 126.152 1.781 . . . . 0.0 113.629 -175.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -123.52 138.66 54.52 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 126.828 2.051 . . . . 0.0 110.701 -178.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -142.39 -33.17 0.48 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.603 1.561 . . . . 0.0 111.966 -155.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.7 p -84.03 113.18 20.83 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.43 1.492 . . . . 0.0 113.102 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.2 m -66.77 153.54 93.64 Favored Pre-proline 0 N--CA 1.484 1.245 0 C-N-CA 124.811 1.245 . . . . 0.0 113.1 -179.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -75.89 151.94 96.21 Favored 'Cis proline' 0 C--N 1.352 0.715 0 CA-C-N 119.327 0.795 . . . . 0.0 113.918 -6.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -93.79 137.05 33.44 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 159.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 46.3 mt -125.1 141.64 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 124.209 1.004 . . . . 0.0 109.243 -168.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -142.41 147.09 35.62 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.391 0.676 . . . . 0.0 111.587 179.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 74.9 mt -127.91 123.37 60.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 125.277 1.431 . . . . 0.0 108.099 175.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 50.62 27.57 3.02 Favored 'General case' 0 CA--C 1.555 1.149 0 N-CA-C 115.257 1.577 . . . . 0.0 115.257 -177.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 89.89 -7.39 81.81 Favored Glycine 0 CA--C 1.543 1.827 0 O-C-N 120.697 -1.252 . . . . 0.0 115.257 -173.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -90.86 143.3 26.87 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.103 1.761 . . . . 0.0 110.336 179.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -90.19 142.6 27.56 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 -167.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 15.9 mm -130.84 125.49 58.36 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 C-N-CA 128.245 2.618 . . . . 0.0 108.981 176.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.7 -13.94 64.3 Favored Glycine 0 CA--C 1.538 1.488 0 N-CA-C 117.166 1.627 . . . . 0.0 117.166 -168.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 158.25 -175.24 35.44 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-N 118.271 1.035 . . . . 0.0 113.528 175.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 14.7 t -63.43 -35.36 80.18 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.507 -0.996 . . . . 0.0 112.943 -178.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 52.2 m -64.65 -23.1 67.15 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 121.113 -0.992 . . . . 0.0 113.271 176.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -88.17 -39.74 14.28 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.504 1.522 . . . . 0.0 112.702 174.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 37.7 tp -58.21 -51.93 67.68 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.38 1.472 . . . . 0.0 111.502 171.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -63.17 -24.52 67.93 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.041 0.536 . . . . 0.0 111.714 178.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -78.84 -31.96 45.9 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 121.304 -0.872 . . . . 0.0 113.334 176.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 14.2 mt -65.34 -34.91 79.43 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 119.278 0.944 . . . . 0.0 112.059 169.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -61.6 -44.87 96.2 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.861 0.864 . . . . 0.0 110.932 171.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.1 mmtt -71.54 -30.4 65.85 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -177.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -72.86 -10.88 60.3 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 172.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 74.89 30.24 59.73 Favored Glycine 0 CA--C 1.533 1.19 0 O-C-N 121.292 -0.88 . . . . 0.0 113.649 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 45.8 mtmt -118.97 -16.0 9.25 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 126.668 1.987 . . . . 0.0 113.021 -169.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 35.1 tp -71.35 -38.94 71.58 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.857 1.263 . . . . 0.0 111.915 -175.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -65.46 -28.42 69.2 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 178.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -85.31 -12.7 72.62 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 125.622 1.582 . . . . 0.0 115.22 172.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 24.9 mt -81.2 -39.31 25.62 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 119.377 1.589 . . . . 0.0 111.055 165.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 79.3 mt -89.29 26.25 1.7 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 126.328 1.851 . . . . 0.0 113.035 -175.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 10.7 p . . . . . 0 C--O 1.251 1.143 0 C-N-CA 127.099 2.159 . . . . 0.0 114.673 -177.502 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 59.8 p . . . . . 0 N--CA 1.471 0.623 0 CA-C-O 120.978 0.418 . . . . 0.0 110.616 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.516 HG23 HD12 ' A' ' 54' ' ' LEU . 29.9 pt -56.08 -25.68 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 O-C-N 120.762 -1.211 . . . . 0.0 112.49 168.342 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.96 -19.77 65.98 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -173.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.3 m -89.08 -19.84 25.07 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.425 1.09 . . . . 0.0 113.256 173.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 66.4 mtp -62.53 -33.35 74.72 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 119.39 0.995 . . . . 0.0 111.804 172.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.2 mm -60.47 -18.09 15.99 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 124.672 1.189 . . . . 0.0 112.267 -177.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.2 mptt -91.37 -9.02 46.34 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.245 1.418 . . . . 0.0 113.859 177.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -88.19 -39.04 7.02 Favored Glycine 0 CA--C 1.538 1.528 0 C-N-CA 124.715 1.15 . . . . 0.0 115.814 -175.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 29.1 m120 -120.96 167.33 12.69 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.369 1.467 . . . . 0.0 112.072 -178.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -68.83 -42.02 77.74 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.57 0.748 . . . . 0.0 112.67 176.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.9 t -125.5 134.17 67.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.95 1.3 . . . . 0.0 110.2 176.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 27.1 t -134.74 135.1 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.249 1.02 . . . . 0.0 110.361 177.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 53.0 t -134.42 149.24 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 124.55 1.14 . . . . 0.0 112.085 -171.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -129.69 123.1 30.32 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.993 1.317 . . . . 0.0 110.873 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 54.1 m -143.9 169.92 16.88 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 114.452 1.278 . . . . 0.0 114.452 -159.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.484 ' CD1' ' HB3' ' A' ' 46' ' ' ASP . 40.5 m0 -115.17 139.5 49.87 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.547 1.539 . . . . 0.0 109.616 161.224 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 24.8 t -60.21 -53.72 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 -161.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.7 t -94.23 3.43 55.26 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 -164.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.447 ' HA ' ' HD3' ' A' ' 24' ' ' PRO . 96.4 m -88.76 142.31 30.6 Favored Pre-proline 0 CA--C 1.542 0.667 0 C-N-CA 124.328 1.051 . . . . 0.0 112.599 -165.005 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 23' ' ' CYS . 65.8 Cg_exo -68.0 -36.97 16.09 Favored 'Trans proline' 0 C--N 1.351 0.68 0 N-CA-C 115.677 1.376 . . . . 0.0 115.677 -162.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -52.93 -41.83 64.83 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 122.24 1.019 . . . . 0.0 113.075 171.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 3.8 m -81.73 -32.52 31.53 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.359 -162.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 99.6 t -62.46 -53.07 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 124.954 1.301 . . . . 0.0 111.51 161.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . 0.263 7.2 ptp180 -67.45 -29.27 68.69 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -173.032 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.28 -53.24 13.05 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.438 1.095 . . . . 0.0 111.685 171.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -46.65 -44.88 18.8 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-N 119.91 1.232 . . . . 0.0 112.879 175.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -64.07 -45.58 88.13 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.501 0.72 . . . . 0.0 112.595 -179.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.2 tt -72.4 -36.55 68.68 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.446 1.098 . . . . 0.0 111.206 -178.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 95.9 mt -61.1 -46.54 90.19 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.443 -0.785 . . . . 0.0 110.735 171.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 8.7 m-70 -66.83 -21.71 66.02 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 173.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -73.0 -18.44 61.35 Favored 'General case' 0 CA--C 1.545 0.782 0 O-C-N 120.716 -1.24 . . . . 0.0 113.069 173.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 21.7 mmt85 -115.73 -19.83 10.34 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 -179.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 48.8 p -147.32 166.89 25.74 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 115.394 1.627 . . . . 0.0 115.394 -166.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 28.9 mtmm -116.69 -32.05 5.29 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 127.165 2.186 . . . . 0.0 113.623 162.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -82.73 50.59 1.71 Allowed 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -175.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.2 113.07 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 126.16 1.784 . . . . 0.0 111.964 177.116 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.4 m -100.49 142.91 31.32 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 127.014 2.125 . . . . 0.0 110.097 175.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.7 p -145.24 140.58 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -178.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 38.8 t60 -116.67 131.8 56.85 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 126.595 1.958 . . . . 0.0 110.98 -176.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -101.93 96.62 7.16 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 122.761 1.267 . . . . 0.0 111.973 -177.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 22.4 m -80.43 -1.63 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -174.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.484 ' HB3' ' CD1' ' A' ' 20' ' ' TRP . 0.0 OUTLIER -83.64 -12.11 56.4 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.146 0.978 . . . . 0.0 112.085 162.855 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -107.29 -44.07 4.43 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.588 1.555 . . . . 0.0 112.013 179.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 29.2 tpp -67.97 127.23 32.07 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 118.833 0.742 . . . . 0.0 110.224 176.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 62.8 m -68.42 -29.49 68.17 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 119.373 0.988 . . . . 0.0 113.354 -174.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 20.5 tp10 -79.74 -3.09 46.01 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.021 0.928 . . . . 0.0 112.648 170.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -56.53 -26.27 51.93 Favored Glycine 0 CA--C 1.529 0.914 0 O-C-N 120.489 -1.382 . . . . 0.0 114.511 -171.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -70.18 -24.11 63.08 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 118.537 1.169 . . . . 0.0 112.67 176.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 16.8 tm0? -86.72 -34.58 19.64 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.126 1.37 . . . . 0.0 111.811 170.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.516 HD12 HG23 ' A' ' 6' ' ' ILE . 3.0 mm? -67.16 -33.76 76.11 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 119.572 1.078 . . . . 0.0 112.293 171.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 30.1 ttt180 -62.01 -29.93 70.6 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.405 1.482 . . . . 0.0 110.937 165.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.29 -24.7 75.94 Favored Glycine 0 CA--C 1.542 1.72 0 C-N-CA 125.632 1.587 . . . . 0.0 115.784 165.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -71.96 -25.78 62.01 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 121.19 2.495 . . . . 0.0 112.017 169.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 23.8 mt -74.66 -46.46 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 123.253 0.621 . . . . 0.0 109.461 166.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -63.69 -42.21 98.02 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.14 -0.975 . . . . 0.0 113.398 -176.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 95.0 mm-40 -71.87 -10.0 59.14 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 178.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -107.54 -35.64 6.68 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.536 1.135 . . . . 0.0 113.547 176.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -137.49 4.7 2.64 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.349 1.459 . . . . 0.0 114.703 -169.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 50.71 42.3 27.18 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 127.006 2.122 . . . . 0.0 114.516 176.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 61.8 t60 -127.44 129.92 48.36 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.847 1.259 . . . . 0.0 111.119 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -119.91 -1.33 10.47 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.621 1.568 . . . . 0.0 113.759 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.3 m -86.06 173.45 9.87 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.998 1.719 . . . . 0.0 110.468 175.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.7 m -132.73 156.95 79.51 Favored Pre-proline 0 N--CA 1.48 1.025 0 O-C-N 120.631 -1.293 . . . . 0.0 113.917 -175.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -73.16 159.8 96.73 Favored 'Cis proline' 0 C--N 1.349 0.591 0 CA-C-N 118.588 0.531 . . . . 0.0 112.471 -13.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -101.9 141.02 35.39 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.972 0.909 . . . . 0.0 108.986 159.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 82.0 mt -130.68 144.15 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 123.726 0.811 . . . . 0.0 109.65 -168.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -140.5 146.37 38.07 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.243 1.017 . . . . 0.0 111.998 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 71.5 mt -129.26 118.98 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 125.367 1.467 . . . . 0.0 108.241 172.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 47.49 38.23 7.5 Favored 'General case' 0 CA--C 1.552 1.056 0 N-CA-C 115.821 1.785 . . . . 0.0 115.821 176.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 93.48 -7.51 74.9 Favored Glycine 0 CA--C 1.538 1.477 0 C-N-CA 124.593 1.092 . . . . 0.0 115.312 -178.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -102.47 138.03 39.93 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.939 1.696 . . . . 0.0 110.406 -174.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -85.23 147.73 26.43 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.073 0.949 . . . . 0.0 113.076 -170.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 20.6 mm -133.34 120.64 39.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 128.473 2.709 . . . . 0.0 106.279 177.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.88 -15.66 55.68 Favored Glycine 0 CA--C 1.533 1.182 0 N-CA-C 116.851 1.5 . . . . 0.0 116.851 -160.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 138.8 -152.14 22.01 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 125.609 1.576 . . . . 0.0 112.739 179.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 8.6 t -72.25 -20.48 61.53 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -173.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.8 m -83.38 -38.52 21.87 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 121.254 -0.904 . . . . 0.0 112.012 171.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -70.7 -36.38 73.23 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.148 0.979 . . . . 0.0 111.641 177.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 47.5 tp -59.82 -57.49 12.68 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.405 1.482 . . . . 0.0 111.645 -179.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -69.59 -30.58 68.38 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.892 -0.505 . . . . 0.0 111.305 178.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.02 -38.25 87.98 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 119.474 1.034 . . . . 0.0 112.49 176.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 85.4 mt -73.81 -25.24 60.0 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.917 0.887 . . . . 0.0 112.702 176.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -73.08 -40.12 65.29 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 118.779 0.718 . . . . 0.0 111.609 169.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.1 mptt -65.19 -30.4 71.3 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.371 1.068 . . . . 0.0 112.889 173.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -80.34 1.97 26.69 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.083 1.353 . . . . 0.0 113.851 169.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 71.21 24.13 77.34 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 124.732 1.158 . . . . 0.0 114.761 175.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -113.2 -31.74 6.52 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 126.051 1.74 . . . . 0.0 113.365 -170.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 36.7 tp -57.23 -42.7 81.92 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 122.618 0.367 . . . . 0.0 111.467 -175.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -63.56 -42.73 98.33 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -178.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -73.05 -29.45 64.72 Favored Glycine 0 CA--C 1.528 0.876 0 CA-C-O 119.123 -0.821 . . . . 0.0 114.439 177.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 81.8 mt -72.8 -34.21 66.74 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 118.332 1.066 . . . . 0.0 112.188 172.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 66.5 mt -86.7 -16.32 36.83 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.294 1.038 . . . . 0.0 113.607 179.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 58.7 m . . . . . 0 C--O 1.254 1.314 0 C-N-CA 124.976 1.31 . . . . 0.0 111.714 175.031 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.0 m . . . . . 0 CA--C 1.547 0.844 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.5 pt -60.99 -23.09 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 124.529 1.131 . . . . 0.0 113.941 -168.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -54.58 -27.25 37.65 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.729 1.212 . . . . 0.0 112.177 178.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 92.9 p -68.56 -36.37 78.68 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.765 1.226 . . . . 0.0 113.444 172.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 45.3 mtt -72.45 -38.56 68.25 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.385 1.474 . . . . 0.0 111.59 -177.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -66.52 -25.59 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 124.074 0.95 . . . . 0.0 111.551 -171.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -70.75 -11.13 60.76 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.826 1.65 . . . . 0.0 114.123 179.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -84.48 -31.27 25.2 Favored Glycine 0 CA--C 1.534 1.258 0 N-CA-C 115.944 1.137 . . . . 0.0 115.944 -167.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -136.71 156.72 48.15 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 119.499 1.649 . . . . 0.0 112.568 -174.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 28.4 ttpt -62.54 -39.41 93.52 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.986 0.914 . . . . 0.0 112.657 -176.139 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.9 t -124.96 129.08 73.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.524 1.13 . . . . 0.0 109.821 167.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 83.1 t -126.11 127.09 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.389 1.476 . . . . 0.0 109.04 178.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 40.3 t -123.53 144.55 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 123.611 0.765 . . . . 0.0 111.169 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -118.3 113.18 21.07 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.672 1.189 . . . . 0.0 109.018 171.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 28.4 m -131.35 168.17 18.01 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.384 1.474 . . . . 0.0 112.281 -170.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 51.7 m0 -107.92 126.12 52.31 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.644 1.178 . . . . 0.0 107.872 159.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 25.9 t -49.95 -36.48 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 126.49 1.916 . . . . 0.0 113.237 -164.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.5 t -93.3 -8.91 40.76 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 127.175 2.19 . . . . 0.0 115.137 -167.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 95.6 m -94.28 149.31 36.53 Favored Pre-proline 0 CA--C 1.535 0.374 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -159.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -67.39 -47.34 2.23 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 CA-C-N 119.127 0.724 . . . . 0.0 113.603 -163.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -68.22 -33.43 74.39 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.438 1.095 . . . . 0.0 113.243 -179.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -51.25 -53.37 36.07 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.776 0.83 . . . . 0.0 109.246 167.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 62.6 t -68.75 -36.36 73.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 O-C-N 121.714 -0.617 . . . . 0.0 112.244 -177.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 27.7 mmt85 -52.79 -42.07 64.71 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 119.227 0.922 . . . . 0.0 112.046 170.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.64 -56.56 5.14 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.396 0.678 . . . . 0.0 111.878 173.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -50.82 -39.52 53.35 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 119.435 1.016 . . . . 0.0 113.028 -177.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -69.6 -43.64 72.38 Favored 'General case' 0 C--O 1.233 0.184 0 C-N-CA 123.892 0.877 . . . . 0.0 112.312 -178.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.4 tt -73.77 -37.62 64.95 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 124.309 1.044 . . . . 0.0 111.464 -178.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 98.0 mt -62.61 -42.84 99.81 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.239 0.616 . . . . 0.0 110.9 174.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -67.93 -13.15 61.93 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 171.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -95.6 -13.03 24.7 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.301 1.041 . . . . 0.0 113.751 170.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 20.1 mmt180 -111.67 -30.34 7.37 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 114.981 1.474 . . . . 0.0 114.981 -173.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.0 t -149.03 156.6 42.48 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -173.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 48.1 mtmt -91.6 -9.13 45.24 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 126.785 2.034 . . . . 0.0 112.499 166.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -105.51 20.49 18.81 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -162.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.26 136.81 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 125.481 1.513 . . . . 0.0 112.692 -178.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.9 m -125.44 133.7 52.36 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 126.696 1.999 . . . . 0.0 110.014 168.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.4 p -121.29 136.11 59.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 125.013 1.325 . . . . 0.0 112.998 173.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -104.1 116.65 32.6 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.917 2.087 . . . . 0.0 108.989 174.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -88.56 96.37 10.6 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 121.0 -1.063 . . . . 0.0 111.2 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 22.0 m -73.74 1.65 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 -172.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -85.29 -22.44 28.56 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.437 1.095 . . . . 0.0 112.756 163.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.5 mmmt -90.34 -35.08 15.43 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.035 1.734 . . . . 0.0 111.667 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -89.35 130.44 35.73 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.692 0.797 . . . . 0.0 110.962 -177.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 74.4 m -70.69 -16.09 62.77 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 115.235 1.569 . . . . 0.0 115.235 -169.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -93.02 6.67 47.11 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.843 1.657 . . . . 0.0 112.908 173.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -51.7 -29.03 24.56 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 125.368 1.461 . . . . 0.0 116.385 -174.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -79.73 -25.13 41.2 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.052 1.426 . . . . 0.0 113.358 178.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -74.81 -33.95 62.29 Favored 'General case' 0 N--CA 1.469 0.489 0 O-C-N 121.462 -0.774 . . . . 0.0 111.052 168.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.54 -42.79 86.63 Favored 'General case' 0 CA--C 1.548 0.882 0 O-C-N 121.716 -0.615 . . . . 0.0 110.342 171.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 56.3 mtp85 -54.76 -43.96 73.21 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 119.397 0.999 . . . . 0.0 111.936 167.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.41 -42.94 99.14 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 124.24 0.924 . . . . 0.0 113.732 178.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 51.2 mm-40 -63.44 -38.18 90.16 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 118.413 1.107 . . . . 0.0 113.449 173.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 65.9 mt -66.46 -44.58 90.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 118.573 0.624 . . . . 0.0 109.621 175.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -64.26 -40.35 95.81 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 121.432 -0.793 . . . . 0.0 112.059 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -69.46 -24.88 63.86 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 121.092 -1.005 . . . . 0.0 113.363 -179.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -99.53 -25.17 14.52 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 115.008 1.485 . . . . 0.0 115.008 176.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -135.92 0.52 2.66 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 114.741 1.386 . . . . 0.0 114.741 -171.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp 48.6 46.05 21.19 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 126.525 1.93 . . . . 0.0 113.729 175.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 8.5 t60 -140.39 134.2 30.5 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.283 1.833 . . . . 0.0 109.46 -175.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -117.3 -25.38 7.08 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.696 1.599 . . . . 0.0 113.418 -178.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.3 p -77.8 129.02 34.93 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.047 0.939 . . . . 0.0 112.621 -171.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.6 m -83.77 151.11 60.66 Favored Pre-proline 0 N--CA 1.478 0.93 0 C-N-CA 123.652 0.781 . . . . 0.0 112.109 -173.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -80.2 156.55 87.12 Favored 'Cis proline' 0 C--N 1.352 0.717 0 N-CA-C 114.118 0.776 . . . . 0.0 114.118 -0.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -101.34 135.35 42.96 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.907 0.883 . . . . 0.0 108.856 159.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 50.9 mt -128.28 139.53 51.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 123.984 0.914 . . . . 0.0 109.149 -166.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -140.0 148.23 41.57 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.62 0.768 . . . . 0.0 112.467 -179.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 62.1 mt -130.28 120.19 48.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.445 1.498 . . . . 0.0 108.633 174.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 45.3 40.62 5.4 Favored 'General case' 0 CA--C 1.558 1.269 0 C-N-CA 125.599 1.559 . . . . 0.0 114.625 -176.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 82.16 0.85 90.1 Favored Glycine 0 CA--C 1.542 1.762 0 O-C-N 120.822 -1.174 . . . . 0.0 115.629 -178.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -95.62 140.12 30.89 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.885 1.674 . . . . 0.0 110.416 176.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -85.07 144.85 27.98 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 119.253 0.933 . . . . 0.0 113.444 -177.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 31.5 mm -123.44 127.44 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 128.764 2.826 . . . . 0.0 107.023 177.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -69.82 18.28 0.64 Allowed Glycine 0 CA--C 1.532 1.118 0 N-CA-C 119.135 2.414 . . . . 0.0 119.135 -163.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 114.82 -173.15 14.61 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 128.85 3.119 . . . . 0.0 112.666 -178.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 12.9 t -63.5 -33.71 76.18 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 121.485 -1.009 . . . . 0.0 111.688 179.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 67.4 m -61.78 -21.99 65.05 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 172.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -88.88 -43.8 10.93 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.652 1.181 . . . . 0.0 110.903 174.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 48.8 tp -57.24 -48.24 79.33 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.027 1.331 . . . . 0.0 111.683 176.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -72.47 -25.96 61.63 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 121.734 -0.604 . . . . 0.0 112.054 179.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.48 -28.98 63.24 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.196 -0.94 . . . . 0.0 112.54 175.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 52.2 mt -73.78 -26.73 60.79 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.124 1.37 . . . . 0.0 112.808 171.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -64.58 -44.43 90.7 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 118.616 0.644 . . . . 0.0 110.343 162.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 20.3 mmtt -68.74 -34.18 75.17 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 121.828 -0.545 . . . . 0.0 112.28 -177.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . 0.42 ' HB3' ' HE2' ' A' ' 91' ' ' LYS . 6.4 mt-10 -79.83 -3.23 46.93 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 168.322 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.18 44.64 93.64 Favored Glycine 0 CA--C 1.532 1.105 0 CA-C-N 120.262 1.392 . . . . 0.0 112.983 172.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.42 ' HE2' ' HB3' ' A' ' 89' ' ' GLU . 36.6 mtmt -131.18 -8.68 3.81 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 126.996 2.118 . . . . 0.0 113.487 -170.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 29.8 tp -66.08 -34.66 78.58 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 122.205 1.002 . . . . 0.0 110.663 -176.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -60.87 -48.05 83.57 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 127.577 2.351 . . . . 0.0 114.053 171.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -69.42 -22.68 76.5 Favored Glycine 0 CA--C 1.53 1.012 0 O-C-N 121.131 -0.98 . . . . 0.0 113.697 175.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 36.7 mt -74.03 -37.33 64.37 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 117.663 0.731 . . . . 0.0 111.3 172.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 69.4 mt -75.47 -7.01 53.0 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.603 1.561 . . . . 0.0 114.29 176.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 19.6 m . . . . . 0 C--O 1.249 1.03 0 C-N-CA 127.15 2.18 . . . . 0.0 113.739 177.691 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 89.4 p . . . . . 0 N--CA 1.476 0.828 0 N-CA-C 110.79 -0.078 . . . . 0.0 110.79 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.571 HG23 HD12 ' A' ' 54' ' ' LEU . 20.5 pt -55.02 -21.32 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 179.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.14 -18.93 51.07 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 123.817 0.847 . . . . 0.0 113.203 -178.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 40.9 m -83.78 -25.76 30.19 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.807 1.243 . . . . 0.0 113.486 172.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 76.9 mtp -69.49 -28.69 66.29 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.281 1.032 . . . . 0.0 112.09 178.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.1 mm -64.11 -21.17 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 124.248 1.019 . . . . 0.0 112.342 179.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -81.77 -28.24 33.37 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 121.113 -0.992 . . . . 0.0 113.058 173.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -87.41 -8.03 75.08 Favored Glycine 0 CA--C 1.53 1.02 0 N-CA-C 116.742 1.457 . . . . 0.0 116.742 -166.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -143.61 151.83 40.64 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 119.354 1.577 . . . . 0.0 111.431 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -67.41 -42.56 83.03 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.941 1.296 . . . . 0.0 112.413 -178.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.6 t -121.4 130.94 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 124.878 1.271 . . . . 0.0 110.065 170.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.6 t -129.7 128.1 65.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.528 1.131 . . . . 0.0 110.167 178.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 42.2 t -127.43 148.11 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 123.785 0.834 . . . . 0.0 111.715 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -123.64 116.56 23.29 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.798 1.239 . . . . 0.0 109.208 173.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 25.2 m -134.09 172.73 12.43 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.28 1.432 . . . . 0.0 112.203 -167.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.438 ' CD1' ' HB3' ' A' ' 46' ' ' ASP . 28.0 m0 -120.42 142.28 49.36 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.266 1.026 . . . . 0.0 109.784 161.285 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 75.4 t -59.91 -31.6 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 123.042 0.537 . . . . 0.0 111.332 172.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -69.09 -15.31 63.41 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 175.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 44.1 t -92.99 143.16 26.37 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-N 120.385 1.448 . . . . 0.0 111.278 -167.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -83.57 -31.32 0.62 Allowed 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 121.498 1.465 . . . . 0.0 113.157 174.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -69.05 -33.56 73.78 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.29 1.436 . . . . 0.0 113.54 178.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -45.74 -55.55 6.38 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.363 1.065 . . . . 0.0 109.356 164.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 85.9 t -63.91 -38.84 83.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 123.983 0.913 . . . . 0.0 112.068 -179.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.4 mmt85 -54.9 -37.82 66.81 Favored 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 119.536 1.062 . . . . 0.0 112.777 174.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -76.37 -59.18 2.88 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 123.735 0.647 . . . . 0.0 111.859 172.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -44.75 -47.56 10.78 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.854 1.262 . . . . 0.0 112.583 -179.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -65.53 -44.22 87.58 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 123.689 0.796 . . . . 0.0 111.627 -173.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.9 tt -69.6 -41.24 76.0 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.632 1.573 . . . . 0.0 110.775 179.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 92.2 mt -60.99 -50.43 73.42 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.095 0.558 . . . . 0.0 110.816 176.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 69.2 m-70 -66.64 -18.0 65.14 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 173.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.73 -13.73 59.66 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 119.908 1.231 . . . . 0.0 113.702 174.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 26.5 mmt85 -119.63 -25.89 5.85 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.73 1.612 . . . . 0.0 114.558 -178.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 19.3 m -145.98 150.39 35.95 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.605 1.162 . . . . 0.0 112.909 -157.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? -108.53 -23.52 11.8 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 126.766 2.027 . . . . 0.0 112.654 165.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -79.76 50.58 1.18 Allowed 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 125.317 1.447 . . . . 0.0 112.762 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -121.99 130.78 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 126.19 1.796 . . . . 0.0 111.013 -178.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.1 m -123.07 123.85 41.77 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.861 1.664 . . . . 0.0 109.57 176.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.5 p -119.49 143.43 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 123.938 0.895 . . . . 0.0 112.375 175.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 30.0 t60 -111.55 117.28 32.54 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.515 1.526 . . . . 0.0 110.236 173.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -86.67 91.89 8.75 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 175.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 27.6 m -67.09 -17.41 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -176.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.438 ' HB3' ' CD1' ' A' ' 20' ' ' TRP . 0.3 OUTLIER -68.47 -26.48 65.5 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 121.174 -0.953 . . . . 0.0 111.995 172.646 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 20.1 mtmt -98.67 -5.71 31.12 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 126.275 1.83 . . . . 0.0 114.227 -179.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . 0.43 ' HG3' ' H ' ' A' ' 50' ' ' GLU . 13.1 tpt -93.28 133.04 36.92 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.246 1.418 . . . . 0.0 111.467 -178.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 17.0 p -63.76 2.14 0.52 Allowed 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 126.657 1.983 . . . . 0.0 116.184 -179.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.43 ' H ' ' HG3' ' A' ' 48' ' ' MET . 7.0 tp10 -143.98 13.69 1.67 Allowed 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.522 1.529 . . . . 0.0 112.804 170.341 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -57.77 -24.58 53.9 Favored Glycine 0 CA--C 1.53 1.012 0 O-C-N 120.52 -1.363 . . . . 0.0 116.121 -167.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -63.66 -30.98 72.01 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 119.518 1.659 . . . . 0.0 112.096 174.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -74.89 -29.11 60.9 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.7 0.8 . . . . 0.0 111.941 176.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.571 HD12 HG23 ' A' ' 6' ' ' ILE . 2.8 mm? -81.02 -32.68 34.05 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.687 1.195 . . . . 0.0 111.602 176.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.8 ttt85 -56.87 -36.43 70.07 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.904 1.281 . . . . 0.0 110.667 159.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.53 -35.15 90.88 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 124.495 1.045 . . . . 0.0 115.465 167.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -64.98 -32.23 73.86 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 120.394 2.097 . . . . 0.0 112.267 176.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.2 mt -70.5 -42.13 78.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 123.682 0.793 . . . . 0.0 109.643 171.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -62.92 -41.44 99.47 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 178.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 33.0 mm-40 -62.09 -30.08 70.76 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 120.923 -1.111 . . . . 0.0 112.844 176.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -88.83 -38.41 14.62 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 179.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -133.76 0.82 3.28 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 -168.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.5 mptt 44.66 50.27 8.5 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 127.016 2.126 . . . . 0.0 113.126 -177.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 48.9 t60 -129.25 127.09 40.52 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 127.53 2.332 . . . . 0.0 108.102 178.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -108.13 -14.03 14.81 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.208 1.003 . . . . 0.0 113.53 178.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.9 m -74.82 141.86 44.25 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.3 1.04 . . . . 0.0 111.685 -176.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.0 m -97.88 150.81 37.15 Favored Pre-proline 0 N--CA 1.477 0.904 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 172.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -81.08 161.71 81.73 Favored 'Cis proline' 0 C--N 1.351 0.703 0 CA-C-N 118.686 0.566 . . . . 0.0 113.556 -3.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -107.61 139.45 42.14 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.093 0.957 . . . . 0.0 109.13 158.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 75.7 mt -131.88 139.08 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 124.22 1.008 . . . . 0.0 109.374 -165.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -140.98 145.39 35.91 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.937 0.895 . . . . 0.0 112.432 -178.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 58.2 mt -132.19 122.28 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 124.702 1.201 . . . . 0.0 109.405 172.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 32.0 m120 44.31 45.13 7.16 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 125.017 1.327 . . . . 0.0 113.327 -177.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 86.02 -12.96 58.64 Favored Glycine 0 CA--C 1.539 1.553 0 O-C-N 120.463 -1.398 . . . . 0.0 116.284 -178.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 59.8 m-80 -86.6 141.13 29.23 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.353 1.576 . . . . 0.0 110.634 -177.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -86.47 136.95 32.9 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.32 0.648 . . . . 0.0 112.177 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 38.5 mm -115.1 117.97 57.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 126.937 2.095 . . . . 0.0 107.099 178.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -70.55 3.58 11.47 Favored Glycine 0 N--CA 1.475 1.281 0 N-CA-C 117.919 1.928 . . . . 0.0 117.919 -159.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 155.64 173.91 24.86 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 128.072 2.749 . . . . 0.0 111.048 178.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 39.4 t -58.56 -32.79 69.24 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 121.317 -1.108 . . . . 0.0 112.494 171.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 69.7 m -66.61 -28.54 68.58 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 120.654 -1.279 . . . . 0.0 112.957 173.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -74.47 -36.21 63.3 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 119.516 1.053 . . . . 0.0 111.632 173.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 43.5 tp -62.91 -50.84 69.25 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.877 1.271 . . . . 0.0 110.794 172.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -59.5 -37.93 79.58 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.689 0.796 . . . . 0.0 111.481 176.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.98 -29.7 68.8 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.019 0.928 . . . . 0.0 113.483 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 35.7 mt -70.96 -25.48 62.74 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.066 0.848 . . . . 0.0 112.303 172.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -73.52 -37.54 65.6 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 118.56 0.618 . . . . 0.0 111.036 170.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 43.3 mmtt -66.57 -34.7 78.49 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 176.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -73.43 -9.36 58.61 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 169.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 79.46 22.36 64.96 Favored Glycine 0 CA--C 1.535 1.282 0 CA-C-N 119.686 1.13 . . . . 0.0 114.579 178.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -107.29 -32.01 7.96 Favored 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 125.678 1.591 . . . . 0.0 112.305 -172.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 46.0 tp -57.71 -41.76 82.38 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 118.454 0.57 . . . . 0.0 112.432 -176.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -60.44 -43.64 96.61 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 118.928 -0.558 . . . . 0.0 112.437 -178.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -74.77 -38.09 43.3 Favored Glycine 0 CA--C 1.535 1.306 0 O-C-N 123.556 0.535 . . . . 0.0 113.324 177.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 37.6 mt -57.66 -36.42 71.87 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.404 1.082 . . . . 0.0 112.309 177.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 86.5 mt -73.92 -4.03 32.56 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 114.895 1.442 . . . . 0.0 114.895 -179.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 6.8 t . . . . . 0 C--O 1.257 1.495 0 C-N-CA 125.146 1.378 . . . . 0.0 112.733 -178.993 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 15.8 p . . . . . 0 CA--C 1.537 0.478 0 CA-C-O 122.108 0.956 . . . . 0.0 112.844 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.458 HG23 HD12 ' A' ' 54' ' ' LEU . 25.4 pt -55.71 -25.21 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.471 1.108 . . . . 0.0 112.717 170.311 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.38 -23.85 66.4 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -171.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.1 t -87.96 -20.04 26.43 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 121.238 -0.914 . . . . 0.0 113.424 170.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 41.3 mtt -68.39 -26.09 65.38 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 121.27 -0.894 . . . . 0.0 112.334 175.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.6 mm -58.06 -31.4 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.953 0.901 . . . . 0.0 111.667 177.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.1 mptt -80.56 -4.23 53.24 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.899 1.28 . . . . 0.0 114.039 -173.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -82.99 -28.4 37.68 Favored Glycine 0 CA--C 1.538 1.496 0 N-CA-C 115.953 1.141 . . . . 0.0 115.953 -173.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -145.35 163.71 33.73 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.597 1.199 . . . . 0.0 112.526 -173.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -63.16 -43.58 97.9 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.298 1.439 . . . . 0.0 112.723 -179.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.3 t -121.88 131.89 72.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 123.798 0.839 . . . . 0.0 110.26 171.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 54.4 t -132.56 127.39 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 125.006 1.322 . . . . 0.0 109.263 179.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 42.4 t -124.56 148.24 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 124.337 1.055 . . . . 0.0 111.624 -177.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -121.92 112.3 18.14 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.202 1.401 . . . . 0.0 108.869 172.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 10.7 m -126.5 174.14 8.87 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 126.646 1.978 . . . . 0.0 111.356 -171.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 20.8 m0 -118.78 137.75 53.16 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.317 1.047 . . . . 0.0 109.078 161.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.407 ' CG2' ' HE2' ' A' ' 47' ' ' LYS . 82.6 t -62.67 -15.86 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.013 0.925 . . . . 0.0 112.378 177.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.4 p -89.7 -9.68 48.57 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.484 1.914 . . . . 0.0 116.046 175.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 8.0 t -94.2 142.03 24.38 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-N 119.424 1.011 . . . . 0.0 111.565 -170.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -79.67 -32.58 1.53 Allowed 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 121.812 1.675 . . . . 0.0 112.226 173.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -62.85 -35.28 79.45 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.122 1.369 . . . . 0.0 113.543 177.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -49.04 -54.24 16.73 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.518 1.127 . . . . 0.0 109.451 165.285 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.2 t -64.88 -39.47 85.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.117 0.967 . . . . 0.0 112.766 -179.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 78.4 mmt-85 -53.35 -41.78 66.15 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-N 119.118 0.872 . . . . 0.0 111.811 173.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.86 -53.7 8.61 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.123 0.969 . . . . 0.0 112.592 174.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -52.41 -32.99 41.69 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.608 1.163 . . . . 0.0 112.992 -179.398 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -72.36 -47.37 50.05 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.838 0.855 . . . . 0.0 112.581 177.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.8 tt -72.81 -36.75 67.62 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.582 1.153 . . . . 0.0 111.465 -176.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 70.3 mt -63.47 -47.65 80.91 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.401 0.68 . . . . 0.0 111.283 173.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -64.76 -14.82 60.31 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 172.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.21 -17.74 58.26 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 120.158 1.344 . . . . 0.0 113.828 175.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 87.2 mmt-85 -131.97 -13.09 3.23 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 -177.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 29.0 m -138.62 136.99 36.51 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.315 1.046 . . . . 0.0 112.601 -172.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.24 -30.48 12.59 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 126.868 2.067 . . . . 0.0 111.207 166.321 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -79.26 48.09 0.85 Allowed 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.507 1.523 . . . . 0.0 113.409 177.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.28 118.89 60.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 125.758 1.623 . . . . 0.0 110.688 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 54.9 m -101.48 135.47 42.92 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 126.205 1.802 . . . . 0.0 109.672 172.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.6 p -128.1 141.6 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-O 122.277 1.037 . . . . 0.0 112.961 169.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -113.6 133.27 55.38 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 129.12 2.968 . . . . 0.0 109.523 -177.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -111.06 90.59 3.38 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 122.04 0.924 . . . . 0.0 111.52 -176.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 16.7 m -67.8 -8.94 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 O-C-N 121.341 -0.849 . . . . 0.0 113.17 -178.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.45 -18.35 61.14 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 119.042 0.837 . . . . 0.0 112.657 170.155 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.407 ' HE2' ' CG2' ' A' ' 21' ' ' VAL . 57.3 mmtt -102.44 -32.24 10.07 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 127.156 2.182 . . . . 0.0 113.009 179.1 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 58.9 mtt -65.03 126.64 28.67 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.193 0.997 . . . . 0.0 110.783 177.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 18.2 m -74.87 20.31 0.13 Allowed 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 114.614 1.338 . . . . 0.0 114.614 -172.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -150.24 10.26 0.68 Allowed 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 127.395 2.278 . . . . 0.0 111.528 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -53.96 -25.87 32.32 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 125.81 1.672 . . . . 0.0 116.954 -172.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -66.22 -28.04 68.44 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 120.079 1.939 . . . . 0.0 111.698 173.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -82.27 -28.75 31.6 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 121.03 -1.044 . . . . 0.0 112.005 177.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.458 HD12 HG23 ' A' ' 6' ' ' ILE . 2.7 mm? -78.16 -32.21 50.12 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.624 0.77 . . . . 0.0 111.559 172.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 67.0 mtp180 -55.25 -40.34 70.82 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 119.524 1.056 . . . . 0.0 111.257 162.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -58.78 -36.25 85.85 Favored Glycine 0 CA--C 1.536 1.37 0 CA-C-O 119.255 -0.747 . . . . 0.0 114.044 171.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -65.42 -35.55 81.26 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 119.41 1.605 . . . . 0.0 112.446 176.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 53.3 mt -73.05 -48.87 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 124.306 1.042 . . . . 0.0 109.724 176.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -67.07 -41.28 86.65 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 121.449 -0.782 . . . . 0.0 112.477 -174.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 77.4 mm-40 -69.07 -21.57 64.07 Favored 'General case' 0 CA--C 1.546 0.812 0 O-C-N 121.138 -0.976 . . . . 0.0 112.471 176.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -88.79 -29.78 19.49 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 177.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -140.4 -1.41 1.51 Allowed 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 116.075 1.88 . . . . 0.0 116.075 -170.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.5 mptt 45.75 48.32 11.72 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 125.922 1.689 . . . . 0.0 112.716 -165.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 60.2 t-80 -129.26 133.51 47.54 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 125.333 1.453 . . . . 0.0 110.471 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -142.27 -25.1 0.66 Allowed 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -160.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 60.6 p -77.78 151.97 33.78 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 121.727 -0.608 . . . . 0.0 111.603 168.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 13.6 m -104.55 155.95 36.62 Favored Pre-proline 0 N--CA 1.478 0.949 0 C-N-CA 124.673 1.189 . . . . 0.0 111.67 -176.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -75.04 154.31 99.58 Favored 'Cis proline' 0 CA--C 1.535 0.542 0 CA-C-N 119.071 0.704 . . . . 0.0 113.782 -6.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -99.23 138.08 36.83 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 159.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 60.9 mt -131.03 140.62 48.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 124.199 1.0 . . . . 0.0 109.35 -165.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -138.56 144.96 40.1 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.808 0.843 . . . . 0.0 111.982 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 65.8 mt -130.01 117.05 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.973 1.309 . . . . 0.0 109.186 175.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 46.13 44.64 12.12 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 125.565 1.546 . . . . 0.0 113.503 -176.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 82.46 -7.47 64.66 Favored Glycine 0 CA--C 1.534 1.229 0 N-CA-C 116.293 1.277 . . . . 0.0 116.293 -177.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -91.03 138.34 31.68 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 119.168 1.484 . . . . 0.0 110.578 -178.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 39.6 t80 -82.14 133.89 35.29 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.858 0.837 . . . . 0.0 112.915 -176.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 37.9 mm -113.98 119.73 61.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 126.656 1.983 . . . . 0.0 107.726 175.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -71.07 27.08 0.54 Allowed Glycine 0 N--CA 1.472 1.086 0 N-CA-C 119.137 2.415 . . . . 0.0 119.137 -167.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 116.21 -175.63 15.93 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 128.076 2.75 . . . . 0.0 114.552 175.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 25.1 t -64.54 -33.38 75.77 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.364 -1.08 . . . . 0.0 112.866 -179.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 37.0 m -70.01 -34.88 73.87 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 121.088 -1.007 . . . . 0.0 111.924 175.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.87 -39.04 90.33 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.452 1.101 . . . . 0.0 111.974 171.009 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 51.9 tp -62.93 -45.84 90.61 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.246 1.019 . . . . 0.0 111.196 175.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -64.77 -33.26 75.55 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.582 -0.699 . . . . 0.0 112.324 173.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.83 -29.84 71.0 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 121.008 -1.057 . . . . 0.0 111.954 177.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 83.6 mt -71.75 -30.03 65.15 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.441 1.096 . . . . 0.0 112.985 170.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -67.82 -41.13 83.52 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.698 0.799 . . . . 0.0 110.25 172.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -71.81 -39.75 69.62 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.113 0.965 . . . . 0.0 113.575 175.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -69.69 -18.27 63.54 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 119.547 1.067 . . . . 0.0 112.82 171.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 78.01 35.48 34.71 Favored Glycine 0 CA--C 1.531 1.083 0 CA-C-N 118.801 0.728 . . . . 0.0 113.65 175.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -116.19 -19.51 10.21 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 127.787 2.435 . . . . 0.0 113.351 -174.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 27.2 tp -63.21 -31.82 73.06 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.919 0.888 . . . . 0.0 111.684 -174.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -54.55 -53.6 52.34 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.526 1.131 . . . . 0.0 112.933 175.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -76.89 -23.4 69.45 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-O 119.446 -0.641 . . . . 0.0 113.862 -178.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 75.5 mt -69.91 -37.75 76.06 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 118.869 1.334 . . . . 0.0 112.012 172.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 92.8 mt -86.47 5.89 33.05 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -178.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 81.7 p . . . . . 0 C--O 1.255 1.387 0 C-N-CA 126.566 1.947 . . . . 0.0 115.973 -174.755 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 39.5 p . . . . . 0 C--O 1.239 0.502 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.586 HG23 HD12 ' A' ' 54' ' ' LEU . 19.6 pt -49.37 -25.3 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 125.981 1.712 . . . . 0.0 114.07 171.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.29 -28.48 69.22 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 118.935 0.789 . . . . 0.0 112.063 -176.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 96.4 p -72.32 -32.7 66.78 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 171.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 59.9 mtp -70.61 -30.65 67.38 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.15 0.98 . . . . 0.0 111.914 -176.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -64.88 -24.06 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 124.315 1.046 . . . . 0.0 111.573 -174.077 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -82.04 -9.54 59.52 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.063 1.745 . . . . 0.0 114.716 176.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -91.28 -22.06 33.32 Favored Glycine 0 CA--C 1.54 1.638 0 N-CA-C 117.451 1.741 . . . . 0.0 117.451 -166.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -135.86 170.04 16.61 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 118.941 1.37 . . . . 0.0 110.941 169.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 20.9 ttpt -66.59 -30.71 71.06 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 119.146 -0.454 . . . . 0.0 111.945 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 28.4 t -133.4 130.22 56.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.563 1.545 . . . . 0.0 109.394 177.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 42.9 t -134.21 127.67 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 124.245 1.018 . . . . 0.0 109.809 -177.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.1 t -128.35 146.92 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.295 1.038 . . . . 0.0 112.053 -170.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -125.97 106.88 9.95 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.797 1.239 . . . . 0.0 109.526 178.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 37.2 m -128.41 176.94 7.33 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 127.044 2.137 . . . . 0.0 112.371 -164.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.421 ' CD2' HG21 ' A' ' 67' ' ' VAL . 43.8 m0 -125.71 129.23 49.12 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.609 1.563 . . . . 0.0 108.335 163.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 46.6 t -53.63 -38.9 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 124.842 1.257 . . . . 0.0 114.325 -158.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.7 t -89.79 -6.99 55.4 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 -170.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 94.9 m -92.63 146.25 31.95 Favored Pre-proline 0 CA--C 1.537 0.456 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -160.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -69.59 -34.47 15.07 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 120.662 0.908 . . . . 0.0 114.057 -162.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -71.22 -42.12 69.31 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 124.073 0.949 . . . . 0.0 112.675 176.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -51.96 -54.65 27.23 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 169.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 53.3 t -60.23 -51.78 69.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 124.149 0.98 . . . . 0.0 111.63 -175.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . 0.272 7.7 ptp180 -61.67 -35.99 79.58 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 119.05 0.841 . . . . 0.0 112.164 -178.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.73 -55.91 8.63 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 118.226 -0.892 . . . . 0.0 112.716 173.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -48.02 -41.98 26.96 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 120.283 1.401 . . . . 0.0 112.584 176.149 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.28 -45.37 66.5 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 124.558 1.143 . . . . 0.0 111.577 -175.036 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.2 tt -70.4 -37.7 74.53 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.414 1.086 . . . . 0.0 112.021 176.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 80.7 mt -63.64 -41.71 98.21 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 120.923 -1.11 . . . . 0.0 111.461 176.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -64.41 -24.07 67.5 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 169.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.2 -16.07 53.85 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 119.974 1.261 . . . . 0.0 113.37 171.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 3.0 mmt180 -107.41 -36.69 6.43 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 115.972 1.842 . . . . 0.0 115.972 -173.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 13.9 t -155.04 150.56 27.41 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-N 120.312 1.415 . . . . 0.0 114.611 -176.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -84.03 -19.29 34.7 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.826 1.25 . . . . 0.0 113.02 170.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -85.97 37.1 0.7 Allowed 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -176.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -106.12 136.05 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 124.617 1.167 . . . . 0.0 111.984 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.3 m -128.6 142.25 51.1 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 126.489 1.915 . . . . 0.0 109.819 169.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.4 p -135.4 143.62 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 125.041 1.336 . . . . 0.0 113.315 177.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -118.99 135.98 54.34 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 127.187 2.195 . . . . 0.0 110.55 176.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -103.52 88.17 3.02 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.873 0.869 . . . . 0.0 111.604 -172.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 31.6 m -80.31 40.34 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 -168.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -141.92 -30.82 0.57 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 128.56 2.744 . . . . 0.0 109.879 171.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 26.4 mmmt -65.48 -31.29 72.29 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.088 1.355 . . . . 0.0 111.554 158.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -94.02 117.63 30.38 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.724 1.21 . . . . 0.0 109.387 178.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 73.8 m -70.89 -19.09 62.65 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 -163.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -92.39 5.96 48.75 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.453 1.501 . . . . 0.0 113.095 173.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -52.1 -25.23 17.16 Favored Glycine 0 CA--C 1.539 1.545 0 C-N-CA 125.524 1.535 . . . . 0.0 116.8 -173.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -64.24 -28.75 69.95 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 120.378 2.089 . . . . 0.0 112.802 172.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -80.11 -31.16 39.18 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.88 1.272 . . . . 0.0 112.441 176.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.586 HD12 HG23 ' A' ' 6' ' ' ILE . 2.8 mm? -78.15 -36.2 47.99 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.615 0.766 . . . . 0.0 110.768 174.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 57.3 mtp180 -54.93 -36.22 65.03 Favored 'General case' 0 N--CA 1.477 0.9 0 O-C-N 121.43 -0.794 . . . . 0.0 111.165 159.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.04 -44.08 97.61 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 124.498 1.047 . . . . 0.0 113.995 170.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -61.61 -32.3 72.42 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 119.745 1.772 . . . . 0.0 112.296 176.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 57.6 mt -74.48 -43.5 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.095 0.958 . . . . 0.0 110.08 174.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -64.83 -44.35 90.12 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 121.286 -0.884 . . . . 0.0 112.253 -179.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -57.05 -41.34 78.5 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.431 0.692 . . . . 0.0 111.674 -179.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -91.34 -28.26 17.84 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 -176.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -133.42 2.78 3.56 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 114.973 1.471 . . . . 0.0 114.973 -171.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 44.2 mmtm 54.12 33.65 18.3 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 127.039 2.136 . . . . 0.0 114.172 178.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 65.6 t-80 -130.92 141.82 50.32 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 126.088 1.755 . . . . 0.0 110.759 -175.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -142.0 -20.22 0.72 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.742 1.217 . . . . 0.0 113.593 -164.124 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.8 p -68.54 153.31 44.01 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.716 1.607 . . . . 0.0 111.876 167.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.421 HG21 ' CD2' ' A' ' 20' ' ' TRP . 25.6 m -115.92 151.25 46.24 Favored Pre-proline 0 N--CA 1.476 0.856 0 C-N-CA 124.421 1.088 . . . . 0.0 112.736 177.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -74.58 147.33 89.12 Favored 'Cis proline' 0 N--CA 1.457 -0.62 0 CA-C-N 119.079 0.707 . . . . 0.0 113.884 0.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -99.02 138.35 36.25 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.414 158.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 44.4 mt -130.45 141.07 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 123.714 0.805 . . . . 0.0 109.089 -164.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -140.16 146.07 38.31 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.007 0.923 . . . . 0.0 111.555 -179.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 65.2 mt -128.85 127.19 66.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 125.384 1.474 . . . . 0.0 107.916 174.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 35.8 m120 50.54 28.17 3.28 Favored 'General case' 0 CA--C 1.56 1.355 0 N-CA-C 115.651 1.723 . . . . 0.0 115.651 -178.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 82.4 0.97 90.34 Favored Glycine 0 CA--C 1.544 1.891 0 O-C-N 120.397 -1.44 . . . . 0.0 115.047 -173.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -91.72 151.65 20.55 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 126.964 2.106 . . . . 0.0 110.387 172.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -93.97 142.37 27.46 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -174.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 31.7 mm -121.22 130.07 75.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 128.56 2.744 . . . . 0.0 107.512 176.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -71.38 23.37 0.62 Allowed Glycine 0 N--CA 1.472 1.034 0 C-N-CA 126.744 2.116 . . . . 0.0 118.101 -165.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 107.79 -171.9 16.79 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 127.941 2.686 . . . . 0.0 113.498 178.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 42.7 t -54.12 -41.94 68.89 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.821 1.248 . . . . 0.0 112.362 -178.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 10.4 m -82.58 -10.28 59.04 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -178.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -76.6 -42.68 41.57 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 120.002 1.273 . . . . 0.0 109.838 162.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 48.7 tp -64.13 -50.03 69.84 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.115 1.366 . . . . 0.0 112.395 177.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -70.01 -12.95 61.98 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 113.24 0.829 . . . . 0.0 113.24 178.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -85.89 -39.41 17.03 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 121.206 -0.934 . . . . 0.0 112.121 164.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 33.6 mt -64.42 -33.66 76.38 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 120.375 1.443 . . . . 0.0 113.29 175.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -62.98 -47.39 83.35 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.975 1.31 . . . . 0.0 111.352 171.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 6.8 mptt -73.44 -34.91 65.65 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.598 1.559 . . . . 0.0 112.319 -177.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -70.41 -11.58 61.01 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.231 1.813 . . . . 0.0 113.142 169.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 70.17 10.65 65.97 Favored Glycine 0 CA--C 1.534 1.258 0 CA-C-N 119.053 0.842 . . . . 0.0 114.301 -177.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 17.4 mtpt -81.5 -26.6 35.04 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 125.949 1.7 . . . . 0.0 112.103 -178.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 34.7 tp -59.51 -40.23 86.41 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.645 1.178 . . . . 0.0 112.126 170.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -60.66 -42.04 96.22 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.812 -0.555 . . . . 0.0 111.932 174.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -70.33 -14.08 71.28 Favored Glycine 0 CA--C 1.535 1.301 0 CA-C-O 119.16 -0.8 . . . . 0.0 114.959 176.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 88.7 mt -97.64 -21.99 16.73 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.065 1.746 . . . . 0.0 113.341 175.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 93.2 mt -103.8 -5.67 22.2 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.236 1.415 . . . . 0.0 114.447 -179.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 61.2 p . . . . . 0 C--O 1.25 1.1 0 C-N-CA 126.07 1.748 . . . . 0.0 114.159 173.465 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.07 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.81 -14.13 62.61 Favored 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 115.43 1.641 . . . . 0.0 115.43 -177.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 50.2 mtp -115.18 92.39 31.39 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 125.878 1.671 . . . . 0.0 113.02 -171.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -50.51 138.25 39.59 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 124.122 3.215 . . . . 0.0 116.191 -175.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.4 t -151.18 -147.89 0.25 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 127.939 2.495 . . . . 0.0 109.766 -175.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.6 pt -49.21 -24.82 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 126.741 2.016 . . . . 0.0 116.222 -165.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.26 -21.84 26.16 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.929 1.691 . . . . 0.0 114.264 -178.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.9 m -77.32 -32.74 55.49 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.81 1.244 . . . . 0.0 113.437 170.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 78.8 mtp -63.26 -33.76 76.19 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 121.306 -0.871 . . . . 0.0 111.371 -176.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.0 mm -62.35 -22.47 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 125.726 1.611 . . . . 0.0 112.767 -176.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -85.86 -17.74 34.77 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.24 1.416 . . . . 0.0 113.876 179.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -88.77 -7.5 71.15 Favored Glycine 0 CA--C 1.536 1.395 0 N-CA-C 115.933 1.133 . . . . 0.0 115.933 -173.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -145.04 161.16 40.09 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.292 1.437 . . . . 0.0 110.738 169.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -67.77 -48.33 66.65 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.091 0.956 . . . . 0.0 111.176 177.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.4 t -114.53 131.12 67.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 C-N-CA 124.937 1.295 . . . . 0.0 110.961 171.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 85.3 t -131.06 130.74 63.96 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 125.014 1.326 . . . . 0.0 110.206 179.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 49.3 t -128.81 146.03 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 124.13 0.972 . . . . 0.0 112.421 -175.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -121.84 111.53 17.23 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.789 1.235 . . . . 0.0 109.099 173.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 18.7 m -121.14 172.68 7.8 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 126.728 2.011 . . . . 0.0 111.319 -173.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.486 ' CD1' ' HB3' ' A' ' 46' ' ' ASP . 23.6 m0 -120.31 135.88 54.86 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.57 1.148 . . . . 0.0 108.86 162.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 60.7 t -57.72 -35.54 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 CA-C-N 118.849 0.75 . . . . 0.0 111.13 -177.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 65.3 p -74.34 -10.82 59.96 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 127.308 2.243 . . . . 0.0 116.408 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 38.0 t -90.61 143.73 29.52 Favored Pre-proline 0 CA--C 1.537 0.48 0 O-C-N 121.264 -0.898 . . . . 0.0 110.513 -170.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.33 -39.05 0.61 Allowed 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 121.114 1.209 . . . . 0.0 112.655 173.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -59.01 -36.31 74.73 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.307 1.043 . . . . 0.0 113.744 178.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -48.44 -54.73 13.06 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 124.713 1.205 . . . . 0.0 109.584 168.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 57.5 t -65.2 -39.64 86.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 C-N-CA 124.242 1.017 . . . . 0.0 112.139 -179.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 79.6 mmt-85 -54.78 -41.67 70.8 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 118.687 0.676 . . . . 0.0 111.572 174.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.17 -54.27 8.88 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.608 0.763 . . . . 0.0 113.007 173.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -54.24 -31.94 54.67 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 119.498 1.044 . . . . 0.0 113.349 -177.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -69.32 -49.23 57.68 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.0 0.92 . . . . 0.0 112.669 176.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 8.0 tt -72.59 -36.74 68.22 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 124.651 1.181 . . . . 0.0 111.861 -177.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 93.2 mt -62.25 -44.78 95.77 Favored 'General case' 0 CA--C 1.53 0.175 0 O-C-N 121.607 -0.683 . . . . 0.0 111.395 177.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 14.8 m-70 -69.61 -20.88 63.61 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 172.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.61 -31.91 53.19 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 119.698 1.135 . . . . 0.0 113.203 173.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 39.6 mmt-85 -97.36 -23.79 15.94 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 114.827 1.418 . . . . 0.0 114.827 -176.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 14.6 t -153.78 170.25 21.39 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 -177.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 77.6 mttt -112.68 3.82 16.81 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 126.411 1.884 . . . . 0.0 112.224 167.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 53.0 m-20 -105.83 42.94 1.18 Allowed 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 126.081 1.752 . . . . 0.0 113.114 -171.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -119.54 134.97 61.39 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.858 1.663 . . . . 0.0 111.959 -177.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.0 m -119.19 141.85 48.51 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.803 2.041 . . . . 0.0 110.242 167.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.5 p -135.37 141.04 43.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 125.072 1.349 . . . . 0.0 113.308 176.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -112.77 134.68 54.17 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 127.414 2.286 . . . . 0.0 110.394 175.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -101.62 89.44 3.71 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 124.15 0.98 . . . . 0.0 110.509 -179.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 5.9 m -76.1 4.65 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -170.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.486 ' HB3' ' CD1' ' A' ' 20' ' ' TRP . 2.5 p-10 -85.23 -22.92 28.47 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.759 1.224 . . . . 0.0 112.038 167.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 30.0 mtmt -90.0 5.09 48.08 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.904 2.082 . . . . 0.0 113.41 176.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 12.2 tpt -120.63 124.25 44.79 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.975 1.71 . . . . 0.0 111.413 -165.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 10.5 m -65.21 -22.91 66.95 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.735 0.814 . . . . 0.0 112.847 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.4 5.58 51.36 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 126.16 1.784 . . . . 0.0 113.549 174.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -55.88 -30.57 57.14 Favored Glycine 0 CA--C 1.532 1.106 0 O-C-N 120.402 -1.436 . . . . 0.0 114.651 -174.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -70.23 -26.23 63.76 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 118.541 1.17 . . . . 0.0 113.043 175.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -72.21 -44.11 63.45 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.97 0.908 . . . . 0.0 110.53 170.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.23 -36.65 83.57 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.044 0.538 . . . . 0.0 110.459 178.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 43.0 mtp180 -63.93 -42.01 97.47 Favored 'General case' 0 N--CA 1.477 0.897 0 O-C-N 121.077 -1.014 . . . . 0.0 112.176 167.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -58.91 -38.38 92.49 Favored Glycine 0 CA--C 1.535 1.313 0 C-N-CA 124.225 0.917 . . . . 0.0 113.627 176.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.6 mm-40 -61.18 -32.29 72.03 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 118.597 1.199 . . . . 0.0 113.637 173.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 52.0 mt -81.28 -42.55 19.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 123.939 0.896 . . . . 0.0 109.214 177.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -71.93 -39.59 69.36 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 121.115 -0.991 . . . . 0.0 112.941 -176.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 42.2 mm-40 -68.63 -23.91 64.49 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 119.939 1.245 . . . . 0.0 113.069 177.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -98.75 -31.75 11.73 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.533 1.133 . . . . 0.0 113.827 -178.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -134.87 5.0 3.33 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 -170.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 66.7 mmtt 47.37 38.94 8.14 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 126.565 1.946 . . . . 0.0 114.429 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -139.88 147.69 40.99 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.704 1.202 . . . . 0.0 111.446 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -140.29 2.47 1.88 Allowed 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.998 1.319 . . . . 0.0 113.861 -172.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 90.2 m -82.22 141.04 33.32 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.284 1.034 . . . . 0.0 111.851 175.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.9 m -101.97 156.06 35.68 Favored Pre-proline 0 N--CA 1.475 0.785 0 C-N-CA 124.826 1.251 . . . . 0.0 112.73 -176.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -73.69 150.96 96.42 Favored 'Cis proline' 0 C--N 1.348 0.546 0 CA-C-N 118.759 0.592 . . . . 0.0 113.013 -5.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -98.02 130.84 44.83 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 161.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 47.8 mt -126.28 141.39 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 C-N-CA 124.084 0.954 . . . . 0.0 109.294 -167.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -139.34 141.11 37.66 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.516 0.727 . . . . 0.0 111.736 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 43.4 mt -136.5 117.07 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.659 1.184 . . . . 0.0 109.508 -179.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 46.37 38.58 5.4 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 125.135 1.374 . . . . 0.0 114.165 -171.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 78.83 0.29 80.64 Favored Glycine 0 CA--C 1.54 1.654 0 N-CA-C 115.723 1.049 . . . . 0.0 115.723 -177.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 -88.61 145.84 25.46 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 119.088 1.444 . . . . 0.0 110.261 174.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -94.06 137.62 33.05 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -172.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 18.3 mm -130.75 115.46 30.95 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 C-N-CA 127.825 2.45 . . . . 0.0 107.663 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -70.97 -16.97 75.11 Favored Glycine 0 CA--C 1.537 1.461 0 N-CA-C 116.41 1.324 . . . . 0.0 116.41 -165.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 172.99 -173.87 45.72 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 124.558 1.075 . . . . 0.0 113.52 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 34.1 t -62.92 -35.63 80.73 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 122.262 -0.552 . . . . 0.0 111.469 174.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 43.5 t -60.96 -44.29 97.5 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.795 -0.565 . . . . 0.0 112.319 173.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -70.94 -31.11 67.61 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.51 1.124 . . . . 0.0 112.015 -179.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 42.5 tp -69.38 -50.82 42.55 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.815 1.646 . . . . 0.0 111.289 172.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -64.36 -31.45 72.66 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 121.422 -0.799 . . . . 0.0 112.521 178.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.43 -22.63 65.2 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 119.131 0.878 . . . . 0.0 112.771 175.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 68.7 mt -90.13 -29.81 18.06 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.987 1.315 . . . . 0.0 112.088 171.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -65.16 -45.4 85.09 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.041 0.936 . . . . 0.0 112.264 172.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -60.33 -22.52 63.32 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.747 1.619 . . . . 0.0 114.059 177.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -105.07 -7.81 18.9 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 125.061 1.344 . . . . 0.0 114.584 -176.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 84.08 6.11 86.88 Favored Glycine 0 CA--C 1.54 1.627 0 CA-C-N 118.881 0.764 . . . . 0.0 114.673 -176.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 34.0 mtmt -90.51 -25.68 20.15 Favored 'General case' 0 C--N 1.342 0.265 0 C-N-CA 125.662 1.585 . . . . 0.0 113.252 -171.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 52.4 tp -65.19 -38.55 90.85 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.283 1.033 . . . . 0.0 111.258 173.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -62.06 -23.6 66.59 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 173.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -85.2 -23.41 48.51 Favored Glycine 0 CA--C 1.532 1.123 0 O-C-N 121.545 -0.722 . . . . 0.0 114.141 172.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 41.9 mt -79.18 -35.03 42.53 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.893 1.277 . . . . 0.0 112.336 175.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 51.5 mt -81.01 -0.73 40.89 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 115.421 1.638 . . . . 0.0 115.421 -166.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 16.4 m . . . . . 0 C--O 1.254 1.34 0 C-N-CA 127.073 2.149 . . . . 0.0 113.027 -179.57 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.219 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -147.6 144.46 28.46 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.895 0.878 . . . . 0.0 112.234 177.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.76 90.03 42.73 Favored Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 126.03 1.732 . . . . 0.0 110.576 -178.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -60.77 108.62 0.56 Allowed 'Trans proline' 0 CA--C 1.538 0.722 0 C-N-CA 123.245 2.63 . . . . 0.0 112.938 176.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 53.8 p -149.66 -179.34 7.03 Favored 'General case' 0 C--O 1.238 0.498 0 C-N-CA 125.514 1.526 . . . . 0.0 109.557 165.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.464 HG23 HD12 ' A' ' 54' ' ' LEU . 21.3 pt -53.44 -27.55 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 123.344 0.658 . . . . 0.0 112.621 172.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.88 -25.12 64.46 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 113.548 0.944 . . . . 0.0 113.548 -172.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 21.1 m -81.07 -31.95 34.18 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 121.096 -1.003 . . . . 0.0 111.904 167.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 56.5 mtm -68.37 -17.97 64.36 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 178.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.5 mm -60.84 -31.16 48.85 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 CA-C-N 119.223 0.919 . . . . 0.0 111.99 171.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.2 mptt -75.53 -1.52 24.71 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -174.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -81.86 -38.03 14.78 Favored Glycine 0 CA--C 1.537 1.436 0 N-CA-C 115.659 1.024 . . . . 0.0 115.659 -172.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -140.84 171.92 13.41 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.304 1.442 . . . . 0.0 112.641 -174.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 29.0 ttpt -68.7 -39.29 80.56 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.849 1.26 . . . . 0.0 112.813 -178.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.1 t -122.47 134.44 65.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.031 0.932 . . . . 0.0 110.357 172.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 25.2 t -135.27 130.51 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 124.368 1.067 . . . . 0.0 109.985 177.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 54.8 t -127.4 149.12 32.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 124.472 1.109 . . . . 0.0 111.977 -173.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -127.31 114.33 17.45 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.408 1.483 . . . . 0.0 109.409 175.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.7 m -130.14 172.13 12.1 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 126.571 1.948 . . . . 0.0 111.444 -168.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 23.0 m0 -114.55 138.99 49.95 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 158.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.41 ' CG2' ' HE2' ' A' ' 47' ' ' LYS . 96.6 t -65.56 -22.82 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 CA-C-N 118.465 0.575 . . . . 0.0 111.208 175.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 76.6 p -68.54 -18.73 64.42 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.639 1.576 . . . . 0.0 115.001 172.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 49.9 t -93.14 143.3 26.53 Favored Pre-proline 0 CA--C 1.539 0.522 0 CA-C-N 119.698 1.135 . . . . 0.0 111.498 -165.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -82.92 -33.53 0.42 Allowed 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 121.217 1.278 . . . . 0.0 112.932 174.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -61.23 -36.64 80.5 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.67 1.188 . . . . 0.0 112.705 176.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -49.85 -55.13 15.43 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.382 1.473 . . . . 0.0 109.517 168.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 86.0 t -63.97 -39.02 83.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 124.221 1.008 . . . . 0.0 112.558 -176.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 25.4 mmm180 -53.89 -48.11 70.41 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 118.745 0.702 . . . . 0.0 111.029 173.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -66.81 -55.77 13.39 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.617 0.767 . . . . 0.0 112.342 175.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -50.79 -38.27 47.41 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.722 1.209 . . . . 0.0 113.698 -178.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 34.5 ttpt -71.28 -51.08 26.47 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.394 0.678 . . . . 0.0 111.172 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.2 tt -66.19 -38.63 88.46 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 125.151 1.381 . . . . 0.0 111.754 -177.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 71.5 mt -61.86 -52.94 62.07 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.897 0.879 . . . . 0.0 111.172 176.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -63.43 -25.23 68.18 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 172.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.04 -13.27 60.22 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 120.514 -1.366 . . . . 0.0 113.514 175.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 12.3 mmp_? -99.87 -56.88 2.26 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.842 1.257 . . . . 0.0 112.433 171.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 25.4 p -150.02 143.15 24.98 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.556 1.142 . . . . 0.0 113.915 -164.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -83.73 -0.98 53.11 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 126.572 1.949 . . . . 0.0 113.528 175.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -83.29 29.35 0.5 Allowed 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.075 1.35 . . . . 0.0 113.383 -177.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -110.15 132.49 58.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 C-N-CA 126.818 2.047 . . . . 0.0 111.089 -174.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 46.8 m -110.2 138.88 45.97 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 126.956 2.103 . . . . 0.0 108.89 166.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.1 p -134.6 139.61 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.478 0 CA-C-O 122.537 1.161 . . . . 0.0 113.37 170.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 34.6 m-70 -116.23 145.95 42.72 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 127.939 2.496 . . . . 0.0 110.918 -178.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -123.58 90.77 3.34 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.967 0.889 . . . . 0.0 111.335 -168.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 34.9 m -68.24 -11.66 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -174.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.41 -23.58 54.03 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.865 0.866 . . . . 0.0 112.963 170.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.41 ' HE2' ' CG2' ' A' ' 21' ' ' VAL . 71.2 mmtt -86.43 -32.26 20.97 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.703 1.201 . . . . 0.0 111.977 175.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 67.1 mtt -61.75 143.83 55.62 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.122 0.969 . . . . 0.0 112.157 174.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 9.4 t -70.42 -37.58 74.46 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.835 0.854 . . . . 0.0 111.103 168.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -100.16 7.92 44.22 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.776 1.63 . . . . 0.0 114.026 -176.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -57.02 -27.41 57.12 Favored Glycine 0 CA--C 1.534 1.244 0 O-C-N 120.598 -1.314 . . . . 0.0 115.795 -172.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -67.6 -20.01 65.31 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.052 1.426 . . . . 0.0 112.82 174.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -80.34 -33.82 37.08 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.984 1.314 . . . . 0.0 112.0 170.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.464 HD12 HG23 ' A' ' 6' ' ' ILE . 3.0 mm? -77.9 -27.98 49.71 Favored 'General case' 0 CA--C 1.544 0.725 0 O-C-N 121.52 -0.737 . . . . 0.0 111.495 177.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 66.5 mtp180 -54.72 -39.74 68.53 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-N 119.633 1.106 . . . . 0.0 111.337 159.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.23 -28.02 73.06 Favored Glycine 0 CA--C 1.534 1.271 0 CA-C-O 119.095 -0.836 . . . . 0.0 115.033 175.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -65.0 -35.0 79.79 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 119.557 1.678 . . . . 0.0 112.398 174.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 27.9 mt -72.93 -41.3 60.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 C-N-CA 124.44 1.096 . . . . 0.0 109.278 173.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -64.53 -46.29 83.5 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 121.49 -0.757 . . . . 0.0 112.947 -177.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 93.5 mm-40 -70.58 -18.02 62.9 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -92.74 -33.03 14.47 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 175.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -136.35 -0.73 2.41 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 115.678 1.733 . . . . 0.0 115.678 -168.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 53.06 41.35 32.16 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 126.803 2.041 . . . . 0.0 113.835 -169.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -128.72 140.61 51.65 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.592 1.157 . . . . 0.0 113.056 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -142.18 -18.03 0.73 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.684 1.194 . . . . 0.0 113.949 -169.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.7 p -72.68 164.55 26.34 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.49 1.116 . . . . 0.0 113.524 169.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 20.1 m -123.65 155.03 66.82 Favored Pre-proline 0 N--CA 1.478 0.955 0 C-N-CA 124.715 1.206 . . . . 0.0 113.597 -175.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -75.47 151.73 96.59 Favored 'Cis proline' 0 C--N 1.35 0.619 0 CA-C-N 118.793 0.605 . . . . 0.0 112.913 -4.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -100.12 132.5 45.45 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 162.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 69.3 mt -126.23 142.4 42.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 123.977 0.911 . . . . 0.0 108.725 -167.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -138.68 146.04 41.1 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.669 0.788 . . . . 0.0 112.08 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 51.8 mt -132.73 119.99 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 124.907 1.283 . . . . 0.0 109.994 176.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 48.05 29.75 1.86 Allowed 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 126.224 1.81 . . . . 0.0 114.57 -176.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 91.21 0.51 73.74 Favored Glycine 0 CA--C 1.541 1.703 0 C-N-CA 125.428 1.489 . . . . 0.0 116.759 -175.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -93.0 144.96 24.74 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 126.022 1.729 . . . . 0.0 110.744 175.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -91.96 141.56 28.5 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.704 1.202 . . . . 0.0 114.065 -176.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 26.4 mm -127.79 123.2 60.53 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 C-N-CA 128.076 2.55 . . . . 0.0 108.364 -178.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -72.02 16.63 1.51 Allowed Glycine 0 N--CA 1.475 1.274 0 N-CA-C 118.863 2.305 . . . . 0.0 118.863 -167.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 114.59 -159.8 13.53 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 126.831 2.158 . . . . 0.0 114.196 178.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 53.6 t -65.25 -42.22 93.5 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.796 0.838 . . . . 0.0 113.229 -172.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 21.5 m -61.27 -40.9 95.8 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 118.924 0.784 . . . . 0.0 112.025 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -66.03 -40.45 91.05 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.774 1.23 . . . . 0.0 112.107 176.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 56.1 tp -64.14 -50.83 66.68 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.326 1.45 . . . . 0.0 111.35 177.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -63.3 -39.51 94.77 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 118.108 0.413 . . . . 0.0 111.106 175.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.29 -38.67 90.26 Favored 'General case' 0 CA--C 1.536 0.413 0 O-C-N 121.541 -0.724 . . . . 0.0 111.869 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 29.4 mt -66.53 -27.38 67.71 Favored 'General case' 0 N--CA 1.468 0.425 0 O-C-N 121.302 -0.874 . . . . 0.0 112.151 176.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -75.04 -43.42 53.68 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 118.748 0.704 . . . . 0.0 111.634 174.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -65.87 -32.41 73.9 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.582 0.753 . . . . 0.0 112.083 175.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -78.84 -0.48 30.79 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 126.119 1.768 . . . . 0.0 113.601 172.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 73.22 23.0 78.38 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 124.461 1.029 . . . . 0.0 114.925 173.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 43.2 mtmt -113.59 -24.06 9.43 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 127.31 2.244 . . . . 0.0 113.877 -168.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 38.7 tp -63.24 -37.33 86.81 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 123.43 0.692 . . . . 0.0 111.825 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -54.92 -44.14 73.96 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.545 0.738 . . . . 0.0 112.375 175.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -73.53 -33.67 58.09 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 123.991 0.805 . . . . 0.0 113.894 177.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 82.3 mt -68.24 -36.39 79.39 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 118.764 1.282 . . . . 0.0 111.801 173.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 83.0 mt -83.9 6.2 22.55 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 124.932 1.293 . . . . 0.0 113.184 176.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 61.4 m . . . . . 0 C--O 1.253 1.286 0 C-N-CA 124.054 0.942 . . . . 0.0 111.1 171.891 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.929 0 N-CA-C 112.347 -0.301 . . . . 0.0 112.347 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.75 163.53 38.96 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 125.368 1.467 . . . . 0.0 112.752 -179.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 28.3 ttt -149.18 95.11 3.88 Favored Pre-proline 0 CA--C 1.55 0.967 0 C-N-CA 125.34 1.456 . . . . 0.0 112.31 -174.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -78.09 179.76 29.78 Favored 'Cis proline' 0 C--N 1.351 0.661 0 CA-C-N 120.454 1.198 . . . . 0.0 111.421 0.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 7.8 p -143.64 -168.42 2.83 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 114.212 1.19 . . . . 0.0 114.212 -174.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.429 HG23 HD12 ' A' ' 54' ' ' LEU . 21.8 pt -54.53 -23.15 10.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 125.072 1.349 . . . . 0.0 113.044 168.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -64.58 -22.19 66.9 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -174.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 70.5 m -79.12 -28.95 42.97 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 121.08 -1.013 . . . . 0.0 113.148 170.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 54.8 mtt -64.3 -30.97 72.0 Favored 'General case' 0 N--CA 1.473 0.706 0 O-C-N 121.382 -0.824 . . . . 0.0 111.723 -178.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.7 mm -60.74 -27.67 41.35 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 125.012 1.325 . . . . 0.0 112.279 -178.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.4 mptt -81.0 -11.39 59.57 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.996 1.318 . . . . 0.0 113.577 178.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -80.87 -32.71 32.04 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 124.12 0.866 . . . . 0.0 114.985 -176.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 55.0 m-80 -141.56 162.47 35.4 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 115.445 1.646 . . . . 0.0 115.445 -172.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -61.62 -42.36 98.77 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.958 1.303 . . . . 0.0 112.705 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.4 t -127.55 132.12 69.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 124.129 0.972 . . . . 0.0 110.317 175.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 48.0 t -132.08 131.17 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.015 0.926 . . . . 0.0 110.92 178.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.0 t -129.84 150.45 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 124.275 1.03 . . . . 0.0 113.029 -174.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 87.9 m-85 -126.28 106.87 9.83 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.692 1.197 . . . . 0.0 109.992 175.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 60.9 m -125.02 167.33 14.89 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 126.058 1.743 . . . . 0.0 112.134 -169.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 41.7 m0 -113.66 121.55 44.49 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.046 1.338 . . . . 0.0 109.289 166.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 96.4 t -55.99 -27.61 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 C-N-CA 124.777 1.231 . . . . 0.0 112.772 -174.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.6 p -74.45 -17.04 60.84 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 126.998 2.119 . . . . 0.0 115.054 178.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 76.1 m -107.74 158.19 34.01 Favored Pre-proline 0 CA--C 1.54 0.591 0 CA-C-N 120.135 1.334 . . . . 0.0 114.02 -160.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -79.86 -48.11 0.08 OUTLIER 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.175 1.917 . . . . 0.0 112.879 -168.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -60.99 -36.31 79.13 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.067 0.947 . . . . 0.0 113.281 -179.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -43.61 -55.42 4.32 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.701 1.2 . . . . 0.0 110.128 165.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 54.5 t -68.3 -40.31 82.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 C-N-CA 123.89 0.876 . . . . 0.0 111.967 -178.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 43.6 mmt-85 -56.14 -41.38 75.3 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 118.865 0.757 . . . . 0.0 111.828 175.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.94 -56.72 5.61 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.732 1.213 . . . . 0.0 112.909 173.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -51.44 -35.78 41.1 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 119.857 1.208 . . . . 0.0 113.243 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 25.3 ttpt -69.44 -50.35 46.52 Favored 'General case' 0 CA--C 1.528 0.12 0 C-N-CA 124.203 1.001 . . . . 0.0 111.647 178.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.5 tt -65.72 -41.65 92.0 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 124.63 1.172 . . . . 0.0 111.006 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 53.0 mt -62.22 -50.05 73.31 Favored 'General case' 0 C--O 1.227 -0.095 0 CA-C-O 118.359 -0.829 . . . . 0.0 111.112 177.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 14.7 m170 -61.6 -21.81 64.67 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 118.74 0.7 . . . . 0.0 112.617 173.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -83.54 -14.16 52.87 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 119.79 1.177 . . . . 0.0 114.033 174.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.91 -36.99 4.96 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.109 1.364 . . . . 0.0 114.1 -178.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.0 m -147.97 138.98 23.3 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 126.312 1.845 . . . . 0.0 111.107 -171.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 70.4 mmtt -97.37 -22.95 16.33 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.195 0.998 . . . . 0.0 112.665 174.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 -78.3 52.5 1.13 Allowed 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 125.263 1.425 . . . . 0.0 112.921 172.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -112.3 136.36 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 127.665 2.386 . . . . 0.0 109.934 178.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.6 m -123.13 119.79 31.32 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 125.723 1.609 . . . . 0.0 110.185 172.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.3 p -110.26 133.66 54.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 123.772 0.829 . . . . 0.0 111.743 170.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -103.84 125.94 50.62 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.881 1.272 . . . . 0.0 109.802 170.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -95.74 101.83 13.57 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 121.866 0.841 . . . . 0.0 111.169 -176.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . 0.278 29.8 m -81.97 5.57 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 O-C-N 120.552 -1.342 . . . . 0.0 114.481 -173.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -92.04 -20.61 21.14 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 125.26 1.424 . . . . 0.0 112.163 161.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.4 mmmt -89.66 -37.04 14.9 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 126.784 2.034 . . . . 0.0 111.878 176.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 46.1 tpp -85.2 121.12 27.5 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.683 0.793 . . . . 0.0 110.236 177.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 73.2 m -64.46 -24.45 67.62 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 115.411 1.634 . . . . 0.0 115.411 -168.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -86.78 1.46 52.16 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 126.911 2.085 . . . . 0.0 114.551 171.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -50.97 -27.35 13.45 Favored Glycine 0 CA--C 1.533 1.2 0 N-CA-C 116.92 1.528 . . . . 0.0 116.92 -169.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -73.98 -20.86 60.21 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 119.808 1.804 . . . . 0.0 113.157 177.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 63.2 mm-40 -83.3 -29.89 28.0 Favored 'General case' 0 N--CA 1.472 0.66 0 O-C-N 121.03 -1.043 . . . . 0.0 111.803 172.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.429 HD12 HG23 ' A' ' 6' ' ' ILE . 2.7 mm? -73.92 -34.34 64.32 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 123.777 0.831 . . . . 0.0 111.509 170.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 63.7 mtp85 -53.87 -39.16 65.45 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 119.606 1.094 . . . . 0.0 111.196 161.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -55.54 -42.01 82.95 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.054 0.835 . . . . 0.0 114.13 171.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -65.81 -25.64 67.32 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 119.697 1.748 . . . . 0.0 113.272 177.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.1 mt -79.66 -47.59 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 123.997 0.919 . . . . 0.0 109.477 172.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 29.8 t80 -66.64 -42.62 86.41 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.441 -0.787 . . . . 0.0 112.434 -175.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -60.76 -26.65 67.39 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 121.409 -0.807 . . . . 0.0 113.057 177.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -94.52 -36.65 11.75 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 -178.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -129.15 -4.03 5.01 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 115.045 1.498 . . . . 0.0 115.045 -168.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 98.5 mttt 43.9 61.68 2.22 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 127.939 2.496 . . . . 0.0 113.484 -174.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -135.16 109.0 8.07 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 112.428 -2.169 . . . . 0.0 110.896 -171.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -99.92 -5.9 27.56 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 125.68 1.592 . . . . 0.0 112.555 177.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.0 t -51.35 148.71 4.64 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 127.17 2.188 . . . . 0.0 113.452 162.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.2 m -136.8 141.12 33.92 Favored Pre-proline 0 N--CA 1.477 0.882 0 C-N-CA 125.962 1.705 . . . . 0.0 109.926 164.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -78.6 152.21 89.83 Favored 'Cis proline' 0 N--CA 1.46 -0.492 0 CA-C-N 119.862 0.986 . . . . 0.0 114.086 5.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -97.06 142.14 29.36 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.639 0.776 . . . . 0.0 109.535 161.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 53.6 mt -133.68 139.58 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 C-N-CA 123.816 0.846 . . . . 0.0 110.016 -164.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -138.46 144.1 39.94 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.626 1.17 . . . . 0.0 111.468 179.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 66.5 mt -133.72 120.5 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 124.926 1.29 . . . . 0.0 109.029 177.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 45.91 38.96 4.98 Favored 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 125.85 1.66 . . . . 0.0 114.134 -176.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 82.36 -3.0 83.58 Favored Glycine 0 CA--C 1.539 1.535 0 N-CA-C 116.514 1.366 . . . . 0.0 116.514 -176.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -88.25 147.14 24.97 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 125.371 1.468 . . . . 0.0 109.675 174.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -89.65 143.74 26.56 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.809 0.844 . . . . 0.0 112.104 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 20.1 mm -126.92 115.44 41.38 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 C-N-CA 127.039 2.135 . . . . 0.0 107.273 175.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.85 -16.1 61.09 Favored Glycine 0 CA--C 1.534 1.242 0 N-CA-C 116.908 1.523 . . . . 0.0 116.908 -167.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 173.46 177.74 42.91 Favored Glycine 0 CA--C 1.525 0.71 0 CA-C-N 118.796 1.298 . . . . 0.0 115.935 174.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 29.8 t -59.41 -35.19 73.52 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 122.904 0.482 . . . . 0.0 112.068 175.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 50.4 m -72.96 -16.91 61.52 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.647 1.179 . . . . 0.0 113.584 178.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -86.72 -39.13 16.3 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.446 1.098 . . . . 0.0 111.386 169.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 51.0 tp -61.06 -51.01 70.98 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.222 1.409 . . . . 0.0 111.514 174.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -55.57 -38.06 68.86 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.554 1.141 . . . . 0.0 111.028 173.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.04 -31.17 65.91 Favored 'General case' 0 CA--C 1.54 0.568 0 O-C-N 121.09 -1.006 . . . . 0.0 113.235 -177.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 32.1 mt -72.32 -30.94 65.24 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 119.227 0.921 . . . . 0.0 112.339 173.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -65.27 -33.83 76.92 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.791 1.236 . . . . 0.0 111.083 169.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 15.1 mmtt -80.23 -9.32 59.72 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 176.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -98.51 -11.7 21.99 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.92 1.288 . . . . 0.0 114.329 172.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 67.65 29.09 73.59 Favored Glycine 0 CA--C 1.539 1.569 0 C-N-CA 121.163 -0.541 . . . . 0.0 112.357 -171.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 31.8 mtmt -111.98 -16.32 13.12 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 126.547 1.939 . . . . 0.0 113.272 -176.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 42.9 tp -68.35 -36.9 79.91 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.748 0.819 . . . . 0.0 111.776 178.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 47.5 m-20 -54.37 -48.41 71.51 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.269 1.028 . . . . 0.0 111.789 175.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -76.06 -15.6 81.28 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 125.274 1.416 . . . . 0.0 114.852 178.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 53.9 mt -78.18 -32.04 49.92 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 119.393 1.597 . . . . 0.0 111.495 167.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 81.2 mt -92.85 8.63 38.77 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.977 1.711 . . . . 0.0 114.089 -178.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 35.2 t . . . . . 0 C--O 1.252 1.211 0 C-N-CA 127.097 2.159 . . . . 0.0 113.655 178.921 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.156 0 N-CA-C 110.857 -0.897 . . . . 0.0 110.857 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -89.89 10.54 23.42 Favored 'General case' 0 CA--C 1.551 1.004 0 N-CA-C 115.751 1.76 . . . . 0.0 115.751 -172.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 22.7 mmt -119.98 77.87 23.74 Favored Pre-proline 0 CA--C 1.55 0.957 0 CA-C-N 119.551 1.069 . . . . 0.0 113.212 -170.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -79.07 90.51 1.27 Allowed 'Trans proline' 0 CA--C 1.545 1.059 0 C-N-CA 123.638 2.892 . . . . 0.0 110.917 174.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 19.6 m -108.79 -151.18 0.47 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.704 1.202 . . . . 0.0 113.906 -166.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.7 pt -62.23 -20.86 25.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 -156.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -54.9 -26.44 35.84 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.553 1.541 . . . . 0.0 113.821 -178.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.4 m -72.08 -34.58 68.78 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.939 1.696 . . . . 0.0 113.205 174.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 58.7 mtt -64.39 -36.15 83.2 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.968 0.907 . . . . 0.0 111.247 -178.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.2 mm -62.89 -27.32 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.273 1.029 . . . . 0.0 111.919 -172.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -77.9 -20.53 52.76 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 -173.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -78.29 -29.17 54.18 Favored Glycine 0 CA--C 1.533 1.187 0 CA-C-N 119.576 1.08 . . . . 0.0 114.819 -168.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -129.26 170.57 13.43 Favored 'General case' 0 CA--C 1.539 0.541 0 O-C-N 121.555 -0.967 . . . . 0.0 112.562 -167.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 29.9 ttpt -75.22 -38.38 60.71 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.273 0.629 . . . . 0.0 112.113 177.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.1 t -125.18 139.13 52.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 124.733 1.213 . . . . 0.0 110.158 168.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 60.9 t -130.82 125.43 58.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 124.634 1.174 . . . . 0.0 108.919 171.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 50.4 t -127.6 147.65 32.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 123.867 0.867 . . . . 0.0 111.909 -170.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -121.05 111.43 17.45 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.673 1.189 . . . . 0.0 109.012 174.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.454 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 71.9 m -127.77 168.6 14.9 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 126.447 1.899 . . . . 0.0 110.911 -172.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.528 ' CD1' ' HB3' ' A' ' 46' ' ' ASP . 18.3 m0 -116.06 132.23 56.71 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.521 1.129 . . . . 0.0 108.424 163.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 60.7 t -56.48 -29.14 28.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 CA-C-N 119.098 0.863 . . . . 0.0 112.288 -176.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.8 p -85.64 -11.09 54.73 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 127.464 2.306 . . . . 0.0 115.65 -175.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 8.5 t -90.04 141.43 27.94 Favored Pre-proline 0 CA--C 1.54 0.592 0 CA-C-N 119.77 1.168 . . . . 0.0 111.146 -170.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -69.62 -39.02 7.29 Favored 'Trans proline' 0 C--N 1.348 0.523 0 CA-C-N 120.584 1.244 . . . . 0.0 112.825 179.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -61.43 -31.83 71.78 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 126.485 1.914 . . . . 0.0 114.4 178.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.454 ' SG ' ' HB3' ' A' ' 19' ' ' SER . 0.1 OUTLIER -60.16 -63.48 1.28 Allowed 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 126.253 1.821 . . . . 0.0 108.856 174.037 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 63.4 t -59.09 -38.99 77.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 124.032 0.933 . . . . 0.0 110.998 -178.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 18.6 ttt180 -56.37 -31.66 64.02 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.259 1.824 . . . . 0.0 114.801 171.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -87.12 -50.97 6.26 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 119.511 1.051 . . . . 0.0 112.65 169.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 -49.15 -36.78 20.17 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.232 1.413 . . . . 0.0 112.981 178.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -67.22 -45.86 75.53 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 123.632 0.773 . . . . 0.0 112.914 178.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.9 tt -76.73 -35.31 57.87 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.17 1.388 . . . . 0.0 111.364 -176.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 96.2 mt -62.6 -48.06 81.08 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.389 0.676 . . . . 0.0 111.37 174.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 16.7 m-70 -65.15 -23.29 67.08 Favored 'General case' 0 CA--C 1.543 0.675 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 173.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.42 -28.75 56.75 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 119.683 1.129 . . . . 0.0 112.758 172.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.83 -18.81 19.31 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 -177.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.8 t -162.25 173.72 13.83 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 -178.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -114.6 -30.03 6.63 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.889 1.276 . . . . 0.0 113.565 175.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -84.05 43.59 0.94 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.541 1.137 . . . . 0.0 113.337 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -101.85 118.29 48.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 126.361 1.864 . . . . 0.0 110.909 173.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 22.0 m -106.23 141.39 37.65 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.582 1.553 . . . . 0.0 110.005 172.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.4 p -131.19 146.46 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 124.574 1.15 . . . . 0.0 112.525 173.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -114.29 119.13 35.95 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.477 1.911 . . . . 0.0 108.98 173.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -87.44 90.96 8.56 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 122.157 0.98 . . . . 0.0 109.96 179.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.9 m -73.33 0.68 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 N-CA-C 113.301 0.852 . . . . 0.0 113.301 -171.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.528 ' HB3' ' CD1' ' A' ' 20' ' ' TRP . 2.8 p-10 -88.74 -12.76 41.28 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.443 1.097 . . . . 0.0 113.138 167.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 38.0 mtmt -99.11 -26.22 14.28 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 126.118 1.767 . . . . 0.0 113.794 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 10.1 ttt -98.38 137.87 36.45 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.488 1.115 . . . . 0.0 112.202 178.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 66.1 m -64.42 -26.87 68.64 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 177.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -79.41 -0.29 32.3 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 121.029 -1.045 . . . . 0.0 113.376 175.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -52.2 -31.4 34.05 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 125.268 1.413 . . . . 0.0 115.329 -174.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -83.92 -16.29 44.83 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 118.263 1.031 . . . . 0.0 112.996 -178.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 7.8 mp0 -81.16 -39.28 25.78 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 121.04 -1.037 . . . . 0.0 110.238 167.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.78 -46.12 90.91 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.042 0.537 . . . . 0.0 110.526 171.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 67.2 mtp180 -59.76 -33.14 71.3 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.283 1.033 . . . . 0.0 112.96 170.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.78 -46.66 91.3 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.121 0.867 . . . . 0.0 112.407 174.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -59.46 -42.95 93.19 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 117.997 0.898 . . . . 0.0 112.591 175.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 73.2 mt -66.41 -42.37 90.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 123.483 0.713 . . . . 0.0 110.505 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -71.58 -41.43 69.02 Favored 'General case' 0 CA--C 1.535 0.404 0 O-C-N 121.463 -0.773 . . . . 0.0 112.862 -179.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -63.37 -36.99 85.54 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 119.733 1.151 . . . . 0.0 112.448 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -82.99 -47.22 11.97 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 178.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -120.16 -4.15 10.03 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 -164.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.7 mptt 49.89 53.53 12.63 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.886 1.674 . . . . 0.0 112.185 -177.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 23.2 t-80 -131.44 136.53 48.05 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 125.951 1.7 . . . . 0.0 109.863 173.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -141.81 -34.46 0.47 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.989 0.915 . . . . 0.0 112.667 -166.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.3 p -63.57 165.53 7.94 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.085 1.354 . . . . 0.0 111.588 156.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.425 ' HB ' ' HA ' ' A' ' 68' ' ' PRO . 23.1 m -122.33 159.44 52.34 Favored Pre-proline 0 N--CA 1.48 1.043 0 C-N-CA 124.803 1.241 . . . . 0.0 112.402 -174.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.425 ' HA ' ' HB ' ' A' ' 67' ' ' VAL . 63.2 Cg_endo -81.85 152.58 77.53 Favored 'Cis proline' 0 C--N 1.349 0.592 0 CA-C-N 119.389 0.817 . . . . 0.0 113.803 -4.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -106.32 136.44 46.05 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.393 1.477 . . . . 0.0 108.979 163.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 73.2 mt -131.16 142.83 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 C-N-CA 123.866 0.866 . . . . 0.0 110.164 -163.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -136.98 140.85 42.47 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.349 1.06 . . . . 0.0 110.912 176.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 83.9 mt -128.11 122.11 57.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 125.829 1.652 . . . . 0.0 109.42 179.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 44.7 42.32 5.75 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 125.432 1.493 . . . . 0.0 114.203 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 86.27 -4.63 85.84 Favored Glycine 0 CA--C 1.541 1.713 0 C-N-CA 125.077 1.323 . . . . 0.0 116.219 -177.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -102.49 135.19 44.56 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.654 1.727 . . . . 0.0 111.479 -176.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -73.9 144.26 45.43 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.8 0.84 . . . . 0.0 112.378 178.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 32.2 mm -122.22 127.42 75.2 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 127.384 2.274 . . . . 0.0 107.995 177.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.81 -5.89 27.46 Favored Glycine 0 CA--C 1.536 1.37 0 N-CA-C 118.212 2.045 . . . . 0.0 118.212 -163.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 144.79 -171.85 25.88 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 126.478 1.99 . . . . 0.0 112.752 176.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 11.4 t -61.41 -32.73 72.69 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 122.067 -0.666 . . . . 0.0 112.441 173.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 35.6 t -67.17 -41.11 86.52 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 121.317 -0.865 . . . . 0.0 111.735 178.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -66.55 -37.15 84.37 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.273 1.029 . . . . 0.0 113.167 171.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 13.8 tp -63.7 -50.73 68.04 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.278 1.431 . . . . 0.0 110.908 177.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -64.46 -37.76 88.66 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 122.963 0.505 . . . . 0.0 110.836 176.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.55 -34.37 76.79 Favored 'General case' 0 CA--C 1.545 0.768 0 O-C-N 121.066 -1.021 . . . . 0.0 112.77 175.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 64.0 mt -70.99 -24.33 62.37 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.028 0.931 . . . . 0.0 113.186 172.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -77.09 -35.02 56.79 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 119.012 0.824 . . . . 0.0 111.946 172.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -69.35 -29.28 67.04 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.942 0.897 . . . . 0.0 112.906 169.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -81.76 -3.13 53.03 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 169.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 66.8 14.85 63.66 Favored Glycine 0 CA--C 1.541 1.675 0 CA-C-N 120.11 1.323 . . . . 0.0 114.72 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 34.3 mtpt -100.51 -29.31 12.43 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 126.472 1.909 . . . . 0.0 112.189 -171.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 46.3 tp -58.68 -39.6 81.18 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 118.718 0.69 . . . . 0.0 111.937 177.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -55.97 -48.46 75.77 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.499 0.72 . . . . 0.0 112.579 174.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -76.86 -37.97 32.28 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 123.884 0.754 . . . . 0.0 113.957 -177.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 69.3 mt -58.52 -26.41 63.47 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.767 1.227 . . . . 0.0 112.056 169.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 81.8 mt -103.95 16.77 25.54 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.324 1.45 . . . . 0.0 114.135 176.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 62.4 m . . . . . 0 C--O 1.252 1.229 0 C-N-CA 124.63 1.172 . . . . 0.0 111.989 172.899 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.14 0 N-CA-C 111.355 -0.698 . . . . 0.0 111.355 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 49.55 40.73 20.0 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 125.821 1.648 . . . . 0.0 114.836 -177.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 48.0 mtt -130.41 85.34 56.78 Favored Pre-proline 0 N--CA 1.474 0.74 0 C-N-CA 125.236 1.414 . . . . 0.0 111.529 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -81.7 59.1 7.07 Favored 'Trans proline' 0 CA--C 1.545 1.04 0 C-N-CA 123.066 2.511 . . . . 0.0 111.904 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 75.3 m -150.75 -159.65 1.06 Allowed 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 126.765 2.026 . . . . 0.0 110.6 171.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.8 pt -55.76 -26.2 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 125.585 1.554 . . . . 0.0 115.13 -162.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -54.03 -32.15 53.52 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 125.591 1.557 . . . . 0.0 113.241 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 47.6 t -71.7 -34.15 69.38 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.096 1.358 . . . . 0.0 112.452 174.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 52.0 mtt -68.68 -34.32 75.48 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.346 1.058 . . . . 0.0 112.255 178.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 10.6 mm -59.48 -27.67 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 124.267 1.027 . . . . 0.0 111.679 -176.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 26.9 mttm -82.58 -8.08 59.62 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 126.034 1.734 . . . . 0.0 114.58 178.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -80.89 -17.78 71.68 Favored Glycine 0 CA--C 1.536 1.349 0 C-N-CA 124.005 0.812 . . . . 0.0 114.862 -175.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 60.7 m-80 -149.53 164.92 33.74 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 127.087 2.155 . . . . 0.0 110.392 -177.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 30.7 ttpt -65.95 -47.42 74.71 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.235 0.614 . . . . 0.0 112.338 173.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.5 t -115.63 129.8 71.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.366 1.067 . . . . 0.0 110.621 176.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 60.3 t -133.51 131.6 57.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 124.806 1.243 . . . . 0.0 109.568 178.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 60.5 t -134.17 154.32 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 123.82 0.848 . . . . 0.0 111.736 -170.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 -129.45 121.54 27.5 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.975 1.31 . . . . 0.0 110.488 175.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 67.2 m -140.93 172.27 12.92 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.354 1.062 . . . . 0.0 113.764 -162.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.447 ' CD1' ' HB3' ' A' ' 46' ' ' ASP . 45.7 m0 -120.73 128.91 53.36 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.944 1.298 . . . . 0.0 110.534 168.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 71.2 t -62.66 -23.32 32.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 CA-C-N 119.245 0.93 . . . . 0.0 111.854 175.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 51.3 p -72.62 -13.03 61.28 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 116.067 1.877 . . . . 0.0 116.067 -175.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 57.6 m -124.39 149.81 62.43 Favored Pre-proline 0 CA--C 1.551 1.015 0 N-CA-C 116.164 1.913 . . . . 0.0 116.164 -162.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -74.52 -36.72 2.79 Favored 'Trans proline' 0 C--N 1.356 0.947 0 C-N-CA 122.3 2.0 . . . . 0.0 114.317 -166.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -52.06 -41.09 62.07 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.274 1.43 . . . . 0.0 112.141 173.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 5.2 m -86.34 -13.4 46.62 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 113.056 -1.884 . . . . 0.0 111.587 -166.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 95.9 t -77.36 -54.41 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.525 0 C-N-CA 124.487 1.115 . . . . 0.0 110.839 155.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -72.91 -26.89 61.57 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 115.643 1.72 . . . . 0.0 115.643 -166.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -77.6 -50.22 12.98 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 119.175 0.898 . . . . 0.0 109.656 173.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.19 -36.17 79.16 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.177 0.991 . . . . 0.0 111.987 -176.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -60.97 -47.06 88.2 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.484 0.714 . . . . 0.0 112.521 172.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.2 tt -69.0 -38.24 79.17 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.672 1.589 . . . . 0.0 111.695 -179.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 81.7 mt -62.48 -48.14 80.88 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.496 0.719 . . . . 0.0 110.772 173.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 11.6 m-70 -63.61 -30.91 71.96 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 172.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -67.32 -26.98 66.77 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 120.783 -1.198 . . . . 0.0 112.022 174.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -94.09 -35.87 12.35 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.009 1.724 . . . . 0.0 114.701 -173.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 14.0 t -153.16 158.08 41.27 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.19 0.996 . . . . 0.0 113.648 -172.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 36.4 mtmt -91.67 -10.78 39.03 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.206 1.402 . . . . 0.0 112.55 163.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -84.76 40.07 0.78 Allowed 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 124.335 1.054 . . . . 0.0 113.591 -173.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -129.63 131.88 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 125.437 1.495 . . . . 0.0 113.768 -170.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 21.7 m -123.82 139.77 53.64 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 126.996 2.118 . . . . 0.0 110.048 175.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.3 p -139.72 125.35 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 124.724 1.21 . . . . 0.0 112.749 178.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 8.3 t60 -94.25 126.25 39.39 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.587 0.755 . . . . 0.0 110.895 174.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -89.75 97.25 11.08 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 123.387 0.675 . . . . 0.0 109.307 178.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 19.9 m -75.45 -12.32 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 CA-C-O 119.021 -0.514 . . . . 0.0 112.386 -174.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.447 ' HB3' ' CD1' ' A' ' 20' ' ' TRP . 0.4 OUTLIER -69.33 -15.26 63.29 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.785 1.234 . . . . 0.0 113.248 174.765 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -82.99 -19.1 37.67 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 127.289 2.236 . . . . 0.0 112.448 176.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 58.8 mmm 59.3 18.53 6.75 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 127.592 2.357 . . . . 0.0 116.932 160.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.1 t -61.74 -40.21 94.27 Favored 'General case' 0 N--CA 1.48 1.034 0 O-C-N 119.915 -1.74 . . . . 0.0 111.251 170.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -138.86 0.34 1.97 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.489 1.516 . . . . 0.0 112.414 167.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -48.45 -33.3 11.49 Favored Glycine 0 CA--C 1.531 1.055 0 C-N-CA 125.786 1.66 . . . . 0.0 116.526 -174.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -69.69 -37.5 76.63 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 119.996 1.898 . . . . 0.0 110.647 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -76.74 -30.02 56.41 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 121.777 -0.577 . . . . 0.0 111.576 179.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -70.78 -45.57 64.48 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.272 0.629 . . . . 0.0 110.787 172.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -57.65 -38.73 75.56 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 126.203 1.801 . . . . 0.0 111.503 171.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.37 -41.5 94.46 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 124.303 0.954 . . . . 0.0 113.438 175.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -58.04 -43.64 86.95 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 119.214 1.507 . . . . 0.0 112.408 173.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 77.1 mt -64.35 -45.93 94.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.15 0.98 . . . . 0.0 110.328 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 8.0 t80 -66.75 -41.08 88.38 Favored 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.636 -0.665 . . . . 0.0 112.004 176.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -66.75 -25.23 66.39 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 120.774 -1.204 . . . . 0.0 113.337 177.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -92.61 -39.42 11.33 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 119.534 1.061 . . . . 0.0 113.516 178.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -128.39 0.81 5.67 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.669 1.188 . . . . 0.0 114.161 -167.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 48.79 43.3 21.07 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 126.782 2.033 . . . . 0.0 113.258 -176.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 63.7 t-80 -131.82 141.6 49.49 Favored 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 125.701 1.6 . . . . 0.0 111.446 -176.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -142.5 -13.92 0.77 Allowed 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 -164.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 51.3 m -70.99 150.07 46.02 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.097 1.359 . . . . 0.0 111.069 167.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 10.5 m -122.46 152.99 62.2 Favored Pre-proline 0 N--CA 1.477 0.894 0 C-N-CA 126.0 1.72 . . . . 0.0 112.599 -175.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -73.03 154.45 99.56 Favored 'Cis proline' 0 C--N 1.35 0.652 0 CA-C-N 119.126 0.724 . . . . 0.0 113.815 -2.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -107.27 129.42 54.89 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.019 1.328 . . . . 0.0 108.613 167.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 98.5 mt -124.27 142.86 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 123.646 0.779 . . . . 0.0 109.981 -162.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -136.27 139.16 42.47 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.803 0.841 . . . . 0.0 111.795 179.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 62.4 mt -131.71 116.25 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 124.85 1.26 . . . . 0.0 109.75 179.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 45.43 39.04 4.18 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 126.015 1.726 . . . . 0.0 113.847 -173.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 79.95 12.31 83.55 Favored Glycine 0 CA--C 1.539 1.559 0 N-CA-C 116.403 1.321 . . . . 0.0 116.403 -176.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -103.36 137.92 40.82 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 119.549 1.674 . . . . 0.0 110.691 172.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -85.93 131.0 34.38 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 -176.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 15.3 mm -116.27 125.29 73.26 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 128.506 2.722 . . . . 0.0 108.561 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -69.23 -15.74 70.32 Favored Glycine 0 CA--C 1.537 1.421 0 N-CA-C 117.407 1.723 . . . . 0.0 117.407 -165.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 149.54 -165.29 29.54 Favored Glycine 0 CA--C 1.527 0.815 0 CA-C-N 118.847 1.323 . . . . 0.0 115.36 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 32.2 t -65.17 -37.56 87.77 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.355 1.062 . . . . 0.0 112.563 -175.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 72.6 p -74.39 -15.62 60.92 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 178.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -87.34 -43.17 12.34 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.667 1.187 . . . . 0.0 110.598 166.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 51.7 tp -59.41 -47.9 83.68 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.571 1.149 . . . . 0.0 111.872 177.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -74.75 -11.78 60.24 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.804 0.842 . . . . 0.0 112.968 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -78.79 -46.84 17.91 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.117 0.967 . . . . 0.0 111.516 163.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 88.5 mt -61.17 -28.98 69.52 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.286 1.035 . . . . 0.0 112.85 175.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -64.48 -52.89 55.61 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.405 1.082 . . . . 0.0 112.093 169.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 6.9 mptt -71.14 -30.77 66.89 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.725 1.21 . . . . 0.0 112.546 -173.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -82.56 -1.94 52.18 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.29 1.036 . . . . 0.0 113.452 169.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 73.84 8.11 76.84 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 124.727 1.156 . . . . 0.0 115.759 174.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 47.5 mtmt -82.18 -29.6 31.4 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 127.639 2.376 . . . . 0.0 112.453 -172.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 36.8 tp -52.39 -36.23 53.58 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.603 1.161 . . . . 0.0 112.169 175.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -73.88 -36.17 64.77 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 179.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -67.94 -29.5 73.62 Favored Glycine 0 CA--C 1.536 1.379 0 O-C-N 120.818 -1.176 . . . . 0.0 113.325 170.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 89.3 mt -74.96 -23.63 58.32 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.621 1.168 . . . . 0.0 112.582 173.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 81.0 mt -95.58 -2.2 48.84 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.853 1.661 . . . . 0.0 114.869 174.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 39.7 m . . . . . 0 C--O 1.252 1.206 0 C-N-CA 126.028 1.731 . . . . 0.0 114.289 -175.603 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.103 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.76 27.73 0.62 Allowed 'General case' 0 CA--C 1.552 1.029 0 N-CA-C 114.84 1.422 . . . . 0.0 114.84 -176.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 43.9 ttp -121.49 86.06 43.84 Favored Pre-proline 0 CA--C 1.547 0.852 0 C-N-CA 125.538 1.535 . . . . 0.0 108.821 174.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -81.18 -171.58 1.27 Allowed 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 123.91 3.074 . . . . 0.0 114.516 -161.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 61.4 m -80.61 -151.81 0.08 Allowed 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 126.541 1.937 . . . . 0.0 111.178 167.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 5.6 pt -56.17 -19.71 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 N-CA-C 116.083 1.883 . . . . 0.0 116.083 -161.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -49.7 -30.19 8.81 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.584 1.554 . . . . 0.0 113.005 175.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 45.4 p -70.04 -38.05 75.74 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.087 0.955 . . . . 0.0 112.998 173.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 54.5 mtt -66.56 -32.41 73.74 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.599 1.56 . . . . 0.0 111.493 -174.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.6 mm -57.62 -33.81 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 123.919 0.888 . . . . 0.0 111.249 176.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 46.9 mttm -81.3 -9.22 59.8 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.054 1.342 . . . . 0.0 113.215 -173.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -75.69 -27.04 63.76 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 124.264 0.935 . . . . 0.0 115.201 -173.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -145.7 165.83 27.61 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.714 1.605 . . . . 0.0 112.606 179.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -63.09 -38.18 90.16 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.946 0.898 . . . . 0.0 113.128 178.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.5 t -125.26 129.58 73.09 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.864 1.266 . . . . 0.0 111.007 175.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 58.5 t -133.26 129.79 57.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.552 1.141 . . . . 0.0 110.559 -179.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 42.4 t -128.69 147.65 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 124.202 1.001 . . . . 0.0 112.337 -177.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -118.15 123.86 46.57 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.572 1.149 . . . . 0.0 109.802 170.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.8 m -140.63 177.71 7.84 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 126.328 1.851 . . . . 0.0 112.458 -165.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 37.7 m0 -123.54 136.87 54.78 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 126.645 1.978 . . . . 0.0 107.016 159.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 82.3 t -54.22 -31.69 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 C-N-CA 125.763 1.625 . . . . 0.0 113.64 -165.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.7 t -105.62 -5.12 20.35 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 114.865 1.432 . . . . 0.0 114.865 -165.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 71.8 m -90.24 141.93 28.07 Favored Pre-proline 0 C--O 1.234 0.249 0 O-C-N 121.651 -0.655 . . . . 0.0 111.268 -165.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -70.82 -36.82 7.4 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 CA-C-N 119.114 0.719 . . . . 0.0 112.769 -160.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -59.91 -38.26 81.8 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 127.783 2.433 . . . . 0.0 114.207 174.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 1.6 t -59.12 -49.55 77.46 Favored 'General case' 0 C--O 1.222 -0.352 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 173.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 52.8 t -63.47 -40.42 88.97 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 C-N-CA 123.948 0.899 . . . . 0.0 111.451 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 6.2 mmp_? -56.12 -46.11 79.27 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 118.789 0.722 . . . . 0.0 111.916 175.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.98 -55.47 9.53 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.658 0.783 . . . . 0.0 111.692 177.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -42.28 -48.56 4.99 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 126.739 2.016 . . . . 0.0 111.755 178.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.53 ' HA ' ' CD2' ' A' ' 34' ' ' HIS . 16.9 ttpp -76.07 -27.31 57.17 Favored 'General case' 0 C--O 1.225 -0.23 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 -171.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.1 tt -79.24 -38.18 36.23 Favored 'General case' 0 C--N 1.317 -0.825 0 O-C-N 121.257 -0.902 . . . . 0.0 111.133 173.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 17.8 mt -67.45 -59.71 3.16 Favored 'General case' 0 CA--C 1.514 -0.415 0 C-N-CA 125.867 1.667 . . . . 0.0 112.956 -176.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.53 ' CD2' ' HA ' ' A' ' 31' ' ' LYS . 0.1 OUTLIER -52.61 -28.93 23.36 Favored 'General case' 0 C--O 1.233 0.188 0 O-C-N 124.173 0.921 . . . . 0.0 110.217 176.244 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.0 -14.27 47.96 Favored 'General case' 0 N--CA 1.441 -0.876 0 C-N-CA 120.872 -0.331 . . . . 0.0 111.814 -172.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -105.19 -40.47 5.85 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 126.533 1.933 . . . . 0.0 112.612 179.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 23.0 m -142.63 128.13 19.02 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 125.743 1.617 . . . . 0.0 110.807 -175.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 45.2 mtmt -76.5 -23.95 53.74 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.47 1.508 . . . . 0.0 112.768 177.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -79.2 54.26 1.62 Allowed 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.417 1.087 . . . . 0.0 113.908 175.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.67 139.03 24.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 125.821 1.649 . . . . 0.0 110.872 173.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.4 m -127.24 132.72 50.33 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 126.783 2.033 . . . . 0.0 109.306 167.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.7 p -128.02 139.96 50.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-O 122.238 1.018 . . . . 0.0 113.029 171.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -109.12 119.64 40.12 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.385 1.874 . . . . 0.0 109.405 176.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 59.5 m-85 -91.44 92.05 8.38 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.427 0.691 . . . . 0.0 110.079 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.6 m -77.02 14.65 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 N-CA-C 115.874 1.805 . . . . 0.0 115.874 -162.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -100.69 -20.74 15.48 Favored 'General case' 0 CA--C 1.545 0.764 0 O-C-N 120.693 -1.254 . . . . 0.0 112.252 160.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 23.4 mmmt -71.46 -36.77 71.31 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 124.146 0.978 . . . . 0.0 111.34 175.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -96.13 142.23 28.56 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.098 0.959 . . . . 0.0 112.885 -167.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 16.4 m -69.3 -7.96 41.85 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 115.598 1.703 . . . . 0.0 115.598 -172.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -113.46 8.86 17.98 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.978 1.711 . . . . 0.0 113.062 175.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -54.59 -32.51 53.62 Favored Glycine 0 CA--C 1.531 1.063 0 N-CA-C 116.211 1.244 . . . . 0.0 116.211 -173.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -72.92 -29.4 63.1 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 119.169 1.485 . . . . 0.0 112.581 176.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -79.62 -31.26 41.61 Favored 'General case' 0 CA--C 1.535 0.369 0 O-C-N 121.586 -0.696 . . . . 0.0 111.852 174.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.04 -41.91 81.35 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 121.657 -0.652 . . . . 0.0 110.491 170.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 59.6 mtp85 -53.89 -45.75 71.16 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 119.344 0.974 . . . . 0.0 111.56 166.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.17 -38.47 93.18 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 124.15 0.881 . . . . 0.0 114.472 178.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -68.49 -25.14 64.81 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 119.088 1.444 . . . . 0.0 113.709 176.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 57.7 mt -76.88 -45.19 31.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 123.505 0.722 . . . . 0.0 109.263 173.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -67.42 -36.93 82.22 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 121.525 -0.734 . . . . 0.0 112.66 -178.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -57.57 -51.61 68.8 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 121.403 -0.811 . . . . 0.0 112.12 176.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -81.1 -33.08 33.56 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 114.452 1.278 . . . . 0.0 114.452 -175.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -123.52 -7.53 8.05 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 -166.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.5 mmtm 50.13 47.28 23.77 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 126.824 2.05 . . . . 0.0 112.745 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 17.7 t60 -138.18 136.18 36.37 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 127.082 2.153 . . . . 0.0 109.028 -177.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -123.54 -22.66 4.95 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 -177.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.2 p -68.19 135.17 51.64 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.644 0.778 . . . . 0.0 112.507 -178.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.8 m -88.91 149.06 42.73 Favored Pre-proline 0 N--CA 1.478 0.952 0 N-CA-C 112.519 0.562 . . . . 0.0 112.519 -178.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -83.82 160.73 71.09 Favored 'Cis proline' 0 CA--C 1.537 0.645 0 CA-C-N 119.654 0.912 . . . . 0.0 114.181 -2.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -104.2 142.23 34.88 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.49 1.116 . . . . 0.0 109.479 159.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 56.6 mt -131.76 139.92 49.35 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.084 0.954 . . . . 0.0 110.301 -166.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -140.44 145.65 37.26 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.141 0.976 . . . . 0.0 111.964 178.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 70.1 mt -136.73 124.35 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 C-N-CA 125.111 1.364 . . . . 0.0 109.307 177.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 47.56 37.93 7.28 Favored 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 124.649 1.18 . . . . 0.0 113.967 -177.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 73.05 11.88 79.14 Favored Glycine 0 CA--C 1.541 1.659 0 O-C-N 120.013 -1.68 . . . . 0.0 115.864 -176.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 24.8 m-80 -97.61 143.82 27.9 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 126.008 1.723 . . . . 0.0 110.032 169.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -89.2 141.51 28.46 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.94 0.896 . . . . 0.0 112.982 176.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 22.4 mm -126.32 122.97 62.54 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 127.731 2.412 . . . . 0.0 108.331 -179.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -63.95 -2.72 6.89 Favored Glycine 0 CA--C 1.538 1.501 0 N-CA-C 118.981 2.352 . . . . 0.0 118.981 -166.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 137.45 -166.9 24.92 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 126.934 2.207 . . . . 0.0 112.988 176.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 16.6 t -66.63 -33.48 75.74 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 121.65 -0.912 . . . . 0.0 113.008 -175.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 68.1 m -76.76 -28.7 55.82 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 121.277 -0.89 . . . . 0.0 111.993 178.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.11 -35.71 71.89 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 119.089 0.859 . . . . 0.0 112.782 167.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 51.6 tp -61.84 -48.64 79.67 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.797 0.839 . . . . 0.0 111.106 170.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -69.83 -13.62 62.36 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.161 0.984 . . . . 0.0 113.305 175.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -82.65 -43.5 16.86 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 121.04 -1.038 . . . . 0.0 111.331 168.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 76.6 mt -66.5 -28.53 68.64 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 120.93 -1.106 . . . . 0.0 113.0 177.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -61.08 -39.51 90.18 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.678 1.591 . . . . 0.0 112.23 168.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 5.0 mptt -84.3 -34.33 23.76 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.403 1.481 . . . . 0.0 112.364 -178.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -75.07 -0.9 20.56 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.732 1.213 . . . . 0.0 113.606 174.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 75.76 22.23 75.18 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 124.457 1.027 . . . . 0.0 114.51 170.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 35.5 mtmt -113.96 -20.2 11.13 Favored 'General case' 0 C--N 1.341 0.231 0 C-N-CA 126.551 1.94 . . . . 0.0 113.263 -170.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 43.0 tp -60.9 -40.37 92.84 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 118.738 0.699 . . . . 0.0 111.449 178.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -65.2 -42.28 93.71 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 177.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -70.7 -26.75 73.53 Favored Glycine 0 CA--C 1.537 1.439 0 C-N-CA 124.323 0.963 . . . . 0.0 114.511 175.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 30.0 mt -71.03 -31.95 68.57 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 118.276 1.038 . . . . 0.0 112.187 172.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 85.1 mt -97.85 -27.11 14.44 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 114.487 1.291 . . . . 0.0 114.487 -174.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 56.9 m . . . . . 0 C--O 1.254 1.29 0 N-CA-C 114.303 1.223 . . . . 0.0 114.303 -170.964 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.226 0 N-CA-C 113.35 0.1 . . . . 0.0 113.35 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -67.92 151.84 46.49 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.092 1.757 . . . . 0.0 113.633 -178.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 4.6 mpp? 52.16 57.77 15.58 Favored Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 125.652 1.581 . . . . 0.0 112.56 -176.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -72.69 168.19 25.16 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 124.669 3.579 . . . . 0.0 115.435 -165.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 60.0 p -145.84 -154.66 0.56 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.608 1.963 . . . . 0.0 111.448 174.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.422 HG23 HD12 ' A' ' 54' ' ' LEU . 19.7 pt -56.35 -19.7 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 C-N-CA 124.591 1.156 . . . . 0.0 113.264 170.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -58.88 -29.87 67.33 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.686 0.794 . . . . 0.0 112.816 -174.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 67.7 m -68.18 -24.45 64.97 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 173.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 54.4 mtt -72.5 -33.89 67.25 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 121.46 -0.775 . . . . 0.0 111.429 -178.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.8 mm -60.29 -30.78 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 123.681 0.792 . . . . 0.0 111.67 -175.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -80.36 -8.75 59.64 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.162 1.385 . . . . 0.0 114.148 179.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -80.03 -35.55 27.2 Favored Glycine 0 CA--C 1.535 1.292 0 N-CA-C 115.158 0.823 . . . . 0.0 115.158 -173.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 55.5 m-80 -145.08 164.13 32.17 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 118.626 1.213 . . . . 0.0 112.186 -172.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 21.7 ttpt -63.89 -42.25 97.52 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.285 1.034 . . . . 0.0 113.111 -178.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 19.9 t -119.84 130.62 73.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.251 1.021 . . . . 0.0 110.65 172.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 57.0 t -132.88 126.93 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 124.849 1.26 . . . . 0.0 109.744 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 40.4 t -127.1 149.29 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.129 0.972 . . . . 0.0 112.253 -173.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -123.15 114.4 20.25 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.355 1.462 . . . . 0.0 110.111 175.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.439 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 35.2 m -134.28 173.32 11.74 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.556 1.542 . . . . 0.0 112.754 -167.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 47.6 m0 -121.9 143.1 49.64 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 124.69 1.196 . . . . 0.0 110.237 166.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 76.7 t -65.18 -25.58 37.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 CA-C-O 120.771 0.32 . . . . 0.0 111.25 177.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 30.5 p -75.98 -18.49 59.29 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 126.196 1.798 . . . . 0.0 115.599 177.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.8 t -94.89 140.02 22.36 Favored Pre-proline 0 CA--C 1.538 0.501 0 CA-C-N 120.241 1.382 . . . . 0.0 112.571 -163.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -73.91 -37.17 3.0 Favored 'Trans proline' 0 CA--C 1.534 0.496 0 CA-C-N 120.704 1.287 . . . . 0.0 112.008 174.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -55.84 -37.66 69.02 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.164 1.386 . . . . 0.0 113.528 176.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.439 ' SG ' ' HB3' ' A' ' 19' ' ' SER . 0.5 OUTLIER -55.1 -51.89 64.98 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.192 0.997 . . . . 0.0 109.636 172.759 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.1 t -66.27 -37.53 79.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 123.943 0.897 . . . . 0.0 111.614 -177.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.1 mmt180 -54.06 -42.62 69.46 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-N 118.787 0.721 . . . . 0.0 112.115 173.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.93 -55.17 7.96 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.007 0.923 . . . . 0.0 112.463 173.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -54.18 -35.05 61.91 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 119.506 1.048 . . . . 0.0 113.398 -177.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.95 -38.25 69.83 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.273 1.029 . . . . 0.0 112.598 -178.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.4 tt -74.49 -46.18 41.11 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 126.499 1.92 . . . . 0.0 110.892 178.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 68.0 mt -64.69 -38.21 90.22 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.556 0.742 . . . . 0.0 112.765 -176.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 45.7 m-70 -74.74 -22.07 59.01 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 170.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -73.39 -36.38 66.04 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 119.894 1.225 . . . . 0.0 112.062 172.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 13.5 mmp_? -73.52 -52.64 12.85 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.378 1.471 . . . . 0.0 113.247 175.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.2 p -140.68 166.24 25.29 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 116.167 1.914 . . . . 0.0 116.167 -157.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 71.5 mttt -109.51 -27.74 9.27 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 127.976 2.511 . . . . 0.0 113.108 173.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -84.5 43.55 0.97 Allowed 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 125.205 1.402 . . . . 0.0 112.274 -178.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -113.43 129.13 69.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 126.558 1.943 . . . . 0.0 111.982 178.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.9 m -122.3 141.83 51.11 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 126.644 1.978 . . . . 0.0 111.169 174.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.4 p -135.72 136.27 50.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 124.441 1.096 . . . . 0.0 113.232 178.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 38.6 t60 -105.48 122.4 45.92 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 126.957 2.103 . . . . 0.0 109.752 175.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -92.22 89.12 6.74 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 123.689 0.796 . . . . 0.0 108.986 179.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 35.7 m -65.2 -18.69 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.248 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 -175.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -55.88 -43.13 76.88 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 125.409 1.484 . . . . 0.0 111.572 164.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 34.1 mtmt -86.68 7.87 24.79 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 127.188 2.195 . . . . 0.0 113.756 179.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -114.68 129.9 56.74 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.192 1.397 . . . . 0.0 110.229 178.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 11.8 p -64.52 -20.24 66.09 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 115.753 1.76 . . . . 0.0 115.753 -170.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -113.95 8.4 17.17 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.502 1.921 . . . . 0.0 112.389 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -51.95 -25.19 16.04 Favored Glycine 0 CA--C 1.536 1.357 0 C-N-CA 125.807 1.67 . . . . 0.0 116.896 -168.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -69.05 -27.94 66.1 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 118.947 1.373 . . . . 0.0 112.853 174.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -80.48 -25.56 38.74 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 120.573 -1.33 . . . . 0.0 112.083 172.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.422 HD12 HG23 ' A' ' 6' ' ' ILE . 2.7 mm? -79.72 -32.65 41.21 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.722 0.809 . . . . 0.0 111.883 174.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 55.4 mtp180 -52.79 -43.32 65.8 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 119.119 0.872 . . . . 0.0 110.769 158.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.56 -35.78 89.96 Favored Glycine 0 CA--C 1.539 1.557 0 CA-C-O 118.972 -0.904 . . . . 0.0 115.21 173.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -63.47 -31.84 73.11 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 119.828 1.814 . . . . 0.0 112.914 176.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 65.2 mt -79.57 -45.73 23.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 C-N-CA 125.806 1.642 . . . . 0.0 109.608 175.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -64.77 -41.21 96.05 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 121.458 -0.776 . . . . 0.0 112.483 -178.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 76.6 mm-40 -72.14 -16.11 61.99 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 120.898 -1.126 . . . . 0.0 113.617 177.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -89.88 -41.49 11.77 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 169.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -135.0 0.43 2.88 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 115.329 1.603 . . . . 0.0 115.329 -163.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp 55.55 26.0 8.57 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 126.402 1.881 . . . . 0.0 115.513 177.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 37.2 t60 -114.96 140.03 49.35 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.391 1.077 . . . . 0.0 111.196 167.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -125.79 -27.42 3.35 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.167 0.987 . . . . 0.0 112.644 -163.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.2 p -85.96 144.09 27.81 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 124.474 1.11 . . . . 0.0 113.907 -178.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.3 m -89.35 153.76 48.62 Favored Pre-proline 0 N--CA 1.481 1.087 0 C-N-CA 125.017 1.327 . . . . 0.0 113.292 -173.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -79.49 158.08 89.75 Favored 'Cis proline' 0 C--N 1.349 0.577 0 CA-C-N 119.441 0.836 . . . . 0.0 113.4 -3.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -109.55 136.84 48.29 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.089 1.356 . . . . 0.0 108.709 162.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.9 mt -126.21 144.27 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 124.243 1.017 . . . . 0.0 109.444 -169.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -137.53 143.94 41.88 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.23 1.012 . . . . 0.0 110.967 177.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 48.9 mt -135.3 118.47 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 124.879 1.272 . . . . 0.0 109.059 179.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 47.44 43.78 15.95 Favored 'General case' 0 CA--C 1.556 1.202 0 C-N-CA 125.023 1.329 . . . . 0.0 113.831 -175.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.18 1.17 59.46 Favored Glycine 0 CA--C 1.544 1.893 0 O-C-N 120.709 -1.245 . . . . 0.0 116.015 -176.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 35.9 m-80 -92.26 134.84 34.51 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.223 1.409 . . . . 0.0 109.759 175.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 33.7 t80 -84.33 137.7 33.29 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.897 0.879 . . . . 0.0 112.831 -178.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 36.0 mm -118.1 122.84 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 C-N-CA 127.662 2.385 . . . . 0.0 108.538 177.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.37 -6.19 39.52 Favored Glycine 0 CA--C 1.536 1.371 0 N-CA-C 118.252 2.061 . . . . 0.0 118.252 -162.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 152.91 -174.53 31.68 Favored Glycine 0 CA--C 1.531 1.081 0 C-N-CA 125.851 1.691 . . . . 0.0 112.99 176.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 12.8 t -65.32 -31.53 72.72 Favored 'General case' 0 CA--C 1.538 0.49 0 O-C-N 121.975 -0.721 . . . . 0.0 112.373 177.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 12.5 m -69.01 -32.63 72.32 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.732 -0.605 . . . . 0.0 111.829 -177.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -76.41 -40.65 50.26 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 125.122 1.369 . . . . 0.0 112.458 170.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 56.9 tp -59.48 -45.27 92.13 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.334 1.054 . . . . 0.0 111.488 175.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -64.92 -37.66 88.39 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.822 0.849 . . . . 0.0 111.35 173.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -66.45 -23.58 66.31 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 120.914 -1.116 . . . . 0.0 113.223 177.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 40.3 mt -84.69 -32.33 23.64 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 126.038 1.735 . . . . 0.0 112.709 170.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -67.46 -46.92 71.61 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 124.154 0.982 . . . . 0.0 112.38 175.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.2 mptt -62.25 -42.24 99.16 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.796 1.238 . . . . 0.0 111.772 178.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -76.16 -6.75 52.68 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 176.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 72.21 22.88 78.69 Favored Glycine 0 CA--C 1.535 1.293 0 CA-C-N 119.375 0.989 . . . . 0.0 114.88 174.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 40.7 mtmt -102.37 -14.21 17.0 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 127.995 2.518 . . . . 0.0 112.381 -172.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 30.5 tp -64.75 -31.75 73.12 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.047 1.739 . . . . 0.0 112.067 175.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -57.0 -46.28 82.41 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.703 -0.623 . . . . 0.0 112.281 174.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -66.39 -27.61 73.19 Favored Glycine 0 CA--C 1.535 1.336 0 C-N-CA 123.918 0.77 . . . . 0.0 113.677 176.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 83.3 mt -76.74 -26.11 54.24 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.475 1.11 . . . . 0.0 113.416 174.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 84.9 mt -102.93 -9.65 19.67 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 115.602 1.704 . . . . 0.0 115.602 -172.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 16.1 m . . . . . 0 N--CA 1.486 1.365 0 C-N-CA 127.25 2.22 . . . . 0.0 115.642 167.81 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.119 0 N-CA-C 111.526 -0.629 . . . . 0.0 111.526 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 51.3 -153.78 0.17 Allowed 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 126.752 2.021 . . . . 0.0 114.739 176.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -122.9 145.87 46.83 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 125.037 1.335 . . . . 0.0 110.485 173.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -80.17 71.99 6.76 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 124.032 3.154 . . . . 0.0 110.33 175.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 54.5 p -158.22 -167.15 2.11 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 126.035 1.734 . . . . 0.0 110.222 179.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.522 HG23 HD12 ' A' ' 54' ' ' LEU . 14.0 pt -45.33 -28.64 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 C-N-CA 124.846 1.259 . . . . 0.0 113.115 168.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -57.13 -33.32 67.26 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 25.9 m -84.34 -20.08 32.62 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 175.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 45.1 mtt -68.39 -28.05 66.76 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 119.639 1.108 . . . . 0.0 112.063 173.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.491 HG21 ' HA2' ' A' ' 74' ' ' GLY . 83.8 mt -67.17 -22.4 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 CA-C-O 122.457 1.122 . . . . 0.0 112.165 -171.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -82.55 3.63 27.8 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.354 1.861 . . . . 0.0 114.482 174.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -87.87 -13.62 64.3 Favored Glycine 0 CA--C 1.541 1.682 0 C-N-CA 125.153 1.358 . . . . 0.0 116.365 -178.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -156.87 175.78 13.62 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 119.285 1.543 . . . . 0.0 112.318 177.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -72.61 -33.33 66.6 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 121.805 -0.56 . . . . 0.0 112.234 174.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.4 t -125.72 130.18 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 124.894 1.278 . . . . 0.0 110.151 173.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 62.1 t -131.49 130.49 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 123.842 0.857 . . . . 0.0 110.636 178.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 47.0 t -130.43 148.11 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.321 1.048 . . . . 0.0 112.277 -170.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -126.18 113.67 17.32 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.917 1.287 . . . . 0.0 110.097 177.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 59.8 m -132.25 167.32 20.03 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 126.0 1.72 . . . . 0.0 111.879 -166.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.463 ' CD1' ' HB3' ' A' ' 46' ' ' ASP . 34.6 m0 -117.66 126.12 51.93 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.763 1.225 . . . . 0.0 109.389 166.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 89.3 t -56.42 -39.61 62.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -166.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.7 t -74.87 -12.57 60.4 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 127.66 2.384 . . . . 0.0 115.716 -179.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.9 t -88.6 139.51 29.72 Favored Pre-proline 0 CA--C 1.539 0.523 0 O-C-N 121.395 -0.816 . . . . 0.0 110.87 -165.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -66.75 -38.25 18.45 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 CA-C-N 120.327 1.152 . . . . 0.0 112.943 -178.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 51.9 m-85 -62.24 -36.72 82.87 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.263 1.425 . . . . 0.0 114.225 178.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -56.13 -54.49 44.51 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.3 1.04 . . . . 0.0 108.989 169.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 73.2 t -62.74 -37.5 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 124.291 1.037 . . . . 0.0 112.388 -178.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 71.0 mmt-85 -52.95 -45.94 67.95 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 119.205 0.911 . . . . 0.0 112.001 172.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -73.75 -53.26 10.72 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.885 0.874 . . . . 0.0 112.113 178.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -59.32 -25.57 64.28 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -177.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -71.44 -46.39 60.17 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.637 0.775 . . . . 0.0 112.615 173.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.7 tt -74.26 -38.32 63.48 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.59 1.556 . . . . 0.0 111.808 -177.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 87.0 mt -63.56 -46.5 85.63 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.073 0.549 . . . . 0.0 111.047 178.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -64.32 -22.6 67.01 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 172.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -80.9 -17.2 51.41 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 176.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 10.6 mmt180 -131.94 -10.27 3.43 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 117.078 2.251 . . . . 0.0 117.078 -168.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 14.9 t -152.54 155.8 38.12 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 170.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 8.8 mptt -105.91 0.82 26.18 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 125.385 1.474 . . . . 0.0 112.722 166.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -105.07 40.76 1.45 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.536 1.535 . . . . 0.0 112.411 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -113.88 141.63 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 126.199 1.8 . . . . 0.0 111.695 177.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.9 m -129.33 129.39 44.76 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 127.363 2.265 . . . . 0.0 109.29 172.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -121.32 136.49 58.08 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 125.027 1.331 . . . . 0.0 112.784 172.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -108.99 130.97 55.49 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 125.295 1.438 . . . . 0.0 110.569 173.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -97.81 94.43 6.91 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.708 -0.62 . . . . 0.0 110.821 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.8 m -73.77 -6.59 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.18 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -176.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.463 ' HB3' ' CD1' ' A' ' 20' ' ' TRP . 0.0 OUTLIER -80.73 -19.28 45.34 Favored 'General case' 0 CA--C 1.545 0.766 0 O-C-N 121.15 -0.969 . . . . 0.0 112.004 169.161 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 39.9 mtmt -95.96 11.07 35.25 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 127.468 2.307 . . . . 0.0 113.772 175.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 12.8 ttt -125.32 128.78 48.74 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 127.584 2.353 . . . . 0.0 110.502 -167.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 25.8 m -68.49 -36.7 79.31 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.972 0.909 . . . . 0.0 113.232 -176.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.4 mp0 -84.7 -0.58 54.08 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.845 1.258 . . . . 0.0 113.289 173.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -56.35 -24.44 45.4 Favored Glycine 0 CA--C 1.535 1.321 0 O-C-N 120.471 -1.393 . . . . 0.0 115.879 -169.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 60.7 mt-10 -73.58 -28.71 61.98 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 118.714 1.257 . . . . 0.0 112.649 174.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -74.42 -37.24 63.38 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 120.908 -1.12 . . . . 0.0 111.403 172.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.522 HD12 HG23 ' A' ' 6' ' ' ILE . 3.0 mm? -69.56 -32.1 70.68 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.77 0.828 . . . . 0.0 112.765 173.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 60.6 mtp180 -56.16 -38.17 70.53 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 120.004 1.274 . . . . 0.0 111.511 164.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -64.1 -38.4 95.93 Favored Glycine 0 CA--C 1.539 1.546 0 CA-C-O 118.744 -1.031 . . . . 0.0 114.176 169.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -61.5 -29.55 70.05 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 119.988 1.894 . . . . 0.0 113.06 173.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 38.6 mt -77.38 -46.78 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 118.549 0.613 . . . . 0.0 109.973 171.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -65.83 -42.18 90.86 Favored 'General case' 0 CA--C 1.538 0.491 0 O-C-N 120.868 -1.145 . . . . 0.0 113.183 -175.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -73.92 -9.83 59.04 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -178.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -108.04 -32.98 7.32 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.705 1.202 . . . . 0.0 114.197 173.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -133.4 -0.11 3.29 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 114.879 1.437 . . . . 0.0 114.879 -171.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 9.5 mptt 48.02 51.94 13.81 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 126.033 1.733 . . . . 0.0 113.256 -177.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 33.9 t-80 -134.79 131.75 37.89 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.251 1.42 . . . . 0.0 110.587 175.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -135.82 11.94 3.4 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 126.193 1.797 . . . . 0.0 112.595 -166.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.447 HG22 ' H ' ' A' ' 67' ' ' VAL . 0.3 OUTLIER -106.59 -172.04 2.01 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 126.438 1.895 . . . . 0.0 110.266 173.414 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.447 ' H ' HG22 ' A' ' 66' ' ' THR . 21.4 m -137.93 158.47 71.3 Favored Pre-proline 0 N--CA 1.48 1.026 0 O-C-N 120.53 -1.356 . . . . 0.0 113.025 175.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -71.77 155.08 97.95 Favored 'Cis proline' 0 C--N 1.348 0.548 0 CA-C-N 118.486 0.495 . . . . 0.0 112.673 -11.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -102.57 134.01 46.62 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.437 1.095 . . . . 0.0 108.391 161.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 46.9 mt -128.59 141.39 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 123.542 0.737 . . . . 0.0 109.916 -165.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -137.95 145.56 42.17 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.983 0.913 . . . . 0.0 112.102 179.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 64.7 mt -130.28 114.06 27.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 125.214 1.405 . . . . 0.0 108.675 174.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 49.91 41.53 22.92 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 125.0 1.32 . . . . 0.0 113.951 -172.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.491 ' HA2' HG21 ' A' ' 10' ' ' ILE . . . 75.31 4.11 72.76 Favored Glycine 0 CA--C 1.54 1.651 0 O-C-N 120.606 -1.309 . . . . 0.0 115.128 -178.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -97.07 133.98 41.02 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.157 1.383 . . . . 0.0 109.896 173.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -83.31 146.61 28.42 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.694 1.198 . . . . 0.0 113.691 -170.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 28.6 mm -130.56 120.3 47.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 128.365 2.666 . . . . 0.0 108.131 -178.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -65.11 -9.87 43.87 Favored Glycine 0 CA--C 1.534 1.28 0 N-CA-C 119.084 2.393 . . . . 0.0 119.084 -163.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 158.13 -175.35 35.34 Favored Glycine 0 CA--C 1.532 1.127 0 CA-C-N 118.936 1.368 . . . . 0.0 113.766 176.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 30.1 t -65.65 -37.66 87.16 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 121.97 -0.724 . . . . 0.0 112.474 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 66.5 m -70.47 -32.14 69.55 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.436 -0.79 . . . . 0.0 112.097 177.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -68.62 -41.37 79.61 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.363 0.983 . . . . 0.0 112.108 172.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 15.1 tp -58.45 -50.92 71.99 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.731 1.612 . . . . 0.0 110.843 173.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -64.37 -36.32 83.75 Favored 'General case' 0 N--CA 1.469 0.478 0 O-C-N 121.934 -0.479 . . . . 0.0 112.056 175.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.04 -34.56 77.98 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 121.147 -0.971 . . . . 0.0 111.824 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 92.4 mt -70.78 -31.19 67.88 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.815 0.846 . . . . 0.0 112.052 169.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -69.45 -39.1 77.96 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 176.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -63.79 -32.96 74.63 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.986 0.914 . . . . 0.0 112.59 174.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -75.51 -13.03 60.35 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 114.29 1.218 . . . . 0.0 114.29 169.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 78.74 6.32 88.43 Favored Glycine 0 CA--C 1.538 1.494 0 CA-C-N 118.84 0.746 . . . . 0.0 114.078 -173.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 35.4 mtpt -81.66 -27.65 33.96 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 126.823 2.049 . . . . 0.0 112.15 -171.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 59.2 tp -64.78 -43.73 92.27 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.081 0.952 . . . . 0.0 111.559 172.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 32.8 m-20 -59.07 -34.89 72.48 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.788 -0.57 . . . . 0.0 111.622 177.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -77.11 -18.71 78.21 Favored Glycine 0 CA--C 1.536 1.354 0 N-CA-C 115.605 1.002 . . . . 0.0 115.605 175.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 39.0 mt -81.61 -35.57 29.92 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.965 1.306 . . . . 0.0 111.533 168.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 84.2 mt -72.76 -3.28 24.33 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.386 1.474 . . . . 0.0 113.893 177.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.1 t . . . . . 0 C--O 1.252 1.217 0 C-N-CA 127.454 2.301 . . . . 0.0 112.333 177.492 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.012 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.63 159.43 21.96 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 -171.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 34.7 ttp 54.9 64.77 5.56 Favored Pre-proline 0 CA--C 1.549 0.918 0 C-N-CA 127.384 2.273 . . . . 0.0 113.059 -168.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -71.09 -26.19 21.71 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 123.075 2.517 . . . . 0.0 114.299 -173.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 53.8 p -164.08 -170.27 2.07 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 127.314 2.246 . . . . 0.0 111.579 166.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.571 HG23 HD12 ' A' ' 54' ' ' LEU . 23.5 pt -59.47 -23.94 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 123.846 0.859 . . . . 0.0 113.295 174.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.52 -32.62 72.67 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-N 118.244 0.474 . . . . 0.0 111.944 -175.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 83.4 p -69.26 -33.59 73.48 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.729 1.212 . . . . 0.0 113.319 170.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 43.3 mtt -67.19 -31.39 71.76 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.023 0.929 . . . . 0.0 111.516 -178.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.3 mm -56.47 -35.87 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.847 0 C-N-CA 123.592 0.757 . . . . 0.0 111.834 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -73.61 -19.01 60.98 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.08 0.952 . . . . 0.0 113.263 -175.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -77.79 -26.92 59.7 Favored Glycine 0 CA--C 1.533 1.202 0 N-CA-C 115.998 1.159 . . . . 0.0 115.998 -166.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 26.7 m-80 -134.69 172.32 13.12 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.896 1.278 . . . . 0.0 111.993 -177.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -70.03 -40.72 75.01 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.233 1.013 . . . . 0.0 112.208 178.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.0 t -128.37 136.36 60.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 124.774 1.23 . . . . 0.0 110.172 174.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 43.5 t -132.7 130.34 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.4 1.08 . . . . 0.0 109.997 176.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 37.6 t -127.93 145.92 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 124.279 1.032 . . . . 0.0 111.94 -176.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -120.35 116.51 25.65 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.894 1.278 . . . . 0.0 108.54 172.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 14.7 m -130.64 169.14 16.02 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 125.911 1.684 . . . . 0.0 111.492 -169.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.412 ' CD1' ' HB3' ' A' ' 46' ' ' ASP . 25.6 m0 -115.59 135.88 53.63 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 124.197 0.999 . . . . 0.0 108.975 162.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.421 HG21 ' HE2' ' A' ' 47' ' ' LYS . 54.9 t -58.28 -28.54 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 CA-C-O 121.295 0.569 . . . . 0.0 111.071 176.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.7 p -82.72 -6.87 59.61 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 116.284 1.957 . . . . 0.0 116.284 178.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.9 t -92.47 140.15 24.03 Favored Pre-proline 0 CA--C 1.544 0.717 0 CA-C-N 120.55 1.523 . . . . 0.0 111.339 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -75.13 -34.75 3.48 Favored 'Trans proline' 0 CA--C 1.534 0.489 0 C-N-CA 121.855 1.704 . . . . 0.0 112.871 173.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -59.29 -38.12 79.4 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.611 1.164 . . . . 0.0 113.408 176.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -49.98 -52.65 32.09 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.288 1.035 . . . . 0.0 109.746 171.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 57.5 t -63.29 -40.46 89.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 C-N-CA 124.005 0.922 . . . . 0.0 111.63 -176.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 37.0 mmt-85 -53.98 -48.74 70.05 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 118.997 0.817 . . . . 0.0 111.098 175.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.34 -54.14 23.28 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.896 0.878 . . . . 0.0 112.455 177.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -48.94 -40.48 30.39 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.544 1.138 . . . . 0.0 113.142 178.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.05 -45.22 58.76 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 124.676 1.19 . . . . 0.0 112.154 -175.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.9 tt -68.72 -41.1 79.51 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.538 1.535 . . . . 0.0 111.558 176.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 63.0 mt -63.02 -46.46 87.5 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 123.282 0.633 . . . . 0.0 111.197 175.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -64.81 -20.11 66.21 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 112.994 0.738 . . . . 0.0 112.994 174.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -82.33 -12.87 57.71 Favored 'General case' 0 CA--C 1.547 0.855 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 173.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -116.47 -30.51 5.85 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.762 1.225 . . . . 0.0 114.302 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.7 m -146.9 134.77 21.3 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 119.678 1.126 . . . . 0.0 112.577 -168.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 10.6 mmpt? -86.87 -32.38 20.26 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.242 1.417 . . . . 0.0 112.717 169.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -77.33 47.56 0.58 Allowed 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 125.579 1.552 . . . . 0.0 113.296 177.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -110.46 128.44 66.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 127.265 2.226 . . . . 0.0 109.833 175.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.5 m -112.17 129.0 56.39 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.494 1.918 . . . . 0.0 108.728 174.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.5 p -125.55 142.54 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 CA-C-O 122.117 0.96 . . . . 0.0 113.042 172.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 33.0 m-70 -120.09 121.68 39.39 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 127.302 2.241 . . . . 0.0 110.51 -174.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -94.63 90.99 6.34 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 122.558 1.17 . . . . 0.0 110.513 -177.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 34.4 m -70.18 -16.13 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-N 115.154 -0.93 . . . . 0.0 112.735 -176.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.412 ' HB3' ' CD1' ' A' ' 20' ' ' TRP . 0.2 OUTLIER -69.13 -32.97 72.72 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.396 -0.815 . . . . 0.0 112.123 174.377 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.421 ' HE2' HG21 ' A' ' 21' ' ' VAL . 70.4 mmtt -77.58 -27.57 51.42 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.52 1.928 . . . . 0.0 112.244 174.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.411 ' HG2' ' H ' ' A' ' 50' ' ' GLU . 21.2 ttt -71.43 142.18 50.26 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.612 1.565 . . . . 0.0 112.48 -177.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 4.9 m -76.34 -12.28 60.04 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 177.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.411 ' H ' ' HG2' ' A' ' 48' ' ' MET . 2.0 mt-10 -125.21 9.9 8.02 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 126.116 1.766 . . . . 0.0 113.825 178.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -53.5 -29.01 38.27 Favored Glycine 0 CA--C 1.539 1.566 0 N-CA-C 116.457 1.343 . . . . 0.0 116.457 -171.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -69.19 -28.91 66.81 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 118.829 1.315 . . . . 0.0 112.869 174.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -67.39 -28.97 68.37 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.937 0.895 . . . . 0.0 111.424 169.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.571 HD12 HG23 ' A' ' 6' ' ' ILE . 2.9 mm? -83.57 -31.89 26.1 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.012 0.925 . . . . 0.0 111.961 178.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 49.5 mtp85 -53.36 -41.71 66.11 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-N 119.628 1.104 . . . . 0.0 111.058 154.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -57.93 -38.17 87.85 Favored Glycine 0 CA--C 1.536 1.405 0 CA-C-O 118.631 -1.094 . . . . 0.0 114.445 172.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 -62.19 -41.8 98.68 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 120.299 2.049 . . . . 0.0 111.864 176.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 52.1 mt -70.13 -42.43 79.19 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.243 1.417 . . . . 0.0 110.069 179.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -67.84 -43.22 80.02 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 121.8 -0.563 . . . . 0.0 111.895 179.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -64.09 -33.94 76.91 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 121.459 -0.776 . . . . 0.0 111.812 177.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -79.35 -48.88 13.3 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 176.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -125.58 -1.45 7.42 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 114.552 1.316 . . . . 0.0 114.552 -164.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 21.2 mmtp 55.25 36.11 26.33 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 126.83 2.052 . . . . 0.0 114.148 -178.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 25.1 m80 -119.84 140.81 50.22 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 128.128 2.571 . . . . 0.0 109.367 176.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -125.88 -32.0 2.85 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.508 1.523 . . . . 0.0 114.395 -176.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 77.7 p -67.76 147.93 51.94 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 -169.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.3 m -99.46 152.68 37.88 Favored Pre-proline 0 N--CA 1.474 0.75 0 C-N-CA 123.726 0.811 . . . . 0.0 112.34 177.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -70.32 149.37 89.8 Favored 'Cis proline' 0 N--CA 1.458 -0.597 0 CA-C-N 119.029 0.689 . . . . 0.0 111.28 -9.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -102.85 130.78 49.98 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.219 1.007 . . . . 0.0 108.346 166.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 13.2 mt -124.62 142.28 41.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 124.163 0.985 . . . . 0.0 109.338 -164.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -138.36 141.21 39.68 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 123.764 0.826 . . . . 0.0 111.052 177.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 55.8 mt -133.7 117.44 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 124.467 1.107 . . . . 0.0 109.428 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 74.9 m-80 48.83 35.98 7.39 Favored 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 125.633 1.573 . . . . 0.0 114.092 -174.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 80.35 5.65 89.66 Favored Glycine 0 CA--C 1.537 1.423 0 N-CA-C 116.737 1.455 . . . . 0.0 116.737 -176.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 -95.76 139.33 32.15 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 118.834 1.317 . . . . 0.0 110.77 168.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -81.32 137.93 35.72 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.074 0.949 . . . . 0.0 112.181 178.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 28.6 mm -116.97 121.93 68.9 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 127.349 2.259 . . . . 0.0 107.416 174.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -64.9 -22.81 68.84 Favored Glycine 0 CA--C 1.534 1.223 0 N-CA-C 116.211 1.244 . . . . 0.0 116.211 -162.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 168.93 -171.47 42.92 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-N 118.193 0.997 . . . . 0.0 113.785 179.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 49.1 t -61.87 -37.85 86.08 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.784 1.234 . . . . 0.0 112.174 175.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 71.1 m -56.46 -44.66 80.74 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 118.908 0.777 . . . . 0.0 112.486 176.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -72.45 -39.14 68.02 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.998 0.919 . . . . 0.0 111.589 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 67.2 tp -62.42 -50.21 72.42 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.035 0.934 . . . . 0.0 112.168 174.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -68.67 -15.15 63.43 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 121.754 -0.591 . . . . 0.0 112.508 176.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -81.68 -47.12 13.38 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.417 -0.802 . . . . 0.0 111.49 169.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 66.5 mt -62.42 -32.58 73.44 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 120.831 -1.168 . . . . 0.0 112.783 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -64.72 -29.68 70.67 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.707 1.603 . . . . 0.0 113.467 173.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.1 mptt -93.36 -37.08 12.19 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 126.58 1.952 . . . . 0.0 112.089 -178.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -71.33 -6.2 38.22 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.996 1.318 . . . . 0.0 113.582 171.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 76.2 17.63 79.86 Favored Glycine 0 CA--C 1.534 1.256 0 O-C-N 120.942 -1.099 . . . . 0.0 113.945 177.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 44.6 mtmt -99.5 -21.45 15.93 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 126.27 1.828 . . . . 0.0 113.061 -172.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 31.1 tp -66.34 -34.82 78.84 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.861 0.865 . . . . 0.0 111.615 176.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -53.27 -41.77 65.87 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.694 1.198 . . . . 0.0 112.068 173.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -85.45 -6.9 83.15 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 125.966 1.746 . . . . 0.0 114.794 179.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 69.7 mt -95.73 -26.16 15.8 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.144 1.378 . . . . 0.0 112.471 172.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 76.6 mt -105.69 -16.13 14.77 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 114.838 1.422 . . . . 0.0 114.838 -177.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 63.3 p . . . . . 0 N--CA 1.479 1.009 0 C-N-CA 126.229 1.812 . . . . 0.0 114.836 178.479 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.97 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -58.5 -31.49 67.93 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.246 1.018 . . . . 0.0 112.595 170.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 5.3 mpp? -74.34 98.34 0.22 Allowed Pre-proline 0 CA--C 1.548 0.875 0 C-N-CA 126.934 2.094 . . . . 0.0 108.875 158.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -31.71 124.26 0.09 OUTLIER 'Trans proline' 0 C--N 1.354 0.821 1 C-N-CA 127.223 5.282 . . . . 0.0 117.96 -160.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 74.1 p -152.63 -164.07 1.86 Allowed 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 126.359 1.864 . . . . 0.0 110.462 174.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.567 HG23 HD12 ' A' ' 54' ' ' LEU . 27.5 pt -51.53 -23.0 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 124.181 0.993 . . . . 0.0 113.493 173.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.28 -18.59 61.69 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.477 1.111 . . . . 0.0 113.407 -175.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.5 m -84.16 -19.39 34.2 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 171.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 64.7 mtt -64.2 -37.28 86.91 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 119.557 1.072 . . . . 0.0 110.851 175.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.4 mm -59.64 -20.63 19.28 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 124.004 0.921 . . . . 0.0 113.069 -173.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.3 mptt -91.74 -7.67 49.06 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.452 1.501 . . . . 0.0 114.143 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -96.82 -18.65 29.16 Favored Glycine 0 CA--C 1.539 1.579 0 N-CA-C 116.754 1.462 . . . . 0.0 116.754 -174.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 27.7 m120 -141.33 151.0 43.21 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 118.894 1.347 . . . . 0.0 112.164 -176.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt -54.85 -40.9 70.12 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.008 1.323 . . . . 0.0 112.992 176.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.6 t -129.83 134.43 63.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 124.131 0.972 . . . . 0.0 110.175 174.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 58.9 t -131.8 129.85 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 C-N-CA 125.065 1.346 . . . . 0.0 109.751 177.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 47.0 t -127.33 146.9 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 124.294 1.038 . . . . 0.0 111.855 -175.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -121.72 113.48 19.77 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.696 1.198 . . . . 0.0 109.971 173.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.4 m -131.17 170.83 14.02 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.529 1.532 . . . . 0.0 112.092 -167.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.437 ' CD1' ' HB3' ' A' ' 46' ' ' ASP . 33.2 m0 -117.36 133.85 55.5 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 124.571 1.149 . . . . 0.0 108.867 162.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 71.4 t -58.55 -30.43 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 C-N-CA 123.567 0.747 . . . . 0.0 111.887 -175.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.8 p -82.56 -8.49 59.61 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 126.496 1.919 . . . . 0.0 116.08 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 4.7 t -91.62 141.4 25.74 Favored Pre-proline 0 CA--C 1.54 0.567 0 CA-C-N 120.372 1.442 . . . . 0.0 112.394 -168.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -69.26 -39.58 7.27 Favored 'Trans proline' 0 C--N 1.349 0.576 0 CA-C-N 120.343 1.158 . . . . 0.0 112.058 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -62.45 -36.47 82.52 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 126.166 1.786 . . . . 0.0 113.083 -178.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -55.1 -53.15 59.61 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.265 1.026 . . . . 0.0 109.125 169.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 94.8 t -64.32 -39.8 86.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 123.716 0.806 . . . . 0.0 111.871 -178.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.5 mmt85 -53.37 -43.4 67.75 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 118.87 0.759 . . . . 0.0 111.566 172.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.75 -54.27 9.37 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.487 0.715 . . . . 0.0 112.839 175.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.38 -33.32 58.96 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.671 1.188 . . . . 0.0 113.395 -179.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -68.68 -49.94 54.99 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.512 0.725 . . . . 0.0 111.58 177.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.6 tt -65.66 -43.32 89.74 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.796 1.639 . . . . 0.0 111.378 -178.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 95.0 mt -64.0 -40.07 95.54 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.633 0.773 . . . . 0.0 111.921 -178.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 54.3 m-70 -78.48 -13.38 59.86 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 171.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -80.37 -39.35 28.65 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 119.208 0.913 . . . . 0.0 111.952 172.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -87.46 -28.56 22.01 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 125.053 1.341 . . . . 0.0 114.267 -178.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.2 p -151.15 170.38 19.58 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 125.118 1.367 . . . . 0.0 112.628 -168.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -116.85 -19.33 9.91 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 126.562 1.945 . . . . 0.0 114.047 164.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -78.35 27.82 0.2 Allowed 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -171.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.21 132.47 44.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.365 0 C-N-CA 126.887 2.075 . . . . 0.0 111.563 -178.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 16.5 m -112.81 141.53 46.51 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 126.107 1.763 . . . . 0.0 109.65 168.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.4 p -132.85 140.24 47.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.546 0 C-N-CA 125.259 1.424 . . . . 0.0 111.883 173.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -116.06 127.85 55.22 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.975 1.31 . . . . 0.0 110.46 176.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -95.99 87.95 4.74 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 122.06 0.933 . . . . 0.0 111.714 -172.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 13.0 m -71.79 3.61 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 -174.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.437 ' HB3' ' CD1' ' A' ' 20' ' ' TRP . 0.0 OUTLIER -87.33 -31.03 20.39 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 121.294 -0.879 . . . . 0.0 111.732 165.873 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 25.1 mtmt -81.42 -23.81 37.3 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.822 1.249 . . . . 0.0 113.367 176.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 21.0 ttt -85.2 121.97 28.71 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.212 1.805 . . . . 0.0 110.955 173.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 72.5 m -63.55 -31.6 72.81 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -176.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -83.32 1.48 40.93 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 175.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -56.12 -21.71 33.03 Favored Glycine 0 CA--C 1.535 1.311 0 N-CA-C 116.663 1.425 . . . . 0.0 116.663 -169.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -67.11 -29.07 68.72 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 119.365 1.582 . . . . 0.0 112.576 173.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -76.9 -25.37 52.93 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 121.103 -0.998 . . . . 0.0 111.724 174.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.567 HD12 HG23 ' A' ' 6' ' ' ILE . 2.8 mm? -84.48 -30.07 25.51 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.438 1.095 . . . . 0.0 111.57 175.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 41.1 mtp180 -54.18 -41.96 69.14 Favored 'General case' 0 N--CA 1.484 1.241 0 O-C-N 120.977 -1.077 . . . . 0.0 110.666 154.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.13 -38.86 93.68 Favored Glycine 0 CA--C 1.536 1.351 0 C-N-CA 124.329 0.966 . . . . 0.0 114.203 171.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -65.37 -31.66 72.88 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 120.038 1.919 . . . . 0.0 113.501 176.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 28.2 mt -71.68 -46.89 60.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 172.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -62.9 -39.58 94.92 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 121.109 -0.995 . . . . 0.0 113.039 -178.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 38.6 mm-40 -71.81 -10.74 60.21 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.865 1.266 . . . . 0.0 114.135 -179.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -113.99 -26.12 8.26 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 114.217 1.192 . . . . 0.0 114.217 173.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -135.31 0.87 2.85 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 115.255 1.576 . . . . 0.0 115.255 -170.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp 49.49 35.23 7.87 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 127.089 2.155 . . . . 0.0 115.226 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -141.06 153.79 45.65 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 125.148 1.379 . . . . 0.0 110.311 175.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -141.35 -24.33 0.73 Allowed 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -160.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 22.0 m -77.36 131.99 38.34 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.988 1.315 . . . . 0.0 112.353 -173.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 14.1 m -81.22 158.43 69.53 Favored Pre-proline 0 CA--C 1.547 0.857 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 -171.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -68.63 153.18 89.74 Favored 'Cis proline' 0 CA--C 1.534 0.503 0 CA-C-N 118.528 0.51 . . . . 0.0 112.219 -15.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -98.6 135.63 39.84 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 159.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 69.4 mt -129.61 142.52 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 C-N-CA 123.599 0.759 . . . . 0.0 109.28 -166.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -138.22 140.67 39.82 Favored 'General case' 0 C--N 1.332 -0.152 0 C-N-CA 123.934 0.894 . . . . 0.0 111.145 177.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 73.8 mt -128.5 115.03 36.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 124.994 1.318 . . . . 0.0 108.202 176.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 45.69 47.83 11.59 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.547 1.539 . . . . 0.0 113.54 -174.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 79.54 -10.48 37.11 Favored Glycine 0 CA--C 1.535 1.302 0 N-CA-C 115.793 1.077 . . . . 0.0 115.793 -178.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 26.8 m-80 -86.65 132.77 33.79 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 118.887 1.343 . . . . 0.0 109.541 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -82.65 143.01 31.26 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.531 1.132 . . . . 0.0 113.056 -174.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 20.2 mm -132.5 119.58 39.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 127.93 2.492 . . . . 0.0 107.246 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.97 -22.75 65.05 Favored Glycine 0 CA--C 1.537 1.426 0 N-CA-C 116.785 1.474 . . . . 0.0 116.785 -164.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 156.64 -152.51 23.89 Favored Glycine 0 CA--C 1.527 0.79 0 CA-C-N 118.058 0.929 . . . . 0.0 114.154 173.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 8.2 t -54.91 -56.23 21.88 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.196 0.998 . . . . 0.0 112.593 -175.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 65.6 m -75.27 3.16 9.4 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -95.73 -43.09 8.05 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.357 1.063 . . . . 0.0 111.646 165.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 28.6 tp -63.39 -51.21 66.8 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.188 1.395 . . . . 0.0 111.003 175.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -57.39 -43.81 83.99 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.5 0.72 . . . . 0.0 110.24 174.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.16 -35.36 78.54 Favored 'General case' 0 CA--C 1.542 0.672 0 O-C-N 121.351 -0.843 . . . . 0.0 112.861 -177.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 42.8 mt -73.65 -26.74 60.9 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.681 0.792 . . . . 0.0 112.91 173.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -72.75 -38.92 67.23 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 119.24 0.927 . . . . 0.0 111.601 169.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -64.21 -38.64 91.77 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.565 0.746 . . . . 0.0 111.549 173.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -73.32 -7.68 52.64 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 171.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.95 28.94 74.08 Favored Glycine 0 CA--C 1.539 1.534 0 CA-C-N 120.617 1.553 . . . . 0.0 112.993 -176.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 21.2 mtpp -110.09 -30.19 7.88 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.882 2.073 . . . . 0.0 112.392 -176.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 50.2 tp -56.36 -37.51 70.14 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.444 0.697 . . . . 0.0 111.837 172.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -51.13 -46.44 61.95 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.695 1.598 . . . . 0.0 112.577 174.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -78.23 -25.42 61.62 Favored Glycine 0 CA--C 1.531 1.061 0 O-C-N 121.616 -0.677 . . . . 0.0 114.279 177.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 79.6 mt -71.19 -37.6 72.13 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 118.642 1.221 . . . . 0.0 111.734 175.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 87.3 mt -86.89 -8.26 57.43 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.166 0.987 . . . . 0.0 112.973 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 3.9 t . . . . . 0 C--O 1.253 1.246 0 C-N-CA 126.695 1.998 . . . . 0.0 111.224 173.456 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.902 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -70.19 159.72 33.44 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.402 1.481 . . . . 0.0 114.345 -171.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 79.0 mmm -113.43 78.23 3.45 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 125.949 1.699 . . . . 0.0 110.673 178.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -68.82 158.14 59.04 Favored 'Trans proline' 0 CA--C 1.536 0.622 0 C-N-CA 122.868 2.379 . . . . 0.0 112.806 -176.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 51.0 m -97.09 -170.71 2.08 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.495 1.518 . . . . 0.0 111.549 172.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.481 HG23 HD12 ' A' ' 54' ' ' LEU . 13.2 pt -54.81 -22.25 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 N-CA-C 115.198 1.555 . . . . 0.0 115.198 -168.136 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.36 -22.03 60.72 Favored 'General case' 0 CA--C 1.548 0.893 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 93.4 p -80.48 -25.89 38.54 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.668 1.587 . . . . 0.0 113.923 172.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 62.1 mtt -65.12 -33.62 76.47 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 120.624 -1.297 . . . . 0.0 111.704 176.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.403 HG22 ' HA2' ' A' ' 74' ' ' GLY . 1.5 mm -61.89 -24.49 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 124.017 0.927 . . . . 0.0 112.222 -174.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -75.75 -11.02 59.91 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.356 1.462 . . . . 0.0 114.265 177.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -95.73 -26.38 11.86 Favored Glycine 0 CA--C 1.536 1.346 0 N-CA-C 117.8 1.88 . . . . 0.0 117.8 -164.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -143.35 158.72 43.4 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 119.335 1.568 . . . . 0.0 111.918 -173.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -59.69 -38.73 82.35 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.837 1.255 . . . . 0.0 112.931 -176.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.4 t -131.54 134.66 60.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.322 1.449 . . . . 0.0 109.446 173.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 56.1 t -132.26 128.48 58.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 124.702 1.201 . . . . 0.0 110.075 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 44.9 t -131.33 153.03 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.49 1.116 . . . . 0.0 111.981 -173.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -128.37 105.95 8.68 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.582 1.153 . . . . 0.0 109.393 176.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 68.9 m -126.46 171.23 11.21 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 125.744 1.618 . . . . 0.0 111.816 -170.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 47.3 m0 -118.94 129.4 55.15 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.847 1.259 . . . . 0.0 109.399 168.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 31.6 t -61.61 -20.33 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 C-N-CA 124.864 1.266 . . . . 0.0 112.661 -168.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.7 p -83.08 -22.26 33.5 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 128.671 2.788 . . . . 0.0 115.485 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 66.3 m -105.24 153.97 39.23 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 120.154 1.343 . . . . 0.0 114.06 -154.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -71.8 -49.48 0.32 Allowed 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 121.382 1.388 . . . . 0.0 114.023 -168.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -62.16 -37.37 84.99 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 -177.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -42.73 -58.29 2.4 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.973 1.709 . . . . 0.0 110.341 164.049 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 61.4 t -66.34 -38.45 81.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 O-C-N 121.5 -0.75 . . . . 0.0 112.125 -177.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 37.6 mmt-85 -54.37 -39.74 67.48 Favored 'General case' 0 N--CA 1.484 1.258 0 CA-C-N 119.12 0.873 . . . . 0.0 111.915 174.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -75.64 -54.74 6.5 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.55 1.14 . . . . 0.0 112.988 174.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -54.3 -30.4 50.83 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 119.392 0.997 . . . . 0.0 113.27 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 23.6 ttpt -69.53 -50.58 43.61 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 123.675 0.79 . . . . 0.0 112.21 175.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.1 tt -64.13 -43.04 96.46 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.521 1.528 . . . . 0.0 111.132 -177.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 90.5 mt -66.45 -24.27 66.41 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.263 1.025 . . . . 0.0 113.335 -177.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 44.1 m-70 -92.46 -16.3 26.02 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 168.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.0 -27.44 22.05 Favored 'General case' 0 CA--C 1.545 0.76 0 O-C-N 120.793 -1.192 . . . . 0.0 113.967 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 7.5 mmm-85 -103.2 -18.93 14.69 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 125.23 1.412 . . . . 0.0 113.973 177.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -153.02 174.49 14.1 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 127.037 2.135 . . . . 0.0 111.739 -171.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -129.78 -7.81 4.52 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 125.309 1.444 . . . . 0.0 114.532 170.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -97.76 87.69 4.1 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 119.506 1.048 . . . . 0.0 111.454 179.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.42 129.55 22.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 125.073 1.349 . . . . 0.0 110.641 -179.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 22.7 m -104.49 127.53 52.22 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.319 1.448 . . . . 0.0 108.632 168.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.5 p -125.18 134.29 67.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 118.957 0.798 . . . . 0.0 112.264 170.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -104.06 122.93 46.29 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.941 1.296 . . . . 0.0 110.3 175.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 85.8 m-85 -93.7 82.91 4.36 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 121.568 0.699 . . . . 0.0 111.964 -172.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 29.6 m -76.08 33.32 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 -169.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -129.04 -16.67 4.03 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 126.449 1.9 . . . . 0.0 111.708 161.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 20.4 mtmt -80.2 -24.7 40.1 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.445 1.098 . . . . 0.0 112.229 162.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -92.21 127.62 37.76 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.677 1.591 . . . . 0.0 110.781 177.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 58.1 m -71.55 -20.95 61.96 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 -165.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -97.85 7.49 46.29 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 126.028 1.731 . . . . 0.0 112.686 174.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -49.51 -30.83 13.46 Favored Glycine 0 CA--C 1.537 1.416 0 CA-C-N 119.743 1.156 . . . . 0.0 115.028 -175.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -58.4 -35.34 71.89 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.368 1.867 . . . . 0.0 114.907 171.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -80.36 -36.14 34.48 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.809 1.244 . . . . 0.0 112.08 175.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.481 HD12 HG23 ' A' ' 6' ' ' ILE . 2.5 mm? -69.67 -36.11 75.73 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 121.715 -0.615 . . . . 0.0 111.075 176.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 42.2 mtp180 -53.14 -38.83 63.05 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.834 1.254 . . . . 0.0 112.258 165.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -57.94 -40.08 92.71 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 123.974 0.797 . . . . 0.0 113.797 173.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 56.7 mm-40 -66.55 -24.87 66.43 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 118.841 1.321 . . . . 0.0 112.984 175.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 26.1 mt -74.72 -45.45 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 O-C-N 121.498 -0.751 . . . . 0.0 109.722 172.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -68.88 -39.11 79.97 Favored 'General case' 0 CA--C 1.537 0.447 0 O-C-N 121.618 -0.677 . . . . 0.0 112.671 -177.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -59.58 -35.31 74.03 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 121.456 -0.777 . . . . 0.0 112.834 176.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -94.61 -32.13 13.56 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 114.293 1.219 . . . . 0.0 114.293 -175.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -134.69 4.02 3.3 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 114.741 1.386 . . . . 0.0 114.741 -169.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt 52.96 31.48 11.0 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 126.513 1.925 . . . . 0.0 114.903 176.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 -116.71 111.31 19.62 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 127.745 2.418 . . . . 0.0 110.466 -166.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -100.13 -5.37 27.93 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 115.942 1.83 . . . . 0.0 115.942 -177.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 44.7 p -81.29 171.13 15.2 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 124.895 1.278 . . . . 0.0 113.51 178.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.3 m -125.7 143.58 45.49 Favored Pre-proline 0 N--CA 1.481 1.119 0 C-N-CA 124.189 0.996 . . . . 0.0 111.748 169.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -88.64 162.62 41.42 Favored 'Cis proline' 0 N--CA 1.457 -0.621 0 CA-C-N 119.525 0.866 . . . . 0.0 113.976 5.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -100.14 143.25 30.56 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.81 0.844 . . . . 0.0 109.476 159.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 15.8 mt -133.03 141.71 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 124.21 1.004 . . . . 0.0 110.137 -167.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 53.5 m-85 -142.77 147.63 35.85 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.119 0.968 . . . . 0.0 112.253 -179.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 79.8 mt -130.65 122.79 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 C-N-CA 125.731 1.613 . . . . 0.0 109.765 177.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 31.2 m120 44.78 39.5 3.53 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 125.645 1.578 . . . . 0.0 114.305 -178.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.403 ' HA2' HG22 ' A' ' 10' ' ' ILE . . . 92.72 -6.25 77.05 Favored Glycine 0 CA--C 1.539 1.574 0 O-C-N 120.208 -1.558 . . . . 0.0 116.231 -176.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -104.77 134.79 47.32 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.292 1.437 . . . . 0.0 111.755 -173.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -75.42 143.83 42.51 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 27.0 mm -125.61 133.19 69.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 128.266 2.627 . . . . 0.0 108.522 178.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -72.95 53.63 1.73 Allowed Glycine 0 N--CA 1.474 1.226 0 C-N-CA 126.324 1.916 . . . . 0.0 117.353 -177.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 78.21 -164.63 51.36 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 128.075 2.75 . . . . 0.0 113.459 175.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 18.6 t -62.15 -29.39 70.32 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 122.087 -0.655 . . . . 0.0 111.672 175.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 36.6 m -64.1 -45.01 90.54 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.338 1.055 . . . . 0.0 112.664 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -72.79 -37.83 67.45 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 118.823 0.738 . . . . 0.0 112.205 172.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 50.6 tp -58.67 -50.07 75.23 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.74 0.816 . . . . 0.0 111.38 176.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -61.55 -43.55 98.66 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.845 0.858 . . . . 0.0 110.697 173.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.98 -33.68 75.91 Favored 'General case' 0 CA--C 1.544 0.749 0 O-C-N 120.848 -1.158 . . . . 0.0 112.806 -176.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 98.7 mt -78.34 -23.82 46.81 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.511 1.124 . . . . 0.0 113.345 173.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -70.51 -41.24 72.89 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 119.566 1.076 . . . . 0.0 110.85 166.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -65.02 -28.85 69.78 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.564 1.146 . . . . 0.0 113.148 175.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.447 ' HB3' ' HE2' ' A' ' 91' ' ' LYS . 7.3 mt-10 -91.28 2.1 56.62 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 114.641 1.349 . . . . 0.0 114.641 169.019 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 67.77 4.7 34.62 Favored Glycine 0 CA--C 1.537 1.41 0 O-C-N 120.948 -1.095 . . . . 0.0 115.261 179.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.447 ' HE2' ' HB3' ' A' ' 89' ' ' GLU . 44.2 mtmt -78.57 -28.13 45.85 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 126.178 1.791 . . . . 0.0 111.949 -174.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 35.4 tp -56.07 -36.15 67.78 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.528 1.131 . . . . 0.0 112.361 172.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -65.75 -28.38 69.0 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 113.416 0.895 . . . . 0.0 113.416 178.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -76.19 -36.88 38.77 Favored Glycine 0 CA--C 1.53 0.974 0 O-C-N 121.584 -0.698 . . . . 0.0 111.992 171.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 90.4 mt -70.52 -25.87 63.32 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.986 0.914 . . . . 0.0 113.367 -178.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 85.2 mt -105.42 2.14 28.4 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 115.078 1.51 . . . . 0.0 115.078 -173.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 41.6 m . . . . . 0 C--O 1.255 1.351 0 C-N-CA 125.645 1.578 . . . . 0.0 114.487 -174.619 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.144 0 N-CA-C 112.182 -0.367 . . . . 0.0 112.182 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 50.12 39.98 20.64 Favored 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 125.215 1.406 . . . . 0.0 114.503 -177.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 52.5 mtt -136.29 86.96 23.52 Favored Pre-proline 0 CA--C 1.542 0.648 0 C-N-CA 126.13 1.772 . . . . 0.0 109.684 -175.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -67.87 148.08 75.98 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 122.575 2.183 . . . . 0.0 112.841 -178.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 60.6 p -110.75 -152.21 0.49 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 127.253 2.221 . . . . 0.0 111.244 -178.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.584 HG23 HD12 ' A' ' 54' ' ' LEU . 12.4 pt -53.22 -22.88 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 125.136 1.374 . . . . 0.0 113.89 174.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.62 -32.39 72.53 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 118.868 0.758 . . . . 0.0 112.574 -174.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 62.9 m -76.84 -19.3 57.67 Favored 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 173.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 38.4 mtt -73.68 -25.72 60.39 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 121.036 -1.04 . . . . 0.0 112.01 176.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.8 mm -63.54 -33.13 59.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.862 0.865 . . . . 0.0 111.615 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -76.45 1.41 16.56 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.884 1.274 . . . . 0.0 113.416 175.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -86.03 -18.82 58.78 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 125.115 1.341 . . . . 0.0 115.385 -177.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 22.2 m-80 -151.37 170.56 19.25 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 126.133 1.773 . . . . 0.0 111.943 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -70.19 -36.8 74.87 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.257 0.623 . . . . 0.0 112.651 174.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.3 t -128.09 135.09 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.842 1.257 . . . . 0.0 110.574 172.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 47.2 t -131.48 129.18 61.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 124.411 1.084 . . . . 0.0 110.069 174.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.0 t -124.9 144.73 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 124.565 1.146 . . . . 0.0 111.883 -176.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -120.2 113.01 19.8 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.17 1.388 . . . . 0.0 108.692 173.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.412 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 14.2 m -130.63 -179.06 5.07 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 127.279 2.232 . . . . 0.0 110.58 -169.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 19.7 m0 -126.82 138.08 53.29 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.491 1.116 . . . . 0.0 108.425 159.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 40.6 t -59.36 -31.07 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 CA-C-O 122.06 0.933 . . . . 0.0 111.619 -170.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.6 p -81.96 -11.08 59.05 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 127.349 2.26 . . . . 0.0 115.526 -177.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 8.2 t -89.01 141.9 29.83 Favored Pre-proline 0 CA--C 1.542 0.653 0 CA-C-N 120.373 1.442 . . . . 0.0 110.384 -168.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -75.75 -31.39 5.34 Favored 'Trans proline' 0 C--N 1.347 0.467 0 CA-C-N 120.605 1.252 . . . . 0.0 113.361 179.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -62.65 -41.45 99.06 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.532 1.133 . . . . 0.0 113.264 174.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.412 ' SG ' ' HB3' ' A' ' 19' ' ' SER . 0.2 OUTLIER -50.72 -56.51 11.65 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.597 1.159 . . . . 0.0 109.55 171.924 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 81.3 t -63.23 -40.92 90.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 118.761 -0.637 . . . . 0.0 112.579 -173.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 7.7 ptp180 -66.94 -20.19 65.85 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 176.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.2 -54.42 5.53 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 118.448 -0.787 . . . . 0.0 111.042 165.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -46.36 -46.76 18.55 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.438 1.095 . . . . 0.0 112.756 178.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -67.37 -36.31 81.1 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.005 1.322 . . . . 0.0 113.01 -176.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -77.27 -35.72 54.99 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.225 1.01 . . . . 0.0 111.402 175.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 96.7 mt -64.94 -34.54 78.66 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 121.126 -0.984 . . . . 0.0 111.409 171.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -70.25 -27.08 64.16 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.912 1.078 . . . . 0.0 113.912 167.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -74.11 -36.74 64.23 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 119.69 1.132 . . . . 0.0 112.711 174.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 73.7 mmt-85 -99.31 -28.02 13.5 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 -172.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.417 HG22 HD13 ' A' ' 96' ' ' LEU . 1.3 p -136.76 163.89 29.55 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.313 1.045 . . . . 0.0 113.442 -162.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -122.88 -26.04 4.5 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.949 1.3 . . . . 0.0 113.189 165.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -85.44 48.16 1.54 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 125.427 1.491 . . . . 0.0 113.569 -178.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.04 134.17 58.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 126.128 1.771 . . . . 0.0 112.083 -176.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.1 m -121.09 136.87 54.89 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.817 1.647 . . . . 0.0 110.66 171.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.1 p -127.17 141.29 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 125.013 1.325 . . . . 0.0 113.002 173.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 56.9 m-70 -119.43 135.82 54.58 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 128.641 2.776 . . . . 0.0 109.804 -176.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -109.25 93.18 4.38 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.251 0.62 . . . . 0.0 111.668 -173.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . 0.266 34.5 m -79.76 44.81 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 CA-C-O 123.117 1.437 . . . . 0.0 114.578 -173.323 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -145.84 -27.3 0.44 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 129.057 2.943 . . . . 0.0 110.217 172.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 28.2 mmmt -70.45 -39.06 74.56 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.444 1.098 . . . . 0.0 110.478 155.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 14.3 ttt -69.71 127.94 34.71 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.703 0.801 . . . . 0.0 111.579 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 9.1 m -78.92 -18.78 53.26 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.725 1.21 . . . . 0.0 113.927 179.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -95.54 -5.29 43.09 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.944 1.297 . . . . 0.0 112.807 167.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -51.34 -25.54 12.43 Favored Glycine 0 CA--C 1.533 1.171 0 C-N-CA 126.067 1.794 . . . . 0.0 116.841 -169.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -73.22 -28.13 61.99 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 118.871 1.336 . . . . 0.0 112.673 177.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 14.4 tm0? -70.04 -37.36 75.54 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.409 1.084 . . . . 0.0 110.714 172.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.584 HD12 HG23 ' A' ' 6' ' ' ILE . 2.2 mm? -74.43 -36.19 63.39 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.825 1.25 . . . . 0.0 112.52 177.074 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 72.0 mtp180 -54.13 -40.17 67.14 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 119.097 0.862 . . . . 0.0 111.158 162.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.45 -33.36 86.24 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 125.256 1.408 . . . . 0.0 114.631 172.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -63.51 -42.56 98.47 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 120.414 2.107 . . . . 0.0 111.088 175.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 26.4 mt -69.64 -39.47 78.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.554 0 C-N-CA 123.828 0.851 . . . . 0.0 110.308 177.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 14.3 t80 -70.28 -44.23 68.8 Favored 'General case' 0 N--CA 1.467 0.381 0 O-C-N 121.148 -0.97 . . . . 0.0 112.808 -179.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -62.6 -30.66 71.51 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 118.93 0.786 . . . . 0.0 112.477 179.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -83.47 -55.09 4.5 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 174.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -117.84 -1.74 11.48 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 124.446 1.098 . . . . 0.0 113.918 -161.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 25.5 mmtp 54.21 29.74 11.08 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 126.364 1.866 . . . . 0.0 114.102 -178.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -99.74 119.88 38.84 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.087 1.755 . . . . 0.0 109.939 -179.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -115.37 -17.75 11.2 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.01 1.324 . . . . 0.0 114.502 -172.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.3 p -75.2 166.48 23.57 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.564 1.146 . . . . 0.0 112.419 172.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 21.6 m -120.52 151.27 53.73 Favored Pre-proline 0 N--CA 1.475 0.783 0 C-N-CA 124.912 1.285 . . . . 0.0 110.609 166.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -78.32 154.56 93.03 Favored 'Cis proline' 0 C--N 1.349 0.56 0 CA-C-N 118.986 0.673 . . . . 0.0 113.561 -0.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -104.84 135.25 46.56 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.144 1.378 . . . . 0.0 108.776 161.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.9 mt -126.69 142.78 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.391 1.076 . . . . 0.0 109.514 -167.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -139.9 136.41 33.87 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.274 1.03 . . . . 0.0 110.272 178.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 52.5 mt -133.84 122.03 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.02 0.928 . . . . 0.0 110.403 -176.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 48.5 m-20 49.75 30.91 4.02 Favored 'General case' 0 CA--C 1.554 1.114 0 O-C-N 121.238 -0.914 . . . . 0.0 113.257 -175.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 95.21 -8.99 69.91 Favored Glycine 0 CA--C 1.54 1.602 0 N-CA-C 117.606 1.802 . . . . 0.0 117.606 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 25.4 p30 -76.33 169.28 18.53 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 121.248 2.524 . . . . 0.0 113.482 175.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 59.0 t80 -108.16 129.45 55.18 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.447 0.699 . . . . 0.0 111.808 169.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 45.5 mm -113.99 121.88 67.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 126.611 1.964 . . . . 0.0 108.64 -178.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -74.14 21.77 1.34 Allowed Glycine 0 N--CA 1.472 1.073 0 N-CA-C 118.569 2.188 . . . . 0.0 118.569 -164.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 121.39 -172.03 15.18 Favored Glycine 0 CA--C 1.533 1.208 0 C-N-CA 126.639 2.066 . . . . 0.0 115.058 174.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 29.9 t -66.49 -38.51 87.43 Favored 'General case' 0 CA--C 1.542 0.667 0 O-C-N 121.853 -0.792 . . . . 0.0 113.033 -174.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 63.4 m -63.1 -20.27 65.21 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 176.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -90.13 -43.6 10.35 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.763 1.225 . . . . 0.0 111.008 175.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 48.4 tp -57.43 -49.48 76.1 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.442 1.097 . . . . 0.0 111.435 174.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -67.28 -29.43 69.03 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.26 0.624 . . . . 0.0 111.825 177.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -73.3 -40.2 64.72 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 121.025 -1.047 . . . . 0.0 112.672 176.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 75.8 mt -65.29 -28.2 69.16 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.083 0.953 . . . . 0.0 112.616 177.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -59.78 -47.44 85.69 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.535 1.134 . . . . 0.0 111.515 171.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -68.71 -40.74 79.83 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.199 1.0 . . . . 0.0 112.944 178.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -73.3 2.87 6.62 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 70.0 16.5 72.78 Favored Glycine 0 CA--C 1.538 1.508 0 O-C-N 120.332 -1.48 . . . . 0.0 114.145 178.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 44.4 mtmt -100.29 -34.23 10.08 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.874 1.669 . . . . 0.0 112.592 -175.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 54.4 tp -59.39 -41.36 89.23 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 119.244 0.929 . . . . 0.0 111.411 175.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -57.21 -41.0 78.59 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.805 0.842 . . . . 0.0 113.134 176.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -76.58 -34.05 45.59 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 124.542 1.068 . . . . 0.0 113.376 178.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 62.9 mt -65.07 -23.21 67.1 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.909 0.884 . . . . 0.0 112.483 172.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.417 HD13 HG22 ' A' ' 37' ' ' THR . 46.5 mt -100.65 -3.29 30.63 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 126.069 1.748 . . . . 0.0 113.751 177.062 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 69.3 m . . . . . 0 C--O 1.253 1.277 0 C-N-CA 125.311 1.445 . . . . 0.0 112.091 -179.284 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.257 0 N-CA-C 110.731 -0.948 . . . . 0.0 110.731 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.69 138.58 37.39 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 117.767 0.784 . . . . 0.0 110.679 172.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 3.0 tpt 49.88 57.23 17.96 Favored Pre-proline 0 CA--C 1.554 1.107 0 C-N-CA 124.711 1.204 . . . . 0.0 112.286 -172.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -69.5 139.7 41.78 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 123.699 2.933 . . . . 0.0 113.061 -167.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 25.5 p -151.51 -167.63 2.85 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.175 0.99 . . . . 0.0 112.224 177.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.634 HG23 HD12 ' A' ' 54' ' ' LEU . 26.8 pt -57.21 -22.46 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 124.068 0.947 . . . . 0.0 113.127 169.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -68.47 -21.28 64.63 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -173.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 74.0 m -83.28 -33.02 26.08 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.291 1.037 . . . . 0.0 112.48 166.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 73.4 mtp -61.78 -25.93 67.77 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.081 0.952 . . . . 0.0 112.736 178.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.9 mm -57.66 -34.59 47.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 124.283 1.033 . . . . 0.0 112.039 175.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.3 mptt -76.95 -3.41 38.73 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.29 1.036 . . . . 0.0 113.427 -178.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -76.11 -26.51 64.03 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.791 1.186 . . . . 0.0 114.96 -176.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -146.52 171.89 14.38 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 118.662 1.231 . . . . 0.0 114.026 -173.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -66.57 -35.9 81.34 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.286 1.034 . . . . 0.0 111.886 172.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.9 t -134.57 131.49 54.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 124.857 1.263 . . . . 0.0 110.23 177.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 39.5 t -134.85 130.0 52.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 124.467 1.107 . . . . 0.0 110.005 -179.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 48.8 t -131.67 148.75 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 124.224 1.01 . . . . 0.0 112.513 -171.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -125.59 110.58 14.0 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.252 1.421 . . . . 0.0 109.423 175.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 58.3 m -130.61 173.66 10.67 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 125.604 1.562 . . . . 0.0 111.698 -169.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 47.8 m0 -122.73 129.63 51.99 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.809 1.244 . . . . 0.0 108.63 166.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 49.0 t -63.45 -23.88 34.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 123.361 0.664 . . . . 0.0 112.689 -164.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.4 p -78.07 -16.49 57.98 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 177.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 84.0 m -99.51 148.37 34.62 Favored Pre-proline 0 CA--C 1.537 0.45 0 CA-C-N 120.346 1.43 . . . . 0.0 114.212 -154.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -67.76 -48.68 1.37 Allowed 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 121.282 1.321 . . . . 0.0 113.964 -165.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -69.47 -31.44 69.73 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.463 1.105 . . . . 0.0 113.364 -178.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -50.71 -54.3 24.31 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.829 0.852 . . . . 0.0 109.641 168.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.7 t -66.93 -39.07 82.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 123.284 0.634 . . . . 0.0 111.658 -177.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 17.3 mmt85 -54.26 -49.2 70.1 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 118.612 0.642 . . . . 0.0 111.565 172.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.71 -57.94 7.64 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.93 0.892 . . . . 0.0 112.429 176.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -48.19 -44.51 32.79 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.538 1.135 . . . . 0.0 112.963 179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -65.85 -43.34 88.75 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 123.727 0.811 . . . . 0.0 111.943 -177.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.6 tt -72.76 -34.36 66.94 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.995 1.318 . . . . 0.0 111.969 -179.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 76.5 mt -67.47 -42.95 82.17 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.529 0.732 . . . . 0.0 111.282 172.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -60.92 -28.2 68.76 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 118.472 0.578 . . . . 0.0 112.301 167.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.73 4.07 38.37 Favored 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 114.877 1.436 . . . . 0.0 114.877 175.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -126.68 -39.72 1.97 Allowed 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 114.359 1.244 . . . . 0.0 114.359 174.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 17.9 p -143.15 131.96 22.7 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 119.236 0.925 . . . . 0.0 113.343 -166.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 39.4 mtmt -70.05 -27.0 64.29 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 163.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -88.05 60.4 5.8 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.224 1.01 . . . . 0.0 113.059 -175.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -120.83 137.86 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 125.759 1.624 . . . . 0.0 111.622 178.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 75.6 m -120.82 135.13 55.24 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 127.288 2.235 . . . . 0.0 109.434 172.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.7 p -133.8 141.76 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 114.017 1.117 . . . . 0.0 114.017 169.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 33.3 t60 -121.13 119.22 31.77 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 126.837 2.055 . . . . 0.0 109.632 -178.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -94.93 91.32 6.35 Favored 'General case' 0 CA--C 1.539 0.533 0 O-C-N 121.223 -0.923 . . . . 0.0 112.387 -168.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . 0.252 32.0 m -78.26 36.73 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 115.735 1.754 . . . . 0.0 115.735 -168.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -134.68 -28.68 1.22 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 127.91 2.484 . . . . 0.0 110.473 163.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 20.0 mmmt -64.09 -25.93 68.32 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.592 1.157 . . . . 0.0 112.086 160.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 91.6 mmm -91.02 144.22 25.89 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.039 1.336 . . . . 0.0 110.922 176.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.9 m -82.55 -27.09 31.85 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -174.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -99.12 8.02 45.29 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.255 1.822 . . . . 0.0 112.877 178.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -52.35 -26.56 22.4 Favored Glycine 0 CA--C 1.537 1.467 0 N-CA-C 116.751 1.46 . . . . 0.0 116.751 -173.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 70.2 mt-10 -70.39 -26.67 63.81 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 120.76 2.28 . . . . 0.0 112.895 174.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -78.08 -28.26 48.71 Favored 'General case' 0 N--CA 1.469 0.488 0 O-C-N 120.98 -1.075 . . . . 0.0 111.611 173.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.634 HD12 HG23 ' A' ' 6' ' ' ILE . 3.0 mm? -80.88 -33.21 34.5 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.539 -0.726 . . . . 0.0 111.343 175.003 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 56.5 mtp180 -58.82 -33.53 70.48 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 120.852 -1.155 . . . . 0.0 111.521 161.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -56.31 -40.18 84.36 Favored Glycine 0 CA--C 1.537 1.437 0 C-N-CA 124.013 0.816 . . . . 0.0 113.919 168.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -66.55 -24.8 66.42 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 119.442 1.621 . . . . 0.0 113.172 175.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 52.3 mt -81.43 -46.07 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 124.565 1.146 . . . . 0.0 109.725 175.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -69.38 -44.2 71.96 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 121.42 -0.8 . . . . 0.0 112.192 -178.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -58.11 -41.2 83.06 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.415 -0.803 . . . . 0.0 112.216 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -89.11 -37.83 14.79 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 114.247 1.202 . . . . 0.0 114.247 -175.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -124.25 -2.01 8.12 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 -170.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 53.71 47.99 22.51 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 126.703 2.001 . . . . 0.0 113.369 -176.171 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -132.2 142.39 49.42 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.679 1.192 . . . . 0.0 111.781 175.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -135.71 -28.83 1.08 Allowed 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.076 1.35 . . . . 0.0 112.996 -157.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 20.8 p -79.12 167.05 21.57 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 128.023 2.529 . . . . 0.0 113.265 177.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 26.8 m -114.99 152.92 47.02 Favored Pre-proline 0 N--CA 1.48 1.063 0 C-N-CA 124.173 0.989 . . . . 0.0 112.694 173.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -77.28 143.28 74.54 Favored 'Cis proline' 0 C--N 1.349 0.592 0 CA-C-N 119.18 0.743 . . . . 0.0 112.498 -6.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -97.63 127.9 43.93 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 165.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 35.4 mt -123.73 142.37 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 124.128 0.971 . . . . 0.0 109.527 -165.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -137.63 143.03 41.22 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.813 0.845 . . . . 0.0 111.666 177.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 89.1 mt -130.01 119.65 47.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 125.165 1.386 . . . . 0.0 108.753 176.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 44.2 46.1 7.28 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 125.112 1.365 . . . . 0.0 113.178 -177.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 77.65 -2.35 63.72 Favored Glycine 0 CA--C 1.541 1.716 0 N-CA-C 117.066 1.586 . . . . 0.0 117.066 -178.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 25.7 m-80 -88.5 138.09 31.74 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 120.291 2.046 . . . . 0.0 110.326 175.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -82.61 136.11 34.89 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 118.994 0.816 . . . . 0.0 112.37 176.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 40.6 mm -115.98 124.97 72.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 127.016 2.126 . . . . 0.0 108.928 -178.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -68.72 2.63 7.63 Favored Glycine 0 CA--C 1.535 1.313 0 N-CA-C 119.25 2.46 . . . . 0.0 119.25 -163.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 142.6 -171.25 24.83 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 126.137 1.827 . . . . 0.0 113.216 175.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 42.4 t -64.07 -40.87 97.2 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 121.757 -0.849 . . . . 0.0 112.4 -177.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 68.1 m -72.89 -21.06 60.98 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 121.131 -0.981 . . . . 0.0 113.374 178.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -73.26 -42.65 62.24 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.262 0.937 . . . . 0.0 111.882 167.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 53.5 tp -61.06 -45.17 95.83 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.956 0.902 . . . . 0.0 110.988 175.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -64.71 -38.98 92.85 Favored 'General case' 0 CA--C 1.538 0.514 0 O-C-N 122.065 -0.397 . . . . 0.0 111.823 173.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.08 -36.95 83.23 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.081 -1.012 . . . . 0.0 112.106 178.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 92.4 mt -67.79 -28.69 67.81 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.69 -0.631 . . . . 0.0 112.173 175.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -69.7 -43.82 71.67 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 123.313 0.645 . . . . 0.0 111.098 173.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -69.93 -36.19 75.12 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.299 1.039 . . . . 0.0 113.065 175.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -73.15 -7.68 52.45 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.157 1.383 . . . . 0.0 113.299 175.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 79.37 10.13 86.27 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 123.846 0.736 . . . . 0.0 114.523 177.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 40.7 mtmt -91.11 -30.62 16.62 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 126.424 1.89 . . . . 0.0 112.527 -174.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 19.5 tp -61.97 -35.91 79.88 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 119.147 0.885 . . . . 0.0 111.392 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -65.55 -35.62 81.38 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.19 0.996 . . . . 0.0 112.318 171.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -77.36 -23.77 67.33 Favored Glycine 0 CA--C 1.532 1.121 0 O-C-N 120.879 -1.138 . . . . 0.0 114.566 177.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 86.8 mt -86.95 -27.38 23.34 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.412 1.485 . . . . 0.0 113.021 176.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 74.8 mt -117.93 -16.84 9.86 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 -170.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 4.7 m . . . . . 0 C--O 1.254 1.322 0 C-N-CA 126.625 1.97 . . . . 0.0 114.152 177.278 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.062 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -77.37 156.32 31.3 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -175.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.4 ttt -116.52 85.57 16.74 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 124.857 1.263 . . . . 0.0 111.789 179.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -76.76 146.53 26.68 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.785 2.323 . . . . 0.0 112.833 177.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 44.1 p -86.6 -169.88 2.83 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.453 1.501 . . . . 0.0 111.786 169.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.557 HG23 HD12 ' A' ' 54' ' ' LEU . 11.5 pt -50.98 -23.32 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 124.841 1.256 . . . . 0.0 113.553 168.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.69 -27.27 69.13 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 113.67 0.989 . . . . 0.0 113.67 -175.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.6 m -85.4 -11.44 54.46 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 172.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 55.7 mtt -68.79 -32.7 72.63 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 120.795 -1.19 . . . . 0.0 111.176 170.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.3 mm -60.51 -30.41 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 123.788 0.835 . . . . 0.0 111.905 -176.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.0 mttm -74.28 -8.9 57.82 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.825 1.25 . . . . 0.0 113.725 -177.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -89.8 -28.37 18.86 Favored Glycine 0 CA--C 1.537 1.41 0 N-CA-C 116.961 1.544 . . . . 0.0 116.961 -166.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -145.07 159.27 43.22 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.504 1.522 . . . . 0.0 111.05 -178.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -52.91 -42.29 65.23 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.711 1.605 . . . . 0.0 113.63 178.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.2 t -125.09 135.68 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 124.809 1.244 . . . . 0.0 110.464 174.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 48.4 t -133.85 131.73 56.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 124.394 1.078 . . . . 0.0 110.46 178.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 29.4 t -129.36 147.43 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 125.265 1.426 . . . . 0.0 111.545 -172.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -124.3 115.39 20.94 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.18 0.992 . . . . 0.0 109.212 172.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.407 ' HB3' ' SG ' ' A' ' 26' ' ' CYS . 21.0 m -130.19 168.22 17.17 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 126.18 1.792 . . . . 0.0 111.022 -168.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.45 ' CD1' ' HB3' ' A' ' 46' ' ' ASP . 19.5 m0 -111.81 135.79 51.96 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 157.232 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 72.2 t -59.22 -28.23 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 O-C-N 123.189 0.305 . . . . 0.0 111.109 175.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 48.7 p -67.65 -20.33 65.31 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 175.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 46.0 t -89.76 143.81 30.8 Favored Pre-proline 0 CA--C 1.538 0.491 0 O-C-N 121.281 -0.887 . . . . 0.0 111.193 -163.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -77.05 -39.48 0.6 Allowed 'Trans proline' 0 N--CA 1.459 -0.544 0 CA-C-N 119.656 0.913 . . . . 0.0 114.122 177.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -58.82 -36.33 74.32 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.049 1.739 . . . . 0.0 113.4 175.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.407 ' SG ' ' HB3' ' A' ' 19' ' ' SER . 0.3 OUTLIER -52.63 -55.67 20.82 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.949 1.3 . . . . 0.0 109.14 171.847 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.8 t -65.9 -39.99 86.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 123.53 0.732 . . . . 0.0 111.124 -178.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . 0.288 2.4 ttp180 -54.22 -28.84 43.67 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 126.012 1.725 . . . . 0.0 115.369 167.036 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -85.38 -55.53 3.97 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-N 119.911 1.232 . . . . 0.0 111.883 167.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -48.37 -38.33 19.06 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.96 1.704 . . . . 0.0 113.776 -178.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.7 ttpt -75.0 -43.69 52.45 Favored 'General case' 0 C--O 1.231 0.081 0 C-N-CA 124.385 1.074 . . . . 0.0 111.889 -177.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 8.4 tt -71.53 -39.56 70.67 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 124.714 1.206 . . . . 0.0 110.888 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 88.8 mt -61.75 -51.77 66.97 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.56 0.744 . . . . 0.0 110.746 176.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 24.2 m-70 -65.87 -15.92 63.37 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 172.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.72 -43.84 24.87 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 119.844 1.202 . . . . 0.0 111.43 169.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 68.7 mmt-85 -82.0 -50.41 9.15 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.219 1.008 . . . . 0.0 113.43 -171.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 21.9 m -160.54 129.09 4.7 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 125.106 1.362 . . . . 0.0 111.95 177.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 42.9 mttm -85.98 2.25 46.99 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 126.007 1.723 . . . . 0.0 115.228 -166.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -82.31 53.83 2.39 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.534 1.133 . . . . 0.0 112.04 172.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -118.87 127.43 75.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 126.567 1.947 . . . . 0.0 111.14 -177.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.6 m -110.78 141.31 44.28 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 126.067 1.747 . . . . 0.0 110.44 171.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.6 p -137.47 135.92 46.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 C-N-CA 124.535 1.134 . . . . 0.0 112.766 175.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -110.79 125.9 54.04 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.379 1.472 . . . . 0.0 109.45 175.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -97.21 88.27 4.41 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 122.526 1.155 . . . . 0.0 110.966 -174.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 22.1 m -64.6 -12.86 13.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 -174.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.45 ' HB3' ' CD1' ' A' ' 20' ' ' TRP . 0.1 OUTLIER -73.69 -21.37 60.27 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.619 1.168 . . . . 0.0 113.323 172.612 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -86.78 -27.1 23.8 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.257 1.423 . . . . 0.0 113.14 177.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 90.7 mtp -69.55 154.28 42.24 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.724 1.61 . . . . 0.0 112.117 175.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 8.6 t -84.02 -24.85 30.34 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.902 0.881 . . . . 0.0 111.691 163.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -93.47 -5.38 49.33 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.49 1.516 . . . . 0.0 114.779 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -57.41 -24.16 51.09 Favored Glycine 0 CA--C 1.536 1.386 0 N-CA-C 116.147 1.219 . . . . 0.0 116.147 -172.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -69.65 -22.49 63.46 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 118.687 1.243 . . . . 0.0 112.898 174.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -82.0 -35.63 28.68 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.937 0.895 . . . . 0.0 111.345 170.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.557 HD12 HG23 ' A' ' 6' ' ' ILE . 2.9 mm? -74.45 -32.94 62.78 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.132 -0.98 . . . . 0.0 111.996 177.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 62.0 mtp180 -53.71 -39.97 65.67 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 121.123 -0.985 . . . . 0.0 111.632 162.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -67.83 -37.06 88.05 Favored Glycine 0 CA--C 1.535 1.321 0 CA-C-O 118.3 -1.278 . . . . 0.0 114.155 172.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -60.72 -32.32 71.59 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 120.746 2.273 . . . . 0.0 113.296 174.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 57.2 mt -75.53 -43.99 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 123.904 0.882 . . . . 0.0 109.95 174.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 19.0 t80 -67.7 -43.19 80.68 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 121.026 -1.046 . . . . 0.0 112.728 -177.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -67.38 -15.2 63.55 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 113.944 1.091 . . . . 0.0 113.944 178.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -106.71 -26.54 11.27 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 177.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 27.3 m-85 -143.44 4.84 1.4 Allowed 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 115.858 1.799 . . . . 0.0 115.858 -170.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 44.6 mmtm 54.42 24.49 5.26 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 127.608 2.363 . . . . 0.0 116.952 178.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 -101.52 111.13 23.27 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.057 1.343 . . . . 0.0 111.615 -174.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -96.36 -17.16 20.85 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 178.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 98.3 m -72.52 153.71 41.19 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.682 1.593 . . . . 0.0 111.862 176.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.7 m -115.99 151.74 46.85 Favored Pre-proline 0 N--CA 1.477 0.904 0 C-N-CA 123.713 0.805 . . . . 0.0 111.546 165.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -74.19 155.62 99.84 Favored 'Cis proline' 0 N--CA 1.459 -0.539 0 CA-C-N 119.207 0.753 . . . . 0.0 112.944 -3.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -98.13 139.33 34.1 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.542 1.137 . . . . 0.0 108.447 159.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 53.0 mt -129.91 140.81 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 123.972 0.909 . . . . 0.0 109.487 -165.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -138.13 143.13 40.2 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.126 0.97 . . . . 0.0 111.18 178.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 72.4 mt -135.22 123.13 38.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 125.346 1.458 . . . . 0.0 109.17 -178.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 45.27 48.33 10.26 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 124.902 1.281 . . . . 0.0 113.371 -179.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 75.04 10.92 84.19 Favored Glycine 0 CA--C 1.539 1.545 0 N-CA-C 116.066 1.186 . . . . 0.0 116.066 179.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 21.1 m-80 -116.04 140.39 49.32 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.472 1.509 . . . . 0.0 111.683 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -82.47 131.9 35.21 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.596 1.158 . . . . 0.0 112.944 179.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 41.1 mm -107.25 123.43 62.45 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 127.047 2.139 . . . . 0.0 108.288 177.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.18 12.02 0.66 Allowed Glycine 0 CA--C 1.531 1.055 0 N-CA-C 119.089 2.395 . . . . 0.0 119.089 -166.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 142.36 -177.1 21.83 Favored Glycine 0 CA--C 1.535 1.316 0 C-N-CA 127.582 2.515 . . . . 0.0 113.643 170.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 39.1 t -57.09 -42.86 81.52 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.721 -0.87 . . . . 0.0 111.458 173.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 68.5 m -65.53 -26.06 67.72 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 178.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.44 -40.56 64.13 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 119.703 1.138 . . . . 0.0 111.768 172.08 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 40.1 tp -60.55 -48.96 79.45 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.865 0.866 . . . . 0.0 110.738 173.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -66.19 -34.36 77.86 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.522 0.729 . . . . 0.0 111.438 177.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.85 -35.66 74.9 Favored 'General case' 0 CA--C 1.543 0.677 0 O-C-N 120.227 -1.546 . . . . 0.0 112.79 175.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 84.0 mt -72.55 -31.05 64.97 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.216 1.007 . . . . 0.0 112.777 173.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -59.4 -48.55 81.2 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.788 0.835 . . . . 0.0 110.109 166.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.92 -34.4 75.33 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 -178.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -75.74 0.72 16.86 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 114.361 1.245 . . . . 0.0 114.361 172.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 71.05 21.47 78.36 Favored Glycine 0 CA--C 1.534 1.219 0 O-C-N 121.322 -0.861 . . . . 0.0 113.445 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 44.0 mtmt -101.38 -25.96 13.76 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 125.688 1.595 . . . . 0.0 113.107 -174.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 39.4 tp -64.2 -37.4 87.33 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.267 1.027 . . . . 0.0 112.189 176.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -52.8 -44.09 66.39 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.002 0.921 . . . . 0.0 111.973 173.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -75.01 -29.78 60.2 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.044 0.831 . . . . 0.0 114.525 178.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 85.1 mt -66.09 -40.84 91.13 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 118.382 1.091 . . . . 0.0 111.356 170.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 86.4 mt -90.53 -18.87 24.51 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 -170.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 72.7 m . . . . . 0 C--O 1.252 1.205 0 C-N-CA 124.506 1.122 . . . . 0.0 113.385 -179.286 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.105 0 N-CA-C 111.261 -0.736 . . . . 0.0 111.261 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -81.66 161.47 23.4 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.651 1.18 . . . . 0.0 113.068 -176.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 16.6 tpt -70.06 140.48 88.4 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 124.062 0.945 . . . . 0.0 110.796 176.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -75.5 130.24 12.6 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.502 2.135 . . . . 0.0 111.129 171.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 17.5 p -132.05 -162.48 1.23 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.323 1.049 . . . . 0.0 111.865 176.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.493 HG23 HD12 ' A' ' 54' ' ' LEU . 16.2 pt -51.03 -24.04 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 124.496 1.118 . . . . 0.0 113.589 173.107 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.86 -27.99 67.14 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.87 0.868 . . . . 0.0 113.094 -175.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.1 p -80.65 -28.82 36.78 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 121.242 -0.911 . . . . 0.0 113.426 174.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 43.3 mtt -63.97 -35.47 80.79 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.29 1.036 . . . . 0.0 110.478 179.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -62.88 -27.39 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 125.89 1.676 . . . . 0.0 111.826 -176.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 45.2 mmtm -79.21 -17.04 55.61 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.018 1.327 . . . . 0.0 113.779 -175.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -87.34 -26.77 29.64 Favored Glycine 0 CA--C 1.533 1.198 0 N-CA-C 116.331 1.292 . . . . 0.0 116.331 -167.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -134.05 153.77 51.59 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.694 1.197 . . . . 0.0 111.628 -178.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -62.77 -34.62 77.62 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.002 0.741 . . . . 0.0 113.002 -174.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.4 t -122.27 131.53 72.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.373 1.069 . . . . 0.0 109.896 167.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 65.1 t -132.01 127.77 58.54 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 124.158 0.983 . . . . 0.0 109.571 176.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 37.5 t -126.28 147.3 31.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 C-N-CA 123.929 0.892 . . . . 0.0 111.773 -175.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -122.55 108.81 13.56 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.568 1.147 . . . . 0.0 109.44 176.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 37.1 m -128.93 173.88 10.01 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 126.638 1.975 . . . . 0.0 111.458 -167.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 28.9 m0 -120.11 144.58 47.54 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 124.367 1.067 . . . . 0.0 109.699 163.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 16.5 t -68.73 -17.2 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 CA-C-O 120.934 0.397 . . . . 0.0 111.079 178.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.3 p -86.31 -10.81 53.75 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 128.066 2.547 . . . . 0.0 116.579 178.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 5.9 t -96.45 143.42 26.08 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-N 120.017 1.28 . . . . 0.0 112.731 -170.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -72.21 -40.19 2.55 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 121.28 1.32 . . . . 0.0 113.634 173.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -58.0 -36.81 73.18 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 125.334 1.453 . . . . 0.0 113.802 179.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -54.02 -61.22 2.45 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.477 1.911 . . . . 0.0 109.573 174.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 92.0 t -60.9 -39.37 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.346 1.058 . . . . 0.0 111.104 -179.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 12.2 ttt180 -52.54 -38.57 60.02 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.684 1.594 . . . . 0.0 114.901 169.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -79.53 -54.59 5.75 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 119.079 0.854 . . . . 0.0 111.79 171.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -48.19 -43.35 31.72 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.386 1.474 . . . . 0.0 113.137 -178.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -62.3 -40.22 95.57 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 123.722 0.809 . . . . 0.0 112.35 -175.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.4 tt -79.08 -42.34 26.59 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 126.538 1.935 . . . . 0.0 110.867 -178.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 91.5 mt -62.07 -40.66 96.56 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 121.868 -0.52 . . . . 0.0 111.665 177.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -71.27 -24.48 62.17 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 172.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.56 -25.04 53.62 Favored 'General case' 0 CA--C 1.548 0.899 0 CA-C-N 120.144 1.338 . . . . 0.0 112.921 174.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 7.5 tpt180 -106.88 -31.98 8.12 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.868 1.667 . . . . 0.0 114.823 -170.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 13.6 p -134.05 154.44 51.15 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 -166.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -103.81 -31.91 9.58 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 127.406 2.282 . . . . 0.0 112.455 174.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -93.06 38.52 1.03 Allowed 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 125.451 1.5 . . . . 0.0 113.186 -171.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.14 122.4 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 124.974 1.309 . . . . 0.0 112.96 -175.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.9 m -113.3 135.28 54.02 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 125.811 1.645 . . . . 0.0 109.847 170.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.3 p -124.21 138.05 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.457 1.103 . . . . 0.0 112.304 171.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -109.37 125.95 52.91 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.015 1.726 . . . . 0.0 110.637 177.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -98.17 79.82 2.62 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.351 1.061 . . . . 0.0 110.233 -177.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 31.0 m -56.89 -28.55 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -167.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -70.66 -14.25 62.4 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 124.329 1.052 . . . . 0.0 113.693 176.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 21.2 mmmt -83.0 -13.02 56.76 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 126.3 1.84 . . . . 0.0 112.559 173.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 22.3 mmt -101.5 172.26 7.07 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.178 1.791 . . . . 0.0 111.787 -178.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 19.0 m -81.19 -18.75 45.12 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 121.063 -1.023 . . . . 0.0 113.331 -177.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -122.05 8.29 9.82 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.702 1.601 . . . . 0.0 114.42 -163.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -55.45 -27.98 49.51 Favored Glycine 0 CA--C 1.538 1.523 0 CA-C-N 120.035 1.289 . . . . 0.0 115.18 -172.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -67.82 -31.65 71.65 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 119.973 1.886 . . . . 0.0 113.088 171.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 63.8 mt-30 -73.69 -38.55 64.85 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.686 1.194 . . . . 0.0 111.344 173.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.493 HD12 HG23 ' A' ' 6' ' ' ILE . 2.7 mm? -75.18 -33.9 61.49 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 119.484 1.038 . . . . 0.0 111.962 177.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 15.7 mtp85 -55.32 -41.06 71.93 Favored 'General case' 0 N--CA 1.478 0.965 0 O-C-N 120.953 -1.092 . . . . 0.0 111.303 161.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -63.38 -24.16 67.27 Favored Glycine 0 CA--C 1.537 1.431 0 C-N-CA 124.444 1.021 . . . . 0.0 115.127 171.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 39.6 mm-40 -71.45 -37.29 71.41 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 120.471 2.136 . . . . 0.0 111.72 172.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 44.1 mt -72.35 -43.55 64.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.403 0 C-N-CA 123.948 0.899 . . . . 0.0 109.539 179.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -67.76 -42.75 81.27 Favored 'General case' 0 CA--C 1.532 0.262 0 O-C-N 121.298 -0.876 . . . . 0.0 112.914 -178.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -65.7 -26.06 67.6 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -177.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -100.19 -29.55 12.42 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -131.58 -2.41 3.81 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 114.752 1.39 . . . . 0.0 114.752 -172.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt 51.33 39.0 23.11 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 126.152 1.781 . . . . 0.0 113.629 -175.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -123.52 138.66 54.52 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 126.828 2.051 . . . . 0.0 110.701 -178.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -142.39 -33.17 0.48 Allowed 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.603 1.561 . . . . 0.0 111.966 -155.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.7 p -84.03 113.18 20.83 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 125.43 1.492 . . . . 0.0 113.102 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.2 m -66.77 153.54 93.64 Favored Pre-proline 0 N--CA 1.484 1.245 0 C-N-CA 124.811 1.245 . . . . 0.0 113.1 -179.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -75.89 151.94 96.21 Favored 'Cis proline' 0 C--N 1.352 0.715 0 CA-C-N 119.327 0.795 . . . . 0.0 113.918 -6.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -93.79 137.05 33.44 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 159.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 46.3 mt -125.1 141.64 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 C-N-CA 124.209 1.004 . . . . 0.0 109.243 -168.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 72.6 m-85 -142.41 147.09 35.62 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.391 0.676 . . . . 0.0 111.587 179.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 74.9 mt -127.91 123.37 60.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 125.277 1.431 . . . . 0.0 108.099 175.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 50.62 27.57 3.02 Favored 'General case' 0 CA--C 1.555 1.149 0 N-CA-C 115.257 1.577 . . . . 0.0 115.257 -177.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 89.89 -7.39 81.81 Favored Glycine 0 CA--C 1.543 1.827 0 O-C-N 120.697 -1.252 . . . . 0.0 115.257 -173.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -90.86 143.3 26.87 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.103 1.761 . . . . 0.0 110.336 179.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -90.19 142.6 27.56 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 -167.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 15.9 mm -130.84 125.49 58.36 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 C-N-CA 128.245 2.618 . . . . 0.0 108.981 176.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -67.7 -13.94 64.3 Favored Glycine 0 CA--C 1.538 1.488 0 N-CA-C 117.166 1.627 . . . . 0.0 117.166 -168.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 158.25 -175.24 35.44 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-N 118.271 1.035 . . . . 0.0 113.528 175.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 14.7 t -63.43 -35.36 80.18 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.507 -0.996 . . . . 0.0 112.943 -178.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 52.2 m -64.65 -23.1 67.15 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 121.113 -0.992 . . . . 0.0 113.271 176.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -88.17 -39.74 14.28 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.504 1.522 . . . . 0.0 112.702 174.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 37.7 tp -58.21 -51.93 67.68 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.38 1.472 . . . . 0.0 111.502 171.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -63.17 -24.52 67.93 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.041 0.536 . . . . 0.0 111.714 178.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -78.84 -31.96 45.9 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 121.304 -0.872 . . . . 0.0 113.334 176.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 14.2 mt -65.34 -34.91 79.43 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 119.278 0.944 . . . . 0.0 112.059 169.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -61.6 -44.87 96.2 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.861 0.864 . . . . 0.0 110.932 171.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 14.1 mmtt -71.54 -30.4 65.85 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -177.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -72.86 -10.88 60.3 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 172.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 74.89 30.24 59.73 Favored Glycine 0 CA--C 1.533 1.19 0 O-C-N 121.292 -0.88 . . . . 0.0 113.649 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 45.8 mtmt -118.97 -16.0 9.25 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 126.668 1.987 . . . . 0.0 113.021 -169.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 35.1 tp -71.35 -38.94 71.58 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.857 1.263 . . . . 0.0 111.915 -175.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -65.46 -28.42 69.2 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 178.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -85.31 -12.7 72.62 Favored Glycine 0 CA--C 1.534 1.249 0 C-N-CA 125.622 1.582 . . . . 0.0 115.22 172.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 24.9 mt -81.2 -39.31 25.62 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 119.377 1.589 . . . . 0.0 111.055 165.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 79.3 mt -89.29 26.25 1.7 Allowed 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 126.328 1.851 . . . . 0.0 113.035 -175.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 10.7 p . . . . . 0 C--O 1.251 1.143 0 C-N-CA 127.099 2.159 . . . . 0.0 114.673 -177.502 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.861 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -58.72 -23.44 59.71 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.86 1.264 . . . . 0.0 114.378 179.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 63.7 mtt -121.65 156.9 58.15 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 125.798 1.639 . . . . 0.0 109.021 158.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -64.5 112.04 1.83 Allowed 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.02 1.813 . . . . 0.0 112.192 -175.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 59.8 p -107.52 -161.57 0.79 Allowed 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 126.082 1.753 . . . . 0.0 110.616 179.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.516 HG23 HD12 ' A' ' 54' ' ' LEU . 29.9 pt -56.08 -25.68 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 O-C-N 120.762 -1.211 . . . . 0.0 112.49 168.342 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -65.96 -19.77 65.98 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -173.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.3 m -89.08 -19.84 25.07 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.425 1.09 . . . . 0.0 113.256 173.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 66.4 mtp -62.53 -33.35 74.72 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 119.39 0.995 . . . . 0.0 111.804 172.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.2 mm -60.47 -18.09 15.99 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 124.672 1.189 . . . . 0.0 112.267 -177.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.2 mptt -91.37 -9.02 46.34 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.245 1.418 . . . . 0.0 113.859 177.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -88.19 -39.04 7.02 Favored Glycine 0 CA--C 1.538 1.528 0 C-N-CA 124.715 1.15 . . . . 0.0 115.814 -175.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 29.1 m120 -120.96 167.33 12.69 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.369 1.467 . . . . 0.0 112.072 -178.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -68.83 -42.02 77.74 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.57 0.748 . . . . 0.0 112.67 176.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.9 t -125.5 134.17 67.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.95 1.3 . . . . 0.0 110.2 176.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 27.1 t -134.74 135.1 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 124.249 1.02 . . . . 0.0 110.361 177.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 53.0 t -134.42 149.24 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 C-N-CA 124.55 1.14 . . . . 0.0 112.085 -171.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -129.69 123.1 30.32 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.993 1.317 . . . . 0.0 110.873 -179.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 54.1 m -143.9 169.92 16.88 Favored 'General case' 0 N--CA 1.469 0.525 0 N-CA-C 114.452 1.278 . . . . 0.0 114.452 -159.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.484 ' CD1' ' HB3' ' A' ' 46' ' ' ASP . 40.5 m0 -115.17 139.5 49.87 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.547 1.539 . . . . 0.0 109.616 161.224 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 24.8 t -60.21 -53.72 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 -161.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.7 t -94.23 3.43 55.26 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 -164.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.447 ' HA ' ' HD3' ' A' ' 24' ' ' PRO . 96.4 m -88.76 142.31 30.6 Favored Pre-proline 0 CA--C 1.542 0.667 0 C-N-CA 124.328 1.051 . . . . 0.0 112.599 -165.005 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 23' ' ' CYS . 65.8 Cg_exo -68.0 -36.97 16.09 Favored 'Trans proline' 0 C--N 1.351 0.68 0 N-CA-C 115.677 1.376 . . . . 0.0 115.677 -162.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -52.93 -41.83 64.83 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 122.24 1.019 . . . . 0.0 113.075 171.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 3.8 m -81.73 -32.52 31.53 Favored 'General case' 0 N--CA 1.435 -1.182 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.359 -162.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 99.6 t -62.46 -53.07 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 124.954 1.301 . . . . 0.0 111.51 161.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . 0.263 7.2 ptp180 -67.45 -29.27 68.69 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -173.032 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.28 -53.24 13.05 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.438 1.095 . . . . 0.0 111.685 171.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -46.65 -44.88 18.8 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-N 119.91 1.232 . . . . 0.0 112.879 175.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -64.07 -45.58 88.13 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.501 0.72 . . . . 0.0 112.595 -179.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.2 tt -72.4 -36.55 68.68 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.446 1.098 . . . . 0.0 111.206 -178.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 95.9 mt -61.1 -46.54 90.19 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.443 -0.785 . . . . 0.0 110.735 171.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 8.7 m-70 -66.83 -21.71 66.02 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 173.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -73.0 -18.44 61.35 Favored 'General case' 0 CA--C 1.545 0.782 0 O-C-N 120.716 -1.24 . . . . 0.0 113.069 173.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 21.7 mmt85 -115.73 -19.83 10.34 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 -179.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 48.8 p -147.32 166.89 25.74 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 115.394 1.627 . . . . 0.0 115.394 -166.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 28.9 mtmm -116.69 -32.05 5.29 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 127.165 2.186 . . . . 0.0 113.623 162.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -82.73 50.59 1.71 Allowed 'General case' 0 CA--C 1.549 0.914 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 -175.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -115.2 113.07 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 126.16 1.784 . . . . 0.0 111.964 177.116 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.4 m -100.49 142.91 31.32 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 127.014 2.125 . . . . 0.0 110.097 175.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.7 p -145.24 140.58 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -178.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 38.8 t60 -116.67 131.8 56.85 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 126.595 1.958 . . . . 0.0 110.98 -176.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -101.93 96.62 7.16 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 122.761 1.267 . . . . 0.0 111.973 -177.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 22.4 m -80.43 -1.63 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 114.003 1.112 . . . . 0.0 114.003 -174.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.484 ' HB3' ' CD1' ' A' ' 20' ' ' TRP . 0.0 OUTLIER -83.64 -12.11 56.4 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.146 0.978 . . . . 0.0 112.085 162.855 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 70.0 mmtt -107.29 -44.07 4.43 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.588 1.555 . . . . 0.0 112.013 179.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 29.2 tpp -67.97 127.23 32.07 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 118.833 0.742 . . . . 0.0 110.224 176.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 62.8 m -68.42 -29.49 68.17 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 119.373 0.988 . . . . 0.0 113.354 -174.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 20.5 tp10 -79.74 -3.09 46.01 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.021 0.928 . . . . 0.0 112.648 170.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -56.53 -26.27 51.93 Favored Glycine 0 CA--C 1.529 0.914 0 O-C-N 120.489 -1.382 . . . . 0.0 114.511 -171.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -70.18 -24.11 63.08 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 118.537 1.169 . . . . 0.0 112.67 176.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 16.8 tm0? -86.72 -34.58 19.64 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.126 1.37 . . . . 0.0 111.811 170.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.516 HD12 HG23 ' A' ' 6' ' ' ILE . 3.0 mm? -67.16 -33.76 76.11 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 119.572 1.078 . . . . 0.0 112.293 171.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 30.1 ttt180 -62.01 -29.93 70.6 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.405 1.482 . . . . 0.0 110.937 165.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.29 -24.7 75.94 Favored Glycine 0 CA--C 1.542 1.72 0 C-N-CA 125.632 1.587 . . . . 0.0 115.784 165.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -71.96 -25.78 62.01 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 121.19 2.495 . . . . 0.0 112.017 169.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 23.8 mt -74.66 -46.46 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 123.253 0.621 . . . . 0.0 109.461 166.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -63.69 -42.21 98.02 Favored 'General case' 0 CA--C 1.537 0.458 0 O-C-N 121.14 -0.975 . . . . 0.0 113.398 -176.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 95.0 mm-40 -71.87 -10.0 59.14 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 178.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -107.54 -35.64 6.68 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.536 1.135 . . . . 0.0 113.547 176.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -137.49 4.7 2.64 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 125.349 1.459 . . . . 0.0 114.703 -169.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 50.71 42.3 27.18 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 127.006 2.122 . . . . 0.0 114.516 176.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 61.8 t60 -127.44 129.92 48.36 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.847 1.259 . . . . 0.0 111.119 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -119.91 -1.33 10.47 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.621 1.568 . . . . 0.0 113.759 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.3 m -86.06 173.45 9.87 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.998 1.719 . . . . 0.0 110.468 175.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.7 m -132.73 156.95 79.51 Favored Pre-proline 0 N--CA 1.48 1.025 0 O-C-N 120.631 -1.293 . . . . 0.0 113.917 -175.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -73.16 159.8 96.73 Favored 'Cis proline' 0 C--N 1.349 0.591 0 CA-C-N 118.588 0.531 . . . . 0.0 112.471 -13.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -101.9 141.02 35.39 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.972 0.909 . . . . 0.0 108.986 159.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 82.0 mt -130.68 144.15 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 123.726 0.811 . . . . 0.0 109.65 -168.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -140.5 146.37 38.07 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 124.243 1.017 . . . . 0.0 111.998 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 71.5 mt -129.26 118.98 47.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 125.367 1.467 . . . . 0.0 108.241 172.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 47.49 38.23 7.5 Favored 'General case' 0 CA--C 1.552 1.056 0 N-CA-C 115.821 1.785 . . . . 0.0 115.821 176.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 93.48 -7.51 74.9 Favored Glycine 0 CA--C 1.538 1.477 0 C-N-CA 124.593 1.092 . . . . 0.0 115.312 -178.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -102.47 138.03 39.93 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.939 1.696 . . . . 0.0 110.406 -174.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -85.23 147.73 26.43 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.073 0.949 . . . . 0.0 113.076 -170.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 20.6 mm -133.34 120.64 39.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 128.473 2.709 . . . . 0.0 106.279 177.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -62.88 -15.66 55.68 Favored Glycine 0 CA--C 1.533 1.182 0 N-CA-C 116.851 1.5 . . . . 0.0 116.851 -160.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 138.8 -152.14 22.01 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 125.609 1.576 . . . . 0.0 112.739 179.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 8.6 t -72.25 -20.48 61.53 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -173.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 19.8 m -83.38 -38.52 21.87 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 121.254 -0.904 . . . . 0.0 112.012 171.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -70.7 -36.38 73.23 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.148 0.979 . . . . 0.0 111.641 177.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 47.5 tp -59.82 -57.49 12.68 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.405 1.482 . . . . 0.0 111.645 -179.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -69.59 -30.58 68.38 Favored 'General case' 0 CA--C 1.536 0.421 0 O-C-N 121.892 -0.505 . . . . 0.0 111.305 178.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.02 -38.25 87.98 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 119.474 1.034 . . . . 0.0 112.49 176.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 85.4 mt -73.81 -25.24 60.0 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.917 0.887 . . . . 0.0 112.702 176.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -73.08 -40.12 65.29 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 118.779 0.718 . . . . 0.0 111.609 169.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 10.1 mptt -65.19 -30.4 71.3 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.371 1.068 . . . . 0.0 112.889 173.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -80.34 1.97 26.69 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.083 1.353 . . . . 0.0 113.851 169.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 71.21 24.13 77.34 Favored Glycine 0 CA--C 1.534 1.262 0 C-N-CA 124.732 1.158 . . . . 0.0 114.761 175.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -113.2 -31.74 6.52 Favored 'General case' 0 C--N 1.34 0.162 0 C-N-CA 126.051 1.74 . . . . 0.0 113.365 -170.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 36.7 tp -57.23 -42.7 81.92 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 122.618 0.367 . . . . 0.0 111.467 -175.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -63.56 -42.73 98.33 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -178.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -73.05 -29.45 64.72 Favored Glycine 0 CA--C 1.528 0.876 0 CA-C-O 119.123 -0.821 . . . . 0.0 114.439 177.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 81.8 mt -72.8 -34.21 66.74 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 118.332 1.066 . . . . 0.0 112.188 172.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 66.5 mt -86.7 -16.32 36.83 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.294 1.038 . . . . 0.0 113.607 179.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 58.7 m . . . . . 0 C--O 1.254 1.314 0 C-N-CA 124.976 1.31 . . . . 0.0 111.714 175.031 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.893 0 N-CA-C 111.62 -0.592 . . . . 0.0 111.62 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 55.73 21.24 4.52 Favored 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 126.838 2.055 . . . . 0.0 115.834 178.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 7.4 tpt -142.08 86.62 10.2 Favored Pre-proline 0 CA--C 1.547 0.857 0 C-N-CA 124.538 1.135 . . . . 0.0 110.868 -167.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_exo -53.99 -31.91 65.99 Favored 'Trans proline' 0 C--N 1.351 0.658 0 C-N-CA 123.954 3.103 . . . . 0.0 116.091 -171.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.0 m 57.44 -152.0 0.41 Allowed 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.071 1.348 . . . . 0.0 114.594 168.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 8.5 pt -60.99 -23.09 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 124.529 1.131 . . . . 0.0 113.941 -168.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -54.58 -27.25 37.65 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.729 1.212 . . . . 0.0 112.177 178.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 92.9 p -68.56 -36.37 78.68 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.765 1.226 . . . . 0.0 113.444 172.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 45.3 mtt -72.45 -38.56 68.25 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.385 1.474 . . . . 0.0 111.59 -177.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -66.52 -25.59 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 124.074 0.95 . . . . 0.0 111.551 -171.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -70.75 -11.13 60.76 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.826 1.65 . . . . 0.0 114.123 179.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -84.48 -31.27 25.2 Favored Glycine 0 CA--C 1.534 1.258 0 N-CA-C 115.944 1.137 . . . . 0.0 115.944 -167.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -136.71 156.72 48.15 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 119.499 1.649 . . . . 0.0 112.568 -174.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 28.4 ttpt -62.54 -39.41 93.52 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.986 0.914 . . . . 0.0 112.657 -176.139 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.9 t -124.96 129.08 73.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.524 1.13 . . . . 0.0 109.821 167.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 83.1 t -126.11 127.09 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 C-N-CA 125.389 1.476 . . . . 0.0 109.04 178.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 40.3 t -123.53 144.55 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 123.611 0.765 . . . . 0.0 111.169 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 90.2 m-85 -118.3 113.18 21.07 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.672 1.189 . . . . 0.0 109.018 171.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 28.4 m -131.35 168.17 18.01 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.384 1.474 . . . . 0.0 112.281 -170.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 51.7 m0 -107.92 126.12 52.31 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.644 1.178 . . . . 0.0 107.872 159.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 25.9 t -49.95 -36.48 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 126.49 1.916 . . . . 0.0 113.237 -164.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.5 t -93.3 -8.91 40.76 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 127.175 2.19 . . . . 0.0 115.137 -167.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 95.6 m -94.28 149.31 36.53 Favored Pre-proline 0 CA--C 1.535 0.374 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -159.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -67.39 -47.34 2.23 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 CA-C-N 119.127 0.724 . . . . 0.0 113.603 -163.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 56.9 m-85 -68.22 -33.43 74.39 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 124.438 1.095 . . . . 0.0 113.243 -179.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -51.25 -53.37 36.07 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.776 0.83 . . . . 0.0 109.246 167.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 62.6 t -68.75 -36.36 73.99 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 O-C-N 121.714 -0.617 . . . . 0.0 112.244 -177.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 27.7 mmt85 -52.79 -42.07 64.71 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 119.227 0.922 . . . . 0.0 112.046 170.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.64 -56.56 5.14 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.396 0.678 . . . . 0.0 111.878 173.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -50.82 -39.52 53.35 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 119.435 1.016 . . . . 0.0 113.028 -177.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -69.6 -43.64 72.38 Favored 'General case' 0 C--O 1.233 0.184 0 C-N-CA 123.892 0.877 . . . . 0.0 112.312 -178.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.4 tt -73.77 -37.62 64.95 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 124.309 1.044 . . . . 0.0 111.464 -178.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 98.0 mt -62.61 -42.84 99.81 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.239 0.616 . . . . 0.0 110.9 174.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 10.2 m-70 -67.93 -13.15 61.93 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 171.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -95.6 -13.03 24.7 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.301 1.041 . . . . 0.0 113.751 170.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 20.1 mmt180 -111.67 -30.34 7.37 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 114.981 1.474 . . . . 0.0 114.981 -173.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.0 t -149.03 156.6 42.48 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 -173.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 48.1 mtmt -91.6 -9.13 45.24 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 126.785 2.034 . . . . 0.0 112.499 166.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -105.51 20.49 18.81 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -162.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.26 136.81 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 125.481 1.513 . . . . 0.0 112.692 -178.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.9 m -125.44 133.7 52.36 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 126.696 1.999 . . . . 0.0 110.014 168.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.4 p -121.29 136.11 59.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 125.013 1.325 . . . . 0.0 112.998 173.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -104.1 116.65 32.6 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.917 2.087 . . . . 0.0 108.989 174.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -88.56 96.37 10.6 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 121.0 -1.063 . . . . 0.0 111.2 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 22.0 m -73.74 1.65 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 N-CA-C 114.607 1.336 . . . . 0.0 114.607 -172.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -85.29 -22.44 28.56 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.437 1.095 . . . . 0.0 112.756 163.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.5 mmmt -90.34 -35.08 15.43 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.035 1.734 . . . . 0.0 111.667 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -89.35 130.44 35.73 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.692 0.797 . . . . 0.0 110.962 -177.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 74.4 m -70.69 -16.09 62.77 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 115.235 1.569 . . . . 0.0 115.235 -169.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -93.02 6.67 47.11 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.843 1.657 . . . . 0.0 112.908 173.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -51.7 -29.03 24.56 Favored Glycine 0 CA--C 1.534 1.26 0 C-N-CA 125.368 1.461 . . . . 0.0 116.385 -174.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -79.73 -25.13 41.2 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 119.052 1.426 . . . . 0.0 113.358 178.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -74.81 -33.95 62.29 Favored 'General case' 0 N--CA 1.469 0.489 0 O-C-N 121.462 -0.774 . . . . 0.0 111.052 168.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.54 -42.79 86.63 Favored 'General case' 0 CA--C 1.548 0.882 0 O-C-N 121.716 -0.615 . . . . 0.0 110.342 171.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 56.3 mtp85 -54.76 -43.96 73.21 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 119.397 0.999 . . . . 0.0 111.936 167.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.41 -42.94 99.14 Favored Glycine 0 CA--C 1.534 1.24 0 C-N-CA 124.24 0.924 . . . . 0.0 113.732 178.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 51.2 mm-40 -63.44 -38.18 90.16 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 118.413 1.107 . . . . 0.0 113.449 173.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 65.9 mt -66.46 -44.58 90.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 118.573 0.624 . . . . 0.0 109.621 175.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -64.26 -40.35 95.81 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 121.432 -0.793 . . . . 0.0 112.059 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -69.46 -24.88 63.86 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 121.092 -1.005 . . . . 0.0 113.363 -179.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -99.53 -25.17 14.52 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 115.008 1.485 . . . . 0.0 115.008 176.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -135.92 0.52 2.66 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 114.741 1.386 . . . . 0.0 114.741 -171.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp 48.6 46.05 21.19 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 126.525 1.93 . . . . 0.0 113.729 175.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 8.5 t60 -140.39 134.2 30.5 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.283 1.833 . . . . 0.0 109.46 -175.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -117.3 -25.38 7.08 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 125.696 1.599 . . . . 0.0 113.418 -178.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.3 p -77.8 129.02 34.93 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.047 0.939 . . . . 0.0 112.621 -171.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.6 m -83.77 151.11 60.66 Favored Pre-proline 0 N--CA 1.478 0.93 0 C-N-CA 123.652 0.781 . . . . 0.0 112.109 -173.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -80.2 156.55 87.12 Favored 'Cis proline' 0 C--N 1.352 0.717 0 N-CA-C 114.118 0.776 . . . . 0.0 114.118 -0.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -101.34 135.35 42.96 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.907 0.883 . . . . 0.0 108.856 159.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 50.9 mt -128.28 139.53 51.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 123.984 0.914 . . . . 0.0 109.149 -166.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -140.0 148.23 41.57 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.62 0.768 . . . . 0.0 112.467 -179.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 62.1 mt -130.28 120.19 48.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 125.445 1.498 . . . . 0.0 108.633 174.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 45.3 40.62 5.4 Favored 'General case' 0 CA--C 1.558 1.269 0 C-N-CA 125.599 1.559 . . . . 0.0 114.625 -176.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 82.16 0.85 90.1 Favored Glycine 0 CA--C 1.542 1.762 0 O-C-N 120.822 -1.174 . . . . 0.0 115.629 -178.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -95.62 140.12 30.89 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.885 1.674 . . . . 0.0 110.416 176.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -85.07 144.85 27.98 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 119.253 0.933 . . . . 0.0 113.444 -177.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 31.5 mm -123.44 127.44 74.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 C-N-CA 128.764 2.826 . . . . 0.0 107.023 177.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -69.82 18.28 0.64 Allowed Glycine 0 CA--C 1.532 1.118 0 N-CA-C 119.135 2.414 . . . . 0.0 119.135 -163.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 114.82 -173.15 14.61 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 128.85 3.119 . . . . 0.0 112.666 -178.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 12.9 t -63.5 -33.71 76.18 Favored 'General case' 0 CA--C 1.54 0.589 0 O-C-N 121.485 -1.009 . . . . 0.0 111.688 179.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 67.4 m -61.78 -21.99 65.05 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.992 1.108 . . . . 0.0 113.992 172.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -88.88 -43.8 10.93 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.652 1.181 . . . . 0.0 110.903 174.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 48.8 tp -57.24 -48.24 79.33 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.027 1.331 . . . . 0.0 111.683 176.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -72.47 -25.96 61.63 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 121.734 -0.604 . . . . 0.0 112.054 179.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.48 -28.98 63.24 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.196 -0.94 . . . . 0.0 112.54 175.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 52.2 mt -73.78 -26.73 60.79 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.124 1.37 . . . . 0.0 112.808 171.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -64.58 -44.43 90.7 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 118.616 0.644 . . . . 0.0 110.343 162.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 20.3 mmtt -68.74 -34.18 75.17 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 121.828 -0.545 . . . . 0.0 112.28 -177.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.42 ' HB3' ' HE2' ' A' ' 91' ' ' LYS . 6.4 mt-10 -79.83 -3.23 46.93 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 168.322 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 65.18 44.64 93.64 Favored Glycine 0 CA--C 1.532 1.105 0 CA-C-N 120.262 1.392 . . . . 0.0 112.983 172.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.42 ' HE2' ' HB3' ' A' ' 89' ' ' GLU . 36.6 mtmt -131.18 -8.68 3.81 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 126.996 2.118 . . . . 0.0 113.487 -170.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 29.8 tp -66.08 -34.66 78.58 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 122.205 1.002 . . . . 0.0 110.663 -176.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -60.87 -48.05 83.57 Favored 'General case' 0 N--CA 1.431 -1.418 0 C-N-CA 127.577 2.351 . . . . 0.0 114.053 171.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -69.42 -22.68 76.5 Favored Glycine 0 CA--C 1.53 1.012 0 O-C-N 121.131 -0.98 . . . . 0.0 113.697 175.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 36.7 mt -74.03 -37.33 64.37 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 117.663 0.731 . . . . 0.0 111.3 172.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 69.4 mt -75.47 -7.01 53.0 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.603 1.561 . . . . 0.0 114.29 176.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 19.6 m . . . . . 0 C--O 1.249 1.03 0 C-N-CA 127.15 2.18 . . . . 0.0 113.739 177.691 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.533 0 N-CA-C 111.718 -0.553 . . . . 0.0 111.718 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -128.45 -26.4 2.78 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 115.073 1.508 . . . . 0.0 115.073 -177.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.5 mpt? 47.61 59.36 16.7 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 127.867 2.467 . . . . 0.0 114.346 175.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -62.08 146.26 96.22 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 123.097 2.531 . . . . 0.0 112.274 179.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 89.4 p -159.8 -167.14 1.9 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.344 1.458 . . . . 0.0 110.79 178.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.571 HG23 HD12 ' A' ' 54' ' ' LEU . 20.5 pt -55.02 -21.32 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 179.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.14 -18.93 51.07 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 123.817 0.847 . . . . 0.0 113.203 -178.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 40.9 m -83.78 -25.76 30.19 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.807 1.243 . . . . 0.0 113.486 172.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 76.9 mtp -69.49 -28.69 66.29 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.281 1.032 . . . . 0.0 112.09 178.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.1 mm -64.11 -21.17 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 124.248 1.019 . . . . 0.0 112.342 179.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.5 mptt -81.77 -28.24 33.37 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 121.113 -0.992 . . . . 0.0 113.058 173.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -87.41 -8.03 75.08 Favored Glycine 0 CA--C 1.53 1.02 0 N-CA-C 116.742 1.457 . . . . 0.0 116.742 -166.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -143.61 151.83 40.64 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 119.354 1.577 . . . . 0.0 111.431 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 34.0 ttpt -67.41 -42.56 83.03 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 124.941 1.296 . . . . 0.0 112.413 -178.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.6 t -121.4 130.94 74.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 124.878 1.271 . . . . 0.0 110.065 170.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.6 t -129.7 128.1 65.13 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.528 1.131 . . . . 0.0 110.167 178.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 42.2 t -127.43 148.11 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 123.785 0.834 . . . . 0.0 111.715 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -123.64 116.56 23.29 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.798 1.239 . . . . 0.0 109.208 173.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 25.2 m -134.09 172.73 12.43 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.28 1.432 . . . . 0.0 112.203 -167.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.438 ' CD1' ' HB3' ' A' ' 46' ' ' ASP . 28.0 m0 -120.42 142.28 49.36 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.266 1.026 . . . . 0.0 109.784 161.285 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 75.4 t -59.91 -31.6 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 123.042 0.537 . . . . 0.0 111.332 172.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -69.09 -15.31 63.41 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 175.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 44.1 t -92.99 143.16 26.37 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-N 120.385 1.448 . . . . 0.0 111.278 -167.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -83.57 -31.32 0.62 Allowed 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 121.498 1.465 . . . . 0.0 113.157 174.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -69.05 -33.56 73.78 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 125.29 1.436 . . . . 0.0 113.54 178.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -45.74 -55.55 6.38 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.363 1.065 . . . . 0.0 109.356 164.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 85.9 t -63.91 -38.84 83.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 123.983 0.913 . . . . 0.0 112.068 -179.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 24.4 mmt85 -54.9 -37.82 66.81 Favored 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 119.536 1.062 . . . . 0.0 112.777 174.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -76.37 -59.18 2.88 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 123.735 0.647 . . . . 0.0 111.859 172.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -44.75 -47.56 10.78 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.854 1.262 . . . . 0.0 112.583 -179.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -65.53 -44.22 87.58 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 123.689 0.796 . . . . 0.0 111.627 -173.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.9 tt -69.6 -41.24 76.0 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.632 1.573 . . . . 0.0 110.775 179.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 92.2 mt -60.99 -50.43 73.42 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.095 0.558 . . . . 0.0 110.816 176.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 69.2 m-70 -66.64 -18.0 65.14 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 173.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.73 -13.73 59.66 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 119.908 1.231 . . . . 0.0 113.702 174.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 26.5 mmt85 -119.63 -25.89 5.85 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.73 1.612 . . . . 0.0 114.558 -178.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 19.3 m -145.98 150.39 35.95 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 124.605 1.162 . . . . 0.0 112.909 -157.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 2.0 mppt? -108.53 -23.52 11.8 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 126.766 2.027 . . . . 0.0 112.654 165.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -79.76 50.58 1.18 Allowed 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 125.317 1.447 . . . . 0.0 112.762 -179.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -121.99 130.78 74.29 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 126.19 1.796 . . . . 0.0 111.013 -178.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.1 m -123.07 123.85 41.77 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 125.861 1.664 . . . . 0.0 109.57 176.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.5 p -119.49 143.43 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 123.938 0.895 . . . . 0.0 112.375 175.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 30.0 t60 -111.55 117.28 32.54 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.515 1.526 . . . . 0.0 110.236 173.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -86.67 91.89 8.75 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 175.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 27.6 m -67.09 -17.41 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -176.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.438 ' HB3' ' CD1' ' A' ' 20' ' ' TRP . 0.3 OUTLIER -68.47 -26.48 65.5 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 121.174 -0.953 . . . . 0.0 111.995 172.646 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 20.1 mtmt -98.67 -5.71 31.12 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 126.275 1.83 . . . . 0.0 114.227 -179.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.43 ' HG3' ' H ' ' A' ' 50' ' ' GLU . 13.1 tpt -93.28 133.04 36.92 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.246 1.418 . . . . 0.0 111.467 -178.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 17.0 p -63.76 2.14 0.52 Allowed 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 126.657 1.983 . . . . 0.0 116.184 -179.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.43 ' H ' ' HG3' ' A' ' 48' ' ' MET . 7.0 tp10 -143.98 13.69 1.67 Allowed 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.522 1.529 . . . . 0.0 112.804 170.341 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -57.77 -24.58 53.9 Favored Glycine 0 CA--C 1.53 1.012 0 O-C-N 120.52 -1.363 . . . . 0.0 116.121 -167.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -63.66 -30.98 72.01 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 119.518 1.659 . . . . 0.0 112.096 174.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -74.89 -29.11 60.9 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.7 0.8 . . . . 0.0 111.941 176.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.571 HD12 HG23 ' A' ' 6' ' ' ILE . 2.8 mm? -81.02 -32.68 34.05 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.687 1.195 . . . . 0.0 111.602 176.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.8 ttt85 -56.87 -36.43 70.07 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.904 1.281 . . . . 0.0 110.667 159.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.53 -35.15 90.88 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 124.495 1.045 . . . . 0.0 115.465 167.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -64.98 -32.23 73.86 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 120.394 2.097 . . . . 0.0 112.267 176.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.2 mt -70.5 -42.13 78.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 123.682 0.793 . . . . 0.0 109.643 171.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -62.92 -41.44 99.47 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 178.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 33.0 mm-40 -62.09 -30.08 70.76 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 120.923 -1.111 . . . . 0.0 112.844 176.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -88.83 -38.41 14.62 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 179.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -133.76 0.82 3.28 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 -168.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.5 mptt 44.66 50.27 8.5 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 127.016 2.126 . . . . 0.0 113.126 -177.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 48.9 t60 -129.25 127.09 40.52 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 127.53 2.332 . . . . 0.0 108.102 178.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -108.13 -14.03 14.81 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.208 1.003 . . . . 0.0 113.53 178.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.9 m -74.82 141.86 44.25 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.3 1.04 . . . . 0.0 111.685 -176.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.0 m -97.88 150.81 37.15 Favored Pre-proline 0 N--CA 1.477 0.904 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 172.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -81.08 161.71 81.73 Favored 'Cis proline' 0 C--N 1.351 0.703 0 CA-C-N 118.686 0.566 . . . . 0.0 113.556 -3.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -107.61 139.45 42.14 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.093 0.957 . . . . 0.0 109.13 158.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 75.7 mt -131.88 139.08 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 124.22 1.008 . . . . 0.0 109.374 -165.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -140.98 145.39 35.91 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.937 0.895 . . . . 0.0 112.432 -178.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 58.2 mt -132.19 122.28 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 124.702 1.201 . . . . 0.0 109.405 172.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 32.0 m120 44.31 45.13 7.16 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 125.017 1.327 . . . . 0.0 113.327 -177.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 86.02 -12.96 58.64 Favored Glycine 0 CA--C 1.539 1.553 0 O-C-N 120.463 -1.398 . . . . 0.0 116.284 -178.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 59.8 m-80 -86.6 141.13 29.23 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 119.353 1.576 . . . . 0.0 110.634 -177.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -86.47 136.95 32.9 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.32 0.648 . . . . 0.0 112.177 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 38.5 mm -115.1 117.97 57.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 126.937 2.095 . . . . 0.0 107.099 178.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -70.55 3.58 11.47 Favored Glycine 0 N--CA 1.475 1.281 0 N-CA-C 117.919 1.928 . . . . 0.0 117.919 -159.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 155.64 173.91 24.86 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 128.072 2.749 . . . . 0.0 111.048 178.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 39.4 t -58.56 -32.79 69.24 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 121.317 -1.108 . . . . 0.0 112.494 171.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 69.7 m -66.61 -28.54 68.58 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 120.654 -1.279 . . . . 0.0 112.957 173.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -74.47 -36.21 63.3 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 119.516 1.053 . . . . 0.0 111.632 173.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 43.5 tp -62.91 -50.84 69.25 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.877 1.271 . . . . 0.0 110.794 172.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -59.5 -37.93 79.58 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.689 0.796 . . . . 0.0 111.481 176.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.98 -29.7 68.8 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.019 0.928 . . . . 0.0 113.483 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 35.7 mt -70.96 -25.48 62.74 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.066 0.848 . . . . 0.0 112.303 172.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -73.52 -37.54 65.6 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 118.56 0.618 . . . . 0.0 111.036 170.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 43.3 mmtt -66.57 -34.7 78.49 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 176.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -73.43 -9.36 58.61 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 113.407 0.892 . . . . 0.0 113.407 169.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 79.46 22.36 64.96 Favored Glycine 0 CA--C 1.535 1.282 0 CA-C-N 119.686 1.13 . . . . 0.0 114.579 178.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -107.29 -32.01 7.96 Favored 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 125.678 1.591 . . . . 0.0 112.305 -172.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 46.0 tp -57.71 -41.76 82.38 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 118.454 0.57 . . . . 0.0 112.432 -176.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -60.44 -43.64 96.61 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 118.928 -0.558 . . . . 0.0 112.437 -178.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -74.77 -38.09 43.3 Favored Glycine 0 CA--C 1.535 1.306 0 O-C-N 123.556 0.535 . . . . 0.0 113.324 177.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 37.6 mt -57.66 -36.42 71.87 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.404 1.082 . . . . 0.0 112.309 177.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 86.5 mt -73.92 -4.03 32.56 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 114.895 1.442 . . . . 0.0 114.895 -179.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 6.8 t . . . . . 0 C--O 1.257 1.495 0 C-N-CA 125.146 1.378 . . . . 0.0 112.733 -178.993 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.935 0 N-CA-C 110.879 -0.888 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -89.69 -14.22 35.22 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 124.576 1.15 . . . . 0.0 114.005 -177.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 25.6 ttt -128.75 87.42 54.84 Favored Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 125.446 1.498 . . . . 0.0 111.273 -166.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -57.79 130.86 40.65 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 122.024 1.816 . . . . 0.0 109.899 168.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 15.8 p -153.88 -164.86 1.97 Allowed 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 122.108 0.956 . . . . 0.0 112.844 -164.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.458 HG23 HD12 ' A' ' 54' ' ' LEU . 25.4 pt -55.71 -25.21 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 C-N-CA 124.471 1.108 . . . . 0.0 112.717 170.311 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.38 -23.85 66.4 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -171.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.1 t -87.96 -20.04 26.43 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 121.238 -0.914 . . . . 0.0 113.424 170.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 41.3 mtt -68.39 -26.09 65.38 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 121.27 -0.894 . . . . 0.0 112.334 175.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.6 mm -58.06 -31.4 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 C-N-CA 123.953 0.901 . . . . 0.0 111.667 177.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.1 mptt -80.56 -4.23 53.24 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.899 1.28 . . . . 0.0 114.039 -173.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -82.99 -28.4 37.68 Favored Glycine 0 CA--C 1.538 1.496 0 N-CA-C 115.953 1.141 . . . . 0.0 115.953 -173.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 27.3 m120 -145.35 163.71 33.73 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 118.597 1.199 . . . . 0.0 112.526 -173.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -63.16 -43.58 97.9 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.298 1.439 . . . . 0.0 112.723 -179.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.3 t -121.88 131.89 72.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 123.798 0.839 . . . . 0.0 110.26 171.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 54.4 t -132.56 127.39 56.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 125.006 1.322 . . . . 0.0 109.263 179.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 42.4 t -124.56 148.24 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 124.337 1.055 . . . . 0.0 111.624 -177.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -121.92 112.3 18.14 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.202 1.401 . . . . 0.0 108.869 172.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 10.7 m -126.5 174.14 8.87 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 126.646 1.978 . . . . 0.0 111.356 -171.178 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . . . . . . . . . 20.8 m0 -118.78 137.75 53.16 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.317 1.047 . . . . 0.0 109.078 161.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.407 ' CG2' ' HE2' ' A' ' 47' ' ' LYS . 82.6 t -62.67 -15.86 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.013 0.925 . . . . 0.0 112.378 177.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.4 p -89.7 -9.68 48.57 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 126.484 1.914 . . . . 0.0 116.046 175.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 8.0 t -94.2 142.03 24.38 Favored Pre-proline 0 CA--C 1.542 0.642 0 CA-C-N 119.424 1.011 . . . . 0.0 111.565 -170.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -79.67 -32.58 1.53 Allowed 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 121.812 1.675 . . . . 0.0 112.226 173.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -62.85 -35.28 79.45 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.122 1.369 . . . . 0.0 113.543 177.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -49.04 -54.24 16.73 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.518 1.127 . . . . 0.0 109.451 165.285 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.2 t -64.88 -39.47 85.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 124.117 0.967 . . . . 0.0 112.766 -179.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 78.4 mmt-85 -53.35 -41.78 66.15 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-N 119.118 0.872 . . . . 0.0 111.811 173.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -74.86 -53.7 8.61 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.123 0.969 . . . . 0.0 112.592 174.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -52.41 -32.99 41.69 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.608 1.163 . . . . 0.0 112.992 -179.398 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt -72.36 -47.37 50.05 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.838 0.855 . . . . 0.0 112.581 177.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 5.8 tt -72.81 -36.75 67.62 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 124.582 1.153 . . . . 0.0 111.465 -176.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 70.3 mt -63.47 -47.65 80.91 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.401 0.68 . . . . 0.0 111.283 173.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -64.76 -14.82 60.31 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 113.469 0.914 . . . . 0.0 113.469 172.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.21 -17.74 58.26 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 120.158 1.344 . . . . 0.0 113.828 175.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 87.2 mmt-85 -131.97 -13.09 3.23 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 115.817 1.784 . . . . 0.0 115.817 -177.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 29.0 m -138.62 136.99 36.51 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.315 1.046 . . . . 0.0 112.601 -172.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.24 -30.48 12.59 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 126.868 2.067 . . . . 0.0 111.207 166.321 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -79.26 48.09 0.85 Allowed 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 125.507 1.523 . . . . 0.0 113.409 177.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.28 118.89 60.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 125.758 1.623 . . . . 0.0 110.688 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 54.9 m -101.48 135.47 42.92 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 126.205 1.802 . . . . 0.0 109.672 172.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.6 p -128.1 141.6 46.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-O 122.277 1.037 . . . . 0.0 112.961 169.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -113.6 133.27 55.38 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 129.12 2.968 . . . . 0.0 109.523 -177.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -111.06 90.59 3.38 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 122.04 0.924 . . . . 0.0 111.52 -176.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 16.7 m -67.8 -8.94 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 O-C-N 121.341 -0.849 . . . . 0.0 113.17 -178.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.45 -18.35 61.14 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 119.042 0.837 . . . . 0.0 112.657 170.155 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.407 ' HE2' ' CG2' ' A' ' 21' ' ' VAL . 57.3 mmtt -102.44 -32.24 10.07 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 127.156 2.182 . . . . 0.0 113.009 179.1 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 58.9 mtt -65.03 126.64 28.67 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.193 0.997 . . . . 0.0 110.783 177.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 18.2 m -74.87 20.31 0.13 Allowed 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 114.614 1.338 . . . . 0.0 114.614 -172.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -150.24 10.26 0.68 Allowed 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 127.395 2.278 . . . . 0.0 111.528 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -53.96 -25.87 32.32 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 125.81 1.672 . . . . 0.0 116.954 -172.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -66.22 -28.04 68.44 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 120.079 1.939 . . . . 0.0 111.698 173.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 66.7 mt-30 -82.27 -28.75 31.6 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 121.03 -1.044 . . . . 0.0 112.005 177.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.458 HD12 HG23 ' A' ' 6' ' ' ILE . 2.7 mm? -78.16 -32.21 50.12 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.624 0.77 . . . . 0.0 111.559 172.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 67.0 mtp180 -55.25 -40.34 70.82 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 119.524 1.056 . . . . 0.0 111.257 162.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -58.78 -36.25 85.85 Favored Glycine 0 CA--C 1.536 1.37 0 CA-C-O 119.255 -0.747 . . . . 0.0 114.044 171.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -65.42 -35.55 81.26 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 119.41 1.605 . . . . 0.0 112.446 176.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 53.3 mt -73.05 -48.87 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 124.306 1.042 . . . . 0.0 109.724 176.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.4 t80 -67.07 -41.28 86.65 Favored 'General case' 0 CA--C 1.534 0.352 0 O-C-N 121.449 -0.782 . . . . 0.0 112.477 -174.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 77.4 mm-40 -69.07 -21.57 64.07 Favored 'General case' 0 CA--C 1.546 0.812 0 O-C-N 121.138 -0.976 . . . . 0.0 112.471 176.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -88.79 -29.78 19.49 Favored 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 177.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -140.4 -1.41 1.51 Allowed 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 116.075 1.88 . . . . 0.0 116.075 -170.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 8.5 mptt 45.75 48.32 11.72 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 125.922 1.689 . . . . 0.0 112.716 -165.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 60.2 t-80 -129.26 133.51 47.54 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 125.333 1.453 . . . . 0.0 110.471 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -142.27 -25.1 0.66 Allowed 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -160.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 60.6 p -77.78 151.97 33.78 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 121.727 -0.608 . . . . 0.0 111.603 168.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 13.6 m -104.55 155.95 36.62 Favored Pre-proline 0 N--CA 1.478 0.949 0 C-N-CA 124.673 1.189 . . . . 0.0 111.67 -176.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -75.04 154.31 99.58 Favored 'Cis proline' 0 CA--C 1.535 0.542 0 CA-C-N 119.071 0.704 . . . . 0.0 113.782 -6.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -99.23 138.08 36.83 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 159.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 60.9 mt -131.03 140.62 48.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 124.199 1.0 . . . . 0.0 109.35 -165.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -138.56 144.96 40.1 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.808 0.843 . . . . 0.0 111.982 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 65.8 mt -130.01 117.05 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.973 1.309 . . . . 0.0 109.186 175.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 46.13 44.64 12.12 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 125.565 1.546 . . . . 0.0 113.503 -176.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 82.46 -7.47 64.66 Favored Glycine 0 CA--C 1.534 1.229 0 N-CA-C 116.293 1.277 . . . . 0.0 116.293 -177.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -91.03 138.34 31.68 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 119.168 1.484 . . . . 0.0 110.578 -178.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 39.6 t80 -82.14 133.89 35.29 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.858 0.837 . . . . 0.0 112.915 -176.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 37.9 mm -113.98 119.73 61.91 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.368 0 C-N-CA 126.656 1.983 . . . . 0.0 107.726 175.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -71.07 27.08 0.54 Allowed Glycine 0 N--CA 1.472 1.086 0 N-CA-C 119.137 2.415 . . . . 0.0 119.137 -167.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 116.21 -175.63 15.93 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 128.076 2.75 . . . . 0.0 114.552 175.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 25.1 t -64.54 -33.38 75.77 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.364 -1.08 . . . . 0.0 112.866 -179.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 37.0 m -70.01 -34.88 73.87 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 121.088 -1.007 . . . . 0.0 111.924 175.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.87 -39.04 90.33 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.452 1.101 . . . . 0.0 111.974 171.009 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 51.9 tp -62.93 -45.84 90.61 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.246 1.019 . . . . 0.0 111.196 175.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -64.77 -33.26 75.55 Favored 'General case' 0 N--CA 1.469 0.52 0 O-C-N 121.582 -0.699 . . . . 0.0 112.324 173.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.83 -29.84 71.0 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 121.008 -1.057 . . . . 0.0 111.954 177.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 83.6 mt -71.75 -30.03 65.15 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.441 1.096 . . . . 0.0 112.985 170.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -67.82 -41.13 83.52 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.698 0.799 . . . . 0.0 110.25 172.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -71.81 -39.75 69.62 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.113 0.965 . . . . 0.0 113.575 175.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -69.69 -18.27 63.54 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 119.547 1.067 . . . . 0.0 112.82 171.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 78.01 35.48 34.71 Favored Glycine 0 CA--C 1.531 1.083 0 CA-C-N 118.801 0.728 . . . . 0.0 113.65 175.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -116.19 -19.51 10.21 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 127.787 2.435 . . . . 0.0 113.351 -174.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 27.2 tp -63.21 -31.82 73.06 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.919 0.888 . . . . 0.0 111.684 -174.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -54.55 -53.6 52.34 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.526 1.131 . . . . 0.0 112.933 175.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -76.89 -23.4 69.45 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-O 119.446 -0.641 . . . . 0.0 113.862 -178.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 75.5 mt -69.91 -37.75 76.06 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 118.869 1.334 . . . . 0.0 112.012 172.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 92.8 mt -86.47 5.89 33.05 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 -178.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 81.7 p . . . . . 0 C--O 1.255 1.387 0 C-N-CA 126.566 1.947 . . . . 0.0 115.973 -174.755 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.998 0 N-CA-C 110.401 -1.08 . . . . 0.0 110.401 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -142.65 -3.45 1.01 Allowed 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 -176.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 21.2 mmt -113.76 77.43 3.5 Favored Pre-proline 0 CA--C 1.548 0.877 0 CA-C-N 119.737 1.153 . . . . 0.0 111.426 -177.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -71.63 156.34 57.73 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 123.85 3.034 . . . . 0.0 113.239 -175.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 39.5 p -157.39 173.22 17.25 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 -174.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.586 HG23 HD12 ' A' ' 54' ' ' LEU . 19.6 pt -49.37 -25.3 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 125.981 1.712 . . . . 0.0 114.07 171.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.29 -28.48 69.22 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 118.935 0.789 . . . . 0.0 112.063 -176.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 96.4 p -72.32 -32.7 66.78 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.197 0.814 . . . . 0.0 113.197 171.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 59.9 mtp -70.61 -30.65 67.38 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.15 0.98 . . . . 0.0 111.914 -176.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -64.88 -24.06 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 124.315 1.046 . . . . 0.0 111.573 -174.077 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -82.04 -9.54 59.52 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.063 1.745 . . . . 0.0 114.716 176.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -91.28 -22.06 33.32 Favored Glycine 0 CA--C 1.54 1.638 0 N-CA-C 117.451 1.741 . . . . 0.0 117.451 -166.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -135.86 170.04 16.61 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 118.941 1.37 . . . . 0.0 110.941 169.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 20.9 ttpt -66.59 -30.71 71.06 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-O 119.146 -0.454 . . . . 0.0 111.945 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 28.4 t -133.4 130.22 56.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 125.563 1.545 . . . . 0.0 109.394 177.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 42.9 t -134.21 127.67 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 124.245 1.018 . . . . 0.0 109.809 -177.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.1 t -128.35 146.92 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.295 1.038 . . . . 0.0 112.053 -170.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -125.97 106.88 9.95 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.797 1.239 . . . . 0.0 109.526 178.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 37.2 m -128.41 176.94 7.33 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 127.044 2.137 . . . . 0.0 112.371 -164.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.421 ' CD2' HG21 ' A' ' 67' ' ' VAL . 43.8 m0 -125.71 129.23 49.12 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 125.609 1.563 . . . . 0.0 108.335 163.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 46.6 t -53.63 -38.9 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 124.842 1.257 . . . . 0.0 114.325 -158.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.7 t -89.79 -6.99 55.4 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 -170.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 94.9 m -92.63 146.25 31.95 Favored Pre-proline 0 CA--C 1.537 0.456 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -160.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -69.59 -34.47 15.07 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 120.662 0.908 . . . . 0.0 114.057 -162.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -71.22 -42.12 69.31 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 124.073 0.949 . . . . 0.0 112.675 176.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -51.96 -54.65 27.23 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 169.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 53.3 t -60.23 -51.78 69.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 124.149 0.98 . . . . 0.0 111.63 -175.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . 0.272 7.7 ptp180 -61.67 -35.99 79.58 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 119.05 0.841 . . . . 0.0 112.164 -178.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.73 -55.91 8.63 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 118.226 -0.892 . . . . 0.0 112.716 173.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -48.02 -41.98 26.96 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 120.283 1.401 . . . . 0.0 112.584 176.149 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.28 -45.37 66.5 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 124.558 1.143 . . . . 0.0 111.577 -175.036 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.2 tt -70.4 -37.7 74.53 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.414 1.086 . . . . 0.0 112.021 176.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 80.7 mt -63.64 -41.71 98.21 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 120.923 -1.11 . . . . 0.0 111.461 176.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 3.4 m-70 -64.41 -24.07 67.5 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 169.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -81.2 -16.07 53.85 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 119.974 1.261 . . . . 0.0 113.37 171.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 3.0 mmt180 -107.41 -36.69 6.43 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 115.972 1.842 . . . . 0.0 115.972 -173.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 13.9 t -155.04 150.56 27.41 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-N 120.312 1.415 . . . . 0.0 114.611 -176.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.0 mptp? -84.03 -19.29 34.7 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.826 1.25 . . . . 0.0 113.02 170.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -85.97 37.1 0.7 Allowed 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -176.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -106.12 136.05 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 124.617 1.167 . . . . 0.0 111.984 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.3 m -128.6 142.25 51.1 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 126.489 1.915 . . . . 0.0 109.819 169.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.4 p -135.4 143.62 36.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 125.041 1.336 . . . . 0.0 113.315 177.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -118.99 135.98 54.34 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 127.187 2.195 . . . . 0.0 110.55 176.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 58.0 m-85 -103.52 88.17 3.02 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.873 0.869 . . . . 0.0 111.604 -172.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 31.6 m -80.31 40.34 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 -168.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -141.92 -30.82 0.57 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 128.56 2.744 . . . . 0.0 109.879 171.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 26.4 mmmt -65.48 -31.29 72.29 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 125.088 1.355 . . . . 0.0 111.554 158.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -94.02 117.63 30.38 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.724 1.21 . . . . 0.0 109.387 178.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 73.8 m -70.89 -19.09 62.65 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 -163.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -92.39 5.96 48.75 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.453 1.501 . . . . 0.0 113.095 173.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -52.1 -25.23 17.16 Favored Glycine 0 CA--C 1.539 1.545 0 C-N-CA 125.524 1.535 . . . . 0.0 116.8 -173.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -64.24 -28.75 69.95 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 120.378 2.089 . . . . 0.0 112.802 172.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -80.11 -31.16 39.18 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.88 1.272 . . . . 0.0 112.441 176.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.586 HD12 HG23 ' A' ' 6' ' ' ILE . 2.8 mm? -78.15 -36.2 47.99 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.615 0.766 . . . . 0.0 110.768 174.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 57.3 mtp180 -54.93 -36.22 65.03 Favored 'General case' 0 N--CA 1.477 0.9 0 O-C-N 121.43 -0.794 . . . . 0.0 111.165 159.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.04 -44.08 97.61 Favored Glycine 0 CA--C 1.535 1.34 0 C-N-CA 124.498 1.047 . . . . 0.0 113.995 170.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -61.61 -32.3 72.42 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 119.745 1.772 . . . . 0.0 112.296 176.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 57.6 mt -74.48 -43.5 48.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.095 0.958 . . . . 0.0 110.08 174.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -64.83 -44.35 90.12 Favored 'General case' 0 CA--C 1.531 0.228 0 O-C-N 121.286 -0.884 . . . . 0.0 112.253 -179.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -57.05 -41.34 78.5 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.431 0.692 . . . . 0.0 111.674 -179.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -91.34 -28.26 17.84 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 -176.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -133.42 2.78 3.56 Favored 'General case' 0 N--CA 1.48 1.075 0 N-CA-C 114.973 1.471 . . . . 0.0 114.973 -171.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 44.2 mmtm 54.12 33.65 18.3 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 127.039 2.136 . . . . 0.0 114.172 178.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 65.6 t-80 -130.92 141.82 50.32 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 126.088 1.755 . . . . 0.0 110.759 -175.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -142.0 -20.22 0.72 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.742 1.217 . . . . 0.0 113.593 -164.124 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.8 p -68.54 153.31 44.01 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.716 1.607 . . . . 0.0 111.876 167.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.421 HG21 ' CD2' ' A' ' 20' ' ' TRP . 25.6 m -115.92 151.25 46.24 Favored Pre-proline 0 N--CA 1.476 0.856 0 C-N-CA 124.421 1.088 . . . . 0.0 112.736 177.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -74.58 147.33 89.12 Favored 'Cis proline' 0 N--CA 1.457 -0.62 0 CA-C-N 119.079 0.707 . . . . 0.0 113.884 0.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -99.02 138.35 36.25 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.414 158.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 44.4 mt -130.45 141.07 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 123.714 0.805 . . . . 0.0 109.089 -164.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -140.16 146.07 38.31 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.007 0.923 . . . . 0.0 111.555 -179.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 65.2 mt -128.85 127.19 66.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 125.384 1.474 . . . . 0.0 107.916 174.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 35.8 m120 50.54 28.17 3.28 Favored 'General case' 0 CA--C 1.56 1.355 0 N-CA-C 115.651 1.723 . . . . 0.0 115.651 -178.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 82.4 0.97 90.34 Favored Glycine 0 CA--C 1.544 1.891 0 O-C-N 120.397 -1.44 . . . . 0.0 115.047 -173.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -91.72 151.65 20.55 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 126.964 2.106 . . . . 0.0 110.387 172.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -93.97 142.37 27.46 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 113.559 0.948 . . . . 0.0 113.559 -174.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 31.7 mm -121.22 130.07 75.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 128.56 2.744 . . . . 0.0 107.512 176.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -71.38 23.37 0.62 Allowed Glycine 0 N--CA 1.472 1.034 0 C-N-CA 126.744 2.116 . . . . 0.0 118.101 -165.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 107.79 -171.9 16.79 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 127.941 2.686 . . . . 0.0 113.498 178.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 42.7 t -54.12 -41.94 68.89 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.821 1.248 . . . . 0.0 112.362 -178.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 10.4 m -82.58 -10.28 59.04 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -178.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -76.6 -42.68 41.57 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 120.002 1.273 . . . . 0.0 109.838 162.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 48.7 tp -64.13 -50.03 69.84 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.115 1.366 . . . . 0.0 112.395 177.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -70.01 -12.95 61.98 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 113.24 0.829 . . . . 0.0 113.24 178.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -85.89 -39.41 17.03 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 121.206 -0.934 . . . . 0.0 112.121 164.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 33.6 mt -64.42 -33.66 76.38 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 120.375 1.443 . . . . 0.0 113.29 175.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -62.98 -47.39 83.35 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.975 1.31 . . . . 0.0 111.352 171.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 6.8 mptt -73.44 -34.91 65.65 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.598 1.559 . . . . 0.0 112.319 -177.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -70.41 -11.58 61.01 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.231 1.813 . . . . 0.0 113.142 169.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 70.17 10.65 65.97 Favored Glycine 0 CA--C 1.534 1.258 0 CA-C-N 119.053 0.842 . . . . 0.0 114.301 -177.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 17.4 mtpt -81.5 -26.6 35.04 Favored 'General case' 0 N--CA 1.463 0.183 0 C-N-CA 125.949 1.7 . . . . 0.0 112.103 -178.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 34.7 tp -59.51 -40.23 86.41 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.645 1.178 . . . . 0.0 112.126 170.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -60.66 -42.04 96.22 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.812 -0.555 . . . . 0.0 111.932 174.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -70.33 -14.08 71.28 Favored Glycine 0 CA--C 1.535 1.301 0 CA-C-O 119.16 -0.8 . . . . 0.0 114.959 176.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 88.7 mt -97.64 -21.99 16.73 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 126.065 1.746 . . . . 0.0 113.341 175.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 93.2 mt -103.8 -5.67 22.2 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 125.236 1.415 . . . . 0.0 114.447 -179.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 61.2 p . . . . . 0 C--O 1.25 1.1 0 C-N-CA 126.07 1.748 . . . . 0.0 114.159 173.465 . . . . . . . . 0 0 . 1 stop_ save_